<SEC-DOCUMENT>0001683168-20-000836.txt : 20200316
<SEC-HEADER>0001683168-20-000836.hdr.sgml : 20200316
<ACCEPTANCE-DATETIME>20200316164454
ACCESSION NUMBER:		0001683168-20-000836
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		100
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200316
DATE AS OF CHANGE:		20200316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACACIA RESEARCH CORP
		CENTRAL INDEX KEY:			0000934549
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				954405754
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37721
		FILM NUMBER:		20717788

	BUSINESS ADDRESS:	
		STREET 1:		4 PARK PLAZA
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9494808300

	MAIL ADDRESS:	
		STREET 1:		4 PARK PLAZA
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>acacia_10k-123119.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><A HREF="#toc"><FONT STYLE="font-size: 7pt">Table of Contents</FONT></A></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 10-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;&nbsp;&nbsp;<B>ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE FISCAL YEAR ENDED DECEMBER 31,
2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 9pt"><B>OR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;<B>TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE TRANSITION PERIOD FROM&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number 001-37721</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DELAWARE</B></FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>95-4405754</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(State or other jurisdiction of</FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(I.R.S. Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">incorporation organization)</FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Identification No.)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4 PARK PLAZA, SUITE 550</B></FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IRVINE, CA</B></FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>92614</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <B>(949) 480-8300</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section
12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Title of Each Class</U></B></FONT></TD>
    <TD STYLE="text-align: center; width: 33%"><B><U>Trading Symbol(s)</U></B></TD>
    <TD STYLE="text-align: center; font-size: 10pt; width: 33%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Name of Each Exchange on Which Registered</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Common Stock, $0.001 par value</B></FONT></TD>
    <TD STYLE="text-align: center"><B>ACTG</B></TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The NASDAQ Stock Market, LLC</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section
12(g) of the Act: None</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark if the registrant
is a well-known seasoned issuer, as defined in Rule 405 of the Securities <FONT STYLE="font-family: Times New Roman, Times, Serif">Act.&nbsp;&nbsp;
Yes&nbsp;</FONT>&#9744; <FONT STYLE="font-family: Times New Roman, Times, Serif">No&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes&nbsp;</FONT>&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
No&nbsp;&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;Yes </FONT>&#9746;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;No
</FONT>&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T(&sect;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit such files).&nbsp;&nbsp;&nbsp;Yes&nbsp;&#9746; No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth
company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting
company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 59%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Large accelerated filer &#9744;&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>Accelerated filer&nbsp;&#9746;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-accelerated
        filer&nbsp; &#9744;&nbsp;</FONT></P></TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Smaller&nbsp;reporting&nbsp;company&nbsp;
    &#9746;</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging growth company&nbsp; &#9744;</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&#9744;</FONT>&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</FONT>&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;No&nbsp;&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The aggregate market value of the registrant&rsquo;s
voting and non-voting common stock held by non-affiliates of the registrant on June 30, 2019, the last business day of the registrant&rsquo;s
most recently completed second fiscal quarter, computed by reference to the last sale price of the registrant&rsquo;s common stock
as reported by The Nasdaq Global Select Market on such date, was approximately $147,673,000. This computation assumes that all
executive officers and directors are affiliates of the registrant. Such assumption should not be deemed conclusive for any other
purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March&nbsp;11, 2020, 50,385,341 shares
of common stock were issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DOCUMENTS INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with General Instruction G(3)
to Form 10-K, portions of the registrant&rsquo;s Definitive Proxy Statement on Schedule 14A for its Annual Meeting of Stockholders
to be filed with the Commission within 120 days after the close of the fiscal year covered by this Annual Report on Form 10-K are
incorporated by reference into Part III of this Annual Report on Form 10-K. Only those portions of the proxy statement that are
specifically incorporated by reference herein shall constitute a part of this Annual Report on Form 10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANNUAL REPORT ON FORM 10-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FISCAL YEAR ENDED DECEMBER 31, 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="toc"></A><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 88%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Page</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><A HREF="#a1"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PART I</B></FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 1.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a3"><FONT STYLE="font-family: Times New Roman, Times, Serif">Business</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">1</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 1A.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a4"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk Factors</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 1B.</FONT></TD>
    <TD><A HREF="#a5"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unresolved Staff Comments</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 2.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a6">Properties</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 3.</FONT></TD>
    <TD><A HREF="#a7"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal Proceedings</FONT></A></TD>
    <TD STYLE="text-align: right">17</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 4.</FONT></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#a8"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mine Safety Disclosures</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><A HREF="#a9"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PART II</B></FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 5.</FONT></TD>
    <TD STYLE="vertical-align: bottom"><A HREF="#a10"><FONT STYLE="font-family: Times New Roman, Times, Serif">Market for Registrant&rsquo;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 6.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a11"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selected Financial Data</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 7.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a12"><FONT STYLE="font-family: Times New Roman, Times, Serif">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 7A.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a15"><FONT STYLE="font-family: Times New Roman, Times, Serif">Quantitative and Qualitative Disclosures About Market Risk</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 8.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a16"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financial Statements and Supplementary Data</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 9.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a17"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 9A.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a18"><FONT STYLE="font-family: Times New Roman, Times, Serif">Controls and Procedures</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 9B.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a19"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other Information</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><A HREF="#a20"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PART III</B></FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 10.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a21"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directors, Executive Officers and Corporate Governance</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 11.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a22"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive Compensation</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 12.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a23"><FONT STYLE="font-family: Times New Roman, Times, Serif">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 13.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a24"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain Relationships and Related Transactions, and Director Independence</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 14.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a25"><FONT STYLE="font-family: Times New Roman, Times, Serif">Principal Accounting Fees and Services</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><A HREF="#a26"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PART IV</B></FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item 15.</FONT></TD>
    <TD STYLE="vertical-align: top"><A HREF="#a27"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibits, Financial Statement Schedules</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a1"></A><B>PART I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a2"></A><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As used in this Annual Report on Form
10-K, or the annual report, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Acacia Research Corporation
and/or its wholly and majority-owned operating subsidiaries. All patent portfolio investments, development, licensing and
enforcement activities are conducted solely by certain of our wholly owned operating subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This annual report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended,
or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which include,
without limitation, statements about our future business operations and results, our strategies and competition, and other forward-looking
statements included in this annual report. Such statements may be identified by the use of forward-looking terminology such as
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;intend,&rdquo; &ldquo;continue,&rdquo; or similar terms, variations of such terms or the negative of such terms. Such statements
are based on management&rsquo;s current expectations and are subject to a number of risks and uncertainties, which could cause
actual results to differ materially from those described in the forward-looking statements. Such statements address future events
and conditions concerning earnings, capital expenditures, litigation, competition, regulatory matters, stock price volatility,
liquidity and capital resources, accounting matters and investments. Actual results in each case could differ materially from those
anticipated in such statements by reason of factors such as future economic conditions, legislative, regulatory and competitive
developments in markets in which we and our subsidiaries operate, and other circumstances affecting anticipated revenues and costs,
as more fully disclosed in our discussion of &ldquo;Risk Factors&rdquo; in Item 1A of Part I of this annual report. We expressly
disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained
herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which
any such statement is based. Additional factors that could cause such results to differ materially from those described in the
forward-looking statements are set forth in connection with the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a3"></A><B>ITEM 1.&nbsp;&nbsp;BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We invest in intellectual property, or IP,
and related absolute return assets and engage in the licensing and enforcement of patented technologies. We partner with inventors
and patent owners, from small entities to large corporations, applying our legal and technology expertise to patent assets to unlock
the financial value in their patented inventions. We are an intermediary in the patent marketplace, bridging the gap between invention
and application, and facilitating efficiency in connection with the monetization of patent assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We generate revenues and related cash flows
from the granting of IP rights for the use of patented technologies that our operating subsidiaries control or own. We assist patent
owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized
use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against
unauthorized users of their patented technologies through the filing of patent infringement litigation. Currently, on a consolidated
basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain
foreign counterparts, covering technologies used in a variety of industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have established a proven track record
of licensing and enforcement success with over 1,570 license agreements executed to date, across nearly 200 patent portfolio licensing
and enforcement programs. To date, we have generated gross licensing revenue of approximately $1.6 billion, and have returned more
than $776 million to our patent partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We were originally
incorporated in California in January 1993 and reincorporated in Delaware in December 1999. Our website address is <U>www.acaciaresearch.com</U>.
Reference in this annual report to this website address does not constitute incorporation by reference of the information
contained on or accessed through our website and references to our website address in this annual report are inactive textual
references only. We make our filings with the Securities and Exchange Commission, or the SEC, including our annual reports on
Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, other reports filed or furnished pursuant to Section
13(a) or 15(d) of the Exchange Act, and amendments to the foregoing reports, available free of charge on or through our
website as soon as reasonably practicable after we file these reports with, or furnish such reports to, the SEC. In addition,
we post the following information on our website:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our code of conduct for chief executive officer and other senior financial officers;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our code of conduct for employees and directors and our fraud policy;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our insider trading policy;&nbsp;and</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">charters for our audit committee, nominating and corporate governance committee and compensation committee.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Also, the SEC maintains an Internet website
that contains reports, proxy and information statements, and other information regarding issuers, including us, that file electronically
with the SEC. The public can obtain any documents that we file with the SEC at <U>http://www.sec.gov</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Patent Licensing and Enforcement Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Patents are an important asset class worldwide.
Licensing and enforcing patents requires an experienced, well-capitalized, licensing partner. We have partnered with patent owners,
including individual inventors, universities, small companies and large multi-national corporations in a variety of technology
sectors. These patent owners may possess limited internal resources and/or expertise to effectively address the unauthorized use
of their patented technologies, or may seek to effectively and efficiently monetize their portfolio of patented technologies on
an outsourced basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under U.S. law, a patent owner has the right
to exclude others from making, selling or using&nbsp;their patented invention. A third-party infringes a patent by making, offering
for sale, selling, or using a patented invention without a license from the patent owner. In the majority of cases, infringers
are generally unwilling, at least initially, to negotiate or pay reasonable license fees for their unauthorized use of third-party
patents and will typically indiscriminately challenge any allegations of patent infringement. Inventors and patent holders&nbsp;without
sufficient legal, financial and expert technical resources to bring and continue the pursuit of costly and complex patent infringement
actions are often effectively ignored.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a result of the common reluctance of
patent infringers to negotiate and ultimately enter into a patent license for the use of patented technologies without at least
the threat of legal action, patent licensing and enforcement often begins with the filing of patent infringement litigation. However,
in our experience, most patent infringement litigation settles out of court at amounts that are related to the strength of the
patent portfolio and the value of the invention or inventions in the infringer&rsquo;s products or services. We execute agreements
that grant rights in our patents to users of our patented technologies. Our agreements can be negotiated without the filing of
patent litigation, or negotiated within the context of ongoing patent litigation, depending on the specific facts and circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are a principal in the licensing and
enforcement effort, with our operating subsidiaries obtaining control of the rights in the patent portfolio, or control of the
patent portfolio outright. Our relationship with patent owners drives our corporate strategy. We assume all responsibility for
advancing operational expenses while pursuing a patent licensing and enforcement program, and then, when applicable, share net
licensing revenue with our patent partners as that program matures, on a pre-arranged and negotiated basis. We may also provide
upfront capital to patent owners as an advance against future licensing revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Patent Licensing Business Model and Strategy - Overview</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have the flexibility to structure arrangements
in a number of ways to address the needs and specific sets of circumstances presented by each of our unique patent partners, ranging
from outright purchases to various forms of partnering arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Generally, we maintain a 100% to 200% preferred
rate of return until all deployed capital and advanced operational costs are recovered by us. After recovery of these costs, the
net profit revenue share with patent partner commences, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Key Elements of Business Strategy</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Patent licensing and enforcement can be
an effective and efficient way to maximize the profit potential of a patent, or patents, that are being practiced by third-parties
without authorization. A patent license agreement grants a third-party user of an invention specific patent rights to the patented
invention in exchange for patent license fees. Our patent licensing business provides patent holders with an opportunity to generate
income from their patented inventions being practiced by third-parties without authorization and from third-parties that desire
to practice their patented inventions with authorization. Our patent licensing and enforcement business strategy includes three
fundamental elements, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&bull;</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Patent Discovery</I> - Discover potentially valuable patents or patent portfolios.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&bull;</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Assessment of Economic Value -</I> Work internally and with external experts to evaluate the use of the patented invention(s) in the relevant marketplace and assess a patent or patent portfolio's expected economic value.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&bull;</I></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Licensing and Enforcement</I> <B>- </B>License those users wanting to utilize the patented invention with authorization. For unauthorized users of the patented invention, enter into license negotiations and, if necessary, litigation to monetize the patent based on its assessed value. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Patent Discovery. </I>The patent process
breeds, encourages and sustains innovation and invention by granting a limited monopoly to the inventor in exchange for sharing
the invention with the public. Certain technologies become core technologies in the way products and services are manufactured,
sold or delivered by companies across a wide array of industries. Patent discovery involves identifying core, patented technologies
that have been or are anticipated to be widely adopted by third-parties in connection with the manufacture, sale or use of products
and services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Assessment of Economic Value. </I>Subsequent
to the patent discovery process, our executives work internally and/or with external industry experts in the specific technology
field, to evaluate the patented invention and its adoption and implementation in the marketplace. There are a number of factors
to consider when analyzing a patent and determining a patent&rsquo;s value including, (i) infringement, (ii) validity, (iii) enforceability
and (iv) extent of usage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To determine infringement, we must first
identify third-parties that are practicing the invention(s) covered by the patent without obtaining permission from the patent
owner to do so. A key tool in determining whether or not a company is infringing a patent is a claim chart, which demonstrates
how the manufacture, sale, or use of an existing product compares against the claims of the patent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The three main factors analyzed to determine
validity are: (1) anticipation, which occurs when the claims of the patent are entirely revealed within a single piece of prior
art, (2) obviousness which considers whether the differences between prior art and the patented invention are so slight that they
would have been obvious at the time of invention to one who is skilled in the subject matter being patented, and (3) the existence
of non-patentable subject matter, which considers whether the subject matter includes naturally occurring things, abstract concepts,
or algorithms that perform an ordinary function.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To determine enforceability, a number of
factors are analyzed, including whether or not there has been patent misuse, or whether or not there are antitrust violations associated
with the patent. Due to the inherently complex nature of patent law, only a court or specific administrative body, such as the
International Trade Commission, can make a decision whether a patent is infringed, valid and enforceable; however, we employ our
wealth of expertise to make the best assessment possible given a specific fact pattern and set of circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We estimate a patent&rsquo;s economic value
by evaluating the expected value of the license revenue stream based on past, present and future revenue of infringing products
or services, and the risk that a court will disagree with our infringement, validity or enforcement assessments of the patent.
The processes and procedures employed in connection with the evaluation of a specific patent portfolio for future investment, licensing
and enforcement are tailored and unique to each specific situation and can vary widely based on the specific facts and circumstances
of a specific patent portfolio, such as the related technology, related industry and other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business development efforts are geared
toward maintaining those relationships and identifying and growing new relationships in order to generate new technology-based
patent opportunities for sustainable revenue and /or revenue growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Legislative and legal changes have increased
the complexity of patent enforcement actions. We believe that this provides Acacia a competitive advantage, as many patent monetization
entities have either given up or failed. Furthermore, the challenging legislative environment has kept patent asset acquisition
prices low.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In fiscal year 2018 and 2019, Acacia experienced
a number of changes in the Company's outlook and leadership. With new management in place during the years, the focus was on capturing
the value of remaining portfolio assets while starting to rebuild the new business pipeline. In addition, we began to pursue other
business opportunities which complement our legacy licensing and enforcement business and leverage our IP expertise, as described
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Licensing and Enforcement</I>. The final
step in the patent licensing and enforcement process is to seek to monetize the patent portfolio by securing license agreements
based on the patents use in the marketplace and estimated value. While we prefer to convince unauthorized users of our patented
inventions of the value of the patented invention and secure a license agreement in a non-litigious manner, many infringers refuse
to take such licenses even when confronted with substantial and persuasive evidence of infringement, validity, enforceability and
significant economic value. As a result, often we must resort to litigation to demonstrate and prove infringement and ultimately
induce infringers to take a license from us. We often negotiate licenses concurrently with litigation due to the fact that litigation
necessitates and facilitates an information exchange that helps both sides assess the value of a patent and make informed decisions.
Also, litigation eventually leads to a court&rsquo;s judgment. When a court agrees with our assessment of a patent, this judgment
stops recalcitrant infringers from utilizing the patented technology indefinitely, without appropriate authorization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We engage highly competent and experienced
patent lawyers to prosecute our patent portfolio litigation. It is imperative for us to be persistent and patient throughout the
litigation process as it typically takes 18-36 months from the filing date of a lawsuit to yield a license agreement from a potential
licensee. Often, it takes longer to secure a final court judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Patent license negotiations and litigation
initiated by our operating subsidiaries usually lead to serious and thoughtful discussions with the unauthorized users of the patented
inventions. The result can be quite favorable with the user being granted rights under the patents for the patented invention
in its products and services in exchange for financial remuneration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Developments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT>In 2019, as part of its strategy to grow the Company
began evaluating a wide range of strategic opportunities that culminated in the strategic investment in the Company by
certain funds and accounts affiliated with, or managed by, Starboard Value LP, or Starboard. On November 18, 2019, the
Company entered into a Securities Purchase Agreement with Starboard, or the Securities Purchase Agreement, pursuant to which
Starboard purchased (i) 350,000 shares of the Company&rsquo;s newly designated Series A Convertible Preferred Stock, or
Series A Preferred Stock, at an aggregate purchase price of $35,000,000, and warrants to purchase up to 5,000,000 shares of
the Company&rsquo;s common stock, or Series A Warrants. The Securities Purchase Agreements also established the terms of
certain senior secured notes and additional warrants, or the Series B Warrants, which may be issued to Starboard in the
future. Refer to Notes 16, 17 and 19 </FONT>to our notes to consolidated financial statements <FONT>for more information
related to the Series A Preferred Stock, Series A Warrants and Series B Warrants. In connection with Starboard&rsquo;s
investment, Starboard was granted certain corporate governance rights, including the right to appoint Jonathan Sagal,
Managing Director of Starboard, as a director of the Company and recommend two additional directors for appointment to our
board of directors. The investment by Starboard is referred to herein as the &ldquo;Starboard Investment,&rdquo; and the
Series A Preferred Stock, Series A Warrants and Series B Warrants are referred to herein as, collectively, the
&ldquo;Starboard Securities.&rdquo;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In August 2016, we entered into an investment
agreement with Veritone, Inc., or Veritone, in connection with which we provided a total of $53.3 million in funding to Veritone.
As of December 31, 2019, the Company's investment in Veritone, which includes shares of common stock and warrants to purchase common
stock, totaled $1.5 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2017 and February 2018, we made
equity investments totaling $8.25 million in Miso Robotics, Inc., or Miso Robotics. As of June 30, 2019, we recorded an impairment
of $8.2 million for our investment in Miso Robotics. In September 2019, we received a cash payment of $2.0 million upon the sale
of our entire investment, and therefore relinquished our ownership interest in Miso Robotics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Patented Technologies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Currently, on a consolidated basis, our
operating subsidiaries own or control the rights to patent portfolios covering technologies used in a number of industries, including:
transportation and automotive, telecommunications, semiconductor, consumer electronics, energy efficiency, wireless, video/imaging
and medical devices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to Item 7. &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations - Overview&rdquo; for a summary of patent portfolios generating
revenues for the applicable periods presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Competition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We encounter competition in the area of
patent portfolio investment opportunities and enforcement. Existing non-practicing entities compete in acquiring rights to IP assets,
and more entities may enter or leave the market in future periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We also compete with financial firms, corporate
buyers and others acquiring IP and investing in other technology opportunities. Many of these competitors may have more financial
and human resources than us. We may find more companies entering the market for similar technology opportunities, which may reduce
our market share in one or more technology industries that we currently or in the future may rely upon to generate future revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Companies or other entities may develop
competing technologies that offer better or less expensive alternatives to our patented technologies or technology partnerships.
Many potential competitors may have significantly greater resources than the resources that we or our operating subsidiaries possess.
Such technological advances or entirely different approaches developed by one or more of our competitors could render certain
of the technologies owned or controlled by us obsolete and/or uneconomical.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of December&nbsp;31, 2019, on a consolidated
basis, we had 17 full-time employees. Neither we, nor any of our subsidiaries, are a party to any collective bargaining agreement.
We believe we have good relations with our employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a4"></A><B>ITEM 1A.&nbsp;&nbsp;RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>An investment in our common stock involves
risks. You should carefully consider the risks described below, together with all of the other information included in this annual
report, as well as in our other filings with the SEC, in evaluating our business. The risks described below are not the only risks
we face. Additional risks that we do not yet know of or that we currently believe are immaterial may also impair our business operations.
If any of the following risks actually occur, our business, financial condition and results of operations could be materially adversely
affected, and the trading price of our common stock could decline significantly. Certain statements below may be considered forward-looking
statements. For additional information, see &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We have a history of losses and may incur additional losses
in the future</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We
reported a net loss of $17.1 million (includes $9.9 million of unrealized equity investment gains), and a net loss of $105.0 million
(including $59.1 million of unrealized equity investment losses) for the years ended December 31, 2019 and 2018, respectively,
and on a cumulative basis, we have sustained substantial losses since our inception. As of December&nbsp;31, 2019, our accumulated
deficit was $439.7 million. As of December&nbsp;31, 2019, we had approximately $168.3 million in cash and cash equivalents and
trading securities and working capital of $160.1 million. Although we believe that our current cash and cash equivalents and investments
will be sufficient to finance our anticipated capital and operating requirements for at least the next twelve months, we expect
to continue incurring significant legal, general and administrative expenses in connection with our operations. As a result, we
anticipate that we may incur losses in the future. Additional increases in our expenses without commensurate increases in revenues
could significantly increase our operating losses. Any additional operating losses may have a material adverse effect on our stockholders&rsquo;
equity and overall financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Recent U.S. tax legislation may adversely affect
our financial condition, results of operations and cash flows, including the ability to use net operating losses and certain other
tax attributes.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our ability to use our federal and state
net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is dependent
upon our generation of future taxable income before the expiration dates of the net operating losses, and we cannot predict with
certainty when, or whether, we will generate sufficient taxable income to use all or any portion of our net operating losses.
In addition, utilization of net operating losses to offset potential future taxable income and related income taxes that would
otherwise be due is subject to annual limitations under the &ldquo;ownership change&rdquo; provisions of Sections 382 and 383
of the Internal Revenue Code of 1986, as amended, or the Code, and similar state provisions, which may result in the expiration
of net operating losses before future utilization. In general, under the Code, if a corporation undergoes an &ldquo;ownership
change,&rdquo; generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the
corporation&rsquo;s ability to use its pre-change net operating losses and other pre-change tax attributes (such as research and
development credit carryforwards) to offset its post-change taxable income or taxes may be limited. Changes in our stock ownership,
some of which may be outside of our control, could in the future result in an ownership change. Although we have adopted a Tax
Benefits Preservation Plan and a provision in our certificate of incorporation, each of which are designed to
discourage investors from acquiring ownership of our common stock in a manner that could trigger an ownership change, and
we have completed studies to provide reasonable assurance that an ownership change limitation would not apply, we cannot be certain
that a taxing authority would reach the same conclusion. If, after a review or audit, an ownership change limitation were to apply,
utilization of our domestic net operating losses and tax credit carryforwards could be limited in future periods and a portion
of the carryforwards could expire before being available to reduce future income tax liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>If we encounter unforeseen difficulties with our business
or operations in the future that require us to obtain additional working capital, and we cannot obtain additional working capital
on favorable terms, or at all, our business may suffer</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our consolidated cash and cash equivalents
and trading securities totaled $168.3 million and $165.5 million at December 31, 2019 and 2018, respectively. To date, we have
relied primarily upon net cash flows from our operations and from the public and private sale of equity securities to generate
the working capital needed to finance our operations. We may encounter unforeseen difficulties with our business or operations
in the future that may deplete our capital resources more rapidly than anticipated. As a result, we may be required to obtain
additional working capital in the future through bank credit facilities, public or private debt or equity financings, or otherwise.
If we are required to raise additional working capital in the future, such financing may be unavailable to us on favorable terms,
if at all, or may be dilutive to our existing stockholders. If we fail to obtain additional working capital, as and when needed,
such failure could have a material adverse impact on our business, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Failure to effectively manage our operational changes
could strain our managerial, operational and financial resources and could adversely affect our business and operating results.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Operational changes primarily relate to
changes in our board of directors and senior management. During 2018, we announced various changes to our board of directors
and senior management, including a reconstituted board of directors and the terminations of our President, our Chief Financial
Officer, Senior Vice President of Finance and Treasurer and our Executive Vice President, General Counsel and Secretary. We also
announced in 2018 the appointment of our new Chief Intellectual Property Officer Marc W. Booth. In 2019 we appointed Clifford
Press as our new Chief Executive Officer, and Alfred V. Tobia, Jr. as our new President and Chief Investment Officer. Changes
in leadership and key management positions have inherent risks, and there are no assurances that any of our recent changes will
not affect our financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we fail to manage our operational changes
effectively or to develop, expand or otherwise modify our managerial, operational and financial resources and systems, our business
and financial results will be materially harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Patent portfolio investments may present risks, and we
may be unable to achieve the financial or other goals intended at the time of any potential investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our licensing and enforcement business has
depended, in part, on our ability to invest in patented technologies, patent portfolios, or companies holding such patented technologies
and patent portfolios. Accordingly, historically we have engaged in patent portfolio investments in an effort to expand our patent
portfolio assets. Such investments and potential investments are subject to numerous risks, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our inability to enter into a definitive agreement with respect to any potential patent portfolio investment, or if we are able to enter into such agreement, our inability to consummate the potential investment transaction; </FONT></TD></TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">difficulty integrating the operations, technology and personnel of the acquired entity;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our inability to achieve the anticipated financial and other benefits of the specific patent portfolio investment;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our inability to retain key personnel from the acquired company, if necessary;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">difficulty in maintaining controls, procedures and policies during the transition and integration process;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">diversion of our management&rsquo;s attention from other business concerns; and</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">failure of our due diligence process to identify significant issues, including issues with respect to patented technologies and patent portfolios, and other legal and financial contingencies.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we are unable to manage these risks effectively
as part of any patent portfolio investment, our business could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our revenues are unpredictable, and this may harm our
financial condition</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Due to the nature of our licensing business
and uncertainties regarding the amount and timing of the receipt of license and other fees from potential infringers, stemming
primarily from uncertainties regarding the outcome of enforcement actions, rates of adoption of our patented technologies, the
growth rates of our existing licensees and certain other factors, our revenues may vary significantly from quarter to quarter and
period to period, which could make our business difficult to manage, adversely affect our business and operating results, cause
our quarterly and periodic results to fall below market expectations and adversely affect the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our operating subsidiaries depend upon relationships with
others to provide technology-based opportunities that can develop into profitable royalty-bearing licenses, and if they are unable
to maintain and generate new relationships, then they may not be able to sustain existing levels of revenue or increase revenue</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Neither we nor our operating subsidiaries
invent new technologies or products; rather, we depend upon the identification and investment in patents, inventions and companies
that own IP through our relationships with inventors, universities, research institutions, technology companies and others. If
our operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then we may not
be able to identify new technology-based patent opportunities for sustainable revenue and /or revenue growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our current or future relationships may
not provide the volume or quality of technologies necessary to sustain our licensing, enforcement and overall business. If we are
unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such
inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain our
licensing and enforcement business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The success of our operating subsidiaries depends in part
upon their ability to retain the best legal counsel to represent them in patent enforcement litigation in order to achieve favorable
outcomes from such litigation. The outcome of such litigation is uncertain, and any unfavorable outcomes may harm our financial
condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The success of our licensing business depends
upon our operating subsidiaries&rsquo; ability to retain the best legal counsel to prosecute patent infringement litigation. As
our operations evolve and industry conditions increase in complexity, it will become more difficult to find the best legal counsel
to handle all of our cases. This is due in part to many of the best law firms having conflicts of interest that prevents their
representation of our subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We spend a significant amount of our financial
and management resources to pursue our current litigation matters. We believe that these litigation matters and others that we
may in the future determine to pursue could continue for years and continue to consume significant financial and management resources.
The counterparties to our litigation are sometimes large, well-financed companies with substantially greater resources than us.
We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us. In addition,
in part due to the appeals process and other legal processes, even if we obtain favorable interim rulings or verdicts in particular
litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure you that we will
not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. The inability to retain the
best legal counsel to represent our operating subsidiaries in infringement actions may result in unfavorable or adverse outcomes,
which may result in losses, exhaustion of financial resources or other adverse effects which could encumber our ability to effectively
operate our business or execute our business strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our operating subsidiaries, in certain circumstances,
rely on representations, warranties and opinions made by third-parties that, if determined to be false or inaccurate, may expose
us and our operating subsidiaries to certain material liabilities</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From time to time, our operating subsidiaries
may rely upon representations and warranties made by third-parties from whom our operating subsidiaries acquired patents or the
exclusive rights to license and enforce patents. We also may rely upon the opinions of purported experts. In certain instances,
we may not have the opportunity to independently investigate and verify the facts upon which such representations, warranties,
and opinions are made. By relying on these representations, warranties and opinions, our operating subsidiaries may be exposed
to liabilities in connection with the licensing and enforcement of certain patents and patent rights which could have a material
adverse effect on our operating results and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>In connection with patent enforcement actions conducted
by certain of our subsidiaries, a court may rule that we or our subsidiaries have violated certain statutory, regulatory, federal,
local or governing rules or standards, which may expose us and our operating subsidiaries to certain material liabilities</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with any of our patent enforcement
actions, it is possible that a defendant may request and/or a court may rule that we have violated statutory authority, regulatory
authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement
actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney&rsquo;s
fees and/or expenses to a defendant(s), which could be material, and if we or our operating subsidiaries are required to pay such
monetary sanctions, attorneys&rsquo; fees and/or expenses, such payment could materially harm our operating results and our financial
position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>In connection with patent enforcement actions conducted
by certain of our subsidiaries, a court may find the patents invalid, not infringed or unenforceable and/or the U.S. Patent and
Trademark Office, or the USPTO, or other relevant patent office, may either invalidate the patents or materially narrow the scope
of their claims during the course of a reexamination, opposition or other such proceeding.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Patent litigation is inherently risky and
the outcome is uncertain. Some of the parties that we believe infringe on our patents are large and well-financed companies with
substantially greater resources than ours. We believe that these parties would devote a substantial amount of resources in an attempt
to avoid or limit a finding that they are liable for infringing on our patents or, in the event liability is found, to avoid or
limit the amount of associated damages. In addition, there is a risk that these parties may file inter-partes reviews, reexaminations
or other proceedings with the USPTO or other government agencies in the United States or abroad in an attempt to invalidate, narrow
the scope or render unenforceable the patents we own or control. If this were to occur, it may have a material adverse effect on
our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, it is difficult to predict
the outcome of patent enforcement litigation at any level. In the United States, there is a higher rate of appeals in patent enforcement
litigation than standard business litigation. The defendant to any case we bring, may file as many appeals as allowed by right,
including to the first, second and/or final courts of appeal (in the United States those courts would be the Federal Circuit and
Supreme Court, respectively). Such appeals are expensive and time-consuming, and the outcomes of such appeals are sometimes unpredictable,
resulting in increased costs and reduced or delayed revenue which could have a material adverse effect on our operating results
and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our licensing cycle is lengthy and costly, and our legal
and sales efforts may be unsuccessful. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect our operating subsidiaries to
incur significant general and administrative and legal expenses prior to entering into license agreements and generating license
revenues. We also spend considerable resources educating prospective licensees on the benefits of a license arrangement with us.
As such, we may incur significant losses in any particular period before any associated revenue stream begins.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If our efforts to educate prospective licensees
on the benefits of a license arrangement are unsuccessful, we may need to pursue litigation or other enforcement action to protect
our patent rights. We may also need to litigate to enforce the terms of our existing license agreements, protect our trade secrets,
or determine the validity and scope of the proprietary rights of others. Enforcement proceedings are typically protracted and complex.
The costs are typically substantial, and the outcomes are unpredictable. Enforcement actions will divert our managerial, technical,
legal and financial resources from business operations and there are no assurances that such enforcement actions will result in
favorable results for us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Failure to maintain effective internal control over our
financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could cause our financial reports to be inaccurate.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are required pursuant to Section 404
of the Sarbanes-Oxley Act of 2002, or Section 404, to maintain internal control over financial reporting and to assess and report
on the effectiveness of those controls. This assessment includes disclosure of any material weaknesses identified by our management
in our internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management concluded that our internal
control over financial reporting was effective as of December&nbsp;31, 2019. However, there are inherent limitations on effectiveness
of controls. Our management, including our Chief Executive Officer and Corporate Controller, does not expect that our disclosure
controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no
matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&rsquo;s objectives
will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls
must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation
of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues
and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions
about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals
under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject
to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance
with policies or procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we are not able to maintain effective
internal control over financial reporting, our financial statements, including related disclosures, may be inaccurate, which could
have a material adverse effect on our business. Refer to Item 9A. &ldquo;Controls and Procedures&rdquo; for additional information
related to the current period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our equity investments are subject to risks and we may
experience significant financial losses.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our equity investments are subject to a
high degree of risk and could diminish our financial condition. The overall sustained economic uncertainty, as well as financial,
operational and other difficulties encountered by certain companies in which we have equity investments increases the risk that
the actual amounts realized in the future on our debt and equity investments will differ significantly from the fair values currently
assigned to them. In addition, the companies in which we have equity investments may not be able to compete effectively or there
may be insufficient demand for the services and products offered by these companies. These investments could also expose us to
significant financial losses and may limit alternative uses of our capital resources. If our investees suffer losses, our financial
condition could be materially adversely affected. In addition, applicable securities law restrictions and other factors may result
in an inability to liquidate any equity components of our equity investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to Our Industry</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our exposure to uncontrollable outside influences, including
new legislation, court rulings or actions by the USPTO, could adversely affect our licensing and enforcement business and results
of operations</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our licensing and enforcement business is
subject to numerous risks from outside influences, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>New legislation, regulations or rules
related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our operating subsidiaries invest in patents
with enforcement opportunities and spend a significant amount of resources to enforce those patents. If new legislation, regulations
or rules are implemented by Congress, the USPTO or the courts that impact the patent application process, the patent enforcement
process or the rights of patent holders, such changes could negatively affect our business. United States patent laws were amended
with the enactment of the Leahy-Smith America Invents Act, or the America Invents Act, which took effect on March 16, 2013. The
America Invents Act includes a number of significant changes to U.S. patent law. In general, the legislation attempts to address
issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, establishing new
procedures for patent litigation. For example, the America Invents Act changes the way that parties may be joined in patent infringement
actions, increasing the likelihood that such actions will need to be brought against individual allegedly-infringing parties by
their respective individual actions or activities. In addition, the America Invents Act enacted a new inter-partes review process,
or IPR process, at the USPTO which can be, and often is, used by defendants, and other individuals and entities, to separately
challenge the validity of any patent. The IPR process of the America Invents Act has in many instances increased costs for licensing
and litigation and has resulted in the loss of certain portfolio patents which, in some cases, may have negatively impacted the
value of those portfolios. The America Invents Act and its implementation has increased the uncertainties and costs surrounding
the enforcement of our patented technologies, which in certain circumstances could have a material adverse effect on our business
and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Finally, new rules regarding the burden
of proof in patent enforcement actions could significantly increase the cost of our enforcement actions, and new standards or limitations
on liability for patent infringement could negatively impact our revenue derived from such enforcement actions. In addition, recent
federal court decisions have lowered the threshold for obtaining attorneys&rsquo; fees in patent infringement cases and increased
the level of deference given to a district court&rsquo;s fee-shifting determination. These decisions may make it easier for district
courts to shift a prevailing party&rsquo;s attorneys&rsquo; fees to a non-prevailing party if the district court believes that
the case was weak or conducted in an abusive manner. As a result, defendants in patent infringement actions brought by non-practicing
entities may elect not to settle because these decisions make it much easier for defendants to get attorneys&rsquo; fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Changes in patent law could adversely
impact our business.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Patent laws may continue to change, and
may alter the historically consistent protections afforded to owners of patent rights. Such changes may not be advantageous for
us and may make it more difficult to obtain adequate patent protection to enforce our patents against infringing parties. Increased
focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks
of asserting patent enforcement actions. For instance, the United States Congress has considered a bill that would require, among
other things, non-practicing entities that bring patent infringement lawsuits to pay legal costs of the defendants, if the lawsuits
are unsuccessful and certain standards are not met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Trial judges and juries often find it
difficult to understand complex patent enforcement litigation, and as a result, we may need to appeal adverse decisions by lower
courts in order to successfully enforce our patents.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">It is difficult to predict the outcome of
patent enforcement litigation at the trial level. It is often difficult for juries and trial judges to understand complex, patented
technologies, and as a result, there is a higher rate of successful appeals in patent enforcement litigation than more standard
business litigation. Such appeals are expensive and time consuming, resulting in increased costs and delayed revenue. Although
we diligently pursue enforcement litigation, we cannot predict with significant reliability the decisions made by juries and trial
courts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>More patent applications are filed each
year resulting in longer delays in getting patents issued by the USPTO.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain of our operating subsidiaries hold
and continue to invest in pending patents. We have identified a trend of increasing patent applications each year, which we believe
is resulting in longer delays in obtaining approval of pending patent applications. The application delays could cause delays in
recognizing revenue from these patents and could cause us to miss opportunities to license patents before other competing technologies
are developed or introduced into the market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Federal courts are becoming more crowded,
and as a result, patent enforcement litigation is taking longer.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our patent enforcement actions are almost
exclusively prosecuted in federal court. Federal trial courts that hear our patent enforcement actions also hear criminal cases.
Criminal cases always take priority over our actions. As a result, it is difficult to predict the length of time it will take to
complete an enforcement action. Moreover, we believe there is a trend in increasing numbers of civil lawsuits and criminal proceedings
before federal judges and, as a result, we believe that the risk of delays in our patent enforcement actions will have a greater
negative effect on our business in the future unless this trend changes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Any reductions in the funding of the
USPTO could have an adverse impact on the cost of processing pending patent applications and the value of those pending patent
applications.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The assets of our operating subsidiaries
consist of patent portfolios, including pending patent applications before the USPTO. The value of our patent portfolios is dependent
upon the issuance of patents in a timely manner, and any reductions in the funding of the USPTO could negatively impact the value
of our assets. Further, reductions in funding from Congress could result in higher patent application filing and maintenance fees
charged by the USPTO, causing an increase in our expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Competition is intense in the industries
in which our subsidiaries do business and as a result, we may not be able to grow or maintain our market share for our technologies
and patents.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect to encounter competition in the
area of patent portfolio investments and enforcement. This includes competitors seeking to invest in the same or similar patents
and technologies that we may seek to invest in. As new technological advances occur, many of our patented technologies may become
obsolete before they are completely monetized. If we are unable to replace obsolete technologies with more technologically advanced
patented technologies, then this obsolescence could have a negative effect on our ability to generate future revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our licensing business also competes with
venture capital firms and various industry leaders for patent licensing opportunities. Many of these competitors may have more
financial and human resources than we do. As we become more successful, we may find more companies entering the market for similar
technology opportunities, which may reduce our market share in one or more technology industries that we currently rely upon to
generate future revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Our patented technologies face uncertain
market value.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our operating subsidiaries have invested
in patents and technologies that may be in the early stages of adoption in the commercial and consumer markets. Demand for some
of these technologies is untested and is subject to fluctuation based upon the rate at which our licensees will adopt our patents
and technologies in their products and services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Further, significant judgment is required
in connection with estimates of the recoverability of the carrying value of our intangible patent assets, including estimates of
market values, estimates of the amount and timing of future cash flows, and estimates of other factors that are used to determine
the fair value and recoverability of the respective patent asset values. Developments with respect to ongoing patent litigation,
patent challenges and re-exams, legislative and judicial decisions and other factors outside of our control, may unfavorably impact
the validity, applicability, and enforceability of our patent assets, and therefore, negatively impact the future value of our
patent portfolios. If certain of these unfavorable events occur, our estimates or related projections may change materially in
future periods, and future intangible asset impairment tests may result in material charges to earnings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Patent litigation trials and scheduled
trial dates are subject to routine delay, and any such delays could adversely impact our business, results of operations and financial
condition.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Patent infringement trials are components
of our overall patent licensing process and are one of many factors that contribute to the existence of possible future revenue
opportunities for us. Patent litigation schedules in general, and in particular trial dates, are subject to routine adjustment,
and in most cases delay, as courts adjust their calendars or respond to requests from one or more parties. Trial dates often are
rescheduled by the court for various reasons that are often unrelated to the underlying patent assets and typically for reasons
that are beyond our control. As a result, to the extent such events are an indicator of possible future revenue opportunities for
us, or other outcome determinative events, they may and often do change which can result in delay of the expected scheduled event.
Any such delay could be significant and could affect the corresponding future revenue opportunities, thus adversely impacting our
business, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The markets served by our operating subsidiaries are subject
to rapid technological change, and if our operating subsidiaries are unable to develop and invest in new technologies and patents,
our ability to generate revenues could be substantially impaired</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The markets served by our operating subsidiaries
and their licensees frequently undergo transitions in which products rapidly incorporate new features and performance standards
on an industry-wide basis. Products for communications applications and high-speed computing applications, as well as other applications
covered by our operating subsidiaries&rsquo; IP, are based on continually evolving industry standards. In addition, the communications
industry is intensely competitive and has been impacted by price erosion, rapid technological change, short product life cycles,
cyclical market patterns and increasing foreign and domestic competition. Our ability to compete in the future will depend on our
ability to identify and ensure compliance with evolving industry standards. This will require our continued efforts and success
in acquiring new patent portfolios with licensing and enforcement opportunities. If we are unable to&nbsp;invest in new patented
technologies and patent portfolios, or to identify and ensure compliance with evolving industry standards, our ability to generate
revenues could be substantially impaired and our business and financial condition could be materially harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Uncertainty in global economic conditions could negatively
affect our business, results of operations and financial condition</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our revenue-generating opportunities depend
on the use of our patented technologies by existing and prospective licensees, the overall demand for the products and services
of our licensees, and on the overall economic and financial health of our licensees. If economic conditions do not continue to
improve, or if they deteriorate, many of our licensees&rsquo; customers, which may rely on credit financing, may delay or reduce
their purchases of our licensees&rsquo; products and services. In addition, the use or adoption of our patented technologies is
often based on current and forecasted demand for our licensees&rsquo; products and services in the marketplace and may require
companies to make significant initial commitments of capital and other resources. If negative conditions in the global credit markets
delay or prevent our licensees&rsquo; and their customers&rsquo; access to credit, overall consumer spending on the products and
services of our licensees may decrease and the adoption or use of our patented technologies may slow, respectively. Further, if
the markets in which our licensees&rsquo; participate do not continue to improve, or deteriorate further, this could negatively
impact our licensees&rsquo; long-term sales and revenue generation, margins and operating expenses, which could in turn have an
adverse effect on our business, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Public health threats such as COVID-19 could have a material
adverse effect on our operations, the operations of our business partners, and the global economy as a whole.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Public health threats and other highly communicable
diseases, outbreaks of which have already occurred in various parts of the world, could adversely impact our operations, as well
as the operations of our licensees and other business partners. For example, the outbreak in December 2019 of a novel coronavirus
(COVID-19) has resulted in decreased economic activity in China, as well as a number of other countries, and the scope of the outbreak
and its impacts is continuing to expand. We have taken precautions in the operation of our
own business and maintain an up-to-date disaster recovery and business continuity policy as well as have the systems and support
to have our workforce work remotely for an indefinite period of time. However,
any further spread of the COVID-19 outbreak, or the occurrence of other similar outbreaks or epidemics, could have a material
adverse effect on our business, operations and financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to Our Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The availability of shares for sale in the future could
reduce the market price of our common stock</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the future, we may issue securities to
raise cash for operations and patent portfolio investments. We may also pay for interests in additional subsidiary companies by
using shares of our common stock or a combination of cash and shares of our common stock. We may also issue securities convertible
into our common stock. Any of these events may dilute stockholders&rsquo; ownership interests in our company and have an adverse
impact on the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, sales of a substantial amount
of our common stock in the public market, or the perception that these sales may occur, could reduce the market price of our common
stock. This could also impair our ability to raise additional capital through the sale of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Delaware law and our charter documents contain provisions
that could discourage or prevent a potential takeover of our company that might otherwise result in our stockholders receiving
a premium over the market price of their shares</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Provisions of Delaware law and our certificate
of incorporation and bylaws could make the acquisition of our company by means of a tender offer, proxy contest or otherwise,
and the removal of incumbent officers and directors, more difficult. These provisions include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Section 203 of the Delaware General Corporation Law, which prohibits a merger with a 15%-or-greater stockholder, such as a party that has completed a successful tender offer, until three years after that party became a 15%-or-greater stockholder;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">amendment of our bylaws by the stockholders requires a two-thirds approval of the outstanding shares;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the authorization in our certificate of incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent or discourage a takeover; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&bull;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the general restriction in our certificate of incorporation on any direct or indirect transfers of our common stock if the effect would be to (i) increase the direct or indirect ownership of our common stock by any person or group from less than 4.899% to 4.899% or more of our common stock; or (ii) increase the percentage of our common stock owned directly or indirectly by a person or group owning or deemed to own 4.899% or more of our common stock.</FONT></TD></TR>
</TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.5in">Together, these provisions may make the
removal of management more difficult and may discourage transactions that could otherwise involve payment of a premium over prevailing
market prices for our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our Tax Benefits Preservation Plan
could inhibit a change in our control that may otherwise be favorable to our stockholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In March 2019, our
board of directors approved the adoption of a Tax Benefits Preservation Plan in order to protect our ability to utilize potential
tax assets, such as net operating loss carryforwards and tax credits, to offset potential future taxable income by discouraging
investors from acquiring ownership of our common stock in a manner that could trigger an &ldquo;ownership change&rdquo; for purposes
of Section 382 of the Code. Our stockholders ratified the adoption of the Tax Benefits Preservation Plan in July 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Under the terms of
the Tax Benefits Preservation Plan, in general, if a person or group acquires beneficial ownership of 4.9% or more of the outstanding
shares of our Common Stock without prior approval of our board of directors or without meeting certain exceptions, the rights
would become exercisable and our stockholders (other than the acquiring person) will have the right to purchase securities from
us at a discount to such securities&rsquo; fair market value, thus causing substantial dilution to the acquiring person. As a
result, the Tax Benefits Preservation Plan may have the effect of inhibiting or impeding a change in control not approved by our
board of directors and, notwithstanding its purpose, could adversely affect our stockholders&rsquo; ability to realize a premium
over the then-prevailing market price for our common stock in connection with such a transaction. In addition, because our board
of directors may consent to certain transactions, the Tax Benefits Preservation Plan gives our board of directors significant
discretion over whether a potential acquirer&rsquo;s efforts to acquire a large interest in us will be successful. There can be
no assurance that the Tax Benefits Preservation Plan will prevent an &ldquo;ownership change&rdquo; within the meaning of Section
382 of the Code, in which case we may lose all or most of the anticipated tax benefits associated with our prior losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We may fail to meet market expectations because of fluctuations
in quarterly operating results, which could cause the price of our common stock to decline</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our reported revenues and operating results
have fluctuated in the past and may continue to fluctuate significantly from quarter to quarter in the future. It is possible that
in future periods, revenues could fall below the expectations of securities analysts or investors, which could cause the market
price of our common stock to decline. The following are among the factors that could cause our operating results to fluctuate significantly
from period to period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the dollar amount of agreements executed in each period, which is primarily driven by the nature and characteristics of the technology being licensed and the magnitude of infringement associated with a specific licensee;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the specific terms and conditions of agreements executed in each period and the periods of infringement contemplated by the respective payments;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">fluctuations in the total number of agreements executed;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">fluctuations in the sales results or other royalty-per-unit activities of our licensees that impact the calculation of license fees due;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the timing of the receipt of periodic license fee payments and/or reports from licensees;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">fluctuations in the net number of active licensees period to period;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">costs related to investments, alliances, licenses and other efforts to expand our operations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the timing of payments under the terms of any customer or license agreements into which our operating subsidiaries may enter;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">we may elect to account for equity investments in companies where our investment gives us the ability to exercise significant influence over the operating and financial policies of the investee at fair value, which may result in significant fluctuations in operating results (unrealized gains and losses) each period based on fluctuations in the stock price of our investments and the requirement to mark such investments to market at each balance sheet date; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">expenses related to, and the timing and results of, patent filings and other enforcement proceedings relating to IP rights, as more fully described in this section; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">new litigation or developments in current litigation and the unpredictability of litigation results or settlements or appeals. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Technology company stock prices are especially volatile,
and this volatility may depress the price of our common stock</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The stock market has experienced significant
price and volume fluctuations, and the market prices of technology companies have been highly volatile. We believe that various
factors may cause the market price of our common stock to fluctuate, perhaps substantially, including, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">announcements of developments in our patent enforcement actions;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">developments or disputes concerning our patents;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">our or our competitors&rsquo; technological innovations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">developments in relationships with licensees;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">variations in our quarterly operating results;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">our failure to meet or exceed securities analysts&rsquo; expectations of our financial results;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">a change in financial estimates or securities analysts&rsquo; recommendations;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in management&rsquo;s or securities analysts&rsquo; estimates of our financial performance;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in market valuations of similar companies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">concerns about sovereign debt of the United States and the European Union;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">announcements by us or our competitors of significant contracts, investments, partnerships, joint ventures, capital commitments, new technologies, or patents; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">failure to complete significant transactions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For example, the NASDAQ-100 Technology
Sector Index (NDXT) had a range of $3,547.57 - $5,492.35 during the 52 weeks ended December&nbsp;31, 2019 and the NASDAQ
Composite Index (IXIC) had a range of $6,463.50- $9,022.39 over the same period. Over the same period, our common stock
fluctuated within a range of $2.46 - $3.29.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As noted above, our stock price, like many
others, has fluctuated significantly in recent periods and if investors have concerns that our business, operating results and
financial condition will be negatively impacted by industry, global economic or other negative conditions, our stock price could
continue to fluctuate significantly in future periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, we believe that fluctuations
in our stock price during applicable periods can also be impacted by court rulings and/or other developments in our patent licensing
and enforcement actions. Court rulings in patent enforcement actions are often difficult to understand, even when favorable or
neutral to the value of our patents and our overall business, and we believe that investors in the market may overreact, causing
fluctuations in our stock prices that may not accurately reflect the impact of court rulings on our business operations and assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the past, companies that have experienced
volatility in the market price of their stock have been the objects of securities class action litigation. If our common stock
was the object of securities class action litigation, it could result in substantial costs and a diversion of management&rsquo;s
attention and resources, which could materially harm our business and financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We do not currently intend to pay dividends on our common
stock in the foreseeable future, and consequently, your ability to achieve a return on your investment will depend on appreciation
in the price of our common stock. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 23, 2016, our board of directors
eliminated our dividend policy that provided for the discretionary payment of a total annual cash dividend of $0.50 per share to
holders of our common stock, payable in the amount of $0.125 per share per quarter, effective as of February 23, 2016. As a result,
we do not anticipate paying any cash dividends to holders of our common stock in the foreseeable future. Consequently, investors
must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future
gains on their investments. There is no guarantee that shares of our common stock will appreciate in value or even maintain the
price at which our stockholders have purchased their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; color: #212529"><B><I>The
issuance of the Starboard Securities to Starboard and its permitted transferees dilutes the ownership and relative voting power
of holders of our common stock and may adversely affect the market price of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">Pursuant
to the Securities Purchase Agreement, the Company sold to Starboard (i) 350,000 shares of our newly designated Series A Preferred
Stock and Series A Warrants to purchase up to 5,000,000 shares of common stock in 2019, and (ii) Series B Warrants to purchase
up to 100,000,000 shares of common stock in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">As
of December 31, 2019, the Series A Preferred Stock held by Starboard represents approximately 16% of our outstanding common
stock on an as-converted. Because holders of our Series A Preferred Stock are entitled to vote, on an as-converted
basis, together with holders of our common stock on all matters submitted to a vote of the holders of our common stock, the
issuance of the Series A Preferred Stock to Starboard effectively reduces the relative voting power of the holders of our
common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">In
addition, the conversion and/or exercise of the Starboard Securities into common stock would dilute the ownership interest of existing
holders of our common stock. Furthermore, any sales in the public market of the common stock issuable upon conversion or exercise
of the Starboard Securities could adversely affect prevailing market prices of our common stock. Pursuant to a customary Registration
Rights Agreement with Starboard, we have agreed to provide certain registration rights with respect to the Starboard Securities
and the shares of common stock issued upon the conversion or exercise of the Starboard Securities, as applicable. Any such registration
may facilitate the resale of such securities into the public market, and any such resale would increase the number of shares of
our common stock available for public trading. Sales by Starboard of a substantial number of shares of our common stock in the
public market, or the perception that such sales might occur, could have a material adverse effect on the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><B><I>Our
Series A Preferred Stock has rights, preferences and privileges that are not held by, and are preferential to, the rights of, our
common stockholders, which could adversely affect our liquidity and financial condition, result in the interests of holders of
our Series A Preferred Stock differing from those of our common stockholders and delay or prevent an attempt to take over the Company.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Starboard
and the other holders of our Series A Preferred Stock have a liquidation preference entitling them to be paid, before any payment
may be made to holders of our common stock in connection with a liquidation event, an amount per share of Series A Preferred Stock
equal to the greater of (i)&nbsp; the stated value thereof plus accrued and unpaid dividends, and (ii)&nbsp;the amount that would
have been received had such share of Series A Preferred Stock been converted into common stock immediately prior to such liquidation
event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Holders
of Series A Preferred Stock are entitled to a preferential cumulative dividend at the rate of 3.0% per annum, payable quarterly
in arrears. Upon the consummation of a suitable investment or acquisition by the Company, such investment to be identified and
approved by each of the Company and Starboard, the dividend rate will increase to 8.0% per annum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The
holders of our Series A Preferred Stock also have certain redemption rights, including the right to require us to repurchase all
or any portion of the Series A Preferred Stock during certain specified periods and subject to certain conditions set forth in
the Certificate of Designations, Preferences, and Rights of Series A Convertible Preferred Stock, or the Certificate of Designations.
Holders of the Series A Preferred Stock also have the right, subject to certain exceptions, to require us to repurchase all or
any portion of the Series A Preferred Stock upon certain change of control events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">These
dividend and share repurchase obligations could impact our liquidity and reduce the amount of cash flows available for working
capital, capital expenditures, growth opportunities, acquisitions, and other general corporate purposes. The preferential rights
could also result in divergent interests between Starboard and holders of our common stock. Furthermore, a sale of our Company,
as a change of control event, may require us to repurchase Series A Preferred Stock, which could have the effect of making an acquisition
of the Company more expensive and potentially deterring proposed transactions that may otherwise be beneficial to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Starboard
has certain rights, including the ability to designate up to three members of our board of directors.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The
transaction documents entered into in connection with the Starboard Investment grant to Starboard consent rights with respect to
certain actions by us, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>amending our organizational documents in a manner that would have an adverse effect on the Series A Preferred Stock; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>increasing the maximum number of directors on our board to more than seven persons, subject to the terms of the Governance
Agreement entered into in connection with the Securities Purchase Agreement, or the Governance Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">The
Securities Purchase Agreement also imposes a number of affirmative and negative covenants on us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">In
addition, the terms of the Governance Agreement grant Starboard certain rights to designate directors to be nominated for election
by holders of our common stock. For so long as certain criteria set forth in the Governance Agreement are satisfied, including
that Starboard beneficially own, in the aggregate, at least 4.0% of the Company&rsquo;s then-outstanding common stock&nbsp;(on
an as-converted basis, if applicable), Starboard has the right to designate up to three directors for election to our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">The
directors designated by Starboard also are entitled to serve on committees of our Board, subject to applicable law and stock exchange
rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a5"></A><B>ITEM 1B. UNRESOLVED STAFF COMMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a6"></A><B>ITEM 2. PROPERTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our principal executive, corporate and
administrative offices are located in Irvine, California, where we lease approximately 8,293 square feet of office space, under
a lease agreement that expires in 2024. Our primary operating subsidiary, Acacia Research Group, LLC, and its subsidiaries, are
headquartered in Frisco, Texas, where we lease office space under a lease agreement that expires in 2020. We believe that our
facilities are adequate, suitable and of sufficient capacity to support our immediate needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a7"></A><B>ITEM 3. LEGAL PROCEEDINGS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the ordinary course of business, we are
the subject of, or party to, various pending or threatened legal actions, including various counterclaims in connection with our
patent enforcement activities. We believe that any liability arising from these actions will not have a material adverse effect
on our consolidated financial position, results of operations or cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our operating subsidiaries are often required
to engage in litigation to enforce their patents and patent rights. Certain of our operating subsidiaries are parties to ongoing
patent enforcement related litigation, alleging infringement by third-parties of certain of the patented technologies owned or
controlled by our operating subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with any of our patent enforcement
actions, it is possible that a defendant may claim and/or a court may rule that we have violated statutory authority, regulatory
authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement
actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney&rsquo;s
fees and/or expenses to a defendant(s), which could be material, and if required to be paid by us or our operating subsidiaries,
could materially harm our operating results and our financial position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We spend a significant amount of our financial
and management resources to pursue our current litigation matters. We believe that these litigation matters and others that we
may in the future determine to pursue could continue for years and continue to consume significant financial and management resources.
The counterparties to our litigation are sometimes large, well-financed companies with substantially greater resources than us.
We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us. In addition,
in part due to the appeals process and other legal processes, even if we obtain favorable interim rulings or verdicts in particular
litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure you that we will
not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. Unfavorable or adverse outcomes
may result in losses, exhaustion of financial resources or other adverse effects which could encumber our ability to effectively
and efficiently monetize our assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 17, 2015, Celltrace
Communications Ltd., or Celltrace, filed a lawsuit against Acacia in U.S. District Court for the Southern District of New
York, Case No. 1:15-cv-04746, alleging, among other things, significant damages for alleged breach of contract, unjust
enrichment and fraud. Acacia disputes the allegations and does not believe that Celltrace is entitled to any
damages. Acacia successfully moved to compel arbitration of the dispute, and the District Court stayed the litigation
pending arbitration before the International Court of Arbitration for the International Chamber of Commerce, or the
ICC. Celltrace appealed the decision to the U.S. Court of Appeals for the Second Circuit, which denied the
appeal. Celltrace filed its request for arbitration of the claims with the ICC on November 28, 2016. Acacia filed
an answer denying all allegations of wrongdoing and asserting affirmative defenses. A tribunal was appointed to preside
over the arbitration and conducted its first case management conference on June 26, 2017. The parties conducted
discovery and submitted their cases in chief to the tribunal in a series of written submissions per the tribunal&rsquo;s
orders between January 2018 and December 2018. The tribunal held an evidentiary hearing with live witness testimony in
New York City between February 4, 2019 and February 13, 2019. At the end of the hearing, the tribunal set a schedule
for post-hearing briefing by the parties, which concluded in April 2019. We are now waiting for the tribunal to issue its
decision. Acacia continues to vigorously contest all allegations of wrongdoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a8"></A><B>ITEM 4. MINE SAFETY DISCLOSURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a9"></A>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a10"></A><B>ITEM 5. MARKET FOR REGISTRANT&rsquo;S COMMON EQUITY, RELATED
STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock trades on The NASDAQ Global
Select Market under the symbol &ldquo;ACTG.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dividend Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 23, 2013, we announced that our
board of directors approved the adoption of a cash dividend policy that called for the payment of an expected total annual cash
dividend of $0.50 per share to holders of our common stock, payable in the amount of $0.125 per share per quarter. On February
23, 2016, our board of directors terminated the company&rsquo;s dividend policy due to a number of factors, including our financial
performance, our available cash resources, our cash requirements and alternative uses of capital that our board of directors concluded
would represent an opportunity to generate a greater return on investment for us and our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The current policy of our board of directors
is to retain earnings, if any, to provide for our growth. Consequently, we do not expect to pay any cash dividends in the foreseeable
future. Further, there can be no assurance that our proposed operations will generate revenues and cash flow needed to declare
any future cash dividends or that we will have legally available funds to pay future dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Sales of Unregistered Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Stock Repurchase Program </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February 2018, our board of directors
authorized a stock repurchase program, or the Program, to repurchase up to $20 million of our outstanding common stock in open
market purchases or private purchases, from time to time, in amounts and at prices to be determined by the board of directors at
its discretion. In determining whether or not to repurchase any shares of our common stock, our board of directors will consider
such factors as the impact of the repurchase on our cash position, as well as our capital needs and whether there is a better alternative
use of our capital. In fiscal year 2018, we repurchased 1,190,420 shares of common stock at an average price of $3.89 for $4,634,000.
All of these shares were repurchased during the second quarter of fiscal year 2018. The Program expired on February 28, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On August 5, 2019, Acacia&rsquo;s board
of directors approved a new stock repurchase program, which authorized the purchase of up to $10.0 million of the Company's common
stock through open market purchases, through block trades, through 10b5-1 plans, or by means of private purchases, from time to
time, through July 31, 2020. No repurchases of shares of the Company&rsquo;s common stock occurred during the three months ended
December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Holders of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March&nbsp;11, 2020, there were approximately
67 owners of record of our common stock. The majority of the outstanding shares of our common stock are held by a nominee holder
on behalf of an indeterminable number of ultimate beneficial owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a11"></A><B>ITEM 6. SELECTED FINANCIAL DATA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not required for &quot;smaller reporting
companies.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a12"></A><B>ITEM 7. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>The following discussion should be
read in conjunction with our consolidated financial statements included elsewhere in this annual report. This discussion
contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from
those anticipated in these forward-looking statements as a result of various factors including the risks we discuss in Item
1A, &ldquo;Risk Factors,&rdquo; and elsewhere herein.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We invest in IP and related absolute return assets
and engage in the licensing and enforcement of patented technologies. We partner with inventors and patent owners, applying our
legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We generate revenues
and related cash flows from the granting of patent rights for the use of patented technologies that our operating subsidiaries
control or own. We assist patent owners with the prosecution and development of their patent portfolios, the protection of their
patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and,
where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement
litigation. We are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio,
or control of the patent portfolio outright.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have a proven track record of licensing
and enforcement success with over 1,570 license agreements executed to date, across nearly 200 patent portfolio licensing and enforcement
programs. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios,
which include U.S. patents and certain foreign counterparts, covering technologies used in a variety of industries. To date, we
have generated gross licensing revenue of approximately $1.6 billion, and have returned more than $776 million to our patent partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business is described more fully in
Item 1. &ldquo;Business,&rdquo; of this annual report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Executive Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the years ended December 31, 2019 and 2018,
we reported revenues of $11.2 million and $131.5 million. Cash and trading securities totaled $168.3 million as of December&nbsp;31,
2019, as compared to $165.5 million as of December&nbsp;31, 2018. Our operating activities during the periods presented were focused
on the continued operation of our patent licensing and enforcement business, including the continued pursuit of our ongoing patent
licensing and enforcement programs. During 2019 and 2018, we also focused on cost reduction and optimization efforts, including
renegotiation of certain existing arrangements, and reducing facilities costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our team&rsquo;s expertise in identifying
and evaluating complex IP, and in developing and cultivating long-term business relationships, provides us a unique window into
innovation and technological advancement. We are increasing our efforts to leverage our expertise and experience to create new
avenues and monetize our existing IP assets, which we believe will lead to increased stockholder value. We will leverage our experience,
expertise, data and relationships developed as a leader in the IP industry to pursue these opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Patent Licensing and Enforcement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Patent Litigation Trial Dates and
Related Trials</I>.&nbsp;As of the date of this report, our operating subsidiaries have three pending patent infringement
cases with a scheduled trial date in the next twelve months. Patent infringement trials are components of our overall patent
licensing process and are one of many factors that contribute to possible future revenue generating opportunities for us.
Scheduled trial dates, as promulgated by the respective court, merely provide an indication of when, in future periods, the
trials may occur according to the court&rsquo;s scheduling calendar at a specific point in time. A court may change
previously scheduled trial dates. In fact, courts often reschedule trial dates for various reasons that are unrelated to the
underlying patent assets and typically for reasons that are beyond our control. While scheduled trial dates provide an
indication of the timing of possible future revenue generating opportunities for us, the trials themselves and the
immediately preceding periods represent the possible future revenue generating opportunities. These future opportunities
can result in varying outcomes. In fact, it is difficult to predict the outcome of patent enforcement litigation at the
trial level and outcomes can be unfavorable. It can be difficult to understand complex patented technologies, and as a
result, this may lead to a higher rate of unfavorable litigation outcomes. Moreover, in the event of a favorable outcome,
there is, in our experience, a higher rate of successful appeals in patent enforcement litigation than more standard business
litigation. Such appeals are expensive and time consuming, resulting in increased costs and a potential for delayed or
foregone revenue opportunities in the event of modification or reversal of favorable outcomes. Although we diligently pursue
enforcement litigation, we cannot predict with reliability the decisions made by juries and trial courts. Please refer to
Item 1A. &ldquo;Risk Factors&rdquo; for additional information regarding trials, patent litigation and related risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Litigation and Licensing Expense</I>.
We expect patent-related legal expenses to continue to fluctuate from period to period based on the factors summarized herein,
in connection with future trial dates, international enforcement, strategic patent portfolio prosecution and our current and future
patent portfolio investment, prosecution, licensing and enforcement activities. The pursuit of enforcement actions in connection
with our licensing and enforcement programs can involve certain risks and uncertainties, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increases in patent-related legal expenses associated with patent infringement litigation, including, but not limited to, increases in costs billed by outside legal counsel for discovery, depositions, economic analyses, damages assessments, expert witnesses and other consultants, re-exam and inter partes review costs, case-related audio/video presentations and other litigation support and administrative costs could increase our operating costs and decrease our profit generating opportunities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our patented technologies and enforcement actions are complex and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents. Moreover, such appeals may not be successful;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">New legislation, regulations or rules related to enforcement actions, including any fee or cost shifting provisions, could significantly increase our operating costs and decrease our profit generating opportunities. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The complexity of negotiations and potential magnitude of exposure for potential infringers associated with higher quality patent portfolios may lead to increased intervals of time between the filing of litigation and potential revenue events (i.e., markman dates, trial dates), which may lead to increased legal expenses, consistent with the higher revenue potential of such portfolios; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above could harm our operating results and our financial position.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Enforcement Activities. </I>As previously
reported, in March 2017, our subsidiary, Saint Lawrence Communications, LLC, or Saint Lawrence, received a jury verdict in its
case against Motorola, Inc. in the United States District Court for the Eastern District of Texas, or District Court. The jury
returned a verdict that five U.S. patents were valid and infringed. The jury found that the infringement was willful and returned
a damages award of nearly $9.2 million for past infringement. In addition, our German subsidiary, Saint Lawrence Communications
GmbH, was granted injunctions by the German court in enforcement proceedings against Motorola, Inc. In the fourth quarter of 2018,
Saint Lawrence and Saint Lawrence Communications GmbH entered into an agreement with Motorola, Inc. to resolve the patent litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the second quarter of 2017, Saint
Lawrence resolved its enforcement actions against ZTE including the U.S. lawsuit. In February 2018, Saint Lawrence and Saint Lawrence
Communications GmbH entered into an agreement with Apple Inc. to resolve all outstanding litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As previously reported, in September 2016,
our subsidiary Cellular Communications Equipment LLC, or CCE, received a jury verdict of infringement by Apple, Inc. In the third
quarter of 2017, CCE entered into an agreement with Apple Inc. to resolve the patent litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investments in Patent Portfolios</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">One of the significant challenges in our
industry continues to be quality patent intake due to the challenges and complexity associated with the current patent environment.
In fiscal year 2019 we acquired five patent portfolios, compared to none during fiscal year 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">With respect to our licensing,
enforcement and overall business, neither we nor our operating subsidiaries invent new technologies or products; rather, we
depend upon the identification and investment in patents, inventions and companies that own IP through
our relationships with inventors, universities, research institutions, technology companies and others. If our operating
subsidiaries are unable to maintain those relationships and identify and grow new relationships, then we may not be able to
identify new technology-based patent opportunities for sustainable revenue and /or revenue growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our current or future relationships may
not provide the volume or quality of technologies necessary to sustain our licensing, enforcement and overall business. In some
cases, universities and other technology sources compete against us as they seek to develop and commercialize technologies. Universities
may receive financing for basic research in exchange for the exclusive right to commercialize resulting inventions. These and other
strategies employed by potential partners may reduce the number of technology sources and potential clients to whom we can market
our solutions. If we are unable to maintain current relationships and sources of technology or to secure new relationships and
sources of technology, such inability may have a material adverse effect on our revenues, operating results, financial condition
and ability to maintain our licensing and enforcement business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Patent
Portfolio Intake. </I></FONT>One of the significant challenges in our industry continues to be quality patent intake due to the
challenges and complexity associated with the current patent environment. <FONT STYLE="font-family: Times New Roman, Times, Serif">In
fiscal year 2019, we acquired five new patent portfolios covering (i) enterprise networking equipment and residential gateways
technology, (ii) customization of ad insertion for Internet radio streaming technology, (iii) wireless communications and cloud
computing, (iv) optical communications, and (v) commercial food processing. The patents and patent rights acquired in 2019 have
estimated economic useful lives of approximately five years. In fiscal year 2018 we did not acquire any patent portfolios. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Business Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">In
2019, as part of its strategy to grow the Company began evaluating a wide range of strategic opportunities that culminated in
the strategic investment in the Company by Starboard. On November 18, 2019, the Company entered into the Securities Purchase Agreement
with Starboard pursuant to which Starboard purchased (i) 350,000 shares of Series A Preferred Stock at an aggregate purchase price
of $35,000,000, and Series A Warrants to purchase up to 5,000,000 shares of the Company&rsquo;s common stock. The Securities Purchase
Agreements also established the terms of certain senior secured notes and the Series B Warrants, which may be issued to Starboard
in the future. Refer to Notes 16, 17 and 19 to our notes to consolidated financial statements for more information related
to the Starboard Securities. &nbsp; In connection with Starboard&rsquo;s investment, Starboard was granted certain corporate governance
rights, including the right to appoint Jonathan Sagal, Managing Director of Starboard, as a director of the Company and recommend
two additional directors for appointment to our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Operating Activities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our revenues historically have fluctuated
period to period, and can vary significantly, based on a number of factors including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the specific terms and conditions of agreements executed each period including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">fluctuations in the total number of agreements executed each period;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of, timing, results and uncertainties associated with patent licensing negotiations, mediations, patent infringement actions, trial dates and other enforcement proceedings relating to our patent licensing and enforcement programs;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the relative maturity of licensing programs during the applicable periods; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">other external factors, including the periodic status or results of ongoing negotiations, the status or results of ongoing litigations and appeals, actual or perceived shifts in the regulatory environment, impact of unrelated patent related judicial proceedings and other macroeconomic factors; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">the willingness of prospective licensees to settle significant patent infringement cases and pay reasonable license fees for the use of our patented technology, as such infringement cases approached a court determined trial date; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management does not attempt to manage
for smooth sequential periodic growth in revenues period to period, and therefore, periodic results can be uneven. Unlike most
operating businesses and industries, licensing revenues not generated in a current period are not necessarily foregone but, depending
on whether negotiations, litigation or both continue into subsequent periods, and depending on a number of other factors, such
potential revenues may be pushed into subsequent fiscal periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues for the periods presented included
fees from the following licensing and enforcement programs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt"><B></B></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle; background-color: rgb(238,238,238)">
    <TD STYLE="width: 3%">&bull;</TD>
    <TD STYLE="width: 45%">Bone Wedge technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)(2)</SUP></FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 3%">&bull;</TD>
    <TD STYLE="width: 45%">Semiconductor and Memory-Related technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: middle; background-color: White">
    <TD>&bull;</TD>
    <TD>Cardiology and Vascular Device technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>Speech codecs used in wireless and wireline systems technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)(2)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: middle; background-color: rgb(238,238,238)">
    <TD>&bull;</TD>
    <TD>MIPI DSI technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&bull;</TD>
    <TD>Super Resolutions Microscopy technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)(2)</SUP></FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: middle">&bull;</TD>
    <TD STYLE="vertical-align: middle">Online Auction Guarantee technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&bull;</TD>
    <TD STYLE="vertical-align: middle">Video Conferencing technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)(2)</SUP></FONT></TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="vertical-align: middle">&bull;</TD>
    <TD STYLE="vertical-align: middle">Semiconductor Testing technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: middle">&bull;</TD>
    <TD STYLE="vertical-align: middle">Wireless Infrastructure and User Equipment technology<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(2)</SUP></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>______________________________________</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 98%">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)</SUP>&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensing and enforcement program generating revenue in fiscal year 2019.</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(2)</SUP>&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensing and enforcement program generating revenue in fiscal year 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues from one or more of our patents
or patent portfolios may be significant in a specific reporting period, and may be significant to our licensing and enforcement
business as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Summary of Results of Operations - For Fiscal Years 2019
and 2018 </I></B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">$ Change</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">% Change</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-size: 10pt; text-align: center">(In thousands, except percentage change values)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 48%; font-size: 10pt">Revenues</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">11,246</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">131,506</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(120,260</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(91%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Operating costs and expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">34,664</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">156,195</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(121,531</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(78%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Operating loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(23,418</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(24,689</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,271</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(5%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Other income (expense), net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,465</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(78,980</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">83,445</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(106%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Loss before income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(18,953</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(103,669</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">84,716</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(82%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Income tax (expense) benefit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,824</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,179</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,003</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(255%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Net loss attributable to Acacia Research Corporation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(17,115</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(105,029</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">87,914</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(84%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Overview - Fiscal Year 2019 compared with Fiscal Year 2018</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues decreased $120.3 million, or 91% to $11.2 million, primarily
due to decrease in number of and in revenues from the new agreements executed during the year. Refer to &ldquo;<I>Investments in
Patent Portfolios&rdquo; </I>below for additional information regarding the impact of portfolio acquisition trends on current and
future licensing and enforcement related revenues.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss before provision for income taxes was $19.0 million for fiscal
year 2019, as compared to $103.7 million for fiscal year 2018. The net change was primarily comprised of the change in revenues
described above and other changes in operating expenses and other income and expenses as follows:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventor royalties and contingent legal fees, on a combined basis,
decreased $61.1 million, or 92%, to $5.5 million, primarily due to decrease in revenues as describe above. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Litigation and licensing expenses-patents decreased $1.1 million,
or 12%, to $7.8 million, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated
with ongoing litigation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization expense decreased $23.9 million, or 88%, to $3.2 million,
due to a decrease in scheduled amortization resulting from the $28.2 million patent portfolio impairment charges previously recorded
in the second quarter of 2018, and accelerated amortization recorded in the third quarter of 2018.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Impairment of patent-related intangible asset charges decreased $28.2
million. Impairment charges reflect the impact of reductions in expected estimated future net cash flows for certain patent portfolios
and/or the impairment of certain portfolios that management determined it would no longer allocate resources to in future periods.
</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">General and administrative expenses, excluding non-cash stock compensation,
decreased $3.7 million, or 20%, to $15.3 million, primarily due to higher corporate, general and administrative costs related to
the 2018 proxy contest and employee related severance costs in the prior year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">General and administrative non-cash stock compensation expense
                                                                                                             increased $1.4 million, primarily due to a $2.5 million reduction in non-cash stock compensation expense related to profits
                                                                                                             interests in 2018, offset by new restricted stock awards granted to our employees and board of directors in 2019, and
                                                                                                             certain restricted stock units granted in September 2019. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Impairment of other investment increased from $1.0 million to
$8.2 million due to impairment of our investment in Miso Robotics in the second quarter of 2019. Gain on disposal of other investment
increased from $0 to $2.0 million due to the sale of our other investment in Miso Robotics in the third quarter of 2019. Refer
to Note 6 to the consolidated financial statements elsewhere herein for additional information regarding our investment in Miso
Robotics.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40pt"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax expense or benefits for fiscal years 2019 and 2018 primarily reflects
the impact of state taxes and foreign withholding or refund incurred on revenue agreements executed with third-party licensees
domiciled in foreign jurisdictions. </FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B>Revenues and Pretax Net Loss</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Operating activities during the periods
presented included the following:</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left">Revenues (in thousands)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">11,246</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">131,506</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">New agreements executed</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Licensing and enforcement programs generating revenues</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">New patent portfolios</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Year-end cash, cash equivalents and trading securities (in thousands)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">168,342</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">165,463</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented herein, the majority
of the revenue agreements executed provided for the payment of one-time, paid-up license fees in consideration for the grant of
certain IP rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a
perpetual basis, extending until the expiration of the underlying patents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to Note 2 to the consolidated financial
statements elsewhere herein for additional information regarding our revenue concentrations for the periods presented herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to &ldquo;<I>Investments in Patent
Portfolios&rdquo;</I> above for information regarding the impact of portfolio acquisition trends on current and future licensing
and enforcement related revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">$ Change</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">% Change</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-size: 10pt; text-align: center">(In thousands, except percentage change values)</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; width: 48%">Loss before provision for income taxes</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">$</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">(18,953</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">)</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">$</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">(103,669</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">)</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">$</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">84,716</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">(82%</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cost of Revenues</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Inventor Royalties, Contingent Legal
Fees Expense and Other Patent Acquisition Costs.</I> The economic terms of patent portfolio related partnering agreements
and contingent legal fee arrangements, if any, including royalty obligations, if any, royalty rates, contingent fee rates and other
terms and conditions, vary across the patent portfolios owned or controlled by our operating subsidiaries. In certain instances,
we have invested in certain patent portfolios without future inventor royalty obligations. These costs fluctuate period to period,
based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and
the mix of specific patent portfolios with varying economic terms, conditions and obligations generating revenues each period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-size: 10pt; border-bottom: Black 1pt solid"><B>Change</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">$ Change</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">% Change</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-size: 10pt; text-align: center">(In thousands, except percentage change values)</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Inventor royalties</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">4,944</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">35,168</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(30,224</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(86%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Contingent legal fees</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">591</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31,501</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(30,910</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(98%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Patent acquisition expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(100%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Litigation and Licensing Expenses - Patents.&nbsp;&nbsp;</I>Litigation
and licensing expenses-patents include patent-related litigation, enforcement and prosecution costs incurred by external patent
attorneys engaged on an hourly basis and the out-of-pocket expenses incurred by law firms engaged on a contingent fee basis. Litigation
and licensing expenses-patents also includes third-party patent research, development, prosecution, re-exam and inter partes reviews,
consulting, and other costs incurred in connection with the licensing and enforcement of patent portfolios.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Litigation and licensing expenses-patents
decreased for the periods presented due to a net decrease in litigation support, patent prosecution and litigation expenses associated
with ongoing licensing and enforcement programs and an overall decrease in portfolio related enforcement activities. We expect
patent-related legal expenses to continue to decrease based upon the overall decrease in portfolio related enforcement activities
as we continue monetizing our existing patent assets. Refer to &ldquo;<I>Investments in Patent Portfolios&rdquo; </I>above for
additional information regarding the impact of portfolio acquisition trends on licensing and enforcement activities and current
and future licensing and enforcement related revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Amortization of Patents</I>.&nbsp;&nbsp;For
the year ended December 31, 2019, amortization expense decreased $23.9 million, or 88%, as compared to the year ended December
31, 2018. These decreases were due to a decrease in scheduled amortization resulting from the $28.2 million patent portfolio impairment
charges previously recorded in the fiscal 2018, and accelerated amortization recorded in the third quarter of 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Impairment Charges.</I> Impairment charges
for fiscal year 2018 primarily reflect reductions in expected estimated future net cash flows for certain patent portfolios to
which management determined it would no longer allocate resources in future periods. Impairment charges consisted of the excess
of the asset&rsquo;s carrying value over its estimated fair value as of the applicable measurement date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Change</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">$ Change</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">% Change</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-size: 10pt; text-align: center">(In thousands, except percentage change values)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Litigation and licensing expenses - patents</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">7,803</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">8,866</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(1,063</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(12%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Amortization of patents</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,194</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">27,120</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(23,926</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(88%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Impairment of patent-related intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28,210</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(28,210</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(100%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operating Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid; font-size: 10pt"><B>Change</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">$</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-size: 10pt; text-align: center">(In thousands, except percentage change values)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">General and administrative expenses</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">15,301</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">19,045</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(3,744</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(20%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Non-cash stock compensation expense - G&amp;A</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,075</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,133</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,058</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(50%</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Non-cash stock compensation expense - Profits Interests</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,450</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,450</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(100%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total general and administrative expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">16,376</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,728</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,352</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(13%</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>General and Administrative Expenses.&nbsp;&nbsp;</I>General
and administrative expenses include employee compensation and related personnel costs, including variable performance based compensation
and non-cash stock compensation expenses, office and facilities costs, legal and accounting professional fees, public relations,
marketing, stock administration, business development, state taxes based on gross receipts and other corporate costs. A summary
of the main drivers of the change in general and administrative expenses for the periods presented is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019 vs. 2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-style: italic">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-style: italic">&nbsp;</TD><TD STYLE="font-size: 10pt; font-style: italic">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-style: italic; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; font-style: italic; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 63%; font-size: 10pt; text-align: left">Personnel costs and board fees</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(766</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Variable performance-based compensation costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(373</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Corporate, general and administrative costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(734</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left">Non-cash stock compensation expense <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400"><SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,393</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Employee severance costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,872</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total change in general and administrative expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2,352</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>_________________________________________________________________</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><I>(1) - Refer to Note 9 in the
accompany consolidated financial statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Profits interests are classified as liability
awards, which are measured at fair value on the grant date and re-measured each reporting period at fair value until the award
is settled. Compensation expense (included in &ldquo;non-cash stock compensation expense - profits interests&rdquo;
above) is adjusted each reporting period for increases or decreases in the estimated fair value, which is primarily impacted by
changes in the fair value of the underlying Veritone warrants related to the liability. Upon vesting of the units,
which occurred in September 2017, any previously unrecognized compensation expense was immediately recognized for any changes in
fair value. The fair value of the Veritone related profits interests Units totaled $591,000 as of December&nbsp;31, 2019 and December
31, 2018. Refer to Note 9 in the  consolidated financial statements elsewhere herein for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Other. </I>Fiscal year 2019 and 2018
operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $1.8 million
and $2.6 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Other Income (Expense)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Change in Fair Value of Investment, net.
</I>Our equity investment in Veritone is recorded at fair value, and therefore, is marked to market at each balance sheet date.
Results for fiscal year 2019 included a net unrealized gain on our equity investment in Veritone totaling $9.9 million and a realized
loss of $9.2 million on the sale of 1,121,071 shares of Veritone common stock at a weighted average price of $5.91. Results for
fiscal year 2018 included a net unrealized loss on our equity investment in Veritone totaling $59.1 million and a realized loss
of $19.1 million on the sale of 2,700,000 shares of Veritone common stock at a weighted average price of $7.07.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Income Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Income tax benefit (expense) (in thousands)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">1,824</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(1,179</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Effective tax rate</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10)%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our effective tax rates for fiscal year
2019 and 2018, were primarily comprised of foreign taxes withheld and refunded on revenue agreements with licensees in foreign
jurisdictions, state taxes, and the impact of full valuation allowances recorded for net operating loss (2019 and 2018) and foreign
tax credit related tax assets generated in those periods due to uncertainty regarding future realization. Foreign taxes withheld
and refunded related to revenue agreements executed with third-party licensees domiciled in certain foreign jurisdictions for fiscal
year 2019 and 2018 totaled ($1.9) million and $1.1 million, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Inflation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Inflation has not had a significant impact
on us or any of our subsidiaries in the current or prior periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>General</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our primary sources of liquidity are
cash and cash equivalents on hand generated from our operating activities. Our management believes that our cash and cash
equivalent balances and anticipated cash flows from operations will be sufficient to meet our cash requirements through at
least March 2021 and for the foreseeable future. We may, however, encounter unforeseen difficulties that may deplete our
capital resources more rapidly than anticipated, including those set forth under Item 1A, &ldquo;Risk Factors&rdquo;, above.
Any efforts to seek additional funding could be made through issuances of equity or debt, or other external financing.
However, additional funding may not be available on favorable terms, or at all. The capital and credit markets have
experienced extreme volatility and disruption in recent years, and the volatility and impact of the disruption may
continue. At times during this period, the volatility and disruption has reached unprecedented levels. In several cases,
the markets have exerted downward pressure on stock prices and credit capacity for certain issuers, and the commercial paper
markets may not be a reliable source of short-term financing for us. If we fail to obtain additional financing when needed,
we may not be able to execute our business plans and our business, conducted by our operating subsidiaries, may suffer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain of our operating subsidiaries are
often required to engage in litigation to enforce their patents and patent rights. In connection with any of our operating
subsidiaries&rsquo; patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating
subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating
to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions
against us or our operating subsidiaries or award attorney&rsquo;s fees and/or expenses to a defendant(s), which could be material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Cash, Cash Equivalents, Trading Securities, Restricted Cash
and Investments</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our consolidated cash, cash equivalents,
trading securities, and restricted cash totaled $203.3 million at December&nbsp;31, 2019, compared to $165.5 million at December&nbsp;31,
2018. The net change in cash, cash equivalents and restricted cash for the periods presented was comprised of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center"><B>(In thousands)</B></TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Net cash provided by (used in):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Operating activities</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(2,308</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">20,877</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Investing activities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(68,063</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(24,066</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">33,921</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4,606</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(36,450</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(7,795</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Cash Flows from Operating Activities.</I>&nbsp;&nbsp;Cash
receipts from licensees totaled $44.0 million and $103.4 million in fiscal years 2019 and 2018, respectively. The fluctuations
in cash receipts for the periods presented primarily reflects the corresponding fluctuations in revenues recognized during the
same periods, as described above, and the related timing of payments received from licensees. Cash outflows from operations totaled
$46.3 million and $82.5 million in fiscal years 2019 and 2018, respectively. The fluctuations in cash outflows for the periods
presented reflects the fluctuations in revenue-related inventor royalties and contingent legal fees and other operating costs and
expenses during the same periods, as discussed above, and the impact of the timing of payments to inventors, attorneys and other
vendors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Cash Flows from Investing Activities.
</I>Cash flows from investing activities and related changes were comprised of the following for the periods presented:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Patent acquisition costs</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(4,420</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Sale of investment at fair value<SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,628</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,097</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">(Purchase) Sale of other investments<SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Net purchase of trading securities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(72,088</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(36,129</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Purchases of property and equipment</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(183</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(34</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net cash used in investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(68,063</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(24,066</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">_________________</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">(1) Refer to Note 6 for additional information</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investment in Veritone.</I> In fiscal
year 2019, Acacia sold 1,121,071 shares of Veritone common stock at a weighted average price of $5.91 and recorded a realized loss
of $9.2 million on the sale. In fiscal year 2018, Acacia sold 2,700,000 shares of Veritone common stock at a weighted average price
of $7.07 and recorded a realized loss of $19.1 million on the sale. Refer to Note 6 to the consolidated financial statements elsewhere
herein for additional information regarding our investment with Veritone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investment in Miso Robotics.</I> In February
2018, we made a strategic equity investment totaling $6.0 million in the Series B financing round for Miso Robotics. In September
2019, we sold our entire investment in Miso Robotics for proceeds of $2.0 million. Refer to Note 6 to the consolidated financial
statements elsewhere herein for additional information regarding our investment in Miso.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Cash Flows from Financing Activities</I>.
Cash flows from financing activities and related changes included the following for the periods presented (in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Repurchase of common stock</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(4,634</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Repurchase of restricted common stock</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(229</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Issuance of Series A redeemable convertible preferred stock and Series A
    warrant, net of issuance costs (Note 16 and 17)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">33,842</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from exercise of stock options</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">79</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">257</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net cash provided by (used in) financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">33,921</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(4,606</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Stock Repurchase Program.</I> In February
2018, our board of directors authorized the Program to repurchase up to $20 million of our outstanding common stock in open market
purchases or private purchases, from time to time, in amounts and at prices to be determined by the board of directors at its
discretion. In fiscal year 2018, we repurchased 1,190,420 shares at an average price of $3.89 for $4,634,000. The Program expired
on February 28, 2019. On August 5, 2019, our board of directors approved a new stock repurchase program, which authorized the
purchase of up to $10.0 million of the Company's common stock through open market purchases, through block trades, through 10b5-1
plans, or by means of private purchases, from time to time, through July 31, 2020. In determining whether or not to repurchase
any shares of Acacia&rsquo;s common stock, Acacia&rsquo;s board of directors consider such factors as the impact of the repurchase
on Acacia&rsquo;s cash position, as well as Acacia&rsquo;s capital needs and whether there is a better alternative use of Acacia&rsquo;s
capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases
to date were made in the open market in compliance with applicable SEC rules. The authorization to repurchase shares presented
an opportunity to reduce the outstanding share count and enhance stockholder value. The repurchased shares are expected to be
retired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white"><I>Starboard
Investment.</I>&nbsp; On November 18, 2019, the Company entered into the Securities Purchase Agreement with Starboard pursuant
to which Starboard purchased (i) 350,000 shares of Series A Preferred Stock at an aggregate purchase price of $35,000,000, and
Series A Warrants to purchase up to 5,000,000 shares of the Company&rsquo;s common stock. Refer to Notes 16, 17 and 19 to our
notes to consolidated financial statements for more information related to the Starboard Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Working Capital</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The primary components of working capital are cash and cash equivalents, trading securities,
accounts receivable, prepaid expenses, accounts payable, accrued expenses, and royalties and contingent legal fees payable. Working
capital at December&nbsp;31, 2019 was $160.1 million, compared to $170.4 million at December&nbsp;31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Consolidated accounts receivable from licensees
decreased to $0.5 million at December&nbsp;31, 2019, compared to $32.9 million at December&nbsp;31, 2018. Accounts receivable
balances fluctuate based on the timing, magnitude and payment terms associated with revenue agreements executed during the year,
and the timing of cash receipts on accounts receivable balances recorded in previous periods. Two licensees individually represented
approximately 70% and 17%, respectively, of accounts receivable at December&nbsp;31, 2019. Four licensees individually represented
approximately 38%, 36%, 12% and 11%, respectively, of accounts receivable at December&nbsp;31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Accounts payable and accrued expenses increased
to $9.5 million at December&nbsp;31, 2019, from $8.3 million at December&nbsp;31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Consolidated royalties and contingent legal
fees payable decreased to $2.2 million at December&nbsp;31, 2019, compared to $22.7 million at December&nbsp;31, 2018. Royalties
and contingent legal fees payable balances fluctuate based on the magnitude and timing of the execution of related license agreements,
the timing of cash receipts for the related license agreements, and the timing of payment of current and prior period royalties
and contingent legal fees payable to inventor and outside attorneys, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All of accounts receivable from licensees
at December&nbsp;31, 2019 are scheduled to be collected in the first and second quarter of 2020, in accordance with the terms of
the related underlying license agreements. The majority of royalties and contingent legal fees payable are scheduled to be paid
through the third quarter of 2020 in accordance with the underlying contractual arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Critical Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our consolidated financial statements are
prepared in conformity with accounting principles generally accepted in the United States of America. In preparing these financial
statements, we make assumptions, judgments and estimates that can have a significant impact on amounts reported in our consolidated
financial statements. We base our assumptions, judgments and estimates on historical experience and various other factors that
we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different
assumptions or conditions. On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that, of
the significant accounting policies discussed in Note 2 to our notes to consolidated financial statements, the following accounting
policies require our most difficult, subjective or complex judgments:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">revenue recognition;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">stock-based compensation expense;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">valuation of long-lived and intangible assets;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">valuation of Series A Warrants and
    embedded derivatives; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">accounting for income taxes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We discuss below the critical accounting
assumptions, judgments and estimates associated with these policies. Historically, our assumptions, judgments and estimates relative
to our critical accounting policies have not differed materially from actual results. For further information on our critical accounting
policies, refer to Note&nbsp;2 to the notes to consolidated financial statements included herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Revenue Recognition</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As described below, significant management
judgment must be made and used in connection with the revenue recognized in any accounting period. Material differences may result
in the amount and timing of revenue recognized or deferred for any period, if management made different judgments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenue is recognized upon transfer of control
of promised bundled IP rights and other contractual performance obligations to licensees in an amount that reflects the consideration
we expect to receive in exchange for those IP rights. Revenue contracts that provide promises to grant the right to use IP rights
as they exist at the point in time at which the IP rights are granted, are accounted for as performance obligations satisfied at
a point in time and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all
other revenue recognition criteria have been met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, revenue contracts
executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration
for the grant of certain IP rights for patented technologies owned or controlled by Acacia. Revenues also included license
fees from sales-based revenue contracts, or Recurring Revenue Agreement, the majority of which were originally executed in prior
periods, which provide for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees.
Revenues may also include court ordered settlements or awards related to our patent portfolio, or Other Settlements, or sales of
our patent portfolio. IP rights granted included the following, as applicable:&nbsp;&nbsp;(i) the grant of a non-exclusive, retroactive
and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the
release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP rights granted were
perpetual in nature, extending until the legal expiration date of the related patents. The individual IP rights are not accounted
for as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to transfer combined
items to which the promised IP rights are inputs and (ii) the Company's promise to transfer each individual IP right described
above to the customer is not separately identifiable from other promises to transfer IP rights in the contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the promised IP rights are not
individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is
distinct, and accounted for all of the IP rights promised in the contract as a single performance obligation. The IP rights
granted were &ldquo;functional IP rights&rdquo; that have significant standalone functionality. Acacia's subsequent
activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the
licensee has rights. Acacia&rsquo;s operating subsidiaries have no further obligation with respect to the grant of IP rights,
including no express or implied obligation to maintain or upgrade the technology, or provide future support or services. The
contracts provide for the grant (i.e., transfer of control) of the licenses, covenants-not-to-sue, releases, and other
significant deliverables upon execution of the contract. Licensees legally obtain control of the IP rights upon execution of
the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when
collectability is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for
payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or
usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For sales-based royalties, the Company includes
in the transaction price some or all of an amount of estimated variable consideration to the extent that it is&nbsp;probable&nbsp;that
a significant reversal in the amount of cumulative&nbsp;revenue&nbsp;recognized will not occur when the uncertainty associated
with the variable consideration is subsequently resolved. Notwithstanding, revenue&nbsp;is recognized for a sales-based royalty
promised in exchange for a license of IP rights when the later of (i) the subsequent sale or usage occurs, or (ii) the&nbsp;performance
obligation&nbsp;to which some or all of the sales-based royalty has been allocated has been satisfied. Estimates are generally
based on historical levels of activity, if available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues from contracts with significant
financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have
paid if the licensee had paid cash for the IP rights when they transfer to the licensee. In determining the transaction price,
the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient,
the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company
expects, at contract inception, that the period between when the entity transfers promised IP rights to a customer and when the
customer pays for the IP rights will be one year or less.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In general, the Company is required to make
certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include
identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining
whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers
to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining
whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based
royalties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For fiscal years 2019 and 2018, the majority
of our revenue agreements provided for the payment to us of one-time, paid-up license fees in consideration for the grant of certain
IP rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual
basis, extending until the expiration of the underlying patents. Pursuant to the terms of these agreements, our operating subsidiaries
have no further obligation with respect to the grant of the non-exclusive licenses, covenants-not-to-sue, releases, and other deliverables,
including no express or implied obligation on our operating subsidiaries&rsquo; part to maintain or upgrade the technology, or
provide future support or services. The agreements provided for the grant of the licenses, covenants-not-to-sue, releases, and
other significant contractual performance obligations upon execution of the agreement. As such, the earnings process was determined
to be complete and revenue was recognized upon the execution of the agreements. Historically, term license agreements have not
been a material component of our operating revenues, with the majority of license agreements being paid-up, perpetual license agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Stock-based Compensation Expense</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Equity Based Awards.</I> Stock-based
compensation payments to employees and non-employee directors are recognized as expense in the statements of operations. The compensation
cost for all stock-based awards is measured at the grant date, based on the fair value of the award (determined using a Black-Scholes
option pricing model for stock options and intrinsic value on the date of grant for non-vested restricted stock), and is recognized
as an expense over the employee&rsquo;s requisite service period (generally the vesting period of the equity award). Determining
the fair value of stock-based awards at the grant date requires significant estimates and judgments, including estimating the market
price volatility of our common stock, future employee stock option exercise behavior and requisite service periods. We account
for forfeitures of awards as they occur</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the year ended December 31, 2019,
the Company granted restricted stock units with market-based vesting conditions. The restricted stock units with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market-based vesting condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo
valuation technique. <FONT STYLE="color: #212529">Refer to Notes 9 </FONT>to our notes to consolidated financial statements <FONT STYLE="color: #212529">for
more information related to restricted stock units granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Valuation of Long-lived and Intangible Assets</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Patent Portfolio Impairment Testing.
</I>We review long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events
or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted
future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded
equal to the excess of the asset&rsquo;s carrying value over its fair value. If an asset is determined to be impaired, the loss
is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate
of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We did not record any patent portfolio impairment
charges for the fiscal year ended December 31, 2019. We recorded $28.2 million in patent portfolio charges for the fiscal year
ended December 31, 2018. The impairment charges were recorded in the periods due to adverse litigation outcomes, a reduction in
expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future
resources to in connection with the licensing and enforcement of such portfolios. The impairment charges consisted of the excess
of the asset&rsquo;s carrying value over its estimated fair value as of the applicable measurement date. Estimated fair value was
determined based on estimates of future cash flows and estimates of probabilities of realization given adverse litigation outcomes
and resource allocation decisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Valuation of Embedded Derivatives</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Embedded derivatives that are required
to be bifurcated from their host contract are evaluated and valued separately from host instrument. A binomial lattice framework
is used to estimate the fair value of the embedded derivative put option, conversion option, call option, and contingent dividend
rate feature in the Series A Preferred Stock issued by the Company in 2019. The binomial model utilizes the Tsiveriotis and Fernandes
(&ldquo;TF&rdquo;) implementation in which a convertible instrument is split into two separate components: a cash-only component
which is subject to the selected risk-adjusted discount rate and an equity component which is subject only to the risk-free rate.
The model considers the (i) implied volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii)
credit spread, (iv) dividend yield, (v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various
conversion and redemption scenarios.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The implied volatility of the Company&rsquo;s
common stock is estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe
a commonly observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt
is lower than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining
until November 15, 2027 (the maturity date). The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining
term equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&rsquo;s
valuation of the embedded derivative at December 31, 2019 are as follows: volatility of 30 percent, risk-free rate of 1.86 percent,
a credit spread of 25 percent and a dividend yield of 0 percent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Accounting for Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As part of the process of preparing our
consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate.
This process involves the estimating of our actual current tax exposure together with assessing temporary differences resulting
from differing treatment of items. These differences result in deferred tax assets and liabilities, which are included within our
consolidated balance sheets. We must then assess the likelihood that our deferred tax assets will be recovered from future taxable
income and to the extent we believe that recovery is not likely, we must establish a valuation allowance. To the extent we establish
a valuation allowance or increase this allowance in a period, we must include an expense within the tax provision in the consolidated
statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Significant management judgment is required
in determining our provision for income taxes, our deferred tax assets and liabilities and our valuation allowance. Due to uncertainties
related to our ability to utilize certain deferred tax assets in future periods, we have recorded a full valuation allowance against
our net deferred tax assets as of December 31, 2019 and 2018. These assets primarily consist of foreign tax credits, capital loss
carryforwards and net operating loss carryforwards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In assessing the need for a valuation allowance,
management has considered both the positive and negative evidence available, including but not limited to, estimates of future
taxable income and related probabilities, estimates surrounding the character of future income and the timing of realization, consideration
of the period over which our deferred tax assets may be recoverable, our recent history of net income and prior history of losses,
projected future outcomes, industry and market trends and the nature of existing deferred tax assets. In management&rsquo;s estimate,
any positive indicators, including forecasts of potential future profitability of our businesses, are outweighed by the uncertainties
surrounding our estimates and judgments of potential future taxable income, primarily due to uncertainties surrounding the timing
of realization of future taxable income and the character of such income in particular future periods (i.e. foreign or domestic).
In the event that actual results differ from these estimates or we adjust these estimates should we believe we would be able to
realize these deferred tax assets in the future, an adjustment to the valuation allowance would increase income in the period such
determination was made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any changes in the judgments, assumptions
and estimates associated with our analysis of the need for a valuation allowance in any future periods could materially impact
our financial position and results of operations in the periods in which those determinations are made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Recently Adopted Accounting Pronouncements </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February 2016, FASB issued ASU 2016-02,
<I>Leases</I>, or ASC 842 which requires a lessee to recognize in the statement of financial position a liability to make lease
payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset. In July 2018, FASB
issued ASU 2018-11, Leases, which provides an additional transition option for an entity to apply the provisions of ASC 842 by
recognizing a cumulative effect adjustment at the effective date of adoption without adjusting the prior comparative periods presented.
Further, in January 2019, FASB issued ASU 2019-01, Leases: Codification Improvements, which provides disclosure relief for the
interim periods when adopting ASC 842. The primary impact of adopting ASC 842 for the Company was the recognition in the consolidated
balance sheet of certain lease-related assets and liabilities for operating leases with terms longer than 12 months as of January
1, 2019. Such amounts were not previously accounted for in the Company's consolidated balance sheets. The Company adopted ASC 842
as of January 1, 2019, electing the practical expedient approaches. The adoption of ASC 842 did not have a material impact on the
Company's consolidated results of operations for the year ending December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have not entered into off-balance sheet
financing arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Uncertain Tax Positions</I>. At December&nbsp;31,
2019, we had total unrecognized tax benefits of approximately $731,000. A noncurrent liability of $85,000 related to unrecognized
tax benefits primarily associated with state taxes was written off during 2019. No interest and penalties have been recorded for
the unrecognized tax benefits as of December&nbsp;31, 2019. If recognized, approximately $731,000 would impact our effective tax
rate. We do not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recent Accounting Pronouncements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to Note&nbsp;2 to our notes to consolidated
financial statements included elsewhere herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a15"></A><B>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The primary objective of our trading securities
activities is to preserve principal while concurrently maximizing the income we receive from our trading securities without significantly
increasing risk. Some of the securities that we invest in may be subject to interest rate risk and/or market risk. This means that
a change in prevailing interest rates, with respect to interest rate risk, or a change in the value of the United States equity
markets, with respect to market risk, may cause the principal amount or market value of the trading securities to fluctuate. For
example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the prevailing interest
rate later rises, the current value of the principal amount of our investment may decline. To minimize these risks in the future,
we intend to maintain our portfolio of cash equivalents and trading securities in a variety of securities, including commercial
paper, money market funds, high-grade corporate bonds, government and non-government debt securities and certificates of deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December 31, 2019 and December 31, 2018,
our trading securities were comprised of AAA rated money market funds that invest in first-tier only securities, which primarily
include domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations,
and fully collateralized repurchase agreements (included in cash and cash equivalents in the accompanying consolidated balance
sheets), and direct investments in short term, highly liquid, investment grade, U.S. government and corporate securities (included
in trading securities in the accompanying consolidated balance sheets).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In general, money market funds are not
subject to market risk because the interest paid on such funds fluctuates with the prevailing interest rate. Accordingly, a 100
basis point increase in interest rates or a 10% decline in the value of the United States equity markets would not be expected
to have a material impact on the value of such money market funds. Investments in U.S. government fixed income securities are
subject to interest rate risk and will decline in value if interest rates increase. However, due to the relatively short duration
of our trading securities portfolio, an immediate 10% change in interest rates would have no material impact on our financial
condition, results of operations or cash flows. Declines in interest rates over time will, however, reduce our interest income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a16"></A><B>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The financial statements and related financial
information required to be filed hereunder are indexed under Item 15 of this report and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a17"></A><B>ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a18"></A><B>ITEM 9A. CONTROLS AND PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(a) Conclusion Regarding the Effectiveness of Disclosure
Controls and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the supervision and with the participation
of our management, including our Chief Executive Officer and Corporate Controller, we conducted an evaluation of our disclosure
controls and procedures, as defined in Rules&nbsp;13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our
Chief Executive Officer and Corporate Controller concluded that, as of December&nbsp;31, 2019, our disclosure controls and procedures
were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange
Act is accumulated and communicated to our management, including our Chief Executive Officer and Corporate Controller, as appropriate
to allow timely decisions regarding required disclosure, and that such information is recorded, processed, summarized and reported
within the time periods prescribed by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(b) Management&rsquo;s Report on Internal Control Over Financial
Reporting </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our management is responsible for establishing
and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Corporate Controller,
we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the 2013 framework in
<I>Internal Control - Integrated Framework</I> issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Based on our evaluation under the framework in <I>Internal Control - Integrated Framework</I>, our management concluded that our
internal control over financial reporting was effective as of December&nbsp;31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Grant Thornton LLP, the independent registered
public accounting firm who audited our consolidated financial statements included in this annual report, has issued an attestation
report on the effectiveness of our internal control over financial reporting as of December&nbsp;31, 2019, which is included herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Changes in Internal Controls</I>. There
were no changes in our internal control over financial reporting during the fourth fiscal quarter that have materially affected,
or are reasonably likely to materially affect, our internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Inherent Limitations on Effectiveness
of Controls. </I>Our management, including our Chief Executive Officer and Corporate Controller, does not expect that our disclosure
controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no
matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&rsquo;s objectives
will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls
must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation
of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues
and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions
about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals
under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject
to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance
with policies or procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="a19"></A><B>ITEM 9B. OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a20"></A><B>PART III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a21"></A><B>ITEM 10. DIRECTORS, EXECUTIVE OFFICERS
AND CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as provided below, in accordance
with General Instruction G(3) to Form 10-K, certain information required by this Item is incorporated herein by reference to our
definitive proxy statement for our 2020 annual meeting of stockholders to be filed with the SEC no later than April&nbsp;30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Code of Conduct.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have adopted a Code of Conduct
that applies to all employees, including our Chief Executive Officer and Corporate Controller and any persons performing similar
functions. Our Code of Conduct is provided on our internet website at <U>www.acaciaresearch.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a22"></A><B>ITEM 11. EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with General Instruction G(3)
to Form 10-K, the information required by this Item is incorporated herein by reference to our definitive proxy statement for our
2020 annual meeting of stockholders to be filed with the SEC no later than April&nbsp;30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a23"></A><B>ITEM 12. SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with General Instruction G(3)
to Form 10-K, certain information required by this Item is incorporated herein by reference to our definitive proxy statement for
our 2020 annual meeting of stockholders to be filed with the SEC no later than April&nbsp;30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a24"></A><B>ITEM 13. CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS, AND DIRECTOR INDEPENDENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with General Instruction G(3)
to Form 10-K, the information required by this Item is incorporated herein by reference to our definitive proxy statement for our
2020 annual meeting of stockholders to be filed with the SEC no later than April&nbsp;30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a25"></A><B>ITEM 14. PRINCIPAL ACCOUNTING FEES AND
SERVICES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with General Instruction G(3)
to Form 10-K, the information required by this Item is incorporated herein by reference to our definitive proxy statement for our
2020 annual meeting of stockholders to be filed with the SEC no later than April&nbsp;30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a26"></A>PART IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a27"></A><B>ITEM 15. EXHIBITS, FINANCIAL STATEMENT
SCHEDULES</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 97%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The following documents are filed as part of this report.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 89%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)&nbsp;&nbsp;Financial Statements&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acacia Research Corporation Consolidated Financial Statements</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><A HREF="#a35"><FONT STYLE="font-family: Times New Roman, Times, Serif">Reports of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-1</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><A HREF="#a29"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consolidated
Balance Sheets as of December 31, 2019 and 2018</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-3</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><A HREF="#a30"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consolidated Statements of Operations for the Years Ended December 31, 2019 and 201</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>8</U></FONT></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-4</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><A HREF="#a31"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consolidated
    Statements of Comprehensive Loss for the Years Ended December 31, 2019 and 20</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>18</U></FONT></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-5</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><A HREF="#a32"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consolidated Statements
    of Series A Redeemable Convertible Preferred Stock and Stockholders&rsquo; Equity for the Years Ended December 31, 2019 and
    2018</FONT></A></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-6</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><A HREF="#a33"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consolidated Statements of Cash Flows for the Years Ended December 31, 2019 and 2018</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-8</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><A HREF="#a34"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notes to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">F-9</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)&nbsp;&nbsp;&nbsp;Financial Statement Schedules</FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financial statement schedules are omitted because they are not applicable or the required information is shown in the Financial Statements or the Notes thereto.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)&nbsp;&nbsp;Exhibits</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Refer to Item 15(b) below.</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibits.&nbsp; The following exhibits are either filed herewith or incorporated herein by reference:</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: top; width: 10%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Number</U></B></P></TD>
    <TD STYLE="vertical-align: bottom; width: 90%"><FONT STYLE="font-size: 10pt"><B><U>Description</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000101968712000172/acacia_8ka1-ex0201.htm" STYLE="-sec-extract: exhibit">Agreement
    and Plan of Merger, dated November 22, 2011, by and among Acacia Research Group LLC, Apollo Patent Corp., Adaptix, Inc., and
    Baker Communications Fund II (QP), L.P., solely in its capacity as representative for the shareholders of Adaptix, Inc.</A>
    (3)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="acacia_ex0301.htm">Amended and Restated Certificate of Incorporation (as updated through February 18, 2020 and currently in effect)</A></FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312520009993/d839353ddef14a.htm" STYLE="-sec-extract: exhibit">Amended and Restated Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock, as filed with the Delaware Secretary of State on January 7, 2020</A> (1)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454919000042/exhibit3172319.htm" STYLE="-sec-extract: exhibit">Second Amended
    and Restated Bylaws</A> (7)</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454919000017/actgex41123118.htm" STYLE="-sec-extract: exhibit">Tax Benefits Preservation Plan, dated as of March 16, 2019, by and between Acacia Research Corporation and Computershare Inc., as Rights Agent, which includes the Form of Certificate of Designation, Preferences and Rights of Participating Preferred Stock as Exhibit A, the Form of Rights Certificate as Exhibit B and the Summary of Terms as Exhibit C </A>(21) </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="acacia_ex0402.htm">Description of Acacia Research Corporation Capital Stock</A></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312520009993/d839353ddef14a.htm" STYLE="-sec-extract: exhibit">Form of Senior Secured Note</A> (15)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312520009993/d839353ddef14a.htm" STYLE="-sec-extract: exhibit">Form of Series A Warrant to Purchase Common Stock</A> (16)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312520009993/d839353ddef14a.htm" STYLE="-sec-extract: exhibit">Form of Series B Warrant to Purchase Common Stock </A>(17)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="acacia_ex1001.htm">Form of Indemnification Agreement</A></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">10.2*</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000101968709000666/acro_10k-ex1026.htm" STYLE="-sec-extract: exhibit">Acacia Research Corporation Amended and Restated Executive Severance Policy</A> (2)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312512064435/d302610dex101.htm" STYLE="-sec-extract: exhibit">Form of Purchase Agreement</A> (4)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">10.4*</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000101968713001465/acacia_def14a.htm" STYLE="-sec-extract: exhibit">2013 Acacia Research Corporation Stock Incentive Plan</A> (5)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">10.5*</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000101968713002041/acacia_8k-ex1002.htm" STYLE="-sec-extract: exhibit">Form of Stock Issuance Agreement under the 2013 Acacia Research Corporation Stock Incentive Plan</A> (6)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">10.6*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454916000146/ex101.htm" STYLE="-sec-extract: exhibit">2016 Acacia Research Corporation Stock Incentive Plan</A> (8)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">10.7*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000006/actgex1024123116.htm" STYLE="-sec-extract: exhibit">Form of Stock Option Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan</A> (9)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">10.8*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000006/actgex1025123116.htm" STYLE="-sec-extract: exhibit">Form of Stock Issuance Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan</A> (9)</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.9*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000019/ex10103312017.htm" STYLE="-sec-extract: exhibit">Form of Profits Interest Agreement Under AIP Operation LLC Profits Interest Plan</A> (10)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.10</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000008/exhibit101.htm" STYLE="-sec-extract: exhibit">Investment Agreement dated August 15, 2016, by and between Acacia Research Corporation and Veritone, Inc.</A> (11)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.11</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000008/exhibit103primarywarre58.htm" STYLE="-sec-extract: exhibit">Secured Promissory Note dated August 15, 2016, issued by Veritone, Inc. to Acacia Research Corporation</A> (11)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.12</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000008/exhibit103primarywarre58.htm" STYLE="-sec-extract: exhibit">Primary Common Stock Purchase Warrant dated August 15, 2016, issued by Veritone, Inc. to Acacia Research Corporation, together with form of 10% Warrant to Purchase Common Stock</A> (11)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.13</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000008/exhibit104firsttranch470.htm" STYLE="-sec-extract: exhibit">Common Stock Purchase Warrant dated August 15, 2016, issued by Veritone, Inc. to Acacia Research Corporation</A> (11)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.14</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000008/exhibit105firsttranchewa.htm" STYLE="-sec-extract: exhibit">Common Stock Purchase Warrant dated November 25, 2016, issued by Veritone, Inc. to Acacia Research Corporation</A> (11)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.15</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454917000008/exhibit106secondtranchew.htm" STYLE="-sec-extract: exhibit">Common Stock Purchase Warrant dated November 25, 2016, issued by Veritone, Inc. to Acacia Research Corporation</A> (11)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.16*</FONT></TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454918000084/boothengagement1.htm" STYLE="-sec-extract: exhibit">Employment Agreement, effective August 13, 2018, by and between Acacia Research Group, LLC and Marc Booth</A> (12)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.17*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454918000084/haynesseparation.htm" STYLE="-sec-extract: exhibit">Separation Agreement and General Release of Claims, effective August 10, 2018, by and between Acacia Research Group, LLC and Clayton J. Haynes </A>(12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.18*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454918000084/haynesconsulting.htm" STYLE="-sec-extract: exhibit">Consulting Agreement, effective August 10, 2018, by and between Acacia Research Corporation and Clayton J. Haynes </A>(12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>10.19*</TD>
    <TD><FONT STYLE="background-color: white"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454918000084/treskaseparation.htm" STYLE="-sec-extract: exhibit">Separation Agreement and
General Release of Claims, effective August 10, 2018, by and between Acacia Research Group, LLC and Edward J. Treska</A> (12)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-size: 10pt">10.20*</FONT></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454918000084/treskaconsulting.htm" STYLE="-sec-extract: exhibit">Consulting Agreement, effective August 10, 2018, by and between Acacia Research Corporation and Edward J. Treska</A> (12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">10.21*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454919000010/khooverseparationandrele.htm" STYLE="-sec-extract: exhibit">Separation Agreement and General Release of Claims, dated February 12, 2019, by and between Acacia Research Group, LLC and Kirsten Hoover</A> (13)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1</FONT>0.22*</TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000168316819003542/acacia_ex1001.htm" STYLE="-sec-extract: exhibit">Employment Agreement, dated September 3, 2019, by and among Acacia Research Group LLC, Acacia Research Corporation and Clifford Press</A> (14)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1</FONT>0.23*</TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000168316819003542/acacia_ex1002.htm" STYLE="-sec-extract: exhibit">Employment Agreement, dated September 3, 2019, by and among Acacia Research Group LLC, Acacia Research Corporation and Alfred Tobia</A> (14)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1</FONT>0.24</TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312520009993/d839353ddef14a.htm" STYLE="-sec-extract: exhibit">Securities
    Purchase Agreement dated November 18, 2019, by and among Acacia Research Corporation, Starboard Value LP and the investors
    listed on the Schedule of Buyers attached thereto</A></FONT> (18) </TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1</FONT>0.25</TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312520009993/d839353ddef14a.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement dated November 18, 2019, by and among Acacia Research Corporation and the investors listed on the Schedule of Buyers attached thereto</A> (19)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">1</FONT>0.26</TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/934549/000119312520009993/d839353ddef14a.htm" STYLE="-sec-extract: exhibit">Governance Agreement dated November 18, 2019</A> and amended <A HREF="http://www.sec.gov/Archives/edgar/data/934549/000093454920000005/exhibit101amdtgovernance.htm" STYLE="-sec-extract: exhibit">January 7, 2020</A>, by and among Acacia Research Corporation and the entities and natural persons set forth on the signature pages thereto (20)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>10.27</TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="acacia_ex1027.htm">Lease Agreement dated June 7, 2019, by and between Acacia Research Corporation and Jamboree Center 4 LLC</A></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">21.1</FONT></TD>
    <TD><A HREF="acacia_ex2101.htm"><FONT STYLE="font-size: 10pt">List of Subsidiaries</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">23.1</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="acacia_ex2301.htm">Consent of Independent Registered Public Accounting Firm</A></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">24.1</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#a37">Power of Attorney</A></FONT> <FONT STYLE="font-size: 10pt">(included in the signature page hereto).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">31.1&dagger;</FONT></TD>
    <TD><A HREF="acacia_ex3101.htm"><FONT STYLE="font-size: 10pt">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">31.2&dagger;</FONT></TD>
    <TD><A HREF="acacia_ex3102.htm"><FONT STYLE="font-size: 10pt">Certification of Corporate Controller Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">32.1</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="acacia_ex3201.htm">Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350</A></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">32.2</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="acacia_ex3202.htm">Certification of Corporate Controller Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350</A></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">101</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Interactive Date Files Pursuant to Rule 405 of Regulation S-T.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;___________________________</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="width: 20px">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">*</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The referenced exhibit is a management contract, compensatory plan or arrangement required to be filed as an exhibit to this Annual Report on Form 10-K pursuant to Item 15(c) of Form 10-K.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 20px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&dagger;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the SEC and are not to be incorporated by reference into any filing of Acacia Research Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language contained in any filing.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated  by reference to Appendix B to Acacia Research Corporation&rsquo;s
Definitive Proxy Statement on Schedule 14A filed on January 17, 2020 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research
    Corporation&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2008, filed on February 26, 2009 (File No.
    000-26068).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research Corporation&rsquo;s
Current Report on Form 8-K/A filed on January 19, 2012 (File No. 000-26068). Portions of this exhibit have been omitted pursuant
to a request for confidential treatment under Rule 24-b-2 of the Securities Exchange Act of 1934, as amended. The omitted material
has been separately filed with the Securities and Exchange Commission.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research Corporation&rsquo;s
Current Report on Form 8-K filed on February 16, 2012 (File No. 000-26068).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Annex A to Acacia Research Corporation&rsquo;s
Definitive Proxy Statement on Schedule 14A filed on April 24, 2013 (File No. 000-26068).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research
    Corporation&rsquo;s Current Report on Form 8-K on May 22, 2013 (File No. 000-26068)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia
    Research Corporation&rsquo;s Annual Report on Form 8-K filed on July 25, 2019 (File No.&nbsp;001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia
    Research Corporation&rsquo;s Quarterly Report on Form 10-Q for the period ended June 30, 2016, filed on August 9, 2016 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research Corporation&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2016, filed on March 10, 2017 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research Corporation&rsquo;s
Quarterly Report on Form 10-Q for the period ended March 31, 2017, filed on May 10, 2017 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research Corporation&rsquo;s
Current Report on Form 8-K filed on March 16, 2017 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research Corporation&rsquo;s
Current Report on Form 8-K filed on August 16, 2018 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(13)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research Corporation&rsquo;s
Current Report on Form 8-K filed on February 13, 2019 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia
    Research Corporation&rsquo;s Annual Report on Form 10-Q for the period ended September 30, 2019, filed on November 12, 2019
    (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Appendix E to Acacia Research Corporation&rsquo;s
Definitive Proxy Statement on Schedule 14A filed on January 17, 2020 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(16)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Appendix C to Acacia Research Corporation&rsquo;s
Definitive Proxy Statement on Schedule 14A filed on January 17, 2020 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(17)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Appendix D to Acacia Research Corporation&rsquo;s
Definitive Proxy Statement on Schedule 14A filed on January 17, 2020 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(18) </FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Appendix A to Acacia Research Corporation&rsquo;s
Definitive Proxy Statement on Schedule 14A filed on January 17, 2020 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19) </FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Appendix F to Acacia Research Corporation&rsquo;s
Definitive Proxy Statement on Schedule 14A filed on January 17, 2020 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(20)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Appendix G
    to Acacia Research Corporation&rsquo;s Definitive Proxy Statement on Schedule 14A filed on January 17, 2020 (File No.
    001-37721); </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 46px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated by reference to Acacia Research
    Corporation&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2018, filed on March 15, 2019 (File No. 001-37721).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a28"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of Section
13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="5">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 51%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 38%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">ACACIA RESEARCH CORPORATION</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: white 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dated:</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;16, 2020</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: white 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Clifford Press</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: white 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Clifford Press</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Chief Executive Officer</I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;(Authorized Signatory)</I></P></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a37"></A><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We,
the undersigned directors and officers of Acacia Research Corporation, do hereby constitute and appoint Clifford Press and Li
Yu, and each of them, as our true and lawful attorneys-in-fact and agents with power of substitution, to do any and all acts and
things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in
our names in the capacities indicated below, which said attorney-in-fact and agent may deem necessary or advisable to enable said
corporation to comply with the Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the
Securities and Exchange Commission, in connection with this Annual Report on Form 10-K, including specifically but without limitation,
power and authority to sign for us or any of us in our names in the capacities indicated below, any and all amendments hereto;
and we do hereby ratify and confirm all that said attorney-in-fact and agent, shall do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and the capacities
and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="6">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 18%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Signature</U>&nbsp;&nbsp;</B></FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Title</U></B></FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Date</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Clifford Press</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;16, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Clifford Press</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Principal Executive Officer)</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Li Yu</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Corporate Controller</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;16, 2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Li Yu</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Principal Financial Officer)</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Isaac Kohlberg</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;16, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Isaac Kohlberg</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Maureen O'Connell</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;16, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Maureen O'Connell</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">/s/</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">Jonathan Sagal</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Director</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt">March 16, 2020</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Jonathan Sagal</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alfred V. Tobia, Jr.</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;16, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alfred V. Tobia, Jr.</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Katharine Wolanyk</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">March&nbsp;16, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Katharine Wolanyk</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a36"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors and Stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia Research Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Opinion on the financial statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have audited the accompanying consolidated balance sheets
of Acacia Research Corporation and subsidiaries (the &ldquo;Company&rdquo;) as of December 31, 2019 and 2018, the related consolidated
statements of operations, comprehensive loss, changes in series A redeemable convertible preferred stock and stockholders&rsquo;
equity, and cash flows for each of the two years in the period ended December 31, 2019, and the related notes (collectively referred
to as the &ldquo;financial statements&rdquo;). In our opinion, the financial statements present fairly, in all material respects,
the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for
each of the two years in the period ended December 31, 2019, in conformity with accounting principles generally accepted in the
United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;), the Company&rsquo;s internal control over financial
reporting as of December 31, 2019, based on criteria established in the 2013 <I>Internal Control&mdash;Integrated Framework</I>
issued by the Committee of Sponsoring Organizations of the Treadway Commission (&ldquo;COSO&rdquo;), and our report dated March
16, 2020 expressed an unqualified opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Basis for opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These financial statements are the responsibility of the Company&rsquo;s
management. Our responsibility is to express an opinion on the Company&rsquo;s financial statements based on our audits. We are
a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conducted our audits in accordance with the standards of
the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis
for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ GRANT THORNTON LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&rsquo;s auditor since 2007.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newport Beach, CA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 16, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a35"></A><B>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors and Stockholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia Research Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Opinion on internal control over financial reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have audited the internal control over financial reporting
of Acacia Research Corporation and subsidiaries (the &ldquo;Company&rdquo;) as of December 31, 2019, based on criteria established
in the 2013 <I>Internal Control&mdash;Integrated Framework</I> issued by the Committee of Sponsoring Organizations of the Treadway
Commission (&ldquo;COSO&rdquo;). In our opinion, the Company maintained, in all material respects, effective internal control over
financial reporting as of December 31, 2019, based on criteria established in the 2013 <I>Internal Control&mdash;Integrated Framework</I>
issued by COSO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;), the consolidated financial statements of the Company
as of and for the year ended December 31, 2019, and our report dated March 16, 2020 expressed an unqualified opinion on those financial
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Basis for opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s management is responsible for maintaining
effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial
reporting, included in the accompanying Management&rsquo;s Report on Internal Control Over Financial Reporting (&ldquo;Management&rsquo;s
Report&rdquo;). Our responsibility is to express an opinion on the Company&rsquo;s internal control over financial reporting based
on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the
Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conducted our audit in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal
control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal
control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating
effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in
the circumstances. We believe that our audit provides a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Definition and limitations of internal control over financial
reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A company&rsquo;s internal control over financial reporting
is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A company&rsquo;s internal control
over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable
detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance
that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations
of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the company&rsquo;s assets that could have a material effect on the financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ GRANT THORNTON LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newport Beach, CA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 16, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a29"></A><B>CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(In thousands, except share and per share
information)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">December 31,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">December 31,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">ASSETS</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Current assets:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Cash and cash equivalents</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">57,359</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">128,809</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Trading securities - debt</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">93,843</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">33,642</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Trading securities - equity</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">17,140</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">3,012</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Accounts receivable</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">511</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">32,884</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Prepaid
    expenses and other current assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2,912</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">3,125</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Total current assets</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">171,765</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">201,472</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Long-term restricted cash</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">35,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Investment at fair value (Note
    6)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,500</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,459</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Other investments (Note 6)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">8,195</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Patents, net of accumulated
    amortization</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,814</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">6,587</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Leased right-of-use assets</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,264</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Other
    non-current assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">818</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">236</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Total
    assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">218,161</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">223,949</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">LIABILITIES, REDEEMABLE CONVERTIBLE
    PREFERRED STOCK, AND STOCKHOLDERS' EQUITY</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Current liabilities:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Accounts payable</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,765</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">3,698</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Accrued expenses and other
    current liabilities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,265</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">4,299</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Accrued compensation</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">507</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">350</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Royalties
    and contingent legal fees payable</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2,178</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">22,688</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Total current liabilities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">11,715</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">31,035</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Series A warrant liabilities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">3,568</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Series A embedded derivative liabilities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">17,974</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Long-term lease liabilities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,264</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Other long-term liabilities</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">593</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,674</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Total
    liabilities</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">35,114</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">32,709</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Commitments and contingencies (Note 10)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">Series A redeemable convertible
    preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding
    as of December 31, 2019; no shares authorized, issued or outstanding as of December 31, 2018; aggregate liquidation preference
    of $35,125 and $0 as of December 31, 2019 and December 31, 2018, respectively (Note 16)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">8,089</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Stockholders' equity:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">Preferred stock, par value
    $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">Common stock, par value $0.001
    per share; 100,000,000 shares authorized; 50,370,987 and 49,639,319 shares issued and outstanding as of December 31, 2019
    and December 31, 2018, respectively</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">50</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">50</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">Treasury stock, at cost,
    2,919,828 shares as of December 31, 2019 and December 31, 2018</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(39,272</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(39,272</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Additional paid-in capital</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">652,003</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">651,156</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Accumulated
    deficit</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(439,656</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(422,541</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Total Acacia Research Corporation
    stockholders' equity</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">173,125</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">189,393</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Noncontrolling interests</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,833</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,847</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Total stockholders' equity</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">174,958</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">191,240</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Total liabilities, redeemable
    convertible preferred stock, and stockholders' equity</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">218,161</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">223,949</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The accompanying notes are an integral
part of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><I></I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><I></I></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I><B>ACACIA
RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a30"></A>CONSOLIDATED STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(In thousands, except share and per
share information)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 9pt">Years Ended</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 9pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Revenues</FONT></TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 13%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">11,246</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="width: 13%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">131,506</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Portfolio operations:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Inventor royalties</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">4,944</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">35,168</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Contingent legal fees</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">591</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">31,501</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Patent acquisition expenses</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">4,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Litigation and licensing expenses
    - patents</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">7,803</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">8,866</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">Amortization of patents</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">3,194</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">27,120</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Other
    portfolio expenses</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,756</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2,602</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Total
    portfolio operations</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">18,288</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">109,257</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Net portfolio income (loss)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(7,042</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">22,249</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">General and administrative
    expenses <SUP>(1)</SUP></FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">16,376</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">18,728</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Impairment
    of patent-related intangible assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">28,210</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Operating loss</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(23,418</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(24,689</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Other income (expense):</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Change in fair value of investment,
    net (Note 6)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">9,899</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(59,103</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Loss on sale of investment
    (Note 6)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(9,230</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(19,095</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Impairment of other investment
    (Note 6)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(8,195</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(1,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Gain on disposal of other investment
    (Note 6)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">2,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Change in fair value of the
    Series A warrants and embedded derivative</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">4,518</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Interest
    income and other</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">5,473</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">218</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Total
    other income (expense)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">4,465</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(78,980</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Loss before income taxes</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(18,953</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(103,669</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Income taxes (expense) benefit</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">1,824</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(1,179</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Net loss including noncontrolling interests in
    subsidiaries</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(17,129</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(104,848</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Net (income) loss attributable
    to noncontrolling interests in subsidiaries</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">14</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(181</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Net loss attributable to Acacia Research Corporation</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(17,115</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(105,029</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Less: Accretion
    of redeemable preferred stock</FONT></TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 13%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(307</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="width: 13%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Net loss attributable to
    common stockholders - basic</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(17,422</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(105,029</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Basic net loss per share
    of common stock</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(0.35</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(2.10</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">Weighted average number of shares outstanding
    - basic</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">49,764,002</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">49,969,062</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">Add: Accretion of redeemable preferred stock</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">307</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">Less: Mark-to-market adjustment
    for preferred stock embedded derivative</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(3,258</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Net loss attributable to
    common stockholders - diluted</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(20,373</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(105,029</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Diluted net loss per share
    of common stock</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(0.40</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">(2.10</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">Weighted average number of shares outstanding
    - diluted</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">50,896,773</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 9pt">49,969,062</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>






<P STYLE="margin: 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 9pt">__________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 8pt">(1)
General and administrative expenses were comprised of the following:</FONT></P>



<P STYLE="margin: 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center"></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-size: 8pt"><B>Years Ended</B></FONT></TD><TD><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 8pt"><B>December 31,</B></FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">General and administrative expenses</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">15,301</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">19,045</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Non-cash stock compensation expense - G&amp;A</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">1,075</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">2,133</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">Non-cash stock compensation
    expense - Profits Interests</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,450</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">Total
    general and administrative expenses</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">16,376</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">18,728</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The accompanying notes are an integral
part of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a31"></A><B>CONSOLIDATED STATEMENTS OF COMPREHENSIVE
LOSS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(In thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center"></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Years Ended</B></FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>December 31,</B></FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Net loss including noncontrolling
    interests</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(17,129</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(104,848</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Other comprehensive income (loss):</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Unrealized loss
    on foreign currency translation, net of tax of $0.</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">88</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">Total other comprehensive loss</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(17,129</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(104,760</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Comprehensive (income) loss
    attributable to noncontrolling interests</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">14</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(181</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">Comprehensive loss attributable
    to Acacia Research Corporation</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(17,115</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">(104,941</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The accompanying notes are an integral
part of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a32"></A>CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE
CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(In thousands, except share information)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-indent: -5pt">&nbsp;</TD>
    <TD COLSPAN="29" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For the Year Ended December 31, 2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-indent: -5pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Series A
    Redeemable Convertible Preferred Stock</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Common Stock</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Treasury</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Additional<BR> Paid-in</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Accumulated<BR> Comprehensive<BR> Income</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Accumulated</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Noncontrolling<BR> Interests in<BR> Operating</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Total<BR> Stockholders'</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: center; text-indent: -5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="border-left: Black 1pt solid; padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Capital</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(loss)</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Deficit</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Subsidiaries</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Equity</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; width: 20%; font-size: 8pt; font-weight: bold; text-indent: -5pt">Balance at December 31, 2018</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">49,639,319</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">50</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">(39,272</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">651,156</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">(422,541</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">1,847</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">191,240</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Net loss attributable to Acacia Research Corporation</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(17,115</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(17,115</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Issuance of shares of Series A redeemable
    convertible preferred stock, net of embedded derivative, Series A warrants, and issuance costs</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">350,000</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">7,782</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Accretion of Series A redeemable convertible preferred stock to redemption value</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">307</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(307</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(307</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Stock options exercised</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">25,136</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">79</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">79</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Compensation expense for share-based awards, net of forfeitures</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">706,532</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">1,075</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">1,075</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Net loss attributable to noncontrolling interests in subsidiaries</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(14</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(14</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="border-left: Black 1pt solid; padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt">Balance at December 31, 2019</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">350,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">8,089</TD><TD STYLE="border-left: Black 1pt solid; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">50,370,987</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">50</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">(39,272</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">652,003</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">(439,656</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">1,833</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">174,958</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-indent: -5pt">&nbsp;</TD>
    <TD COLSPAN="29" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">For the Year Ended December 31, 2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-indent: -5pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Series A
    Redeemable Convertible Preferred Stock</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: center">Common Stock</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Treasury</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Additional<BR> Paid-in</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Accumulated<BR> Comprehensive<BR> Income</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Accumulated</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Noncontrolling<BR> Interests in<BR> Operating</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center">Total<BR> Stockholders'</TD><TD STYLE="font-size: 8pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: center; text-indent: -5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="border-left: Black 1pt solid; padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Capital</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">(loss)</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Deficit</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Subsidiaries</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 8pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Equity</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; font-weight: bold">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; width: 20%; font-size: 8pt; font-weight: bold; text-indent: -5pt">Balance at December 31, 2017</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">50,639,926</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">51</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">(34,640</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">648,996</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">(88</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">(320,018</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">1,358</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 6%; font-size: 8pt; font-weight: bold; text-align: right">295,659</TD><TD STYLE="width: 1%; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Net loss attributable to Acacia Research Corporation</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(105,029</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(105,029</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Cumulative effect of new accounting principle</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">2,506</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">308</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">2,814</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Stock options exercised</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">82,615</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">257</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">257</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Compensation expense for share-based awards, net of forfeitures</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">166,998</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">1</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">2,132</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">2,133</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Repurchase of restricted common stock</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(59,800</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(229</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(229</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Repurchase of common stock</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(1,190,420</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(2</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(4,632</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">(4,634</TD><TD STYLE="font-size: 8pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Net income attributable to noncontrolling interests in subsidiaries</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">181</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">181</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Unrealized loss on foreign currency translation</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">88</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 8pt; text-align: right">88</TD><TD STYLE="font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="border-left: Black 1pt solid; padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 8pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 5pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt">Balance at December 31, 2018</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="border-left: Black 1pt solid; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">49,639,319</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">50</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">(39,272</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">651,156</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">(422,541</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">)</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">1,847</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right">191,240</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>The accompanying
notes are an integral part of these consolidated financial statements.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a33"></A><B>CONSOLIDATED STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(In thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Years Ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left">Cash flows from operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left">Net loss including noncontrolling interests in subsidiaries</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(17,129</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(104,848</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Adjustments to reconcile net loss including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Change in fair value of investment, net (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(9,899</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">59,103</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Loss on sale of investment (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">9,230</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,095</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Impairment of other investment (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,195</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Gain on disposal of other investment (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Depreciation and amortization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,227</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">27,145</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,258</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Change in fair value of Series A warrant</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,260</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Non-cash stock compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,075</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(317</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Change in value of trading securities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,241</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Impairment of patent-related intangible assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28,210</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt">Other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(436</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Changes in assets and liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Accounts receivable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">32,373</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(28,189</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Prepaid expenses and other assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(220</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(208</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Accounts payable and accrued expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">109</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">963</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Royalties and contingent legal fees payable</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(20,510</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">19,359</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,308</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,877</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left">Cash flows from investing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Patent acquisition costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,420</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Sale of investment at fair value (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,628</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,097</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">(Purchase) Sale of other investments (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Purchases of trading securities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(147,178</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(102,769</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Maturities and sales of trading securities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">75,090</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">66,640</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Purchases of property and equipment</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(183</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(34</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(68,063</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(24,066</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left">Cash flows from financing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Repurchase of common stock</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(4,634</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Repurchase of restricted common stock</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(229</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left">Issuance of Series A redeemable convertible preferred stock and Series A warrants, net of issuance costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">33,842</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from exercise of stock options</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">79</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">257</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in) financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">33,921</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4,606</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Decrease in cash and cash equivalents and restricted cash</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(36,450</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(7,795</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Cash and cash equivalents and restricted cash, beginning</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">128,809</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">136,604</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents and restricted cash, ending</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">92,359</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">128,809</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>The accompanying notes are an integral
part of these consolidated financial statements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a34"></A><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1.&nbsp; DESCRIPTION OF BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Description of Business. </I>As used
herein, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;Acacia&rdquo; and the &ldquo;Company&rdquo; refer to Acacia
Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its
management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&rsquo;s operating subsidiaries invest
in, license and enforce patented technologies. Acacia&rsquo;s operating subsidiaries partner with inventors and patent owners,
applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent
years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed
as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement and/or supplement
Acacia&rsquo;s primary licensing and enforcement business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&rsquo;s operating subsidiaries generate
revenues and related cash flows from the granting of IP rights for the use of patented technologies that its operating subsidiaries
control or own. Acacia&rsquo;s operating subsidiaries assist patent owners with the prosecution and development of their patent
portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of
their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies
through the filing of patent infringement litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&rsquo;s operating subsidiaries are
principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the
patent portfolio outright. Acacia&rsquo;s operating subsidiaries own or control the rights to multiple patent portfolios, which
include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Neither Acacia nor its operating subsidiaries
invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and
companies that own IP through its relationships with inventors, universities, research institutions, technology companies and others.
If Acacia&rsquo;s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then
they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During fiscal year 2019, Acacia obtained
control of five new patent portfolios. During fiscal year 2018, Acacia did not obtain control of any new patent portfolios.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia was incorporated on January 25, 1993
under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2.&nbsp;&nbsp;SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Accounting Principles.&nbsp;&nbsp;</I>The
consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally
accepted accounting principles in the United States of America (&quot;U.S. GAAP&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Principles of Consolidation.&nbsp;&nbsp;</I>The
accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled
subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Noncontrolling interests in
Acacia&rsquo;s majority-owned and controlled operating subsidiaries (&ldquo;noncontrolling interests&rdquo;) are separately presented
as a component of stockholders&rsquo; equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss
attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements
of Series A redeemable convertible preferred stock and stockholders&rsquo; equity for total noncontrolling interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A wholly owned subsidiary of Acacia is the
general partner of the Acacia Intellectual Property Fund, L.P. (the &ldquo;Acacia IP Fund&rdquo;), which was formed in August 2010.
The Acacia IP Fund is included in the Company&rsquo;s consolidated financial statements since 2010, as Acacia&rsquo;s wholly owned
subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia
IP Fund was terminated as of December 31, 2017 and is in the process of being liquidated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Revenue Recognition.&nbsp;&nbsp;</I>Revenue
is recognized upon transfer of control of promised bundled IP rights (hereinafter &ldquo;IP Rights&rdquo;) and other contractual
performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP
Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which
the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized
at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have
been met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, revenue contracts
executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration
for the grant of certain IP Rights for patented technologies owned or controlled by Acacia (&ldquo;Paid-up Revenue Agreements&rdquo;).
Revenues also included license fees from sales-based revenue contracts, the majority of which were originally executed in prior
periods, which provide for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees
(&ldquo;Recurring Revenue Agreements&rdquo;). Revenues may also include court ordered settlements or awards related to our patent
portfolio (&quot;Other Settlements&quot;) or sales of our patent portfolio (&quot;Sales&quot;). IP Rights granted included the
following, as applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products
covered by patented technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv)
the dismissal of any pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration
date of the related patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature
of the promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and
(ii) the Company's promise to transfer each individual IP right described above to the customer is not separately identifiable
from other promises to transfer IP Rights in the contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the promised IP Rights are not
individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is
distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights
granted were &ldquo;functional IP rights&rdquo; that have significant standalone functionality. Acacia's subsequent
activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the
licensee has rights. Acacia&rsquo;s operating subsidiaries have no further obligation with respect to the grant of IP Rights,
including no express or implied obligation to maintain or upgrade the technology, or provide future support or services. The
contracts provide for the grant (i.e., transfer of control) of the licenses, covenants-not-to-sue, releases, and other
significant deliverables upon execution of the contract. Licensees legally obtain control of the IP Rights upon execution of
the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when
collectability is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for
payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or
usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For sales-based royalties, the Company
includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is
probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the
uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue&nbsp;is recognized
for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage
occurs, or (ii) the&nbsp;performance obligation&nbsp;to which some or all of the sales-based royalty has been allocated has
been satisfied. Estimates are generally based on historical levels of activity, if available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues from contracts with significant
financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have
paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price,
the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient,
the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company
expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the
customer pays for the IP Rights will be one year or less.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In general, the Company is required to make
certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include
identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining
whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers
to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining
whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based
royalties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues were comprised of the following
for the periods presented:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left">Paid-up Revenue Agreements</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">6,343</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">100,496</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Recurring Revenue Agreements</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,903</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">13,040</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Other Settlements</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,470</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Sales</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14,500</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">11,246</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">131,506</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to &ldquo;Inventor Royalties and Contingent
Legal Expenses&rdquo; below for information on related direct costs of revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Portfolio Operations.</I>&nbsp;&nbsp;Cost
of revenues include the costs and expenses incurred in connection with Acacia&rsquo;s patent licensing and enforcement activities,
including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related
legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid
to third-parties and the amortization of patent-related investment costs. These costs are included under the caption &ldquo;Portfolio
operations&rdquo; in the accompanying consolidated statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Inventor Royalties and Contingent Legal
Expenses. </I>Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues
are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent
owners by Acacia&rsquo;s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from
future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are
earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements
of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered and included in
amortization expense in the consolidated statements of operations. There were no patent acquisition expenses for fiscal year 2019.
Cost of revenues for fiscal year 2018 included $4.0 million of costs to acquire certain patent rights related to revenues recognized
in the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Contingent legal fees are expensed in the
consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries
from potential infringers, no contingent legal fees are paid; however, Acacia&rsquo;s operating subsidiaries may be liable for
certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Fair Value Measurements.</I> U.S. GAAP
defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability
in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and
also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The
three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level 1 - <I>Observable Inputs</I>:&nbsp;&nbsp;Quoted prices in active markets for identical investments;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level 2 - <I>Pricing Models with Significant Observable Inputs</I>:&nbsp;&nbsp;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 96px"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level 3 - <I>Unobservable Inputs</I>:&nbsp;&nbsp;Significant unobservable inputs, including the entity&rsquo;s own assumptions in determining the fair value of investments.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whenever possible,
the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases,
the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair
value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to
the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair
value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Level 1</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Level 2</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Level 3</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Assets as of December 31, 2019:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left">Trading securities - debt</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">93,843</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Trading securities - equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">17,140</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Investment at fair value - warrants (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">757</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - common stock (Note 6)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">743</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt">Total recurring fair value measurements as of December 31, 2019</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,883</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">94,600</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Assets as of December 31, 2018:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Trading securities - debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">33,642</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Trading securities - equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,012</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Investment at fair value - warrants (Note 6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,064</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - common stock (Note 6)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">5,395</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt">Total recurring fair value measurements as of December 31, 2018</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,407</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">35,706</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Liabilities as of December 31, 2019:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Profits interest units</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">591</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left">Series A warrants</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,568</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">17,974</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt">Total liabilities as of December 31, 2019</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,159</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,974</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Liabilities as of December 31, 2018:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Profits interest units</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">591</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt">Total liabilities as of December 31, 2018</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">591</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth a summary of the changes in the
estimated fair value of the Company&rsquo;s embedded derivative, which is measured at fair value as a Level 3 liability on a recurring
basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Embedded Derivative</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Opening balance as of January 1, 2019</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 83%; font-size: 10pt; text-align: left">Issuance of Series A redeemable convertible preferred stock with embedded derivative</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">21,232</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Remeasurement of Series A redeemable convertible preferred
    stock embedded derivative to fair value</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(3,258</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">Total Level 3 recurring fair value measurements as of December 31, 2019</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">17,974</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Cash and Cash Equivalents</I>.&nbsp;&nbsp;Acacia
considers all highly liquid, trading securities with original maturities of three months or less when purchased to be cash equivalents.
For the periods presented, Acacia&rsquo;s cash equivalents are comprised of investments in AAA rated money market funds that invest
in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S.
government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia&rsquo;s cash equivalents
are measured at fair value using quoted prices that represent Level 1 inputs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Long Term Restricted Cash</I>.&nbsp;&nbsp;Long-term
restricted cash relates to the proceeds received from the issuance of Series A redeemable convertible preferred stock (the &ldquo;Series
A Redeemable Convertible Preferred Stock&rdquo;) which are held in an escrow account. The amounts are to be released to the Company
upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the conversion of
Series A Redeemable Convertible Preferred Stock into common stock (see Note 16).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Trading Securities- Debt.&nbsp;&nbsp;</I>Investments
in debt securities are reported at fair value on a recurring basis, with related realized and unrealized gains and losses recorded
in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific
identification method. Interest is included in other income (expense).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Trading Securities - Equity. </I>Investments
in equity securities are reported at fair value on a recurring basis, with related realized and unrealized gains and losses in
the value of such securities recorded in the statements of operations in other income (expense). Dividend income is included
in other income (expense).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Impairment of Investments. </I>Acacia
evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that
considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated
fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration
and extent to which the fair value is less than cost, and the Company&rsquo;s intent and ability to hold, or plans or ability to
sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments
are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments
associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary.
An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of
time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment&rsquo;s carrying amount
is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive
and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is
recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary
are recognized in the consolidated statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Concentration of Credit Risks.&nbsp;&nbsp;</I>Financial
instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, trading securities and accounts
receivable. Acacia places its cash equivalents and trading securities primarily in highly rated money market funds and investment
grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may,
at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash
equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Three licensees individually accounted for
43%, 22% and 15%, respectively, of revenues recognized during the year ended December&nbsp;31, 2019. Three licensees individually
accounted for 45%, 17% and 17%, respectively, of revenues recognized during the year ended December&nbsp;31, 2018. Two licensees
individually represented approximately 70% and 17%, respectively, of accounts receivable at December&nbsp;31, 2019. Four licensees
individually represented approximately 38%, 36%, 12% and 11%, respectively, of accounts receivable at December&nbsp;31, 2018.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For 2019 and 2018, 39% and 26%, respectively,
of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated
to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia performs credit evaluations of its
licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable
are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful
accounts may be established to reflect the Company&rsquo;s best estimate of probable losses inherent in the accounts receivable
balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of
operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and
other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Fair Value of Financial
Instruments.&nbsp;&nbsp;</I>The carrying value of cash and cash equivalents, restricted cash, accounts receivables, and
current liabilities approximates their fair values due to their short-term maturities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Property and Equipment.&nbsp;&nbsp;</I>Property
and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment
are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold
or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated
statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis
over the following estimated useful lives of the assets:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; width: 57%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furniture and fixtures</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3 to 5 years</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Computer hardware and software</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3 to 5 years</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Leasehold improvements</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2 to 5 years (Lesser of lease term or useful life of improvement)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Rental payments on operating leases are
charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Patents.</I>&nbsp;&nbsp;Patents include
the cost of patents or patent rights (hereinafter, collectively &ldquo;patents&rdquo;) acquired from third-parties or obtained
in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic
useful lives, ranging from one to five years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Leases. </I>The Company adopted ASC
842 as of January 1, 2019, electing the practical expedient approaches. The primary impact of adopting ASC 842 for the Company
was the recognition in the consolidated balance sheet of certain lease-related assets and liabilities for operating leases with
terms longer than 12 months. Such amounts were not previously accounted for in the Company's consolidated balance sheets. The
Company&rsquo;s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether
an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all
leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying
asset for the lease term. Upon adoption of ASC 842 on January 1, 2019, the carrying value of certain lease related liabilities
for its excess of lease payments over anticipated sublease income existing at that date, was offset against the related right-of-use
assets. Lease expense is recognized on a straight-line basis over the lease term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investments at Fair Value</I>. On an
individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise
significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied
to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial
interests in the same entity that are eligible items (i.e., common stock and warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Other Investments</I>. Equity investments
in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has
the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate
share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the  consolidated
statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Investments in preferred stock with substantive
liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted
for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments
of the same issuer. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially
similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock,
is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference
is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation
to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a
fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially
all of the investee's losses, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The initial determination of whether an
investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to
exercise significant influence over the operating and financial policies of the investee. That determination is reconsidered
if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee,
including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an
investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment
at the date at which the Company obtains the additional interest. Refer to Note 6 for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Impairment of Other Investments. </I>Acacia
reviews its investments quarterly for indicators of other-than-temporary impairment. This determination requires significant
judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating potential
impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors,
general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers
specific adverse conditions related to the financial health of and business outlook for the investee, including industry and
sector performance, changes in technology, and operational and financing cash flow factors. Once a decline in fair value is
determined to be other-than-temporary, an impairment charge is recorded in the consolidated statements of operations and a
new cost basis in the investment is established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Impairment of Long-lived Assets.</I>
Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events
or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted
future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded
equal to the excess of the asset&rsquo;s carrying value over its fair value. If an asset is determined to be impaired, the loss
is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate
of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event
that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying
value of the asset is recorded. Refer to Note 5 for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fair value is generally estimated using
the &ldquo;Income Approach,&rdquo; focusing on the estimated future net income-producing capability of the patent portfolios over
the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through &ldquo;discounting,&rdquo;
including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash
inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market
data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty
obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with
a specific patent portfolio&rsquo;s licensing and enforcement program. The analysis also contemplates consideration of current
information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength
of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Contingent Liabilities. </I>The Company, from time to time,
is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and
the Company&rsquo;s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable
and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements.
If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments,
reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations
where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company
records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for
these types of contingencies are recognized in the period in which the litigation services were provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain of Acacia&rsquo;s operating
subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of
Acacia&rsquo;s operating subsidiaries&rsquo; patent enforcement actions, it is possible that a defendant may request and/or a
court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local
court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In
such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney&rsquo;s fees
and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating
subsidiaries, could materially harm the Company&rsquo;s operating results and financial position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Stock-Based
Compensation.</I> The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the
award, and is recognized as an expense on a straight-line basis over the employee&rsquo;s requisite service period (generally
the vesting period of the equity award). The fair value of restricted stock and restricted stock units awards is determined by
the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair
value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted
for as they occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No stock options were granted during the
year ended December 31, 2019. The fair values of stock options granted during the year ended December 31, 2018 were estimated
using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">For the Year
    Ended<BR> December 31, 2018</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 43%; font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</TD>
<TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: center">2.26%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Term</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">4.37</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Volatility</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">51%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Dividend yield</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&ndash;%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Due to a lack of sufficient historical stock
option exercise experience, the Company utilized the simplified method for estimating the expected term. Expected volatility
is based on the historical volatility of the Company&rsquo;s stock for the length of time corresponding to the expected term of
the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the
option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Restricted stock units awards with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation
technique. Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered,
regardless of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation
technique included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent;
and expected dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury
zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield
was based on expectations regarding dividend payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Profits Interest Units (&ldquo;Units&rdquo;)
are accounted for in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;) 718-10, &ldquo;Compensation - Stock
Compensation.&rdquo; The Units vest as described at Note 9, and therefore, the vesting conditions do not meet the definition of
service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability
classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award
is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite
service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&rsquo;s requisite
service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred
during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the
period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. The Company has a
purchase option to purchase the vested Units that are not otherwise forfeited after termination of continuous service. The exercise
price of the purchase option is the fair market value of the Units on the date of termination of continuous service. At each reporting
date, the value of the Units that are subject to the purchase option will be the measured at the fair value on the termination
date. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying
consolidated statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Series A Warrants. </I>The fair value
of the Series A warrants (the &ldquo;Series A Warrants&rdquo;) is estimated using a Black-Scholes
option-pricing model. The fair value of the Series A Warrants as of December 31, 2019 was estimated based on the following assumptions:
volatility of 30 percent, risk-free rate of 1.85 percent, term of 7.79 years and a dividend yield of 0 percent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Embedded derivatives. </I>Embedded derivatives
that are required to be bifurcated from their host contract are valued separately from host instrument. A binomial lattice framework
is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock (see Note
16). The binomial model utilizes the Tsiveriotis and Fernandes (&ldquo;TF&rdquo;) implementation in which a convertible instrument
is split into two separate components: a cash-only component which is subject to the selected risk-adjusted discount rate and an
equity component which is subject only to the risk-free rate. The model considers the (i) implied volatility of the value of our
common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield, (v) dividend accrual (and a step-up
in rates), and (vi) event probabilities of the various conversion and redemption scenarios.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The implied volatility of the Company&rsquo;s
common stock is estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe
a commonly observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt
is lower than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining
until November 15, 2027 (the maturity date). The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining
term equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&rsquo;s
valuation of the embedded derivative at December 31, 2019 are as follows: volatility of 30 percent, risk-free rate of 1.86
percent, a credit spread of 25 percent and a dividend yield of 0 percent. The fair value measurement of the embedded derivative
is sensitive to these assumptions and changes in these assumptions could result in a materially different fair value measurement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Income Taxes.&nbsp;&nbsp;</I>Income taxes
are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for
the expected future tax consequences of events that have been recognized in Acacia&rsquo;s consolidated financial statements or
consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of
such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization
of such assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under U.S. generally accepted accounting
principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing
that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it
is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination.
Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount
of tax benefit that is greater than 50% likely of being realized upon settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Segment Reporting.</I>&nbsp;&nbsp;Acacia
uses the management approach, which designates the internal organization that is used by management for making operating decisions
and assessing performance as the basis of Acacia&rsquo;s reportable segments. Acacia&rsquo;s patent licensing and enforcement business
constitutes its single reportable segment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Use of Estimates</I>.&nbsp;&nbsp;The
preparation of financial statements in conformity with generally accepted accounting principles in the United States of America
requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant
accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the equity
instruments discussed at Note 6, the valuation of Series A redeemable convertible preferred stock, Series A warrants and embedded
derivatives, stock-based compensation expense, impairment of patent-related intangible assets, the determination of the economic
useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its
most difficult, subjective or complex judgments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Loss Per Share.&nbsp;&nbsp;</I>For periods
in which the Company generates net income, the Company computes earnings per share attributable to common stockholders using the
two-class method required for capital structures that include participating securities. Under the two-class method, securities
that participate in non-forfeitable dividends, such as the Company&rsquo;s outstanding unvested restricted stock and Series A Redeemable
Convertible Preferred Stock, are considered participating securities and are allocated a portion of the Company&rsquo;s earnings.
For periods in which the Company generates a net loss, net losses are not allocated to holders of the Company&rsquo;s participating
securities as the security holders are not contractually obligated to share in the Company&rsquo;s losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, due to the Company&rsquo;s
net loss, the Company did not apply the two-class method to allocate earnings to the participating securities. Basic net loss
per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number
of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed by dividing net loss
attributable to common stockholders by the weighted average number of common and dilutive common equivalent shares outstanding
for the period using the treasury stock method or the as-converted method. Potentially dilutive common stock equivalents consist
of stock options, restricted stock units, unvested restricted stock, Series A Redeemable Convertible Preferred Stock, and Series
A Warrants. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table presents the calculation
of basic and diluted loss per share of common stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-size: 10pt">(In thousands, except percentage change values)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Basic</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Numerator:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left">Net loss attributable to Acacia Research Corporation</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(17,115</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(105,029</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Accretion of Series A Redeemable Convertible Preferred Stock</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(307</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders - basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(17,422</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(105,029</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Denominator:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Weighted-average shares used in computing net loss per share attributable to common stockholders - basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,764,002</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,969,062</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Basic net loss per share of common stock</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.35</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2.10</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Diluted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Numerator:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Net loss attributable to Acacia Research Corporation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(17,115</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(105,029</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Mark-to-market adjustment for preferred stock embedded derivative</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(3,258</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders - diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(20,373</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(105,029</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Denominator:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">Weighted-average shares used in computing
    net loss per share attributable to common stockholders - basic</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">49,764,002</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">49,969,062</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">Effect of potentially dilutive securities: Series A preferred stock</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,132,771</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">50,896,773</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">49,969,062</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net loss per share of common stock</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.40</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(2.10</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As the Company reported a net loss for
the years ended December 31, 2019 and 2018, all potentially dilutive shares of common stock other than those associated with the
Series A Redeemable Convertible Preferred Stock have been excluded from the calculation of diluted net loss per share of common
stock because including such instruments would be anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Treasury Stock</I>. Repurchases of the
Company&rsquo;s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the
appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury
stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance
sheets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3.&nbsp;&nbsp;TRADING SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Trading securities for the
periods presented were comprised of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Cost</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Gross<BR> Unrealized<BR> Gain</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Gross<BR> Unrealized<BR> Loss</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fair Value</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: left">Security&nbsp;Type</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">December 31, 2019:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 28%; font-size: 10pt; text-align: left">Trading securities - debt</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">93,712</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">143</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">(12</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">93,843</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Trading securities - equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">17,674</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">211</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(745</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">17,140</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">111,386</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">354</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(757</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">110,983</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">December 31, 2018:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Trading securities - debt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">33,643</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">18</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">(19</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">33,642</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Trading securities - equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,389</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">27</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(404</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,012</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">37,032</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">45</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(423</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">36,654</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Trading securities as of December 31, 2019
and 2018, were comprised of investments in corporate bonds (debt securities) and investments in equity securities of publicly
held companies (equity securities). For the year ended December 31, 2019, proceeds from the sale and maturity of debt securities
and equity securities were $49,751,000 and $25,339,000, respectively. For the year ended December&nbsp;31, 2018, proceeds from
the sale and maturity of debt securities and equity securities were $65,144,000 and $1,496,000, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.&nbsp; ACCRUED EXPENSES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Accrued expenses consist of the following
at December 31, 2019 and 2018:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Accrued litigation liabilities</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">6,181</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">3,803</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Accrued consulting and other professional fees</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">470</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Foreign taxes payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">374</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">State income taxes payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">27</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Short-term lease liability</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">435</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other accrued liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">152</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">122</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,265</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,299</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>5.&nbsp;&nbsp;PATENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&rsquo;s only identifiable intangible
assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to five years. For all periods
presented, all of Acacia&rsquo;s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated
amortization related to investments in intangible assets as of December 31, 2019 and 2018 are as follows (in thousands):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Gross carrying amount - patents</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">330,588</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">326,167</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated amortization - patents<SUP>(1)</SUP></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(322,774</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(319,580</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Patents, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">7,814</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,587</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(1)</SUP> <FONT STYLE="font-size: 8pt">Includes
patent impairment charges for the applicable periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The weighted-average remaining estimated
economic useful life of Acacia&rsquo;s patents and patent rights is 4 years. Scheduled annual aggregate amortization expense is
estimated to be $2,555,000 in 2020, $1,695,000 in 2021, $1,695,000 in 2022, $1,620,000 in 2023 and $249,000 in 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia did not record charges related to
the impairment of patent-related intangible assets for the year ended December 31, 2019. Acacia recorded impairment of patent-related
intangible asset charges totaling $28,210,000 for the year ended December 31, 2018. The impairment charges related to impairments
of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management
determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios,
due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future
resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment
charges for the periods presented consisted of the excess of the asset&rsquo;s carrying value over its estimated fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the year ended December 31, 2018, pursuant
to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights
to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling $8,307,000.
There is no accelerated amortization or sales for patent-related assets for the year ended December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>6. INVESTMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Investment at Fair Value</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During 2016 and 2017, Acacia made certain
investments in Veritone, Inc. (&ldquo;Veritone&rdquo;). As a result of these transactions, Acacia received an aggregate total
of 4,119,521 shares of Veritone common stock and warrants to purchase a total of 1,120,432 shares of Veritone common stock at
an exercise price of $13.61 per share expiring between 2020 and 2027. During the year ended December 31, 2018, Acacia sold 2,700,000
shares Veritone common stock and recorded a realized loss of $19.1 million. During the year ended December 31, 2019, Acacia sold
1,121,071 shares Veritone common stock and recorded a realized loss of $9.2 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December&nbsp;31, 2019, the fair value
of the 298,449 shares of Veritone common stock owned by Acacia totaled $743,000. At December&nbsp;31, 2019, the fair value of
the 1,120,432 common stock purchase warrants held by Acacia totaled $757,000. At December 31, 2018, the fair value of the 1,419,521
shares of Veritone common stock owned by Acacia totaled $5,395,000. At December 31, 2018, the fair value of the 1,120,432 common
stock purchase warrants held by Acacia totaled $2,064,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Changes in the fair value of Acacia&rsquo;s
investment in Veritone are recorded as unrealized gains or losses in the consolidated statements of operations. For the year ended
December&nbsp;31, 2019, and 2018, the accompanying consolidated statements of operations reflected the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center">(In thousands)</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; font-size: 10pt; text-align: left">Change in fair value of investment, warrants</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(1,308</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(11,895</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Change in fair value of investment, common stock</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,207</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(47,208</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Loss on sale of investment, common stock</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(9,230</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(19,095</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net realized and unrealized gain (loss) on investment at fair value</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">669</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(78,198</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Miso Robotics Investment </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2017, Acacia made an investment
in the Series A Preferred financing round for Miso Robotics, Inc. (&ldquo;Miso Robotics&rdquo;), an innovative leader in robotics
and artificial intelligence solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Series A preferred stock of
Miso Robotics, and one board seat. In February 2018, Acacia made an additional equity investment in the Series B Preferred financing
round for Miso Robotics totaling $6,000,000, increasing its ownership interest (Series B preferred stock) in Miso Robotics to approximately
30%, and acquiring an additional board seat. As of June 30, 2019, Acacia recorded an impairment of $8.2 million for its investment
in Miso Robotics. In September 2019, Acacia received a cash payment of $2.0 million upon the sale of its entire investment, and
therefore relinquished its ownership interest in Miso Robotics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.&nbsp;&nbsp;STOCKHOLDERS&rsquo; EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Repurchases of Common Stock. </I>In February
2018, Acacia&rsquo;s Board of Directors authorized the repurchase of up to&nbsp;$20,000,000&nbsp;of the Company&rsquo;s outstanding
common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the
Board of Directors at its discretion (the &ldquo;Stock Repurchase Program&rdquo;). On August 5, 2019, Acacia&rsquo;s Board of Directors
approved a new stock repurchase program, which authorized the purchase of up to $10.0 million of the Company's common stock through
open market purchases, through block trades, through 10b5-1 plans, or by means of private purchases, from time to time, through
July 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In determining whether or not to repurchase
any shares of Acacia&rsquo;s common stock, Acacia&rsquo;s Board of Directors consider such factors as the impact of the repurchase
on Acacia&rsquo;s cash position, as well as Acacia&rsquo;s capital needs and whether there is a better alternative use of Acacia&rsquo;s
capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases
to date were made in the open market in compliance with applicable SEC rules. The authorization to repurchase shares presented
an opportunity to reduce the outstanding share count and enhance stockholder value. The repurchased shares are expected to be retired.
Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program,
were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total Number<BR> of Shares<BR> Purchased</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Average<BR> Price<BR> paid per<BR> Share</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Approximate Dollar<BR> Value of Shares that<BR> May Yet be Purchased<BR> under the Program</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Plan Expiration Date</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 19%; font-size: 10pt; text-align: center; padding-bottom: 1pt">May 1, 2018 - May 30, 2018</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 17%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,190,420</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right">3.89</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right">15,366,000</TD><TD STYLE="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 18%; font-size: 10pt; padding-bottom: 1pt">February 28, 2019</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 2.5pt">Totals for 2018</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,190,420</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">3.89</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Tax Benefits Preservation Plan</I>. On
March 12, 2019, Acacia&rsquo;s Board of Directors announced that it had unanimously approved the adoption of a Tax Benefits Preservation
Plan (the &ldquo;Plan&rdquo;). The purpose of the Plan is to protect the Company&rsquo;s ability to utilize potential tax assets,
such as net operating loss carryforwards and tax credits to offset potential future taxable income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Plan is designed to reduce the likelihood
that the Company will experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership
of 4.9% or more of the Company&rsquo;s outstanding common stock and (ii) any existing stockholders who, as of the time of the first
public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company&rsquo;s then-outstanding shares
of the Company&rsquo;s common stock from acquiring additional shares of the Company&rsquo;s common stock (subject to certain exceptions).
There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the adoption of the Plan,
Acacia&rsquo;s Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the
Company&rsquo;s common stock to stockholders of record at the close of business on March 16, 2019. On or after the distribution
date, each right would initially entitle the holder to purchase one one-thousandth of a share of the Company&rsquo;s Series B Junior
Participating Preferred Stock, $0.001 par value for a purchase price of $12.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company also has a provision in its
Amended and Restated Certificate of Incorporation, as amended (the &ldquo;Charter Provision&rdquo;) which generally prohibits transfers
of its common stock that could result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect
the Company&rsquo;s ability to utilize potential tax assets, such as net operating loss carryforwards and tax credits to offset
potential future taxable income. The Charter Provision was approved by the Company&rsquo;s stockholders on July 15, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>8.&nbsp;&nbsp;INCOME TAXES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&rsquo;s income tax benefit (expense) for the fiscal periods
presented consisted of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center">(in thousands)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">Current:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt">Federal</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 46%; font-size: 10pt">State</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(34</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">(87</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt">Foreign</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,858</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,092</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total current</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,824</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,179</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold">Deferred:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt">Federal</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt">State</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Total deferred</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Income tax benefit (expense)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,824</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1,179</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities
consist of the following at </FONT>December 31, 2019 and 2018<FONT STYLE="font-family: Times New Roman, Times, Serif">:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-size: 10pt">(in thousands)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Deferred tax assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Net operating loss and capital loss carryforwards and credits</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">112,280</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">104,862</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Unrealized loss on investments held at fair value</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">538</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,455</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Stock compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">358</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,365</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Fixed assets and intangibles</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,316</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,330</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Basis of investments in affiliates</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">300</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">286</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt">Accrued liabilities and other</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">631</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">208</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt">State taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">25</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">26</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 20pt">Total deferred tax assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">115,448</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">112,532</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Valuation allowance</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(115,077</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(112,514</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total deferred tax assets, net of valuation allowance</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">371</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">18</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Deferred tax liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">ROU Asset</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(347</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt">Other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(24</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(18</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total deferred tax liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(371</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(18</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">Net deferred tax assets (liabilities)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A reconciliation of the federal statutory
income tax rate and the effective income tax rate is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">Statutory federal tax rate - (benefit) expense</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">21%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">21%</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">State income and foreign taxes, net of federal tax effect</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1)%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">Foreign tax credit</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">Noncontrolling interests in operating subsidiaries</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">Nondeductible permanent items</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1)%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">Change in tax rate</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Expired capitalized loss</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2)%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">Valuation allowance</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(13)%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(20)%</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4)%</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: right">&ndash;%</TD><TD STYLE="padding-bottom: 1pt; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">10%</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1)%</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, the Company recorded
full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance
set forth in ASC 740, &ldquo;Income Taxes.&rdquo; In future periods, if the Company determines it will more likely than not be
able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will
generally be recognized in the statements of operations in the period the determination is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December&nbsp;31, 2019, Acacia had U.S.
federal and state income tax net operating loss carryforwards (&ldquo;NOLs&rdquo;) totaling approximately $253,824,000 and $19,683,000,
respectively. For federal income tax purposes, our NOL carryovers generated for tax years beginning before January 1, 2018 will
begin to expire in 2026. Pursuant to the Tax Cuts and Jobs Act enacted by the U.S. federal government in December 2017, for federal
income tax purposes, NOL carryovers generated for our tax years beginning January 1, 2018 can be carried forward indefinitely
but will be subject to a taxable income limitation. For state income tax purposes, our NOLs will expire between 2028 and 2039.
Our capital loss carryovers totaled $23,652,000 at December&nbsp;31, 2019, expiring between 2025 and 2029.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of December&nbsp;31, 2019, Acacia had
approximately $51,508,000 of foreign tax credits, expiring between 2020 and 2026. In general, foreign taxes withheld may be claimed
as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject
to certain limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Tax expense (benefit) for the periods presented
primarily reflects foreign taxes withheld and refunded on revenue agreements executed with licensees in foreign jurisdictions
and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were 23% for fiscal
year 2019 and 19% for fiscal year 2018. Results for fiscal year 2019 included an unrealized loss on Acacia&rsquo;s investment
in Veritone which created a deferred tax asset totaling approximately $538,000. Results for fiscal year 2018 included an unrealized
loss on Acacia&rsquo;s investment in Veritone which created a deferred tax asset totaling approximately $2,455,000. The 2017 deferred
tax liability was reversed in fiscal year 2018 as a result of the 2018 unrealized loss on Acacia&rsquo;s investment in Veritone
and the realized loss on the sale of Veritone common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia is subject to taxation in the U.S.
and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign
jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities
for years before 2011. The California Franchise Tax Board is auditing the 2011 through 2016 California combined income tax returns.
The California Franchise Tax Board has proposed adjustments for 2011 and 2012 that, if expensed, would not be material to the consolidated
statements of operations for the periods presented. We have protested these adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December&nbsp;31, 2019 and 2018, the
Company had total unrecognized tax benefits of approximately $731,000 and $816,000, respectively. No interest and penalties have
been recorded for the unrecognized tax benefits for the periods presented. At December 31, 2019, if recognized, approximately $731,000
of tax benefits, net of valuation allowance, would impact the Company&rsquo;s effective tax rate. The Company does not expect that
the liability for unrecognized tax benefits will change significantly within the next 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia recognizes interest and
penalties with respect to unrecognized tax benefits in income tax expense (benefit). Acacia has identified no uncertain tax position
for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or
decrease within 12 months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>9.&nbsp;&nbsp;EQUITY-BASED INCENTIVE
PLANS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Stock-Based Incentive Plans</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The 2013 Acacia Research Corporation Stock
Incentive Plan (&ldquo;2013 Plan&rdquo;) and the 2016 Acacia Research Corporation Stock Incentive Plan (&ldquo;2016 Plan&rdquo;)
(collectively, the &ldquo;Plans&rdquo;) were approved by the stockholders of Acacia in May 2013 and June 2016, respectively. All
Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals,
which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of
the Plans are identical in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&rsquo;s compensation committee
administers the discretionary option grant and stock issuance programs. The compensation committee determines which
eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants
or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as
either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in
effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The
exercise price of options is generally equal to the fair market value of Acacia&rsquo;s common stock on the date of
grant. Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten
years after grant. Stock options with time-based vesting generally vest over two to three years and restricted shares
with time based vesting generally vest in full after one to three years (generally representing the requisite service
period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia&rsquo;s
stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Plans provide for the following separate
programs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Discretionary Option Grant Program</I>. Under the discretionary option grant program, Acacia&rsquo;s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia&rsquo;s voting stock or the voting stock of any of its subsidiaries).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Automatic Option Grant Program</I>. Through fiscal year 2016, each non-employee director received restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia&rsquo;s common stock on the grant date. In addition, each new non-employee director received restricted stock units or stock options for the number of shares determined by dividing the annual Board of Directors retainer by the grant date fair value of Acacia&rsquo;s common stock on the commencement date. These restricted stock units and stock options vested in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the unrestricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director&rsquo;s service as a member of the Company&rsquo;s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 60px"><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Stock Issuance Program</I>. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals receiving restricted stock awards (&ldquo;RSA&rdquo;) shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares. The eligible individuals receiving restricted stock units (&ldquo;RSU&rdquo;) shall not have full stockholder rights until they vest.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The number of shares of Common Stock initially
reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without
security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013
Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market. In June 2016, 625,390 shares of common stock available for issuance under
the 2013 Plan were transferred into the 2016 Plan. At December&nbsp;31, 2019, there were 1,024,419 shares available for grant under
the 2013 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The number of shares of Common Stock initially
reserved for issuance under the 2016 Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under
the 2013 Plan, as of the effective date of the Plan. At December&nbsp;31, 2019, there were 4,067,891 shares available for grant
under the 2016 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon the exercise of stock options, the
granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia&rsquo;s policy
to issue new shares of common stock. Acacia&rsquo;s Board of Directors may amend or modify the Plans at any time, subject to any
required stockholder approval. As of December&nbsp;31, 2019, there are 6,875,564 shares of common stock reserved for issuance under
the Plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock-based award grant activity for the
periods presented was as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate fair value (in thousands)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate fair value (in thousands)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Restricted stock awards with time-based service conditions</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">777,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">2,332</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">102,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">386</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Restricted stock units with market-based service conditions</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">900,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">1,280</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Stock options with time-based service vesting conditions</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">930,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,588</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total incentive awards granted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,677,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,612</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,032,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,974</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes stock option
activity for the Plans for the year ended December&nbsp;31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted-Average</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Options</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Exercise Price</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Remaining Contractual Term</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate Intrinsic Value</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; font-size: 10pt">Outstanding at December 31, 2018</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">3,509,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">4.96</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 13%; font-size: 10pt">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Granted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Exercised</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(25,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">3.12</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Expired/forfeited</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(3,158,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">5.04</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">Outstanding at December 31, 2019</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">326,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">4.38</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 2.5pt">4.4 years</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Vested</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">281,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">4.45</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">3.9 years</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Exercisable at December 31, 2019</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">281,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">4.45</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">3.9 years</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The aggregate
intrinsic value of options exercised during the years ended December 31, 2019 and 2018 was $4,000 and $51,000, respectively.
The aggregate intrinsic value of options vested during the year ended December 31, 2019 was $0. No options were granted
during the year ended December 31, 2019. The aggregate fair value of options vested during the years ended December 31, 2019
and 2018 was $294,000 and $1,918,000, respectively. As of December&nbsp;31, 2019, the total unrecognized compensation expense
related to non-vested stock option awards was $1,074,000, which is expected to be recognized over a weighted-average term of
approximately 2 year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
summarizes non-vested restricted share activity for the year ended December&nbsp;31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Non-vested<BR> Restricted<BR> Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average Grant<BR> Date Fair Value</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Non-vested restricted stock at December 31, 2018</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; font-size: 10pt">Granted</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">777,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">3.00</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Vested</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(214,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">3.14</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Canceled</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(87,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">2.81</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Non-vested restricted stock at December 31, 2019</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">476,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">2.98</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The weighted-average grant date fair value
of non-vested restricted stock granted during the years ended December 31, 2019 and 2018 was $2.98 and $3.79, respectively.
The aggregate fair value of restricted stock that vested during the years ended December 31, 2019 and 2018 was $672,000 and $972,000,
respectively. As of December&nbsp;31, 2019, unrecognized compensation expense related to non-vested restricted stock awards
was $1,321,000, which is expected to be recognized over a weighted-average term of approximately 2 year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes restricted
stock units activity for the year ended December&nbsp;31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Non-vested<BR> Restricted<BR> Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average Grant<BR> Date Fair Value</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left">Non-vested <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400">restricted stock units at December 31, 2018</FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; font-size: 10pt">Granted</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">900,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">1.42</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">Vested</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Canceled</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt">Non-vested <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400">restricted stock units at December 31, 2019</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">900,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">1.42</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt">Vested <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: 400">restricted stock units at December 31, 2019</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">14,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: right">16.72</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The weighted-average grant date fair
value of restricted units granted during the years ended December 31, 2019 was $1.42. There were no restricted units granted
during the year ended December 31, 2018. The aggregate fair value of restricted stock units granted during the year ended
December 31, 2019 was $1,280,000. The aggregate fair value of restricted stock units that vested during the years ended
December 31, 2019 and 2018 was $240,000 and $40,000, respectively. As of December&nbsp;31, 2019, unrecognized compensation
expense related to non-vested restricted stock units was $1,140,000. Stock compensation expense is recognized in general and
administrative expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Profits Interest Plan </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February&nbsp;16, 2017, AIP Operation
LLC, a Delaware limited liability company (&ldquo;AIP&rdquo;), and an indirect subsidiary of Acacia, adopted a Profits Interest
Plan (the&nbsp;&ldquo;Plan&rdquo;) that provides for the grant of membership interests in AIP to certain members of management
and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit
granted pursuant to the Plan is intended to qualify as a &ldquo;profits interest&rdquo; for U.S. federal income tax purposes and
will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership
interests. The membership interests are represented by units (the &ldquo;Units&rdquo;) reserved for the issuance of awards
under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share
in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the&nbsp;&ldquo;LLC
Agreement&rdquo;). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which
Units may be granted from time to time. Units vest upon AIP&rsquo;s achievement of certain performance milestones (one-third upon
150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia&rsquo;s aggregate investment in Veritone),
subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest
Agreement and the LLC Agreement. The Units were fully vested in September 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia owns 60% of the membership interests
in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related
to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients.
As of December&nbsp;31, 2019, AIP holds the Veritone Warrant described at Note 6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Profits interests totaling 400 Units, or
40% of the membership interests in AIP, were granted in February 2017, with an aggregate grant date fair value of $722,000. The
fair value of the Units totaled $591,000 as of December&nbsp;31, 2019. Upon full vesting of the units in September 2017, all previously
unrecognized compensation expense was immediately recognized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Compensation expense for the periods presented
was comprised of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(in thousands)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 46%; font-size: 10pt; text-align: left">Restricted stock awards with time-based service conditions</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">907</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 13%; font-size: 10pt; text-align: right">460</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left">Restricted stock units with time-based service conditions</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Restricted stock units with performance-based vesting conditions</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">140</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Stock options with time-based service vesting conditions</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,672</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Profits interests units</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&ndash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2,450</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total compensation expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,075</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(317</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>10.&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Facility Leases</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company primarily leases office facilities
under operating lease arrangements that will end in various years through July 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 7, 2019, we entered into a building
lease agreement (the &ldquo;New Lease&rdquo;) with Jamboree Center 4 LLC (the &ldquo;Landlord&rdquo;). Pursuant to the New Lease,
we have leased approximately 8,293 square feet of office space for our corporate headquarters in Irvine, California. The New Lease
commenced on August 1, 2019. The term of the New Lease is 60 months from the commencement date, provides for annual rent increases,
and does not provide us the right to early terminate or extend our lease terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has subleased a facility under
another operating lease agreement (the &ldquo;Old Lease&rdquo;) that we ceased using in December 2018, and the sublease will go
through the remaining term of the Old Lease, which ended on January 31, 2020. During the year ended December 31, 2018, the Company
recorded a one-time charge of $629,000 for the excess of lease payments over the anticipated sublease income through expiration
of the lease. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Operating lease costs, net of sublease income
of $780,000, were $426,000 for the year ended December 31, 2019. Operating lease costs, net of sublease income of $65,000, were
$1,106,000 for the year ended December 31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The table below presents aggregate future
minimum payments due under the New Lease and the Old Lease, reconciled to lease liabilities included in the consolidated balance
sheet as of December 31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Operating Leases</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">(In thousands)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 31%; text-align: left">2020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">434</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">2021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">334</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">2022</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">2023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">364</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">2024</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">218</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">Total minimum payments</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">1,699</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">Less: short-term lease liabilities</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(435</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">Long-term lease liabilities</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,264</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Inventor Royalties and Contingent Legal Expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the investment in certain
patents and patent rights, certain of Acacia&rsquo;s operating subsidiaries executed related agreements which grant to the former
owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined
in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&rsquo;s operating subsidiaries may
retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing
and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a
scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments
are obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Patent Enforcement </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I>Certain of Acacia&rsquo;s
operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection
with any of Acacia&rsquo;s operating subsidiaries&rsquo; patent enforcement actions, it is possible that a defendant may
request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal
rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement
actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award
attorney&rsquo;s fees and/or expenses to a defendant(s), which could be material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Other</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 17, 2015, Celltrace Communications
Ltd. (&ldquo;Celltrace&rdquo;) filed a lawsuit against Acacia in U.S. District Court for the Southern District of New York, Case
No. 1:15-cv-04746, alleging, among other things, significant damages for alleged breach of contract, unjust enrichment and fraud.
Acacia disputes the allegations and does not believe that Celltrace is entitled to any damages.&nbsp; Acacia successfully moved
to compel arbitration of the dispute, and the District Court stayed the litigation pending arbitration before the International
Court of Arbitration for the International Chamber of Commerce (the &ldquo;ICC&rdquo;). Celltrace appealed the decision to the
U.S. Court of Appeals for the Second Circuit, which denied the appeal. Celltrace filed its request for arbitration of the claims
with the ICC on November 28, 2016. Acacia filed an answer denying all allegations of wrongdoing and asserting affirmative defenses.
A tribunal was appointed to preside over the arbitration and conducted its first case management conference on June 26, 2017. The
parties conducted discovery and submitted their cases in chief to the tribunal in a series of written submissions per the tribunal&rsquo;s
orders between January 2018 and December 2018. The tribunal held an evidentiary hearing with live witness testimony in New York
City between February 4, 2019 and February 13, 2019. At the end of the hearing, the tribunal set a schedule for post-hearing briefing
by the parties, which concluded in April 2019. We are now waiting for the tribunal to issue its decision. Acacia continues to vigorously contest all allegations of wrongdoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In a separate case on December 6, 2017,
the Federal Court of Canada allowed a counterclaim for invalidity of a patent asserted by Rapid Completions LLC and awarded costs
payable by Rapid Completions LLC in an amount to be determined.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia is subject to claims, counterclaims
and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect
to these claims and legal actions, if any, will not have a material effect on Acacia&rsquo;s consolidated financial position,
results of operations or cash flows. Fiscal year 2019 operating expenses included expenses for settlement and contingency accruals
totaling $1,756,000, net of prior accruals. Refer to Note 4 for information on accrued expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Guarantees and Indemnifications</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain of Acacia&rsquo;s operating
subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or
indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In
connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for
certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum
extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy
that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be
payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to
statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential
future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and
indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and
therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance
sheets. Additionally, no events or transactions have occurred that would result in a material liability at December&nbsp;31,
2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Other</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In August 2010, a wholly owned subsidiary
of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund invests in, licenses
and enforces IP consisting primarily of patents, patent rights, and patented technologies. The Acacia IP Fund was terminated as
of December 31, 2017. The final distribution to the partners of the Acacia IP Fund will be made in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>11.&nbsp; RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE
POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Retirement Savings Plan.</I> Acacia
has an employee savings and retirement plan under section 401(k) of the Code (the &ldquo;Plan&rdquo;). The Plan is a
defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the
Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the
discretion of the Board of Directors. There were no contributions made by Acacia during the periods presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Executive Severance Policy.</I>
Under Acacia&rsquo;s Amended Executive Severance Policy, full-time employees as of July 2017 and prior with the title of
Senior Vice President and higher (&ldquo;SVP and higher&rdquo;) are entitled to receive certain benefits upon termination of
employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death
or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a)
accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any
compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and
reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full
year that the SVP and higher employee was employed by the Company (the &ldquo;Severance Period&rdquo;), up to a maximum of
twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii)
provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year
in which the termination occurs, for the duration of the Severance Period. Results for the year ended December 31, 2019 and
2018 include $420,000 and $2,458,000 of expenses incurred under the executive severance policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>12.&nbsp;&nbsp;SUPPLEMENTAL CASH FLOW INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cash paid for state income taxes totaled
$85,000 and $140,000 for the years ended December 31, 2019 and 2018, respectively. Foreign taxes withheld totaled $249,000 and
$1,093,000 for the years ended December 31, 2019 and 2018, respectively. Refer to Note 4 for accrued foreign taxes payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to Note 6 for information regarding
noncash investing activity related to the investment in Veritone for the periods presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>13.&nbsp;&nbsp;RECENT ACCOUNTING PRONOUNCEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Recent Accounting Pronouncements - Recently Adopted. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February 2016, FASB issued ASU 2016-02,
<I>Leases</I>, or ASC 842 which requires a lessee to recognize in the statement of financial position a liability to make lease
payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset. In July 2018, FASB
issued ASU 2018-11, Leases, which provides an additional transition option for an entity to apply the provisions of ASC 842 by
recognizing a cumulative effect adjustment at the effective date of adoption without adjusting the prior comparative periods presented.
Further, in January 2019, FASB issued ASU 2019-01, Leases: Codification Improvements, which provides disclosure relief for the
interim periods when adopting ASC 842. The primary impact of adopting ASC 842 for the Company was the recognition in the consolidated
balance sheet of certain lease-related assets and liabilities for operating leases with terms longer than 12 months as of January
1, 2019. Such amounts were not previously accounted for in the Company's consolidated balance sheets. The Company adopted ASC
842 as of January 1, 2019, electing the practical expedient approaches. As a result, we recognized approximately $1.6 million
of right-of-use assets and an increase of $1.7 million in lease-related liabilities as of December 31, 2019. The adoption of ASC
842 did not have a material impact on the Company's consolidated results of operations for the year ending December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Recent Accounting Pronouncements - Not Yet Adopted. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In December 2019, the FASB issued ASU No.
2019-12 Income Taxes (Topic 740)&mdash;Simplifying the Accounting for Income Taxes, to remove certain exceptions and improve consistency
of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or
rates in the annual effective tax rate computation in the interim period that includes the enactment date. The amendments in this
update will be effective for the Company beginning with fiscal year 2021, with early adoption permitted. Most amendments within
the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or
modified retrospective basis. Management is currently evaluating the impact that the amendments in this update will have on the
Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>14.&nbsp;&nbsp;FAIR VALUE DISCLOSURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia holds
the following types of financial instruments at December 31, 2019 and 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Trading securities - debt. </I>Debt securities
includes corporate bonds with fair value that is determined by third party quotations from outside pricing services and/or computerized
pricing models, which may be based on transactions, bids or estimates. Acacia classifies the fair value of corporate bonds within
Level 2 of the valuation hierarchy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Trading securities - equity. </I>Equity
securities includes investments in public companies common stock and are recorded at fair value based on the quoted market price
of each share on the valuation date. The fair value of these securities are within Level 1 of the valuation hierarchy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investments at fair value - common stock</I>.
Acacia&rsquo;s equity investment in Veritone common stock is recorded at fair value based on the quoted market price of Veritone&rsquo;s
common stock on the applicable valuation date (Level 1).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Investments at fair value - warrants.
</I>Warrants are recorded at fair value, as based on the Black-Scholes option-pricing model (Level 2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Profits
interests. </I>For the years ended December&nbsp;31, 2019 and 2018, the fair value of the Units was estimated at 40% of the fair
value of the 10% Warrant, based on the Black-Scholes option-pricing model (Level 2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Series A
Warrants. </I>Series A Warrants are recorded at fair value, using Black-Scholes option-pricing model (Level 2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Embedded derivative liability. </I>Embedded
derivatives that are required to be bifurcated from their host contract are evaluated and valued separately from the host instrument.
A binomial lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible
Preferred Stock issued by the Company in 2019 (Level 3).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>15.&nbsp;&nbsp;RELATED PARTY TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During
the year ended December 31, 2019, the Company purchased shares of common stock of Drive Shack, Inc. (&ldquo;Drive Shack&rdquo;)
for an aggregate purchase price of $2.4 million. Drive Shack and Clifford Press, Chief Executive Officer and director of Acacia,
are related parties as Mr. Press is a board member of Drive Shack. During
the year ended December 31, 2018, the Company paid $976,000 in expenses related to the reimbursement of costs incurred by Sidus
Investment Management, LLC (&ldquo;Sidus&rdquo;) on behalf of the participants (together with Sidus, the &ldquo;Participants&rdquo;)
named in the proxy statement filed on June 7, 2018 by the Participants, in connection with a contested proxy election. These expenses
are included in general and administrative expenses on the consolidated statements of operations. Alfred V. Tobia, Jr. and Clifford
Press are related parties as each of them are Participants and members of the Company&rsquo;s Board of Directors. In addition,
Sidus is a related party as Mr. Tobia is a Co-Founder and Managing Member at Sidus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>16.&nbsp;&nbsp;SERIES A REDEEMABLE CONVERTIBLE PREFERRED
STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 18, 2019, the Company entered
into a Securities Purchase Agreement with Starboard Value LP (&ldquo;Starboard&rdquo;) pursuant to which the Company issued (i)
350,000 shares of Series A Redeemable Convertible Preferred Stock with a par value of $0.001
per share and a stated value of $100 per share, and (ii) Series A Warrants to purchase up to 5,000,000
shares of the Company&rsquo;s common stock (see Note 17) to Starboard. The Securities Purchase Agreement also established the terms
of certain senior secured notes and additional warrants (the &ldquo;Series B Warrants&rdquo;) which may be issued to Starboard
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series A Redeemable Convertible Preferred
Stock can be converted into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends,
divided by (ii) the conversion price of $3.65 (subject to certain anti-dilution adjustments). Holders may elect to convert the
Series A Redeemable Convertible Preferred Stock into common stock at any time. The Company may elect to convert the Series A Redeemable
Convertible Preferred Stock into shares of Common Stock any time on or after November 15, 2025, provided that the closing price
of the Company&rsquo;s common stock equals or exceeds 190% of the conversion price for 30 consecutive trading days and assuming
certain other conditions of the common stock have been met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders have the option to redeem all or
a portion of the Series A Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and
May 15, 2022 through August 15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of senior
secured notes to Starboard pursuant to the Securities Purchase Agreement. Holders also have the option to redeem all or a portion
of the Series A Redeemable Convertible Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally,
holders have the option to redeem all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of
(i) a change of control or (ii) various other triggering events, such as the suspension from trading or delisting of the Company&rsquo;s
common stock. If the Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price
may include a make-whole amount or a stated premium, depending on the redemption scenario.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company may redeem all, and not less
than all, of the Series A Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May
15, 2022 through August 15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of the senior
secured notes, and assuming certain conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred
Stock is redeemed at the option of the Company, the redemption price would include a make-whole amount or a 15% premium depending
on the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If any Series A Redeemable Convertible Preferred
Stock remains outstanding on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in
cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In all redemption scenarios, the redemption
price for the Series A Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In
addition, depending on the redemption scenario, the redemption price may also include a make-whole amount or stated premium as
described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Company issues senior secured notes,
the Holder may exchange the Series A Redeemable Convertible Preferred Stock for (i) senior secured notes and (ii) Series B Warrants
to purchase common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series A Redeemable Convertible Preferred
Stock accrues cumulative dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of an approved investment
(an investment to be identified and approved by each of the Company and Starboard), the dividend rate will increase to 8.0% on
the stated value. Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering event occurs before
an approved investment or 10.0% on the stated value if the triggering event occurs after an approved investment. The Series A Redeemable
Convertible Preferred Stock also participates on an as-converted basis in any regular or special dividends paid to common stockholders.
Total accrued and unpaid dividends as of December 31, 2019 was $0.1 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of the Series A Redeemable Convertible
Preferred Stock have the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable
Convertible Preferred Stock will also be entitled to a separate class vote with respect to amendments to the Company&rsquo;s organizational
documents that generally have an adverse effect on the Series A Redeemable Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon liquidation of the Company, holders
of Series A Redeemable Convertible Preferred Stock have a liquidation preference over holders of our common stock and will be entitled
to receive, prior to any distribution to holders of our common stock, an amount equal to the greater of (i) the stated value plus
accrued and unpaid dividends or (ii) the amount that would have been received if the Series A Redeemable Convertible Preferred
Stock had been converted into common stock immediately prior to the liquidation event at the then effective conversion price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company determined that certain features
of the Series A Redeemable Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features
are bundled together as a single, compound embedded derivative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Total proceeds received and transaction
costs incurred from the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $35 million and $1.3 million,
respectively. Proceeds received were allocated based on the fair value of the instrument without the Series
A Warrants and of the Series A Warrants themselves at the time of issuance. The proceeds
allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated between the host preferred stock
instrument and the embedded derivative, with the embedded derivative recorded at fair value and the Series A Redeemable Convertible
Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the Series
A Warrants, embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and
$8.9 million, respectively. Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock
and the Series A Warrants on the same basis as the proceeds. The transaction costs allocated to
the Series A Redeemable Convertible Preferred Stock were treated as a discount to the Series A Redeemable Convertible Preferred
Stock. The transaction costs allocated to the Series A Warrants were expensed as incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company classifies the Series A Redeemable
Convertible Preferred Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various
scenarios or otherwise on November 15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become
redeemable, the Company accretes the instrument to its redemption value using the effective interest method and recognizes any
changes against additional paid in capital in the absence of retained earnings. Accretion for the year ended December 31, 2019
was $0.3 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the issuance of the Series
A Redeemable Convertible Preferred Stock, the Company executed a Registration Rights Agreement and a Governance Agreement with
Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain registration rights with respect to the
Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon conversion. In accordance with the Governance
Agreement, the Company agreed to (i) increase the size of the Board of Directors from six to seven members, (ii) appoint a director
of the Company, (iii) grant Starboard the right to recommend two additional directors for appointment to the board, (iv) form a
Strategic Committee of the Board tasked with sourcing and performing due diligence on potential acquisition targets, (v) appoint
certain directors to the Strategic Committee, and (vi) appoint a director to the Nominating and Corporate Governance Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following features of the Series A Redeemable
Convertible Preferred Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded
derivative: (i) the right of the holders to redeem the shares (the &ldquo;put option&rdquo;), (ii) the right of the holders to
receive common stock upon conversion of the shares (the &ldquo;conversion option&rdquo;), (iii) the right of the Company to redeem
the shares (the &ldquo;call option&rdquo;), and (iv) the change in dividend rate upon consummation of an approved investment or
a triggering event (the &ldquo;contingent dividend rate feature&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These features are required to be accounted
for separately from the Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly
and closely related to the debt-like host and also did not meet any other scope exceptions for derivative accounting. Therefore,
these features are bundled together and are accounted for as a single, compound embedded derivative liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Accordingly, we have recorded an embedded
derivative liability representing the combined fair value of each of these features. The embedded derivative liability is adjusted
to reflect fair value at each period end with changes in fair value recorded in the &ldquo;Change in fair value of redeemable preferred
stock embedded derivative&rdquo; financial statement line item of the accompanying consolidated statements of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>17.&nbsp;&nbsp;SERIES A WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 18, 2019, in connection with
the issuance of the Series A Redeemable Convertible Preferred Stock, the Company issued a detachable Series A Warrants to acquire
up to purchase 5,000,000 shares of common stock at a price of $3.65 per share (subject to certain anti-dilution adjustments) at
any time during a period of eight years beginning on the instrument&rsquo;s issuance date of the Series A Warrants. The fair value
of the Series A Warrants was $4.8 million. The Series A Warrants will be recognized at fair value at each reporting period until
exercised, with changes in fair value recognized in other income (expense) in the accompanying consolidated statements of operations.
As of December 31, 2019, the fair value of the Series A Warrants was $3.6 million. As of December 31, 2019, the Series A Warrants
have not been exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series A Warrants are classified as
a liability in accordance with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement
upon a change in control, which is outside the control of the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>18.&nbsp;&nbsp; QUARTERLY FINANCIAL DATA
(unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December&nbsp;31, 2019.
This information has been derived from Acacia&rsquo;s unaudited condensed consolidated financial statements that have been prepared
on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments,
consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the
audited consolidated financial statements and related notes thereto. Acacia&rsquo;s quarterly results have been, and may in the
future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should
not be relied upon as any indication of the results to be expected in any future periods.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="23" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">Quarter
    Ended</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Dec. 31,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Sept. 30,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Jun. 30,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Mar. 31,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Dec. 31,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Sept. 30,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Jun. 30,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 7pt">Mar. 31,</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 7pt">2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="23" STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 7pt">(Unaudited, in thousands, except
    share and per share information)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; width: 36%; font-size: 10pt"><FONT STYLE="font-size: 7pt">Revenues</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">688</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,711</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">5,460</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">3,387</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,203</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">13,725</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">6,485</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">62,093</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Portfolio operations:</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Inventor royalties</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">192</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">776</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,623</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,353</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">11,002</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,181</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,241</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">21,744</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Contingent legal fees</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">4</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">35</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">375</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">177</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">11,756</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,949</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,037</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">15,759</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Patent acquisition expenses</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">4,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Litigation and licensing expenses - patents</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,160</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">987</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,855</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">3,801</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,689</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,549</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,639</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,989</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"><FONT STYLE="font-size: 7pt">Amortization of patents</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">857</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">863</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">818</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">656</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">11,560</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">4,952</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">5,278</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">5,330</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Other
    portfolio expenses (income)</FONT> </TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">1,581</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(475</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">650</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">400</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,202</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Total portfolio operations</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">3,794</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,186</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">5,671</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">6,637</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">36,407</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">12,833</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">10,195</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,822</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Net portfolio income (loss)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(3,106</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(475</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(211</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(3,250</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">12,796</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">892</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(3,710</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">12,271</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">General and administrative expenses (including
    non-cash stock compensation expense)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">4,328</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">4,630</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">3,763</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">3,655</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,754</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">5,855</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">6,916</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">3,301</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Impairment of patent-related
    intangible assets</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">28,210</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Operating income (loss)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(7,434</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(5,105</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(3,974</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(6,905</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">10,042</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(4,963</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(38,836</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">8,970</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Total other income (expense)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">5,921</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(2,503</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(1,774</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,821</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(21,012</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(27,595</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">10,615</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(40,890</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Income (loss) before provision for income taxes</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(1,513</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(7,608</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(5,748</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(4,084</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(10,970</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(32,558</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(28,221</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(31,920</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Provision for income taxes</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">2,147</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(9</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(314</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(397</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(306</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(285</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(191</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Net income (loss) including noncontrolling interests</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">634</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(7,608</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(5,757</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(4,398</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(11,367</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(32,864</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(28,506</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(32,111</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Net (income) loss attributable
    to noncontrolling interests in subsidiaries</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">14</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(2</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(331</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">79</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">73</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Net income (loss) attributable
    to Acacia Research Corporation</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">634</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(7,608</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(5,757</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(4,384</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(11,369</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(33,195</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(28,427</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(32,038</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Less: Accretion of redeemable
    preferred stock</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(307</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Net income (loss) attributable
    to common shareholders &ndash; basic:</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">327</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(7,608</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(5,757</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(4,384</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(11,369</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(33,195</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(28,427</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(32,038</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Basic income (loss) per share</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">0.01</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.15</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.12</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.09</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.23</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.67</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.57</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.63</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Weighted-average number
    of shares outstanding, basic</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,875,750</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,828,361</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,696,016</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,655,881</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,639,172</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,557,748</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">50,061,812</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">50,632,958</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; width: 28%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">Add: Accretion of redeemable preferred
    stock</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">307</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">Less: Mark-to-market adjustment
    for preferred stock embedded derivative</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(3,258</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">&ndash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Net
    loss attributable to common shareholders &ndash; diluted:</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(2,624</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(7,608</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(5,757</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(4,384</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(11,369</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(33,195</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(28,427</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(32,038</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Diluted income (loss) per share</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.05</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.15</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.12</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.09</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.23</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.67</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.57</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">(0.63</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">Weighted-average number
    of shares outstanding, diluted</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">54,406,835</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,828,361</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,696,016</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,655,881</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,639,172</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">49,557,748</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">50,061,812</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 7pt">50,632,958</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Restatement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subsequent to the issuance of the interim
reports for the periods ended March, June and September 2019, the Company identified balances that were presented incorrectly relating
to the presentation of cash flows. The Company re-evaluated its determination of the classification of cash flows related to trading
securities and determined the classification of such cash flows within investing activities to be more appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Included below is a summary of the previously
reported amounts, the impact of these adjustments and the as-adjusted amounts for the interim periods ended March, June and September
2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Three months ended</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Three months ended</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Three months ended</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">March 31, 2019</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">June 30, 2019</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">September 30, 2019</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As reported</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As adjusted</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As reported</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As adjusted</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As reported</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">As adjusted</FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 34%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Net cash provided by (used in) operating
    activities</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(58,812</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(1,958</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(66,026</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(2,268</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(65,748</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(846</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Net cash provided by (used in) investing activities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">3,288</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(53,566</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">625</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(63,133</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">3,721</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(61,181</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Net cash provided by financing activities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&ndash;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">79</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">79</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">79</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">79</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">Increase/(decrease) in cash and cash equivalent</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(55,524</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(55,524</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(65,322</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(65,322</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(61,948</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">(61,948</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>19. SUBSEQUENT EVENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Stockholder approval</I>. On February
14, 2020, the Company&rsquo;s stockholders approved, for purposes of Nasdaq Rules 5635(b) and 5635(d), as applicable, (i) the voting
of the Series A Convertible Preferred Stock on an as-converted basis and (ii) the issuance of the maximum number of shares of common
stock issuable in connection with the potential future (A) conversion of the Series A Convertible Preferred Stock and (B) exercise
of the Series A and Series B Warrants, in each case, without giving effect to the exchange cap set forth in the Series A Preferred
Stock Certificate of Designations and in the Series A Warrants, issued pursuant to the Securities Purchase Agreement dated November
18, 2019 (see Note 16). The Company&rsquo;s stockholders also approved an amendment to the Company&rsquo;s Amended and Restated
Certificate of Incorporation to increase the total number of authorized shares of common stock by 200,000,000 shares, from 100,000,000
shares to 300,000,000 shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Issuance of Series B Warrants to Starboard</I>.
On February 25, 2020, pursuant to the terms of the Securities Purchase Agreement with Starboard, the Company issued Series B Warrants
to purchase up to 100 million shares of the Company&rsquo;s common stock at an exercise price of either (i) $5.25 per share, if
exercising by cash payment, or (ii) $3.65 per share, if exercising by cancellation of a portion of senior secured notes. The Company
issued the Series B Warrants for an aggregate purchase price of $4.6 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 75; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>acacia_ex0301.htm
<DESCRIPTION>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 3.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF INCORPORATION OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Acacia Research Corporation,
a corporation organized and existing under the laws of the State of Delaware (the Corporation), certifies that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
name of the Corporation is Acacia Research Corporation. The Corporation&rsquo;s original Certificate of Incorporation was filed
with the Secretary of State of the State of Delaware on October&nbsp;8, 1999.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Amended and Restated Certificate of Incorporation was duly adopted in accordance with Sections 242 and 245 of the General Corporation
Law of the State of Delaware, and restated, integrates, and further amends the provisions of the Corporations Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
text of the Amended and Restated Certificate of Incorporation is amended and restated to read as set forth in EXHIBIT&nbsp;A attached
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
Acacia Research Corporation has caused this Amended and Restated Certificate of Incorporation to be signed by Jennifer Graff, a
duly authorized officer of the Corporation, on February 18, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">/s/ Jennifer Graff</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Jennifer Graff</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Secretary</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 160pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 160pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 160pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;A</U></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE I<BR>
NAME</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The name of the corporation
is Acacia Research Corporation (the &ldquo;Corporation&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE II<BR>
ADDRESS OF REGISTERED OFFICE;<BR>
NAME OF REGISTERED AGENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The address of the
registered office of the Corporation in the State of Delaware 32 W. Loockerman Street, Suite 201, Dover, County of Kent, Delaware.
The name of its registered agent at such address is Registered Agent Solutions, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE III<BR>
PURPOSE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of the
Corporation is to engage in any lawful act or activity for which corporations may be organized under the Delaware General Corporation
Law (the &ldquo;DGCL&rdquo;).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE IV<BR>
CAPITAL STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>AUTHORIZATION</B>. The aggregate number of shares of stock which the Corporation shall have authority to issue is three
hundred and ten million (310,000,000) shares, of which three hundred million (300,000,000) shares shall be shares of common stock
having a par value of $0.001 per share (the &ldquo;Common Stock&rdquo;), and ten million (10,000,000) shares shall be shares of
preferred stock having a par value of $0.001 per share (the &ldquo;Preferred Stock&rdquo;) and issuable in one or more series as
hereinafter provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>COMMON STOCK</B>. The voting powers, preferences and relative, participating, optional or other special rights of the Common
Stock, and the qualifications and restrictions thereon, shall be as follows in this Section&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Dividends</B>. Subject to the rights, preferences, privileges, restrictions and other matters pertaining to the Preferred
Stock that may at that time be outstanding, the holders of the Common Stock shall be entitled to receive, when, as and if declared
by the Board of Directors, out of any assets of the Corporation legally available therefore, such dividends as may be declared
from time to time by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Voting Rights</B>. Except as otherwise required by law, or as otherwise fixed by resolution or resolutions of the Board
of Directors with respect to one or more series of Preferred Stock, the entire voting power and all voting rights shall be vested
exclusively in the Common Stock, and each stockholder of the Corporation who at the time possesses voting power for any purpose
shall be entitled to one vote for each share of such stock standing in his or her name on the books of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Liquidation Rights</B>. In the event of any liquidation, dissolution or winding up (either voluntary or involuntary) of
the Corporation, the holders of shares of Common Stock shall be entitled to receive the assets and funds of the Corporation available
for distribution after payments to creditors and to the holders of any Preferred Stock of the Corporation that may at the time
be outstanding, in proportion to the number of shares held by them. Neither the merger nor consolidation of the Corporation into
or with any other corporation, nor a sale, transfer or lease of all or any part of the assets of the Corporation, shall, alone,
be deemed a liquidation or winding up of the Corporation or cause the dissolution of the Corporation, for purposes of this Section&nbsp;2.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>PREFERRED STOCK</B>. The Preferred Stock may be issued from time to time in one or more series, each with such distinctive
designation as may be stated in the Certificate of Incorporation or in any amendment hereto, or in a resolution or resolutions
providing for the issue of such stock from time to time adopted by the Board of Directors or a duly authorized committee thereof.
The resolution or resolutions providing for the issue of shares of a particular series shall fix, subject to applicable laws and
the provisions of the Certificate of Incorporation, for each such series the number of shares constituting such series and the
designation and the voting powers, preferences and relative, participating, optional or other special rights and the qualifications,
limitations or restrictions thereof, including, without limiting the generality of the foregoing, such provisions as may be desired
concerning voting, redemption, dividends, dissolution or the distribution of assets, conversion or exchange, and such other subjects
or matters as may be fixed by the Board of Directors or a duly authorized committee thereof under the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE V<BR>
BOARD OF DIRECTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>NUMBER OF DIRECTORS AND THEIR ELECTION</B>. The number of directors of the Corporation shall be fixed from time to time
by a by-law of the Corporation or amendment thereof duly adopted by the Board of Directors. Except as otherwise provided for or
fixed pursuant to the provisions of ARTICLE&nbsp;V of this Certificate of Incorporation or any resolution or resolutions of the
Board of Directors providing for the issuance of any class or series of stock having a preference over the Common Stock as to dividends
or upon liquidation to elect additional directors under specified circumstances, the number of directors shall be determined by
the Board of Directors in accordance with the By-laws of the Corporation. Election of directors need not be by written ballot,
unless so provided in the By-laws of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>POWERS OF THE BOARD OF DIRECTORS</B>. In furtherance, and not in limitation, of the powers conferred by the laws of the
State of Delaware, the Board of Directors is expressly authorized to adopt, alter, amend and repeal the By-laws of the Corporation,
subject to the power of the stockholders of the Corporation to alter or repeal any by-law whether adopted by them or otherwise;
provided, however, that the affirmative vote of 66 and 2/3 percent of the voting power of the capital stock of the Corporation
entitled to vote thereon shall be required for stockholders to adopt, amend, alter or repeal any provision of the By-laws of the
Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>TERM</B>. The directors, other than those who may be elected by the holders of Preferred Stock or any other class or series
of stock having a preference over the Common Stock as to dividends or upon liquidation pursuant to the terms of this Certificate
of Incorporation or any resolution or resolutions providing for the issuance of such class or series of stock adopted by the Board
of Directors, shall be elected by stockholders at each annual meeting of stockholders to hold office for a term expiring at the
next annual meeting of stockholders and until his or her successor shall be elected and shall qualify, subject, however, to prior
death, resignation, retirement, disqualification or removal from office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>VACANCIES</B>. Any newly-created directorship resulting from an increase in the authorized number of directors or any vacancies
in the Board of Directors occurring by reason of death, resignation, retirement, disqualification or removal may be filled by a
majority of the remaining directors, though less than a quorum, or by a sole remaining director. A director appointed in accordance
with the preceding sentence shall hold office for the remainder of the full term expiring at the next annual meeting of the stockholders
and until his or her successor shall be elected and shall qualify, subject, however, to prior death, resignation, retirement, disqualification
or removal from office.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VI<BR>
STOCKHOLDER ACTIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>SECTION
1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B></FONT><B>MEETINGS
AND RECORDS</B>. Meetings of stockholders may be held within or without the State of Delaware, as the By-laws of the Corporation
may provide. The books of the Corporations may be kept (subject to the DGCL) outside of the State of Delaware at such place or
places as may be designated from time to time by the Board of Directors or in the By-laws of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SPECIAL MEETINGS</B>. Special meetings of stockholders may be called at any time by the Board of Directors or by the Chairman
of the Board of Directors, or the President, or the Secretary of the Corporation upon the written request of one or more stockholders
of record of the Corporation that hold at least twenty-five percent (25%) in voting power of the outstanding shares of stock of
the Company and who have delivered such requests in accordance with and subject to the procedures and conditions and any other
provisions set forth in the By-laws of the Corporation (as amended from time to time), including any limitations set forth in the
By-laws of the Corporation on the ability to make such a request for such a special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WRITTEN CONSENTS</B>. No action that is required or permitted to be taken by the stockholders of the Corporation at any
annual or special meeting of the stockholders may be effected by written consent of the stockholders in lieu of a meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VII<BR>
LIMITATION ON LIABILITY OF DIRECTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No person shall be
personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, including
without limitation for serving on a committee of the Board of Directors, except to the extent such exemption from liability or
limitation thereof is not permitted under the DGCL as the same exists or hereafter may be amended. If the DGCL is amended after
the date of the filing of this Certificate of Incorporation to authorize corporate action further eliminating or limiting the personal
liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent
permitted by the DGCL as so amended. Any amendment, repeal or modification of this ARTICLE&nbsp;VII shall not adversely affect
any right or protection of a director of the Corporation existing hereunder with respect to any act or omission occurring prior
to such amendment, repeal or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE VIII<BR>
INDEMNIFICATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>SECTION 1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>The Corporation may indemnify to the fullest extent permitted by law any person made or threatened to be made a party
to an action or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that such person, his
or her testator or intestate is or was a director, officer or employee of the Corporation or any predecessor of the Corporation
or serves or served at any other enterprise as a director, officer or employee at the request of the Corporation or any predecessor
to the Corporation. No amendment, repeal or modification of this ARTICLE&nbsp;VIII by the stockholders shall adversely affect any
right or protection of a director of the Corporation existing by virtue of this ARTICLE&nbsp;VIII at the time of such amendment,
repeal or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE IX</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">AMENDMENT OF CERTIFICATE
OF INCORPORATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation hereby
reserves the right from time to time to amend, alter, change or repeal any provision contained in the Certificate of Incorporation,
and other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, in the manner
now or hereafter prescribed by law, and all rights, preferences, and privileges of whatsoever nature conferred upon the stockholders,
directors or any other persons whomsoever by or pursuant to this Certificate of Incorporation in its present form or as hereafter
amended are granted subject to the right reserved in this ARTICLE&nbsp;IX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE X</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;<U><BR>
</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>SECTION
1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Definitions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this ARTICLE
X, the following capitalized terms have the following meanings when used herein with initial capital letters (and any references
to any portions of Treas. Reg. &sect; 1.382-2T shall include any successor provisions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;4.899-percent
Transaction&rdquo; means any Transfer described in clause (a) or (b) of Section 2 of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;4.899-percent
Stockholder&rdquo; means a Person or group of Persons that is a &ldquo;5-percent stockholder&rdquo; of the corporation pursuant
to Treas. Reg. &sect; 1.382-2T(g), as applied by replacing &ldquo;5-percent&rdquo; with &ldquo;4.899-percent&rdquo; and &ldquo;five
percent&rdquo; with &ldquo;4.899 percent,&rdquo; where applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) &ldquo;Agent&rdquo;
has the meaning set forth in Section 5 of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) &ldquo;Code&rdquo;
means the United States Internal Revenue Code of 1986, as amended. For the avoidance of doubt, Code also includes &ldquo;An Act
to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018,&rdquo;
(PL 115-97).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;Corporation
Security&rdquo; or &ldquo;Corporation Securities&rdquo; means (i) any Stock, (ii) shares of preferred stock issued by the Corporation
(other than preferred stock described in &sect; 1504(a)(4) of the Code), and (iii) warrants, rights, or options (including options
within the meaning of Treas. Reg. &sect; 1.382-2T(h)(4)(v) or Treas. Reg. &sect; 1.382-4(d)(9)) to purchase securities of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) &ldquo;Effective
Date&rdquo; means the date of filing of this Certificate of Incorporation of the Corporation with the Secretary of State of the
State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) &ldquo;Excess Securities&rdquo;
has the meaning set forth in Section 4 of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) &ldquo;Expiration
Date&rdquo; means the earliest of (i) the close of business on the date that is the third anniversary of the Effective Date, (ii)
the repeal of Section 382 of the Code or any successor statute if the Board of Directors determines that this ARTICLE X is no longer
necessary or desirable for the preservation of Tax Benefits, (iii) the close of business on the first day of a taxable year of
the Corporation as to which the Board of Directors determines that no Tax Benefits may be carried forward, and (iv) such date as
the Board of Directors shall fix in accordance with Section 12 of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) &ldquo;Percentage
Stock Ownership&rdquo; means the percentage Stock Ownership interest of any Person or group (as the context may require) for purposes
of Section 382 of the Code as determined in accordance with Treas. Reg. &sect; 1.382-2(a)(3), Treas. Reg. &sect; 1.382-2T(g), (h),
(j) and (k) and Treas. Reg. &sect; 1.382-4, or any successor provisions and other pertinent Internal Revenue Service guidance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) &ldquo;Person&rdquo;
means any individual, partnership, joint venture, limited liability company, firm, corporation, unincorporated association or organization,
trust or other entity or any group of such &ldquo;Persons&rdquo; having a formal or informal understanding among themselves to
make a &ldquo;coordinated acquisition&rdquo; of shares within the meaning of Treas. Reg. &sect; 1.382-3(a)(1) or who are otherwise
treated as an &ldquo;entity&rdquo; within the meaning of Treas. Reg. &sect; 1.382-3(a)(1), and shall include any successor (by
merger or otherwise) of any such entity or group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) &ldquo;Prohibited
Distributions&rdquo; means any and all dividends or other distributions paid by the Corporation with respect to any Excess Securities
received by a Purported Transferee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) &ldquo;Prohibited
Transfer&rdquo; means any Transfer or purported Transfer of Corporation Securities to the extent that such Transfer is prohibited
and/or void under this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) &ldquo;Public Group&rdquo;
has the meaning set forth in Treas. Reg. &sect; 1.382-2T(f)(13).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) &ldquo;Purported
Transferee&rdquo; has the meaning set forth in Section 4 of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) &ldquo;Remedial
Holder&rdquo; has the meaning set forth in Section 7 of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) &ldquo;Stock&rdquo;
means any interest that would be treated as &ldquo;stock&rdquo; of the Corporation pursuant to Treas. Reg. &sect; 1.382-2T(f)(18).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) &ldquo;Stock Ownership&rdquo;
means any direct or indirect ownership of Stock, including any ownership by virtue of application of constructive ownership rules,
with such direct, indirect and constructive ownership determined under the provisions of Section 382 of the Code and the Treasury
Regulations thereunder, including, for the avoidance of doubt, any ownership whereby a Person owns Stock pursuant to a &ldquo;coordinated
acquisition&rdquo; treated as a single &ldquo;entity&rdquo; as defined in Treas. Reg. &sect; 1.382-3(a)(1), or such Stock is otherwise
aggregated with Stock owned by such Person pursuant to the provisions of Section 382 of the Code and the Treasury Regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) &ldquo;Tax Benefits&rdquo;
means the net operating loss carry forwards, capital loss carry forwards, general business credit carry forwards, alternative minimum
tax credit carry forwards, foreign tax credit carry forwards, disallowed net business interest expense carry forwards under Section
163(j), any credits under Section 53, and any other item that may reduce or result in any credit against any income taxes owed
by the Corporation or any of its subsidiaries or refundable credits, including, but not limited to, any item subject to limitation
under Section 382 or Section 383 of the Code and the Treasury Regulations promulgated thereunder, and any loss or deduction attributable
to a &ldquo;net unrealized built-in loss&rdquo; within the meaning of Section 382 of the Code and the Treasury Regulations promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) &ldquo;Transfer&rdquo;
means, any direct or indirect sale, transfer, assignment, conveyance, pledge or other disposition, event or occurrence or other
action taken by a Person, other than the Corporation, that alters the Percentage Stock Ownership of any Person or group, including,
a transfer by gift or by operation of law. A Transfer also shall include the creation or grant of an option (including an option
within the meaning of Treas. Reg. &sect;1.382-4(d)). For the avoidance of doubt, a Transfer shall not include the creation or grant
of an option by the Corporation, nor shall a Transfer include the issuance of Stock by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) &ldquo;Transferee&rdquo;
means any Person to whom Corporation Securities are Transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) &ldquo;Treasury
Regulations&rdquo; or &ldquo;Treas. Reg.&rdquo; means the regulations, including temporary regulations or any successor regulations,
promulgated under the Code, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
2. Transfer and Ownership Restrictions.</B></FONT> In order to preserve the Tax Benefits, from and after the Effective Date any
attempted Transfer of Corporation Securities prior to the Expiration Date and any attempted Transfer of Corporation Securities
pursuant to an agreement entered into prior to the Expiration Date shall be prohibited and void ab initio to the extent that, as
a result of such Transfer (or any series of Transfers of which such Transfer is a part), either (a) any Person or Persons would
become a 4.899-percent Stockholder or (b) the Percentage Stock Ownership in the Corporation of any 4.899-percent Stockholder would
be increased. The prior sentence is not intended to prevent Corporation Securities from being DTC-eligible and shall not preclude
the settlement of any transaction in Corporation Securities entered into through the facilities of a national securities exchange;
provided, however, that the Corporation Securities and parties involved in such transaction shall remain subject to the provisions
of this ARTICLE X in respect of such transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
3. Exceptions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) Notwithstanding
anything to the contrary herein, Transfers to a Public Group (including a new Public Group created under Treas. Reg. &sect; 1.382-2T
(j) (3) (i)) shall be permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The restrictions
set forth in Section 2 of this ARTICLE X shall not apply to an attempted Transfer that is a 4.899-percent Transaction if the transferor
or the Transferee obtains the written approval of the Board of Directors or a duly authorized committee thereof. As a condition
to granting its approval pursuant to this Section 3 of this ARTICLE X, the Board of Directors may, in its discretion, require (at
the expense of the transferor and/or Transferee) an opinion of counsel selected by the Board of Directors that the Transfer shall
not result in a limitation on the use of the Tax Benefits as a result of the application of Section 382 of the Code; provided that
the Board of Directors may grant such approval notwithstanding the effect of such approval on the Tax Benefits if it determines
that the approval is in the best interests of the Corporation. The Board of Directors may grant its approval in whole or in part
with respect to such Transfer and may impose any conditions that it deems reasonable and appropriate in connection with such approval,
including, without limitation, restrictions on the ability of any Transferee to Transfer Stock acquired through a Transfer. Approvals
of the Board of Directors hereunder may be given prospectively or retroactively. The Board of Directors, to the fullest extent
permitted by law, may exercise the authority granted by this ARTICLE X through duly authorized officers or agents of the Corporation.
Nothing in this Section 3 of this ARTICLE X shall be construed to limit or restrict the Board of Directors in the exercise of its
fiduciary duties under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
4. Excess Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) No employee or
agent of the Corporation shall record any Prohibited Transfer, and the purported transferee of such a Prohibited Transfer (the
&ldquo;Purported Transferee&rdquo;) shall not be recognized as a stockholder of the Corporation for any purpose whatsoever in respect
of the Corporation Securities which are the subject of the Prohibited Transfer (the &ldquo;Excess Securities&rdquo;). The Purported
Transferee shall not be entitled, with respect to such Excess Securities, to any rights of stockholders of the Corporation, including,
without limitation, the right to vote such Excess Securities and to receive dividends or distributions, whether liquidating or
otherwise, in respect thereof, if any, and the Excess Securities shall be deemed to remain with the transferor unless and until
the Excess Securities are transferred to the Agent pursuant to Section 5 of this ARTICLE X or until an approval is obtained under
Section 3 of this ARTICLE X. After the Excess Securities have been acquired in a Transfer that is not a Prohibited Transfer, the
Corporation Securities shall cease to be Excess Securities. For this purpose, any Transfer of Excess Securities not in accordance
with the provisions of this Section 4 or Section 5 of this ARTICLE X shall also be a Prohibited Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Corporation
may require as a condition to the registration of the Transfer of any Corporation Securities or the payment of any distribution
on any Corporation Securities that the proposed Transferee or payee furnish to the Corporation all information reasonably requested
by the Corporation with respect to its direct or indirect ownership interests in such Corporation Securities. The Corporation may
make such arrangements or issue such instructions to its stock transfer agent as may be determined by the Board of Directors to
be necessary or advisable to implement this ARTICLE X, including, without limitation, authorizing such transfer agent to require
an affidavit from a Purported Transferee regarding such Person&rsquo;s actual and constructive ownership of Stock and other evidence
that a Transfer will not be prohibited by this ARTICLE X as a condition to registering any transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
5. Transfer to Agent. </B></FONT>If the Board of Directors determines that a Transfer of Corporation Securities constitutes a Prohibited
Transfer, then, upon written demand by the Corporation sent within thirty days of the date on which the Board of Directors determines
that the attempted Transfer would result in Excess Securities, the Purported Transferee shall transfer or cause to be transferred
any certificate or other evidence of ownership of the Excess Securities within the Purported Transferee&rsquo;s possession or control,
together with any Prohibited Distributions, to an agent designated by the Board of Directors (the &ldquo;Agent&rdquo;). The Agent
shall thereupon sell to a buyer or buyers, which may include the Corporation, the Excess Securities transferred to it in one or
more arm&rsquo;s-length transactions (on the public securities market on which such Excess Securities are traded, if possible,
or otherwise privately); provided, however, that any such sale must not constitute a Prohibited Transfer and provided, further,
that the Agent shall effect such sale or sales in an orderly fashion and shall not be required to effect any such sale within any
specific time frame if, in the Agent&rsquo;s discretion, such sale or sales would disrupt the market for the Corporation Securities
or otherwise would adversely affect the value of the Corporation Securities. If the Purported Transferee has resold the Excess
Securities before receiving the Corporation&rsquo;s demand to surrender Excess Securities to the Agent, the Purported Transferee
shall be deemed to have sold the Excess Securities for the Agent, and shall be required to transfer to the Agent any Prohibited
Distributions and proceeds of such sale, except to the extent that the Corporation grants written permission to the Purported Transferee
to retain a portion of such sale proceeds not exceeding the amount that the Purported Transferee would have received from the Agent
pursuant to Section 6 of this ARTICLE X if the Agent rather than the Purported Transferee had resold the Excess Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
6. Application of Proceeds and Prohibited Distributions. </B></FONT>The Agent shall apply any proceeds of a sale by it of Excess
Securities and, if the Purported Transferee has previously resold the Excess Securities, any amounts received by it from a Purported
Transferee, together, in either case, with any Prohibited Distributions, as follows: (i) first, such amounts shall be paid to the
Agent to the extent necessary to cover its costs and expenses incurred in connection with its duties hereunder; (ii) second, any
remaining amounts shall be paid to the Purported Transferee, up to the amount paid by the Purported Transferee for the Excess Securities
(or the fair market value at the time of the Transfer, in the event the purported Transfer of the Excess Securities was, in whole
or in part, a gift, inheritance or similar Transfer) which amount (or fair market value) shall be determined at the discretion
of the Board of Directors; and (iii) third, any remaining amounts shall be paid to one or more organizations selected by the Board
of Directors which is described under Section 501(c)(3) of the Code (or any comparable successor provision) and contributions to
which are eligible for deduction under each of Sections 170(b)(1)(A), 2055 and 2552 of the Code. The Purported Transferee of Excess
Securities shall have no claim, cause of action or any other recourse whatsoever against any transferor of Excess Securities. The
Purported Transferee&rsquo;s sole right with respect to such shares shall be limited to the amount payable to the Purported Transferee
pursuant to this Section 6 of this ARTICLE X. In no event shall the proceeds of any sale of Excess Securities pursuant to this
Section 6 of this ARTICLE X inure to the benefit of the Corporation or the Agent, except to the extent used to cover costs and
expenses incurred by Agent in performing its duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
7. Modification of Remedies for Certain Indirect Transfers.</B></FONT> In the event of any Transfer that does not involve a transfer
of Corporation Securities within the meaning of Delaware law but that would cause a 4.899-percent Stockholder to violate a restriction
on Transfers provided for in this ARTICLE X, the application of Sections 5 and 6 of this ARTICLE X shall be modified as described
in this Section 7 of this ARTICLE X. In such case, no such 4.899-percent Stockholder shall be required to dispose of any interest
that is not a Corporation Security, but such 4.899-percent Stockholder and/or any Person whose ownership of Corporation Securities
is attributed to such 4.899-percent Stockholder (such 4.899-percent Stockholder or other Person, a &ldquo;Remedial Holder&rdquo;)
shall be deemed to have disposed of and shall be required to dispose of sufficient Corporation Securities (which Corporation Securities
shall be disposed of in the inverse order in which they were acquired) to cause such 4.899-percent Stockholder, following such
disposition, not to be in violation of this ARTICLE X. Such disposition shall be deemed to occur simultaneously with the Transfer
giving rise to the application of this provision, and such number of Corporation Securities that are deemed to be disposed of shall
be considered Excess Securities and shall be disposed of through the Agent as provided in Sections 5 and 6 of this ARTICLE X, except
that the maximum aggregate amount payable to a Remedial Holder in connection with such sale shall be the fair market value of such
Excess Securities at the time of the purported Transfer. A Remedial Holder shall not be entitled, with respect to such Excess Securities,
to any rights of stockholders of the Corporation, including, without limitation, the right to vote such Excess Securities and to
receive dividends or distributions, whether liquidating or otherwise, in respect thereof, if any, following the time of the purported
Transfer. All expenses incurred by the Agent in disposing of such Excess Securities shall be paid out of any amounts due such 4.899-percent
Stockholder or such other Person. The purpose of this Section 7 of this ARTICLE X is to extend the restrictions in Sections 2 and
5 of this ARTICLE X to situations in which there is a 4.899-percent Transaction without a direct Transfer of Corporation Securities,
and this Section 7 of this ARTICLE X, along with the other provisions of this ARTICLE X, shall be interpreted to produce the same
results, with differences as the context requires, as a direct Transfer of Corporation Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
8. Legal Proceedings; Prompt Enforcement. </B></FONT>If the Purported Transferee fails to surrender the Excess Securities or the
proceeds of a sale thereof, in either case, with any Prohibited Distributions, to the Agent within thirty days from the date on
which the Corporation makes a written demand pursuant to Section 5 of this ARTICLE X (whether or not made within the time specified
in Section 5 of this ARTICLE X), then the Corporation may take such actions as it deems appropriate to enforce the provisions hereof,
including the institution of legal proceedings to compel the surrender. Nothing in this Section 8 of this ARTICLE X shall (i) be
deemed inconsistent with any Transfer of the Excess Securities provided in this ARTICLE X being void ab initio, (ii) preclude the
Corporation in its discretion from immediately bringing legal proceedings without a prior demand or (iii) cause any failure of
the Corporation to act within the time periods set forth in Section 5 of this ARTICLE X to constitute a waiver or loss of any right
of the Corporation under this ARTICLE X. The Board of Directors may authorize such additional actions as it deems advisable to
give effect to the provisions of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
9. Liability. </B></FONT>To the fullest extent permitted by law, any stockholder subject to the provisions of this ARTICLE X who
knowingly violates the provisions of this ARTICLE X and any Persons controlling, controlled by or under common control with such
stockholder shall be jointly and severally liable to the Corporation for, and shall indemnify and hold the Corporation harmless
against, any and all damages suffered as a result of such violation, including but not limited to damages resulting from a reduction
in, or elimination of, the Corporation&rsquo;s ability to utilize its Tax Benefits, and attorneys&rsquo; and auditors&rsquo; fees
incurred in connection with such violation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
10. Obligation to Provide Information. </B></FONT>As a condition to the registration of the Transfer of any Stock, any Person who
is a beneficial, legal or record holder of Stock, and any proposed Transferee and any Person controlling, controlled by or under
common control with the proposed Transferee, shall provide such information as the Corporation may request from time to time in
order to determine compliance with this ARTICLE X or the status of the Tax Benefits of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
11. Legends.</B></FONT> The Board of Directors may require that any certificates issued by the Corporation evidencing ownership
of shares of Stock that are subject to the restrictions on transfer and ownership contained in this ARTICLE X bear the following
legend:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;THE CERTIFICATE
OF INCORPORATION OF THE COMPANY CONTAINS RESTRICTIONS PROHIBITING THE TRANSFER (AS DEFINED IN THE CERTIFICATE OF INCORPORATION)
OF STOCK OF THE COMPANY (INCLUDING THE CREATION OR GRANT OF CERTAIN OPTIONS, RIGHTS AND WARRANTS) WITHOUT THE PRIOR AUTHORIZATION
OF THE BOARD OF DIRECTORS OF THE COMPANY (THE &ldquo;BOARD OF DIRECTORS&rdquo;) IF SUCH TRANSFER AFFECTS THE PERCENTAGE OF STOCK
OF THE CORPORATION (WITHIN THE MEANING OF Section 382 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE &ldquo;CODE&rdquo;)
AND THE TREASURY REGULATIONS PROMULGATED THEREUNDER) THAT IS TREATED AS OWNED BY A 4.899-PERCENT STOCKHOLDER (AS DEFINED IN THE
CERTIFICATE OF INCORPORATION). IF THE TRANSFER RESTRICTIONS ARE VIOLATED, THEN THE TRANSFER WILL BE VOID AB INITIO AND THE PURPORTED
TRANSFEREE OF THE STOCK WILL BE REQUIRED TO TRANSFER EXCESS SECURITIES (AS DEFINED IN THE CERTIFICATE OF INCORPORATION) TO THE
COMPANY&rsquo;S AGENT. IN THE EVENT OF A TRANSFER WHICH DOES NOT INVOLVE SECURITIES OF THE COMPANY WITHIN THE MEANING OF THE GENERAL
CORPORATION LAW OF THE STATE OF DELAWARE (&ldquo;SECURITIES&rdquo;) BUT WHICH WOULD VIOLATE THE TRANSFER RESTRICTIONS, THE PURPORTED
TRANSFEREE (OR THE RECORD OWNER) OF THE SECURITIES THAT VIOLATE THE TRANSFER RESTRICTIONS WILL BE REQUIRED TO TRANSFER SUFFICIENT
SECURITIES PURSUANT TO THE TERMS PROVIDED FOR IN THE CERTIFICATE OF INCORPORATION TO CAUSE THE 4.899-PERCENT STOCKHOLDER TO NO
LONGER BE IN VIOLATION OF THE TRANSFER RESTRICTIONS. THE CORPORATION WILL FURNISH WITHOUT CHARGE TO THE HOLDER OF RECORD OF THIS
CERTIFICATE A COPY OF THE CERTIFICATE OF INCORPORATION CONTAINING THE ABOVE-REFERENCED TRANSFER RESTRICTIONS UPON WRITTEN REQUEST
TO THE CORPORATION AT ITS PRINCIPAL PLACE OF BUSINESS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
may also require that any certificates issued by the Corporation evidencing ownership of shares of Stock that are subject to conditions
imposed by the Board of Directors under Section 3 of this ARTICLE X also bear a conspicuous legend referencing the applicable restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
12. Authority of Board of Directors.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Board of Directors
shall have the power to determine all matters necessary for assessing compliance with this ARTICLE X, including, without limitation,
(1) the identification of 4.899-percent Stockholders, (2) whether a Transfer is a 4.899-percent Transaction or a Prohibited Transfer,
(3) the Percentage Stock Ownership in the Corporation of any 4.899-percent Stockholder, (4) whether an instrument constitutes a
Corporation Security, (5) the amount (or fair market value) due to a Purported Transferee pursuant to Section 6 of this ARTICLE
X, and (6) any other matters which the Board of Directors determines to be relevant; and the good faith determination of the Board
of Directors on such matters shall be conclusive and binding for all the purposes of this ARTICLE X. In addition, the Board of
Directors may, to the extent permitted by law, from time to time establish, modify, amend or rescind by-laws, regulations and procedures
of the Corporation not inconsistent with the provisions of this ARTICLE X for purposes of determining whether any Transfer of Corporation
Securities would jeopardize or endanger the Corporation&rsquo;s ability to preserve and use the Tax Benefits and for the orderly
application, administration and implementation of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Nothing contained
in this ARTICLE X shall limit the authority of the Board of Directors to take such other action to the extent permitted by law
as it deems necessary or advisable to protect the Corporation and its stockholders in preserving the Tax Benefits. Without limiting
the generality of the foregoing, in the event of a change in law making one or more of the following actions necessary or desirable,
the Board of Directors may, by adopting a written resolution, (1) accelerate the Expiration Date, (2) modify the ownership interest
percentage in the Corporation or the Persons or groups covered by this ARTICLE X, (3) modify the definitions of any terms set forth
in this ARTICLE X or (4) modify the terms of this ARTICLE X as appropriate, in each case, in order to prevent an ownership change
for purposes of Section 382 of the Code as a result of any changes in applicable Treasury Regulations or otherwise; provided, however,
that the Board of Directors shall not cause there to be such acceleration or modification unless it determines, by adopting a written
resolution, that such action is reasonably necessary or advisable to preserve the Tax Benefits or that the continuation of these
restrictions is no longer reasonably necessary for the preservation of the Tax Benefits. Stockholders of the Corporation shall
be notified of such determination through a filing with the Securities and Exchange Commission or such other method of notice as
the Secretary of the Corporation shall deem appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) In the case of
an ambiguity in the application of any of the provisions of this ARTICLE X, including any definition used herein, the Board of
Directors shall have the power to determine the application of such provisions with respect to any situation based on its reasonable
belief, understanding or knowledge of the circumstances. In the event this ARTICLE X requires an action by the Board of Directors
but fails to provide specific guidance with respect to such action, the Board of Directors shall have the power to determine the
action to be taken so long as such action is not contrary to the provisions of this ARTICLE X. All such actions, calculations,
interpretations and determinations which are done or made by the Board of Directors in good faith shall be conclusive and binding
on the Corporation, the Agent, and all other parties for all other purposes of this ARTICLE X. The Board of Directors may delegate
all or any portion of its duties and powers under this ARTICLE X to a committee of the Board of Directors as it deems necessary
or advisable and, to the fullest extent permitted by law, may exercise the authority granted by this ARTICLE X through duly authorized
officers or agents of the Corporation. Nothing in this ARTICLE X shall be construed to limit or restrict the Board of Directors
in its exercise of its fiduciary duties under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
13. Reliance. </B></FONT>To the fullest extent permitted by law, the Corporation and the members of the Board of Directors shall
be fully protected in relying in good faith upon the information, opinions, reports or statements of the chief executive officer,
the chief financial officer, the chief accounting officer or the corporate controller of the Corporation and the Corporation&rsquo;s
legal counsel, independent auditors, transfer agent, investment bankers or other employees and agents in making the determinations
and findings contemplated by this ARTICLE X. The members of the Board of Directors shall not be responsible for any good faith
errors made in connection therewith. For purposes of determining the existence and identity of, and the amount of any Corporation
Securities owned by, any stockholder, the Corporation is entitled to rely on the existence and absence of filings of Schedule 13D
or 13G under the Securities and Exchange Act of 1934, as amended (or similar filings), as of any date, subject to its actual knowledge
of the ownership of Corporation Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
14. Benefits of this ARTICLE X. </B></FONT>Nothing in this ARTICLE X shall be construed to give to any Person other than the Corporation
or the Agent any legal or equitable right, remedy or claim under this ARTICLE X. This ARTICLE X shall be for the sole and exclusive
benefit of the Corporation and the Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
15. Severability. </B></FONT>The purpose of this ARTICLE X is to facilitate the Corporation&rsquo;s ability to maintain or preserve
its Tax Benefits. If any provision of this ARTICLE X or the application of any such provision to any Person or under any circumstance
shall be held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality
or unenforceability shall not affect any other provision of this ARTICLE X.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>Section
16. Waiver. </B></FONT>With regard to any power, remedy or right provided herein or otherwise available to the Corporation or the
Agent under this ARTICLE X, (i) no waiver will be effective unless expressly contained in a writing signed by the waiving party
and (ii) no alteration, modification or impairment will be implied by reason of any previous waiver, extension of time, delay or
omission in exercise or other indulgence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>acacia_ex0402.htm
<DESCRIPTION>DESCRIPTION OF CAPITAL STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 4.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>DESCRIPTION
OF CAPITAL STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The following is
a summary of all material characteristics of the capital stock of Acacia Research Corporation, as set forth in our Amended and
Restated Certificate of Incorporation, as amended, or our Charter, and our Second Amended and Restated Bylaws, as amended, or our
Bylaws. References to &ldquo;we,&rdquo; &ldquo;us,&rdquo; or &ldquo;our&rdquo; refer to Acacia Research Corporation The summary
does not purport to be complete and is qualified in its entirety by reference to our Charter and Bylaws, copies of which have been
filed as exhibits to our public filings with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>General.&nbsp;</I>We may issue shares
of our common stock from time to time. We are authorized to issue 300,000,000 shares of common stock, par value $0.001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Dividend Rights.&nbsp;</I>Subject to
preferences that may apply to any shares of preferred stock outstanding at the time, the holders of outstanding shares of our common
stock are entitled to receive dividends out of funds legally available at the times and in the amounts that our board of directors
may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Voting Rights.&nbsp;</I>Holders of our
common stock are entitled to one vote for each share held on all matters submitted to a vote at a meeting of stockholders and do
not have cumulative voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>No Preemptive or Similar Rights.&nbsp;</I>Our
common stock is not entitled to preemptive rights, and is not subject to redemption. There are no sinking fund provisions applicable
to our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Conversion.&nbsp;</I>Our common stock
is not convertible into any other shares of our capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Right to Receive Liquidation Distributions.&nbsp;</I>Upon
our liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would be distributable
ratably among the holders of our common stock after payment of liquidation preferences, if any, on any outstanding shares of preferred
stock and payment of claims of creditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Series A Convertible Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 40.8pt">Pursuant to the terms of our Charter, our
board of directors is authorized, subject to limitations prescribed by Delaware law, to issue up to 10,000,000 shares of preferred
stock, par value $0.001 per share, in one or more series, to establish from time to time the number of shares to be included in
each series, and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications,
limitations or restrictions, in each case without further action by our stockholders. On November 18, 2019, we filed a Certificate
of Designations, Preferences, and Rights of Series A Convertible Preferred Stock with the Secretary of State of the State of Delaware,
or the Certificate of Designations establishing the rights, preferences, privileges, qualifications, restrictions and limitations
relating to 350,000 shares of our Series A Convertible Preferred Stock, par value $0.001 per share. Our Series A Convertible Preferred
Stock rank senior to our common stock and any other class or series of capital stock, with respect to rights as to as to dividends,
distributions, redemptions and payments upon the liquidation, dissolution and winding up of Acacia. Holders of our Series A Convertible
Preferred Stock have the right to vote with holders of our common stock on an as-converted basis on all matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Delaware Law and Certain Charter and Bylaw Provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The provisions of Delaware law, as well
as certain terms of our Charter and Bylaws, may have the effect of delaying, deferring or discouraging another person from acquiring
control of us by means of a tender offer, a proxy contest or otherwise, or removing incumbent officers and directors. These provisions,
some of which are summarized below, are expected to discourage certain types of coercive takeover practices and takeover bids that
our board of directors may consider inadequate and to encourage any person seeking to acquire control of us to first negotiate
with our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.85pt"><I>Delaware Law. </I>We are governed by
the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a public Delaware corporation from engaging in a &ldquo;business
combination&rdquo; with an &ldquo;interested stockholder&rdquo; for a period of three years after the date such stockholder became
an &ldquo;interested stockholder.&rdquo; A &ldquo;business combination&rdquo; includes mergers, asset sales or other transactions
resulting in a financial benefit to the stockholder. An &ldquo;interested stockholder&rdquo; is a person who, together with affiliates
and associates, owns, or within three years did, prior to the determination of interested stockholder status, own, 15% or more
of the corporation&rsquo;s outstanding voting stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.85pt"><I>Charter and Bylaw Provisions. </I>Each
of our Charter and Bylaws include a number of other provisions that may have the effect of deterring hostile takeovers or delaying
or preventing changes in control or our management, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.85pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Issuance of Undesignated Preferred Stock</I>. Our board of directors has the authority, subject to the rights of the holders
of our Series A Convertible Preferred Stock, to issue an additional 9,650,000 shares of preferred stock with rights and preferences
designated from time to time by our board of directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.85pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Advance Notice Requirements for Stockholder Proposals and Director Nominations.</I>&nbsp;Our Bylaws provide advance notice
procedures for stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for
election as directors at our annual meeting of stockholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.85pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Amendment.&nbsp;</I>Our Charter provides that our Bylaws may only be amended by our board of directors or by the holders
of 66 and 2/3 percent, or a super-majority, of the outstanding shares of our common stock, which makes it more difficult for our
stockholders to amend or repeal our Bylaws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.85pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>No Cumulative Voting.</I>&nbsp;The DGCL provides that stockholders are denied the right to cumulate votes in the election
of directors unless our Charter provides otherwise. Our Charter does not provide for cumulative voting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.85pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Size of Board and Vacancies.&nbsp;</I>Our Charter and Bylaws provide that the exact number of directors on our board of
directors is fixed exclusively by our board of directors. Newly created directorships resulting from any increase in our authorized
number of directors, and any vacancies resulting from death, resignation, retirement, disqualification, removal from office or
other cause, will generally be filled by a majority of our board of directors then in office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42.85pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Transfer Restrictions</I>. Our Charter generally restricts any direct or indirect transfers of our common stock if the effect
would be to (i) increase the direct or indirect ownership of our common stock by any person or group from less than 4.899% to 4.899%
or more of our common stock; or (ii) increase the percentage of our common stock owned directly or indirectly by a person or group
owning or deemed to own 4.899% or more of our common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Tax Benefits Preservation Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the terms of our Tax Benefits Preservation
Plan, in general, if a person or group acquires beneficial ownership of 4.9% or more of the outstanding shares of our Common Stock
without prior approval of our board of directors or without meeting certain exceptions, the rights would become exercisable and
our stockholders (other than the acquiring person) will have the right to purchase securities from us at a discount to such securities&rsquo;
fair market value, thus causing substantial dilution to the acquiring person. As a result, the Tax Benefits Preservation Plan may
have the effect of inhibiting or impeding a change in control not approved by our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>acacia_ex1001.htm
<DESCRIPTION>INDEMNIFICATION AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 10.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS INDEMNIFICATION
AGREEMENT (the &ldquo;<B>Agreement</B>&rdquo;) is made as of the ____ day of ______________, ____ by and between Acacia Research
Corporation, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and ____________________ (&ldquo;<B>Indemnitee</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, directors,
officers, and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and
time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the
Company or business enterprise itself;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, highly competent
persons have become more reluctant to serve corporations as directors or in other capacities unless they are provided with adequate
protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out
of their service to and activities on behalf of the corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Board
of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;) has determined that the increased difficulty in attracting and retaining
such persons is detrimental to the best interests of the Company&rsquo;s stockholders and that the Company should act to assure
such persons that there will be increased certainty of such protection in the future;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, it is reasonable,
prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such
persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue
concern that they will not be so indemnified;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Indemnitee
does not regard the protection available under the Company&rsquo;s Bylaws and insurance as adequate in the present circumstances,
may not be willing to serve as an officer or director without adequate protection, and is willing to serve on the condition that
he be so indemnified;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, although the
Bylaws of the Company require indemnification of the officers and directors of the Company or any other Enterprise, and Indemnitee
may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (the &ldquo;<B>DGCL</B>&rdquo;),
the Bylaws and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby
contemplate that contracts may be entered into between the Company and members of the board of directors, officers and other persons
with respect to indemnification; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, this Agreement
is a supplement to and in furtherance of the Bylaws of the Company and any resolutions adopted pursuant thereto, and shall not
be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in
consideration of Indemnitee&rsquo;s agreement to serve as a [director] [officer] [employee] [agent] [fiduciary] after the date
hereof, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Definitions</U>. For purposes of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Corporate Status</B>&rdquo; describes the status of a person who is or was a director, officer, employee, agent
or fiduciary of the Company or any other Enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Disinterested Director</B>&rdquo; means a director of the Company who is not and was not a party to the Proceeding
in respect of which indemnification is sought by Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Enterprise</B>&rdquo; shall mean the Company, any wholly- or majority-owned subsidiary of the Company and any
other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other entity or enterprise
that Indemnitee is or was serving at the request or consent of the Company, or any subsidiary, as a director, officer, employee,
agent or fiduciary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Expenses</B>&rdquo; shall include all reasonable attorneys&rsquo; fees, retainers, court costs, transcript costs,
fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery
service fees and all other disbursements or expenses of the types that may be incurred in connection with prosecuting, defending,
preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding. Expenses
also shall include the foregoing incurred in connection with any appeal resulting from any Proceeding, including without limitation
the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent.
Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Independent Counsel</B>&rdquo; means a law firm, or a member of a law firm, that is experienced in matters of
corporation law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company, any other
Enterprise, or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee
under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding
giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term &ldquo;<B>Independent Counsel</B>&rdquo;
shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict
of interest in representing either the Company, any other Enterprise, or Indemnitee in an action to determine Indemnitee&rsquo;s
rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Proceeding</B>&rdquo; includes any threatened, pending or completed action, suit, arbitration, alternate dispute
resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether
brought by or in the right of the Company, or any other Enterprise, or otherwise and whether civil, criminal, administrative or
investigative, in which Indemnitee was, is or will be involved as a party or otherwise, by reason of the fact that Indemnitee is
or was acting in his or her Corporate Status, by reason of any action taken by him or of any inaction on his part while acting
in his or her Corporate Status, or by reason of the fact that he or she is or was serving at the request of the Company, or any
other Enterprise, as a director, officer, employee, agent or fiduciary; in each case whether or not he was or is acting or serving
in any such capacity before or after the date of this Agreement and whether or not he was or is acting or serving in any such capacity
at the time any liability or expense is incurred for which indemnification can be provided under this Agreement; including one
pending on or before the date of this Agreement, but excluding one initiated by Indemnitee pursuant to <U>Section 8</U> of this
Agreement to enforce his rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnity of Indemnitee</U>. The Company hereby agrees to defend, hold harmless and indemnify Indemnitee to the fullest
extent permitted by applicable law, as such may be amended from time to time. In furtherance of the foregoing indemnification,
and without limiting the generality thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Proceedings Other Than Proceedings by or in the Right of the Company</U>. Indemnitee shall be entitled to the rights
of indemnification provided in this <U>Section 2(a)</U> if, by reason of his or her Corporate Status or otherwise, Indemnitee is,
or is threatened to be made, a party to or participant in any Proceeding other than a Proceeding by or in the right of the Company.
Pursuant to this <U>Section 2(a)</U>, Indemnitee shall be indemnified against all Expenses, judgments, penalties, excise taxes,
fines and amounts paid or to be paid in settlement (if such settlement is approved in advance by the Company, which approval shall
not be unreasonably withheld) actually and reasonably incurred by Indemnitee, or on Indemnitee&rsquo;s behalf, in connection with
such Proceeding or any claim, issue or matter therein until such time as it has been determined in accordance with <U>Section 7</U>
or <U>8</U> that Indemnitee (i) did not act in good faith and did not act in a manner Indemnitee not unreasonably believed to be
in or not opposed to the best interests of the Company, and with respect to any criminal Proceeding, or (ii) did not have a reasonable
cause to believe Indemnitee&rsquo;s conduct was lawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Proceedings by or in the Right of the Company</U>. Indemnitee shall be entitled to the rights of indemnification provided
in this <U>Section 2(b)</U> if, by reason of Indemnitee&rsquo;s Corporate Status or otherwise, Indemnitee is, or is threatened
to be made, a party to or participant in any Proceeding brought by or in the right of the Company. Pursuant to this <U>Section
2(b)</U>, Indemnitee shall be indemnified against all Expenses, judgments, penalties, fines, excise taxes and amounts paid or to
be paid in settlement (if such settlement is approved in advance by the Company, which approval shall not be unreasonably withheld)
actually and reasonably incurred by Indemnitee, or on Indemnitee&rsquo;s behalf, in connection with such Proceeding or any claim,
issue or matter therein until such time as as it has been determined in accordance with <U>Section 7</U> or <U>8 </U>that Indemnitee
(i) did not act in good faith and did not act in a manner Indemnitee not unreasonably believed to be in or not opposed to the best
interests of the Company, or (ii) did not have a reasonable cause to believe Indemnitee&rsquo;s conduct was lawful; <U>provided</U>,
<U>however</U>, if applicable law so provides, no indemnification against such Expenses shall be made in respect of any claim,
issue or matter in such Proceeding as to which it shall be finally determined (under the procedures, and subject to the presumptions,
set forth in <U>Section 7</U> and <U>Section 8</U> hereof), that Indemnitee is liable to the Company unless and to the extent that
the Court of Chancery of the State of Delaware shall determine that such indemnification may be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Overriding Right to Indemnification if Successful on the Merits</U>. Notwithstanding any other provision of this Agreement,
to the extent that Indemnitee is, by reason of his Corporate Status or otherwise, a party to and is successful, on the merits or
otherwise, in any Proceeding, he shall be indemnified to the maximum extent permitted by applicable law, as such may be amended
from time to time, against all Expenses, judgments, penalties, excise taxes, fines and amounts paid or to be paid in settlement
(if such settlement is approved in advance by the Company, which approval shall not be unreasonably withheld) actually and reasonably
incurred by him or on his behalf in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful,
on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall
indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&rsquo;s behalf in connection
with (i) each successfully resolved claim, issue or matter and (ii) each other claim, issue or matter not resolved in Indemnitee&rsquo;s
favor that does not or did not involve a violation of law or a demonstration of bad faith by Indemnitee. For purposes of this Section
and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice,
shall be deemed to be a successful result as to such claim, issue or matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Additional Indemnity</U>. In addition to, and without regard to any limitations on, the indemnification provided for
in <U>Section 2</U> of this Agreement, and subject to the other provisions of this Agreement, the Company shall, and hereby does
indemnify and hold harmless Indemnitee against all Expenses, judgments, penalties, excise taxes, fines and amounts paid or to be
paid in settlement actually and reasonably incurred by him or on his behalf if, by reason of his Corporate Status or otherwise,
he or she is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the right
of the Company), including, without limitation, all liability arising out of the alleged or actual negligence or active or passive
wrongdoing of Indemnitee. The only limitation that shall exist upon the Company&rsquo;s obligations pursuant to this Agreement
shall be that the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures,
and subject to the presumptions, set forth in <U>Section 7</U> and <U>Section 8</U> hereof) to be unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Whether or not the indemnification provided in <U>Section 2</U> and <U>Section 3</U> hereof is available, in respect of
any threatened, pending or completed action, suit or proceeding in which the Company or any other Enterprise is jointly liable
with Indemnitee (or would be if joined in such action, suit or proceeding), the Company shall pay, in the first instance, the entire
amount of any judgment or settlement of such action, suit or proceeding without requiring Indemnitee to contribute to such payment<FONT STYLE="text-underline-style: double"><U>,
and the Company hereby waives and relinquishes any right of contribution it may have against Indemnitee</U></FONT>. Neither the
Company nor any other Enterprise shall enter into any settlement of any action, suit or proceeding in which the Company or any
other Enterprise is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding) unless such settlement
provides for a full and final release of all claims asserted against Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason,
Indemnitee shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed
action, suit or proceeding in which the Company or any other Enterprise is jointly liable with Indemnitee (or would be if joined
in such action, suit or proceeding), the Company shall contribute to the amount of Expenses, judgments, penalties, excise taxes,
fines and amounts paid or to be paid in settlement (if such settlement is approved in advance by the Company, which approval shall
not be unreasonably withheld) actually and reasonably incurred and paid or payable by Indemnitee in proportion to the relative
benefits received by the Company or any other Enterprise and all officers, directors or employees of the Company or any other Enterprise,
other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the
one hand, and Indemnitee, on the other hand, from the transaction from which such action, suit or proceeding arose; <U>provided</U>,
<U>however</U>, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law,
be further adjusted by reference to the relative fault of the Company or any other Enterprise and all officers, directors or employees
of the Company or any other Enterprise other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in such
action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the events that resulted in
such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations which the law may require
to be considered. The relative fault of the Company or any other Enterprise and all officers, directors or employees of the Company
or any other Enterprise, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit
or proceeding), on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the
degree to which their actions were motivated by intent to gain personal profit or advantage, the degree to which their liability
is primary or secondary and the degree to which their conduct is active or passive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claim of contribution brought by officers,
directors, employees, or former employees of the Company and any other Enterprise, other than Indemnitee, based upon a claim of
liability which, if made against Indemnitee directly, would be indemnifiable under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable
to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred
by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement (if such settlement
is approved in advance by the Company, which approval shall not be unreasonably withheld) and/or for Expenses, in connection with
any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light
of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company (together
with its directors, officers, employees and agents) and Indemnitee as a result of the event(s) and/or transaction(s) giving cause
to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee
in connection with such event(s) and/or transaction(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Indemnification for Expenses of a Witness</U>. Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee is, by reason of his Corporate Status or otherwise, a witness in any Proceeding to which Indemnitee is not a party,
he shall be indemnified against all Expenses actually and reasonably incurred by him or on his behalf in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Advancement of Expenses</U>. Notwithstanding any other provision of this Agreement, to the extent not prohibited by law,
the Company shall advance all Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee&rsquo;s
Corporate Status or otherwise within twenty (20) days after the receipt by the Company of a statement or statements from Indemnitee
requesting such advance or advances from time to time, whether prior to or after final disposition of such Proceeding. Such statement
or statements shall reasonably evidence the Expenses incurred by Indemnitee and, </FONT>upon request of the Company, shall include
an undertaking to repay the advancement of Expenses if and to the extent that it is finally determined by a <FONT STYLE="font-size: 10pt">court
of competent jurisdiction in a non-appealable decision</FONT>, <FONT STYLE="font-size: 10pt">that Indemnitee is not entitled to
be indemnified against such Expenses. Any advances and undertakings to repay pursuant to this <U>Section 6</U> shall be unsecured,
interest-free and without regard to Indemnitee&rsquo;s ability to repay the Expenses. Advances shall include any and all Expenses
actually and reasonably incurred by Indemnitee pursuing an action to enforce Indemnitee&rsquo;s right to indemnification under
this Agreement, or otherwise and this right of advancement, including Expenses incurred preparing and forwarding statements to
the Company to support the advances claimed. The right to advances under this Section shall continue until final disposition of
any Proceeding, including any appeal therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Procedures and Presumptions for Determination of Entitlement to Indemnification</U>. It is the intent of this Agreement
to secure for Indemnitee rights of indemnity that are as favorable as may be permitted under the DGCL and public policy of the
State of Delaware. Accordingly, the parties agree that the following procedures and presumptions shall apply in the event of any
question as to whether Indemnitee is entitled to indemnification under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indemnitee shall give the Company notice in writing as soon as practicable of any claim made against Indemnitee for which
indemnification will or could be sought under this Agreement. Such notice shall include Indemnitee&rsquo;s request for indemnification
and such documentation and information as is reasonably available to Indemnitee and as is reasonably necessary for the Company
to determine whether and to what extent Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly
upon receipt of such a request for indemnification, advise the Board of Directors in writing that Indemnitee has requested indemnification.
Failure to provide the notice required hereby shall not impair Indemnitee&rsquo;s rights of indemnification and contribution under
this Agreement except to the extent that such failure to provide notice actually prejudices the rights of the Company to defend
any action or proceeding which is the basis of the claimed indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon written request by Indemnitee for indemnification pursuant to the first sentence of <U>Section 7(a)</U> hereof, a determination,
if, and only if, required by applicable law, with respect to Indemnitee&rsquo;s entitlement thereto shall be made in the specific
case by one of the following four (4) methods within thirty (30) days of receipt of such written request, which shall be at the
election of the Board of Directors: (i) by a majority vote of the Disinterested Directors, even though less than a quorum, (ii)
by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a
quorum, (iii) if there are no Disinterested Directors or if the Disinterested Directors so direct, by Independent Counsel, in a
written opinion of such counsel to the Board of Directors and Indemnitee, or (iv) if so directed by the Board of Directors, by
the stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to <U>Section 7(b)</U>
hereof, the Independent Counsel shall be selected as provided in this <U>Section 7(c)</U>. The Independent Counsel shall be selected
by the Board of Directors. Indemnitee may, within 10 days after such written notice of selection shall have been given, deliver
to the Company, as the case may be, a written objection to such selection; <U>provided</U>, <U>however</U>, that such objection
may be asserted only on the ground that the counsel so selected does not satisfy the definition of &ldquo;Independent Counsel&rdquo;
set forth at <U>Section 1</U> of this Agreement, and the objection shall set forth with particularity the factual basis of such
assertion. Absent a proper and timely objection made in accordance with the foregoing sentence, the person so selected shall act
as Independent Counsel. In the event of a proper and timely objection, the Independent Counsel selected may not serve as Independent
Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If, within
thirty (30) days after submission by Indemnitee of a written request for indemnification pursuant to <U>Section 7(a)</U> hereof,
no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Court of
Chancery of the State of Delaware or other court of competent jurisdiction for resolution of any objection which shall have been
made by Indemnitee to the Company&rsquo;s selection of Independent Counsel and/or for the appointment as Independent Counsel of
a person selected by the court or by such other person as the court shall designate, and the person with respect to whom all objections
are so resolved or the person so appointed shall act as Independent Counsel under <U>Section 7(b)</U> hereof. The Company shall
pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in connection with acting
pursuant to <U>Section 7(b)</U> hereof, and the Company shall pay all reasonable fees and expenses incident to the procedures of
this <U>Section 7(c)</U>, regardless of the manner in which such Independent Counsel was selected or appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In making a determination with respect to entitlement to indemnification hereunder with respect to Section 7(b), the person
or persons or entity making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement.
Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing
evidence. Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior
to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee
has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent
Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption
that Indemnitee has not met the applicable standard of conduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In making a determination with respect to whether Indemnitee acted in good faith and in a manner that Indemnitee not unreasonably
believed to be in or not opposed to the best interests of the Company, the person or persons or entity making such determination
shall presume that Indemnitee acted in good faith and in a manner that Indemnitee not unreasonably believed to be in or not opposed
to the best interests of the Company. Anyone seeking to overcome this presumption shall have the burden of proof and the burden
of persuasion by clear and convincing evidence which shall be determined only by a court of competent jurisdiction. Any action,
or failure to act, by Indemnitee based on Indemnitee&rsquo;s good faith reliance on the records or books of account of the Enterprise,
including financial statements, or on information supplied to Indemnitee by the officers of the Enterprise in the course of their
duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports made to the Enterprise
by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Enterprise
shall not, in and of itself, constitute grounds for an adverse determination with respect to whether Indemnitee acted in good faith
and in a manner that Indemnitee not unreasonably believed to be in or not opposed to the best interests of the Company. In addition,
the knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Enterprise shall not be imputed
to Indemnitee for purposes of determining the right to indemnification under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the person, persons or entity empowered or selected under <U>Section 7(b)</U> to determine whether Indemnitee is entitled
to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor,
the requisite determination of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled
to such indemnification absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary
to make Indemnitee&rsquo;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition
of such indemnification under applicable law; <U>provided</U>, <U>however</U>, that such sixty 60-day period may be extended for
a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making such determination with
respect to entitlement to indemnification in good faith requires such additional time to obtain or evaluate documentation and/or
information relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee&rsquo;s
entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and
reasonably necessary to such determination. Any Independent Counsel, member of the Board of Directors or stockholder of the Company
shall act reasonably and in good faith in making a determination regarding Indemnitee&rsquo;s entitlement to indemnification under
this Agreement. Any costs or expenses (including attorneys&rsquo; fees and disbursements) incurred by Indemnitee in so cooperating
with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as
to Indemnitee&rsquo;s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless
therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event the Company shall be obligated under <U>Section 5</U> hereof to pay the Expenses of any proceeding against
Indemnitee, the Company, if appropriate, shall be entitled to assume the defense of such proceeding, with counsel approved by Indemnitee,
upon the delivery to Indemnitee of written notice of its election to do so. After delivery of such notice, approval of such counsel
by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement
for any fees of counsel subsequently incurred by Indemnitee with respect to the same proceeding, <U>provided</U> that (i) Indemnitee
shall have the right to employ his counsel in any such proceeding at Indemnitee&rsquo;s expense; and (ii) if (A) the employment
of counsel by Indemnitee has been previously authorized by the Company, (B) Indemnitee shall have not unreasonably concluded that
there may be a conflict of interest between the Company and Indemnitee in the conduct of any such defense, or (C) the Company shall
not, in fact, have employed counsel to assume the defense of such proceeding, then the fees and expenses of Indemnitee&rsquo;s
counsel shall be at the expense of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits
a party to avoid expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to
which Indemnitee is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation,
settlement of such action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that
Indemnitee has been successful on the merits or otherwise in such action, suit or proceeding. Anyone seeking to overcome this presumption
shall have the burden of proof and the burden of persuasion by clear and convincing evidence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction,
or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself
<FONT STYLE="text-underline-style: double"><U>adversely affect the right of Indemnitee to indemnification under this Agreement
or </U></FONT>create a presumption that Indemnitee did not act in good faith and in a manner which he not unreasonably believed
to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable
cause to believe that his conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Remedies of Indemnitee</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that (i) a determination is made pursuant to <U>Section 7</U> of this Agreement that Indemnitee is not entitled
to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to <U>Section 6</U> of this Agreement,
(iii) no determination of entitlement to indemnification is made pursuant to <U>Section 7(b)</U> of this Agreement within sixty
(60) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant
to this Agreement within forty-five (45) days after receipt by the Company of a written request therefor or (v) payment of indemnification
is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification or such determination
is deemed to have been made pursuant to <U>Section 7</U> of this Agreement, Indemnitee shall be entitled to an adjudication in
an appropriate court of the State of Delaware, or in any other court of competent jurisdiction, of Indemnitee&rsquo;s entitlement
to such indemnification. The Company shall not oppose Indemnitee&rsquo;s right to seek any such adjudication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that a determination shall have been made pursuant to <U>Section 7(b)</U> of this Agreement that Indemnitee
is not entitled to indemnification, any judicial proceeding commenced pursuant to this <U>Section 8</U> shall be conducted in all
respects as a de novo trial on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination under
<U>Section 7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If a determination shall have been made pursuant to <U>Section 7(b)</U> of this Agreement that Indemnitee is entitled to
indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this <U>Section
8</U>, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&rsquo;s
misstatement not materially misleading in connection with the application for indemnification, or (ii) a prohibition of such indemnification
under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that Indemnitee, pursuant to this <U>Section 8</U>, seeks a judicial adjudication of his rights under, or to
recover damages for breach of, this Agreement, or to recover under any directors&rsquo; and officers&rsquo; liability insurance
policies maintained by the Company, the Company shall pay on his behalf, in advance, any and all Expenses actually and reasonably
incurred by him in such judicial adjudication<FONT STYLE="text-underline-style: double"><U>, regardless of whether Indemnitee is
ultimately determined to be entitled to such indemnification, advancement of Expenses or insurance recovery</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this <U>Section 8</U> that
the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court
that the Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any and all Expenses
and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefore) advance,
to the extent not prohibited by law, such Expenses to Indemnitee, which are incurred by Indemnitee in connection with any action
brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors&rsquo;
and officers&rsquo; liability insurance policies maintained by the Company<FONT STYLE="text-underline-style: double"><U>, regardless
of whether Indemnitee is ultimately determined to be entitled to such indemnification, advancement of Expenses or insurance recovery,
as the case may be</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under
this Agreement shall be required to be made prior to the final disposition of the Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Exclusivity; Survival of Rights; Insurance.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee
may at any time be entitled under applicable law, the certificate of incorporation of the Company, the Bylaws, any agreement, a
vote of stockholders, a resolution of directors or otherwise. No amendment, alteration or repeal of this Agreement or of any provision
hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee
in his Corporate Status or otherwise prior to such amendment, alteration or repeal. To the extent that a change in the DGCL, whether
by statute or judicial decision, permits greater indemnification than would be afforded currently under the Bylaws and this Agreement,
it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change.
No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy
shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity
or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion
or employment of any other right or remedy. <FONT STYLE="text-underline-style: double"><U>Notwithstanding anything in this Agreement
to the contrary, the indemnification and contribution provided for in this Agreement will remain in full force and effect regardless
of any investigation made by or on behalf of Indemnitee or any of Indemnitee&rsquo;s agents.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the extent that the Company, or any entity within the Enterprise, maintains an insurance policy or policies providing
liability insurance for directors, officers, employees, or agents or fiduciaries of the Company or of any other corporation, partnership,
joint venture, trust, employee benefit plan or other enterprise that such person serves at the request of the Company, Indemnitee
shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available
for any director, officer, employee, agent or fiduciary under such policy or policies. If, at the time of the receipt of a notice
of a claim pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall
give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective
policies. The Company shall use commercially reasonable efforts to cause such insurers to pay, on behalf of Indemnitee, all amounts
payable as a result of such proceeding in accordance with the terms of such policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of
the rights of recovery of Indemnitee, who shall execute all papers reasonably required and take all action reasonably necessary
to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such
rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if
and to the extent that Indemnitee has otherwise actually received such payment under any Company insurance policy, Company contract,
Company agreement or otherwise (except to the extent that Indemnitee is required (by court order or otherwise) to return such payment
or to surrender it to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company&rsquo;s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request
of the Company as a director, officer, employee or agent of any other corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement
of expenses from such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise (except to
the extent that Indemnitee is required (by court order or otherwise) to return such payment or to surrender it to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>D&amp;O Insurance</U>. Pursuant to Section 9(b) of the Agreement, Indemnitee currently is covered by one or more insurance
policies maintained by Company that provide liability insurance for directors, officers, employees, agents or fiduciaries of Company
(whether in each case primary or excess in nature, collectively &quot;<B>D&amp;O Insurance</B>&quot;), including without limitation
that certain policy number QPL0453702 issued by QBE Insurance Corporation having a policy period from January 31, 2018 to January
31, 2019 (as the same may be amended, extended, renewed or restated, the &quot;<B>QBE 2018 Policy</B>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Undertaking to Provide Suitable Coverage. During the period of Indemnitee's service as an officer, director, manager or
trustee of Company and for a minimum period of five (5) years thereafter, Company at all times shall procure and maintain continuing
D&amp;O Insurance customary for listed public companies and complying at a minimum to the following requirements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">i.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Having aggregate policy limits of not less than $50 million in total (i.e., primary coverage in combination with any excess),
with not less than $10 million in Side A coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">ii.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Containing insuring clauses, limitations on exclusions and endorsements substantially consistent with those set forth in
the QBE 2018 Policy including without limitation (i) drop down advancement protection to insured persons in the event Company fails
to respond to requests for indemnification, (ii) inclusion of former officers and directors as insured persons, and (iii) extended
reporting periods currently specified by endorsement in the QBE 2018 Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">iii. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Placed with
insurer(s) having an A.M. Best financial strength rating of A- or better.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Exception to Right of Indemnification</U>. Notwithstanding any provision in this Agreement, the Company shall not be
obligated under this Agreement to make any indemnity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or
any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees,
if a court of competent jurisdiction finally determines in a non-appealable decision that each of the material assertions made
by Indemnitee in such Proceeding (or any part of any Proceeding) was not made in good faith or was frivolous;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in connection with any Proceeding (or any part of any Proceeding) for which payment has actually been made to or on behalf
of Indemnitee under any Company insurance policy or other Company indemnity provision, except with respect to any excess beyond
the amount paid under any Company insurance policy or other Company indemnity provision;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in connection with any Proceeding for which a final, non-appealable judgment has been rendered against Indemnitee for an
accounting, disgorgement or repayment of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities
of the Company pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory
law or common law; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or
any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees
(other than any Proceeding initiated by Indemnitee pursuant to <U>Section 8(d)</U>, which shall be governed by the terms of such
section), unless (i) the Board of Directors of the Company authorized the Proceeding (or any part of any Proceeding) prior to its
initiation or (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company
under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Duration of Agreement</U>. All agreements and obligations of the Company contained herein shall continue until six (6)
years after the end of any period Indemnitee is an officer or director of the Company or any other Enterprise (or is or was serving
at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust
or other enterprise) but shall continue thereafter so long as Indemnitee shall be subject to any Proceeding (or any proceeding
commenced under <U>Section 8</U> hereof) by reason of his Corporate Status or otherwise, whether or not he is acting or serving
in any such capacity at the time any liability or Expense is incurred for which indemnification can be provided under this Agreement,
notwithstanding such six (6) year period. This Agreement shall be binding upon and inure to the benefit of and be enforceable by
the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation
or otherwise to all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors and personal
and legal representatives. The Company may not assign this agreement and/or the obligations hereunder to any other entity without
the express written consent of Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Security</U>. To the extent requested by Indemnitee and approved by the Board of Directors of the Company, the Company
may at any time and from time to time provide security to Indemnitee for the Company&rsquo;s obligations hereunder through an irrevocable
bank line of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released
without the prior written consent of Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Enforcement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on
it hereby in order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that Indemnitee
is relying upon this Agreement in serving as an officer or director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and
supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject
matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability
of any other provision. Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee
indemnification rights to the fullest extent permitted by applicable laws. In the event any provision hereof conflicts with any
applicable law, such provision shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to
resolve such conflict.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Modification and Waiver</U>. No supplement, modification, termination or amendment of this Agreement shall be binding
unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed
or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing
waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notice By Indemnitee</U>. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise
receiving any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter
which may be subject to indemnification covered hereunder unless Indemnitee has actual knowledge that Company is already in receipt
of any such document relating to any Proceeding or matter. The failure to so notify the Company shall not relieve the Company of
any obligation which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure
or delay materially prejudices the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. Unless otherwise provided herein, any notice required or permitted under this Agreement shall be deemed
effective upon the earlier of (a) actual receipt, or (b) (i) one (1) business day after the date of delivery by confirmed facsimile
transmission, (ii) one (1) business day after the business day of deposit with a nationally recognized overnight courier service
for next day delivery, freight prepaid, or (iii) three (3) business days after deposit with the United States Post Office for
delivery by registered or certified mail, postage prepaid. Any such notice shall be in writing and shall be addressed to the party
to be notified at the address indicated for such party indicated on the signature pages or exhibits hereto, as otherwise set forth
in this Section 17, or at such other address as such party may designate by ten (10) days&rsquo; advance written notice to the
other parties. All communications shall be sent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To Indemnitee at the address set forth below Indemnitee signature hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the Company at the address set forth below Company signature hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">or to such other address
as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile
signature and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Headings</U>. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed
to constitute part of this Agreement or to affect the construction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law and Consent to Jurisdiction</U>. This Agreement shall be governed by, and construed and enforced in accordance
with, the laws of the State of Delaware, without regard to its conflict of laws rules. The Company and Indemnitee hereby irrevocably
and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought
only in the Chancery Court of the State of Delaware (the &ldquo;<B>Delaware Court</B>&rdquo;), and not in any other state or federal
court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of
the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) waive any
objection to the laying of venue of any such action or proceeding in the Delaware Court, and (iv) waive, and agree not to plead
or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient
forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Construction</U>. The parties acknowledge that both parties have contributed to the drafting of this Agreement and, therefore,
waive the application of any law, regulation, holding or rule of construction providing that ambiguities in an agreement or other
document will be construed against the party drafting such agreement or document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[Remainder of page intentionally
left blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties have executed
this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>INDEMNITEE:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Signature: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Name Typed or Printed: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>COMPANY:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">ACACIA RESEARCH CORPORATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-indent: 0.5in">By: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-indent: 0.5in">Name:
 <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-indent: 0.5in">Title: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>




<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>5
<FILENAME>acacia_ex1027.htm
<DESCRIPTION>JAMBOREE LEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 10.27</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BETWEEN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>JAMBOREE CENTER 4 LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACACIA RESEARCH CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Short Form)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS LEASE is made
as of June&nbsp;7, 2019, by and between <B>JAMBOREE CENTER 4 LLC</B>, a Delaware limited liability company, hereafter called &ldquo;<B>Landlord</B>,&rdquo;
and <B>ACACIA RESEARCH CORPORATION</B>, a Delaware corporation, hereafter called &ldquo;<B>Tenant</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 1. BASIC
LEASE PROVISIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each reference in this
Lease to the &ldquo;<B>Basic Lease Provisions</B>&rdquo; shall mean and refer to the following collective terms, the application
of which shall be governed by the provisions in the remaining Articles of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B>Tenant&rsquo;s Trade Name</B>: N/A</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify; width: 1.5in"><B>Premises</B>:</TD>
    <TD>Suite No. 550</TD></TR>                                                                                                                                                                                                                         <TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>Address of Building</B>:</TD>
    <TD>4 Park Plaza, Irvine, CA
92614</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>Project Description</B>:</TD>
    <TD>Jamboree Center</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">(The Premises are more particularly
described in Section&nbsp;2.1).</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B>Use of Premises</B>: General office and for no other use.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B>Commencement Date</B>: August&nbsp;1, 2019</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B>Lease Term</B>: 60 months, plus such additional days as may be required to cause this Lease
to expire on the final day of the calendar month.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B>Basic Rent</B>:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 24%; border: Black 1pt solid; text-align: center"><B>Months of Term<BR>
or Period</B></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 35%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Monthly Rate Per Rentable<BR>
Square Foot</B></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 41%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><B>Monthly Basic Rent (rounded to<BR>
the nearest dollar)</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">1 to 12</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$3.15</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$26,123.00</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">13 to 24</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$3.29</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$27,284.00</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">25 to 36</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$3.44</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$28,528.00</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">37 to 48</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$3.59</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$29,772.00</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center">49 to 60</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$3.75</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">$31,099.00</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Notwithstanding the above schedule
of Basic Rent to the contrary, as long as Tenant is not in Default (as defined in Section&nbsp;14.1) under this Lease, Tenant shall
be entitled to an abatement of one (1) full calendar month of Basic Rent in the amount of $26,123.00 (the &ldquo;<B>Abated Basic
Rent</B>&rdquo;) for the first full calendar month of the Term (the &ldquo;<B>Abatement Period</B>&rdquo;). In the event Tenant
Defaults at any time during the Term, all Abated Basic Rent shall immediately become due and payable. The payment by Tenant of
the Abated Basic Rent in the event of a Default shall not limit or affect any of Landlord&rsquo;s other rights, pursuant to this
Lease or at law or in equity. Only Basic Rent shall be abated during the Abatement Period and all other additional rent and other
costs and charges specified in this Lease shall remain as due and payable pursuant to the provisions of this Lease.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B>Property Tax Base</B>: The Property Taxes per rentable square foot incurred by Landlord and
attributable to the twelve month period ending June&nbsp;30, 2020 (the &ldquo;<B>Base Year</B>&rdquo;).</TD></TR>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               <TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>Project Cost Base</B>: The
Project Costs per rentable square foot incurred by Landlord and attributable to the Base Year.</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>Expense Recovery Period</B>:
Every twelve month period during the Term (or portion thereof during the first and last Lease years) ending June&nbsp;30.</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B>Floor Area of Premises</B>: approximately 8,293 rentable square feet (Landlord and Tenant stipulate
and agree that the Floor Area of Premises is correct).</TD></TR>                                                                                                                                                                                                <TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD>&nbsp;</TD><TD STYLE="text-align: justify"><B>Floor Area of Building:</B> approximately 409,411 rentable square feet</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><B>Security Deposit</B>: $34,209.00</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><B>Broker(s)</B>: Irvine Management Company (&ldquo;<B>Landlord&rsquo;s Broker</B>&rdquo;) is the
agent of Landlord exclusively and Rand Partners (&ldquo;<B>Tenant&rsquo;s Broker</B>&rdquo;) is the agent of Tenant exclusively.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><B>Parking</B>: 28 parking passes in accordance with the provisions set forth in <B>Exhibit&nbsp;F</B>
to this Lease.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><B>Address for Payments and Notices</B>:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%"><B>LANDLORD</B></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%"><B>TENANT</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment Registration Address:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email tenantportal@irvinecompany.com to</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">request an account for
        the Tenant Payment Portal.</P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ACACIA RESEARCH CORPORATION</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4 Park Plaza, Suite 550</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92614</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notice Address:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">THE IRVINE COMPANY LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5 Park Plaza, Suite 100</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Irvine, CA 92614</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Property Manager</P></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">with a copy of notices to:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">THE IRVINE COMPANY LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">550 Newport Center Drive</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newport Beach, CA 92660</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">Attn:&nbsp;&nbsp;&nbsp;&nbsp;Senior
Vice President, Property</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operations Irvine Office Properties</P></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify"><B>List of Lease Exhibits </B>(all exhibits, riders and addenda attached to this Lease are hereby
incorporated into and made a part of this Lease):</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 1.5in">Exhibit A</TD>
    <TD>Description of Premises</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Exhibit B</TD>
    <TD>Operating Expenses</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Exhibit C</TD>
    <TD>Utilities and Services</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Exhibit D</TD>
    <TD>Tenant&rsquo;s Insurance</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Exhibit E</TD>
    <TD>Rules and Regulations</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Exhibit F</TD>
    <TD>Parking</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Exhibit G</TD>
    <TD>Additional Provisions</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 2. PREMISES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>LEASED PREMISES</B>. Landlord leases to Tenant and Tenant leases from Landlord the Premises shown in <B>Exhibit&nbsp;A </B>(the
&ldquo;<B>Premises</B>&rdquo;), containing approximately the floor area set forth in Item 8 of the Basic Lease Provisions (the
&ldquo;<B>Floor Area</B>&rdquo;). The Premises are located in the building identified in Item 2 of the Basic Lease Provisions (the
&ldquo;<B>Building</B>&rdquo;), which is a portion of the project described in Item 2 (the &ldquo;<B>Project</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>ACCEPTANCE OF PREMISES</B>. Tenant acknowledges that neither Landlord nor any representative of Landlord has made any representation
or warranty with respect to the Premises, the Building or the Project or the suitability or fitness of either for any purpose,
except as set forth in this Lease. The taking of possession or use of the Premises by Tenant for any purpose other than construction
shall conclusively establish that the Premises and the Building were in satisfactory condition and in conformity with the provisions
of this Lease in all respects. Following Landlord&rsquo;s substantial completion of the ReadyNow improvements in the Premises,
Tenant shall accept such improvements in their existing condition, and shall waive any right or claim against Landlord arising
out of the condition of the Premises. Nothing contained in this Section&nbsp;2.2 shall affect the commencement of the Term or the
obligation of Tenant to pay rent.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 3. TERM</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>GENERAL</B>. The term of this Lease (&ldquo;<B>Term</B>&rdquo;) shall commence on the date as set forth in Item 4 of the
Basic Lease Provisions (the &ldquo;<B>Commencement Date</B>&rdquo;) and shall end upon the expiration of the period set forth in
Item 5 of the Basic Lease Provisions (&ldquo;<B>Expiration Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>DELAY IN POSSESSION</B>. If Landlord, for any reason whatsoever, cannot deliver possession of the Premises to Tenant on
or before the Commencement Date set forth in Item 4 of the Basic Lease Provisions, this Lease shall not be void or voidable nor
shall Landlord be liable to Tenant for any resulting loss or damage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 4. RENT AND
OPERATING EXPENSES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>BASIC RENT</B>. From and after the Commencement Date, Tenant shall pay to Landlord without deduction or offset a Basic Rent
for the Premises in the total amount shown (including subsequent adjustments, if any) in Item 6 of the Basic Lease Provisions (the
&ldquo;<B>Basic Rent</B>&rdquo;). If the Commencement Date is other than the first day of a calendar month, any rental adjustment
shown in Item 6 shall be deemed to occur on the first day of the next calendar month following the specified monthly anniversary
of the Commencement Date. The Basic Rent shall be due and payable in advance commencing on the Commencement Date and continuing
thereafter on the first day of each successive calendar month of the Term, as prorated for any partial month. No demand, notice
or invoice shall be required. An installment in the amount of 1 full month&rsquo;s Basic Rent at the initial rate specified in
Item 6 of the Basic Lease Provisions shall be delivered to Landlord concurrently with Tenant&rsquo;s execution of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>OPERATING EXPENSES</B>. Tenant shall pay Tenant&rsquo;s Share of Operating Expenses in accordance with <B>Exhibit&nbsp;B</B>
of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SECURITY DEPOSIT</B>. Concurrently with Tenant&rsquo;s delivery of this Lease, Tenant shall deposit with Landlord the sum,
if any, stated in Item 9 of the Basic Lease Provisions (the &ldquo;<B>Security Deposit</B>&rdquo;), to be held by Landlord as security
for the full and faithful performance of Tenant&rsquo;s obligations under this Lease, to pay any rental sums, including without
limitation such additional rent as may be owing under any provision hereof, and to maintain the Premises as required by this Lease.
Upon any breach of the foregoing obligations by Tenant, Landlord may apply all or part of the Security Deposit as full or partial
compensation. If any portion of the Security Deposit is so applied, Tenant shall within 5 days after written demand by Landlord
deposit cash with Landlord in an amount sufficient to restore the Security Deposit to its original amount. Landlord shall not be
required to keep this Security Deposit separate from its general funds, and Tenant shall not be entitled to interest on the Security
Deposit. In no event may Tenant utilize all or any portion of the Security Deposit as a payment toward any rental sum due under
this Lease. Any unapplied balance of the Security Deposit shall be returned to Tenant or, at Landlord&rsquo;s option, to the last
assignee of Tenant&rsquo;s interest in this Lease within 30 days following the termination of this Lease and Tenant&rsquo;s vacation
of the Premises. Tenant hereby waives the provisions of Section&nbsp;1950.7 of the California Civil Code, or any similar or successor
laws now or hereafter in effect.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 5. USES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>USE</B>. Tenant shall use the Premises only for the purposes stated in Item 3 of the Basic Lease Provisions and for no other
use whatsoever. Tenant shall not do or permit anything to be done in or about the Premises which will in any way interfere with
the rights or quiet enjoyment of other occupants of the Building or the Project, or use or allow the Premises to be used for any
unlawful purpose, nor shall Tenant permit any nuisance in the Premises or the Project. Tenant shall comply at its expense with
all present and future laws, ordinances and requirements of all governmental authorities that pertain to Tenant or its use of the
Premises, and with all energy usage reporting requirements of Landlord. Pursuant to California Civil Code &sect; 1938, Landlord
hereby states that the Premises have not undergone inspection by a Certified Access Specialist (CASp) (defined in California Civil
Code &sect; 55.52(a)(3)). Pursuant to Section&nbsp;1938 of the California Civil Code, Landlord hereby provides the following notification
to Tenant: &ldquo;A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises
comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require
a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining
a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the
lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment
of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction related
accessibility standards within the premises.&rdquo; If Tenant requests to perform a CASp inspection of the Premises, Tenant shall,
at its cost, retain a CASp approved by Landlord (provided that Landlord may designate the CASp, at Landlord&rsquo;s option) to
perform the inspection of the Premises at a time agreed upon by the parties. Tenant shall provide Landlord with a copy of any report
or certificate issued by the CASp (the &ldquo;<B>CASp Report</B>&rdquo;) and Tenant shall, at its cost, promptly complete any modifications
necessary to correct violations of construction related accessibility standards identified in the CASp Report, notwithstanding
anything to the contrary in this Lease. Tenant agrees to keep the information in the CASp Report confidential except as necessary
for the Tenant to complete such modifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SIGNS</B>. Landlord shall affix and maintain a sign (restricted solely to Tenant&rsquo;s name as set forth herein or such
other name as Landlord may consent to in writing) adjacent to the entry door of the Premises, together with a directory strip listing
Tenant&rsquo;s name as set forth herein in the lobby directory of the Building. Tenant shall not place or allow to be placed any
other sign, decoration or advertising matter of any kind that is visible from the exterior of the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>HAZARDOUS MATERIALS</B>. Tenant shall not generate, handle, store or dispose of hazardous or toxic materials (as such materials
may be identified in any federal, state or local law or regulation) in the Premises or Project without the prior written consent
of Landlord. Tenant acknowledges that it has read, understands and, if applicable, shall comply with the provisions of <B>Exhibit&nbsp;H</B>
to this Lease, if that Exhibit is attached.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 6. LANDLORD
SERVICES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>UTILITIES AND SERVICES</B>. Landlord and Tenant shall be responsible to furnish those utilities and services to the Premises
to the extent provided in <B>Exhibit&nbsp;C</B>, subject to the conditions and payment obligations and standards set forth in this
Lease. Landlord&rsquo;s failure to furnish, or any interruption, diminishment or termination of, services due to the application
of laws, the failure of any equipment, the performance of repairs, improvements or alterations, utility interruptions or the occurrence
of an event of force majeure (defined in Section&nbsp;20.8) shall not render Landlord liable to Tenant, constitute a constructive
eviction of Tenant, give rise to an abatement of Rent, nor relieve Tenant from the obligation to fulfill any covenant or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>OPERATION AND MAINTENANCE OF COMMON AREAS</B>. During the Term, Landlord shall operate all Common Areas within the Building
and the Project. The term &ldquo;<B>Common Areas</B>&rdquo; shall mean all areas within the Building, Project and other buildings
in the Project which are not held for exclusive use by persons entitled to occupy space.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>USE OF COMMON AREAS</B>. The occupancy by Tenant of the Premises shall include the use of the Common Areas in common with
Landlord and with all others for whose convenience and use the Common Areas may be provided by Landlord, subject, however, to compliance
with Rules and Regulations described in Article&nbsp;17 below. Landlord shall at all times during the Term have exclusive control
of the Common Areas, and may restrain or permit any use or occupancy. Landlord may temporarily close any portion of the Common
Areas for repairs, remodeling and/or alterations, to prevent a public dedication or the accrual of prescriptive rights, or for
any other reasonable purpose.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 7. REPAIRS
AND MAINTENANCE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>TENANT&rsquo;S MAINTENANCE AND REPAIR</B>. Subject to Articles 11 and 12, Tenant at its sole expense shall make all repairs
necessary to keep the Premises and all improvements and fixtures therein in good condition and repair. Tenant&rsquo;s maintenance
obligation shall include without limitation all appliances, interior glass, doors, door closures, hardware, fixtures, electrical,
plumbing, fire extinguisher equipment and other equipment installed in the Premises, together with any supplemental HVAC equipment
servicing only the Premises. Should Landlord or its management agent agree to make a repair on behalf of Tenant and at Tenant&rsquo;s
request, Tenant shall promptly reimburse Landlord as additional rent for all reasonable costs incurred (including the standard
supervision fee) upon submission of an invoice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>LANDLORD&rsquo;S MAINTENANCE AND REPAIR</B>. Subject to Articles 11 and 12, Landlord shall provide service, maintenance
and repair with respect to the heating, ventilating and air conditioning (&ldquo;<B>HVAC</B>&rdquo;) equipment of the Building
(exclusive of any supplemental HVAC equipment servicing only the Premises) and shall maintain in good repair the Common Areas,
roof, foundations, footings, the exterior surfaces of the exterior walls of the Building (including exterior glass), and the structural,
electrical, mechanical and plumbing systems of the Building (including elevators, if any, serving the Building), except to the
extent provided in Section&nbsp;7.1 above. Notwithstanding any provision of the California Civil Code or any similar or successor
laws to the contrary, Tenant understands that it shall not make repairs at Landlord&rsquo;s expense or by rental offset. Except
as provided in Section&nbsp;11.1 and Article&nbsp;12 below, there shall be no abatement of rent and no liability of Landlord by
reason of any injury to or interference with Tenant&rsquo;s business arising from the making of any repairs, alterations or improvements
to any portion of the Building, including repairs to the Premises, nor shall any related activity by Landlord constitute an actual
or constructive eviction. Tenant hereby waives any and all rights under and benefits of subsection 1 of Section&nbsp;1932, and
Sections 1941 and 1942 of the California Civil Code, or any similar or successor laws now or hereafter in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>ALTERATIONS</B>. Tenant shall make no alterations, additions, decorations, or improvements (collectively referred to as
&ldquo;<B>Alterations</B>&rdquo;) to the Premises without the prior written consent of Landlord. Landlord may impose, as a condition
to its consent, any requirements that Landlord in its discretion may deem reasonable or desirable. Tenant shall use Landlord&rsquo;s
designated mechanical and electrical contractors, obtain all required permits for the Alterations and shall perform the work in
compliance with all applicable laws, regulations and ordinances with contractors reasonably acceptable to Landlord. Landlord shall
be entitled to a supervision fee in the amount of 5% of the cost of the Alterations. Landlord may elect to cause its architect
to review Tenant&rsquo;s architectural plans, and the reasonable cost of that review shall be reimbursed by Tenant. Should the
Alterations proposed by Tenant and consented to by Landlord change the floor plan of the Premises, then Tenant shall, at its expense,
furnish Landlord with as-built drawings and CAD disks compatible with Landlord&rsquo;s systems. Unless Landlord otherwise agrees
in writing, all Alterations affixed to the Premises, including without limitation all Tenant Improvements constructed pursuant
to the Work Letter (except as otherwise provided in the Work Letter), but excluding moveable trade fixtures and furniture, shall
become the property of Landlord and shall be surrendered with the Premises at the end of the Term, except that Landlord may, by
notice to Tenant given at the time of Landlord&rsquo;s approval, require Tenant to remove by the Expiration Date or sooner termination
date of this Lease, all or any Alterations (including without limitation any Tenant Improvements constructed pursuant to the Work
Letter) installed either by Tenant or by Landlord at Tenant&rsquo;s request (collectively, the &ldquo;<B>Required Removables</B>&rdquo;).
In connection with its removal of Required Removables, Tenant shall repair any damage to the Premises arising from that removal
and shall restore the affected area to its pre-existing condition, reasonable wear and tear excepted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MECHANIC&rsquo;S LIENS</B>. Tenant shall keep the Premises free from any liens arising out of any work performed, materials
furnished, or obligations incurred by or for Tenant. In the event that Tenant shall not, within 15 days following the imposition
of any lien, cause the lien to be released of record by payment or posting of a proper bond in accordance with California Civil
Code Section&nbsp;8424 or any successor statute, Landlord shall have, in addition to all other available remedies, the right to
cause the lien to be released by any means it deems proper, including payment of or defense against the claim giving rise to the
lien. All expenses so incurred by Landlord shall be reimbursed by Tenant promptly following Landlord&rsquo;s demand. Tenant shall
give Landlord no less than 20 days&rsquo; prior notice in writing before commencing construction of any kind on the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>ENTRY AND INSPECTION</B>. Landlord shall at all reasonable times and with reasonable prior verbal notice, except in emergencies
or to provide Building services, have the right to enter the Premises to inspect them, to supply services in accordance with this
Lease, to make repairs and renovations as reasonably deemed necessary by Landlord, and to submit the Premises to prospective or
actual purchasers or encumbrance holders (or, during the final twelve months of the Term or when an uncured Default exists, to
prospective tenants), all without being deemed to have caused an eviction of Tenant and without abatement of rent except as provided
elsewhere in this Lease.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 8. SPACE
PLANNING AND SUBSTITUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Landlord shall have
the right, upon providing not less than 45 days written notice, to move Tenant to other space of comparable size in the Building
or in the Project. The new space shall be provided with improvements of comparable quality to those within the Premises. Landlord
shall pay the reasonable out-of-pocket costs to relocate and reconnect Tenant&rsquo;s personal property and equipment within the
new space. Landlord shall also reimburse Tenant for such other reasonable out-of-pocket costs that Tenant may incur in connection
with the relocation. Within 10 days following request by Landlord, Tenant shall execute an amendment to this Lease prepared by
Landlord to memorialize the relocation.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 9. ASSIGNMENT
AND SUBLETTING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>RIGHTS OF PARTIES</B>. Tenant shall not, directly or indirectly, assign, sublease, transfer or encumber any interest in
this Lease or allow any third party to use any portion of the Premises (collectively or individually, a &ldquo;<B>Transfer</B>&rdquo;)
without the prior written consent of Landlord, which consent shall not be unreasonably withheld if Landlord does not exercise its
recapture rights. Tenant agrees that it is not unreasonable for Landlord to withhold consent to a Transfer to a proposed assignee
or subtenant who is an existing tenant or occupant of the Building or Project or to a prospective tenant with whom Landlord or
Landlord&rsquo;s affiliate has been actively negotiating. Within 30 days after receipt of executed copies of the transfer documentation
and such other information as Landlord may request, Landlord shall either: (a)&nbsp;consent to the Transfer by execution of a consent
agreement in a form reasonably designated by Landlord; (b)&nbsp;refuse to consent to the Transfer; or (c)&nbsp;recapture the portion
of the Premises that Tenant is proposing to Transfer. Tenant hereby waives the provisions of Section&nbsp;1995.310 of the California
Civil Code, or any similar or successor Laws, now or hereinafter in effect, and all other remedies, including, without limitation,
any right at law or equity to terminate this Lease, on its own behalf and, to the extent permitted under all applicable laws, on
behalf of the proposed transferee. In no event shall any Transfer release or relieve Tenant from any obligation under this Lease,
as same may be amended. Tenant shall pay Landlord a review fee of $1,000.00 for Landlord&rsquo;s review of any requested Transfer.
Tenant shall pay Landlord, as additional Rent, 50% of all rent and other consideration which Tenant receives as a result of a Transfer
that is in excess of the Rent payable to Landlord for the portion of the Premises and Term covered by the Transfer. If Tenant is
in Default, Landlord may require that all sublease payments be made directly to Landlord, in which case Tenant shall receive a
credit against Rent in the amount of Tenant&rsquo;s share of payments received by Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>PERMITTED TRANSFER</B>. Notwithstanding the foregoing, Tenant may assign this Lease to a successor to Tenant by merger,
consolidation or the purchase of substantially all of Tenant&rsquo;s assets, or assign this Lease or sublet all or a portion of
the Premises to an Affiliate (defined below), without the consent of Landlord, provided that all of the following conditions are
satisfied (a &ldquo;<B>Permitted Transfer</B>&rdquo;): (i)&nbsp;Tenant is not then in Default hereunder; (ii)&nbsp;Tenant gives
Landlord written notice prior to such Permitted Transfer; and (iii)&nbsp;the successor entity resulting from any merger or consolidation
of Tenant or the sale of all or substantially all of the assets of Tenant, has a net worth at the time of the Permitted Transfer
that is at least equal to the net worth of Tenant immediately before the Permitted Transfer. &ldquo;<B>Affiliate</B>&rdquo; shall
mean an entity controlled by, controlling or under common control with Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 10. INSURANCE
AND INDEMNITY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>10.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>TENANT&rsquo;S INSURANCE</B>. Tenant, at its sole cost and expense, shall provide and maintain in effect the insurance described
in <B>Exhibit&nbsp;D</B>. Evidence of that insurance must be delivered to Landlord prior to the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>10.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>TENANT&rsquo;S INDEMNITY</B>. To the fullest extent permitted by law, but subject to Section&nbsp;10.4 below, Tenant shall
defend, indemnify and hold harmless Landlord and Landlord&rsquo;s agents, employees, lenders, and affiliates, from and against
any and all negligence, claims, liabilities, damages, costs or expenses arising either before or after the Commencement Date which
arise from or are caused by Tenant&rsquo;s use or occupancy of the Premises, the Building or the Common Areas of the Project, or
from the conduct of Tenant&rsquo;s business, or from any activity, work, or thing done, permitted or suffered by Tenant or Tenant&rsquo;s
agents, employees, subtenants, vendors, contractors, invitees or licensees in or about the Premises, the Building or the Common
Areas of the Project, or from any Default in the performance of any obligation on Tenant&rsquo;s part to be performed under this
Lease, or from any act, omission or negligence on the part of Tenant or Tenant&rsquo;s agents, employees, subtenants, vendors,
contractors, invitees or licensees. Landlord may, at its option, require Tenant to assume Landlord&rsquo;s defense in any action
covered by this Section&nbsp;10.2 through counsel reasonably satisfactory to Landlord. Notwithstanding the foregoing, Tenant shall
not be obligated to indemnify Landlord against any liability or expense to the extent it is ultimately determined that the same
was caused by the sole negligence or willful misconduct of Landlord, its agents, contractors or employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>10.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>LANDLORD&rsquo;S NONLIABILITY</B>. Landlord shall not be liable to Tenant, its employees, agents and invitees, and Tenant
hereby waives all claims against Landlord, its employees and agents for loss of or damage to any property, or any injury to any
person, resulting from any condition including, but not limited to, acts or omissions (criminal or otherwise) of third parties
and/or other tenants of the Project, or their agents, employees or invitees, fire, explosion, falling plaster, steam, gas, electricity,
water or rain which may leak or flow from or into any part of the Premises or from the breakage, leakage, obstruction or other
defects of the pipes, sprinklers, wires, appliances, plumbing, air conditioning, electrical works or other fixtures in the Building,
whether the damage or injury results from conditions arising in the Premises or in other portions of the Building, regardless of
the negligence of Landlord, its agents or any and all affiliates of Landlord in connection with the foregoing. Notwithstanding
anything to the contrary contained in this Lease, in no event shall Landlord be liable for Tenant&rsquo;s loss or interruption
of business or income (including without limitation, Tenant&rsquo;s consequential damages, lost profits or opportunity costs),
or for interference with light or other similar intangible interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>10.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WAIVER OF SUBROGATION</B>. Landlord and Tenant each hereby waives all rights of recovery against the other on account of
loss and damage occasioned to the property of such waiving party to the extent that the waiving party is entitled to proceeds for
such loss and damage under any property insurance policies carried or otherwise required to be carried by this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 11. DAMAGE
OR DESTRUCTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>11.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>RESTORATION</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Building of which the Premises are a part is damaged as the result of an event of casualty, then subject to the
provisions below, Landlord shall repair that damage as soon as reasonably possible unless Landlord reasonably determines that:
(i)&nbsp;the Premises have been materially damaged and there is less than 1 year of the Term remaining on the date of the casualty;
(ii)&nbsp;any Mortgagee (defined in Section&nbsp;13.1) requires that the insurance proceeds be applied to the payment of the mortgage
debt; or (iii)&nbsp;proceeds necessary to pay the full cost of the repair are not available from Landlord&rsquo;s insurance, including
without limitation earthquake insurance. Should Landlord elect not to repair the damage for one of the preceding reasons, Landlord
shall so notify Tenant in the &ldquo;Casualty Notice&rdquo; (as defined below), and this Lease shall terminate as of the date
of delivery of that notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As soon as reasonably practicable following the casualty event but not later than 60 days thereafter, Landlord shall notify
Tenant in writing (&ldquo;<B>Casualty Notice</B>&rdquo;) of Landlord&rsquo;s election, if applicable, to terminate this Lease.
If this Lease is not so terminated, the Casualty Notice shall set forth the anticipated period for repairing the casualty damage.
If the anticipated repair period exceeds 270 days and if the damage is so extensive as to reasonably prevent Tenant&rsquo;s substantial
use and enjoyment of the Premises, then either party may elect to terminate this Lease by written notice to the other within 10
days following delivery of the Casualty Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that neither Landlord nor Tenant terminates this Lease pursuant to Section&nbsp;11.1(b), Landlord shall repair
all material damage to the Premises or the Building as soon as reasonably possible and this Lease shall continue in effect for
the remainder of the Term. Upon notice from Landlord, Tenant shall assign or endorse over to Landlord (or to any party designated
by Landlord) all property insurance proceeds payable to Tenant under Tenant&rsquo;s insurance with respect to any Alterations.
Within 15 days of demand, Tenant shall also pay Landlord for any additional excess costs that are determined during the performance
of the repairs to such Alterations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From and after the casualty event, the rental to be paid under this Lease shall be abated in the same proportion that the
Floor Area of the Premises that is rendered unusable by the damage from time to time bears to the total Floor Area of the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding the provisions of subsections (a), (b) and (c) of this Section&nbsp;11.1, but subject to Section&nbsp;10.4,
the cost of any repairs shall be borne by Tenant, and Tenant shall not be entitled to rental abatement or termination rights, if
the damage is due to the fault or neglect of Tenant or its employees, subtenants, contractors, invitees or representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>11.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>LEASE GOVERNS</B>. Tenant agrees that the provisions of this Lease, including without limitation Section&nbsp;11.1, shall
govern any damage or destruction and shall accordingly supersede any contrary statute or rule of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 12. EMINENT
DOMAIN</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Either party may terminate
this Lease if any material part of the Premises is taken or condemned for any public or quasi-public use under Law, by eminent
domain or private purchase in lieu thereof (a &ldquo;<B>Taking</B>&rdquo;). Landlord shall also have the right to terminate this
Lease if there is a Taking of any portion of the Building or Project which would have a material adverse effect on Landlord&rsquo;s
ability to profitably operate the remainder of the Building. The termination shall be effective as of the effective date of any
order granting possession to, or vesting legal title in, the condemning authority. All compensation awarded for a Taking shall
be the property of Landlord. Tenant agrees that the provisions of this Lease shall govern any Taking and shall accordingly supersede
any contrary statute or rule of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 13. SUBORDINATION;
ESTOPPEL CERTIFICATE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>13.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SUBORDINATION</B>. Tenant accepts this Lease subject and subordinate to any mortgage(s), deed(s) of trust, ground lease(s)
or other lien(s) now or subsequently arising upon the Premises, the Building or the Project, and to renewals, modifications, refinancings
and extensions thereof (collectively referred to as a &ldquo;<B>Mortgage</B>&rdquo;). The party having the benefit of a Mortgage
shall be referred to as a &ldquo;<B>Mortgagee</B>.&rdquo; This clause shall be self-operative, but upon request from a Mortgagee,
Tenant shall execute a commercially reasonable subordination and attornment agreement in favor of the Mortgagee, provided such
agreement provides a non-disturbance covenant benefitting Tenant. Alternatively, a Mortgagee shall have the right at any time to
subordinate its Mortgage to this Lease. Upon request, Tenant, without charge, shall attorn to any successor to Landlord&rsquo;s
interest in this Lease in the event of a foreclosure of any mortgage. Tenant agrees that any purchaser at a foreclosure sale or
lender taking title under a deed in lieu of foreclosure shall not be responsible for any act or omission of a prior landlord, shall
not be subject to any offsets or defenses Tenant may have against a prior landlord, and shall not be liable for the return of the
Security Deposit not actually recovered by such purchaser nor bound by any rent paid in advance of the calendar month in which
the transfer of title occurred; provided that the foregoing shall not release the applicable prior landlord from any liability
for those obligations. Tenant acknowledges that Landlord&rsquo;s Mortgagees and their successors-in-interest are intended third
party beneficiaries of this Section&nbsp;13.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>13.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>ESTOPPEL CERTIFICATE</B>. Tenant shall, within 10 days after receipt of a written request from Landlord, execute and deliver
a commercially reasonable estoppel certificate in favor of those parties as are reasonably requested by Landlord (including a Mortgagee
or a prospective purchaser of the Building or the Project).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 14. DEFAULTS
AND REMEDIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>TENANT&rsquo;S DEFAULTS</B>. In addition to any other event of default set forth in this Lease, the occurrence of any one
or more of the following events shall constitute a &ldquo;<B>Default</B>&rdquo; by Tenant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The failure by Tenant to make any payment of Rent required to be made by Tenant, as and when due, where the failure continues
for a period of 3 days after written notice from Landlord to Tenant. The term &ldquo;<B>Rent</B>&rdquo; as used in this Lease shall
be deemed to mean the Basic Rent and all other sums, including but not limited to parking charges, required to be paid by Tenant
to Landlord pursuant to the terms of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except where a specific time period is otherwise set forth for Tenant&rsquo;s performance in this Lease (in which event
the failure to perform by Tenant within such time period shall be a Default), the failure or inability by Tenant to observe or
perform any of the covenants or provisions of this Lease to be observed or performed by Tenant, other than as specified in any
other subsection of this Section&nbsp;14.1, where the failure continues for a period of 30 days after written notice from Landlord
to Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The notice periods
provided herein are in lieu of, and not in addition to, any notice periods provided by law, and Landlord shall not be required
to give any additional notice under California Code of Civil Procedure Section&nbsp;1161, or any successor statute, in order to
be entitled to commence an unlawful detainer proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>LANDLORD&rsquo;S REMEDIES</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the occurrence of any Default by Tenant, then in addition to any other remedies available to Landlord, Landlord may
exercise the following remedies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Landlord may terminate Tenant&rsquo;s right to possession of the Premises by any lawful means, in which case this Lease
shall terminate and Tenant shall immediately surrender possession of the Premises to Landlord. Such termination shall not affect
any accrued obligations of Tenant under this Lease. Upon termination, Landlord shall have the right to reenter the Premises and
remove all persons and property. Landlord shall also be entitled to recover from Tenant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(1)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The worth at the time of award of the unpaid Rent which had been earned at the time of termination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(2)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The worth at the time of award of the amount by which the unpaid Rent which would have been earned after termination until
the time of award exceeds the amount of such loss that Tenant proves could have been reasonably avoided;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(3)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The worth at the time of award of the amount by which the unpaid Rent for the balance of the Term after the time of award
exceeds the amount of such loss that Tenant proves could be reasonably avoided;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(4)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any other amount necessary to compensate Landlord for all the detriment proximately caused by Tenant&rsquo;s failure to
perform its obligations under this Lease or which in the ordinary course of things would be likely to result from Tenant&rsquo;s
default, including, but not limited to, the cost of recovering possession of the Premises, commissions and other expenses of reletting,
including necessary repair, renovation, improvement and alteration of the Premises for a new tenant, reasonable attorneys&rsquo;
fees, and any other reasonable costs; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(5)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At Landlord&rsquo;s election, all other amounts in addition to or in lieu of the foregoing as may be permitted by law. Any
sum, other than Basic Rent, shall be computed on the basis of the average monthly amount accruing during the 24 month period immediately
prior to Default, except that if it becomes necessary to compute such rental before the 24 month period has occurred, then the
computation shall be on the basis of the average monthly amount during the shorter period. As used in subparagraphs (1) and (2)
above, the &ldquo;worth at the time of award&rdquo; shall be computed by allowing interest at the rate of 10% per annum. As used
in subparagraph (3) above, the &ldquo;worth at the time of award&rdquo; shall be computed by discounting the amount at the discount
rate of the Federal Reserve Bank of San Francisco at the time of award plus 1%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employ the remedy described in California Civil Code &sect; 1951.4 (Landlord may continue this Lease in effect after Tenant&rsquo;s
breach and abandonment and recover Rent as it becomes due, if Tenant has the right to sublet or assign, subject only to reasonable
limitations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The various rights and remedies reserved to Landlord in this Lease or otherwise shall be cumulative and, except as otherwise
provided by California law, Landlord may pursue any or all of its rights and remedies at the same time. No delay or omission of
Landlord to exercise any right or remedy shall be construed as a waiver of the right or remedy or of any breach or Default by Tenant.
The acceptance by Landlord of rent shall not be a (i)&nbsp;waiver of any preceding breach or Default by Tenant of any provision
of this Lease, other than the failure of Tenant to pay the particular rent accepted, regardless of Landlord&rsquo;s knowledge of
the preceding breach or Default at the time of acceptance of rent, or (ii)&nbsp;a waiver of Landlord&rsquo;s right to exercise
any remedy available to Landlord by virtue of the breach or Default. No payment by Tenant or receipt by Landlord of a lesser amount
than the rent required by this Lease shall be deemed to be other than a partial payment on account of the earliest due stipulated
rent, nor shall any endorsement or statement on any check or letter be deemed an accord and satisfaction and Landlord shall accept
the check or payment without prejudice to Landlord&rsquo;s right to recover the balance of the rent or pursue any other remedy
available to it. Tenant hereby waives any right of redemption or relief from forfeiture under California Code of Civil Procedure
Section&nbsp;1174 or 1179, or under any successor statute, in the event this Lease is terminated by reason of any Default by Tenant.
No act or thing done by Landlord or Landlord&rsquo;s agents during the Term shall be deemed an acceptance of a surrender of the
Premises, and no agreement to accept a surrender shall be valid unless in writing and signed by Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>LATE PAYMENTS</B>. Any Rent due under this Lease that is not paid to Landlord within 5 days of the date when due shall bear
interest at the maximum rate permitted by law from the date due until fully paid and if any Rent due from Tenant shall not be received
by Landlord or Landlord&rsquo;s designee within 5 days after the date due, then Tenant shall pay to Landlord, in addition to the
interest, a late charge for each delinquent payment equal to the greater of (i)&nbsp;5% of that delinquent payment or (ii)&nbsp;$100.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>DEFAULT BY LANDLORD</B>. Landlord shall not be deemed to be in default in the performance of any obligation under this Lease
unless and until it has failed to perform the obligation within 30 days after written notice by Tenant to Landlord specifying in
reasonable detail the nature and extent of the failure; provided, however, that if the nature of Landlord&rsquo;s obligation is
such that more than 30 days are required for its performance, then Landlord shall not be deemed to be in default if it commences
performance within the 30 day period and thereafter diligently pursues the cure to completion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>EXPENSES AND LEGAL FEES</B>. Should either Landlord or Tenant bring any action in connection with this Lease, the prevailing
party shall be entitled to recover as a part of the action its reasonable attorneys&rsquo; fees, and all other reasonable costs.
The prevailing party for the purpose of this paragraph shall be determined by the trier of the facts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WAIVER OF JURY TRIAL/JUDICIAL REFERENCE</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>LANDLORD AND TENANT EACH ACKNOWLEDGES THAT IT IS AWARE OF AND HAS HAD THE ADVICE OF COUNSEL OF ITS CHOICE WITH RESPECT
TO ITS RIGHT TO TRIAL BY JURY, AND EACH PARTY DOES HEREBY EXPRESSLY AND KNOWINGLY WAIVE AND RELEASE ALL SUCH RIGHTS TO TRIAL BY
JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER PARTY HERETO AGAINST THE OTHER (AND/OR AGAINST ITS OFFICERS, DIRECTORS,
EMPLOYEES, AGENTS, OR SUBSIDIARY OR AFFILIATED ENTITIES) ON ANY MATTERS WHATSOEVER ARISING OUT OF OR IN ANY WAY CONNECTED WITH
THIS LEASE, TENANT&rsquo;S USE OR OCCUPANCY OF THE PREMISES, AND/OR ANY CLAIM OF INJURY OR DAMAGE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that the jury waiver provisions of Section&nbsp;14.6(a) are not enforceable under California law, then, unless
otherwise agreed to by the parties, the provisions of this Section&nbsp;14.6(b) shall apply. Landlord and Tenant agree that any
disputes arising in connection with this Lease (including but not limited to a determination of any and all of the issues in such
dispute, whether of fact or of law) shall be resolved (and a decision shall be rendered) by way of a general reference as provided
for in Part&nbsp;2, Title&nbsp;8, Chapter&nbsp;6 (&sect;&sect;&nbsp;638 et. seq.) of the California Code of Civil Procedure, or
any successor California statute governing resolution of disputes by a court appointed referee. Nothing within this Section&nbsp;14.6
shall apply to an unlawful detainer action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SATISFACTION OF JUDGMENT</B>. The obligations of Landlord do not constitute the personal obligations of the individual partners,
trustees, directors, officers, members or shareholders of Landlord or its constituent partners or members. Should Tenant recover
a money judgment against Landlord, such judgment shall be satisfied only from the interest of Landlord in the Project and out of
the rent or other income from such property receivable by Landlord, and no action for any deficiency may be sought or obtained
by Tenant.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 15. END OF
TERM</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>15.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>HOLDING OVER</B>. If Tenant holds over for any period after the Expiration Date (or earlier termination of the Term), such
tenancy shall constitute a tenancy at sufferance only and possession shall be subject to all of the terms of this Lease, except
that the monthly rental shall be 200% of the total monthly rental for the month immediately preceding the date of termination.
The acceptance by Landlord of monthly hold-over rental in a lesser amount shall not constitute a waiver of Landlord&rsquo;s right
to recover the full amount due unless otherwise agreed in writing by Landlord. If Tenant fails to surrender the Premises upon the
expiration of this Lease despite demand to do so by Landlord, Tenant shall indemnify and hold Landlord harmless from all loss or
liability, including without limitation, any claims made by any succeeding tenant relating to such failure to surrender. The foregoing
provisions of this Section&nbsp;15.1 are in addition to and do not affect Landlord&rsquo;s right of re-entry or any other rights
of Landlord under this Lease or at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>15.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SURRENDER OF PREMISES; REMOVAL OF PROPERTY</B>. Upon the Expiration Date or upon any earlier termination of this Lease,
Tenant shall quit and surrender possession of the Premises to Landlord in as good order, condition and repair as when received
or as hereafter may be improved by Landlord or Tenant, reasonable wear and tear and repairs which are Landlord&rsquo;s obligation
excepted, and shall remove or fund to Landlord the cost of removing all wallpapering, voice and/or data transmission cabling installed
by or for Tenant and Required Removables, together with all personal property and debris, and shall perform all work required under
Section&nbsp;7.3 of this Lease. If Tenant shall fail to comply with the provisions of this Section&nbsp;15.2, Landlord may effect
the removal and/or make any repairs, and the cost to Landlord shall be additional rent payable by Tenant upon demand.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 16. PAYMENTS
AND NOTICES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All sums payable by
Tenant to Landlord shall be paid, without deduction or offset, in lawful money of the United States to Landlord at its address
set forth in Item 12 of the Basic Lease Provisions, or at any other place as Landlord may designate in writing. Unless this Lease
expressly provides otherwise, all payments shall be due and payable within 5 days after demand. All payments requiring proration
shall be prorated on the basis of the number of days in the pertinent calendar month or year, as applicable. Any notice, election,
demand, consent or approval to be given or other document to be delivered by either party to the other may be delivered to the
other party, at the address set forth in Item 12 of the Basic Lease Provisions, by personal service or by any courier or &ldquo;overnight&rdquo;
express mailing service. Either party may, by written notice to the other, served in the manner provided in this Article, designate
a different address. The refusal to accept delivery of a notice, or the inability to deliver the notice (whether due to a change
of address for which notice was not duly given or other good reason), shall be deemed delivery and receipt of the notice as of
the date of attempted delivery.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 17. RULES
AND REGULATIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tenant agrees to comply
with the Rules and Regulations attached as <B>Exhibit&nbsp;E</B>, and any reasonable and nondiscriminatory amendments, modifications
and/or additions as may be adopted by Landlord from time to time.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 18. BROKER&rsquo;S
COMMISSION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties recognize
as the broker(s) who negotiated this Lease the firm(s) whose name(s) is (are) stated in Item 10 of the Basic Lease Provisions,
and agree that Landlord shall be responsible for the payment of brokerage commissions to those broker(s) unless otherwise provided
in this Lease. Tenant agrees to indemnify and hold Landlord harmless from any cost, expense or liability (including reasonable
attorneys&rsquo; fees) for any compensation, commissions or charges claimed by any other real estate broker or agent employed or
claiming to represent or to have been employed by Tenant in connection with the negotiation of this Lease.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 19. TRANSFER
OF LANDLORD&rsquo;S INTEREST</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Landlord shall have
the right to transfer and assign, in whole or in part, all of its ownership interest, rights and obligations in the Building, Project
or Lease, including the Security Deposit, and upon transfer Landlord shall be released from any further obligations hereunder,
and Tenant agrees to look solely to the successor in interest of Landlord for the performance of such obligations and the return
of any Security Deposit.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 20. INTERPRETATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>NUMBER</B>. Whenever the context of this Lease requires, the words &ldquo;Landlord&rdquo; and &ldquo;Tenant&rdquo; shall
include the plural as well as the singular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>JOINT AND SEVERAL LIABILITY</B>. If more than one person or entity is named as Tenant, the obligations imposed upon each
shall be joint and several and the act of or notice from, or notice or refund to, or the signature of, any one or more of them
shall be binding on all of them with respect to the tenancy of this Lease, including, but not limited to, any renewal, extension,
termination or modification of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SUCCESSORS</B>. The expiration of the Term, whether by lapse of time, termination or otherwise, shall not relieve either
party of any obligations which accrued prior to or which may continue to accrue after the expiration or termination of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>TIME OF ESSENCE</B>. Time is of the essence with respect to the performance of every provision of this Lease in which time
of performance is a factor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>CONTROLLING LAW/VENUE</B>. This Lease shall be governed by and interpreted in accordance with the laws of the State of California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SEVERABILITY</B>. If any term or provision of this Lease, the deletion of which would not adversely affect the receipt of
any material benefit by either party or the deletion of which is consented to by the party adversely affected, shall be held invalid
or unenforceable to any extent, the remainder of this Lease shall not be affected and each term and provision of this Lease shall
be valid and enforceable to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>WAIVER</B>. One or more waivers by Landlord or Tenant of any breach of any term, covenant or condition contained in this
Lease shall not be a waiver of any subsequent breach of the same or any other term, covenant or condition. Consent to any act by
one of the parties shall not be deemed to render unnecessary the obtaining of that party&rsquo;s consent to any subsequent act.
No breach of this Lease shall be deemed to have been waived unless the waiver is in a writing signed by the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>INABILITY TO PERFORM</B>. In the event that either party shall be delayed or hindered in or prevented from the performance
of any work or in performing any act required under this Lease by reason of any cause beyond the reasonable control of that party,
then the performance of the work or the doing of the act shall be excused for the period of the delay and the time for performance
shall be extended for a period equivalent to the period of the delay. The provisions of this Section&nbsp;20.8 shall not operate
to excuse Tenant from the prompt payment of Rent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>ENTIRE AGREEMENT</B>. This Lease constitutes the entire agreement between the parties and supersedes all prior agreements
and understandings related to the Premises. This Lease may be modified only by a written agreement signed by Landlord and Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>QUIET ENJOYMENT</B>. Upon the observance and performance of all the covenants, terms and conditions on Tenant&rsquo;s part
to be observed and performed, and subject to the other provisions of this Lease, Tenant shall have the right of quiet enjoyment
and use of the Premises for the Term without hindrance or interruption by Landlord or any other person claiming by or through Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT>SURVIVAL</B>. All covenants of Landlord or Tenant which reasonably would be intended to survive the expiration or sooner
termination of this Lease, including without limitation any warranty or indemnity hereunder, shall so survive and continue to be
binding upon and inure to the benefit of the respective parties and their successors and assigns.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 21. EXECUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>21.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>COUNTERPARTS; DIGITAL SIGNATURES</B>. This Lease may be executed in one or more counterparts, each of which shall constitute
an original and all of which shall be one and the same agreement. The parties agree to accept a digital image (including but not
limited to an image in the form of a PDF, JPEG, GIF file, or other e-signature) of this Lease, if applicable, reflecting the execution
of one or both of the parties, as a true and correct original.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>21.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>CORPORATE AND PARTNERSHIP AUTHORITY</B>. Tenant represents and warrants to Landlord, and agrees, that each individual executing
this Lease on behalf of Tenant is authorized to do so on behalf of Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>21.3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>EXECUTION OF LEASE; NO OPTION OR OFFER</B>. The submission of this Lease to Tenant shall be for examination purposes only,
and shall not constitute an offer to or option for Tenant to lease the Premises unless and until Landlord has executed and delivered
this Lease to Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>21.4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>BROKER DISCLOSURE</B>. By the execution of this Lease, each of Landlord and Tenant hereby acknowledge and confirm (a)&nbsp;receipt
of a copy of a Disclosure Regarding Real Estate Agency Relationship conforming to the requirements of California Civil Code 2079.16,
and (b)&nbsp;the agency relationships specified in Item 10 of the Basic Lease Provisions, which acknowledgement and confirmation
is expressly made for the benefit of Tenant&rsquo;s Broker identified in Item 10 of the Basic Lease Provisions. If there is no
Tenant&rsquo;s Broker so identified in Item 10 of the Basic Lease Provisions, then such acknowledgement and confirmation is expressly
made for the benefit of Landlord&rsquo;s Broker. By the execution of this Lease, Landlord and Tenant are executing the confirmation
of the agency relationships set forth in Item 10 of the Basic Lease Provisions.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ARTICLE 22. MISCELLANEOUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>22.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>MORTGAGEE PROTECTION</B>. No act or failure to act on the part of Landlord which would otherwise entitle Tenant to be relieved
of its obligations hereunder or to terminate this Lease shall result in such a release or termination unless (a)&nbsp;Tenant has
given notice by registered or certified mail to any Mortgagee of a Mortgage covering the Building whose address has been furnished
to Tenant and (b)&nbsp;such Mortgagee is afforded a reasonable opportunity to cure the default by Landlord. Tenant shall comply
with any written directions by any Mortgagee to pay Rent due hereunder directly to such Mortgagee without determining whether a
default exists under such Mortgagee&rsquo;s Mortgage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>22.2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>SDN LIST</B>. Tenant hereby represents and warrants that neither Tenant nor any officer, director, employee, partner, member
or other principal of Tenant (collectively, &ldquo;<B>Tenant Parties</B>&rdquo;) is listed as a Specially Designated National and
Blocked Person (&ldquo;<B>SDN</B>&rdquo;) on the list of such persons and entities issued by the U.S. Treasury Office of Foreign
Assets Control (OFAC). In the event Tenant or any Tenant Party is or becomes listed as an SDN, Tenant shall be deemed in breach
of this Lease and Landlord shall have the right to terminate this Lease immediately upon written notice to Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>LANDLORD:</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>JAMBOREE CENTER 4 LLC</B>,<BR>
        a Delaware limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Steven M. Case&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Steven M. Case</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Executive Vice President</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Office Properties</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Christopher J. Popma&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Christopher J. Popma</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Regional Vice President, Operations</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Office Properties</P></TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TENANT:</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ACACIA RESEARCH CORPORATION</B>,<BR>
        a Delaware corporation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Marc W. Booth&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Printed Name: Marc W. Booth</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: Vice President &amp; Chief IP Officer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Jennifer Graff&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Printed Name: Jennifer Graff</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: Corporate Secretary</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 836px; width: 440px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Operating Expenses and Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Base Year)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commencing
12 months following the Commencement Date, Tenant shall pay Landlord, as additional rent, for Tenant&rsquo;s Share of the amount,
if any, by which &ldquo;<B>Project Costs</B>&rdquo; (defined below) for each Expense Recovery Period during the Term exceed Project
Costs for the Project Cost Base and the amount, if any, by which &ldquo;<B>Property Taxes</B>&rdquo; (defined below) for each Expense
Recovery Period during the Term exceed Property Taxes for the Property Tax Base. Property Taxes and Project Costs are mutually
exclusive and may be billed separately or in combination as determined by Landlord. &ldquo;<B>Tenant&rsquo;s Share</B>&rdquo; shall
mean that portion of any Operating Expenses determined by multiplying the cost of such item by a fraction, the numerator of which
is the Floor Area and the denominator of which is the total rentable square footage, as determined from time to time by Landlord,
of (i)&nbsp;the Floor Area of the Building as defined in Item 8 of the Basic Lease Provisions, for expenses determined by Landlord
to benefit or relate substantially to the Building rather than the entire Project, or (ii)&nbsp;all or some of the buildings in
the Project, for expenses determined by Landlord to benefit or relate substantially to all or some of the buildings in the Project
rather than any specific building. Tenant acknowledges Landlord&rsquo;s rights to make changes or additions to the Building and/or
Project from time to time, in which event the total rentable square footage within the Building and/or Project may be adjusted.
For convenience of reference, Property Taxes and Project Costs may sometimes be collectively referred to as &ldquo;<B>Operating
Expenses</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commencing
prior to the start of the first full &ldquo;<B>Expense Recovery Period</B>&rdquo; of the Lease (as defined in Item 7 of the Basic
Lease Provisions) following the Base Year, and prior to the start of each full or partial Expense Recovery Period thereafter, Landlord
shall give Tenant a written estimate of the amount of Tenant&rsquo;s Share of Project Costs and Property Taxes for the Expense
Recovery Period or portion thereof. Commencing 12 months following the Commencement Date, Tenant shall pay the estimated amounts
to Landlord in equal monthly installments, in advance, with Basic Rent. Landlord may from time to time change the Expense Recovery
Period to reflect a calendar year or a new fiscal year of Landlord, as applicable, in which event Tenant&rsquo;s share of Operating
Expenses shall be equitably prorated for any partial year. From time to time during an Expense Recovery Period, Landlord may revise
the estimate based on increases in any of the Operating Expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within
180 days after the end of each Expense Recovery Period, Landlord shall furnish to Tenant a statement setting forth the actual or
prorated Property Taxes and Project Costs attributable to that period, and the parties shall within 30 days thereafter make any
payment or allowance necessary to adjust Tenant&rsquo;s estimated payments, if any, to Tenant&rsquo;s actual Tenant&rsquo;s Share
as shown by the annual statement. If actual Property Taxes or Project Costs allocable to Tenant during any Expense Recovery Period
are less than the Property Tax Base or the Project Cost Base, respectively, Landlord shall not be required to pay that differential
to Tenant, although Landlord shall refund any applicable estimated payments collected from Tenant. Should Tenant fail to object
in writing to Landlord&rsquo;s determination of actual Operating Expenses within 60 days following delivery of Landlord&rsquo;s
expense statement, Landlord&rsquo;s determination of actual Operating Expenses for the applicable Expense Recovery Period shall
be conclusive and binding on Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Even
though the Lease has terminated and the Tenant has vacated the Premises, when the final determination is made of Tenant&rsquo;s
share of Property Taxes and Project Costs for the Expense Recovery Period in which the Lease terminates, Tenant shall upon notice
pay the entire increase due over the estimated expenses paid; conversely, any overpayment made in the event expenses decrease shall
be rebated by Landlord to Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
term &ldquo;<B>Project Costs</B>&rdquo; shall include all charges and expenses pertaining to the operation, management, maintenance
and repair of the Building and the Project, together with all appurtenant Common Areas (as defined in Section&nbsp;6.2), and shall
include the following charges by way of illustration but not limitation: water and sewer charges; insurance premiums and deductibles
and/or reasonable premium equivalents and deductible equivalents should Landlord elect to self-insure any risk that Landlord is
authorized to insure hereunder; license, permit, and inspection fees; heat; light; power; janitorial services; the cost of equipping,
staffing and operating an on-site and/or off-site management office for the Building and Project; all labor and labor-related costs
for personnel applicable to the Building and Project, including both Landlord&rsquo;s personnel and outside personnel; a commercially
reasonable Landlord overhead/management fee; reasonable fees for consulting services; access control/security costs, inclusive
of the reasonable cost of improvements made to enhance access control systems and procedures; repairs; air conditioning; supplies;
materials; equipment; tools; tenant services; programs instituted to comply with transportation management requirements; any expense
incurred pursuant to Sections 6.1, 6.2, 7.2, and <B>Exhibits C </B>and <B>F</B> below; costs incurred (capital or otherwise) on
a regular recurring basis every 3 or more years for normal maintenance projects (e.g., parking lot slurry coat or replacement of
lobby, corridor and elevator cab carpets and coverings); and the amortized cost of capital improvements (as distinguished from
replacement parts or components installed in the ordinary course of business) which are intended to reduce other operating costs
or increases thereof, or upgrade Building and/or Project security, or which are required to bring the Building and/or Project into
compliance with applicable laws and building codes. Landlord shall amortize the cost of capital improvements on a straight-line
basis over the lesser of the Payback Period (as defined below) or the useful life of the capital improvement as reasonably determined
by Landlord. Any amortized Project Costs item may include, at Landlord&rsquo;s option, an actual or imputed interest rate that
Landlord would reasonably be required to pay to finance the cost of the item, applied on the unamortized balance. &ldquo;<B>Payback
Period</B>&rdquo; shall mean the reasonably estimated period of time that it takes for the cost savings, if any, resulting from
a capital improvement item to equal the total cost of the capital improvement. It is understood that Project Costs shall include
competitive charges for direct services provided by any subsidiary or division of Landlord. If any Project Costs are applicable
to one or more buildings or properties in addition to the Building, then that cost shall be equitably prorated and apportioned
among the Building and such other buildings or properties. The term &ldquo;<B>Property Taxes</B>&rdquo; as used herein shall include
the following: (i)&nbsp;all real estate taxes or personal property taxes, as such property taxes may be increased from time to
time due to a reassessment or otherwise; and (ii)&nbsp;other taxes, charges and assessments which are levied with respect to this
Lease or to the Building and/or the Project, and any improvements, fixtures and equipment and other property of Landlord located
in the Building and/or the Project, except that general net income and franchise taxes imposed against Landlord shall be excluded;
and (iii)&nbsp;any tax, surcharge or assessment which shall be levied in addition to or in lieu of real estate or personal property
taxes; and (iv)&nbsp;costs and expenses incurred in contesting the amount or validity of any Property Tax by appropriate proceedings.
A copy of Landlord&rsquo;s unaudited statement of expenses shall be made available to Tenant upon request. The Project Costs, inclusive
of those for the Base Year, shall be extrapolated by Landlord to reflect at least 95% occupancy of the rentable area of the Building.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UTILITIES AND SERVICES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following standards
for utilities and services shall be in effect at the Building. Landlord reserves the right to adopt nondiscriminatory modifications
and additions to these standards. In the case of any conflict between these standards and the Lease, the Lease shall be controlling.
Subject to all of the provisions of the Lease, the following shall apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
shall make available to the Premises during the hours of 8:00 a.m. to 6:00 p.m., Monday through Friday, and upon request, from
8:00 a.m. to 1:00 p.m. on Saturday (&ldquo;<B>Building Hours</B>&rdquo;), generally recognized national holidays excepted, reasonable
HVAC services. Subject to the provisions set forth below, Landlord shall also furnish the Building with elevator service (if applicable),
reasonable amounts of electric current for normal lighting by Landlord&rsquo;s standard overhead fluorescent and incandescent fixtures
and for the operation of office equipment consistent in type and quantity with that utilized by typical office tenants of the Building
and Project, and water for lavatory purposes. Tenant will not, without the prior written consent of Landlord, connect any apparatus,
machine or device with water pipes or electric current (except through existing electrical outlets in the Premises) for the purpose
of using electric current or water.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
written request from Tenant delivered to Landlord at least 24 hours prior to the period for which service is requested, but during
normal business hours, Landlord will provide any of the foregoing building services to Tenant at such times when such services
are not otherwise available. Tenant agrees to pay Landlord for those after-hour services at rates that Landlord may establish from
time to time. If Tenant requires electric current in excess of that which Landlord is obligated to furnish under this <B>Exhibit&nbsp;C</B>,
Tenant shall first obtain the consent of Landlord, and Landlord may cause an electric current meter to be installed in the Premises
to measure the amount of electric current consumed. The cost of installation, maintenance and repair of the meter shall be paid
for by Tenant, and Tenant shall reimburse Landlord promptly upon demand for all electric current consumed for any special power
use as shown by the meter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
shall furnish water for drinking, personal hygiene and lavatory purposes only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that any utility service to the Premises is separately metered or billed to Tenant, Tenant shall pay all charges for
that utility service to the Premises and the cost of furnishing the utility to tenant suites shall be excluded from the Operating
Expenses as to which reimbursement from Tenant is required in the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
shall provide janitorial services 5 days per week, equivalent to that furnished in comparable buildings, and window washing as
reasonably required; provided, however, that Tenant shall pay for any additional or unusual janitorial services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall have access to the Building 24 hours per day, 7 days per week, 52 weeks per year; provided that Landlord may install access
control systems as it deems advisable for the Building. Landlord may impose a reasonable charge for access control cards and/or
keys issued to Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
costs of operating, maintaining and repairing any supplemental air conditioning unit serving only the Premises shall be borne solely
by Tenant. Such installation shall be subject to Landlord&rsquo;s prior written approval, at Tenant&rsquo;s sole expense and shall
include installation of a separate meter for the operation of the unit. Landlord may require Tenant to remove at Lease expiration
any such unit installed by or for Tenant and to repair any resulting damage to the Premises or Building.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">C-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TENANT&rsquo;S INSURANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following requirements
for Tenant&rsquo;s insurance shall be in effect during the Term, and Tenant shall also cause any subtenant to comply with the requirements.
Landlord reserves the right to adopt reasonable nondiscriminatory modifications and additions to these requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall maintain, at its sole cost and expense, during the entire Term: (i)&nbsp;commercial general liability insurance with respect
to the Premises and the operations of Tenant in, on or about the Premises, on a policy form that is at least as broad as Insurance
Service Office (ISO) CGL 00 01 (if alcoholic beverages are sold on the Premises, liquor liability shall be explicitly covered),
which policy(ies) shall be written on an &ldquo;occurrence&rdquo; basis and for not less than $2,000,000 combined single limit
per occurrence for bodily injury, death, and property damage liability; (ii)&nbsp;workers&rsquo; compensation insurance coverage
as required by law, together with employers&rsquo; liability insurance coverage of at least $1,000,000 each accident and each disease;
(iii)&nbsp;with respect to Alterations constructed by Tenant under this Lease, builder&rsquo;s risk insurance, in an amount equal
to the replacement cost of the work; and (iv)&nbsp;insurance against fire, vandalism, malicious mischief and such other additional
perils as may be included in a standard &ldquo;special form&rdquo; policy, insuring all Alterations, trade fixtures, furnishings,
equipment and items of personal property in the Premises, in an amount equal to not less than 90% of their replacement cost (with
replacement cost endorsement), which policy shall also include business interruption coverage in an amount sufficient to cover
1 year of loss. In no event shall the limits of any policy be considered as limiting the liability of Tenant under this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
policies of insurance required to be carried by Tenant pursuant to this <B>Exhibit&nbsp;D</B> shall be written by insurance companies
authorized to do business in the State of California and with a general policyholder rating of not less than &ldquo;A-&rdquo; and
financial rating of not less than &ldquo;VIII&rdquo; in the most current Best&rsquo;s Insurance Report. The deductible or other
retained limit under any policy carried by Tenant shall be commercially reasonable, and Tenant shall be responsible for payment
of such deductible or retained limit with waiver of subrogation in favor of Landlord. Any insurance required of Tenant may be furnished
by Tenant under any blanket policy carried by it or under a separate policy. A certificate of insurance, certifying that the policy
has been issued, provides the coverage required by this Exhibit and contains the required provisions, together with endorsements
acceptable to Landlord evidencing the waiver of subrogation and additional insured provisions required below, shall be delivered
to Landlord prior to the date Tenant is given the right of possession of the Premises. Proper evidence of the renewal of any insurance
coverage shall also be delivered to Landlord not less than thirty (30) days prior to the expiration of the coverage. In the event
of a loss covered by any policy under which Landlord is an additional insured, Landlord shall be entitled to review a copy of such
policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant&rsquo;s
commercial general liability insurance shall contain a provision that the policy shall be primary to and noncontributory with any
policies carried by Landlord, together with a provision including Landlord, The Irvine Company LLC, and any other parties in interest
designated by Landlord as additional insureds. Tenant&rsquo;s policies described in Subsections 1 (ii), (iii) and (iv) above shall
each contain a waiver by the insurer of any right to subrogation against Landlord, its agents, employees, contractors and representatives.
Tenant also waives its right of recovery for any deductible or retained limit under same policies enumerated above. All of Tenant&rsquo;s
policies shall contain a provision that the insurer will not cancel or change the coverage provided by the policy without first
giving Landlord 30 days prior written notice. Tenant shall also name Landlord as an additional insured on any excess or umbrella
liability insurance policy carried by Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTICE TO TENANT: IN ACCORDANCE WITH
THE TERMS OF THIS LEASE, TENANT MUST PROVIDE EVIDENCE OF THE REQUIRED INSURANCE TO LANDLORD&rsquo;S MANAGEMENT AGENT PRIOR TO BEING
AFFORDED ACCESS TO THE PREMISES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">D-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RULES AND REGULATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following Rules
and Regulations shall be in effect at the Building. Landlord reserves the right to adopt reasonable nondiscriminatory modifications
and additions at any time. In the case of any conflict between these regulations and the Lease, the Lease shall be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
sidewalks, halls, passages, elevators, stairways, and other common areas shall not be obstructed by Tenant or used by it for storage,
for depositing items, or for any purpose other than for ingress to and egress from the Premises. Should Tenant have access to any
balcony or patio area, Tenant shall not place any furniture other personal property in such area without the prior written approval
of Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
Tenant nor any employee or contractor of Tenant shall go upon the roof of the Building without the prior written consent of Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall, at its expense, be required to utilize the third party contractor designated by Landlord for the Building to provide any
telephone wiring services from the minimum point of entry of the telephone cable in the Building to the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
antenna or satellite dish shall be installed by Tenant without the prior written agreement of Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
sashes, sash doors, windows, glass lights, solar film and/or screen, and any lights or skylights that reflect or admit light into
the halls or other places of the Building shall not be covered or obstructed. If Landlord, by a notice in writing to Tenant, shall
object to any curtain, blind, tinting, shade or screen attached to, or hung in, or used in connection with, any window or door
of the Premises, the use of that curtain, blind, tinting, shade or screen shall be immediately discontinued and removed by Tenant.
Interior of the Premises visible from the exterior must be maintained in a visually professional manner and consistent with a first
class office building. Tenant shall not place any unsightly items (as determined by Landlord in its reasonable discretion) along
the exterior glass line of the Premises including, but not limited to, boxes, and electrical and data cords. No awnings shall be
permitted on any part of the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
installation and location of any unusually heavy equipment in the Premises, including without limitation file storage units, safes
and electronic data processing equipment, shall require the prior written approval of Landlord. The moving of large or heavy objects
shall occur only between those hours as may be designated by, and only upon previous notice to, Landlord. No freight, furniture
or bulky matter of any description shall be received into or moved out of the lobby of the Building or carried in any elevator
other than the freight elevator (if available) designated by Landlord unless approved in writing by Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
pipes or tubing used by Tenant to transmit water to an appliance or device in the Premises must be made of copper or stainless
steel, and in no event shall plastic tubing be used for that purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not place any lock(s) on any door in the Premises or Building without Landlord&rsquo;s prior written consent, which consent
shall not be unreasonably withheld. Upon the termination of its tenancy, Tenant shall deliver to Landlord all the keys to offices,
rooms and toilet rooms and all access cards which shall have been furnished to Tenant or which Tenant shall have had made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not install equipment requiring electrical or air conditioning service in excess of that to be provided by Landlord under
the Lease without prior written approval from Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">E-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not use space heaters within the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not do or permit anything to be done in the Premises, or bring or keep anything in the Premises, which shall in any way increase
the insurance on the Building, or on the property kept in the Building, or interfere with the rights of other tenants, or conflict
with any government rule or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not use or keep any foul or noxious gas or substance in the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not permit the Premises to be occupied or used in a manner offensive or objectionable to Landlord or other occupants of the
Building by reason of noise, odors and/or vibrations, or interfere in any way with other tenants or those having business with
other tenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not permit any pets or animals in or about the Building. Bona fide service animals are permitted provided such service animals
are pre-approved by Landlord, remain under the direct control of the individual they serve at all times, and do not disturb or
threaten others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
Tenant nor its employees, agents, contractors, invitees or licensees shall bring any firearm, whether loaded or unloaded, into
the Project at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Smoking
tobacco, including via personal vaporizers or other electronic cigarettes, anywhere within the Premises, Building or Project is
strictly prohibited except that smoking tobacco may be permitted outside the Building and within the Project only in areas designated
by Landlord. Smoking, vaping, distributing, growing or manufacturing marijuana or any marijuana derivative anywhere within the
Premises, Building or Project is strictly prohibited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not install an aquarium of any size in the Premises unless otherwise approved by Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not utilize any name selected by Landlord from time to time for the Building and/or the Project as any part of Tenant&rsquo;s
corporate or trade name. Landlord shall have the right to change the name, number or designation of the Building or Project without
liability to Tenant. Tenant shall not use any picture of the Building in its advertising, stationery or in any other manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall, upon request by Landlord, supply Landlord with the names and telephone numbers of personnel designated by Tenant to be contacted
on an after-hours basis should circumstances warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
may from time to time grant tenants individual and temporary variances from these Rules, provided that any variance does not have
a material adverse effect on the use and enjoyment of the Premises by Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fitness
Center Rules</U>. Tenant shall cause its employees (whether members or prospective members of the Fitness Center) to comply with
the following Fitness Center rules and regulations (subject to change from time to time as Landlord may solely determine):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Membership
in the Fitness Center is open to the tenants of Landlord or its affiliates only. No guests will be permitted to use the Fitness
Center without the prior written approval of Landlord or Landlord&rsquo;s representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fitness
Center users are not allowed to be in the Fitness Center other than the hours designated by Landlord from time to time. Landlord
shall have the right to alter the hours of use of the Fitness Center, at Landlord&rsquo;s sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
Fitness Center users must execute Landlord&rsquo;s Waiver of Liability prior to use of the Fitness Center and agree to all terms
and conditions outlined therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Individual
membership and guest keycards to the Fitness Center shall not be shared and shall only be used by the individual to whom such keycard
was issued. Failure to abide by this rule may result in immediate termination of such Fitness Center user&rsquo;s right to use
the Fitness Center.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
Fitness Center users and approved guests must have a pre-authorized keycard to enter the Fitness Center. A pre-authorized keycard
shall not be issued to a prospective Fitness Center user until receipt by Landlord of Landlord&rsquo;s initial fee, if any, for
use of the Fitness Center by such Fitness Center user(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Use
of the Fitness Center is a privilege and not a right. Failure to follow gym rules or to act inappropriately while using the facilities
shall result in termination of Tenant&rsquo;s Fitness Center privileges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;F</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PARKING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following parking
regulations shall be in effect at the Building In the case of any conflict between these regulations and the Lease, the Lease shall
be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
agrees to maintain, or cause to be maintained, an automobile parking area (&ldquo;<B>Parking Area</B>&rdquo;) in reasonable proximity
to the Building for the benefit and use of the visitors and patrons and, except as otherwise provided, employees of Tenant, and
other tenants and occupants of the Building. Landlord shall have the right to determine the nature and extent of the automobile
Parking Area, and of making such changes to the Parking Area from time to time which in its opinion are desirable. Landlord shall
not be liable for any damage to motor vehicles of visitors or employees, for any loss of property from within those motor vehicles,
or for any injury to Tenant, its visitors or employees, unless ultimately determined to be caused by the sole active negligence
or willful misconduct of Landlord. Landlord shall also have the right to establish, and from time to time amend, and to enforce
against all users of the Parking Area all reasonable rules and regulations (including the designation of areas for employee parking)
as Landlord may deem necessary and advisable for the proper and efficient operation and maintenance of the Parking Area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
may, if it deems advisable in its sole discretion, charge for parking and may establish for the Parking Area a system or systems
of permit parking for Tenant, its employees and its visitors. In no event shall Tenant or its employees park in reserved stalls
leased to other tenants or in stalls within designated visitor parking zones, nor shall Tenant or its employees utilize more than
the number of Parking Passes (defined below) allotted in this Lease to Tenant. Tenant shall, upon request of Landlord from time
to time, furnish Landlord with a list of its employees&rsquo; names and of Tenant&rsquo;s and its employees&rsquo; vehicle license
numbers. Parking access devices, if applicable, shall not be transferable. Landlord may impose a reasonable fee for access devices
and a replacement charge for devices which are lost or stolen. Each access device shall be returned to Landlord promptly following
the Expiration Date or sooner termination of this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Washing,
waxing, cleaning or servicing of vehicles, or the parking of any vehicle on an overnight basis, in the Parking Area (other than
emergency services) by any parker or his or her agents or employees is prohibited unless otherwise authorized by Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is understood that the employees of Tenant and the other tenants of Landlord within the Building and Project shall not be permitted
to park their automobiles in the portions of the Parking Area which may from time to time be designated for patrons of the Building
and/or Project. Tenant may purchase from Landlord for the Term of this Lease, all or a portion of the total number of parking passes
set forth in Item 11 of the Basic Lease Provisions (the &ldquo;<B>Parking Passes</B>&rdquo;) for unreserved parking. During the
initial 60 month Lease Term only, the monthly charge for the Parking Passes shall be $55.00 per Parking Pass per month. Thereafter,
the parking charges shall be at Landlord&rsquo;s scheduled parking rates from time to time. Should any monthly parking charge not
be paid within 5 days following the date due, then a late charge shall be payable by Tenant equal to the greater of (i)&nbsp;5%
of the delinquent installment or (ii)&nbsp;$100.00, which late charge shall be separate and in addition to any late charge that
may be assessed pursuant to Section&nbsp;14.3 of the Lease for other than delinquent monthly parking charges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Landlord
shall be entitled to pass on to Tenant its proportionate share of any charges or parking surcharge or transportation management
costs levied by any governmental agency and Tenant shall cooperate in any voluntary or mandated transportation management programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant
shall not assign or sublet any of the Parking Passes, either voluntarily or by operation of law, without the prior written consent
of Landlord, except in connection with an authorized assignment of this Lease or subletting of the Premises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;G</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADDITIONAL PROVISIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>FITNESS
CENTER</B>. Subject to the provisions of this Section, so long as Tenant is not in Default under this Lease, and provided Tenant&rsquo;s
employees execute Landlord&rsquo;s standard waiver of liability form and pay the applicable one time or monthly fee, if any, then
Tenant&rsquo;s employees (the &ldquo;<B>Fitness Center Users</B>&rdquo;) shall be entitled to use the fitness center and the shower
facility located at the Project (collectively, the &ldquo;<B>Fitness Center</B>&rdquo;). No separate charges shall be assessed
to Fitness Center Users for the use of the Fitness Center (with the exception of towel/laundry fees, if any) during the initial
Term of this Lease, provided, however, that the costs of operating, maintaining and repairing the Fitness Center shall be included
as part of Operating Expenses. The use of the Fitness Center shall be subject to the reasonable rules and regulations (including
rules regarding hours of use) established from time to time by Landlord. Landlord and Tenant acknowledge that the use of the Fitness
Center by the Fitness Center Users shall be at their own risk and that the terms and provisions of Section&nbsp;10.2 of this Lease
shall apply to Tenant and the Fitness Center User&rsquo;s use of the Fitness Center. Tenant acknowledges that the provisions of
this Section shall not be deemed to be a representation by Landlord that Landlord shall continuously maintain the Fitness Center
(or any other fitness facility) throughout the Term of this Lease, and Landlord shall have the right, at Landlord&rsquo;s sole
discretion, to expand, contract, eliminate or otherwise modify the Fitness Center. No expansion, contraction, elimination or modification
of the Fitness Center, and no termination of Tenant&rsquo;s or the Fitness Center Users&rsquo; rights to the Fitness Center shall
entitle Tenant to an abatement or reduction in Basic Rent constitute a constructive eviction, or result in an event of default
by Landlord under this Lease. Landlord reserves the right to reasonably limit, restrain, or condition the use of the Fitness Center
by tenants of the Building (including Tenant&rsquo;s Fitness Center Users) if Landlord reasonably determines that their use of
the Fitness Center has a disproportionate and/or inequitable impact on the ability of other tenants to use the Fitness Center.
Tenant hereby voluntarily releases, discharges, waives and relinquishes any and all actions or causes of action for personal injury
or property damage occurring to Tenant or its employees or agents arising as a result of the use of the Fitness Center, or any
activities incidental thereto, wherever or however the same may occur, and further agrees that Tenant will not prosecute any claim
for personal injury or property damage against Landlord or any of its officers, agents, servants or employees for any said causes
of action. It is the intention of Tenant with respect to the Fitness Center to exempt and relieve Landlord from liability for personal
injury or property damage caused by negligence. Tenant&rsquo;s right to use the Fitness Center shall belong solely to Tenant and
may not be transferred or assigned without Landlord&rsquo;s prior written consent, which may be withheld by Landlord in Landlord&rsquo;s
sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>CONFERENCE
CENTER</B>. Landlord currently provides a conference center (the &ldquo;<B>Conference Center</B>&rdquo;) in the Project capable
of accommodating groups of people for use by Project tenants (including Tenant) on a reserved basis. Tenant shall, subject to availability,
have the use of the Conference Center subject to Landlord&rsquo;s procedures and charges, if any. The use of the Conference Center
shall be subject to the reasonable rules and regulations (including rules regarding hours of use and priorities for the tenants
of the particular building in which a Conference Center is located, set up and clean up charges, etc.) established from time to
time by Landlord for the Conference Center. Landlord and Tenant acknowledge that the terms and provisions of Section&nbsp;10.2
of this Lease shall apply to Tenant&rsquo;s use of the Conference Center. Further, Landlord shall have no liability whatsoever
with respect to the existence, condition or availability of any Conference Center nor shall Landlord have any obligation whatsoever
to enforce or make reservations thereof, and Tenant hereby expressly waives all claims against Landlord with respect to the same.
No expansion, contraction, elimination, unavailability or modification of the Conference Center, and no termination of or interference
with Tenant&rsquo;s rights to the Conference Center, shall entitle Tenant to an abatement or reduction in rent or constitute a
constructive eviction or an event of default by Landlord under this Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>MOVING
ALLOWANCE</B>. In consideration of the execution of this Lease by Tenant, Landlord shall reimburse Tenant the actual out-of-pocket
expenses incurred by Tenant in connection with Tenant&rsquo;s move to the Premises, which expenses shall include furniture, fixtures
and equipment, and telecommunications and cabling costs (&ldquo;<B>Moving Allowance</B>&rdquo;). Tenant agrees that all such expenses
shall be supported by paid invoices, and the total thereof shall not to exceed $65,000.00. The reimbursement shall be paid by Landlord
within 30 days following receipt of those invoices, but in no event sooner than the Commencement Date of the Lease. Tenant agrees
that any portion of the Moving Allowance not utilized by Tenant, as evidenced in third party invoices submitted to Landlord within
60 days of the Commencement Date, shall inure to the benefit of Landlord and Tenant shall not be entitled to any credit or payment
for such savings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">G-<!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>acacia_ex2101.htm
<DESCRIPTION>SUBSIDIARIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUBSIDIARIES OF THE REGISTRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 20pt 0pt 0; text-align: right"><B>EXHIBIT 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUBSIDIARIES OF THE REGISTRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following is a listing of the significant
subsidiaries of Acacia Research Corporation:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 56%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jurisdiction of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Incorporation</U></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acacia Global Acquisition LLC and subsidiaries</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acacia Research Group, LLC, formerly Acacia Patent Acquisition, LLC and subsidiaries</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia Global Acquisition LLC and Acacia
Research Group, LLC, wholly own multiple consolidated operating subsidiaries, that are included in Acacia Research Corporation's
consolidated financial statements included elsewhere herein, each of which are separate and distinct legal entities, and all of
which are in the patent acquisition, development, licensing and enforcement business.&nbsp;&nbsp;All of the operating subsidiaries
wholly owned by Acacia Global Acquisition LLC and Acacia Research Group, LLC operate in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>acacia_ex2301.htm
<DESCRIPTION>CONSENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>EXHIBIT 23.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have issued our reports dated March&nbsp;16,
2020, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual
Report of Acacia Research Corporation on Form 10-K for the year ended December&nbsp;31, 2019. We hereby consent to the incorporation
by reference of said reports in the Registration Statements of Acacia Research Corporation on Forms S-8 (File No. 333-189135 and
File No. 333-217878).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ GRANT THORNTON LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newport Beach, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March&nbsp;16, 2020</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>acacia_ex3101.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>EXHIBIT 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Clifford Press, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. I have reviewed
this  Annual Report on Form 10-K of Acacia Research Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2. Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3. Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">4. The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(c). Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(d). Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5. The registrant&rsquo;s other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: March 16, 2020</FONT></TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/
        Clifford Press&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Clifford Press</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Chief Executive Officer</I></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>acacia_ex3102.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL
OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Li Yu, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. I have reviewed
this Annual  Report on Form 10-K of Acacia Research Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2. Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3. Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">4. The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(c). Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(d). Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5. The registrant&rsquo;s other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: March 16, 2020</FONT></TD>
    <TD STYLE="text-align: center; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Li Yu&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Li Yu</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Corporate Controller</I></B></P></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>acacia_ex3201.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER AND PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Annual Report of
Acacia Research Corporation (the &ldquo;Company&rdquo;) on Form 10-K for the fiscal year December 31, 2019, as filed with the
Securities and Exchange Commission on March 16, 2020 (the &ldquo;Report&rdquo;), I, Clifford Press, Chief Executive Officer of
the Company, hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C.
Section 1350, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. The information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: March 16, 2020</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By: <U>/s/ Clifford Press&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clifford Press</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification accompanies the Report
pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not
be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability
of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act
of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>acacia_ex3202.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER AND PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Annual Report
of Acacia Research Corporation (the &ldquo;Company&rdquo;) on Form 10-K for the fiscal year December 31, 2019, as filed with
the Securities and Exchange Commission on March 16, 2020 (the &ldquo;Report&rdquo;), I, Li Yu, Corporate Controller of the Company, hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934
and 18 U.S.C. Section 1350, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. The information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: March 16, 2020</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By: <U>/s/ Li
    Yu&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Li Yu</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate Controller</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification accompanies the Report
pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not
be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability
of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act
of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" ![ 1$# 2(  A$! Q$!_\0
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M6TH4>47.(@CE_P#(WY>J?\/C6T4*7'GPV9<)]N1%?0'&G6E!25I(R""-B#4
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MRH>#G*0@_P"(BN<VK/QJO/ZZ]_.:Z"<=F')'![5J&4E2A <60/R4^\3\@":
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MZQ<AM9&Z2%#="]OJG<8VR-Z Z+4K2K1W:@U79XC4:^P8=\0V  \M18>4/SE
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M,!YUTR5H]4Y"4Y^((]*BK36F=8<6M4O+BIDW*:ZL&5/DJ/=M#S6L[  =$C?
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AUWSAE)[7(_[SGWTJ]?1T7_M?YC_S2JWFPZ%S\O5ZG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" -$ ;@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY0<\9!YZUI#Q!XA/?2O^_<G^-1=%W1VE)FN2@U_5.1=M:@Y^4P(P_/<:AO\
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MZ51WP$7_ 'F=311172>8%8OAK_5:E_V$9_\ T*MJL7PU_JM2_P"PC/\ ^A4
M;5)2TE !FDW>U9VLW=U:01O:ID%\2.$+F-<==HY/.*JV>L33F=2\$HBM?.#Q
M @$Y8<@].G2E=%J#:NC;W>U*#FN:.MWL^CW=U"88Y+8*V"I(8%%;'YFIK:_O
MY=7FLWGC!AV9(MV(;*Y/S=!1S#=*2O?I_7ZG044@I:9F5[];EK&<6+HET8SY
M32#*AL<9]LUS^@Z[HMAI<<$U_'!<@DW$=S(!*)2?GW>^<_I745SFM6'ANS:6
M[U"TMWN96SL S+,_8!1R2: +O_"5:'_T%;/_ +^BC_A*=#_Z"MG_ -_13/#>
MD_V?HL45Q!&DKLTC1CD1[B3M'TSC\*U?(B_YY)_WR* .9UG6-/U>?2[*RU-6
M,UX!(MM/M<IL<]1SC(%4M?\ #EIJ4J:%!/?223@/<%[IV6&('J03C)(P!]3V
MK8\307,<5C<Z=IYNY;:Z$IBC*JQ&QQU..Y%<I%JWB?P[8W5[=:;:;Y7\VXGE
M5\ECP <'@#@"@#T.SM(K&R@M8 1#!&L: G.% P*GJEH]Z^I:-97DB!'N($E*
MKT!(!P*NT %%%% !3)F"Q.S< *233Z@O?^/&X_ZYM_*@#E?#'C+04\-V,9U*
M+='$%8!6.".HZ5)?Z[IVL:QHD6GW(GD2\WLJHW"^6XR>/<5!\* !X*CQ_P ]
M3_Z"M=G0 5%=6T=Y:RV\ZAXI5*.I[@C!J:B@#EKFYU+0-/-O>0B]LP!$ETC@
M2*#P-ZGJ1ZBLWRR>">!ZUU&OP)/ICI)]W<I_6N98;6)SG=T':B:7*GUU_0R;
M?,T3V*XU"W)! $@ ].M=E7'67S7UN>2/,'X5V-3'8N.P4445104444 %%%%
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MO;70E,40RQ&QQ_,BN2MO$/B#0;2YO;[05\V9O,N+B61U!/15^Z< < #_ !H
M]#LK2.PLH;6 $0P(L: G)"@8'-3U3TF].I:19WK((S<0I*4!SMW#.,U<H **
M** "D9@JEF(  R2:6H+W_CQN/^N;?RH Y2S\1:1KFK'49M1M_L5HY2TCW_><
M<-*1^B^V3WK3T*ZAO=>UJ>UD66$F$!UZ$A#FLCX51(W@N(E%/[P]A_=6NT5
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M *YM_*IZBND,EK,B\LR$#ZXH Y#X4_\ (E1?]=#_ .@K79UY1ILOB_P9X?\
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M'>8;4C+&SL3Q(N?EV^PZ?6I-:LM=UJ&*&6Q@B$<@?*R@YK-UR.^>ZE@O;XW
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M_L(2?R6M@UCZ#;RP7.HF1B5DG+*,YQ51A=-WV(<K22[FU1114EB8%<Y\0/\
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M^4>] (ISK*DVIB>(1L&AP-FS*[N#C)ZBO1#UK@X;.$>#/[0VM]IN)D\QBV>
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MQ-(,,20>?RKJZY721_Q,X>F02/TKJJF.Q<=@HHHIE!1110 4444 <?\ %/\
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M=;P(E[=O TI_<LP" @%N@]Q77UC>)?\ 46O_ %T;_P!!-;- !1110!C>+?\
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M"% %_P +_P#(JZ3_ -><7_H K5K*\+_\BKI/_7G%_P"@"M6@ HHHH *@O?\
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M='>/:K@8SC//?TJ[0!4N-*L;N8RW%K%+(1C<PYQ47]@Z7_SX0?\ ?-:%% %
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M_P"A"F2VY;E_PO\ \BII/_7G%_Z *U:RO"__ "*ND_\ 7G%_Z *U:!!1110
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M<Y_2MC3-2CU2!Y8XY(]CF,K(,'(ZUSCA'.BRH%^?4)"& Y(W'%:WAS_57_\
MU^2_SH!EGQ!_R+VH?]<&KU'0_P#D :=_U[1_^@BO+O$'_(O:A_UP:O4=#_Y
M&G?]>T?_ *"*3+@7Z***184444 %%%% #36'%K4.F7DUOJ,<]LKS'R[B2/\
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M"L;3Y8[W6+NZM&#VYB1"X'#N">GT!K9'04UL93O?49/_ *B3_=/\J\<\+_\
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MBJ&N:S%IFBW=W%+$TD49* L,9Z#/MFF_\(GH7_0)M/\ OT*/^$3T+_H$V?\
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M]B7*S2[FQ1114E#9(TE7;(BNOHPR*YCQ[:P1^#KYHX(E8;,%4 /WA74US?Q
M_P"1+OO^ ?\ H0H O^%O^14TG_KSB_\ 016K65X7_P"14TG_ *\XO_0!6K0
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M2_\ "%:$79Y+(RR-C+RS.[''3DF@#=JCKFH?V5HMW>C!,,98 ],]L^V:H_\
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MNV*6DS*2&6-B".QQ0!BWY;Q!J;:9'G[!;,#>N#Q(W40CV[M^7>IM*&WQ+K0
M  \@ #_<-<S\-=-6^\))-<W-Z\C3,21<N,D@,>A]2:Z1_"&DRSO-+%.\KX#.
MUS)DXZ?Q4 ;E4=:U :5H]U>[0QAC+!3W/;]<51_X0[1_^>$W_@3)_P#%4U_!
M>B2(4DM9'4]5:XD(/_CU %;2[;1E:*>]O;.^U1R"TTDJN=_H@S\H!Z 5T]<=
MJG@S0-*LOMMKIZQS02Q2*X9B5PZY.,^F:Z:SU*TU&-WLITF$;;'V_P )ZX(_
M&@"W17GUW\6K&TO)X&TZ\8Q2-&6#+@D''K47_"Y-._Z!EY_WTG^-9NK!=3L6
M7XEJZ@ST6O'_ !;_ ,E=MO\ KO;?^RUM_P#"X]//_,,O/^^D_P :XZ_\0P:W
MX^M-66-X(3/#E9.2 N,]/I652<9V47U.[ X6M1E.52-ERL]U]:=6;#K=C<1F
M2*8LN<9VG_"KEK=0WENDUM*LL3=&4\&NMQ<=T>'&49;,FHK(7Q3HTN[RM0A<
M*Q4E,L 1U' H?Q/I28_TL'/HC?X4DFW9(;:2NS7HJ@NL6<D8=925/0[35FVN
M8KJ$2P2+(A) 93D<'!_44.+6Z$I*6S)J*RE\3Z.Y<)?Q.48HVW)PPZC@4V3Q
M/I28_P!+!SZ(Q_I0DV[)#<E%79KUG:XMU)IDJ6*L;ABH&Q@IQN&<$].,TY-7
MM'C5UE)5NAVFE<0:O9!H;AO+8Y66)L$$'^A%$HM;H<)QNFC&W7G]G7MC;QW*
MWX",%DN0YVD\E7[=#2"ZGM+:6T_TB"[:2-0TLWG85VV[E/Y\>M-BO=#ECG']
MLM/,S!6N%8[E*G@# P,'M2&ZT013"YU&6XDG 4RL#N&#D8P.,'FI49-V1LZL
M$O>V_P"&-.P\RTU::R:>:>+R5F1I3EE))!&?PK7SS6'ITUC 'N?M<US)+A3+
M*.<#H.G3FM6WN8KN$2V\BNA)&1Z@X(I\LH[HRE.,G[K.7U^Y_P!/F.3A<*,^
MM5M/6.U)\Y1([<GV/>L^_O;6[U*9DO Q61D?",V"#TZ=:L)J-HN 9"1CCY&'
M]*X_8RKU'&47V5O^ .<XPIKE>^K-5KJU"@_9LC/?'%1R3P21E8H=AQPU0(//
M02H<IGJ13[6W>Y!:&)Y4#E2RC.".H_"G]0C!W?-][_S,54YMBG;C;)+&V<*^
M1QV/-=\OW!]*\W-S:IJ4@-UDPR%7C"LVQAV.!79'Q-I4:@F\![8"-_A6F&C.
MSBUUT.BLX7YD^FIL45GQ:S9S1^8DI*>NTU8M+VWOHV>VE6158HQ7LPZ@^]=#
MBUNC%24MBQ166WB72$N)8#?Q&6%MLBKDE#Z'%-?Q-I2@G[8N!Z*W^%))O1#;
MMJS6HK.AUJSG3S(Y24]=IJS:7UO>K(;>59/+;8^.JMUP??FFXN.Z$IQELRQ1
M69)XCTF*ZEMGOHO/A.)(QDE#[XZ4Q_$VEJ"?M:D#T5O\*25]$-NVK-:BLZ'7
M+*XCWQS$J.^TBK-K?6U[Y@MYED,9VN!U4XS@_A3<91W0HSC+9EBBLR7Q'I,-
MW+:R7T0N(O\ 61@DLGU Z4Q_$VE*,_;%Q[*W^%"3>B&W;5FM16=!K=E<1EXI
MMRCOM(_I5BUO[>\:18)5=H\;U'5<\C(IN,H[JPE.,MF6:XK4I/&XU6Z^PQ1&
MS$G[@CR^4P.N3GUKH[CQ#I5K>26DU]$MS& 7BSEE!Z9 K/\ [3U+7/.BTB%;
M:V#F(WTQR3ZF-._7J<#ZU)10\+/KHT<B*&Q($\N[S9&!W;SNP%!&,YZ5L^9X
MA_YX:7_W^D_^)J_I]C%IMA#:6X(CB7:,G)/J3[GK5B@#@8&NC\1HOMR0+-YP
MXA8LN/L[^H%=]7$R_P#)38_^NJ_^D[UV] "4M%% !1110 5!>_\ 'C<?]<V_
ME4]07O\ QXW'_7-OY4 <E\*/^1*B_P"NA_\ 05KM*XOX4?\ (E1?]=#_ .@K
M7:4 %%%% "$5A7B76D:Q+J%O;R75I=*HN8HAEXV48#J/XAC@@<\"MZD- 'B7
MA*QM-:^(5Q#>VXFMY&G?RY%([\9'8UZA_P (/X<_Z!%M_P!\G_&O.O O_)4K
MK_>N/YFO8ZYZ,4T[KJ>MF56<*D5&37NKJ8'_  @_AW_H$6WY&G1>"] @F26+
M2K9)(V#*P4Y!'0UNT5MRQ['GO$57O)_>R,1*.P_*L&*67PS<3PS6TTNF2R-+
M%- A<P%CEE=1SC.2" >M=%28%48G'?#)'3P[=+(K(WVZ4[6!!&<'H>E=@R!O
MO 'ZBLCP]_KM8_["#_\ H*ULT ,V#& !^58"23>&[RX66WGGTR>4S)+"A=H&
M;EE91SMSR",]3714F* .4^'F?[(OB59=U](P#*5."%(X//0UU3('^\ ?J*S=
M('^F:O\ ]?G_ +2CK4H 9L4#@#CVK BDE\-7$\<MO/-IDTK31RPH7,!8Y964
M<XSD@@'KS714F* ./^&R,N@W8960F\D;#*0<'!'!]JZ\H&^\ ?J*RM#_ ./K
M5_\ K]/_ * M:] #/+4#[H_*L!7F\.WUR6MII]-N93,)(4+M Y^\&4<E2><C
M.,FNBI,"@+'+^!,MI^HMAE#W\C ,I4X*J0<'GI73E PPP!'N*S]*_P"/[5O^
MOL?^BHZTJ &A%'\(_*L!VG\/ZC<R_9IKC3;I_-8P*7>"3HWRCDJ<9XZ'-=#2
M8H Y/P,XEGUR10P22^9UW*5)4\@X/-=6R!N#R/0UD:/_ ,AS7/\ KO'_ .BU
MK9H 8(U'\*_E6'-]IT+5;BY2VEN=.NR))!"NYX) ,%MO4J0!TY!%;])0!QG@
M)Q)JOB*55<)+=!TWH5)4[L'!YKLF7=P>1Z&L;3/^1KUO_<M__06K;H 9Y:^@
M_*L2Y2XT75Y[Z&WDN;*Z"F>.$9>)U&-X7^($8R!SQ6]10!Q7@V47'BSQ).BR
M".:2-TWHR$C!YP0#ZUV;+NX/3TK$L?\ D<]6_P"O>W_]GK=H 9Y:_P!T8^E8
MEY'<Z-J\NHVUL]S:7*J+F*$9D1EX#J/XN."!SP*WJ3% '$>$9A<^.?$-PB2+
M%,(V3S(V0D=.A /4&NV90PP>GI6/#_R.MU_UXQ?^AO6U0 P1J.P_*L:^AN-*
MU5M4M+=[F":-8[J&(?/\N=KJ.^ 2"/3I6Y24 <-X<G%W\2]9NHTE6*6U389(
MV0G&T'A@#P:[FL0_\CV/^P:?_1E;E !2&EHH \^U>>YL/BMIW[I'M[IE._?A
ME)C=.GX9KT&N"\3_ /)2=!_WH_\ VI7>T %)2T4 %%%% !4%[_QXW'_7-OY5
M/4<T8EA>,G =2I(]Z ./^%/_ ")47_70_P#H*UVE>>Q?"=(HD1-;N JJ%'[E
M1P!@9Q[4[_A58_Z#ES_WZ'^- 'H%)7 ?\*K'_0<N?^_0_P :/^%5C_H-W/\
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M[ZZLR!<1QYC) .&Z#K6'X>U.Y\1VB2VWB"ZBE*!V@EM(@ZCUZ<CW% &SH_\
MR'-<_P"N\?\ Z+6MFN;\/Q7%IXCUJWN+MKHD02[V15.2I'0#'11724 %%9?B
M6_GTSPY?WEJ0)X82T9(R-W:N?\.ZK<^([96A\07,-QMRT$MK$&ZX)''S#(ZB
M@#9TW_D:];_W;?\ ]!:MNN9T2&YL_%^JP7-XUT9+:"4NT:H<Y=<87CH*Z:@
MHJCK=U+8Z)>W,&/-BA=TR.X'%<KX9UFZ\26D;)KUU;W++DPRVD(+8."5.,,,
MCM0!N6'_ ".>K?\ 7O;_ /L];E<YI5G<67BR\%S>O=O/:1N6:-4QAF &%'O7
M1T %%5=3GDMM*NYX<>9%"[IGID*2*X_PQK5YXBMU4Z]<6]X 0T,EK$-Q'#%#
MCYAF@#H(?^1UNO\ KQB_]#>MJN9L+>ZL_&I6YOWNS/89):)4QMD&,;1_M&NF
MH **AO)6@LIY4^\D;,/J!7$>%M>O?$5M&)==N+6\.5,3VL6UV'WMAQ\P'YT
M="?^1['_ &#3_P"C*W*YFSM+JT\:H;J_>\+V# %HE3:!(O\ ='O734 %%%%
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M* .'O#XNTK7!+:V,&JQ?9A$+C(1FPQ(W+N SSU'!]J?_ &]XU_Z%N+_OXO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ()T-%%%=!XX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5\\^,/\ D<-6_P"OI_YU]#5\\^,/^1PU;_KZ?^=<
MN*^%'NY#_%EZ?J8U%%%<1]0?0_A+_D4=)_Z](_\ T$5L5C^$O^11TG_KTC_]
M!%;%>K'X4?G]?^++U844451D%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?//C#_D<-6_Z^G_ )U]#5\\^,/^
M1PU;_KZ?^=<N*^%'NY#_ !9>GZF-1117$?4'T/X2_P"11TG_ *](_P#T$5L5
MC^$O^11TG_KTC_\ 016Q7JQ^%'Y_7_BR]6%%%%49!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>14
<FILENAME>actg-20191231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: acacia_10k%2D2019.xfr; Date: 2020%2D03%2D16T20:32:32Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:ACTG="http://acaciaresearch.com/20191231">
    <link:schemaRef xlink:href="actg-20191231.xsd" xlink:type="simple" />
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_ComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_ComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_ComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TradingSecuritesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TradingSecuritesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TradingSecuritesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TradingSecuritesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_VeritoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_VeritoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_VeritoneMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_VeritoneMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-06-30_custom_MisoRoboticsMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ACTG:MisoRoboticsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_MisoRoboticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ACTG:MisoRoboticsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-02-28_custom_MisoRoboticsMember_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ACTG:MisoRoboticsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MisoRoboticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ACTG:MisoRoboticsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_MisoRoboticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ACTG:MisoRoboticsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-05-01to2018-05-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_StockCompensationExpenseGeneralMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:StockCompensationExpenseGeneralMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_StockCompensationExpenseGeneralMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:StockCompensationExpenseGeneralMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_StockCompensationExpenseProfitsInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:StockCompensationExpenseProfitsInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_StockCompensationExpenseProfitsInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:StockCompensationExpenseProfitsInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OtherSettlementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:OtherSettlementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_OtherSettlementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:OtherSettlementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-28_custom_StockRepurchaseProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ACTG:StockRepurchaseProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-05_custom_StockRepurchaseProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ACTG:StockRepurchaseProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-28_custom_MisoRoboticsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ACTG:MisoRoboticsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_RecurringRevenueAgreementsMember_us-gaap_SalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:SalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_RecurringRevenueAgreementsMember_us-gaap_SalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:SalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_MeasurementInputCommodityFuturePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCommodityFuturePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_DebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_DebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:TimeBasedServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:TimeBasedServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:TimeBasedServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:TimeBasedServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_AllAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:AllAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_AllAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:AllAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ProfitInterestUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:ProfitInterestUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_PerformanceBasedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:PerformanceBasedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_PerformanceBasedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:PerformanceBasedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_Plan2016Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ACTG:Plan2016Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AllPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ACTG:AllPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:NonVestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:NonVestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:NonVestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">ACTG:NonVestedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ProfitsInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:ProfitsInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_StateAndLocalJurisdictionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_custom_AccountingStandardsUpdate201901Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">ACTG:AccountingStandardsUpdate201901Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_SidusInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ACTG:SidusInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EmbeddedDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-11-18_custom_StarboardValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-11-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember516066125">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-11-18_custom_StarboardValueMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-11-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RedeemablePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_ScenarioAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-06-30_us-gaap_ScenarioAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-09-30_us-gaap_ScenarioAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_DriveShackMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">ACTG:DriveShackMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_VeritoneMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_VeritoneMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_StarboardValueMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>ACTG:Integer</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:DocumentType contextRef="From2019-01-01to2019-12-31">10-K</dei:DocumentType>
    <dei:AmendmentFlag contextRef="From2019-01-01to2019-12-31">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2019-01-01to2019-12-31">2019-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2019-01-01to2019-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityRegistrantName contextRef="From2019-01-01to2019-12-31">ACACIA RESEARCH CORP</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2019-01-01to2019-12-31">0000934549</dei:EntityCentralIndexKey>
    <dei:EntityCurrentReportingStatus contextRef="From2019-01-01to2019-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2019-01-01to2019-12-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2019-01-01to2019-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2019-01-01to2019-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2020-03-11" unitRef="Shares" decimals="INF">50385341</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityInteractiveDataCurrent contextRef="From2019-01-01to2019-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFileNumber contextRef="From2019-01-01to2019-12-31">1-37721</dei:EntityFileNumber>
    <dei:DocumentFiscalPeriodFocus contextRef="From2019-01-01to2019-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityIncorporationStateCountryCode contextRef="From2019-01-01to2019-12-31">DE</dei:EntityIncorporationStateCountryCode>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">50370987</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">49639319</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">50370987</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">49639319</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">93843000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">33642000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">17140000</us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">3012000</us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">511000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">32884000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">2912000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">3125000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">171765000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">201472000</us-gaap:AssetsCurrent>
    <us-gaap:Investments contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1500000</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">7459000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestments contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">8195000</us-gaap:EquityMethodInvestments>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">7814000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">6587000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">818000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">236000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">218161000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">223949000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">7265000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">4299000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ACTG:RoyaltiesAndContingentLegalFeesPayable contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">2178000</ACTG:RoyaltiesAndContingentLegalFeesPayable>
    <ACTG:RoyaltiesAndContingentLegalFeesPayable contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">22688000</ACTG:RoyaltiesAndContingentLegalFeesPayable>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">11715000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">31035000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">593000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">1674000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">35114000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">32709000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">50000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">50000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">39272000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">39272000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">652003000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">651156000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">-439656000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">-422541000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">173125000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">189393000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1833000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">1847000</us-gaap:MinorityInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">218161000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">223949000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">11246000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">1711000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">13725000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">131506000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_custom_PaidUpRevenueAgreementsMember" unitRef="USD" decimals="-3">6343000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_custom_PaidUpRevenueAgreementsMember" unitRef="USD" decimals="-3">100496000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_custom_RecurringRevenueAgreementsMember" unitRef="USD" decimals="-3">4903000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_custom_RecurringRevenueAgreementsMember" unitRef="USD" decimals="-3">13040000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_custom_OtherSettlementsMember" unitRef="USD" decimals="-3">3470000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_custom_OtherSettlementsMember" unitRef="USD" decimals="-3">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-12-31_custom_RecurringRevenueAgreementsMember_us-gaap_SalesMember" unitRef="USD" decimals="-3">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-12-31_custom_RecurringRevenueAgreementsMember_us-gaap_SalesMember" unitRef="USD" decimals="-3">14500000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">688000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">5460000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">3387000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">49203000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">6485000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">62093000</us-gaap:Revenues>
    <us-gaap:LossOnSaleOfInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">9230000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">19095000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments contextRef="From2019-01-01to2019-12-31_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">9230000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments contextRef="From2018-01-01to2018-12-31_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">19095000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">8195000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">1000000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments contextRef="From2019-01-01to2019-12-31_custom_MisoRoboticsMember" unitRef="USD" decimals="-3">8200000</us-gaap:ImpairmentOfInvestments>
    <ACTG:NumberOfPatentPortfoliosAcquired contextRef="From2019-01-01to2019-12-31" unitRef="Integer" decimals="INF">5</ACTG:NumberOfPatentPortfoliosAcquired>
    <ACTG:NumberOfPatentPortfoliosAcquired contextRef="From2018-01-01to2018-12-31" unitRef="Integer" decimals="INF">0</ACTG:NumberOfPatentPortfoliosAcquired>
    <us-gaap:ShortTermInvestments contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">111386000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">37032000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2019-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">93712000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2018-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">33643000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2019-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">17674000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2018-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">3389000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">354000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">45000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains contextRef="From2019-01-01to2019-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">143000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains contextRef="From2018-01-01to2018-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">18000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains contextRef="From2019-01-01to2019-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">211000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains contextRef="From2018-01-01to2018-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">27000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">757000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">423000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss contextRef="From2019-01-01to2019-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">12000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss contextRef="From2018-01-01to2018-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">19000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss contextRef="From2019-01-01to2019-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">745000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss contextRef="From2018-01-01to2018-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">404000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">11093000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">36654000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2019-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">93843000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2018-12-31_custom_TradingSecuritesDebtMember" unitRef="USD" decimals="-3">33642000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2019-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">17140000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2018-12-31_custom_TradingSecuritesEquityMember" unitRef="USD" decimals="-3">3012000</us-gaap:InvestmentOwnedAtFairValue>
    <dei:DocumentFiscalYearFocus contextRef="From2019-01-01to2019-12-31">2019</dei:DocumentFiscalYearFocus>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">322774000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">319580000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2019-01-01to2019-12-31">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InvestmentOwnedBalanceShares contextRef="AsOf2019-12-31_custom_VeritoneMember_custom_CommonStockInvestmentMember" unitRef="Shares" decimals="INF">298449</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:InvestmentOwnedBalanceShares contextRef="AsOf2018-12-31_custom_VeritoneMember_custom_CommonStockInvestmentMember" unitRef="Shares" decimals="INF">1419521</us-gaap:InvestmentOwnedBalanceShares>
    <ACTG:InvestmentWarrants contextRef="AsOf2019-12-31_custom_VeritoneMember_custom_WarrantInvestmentMember" unitRef="Shares" decimals="INF">1120432</ACTG:InvestmentWarrants>
    <ACTG:InvestmentWarrants contextRef="AsOf2018-12-31_custom_VeritoneMember_custom_WarrantInvestmentMember" unitRef="Shares" decimals="INF">1120432</ACTG:InvestmentWarrants>
    <ACTG:InvestmentSharesSold contextRef="From2018-01-01to2018-12-31_custom_VeritoneMember" unitRef="Shares" decimals="INF">2700000</ACTG:InvestmentSharesSold>
    <ACTG:InvestmentSharesSold contextRef="From2019-01-01to2019-12-31_custom_VeritoneMember" unitRef="Shares" decimals="INF">1121071</ACTG:InvestmentSharesSold>
    <us-gaap:GainLossOnSaleOfInvestments contextRef="From2018-01-01to2018-12-31_custom_VeritoneMember" unitRef="USD" decimals="-3">-19100000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments contextRef="From2019-01-01to2019-12-31_custom_VeritoneMember" unitRef="USD" decimals="-3">-9200000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="AsOf2019-12-31_custom_VeritoneMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">743000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="AsOf2019-12-31_custom_VeritoneMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">757000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="AsOf2018-12-31_custom_VeritoneMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">5395000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="AsOf2018-12-31_custom_VeritoneMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">2064000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="From2017-01-01to2017-06-30_custom_MisoRoboticsMember_us-gaap_SeriesAPreferredStockMember" unitRef="USD" decimals="-3">2250000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="From2018-01-01to2018-02-28_custom_MisoRoboticsMember_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="-3">6000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2017-06-30_custom_MisoRoboticsMember" unitRef="Percent" decimals="INF">.226</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-12-31_custom_MisoRoboticsMember" unitRef="Percent" decimals="INF">0.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2018-02-28_custom_MisoRoboticsMember" unitRef="Percent" decimals="INF">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">334000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">349000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">364000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">218000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2019-01-02_custom_AccountingStandardsUpdate201901Member" unitRef="USD" decimals="-3">2000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1264000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-01-02_custom_AccountingStandardsUpdate201901Member" unitRef="USD" decimals="-3">1800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:SettlementLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1756000</us-gaap:SettlementLiabilitiesCurrent>
    <us-gaap:TreasuryStockSharesAcquired contextRef="From2018-05-01to2018-05-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1190420</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare contextRef="From2018-05-01to2018-05-30_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">3.89</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchaseProgramExpirationDate contextRef="From2018-05-01to2018-05-30_us-gaap_CommonStockMember">2019-02-28</us-gaap:StockRepurchaseProgramExpirationDate>
    <ACTG:ApproximateValueOfSharesThatMayYetBePurchased contextRef="From2018-05-01to2018-05-30_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">15366000000</ACTG:ApproximateValueOfSharesThatMayYetBePurchased>
    <dei:EntityShellCompany contextRef="From2019-01-01to2019-12-31">false</dei:EntityShellCompany>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">57359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">128809000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RoyaltyExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">4944000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">776000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">1181000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">35168000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">192000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">2623000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">1353000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">11002000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">1241000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">21744000</us-gaap:RoyaltyExpense>
    <ACTG:ContingentLegalFees contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">591000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">35000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">2949000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">31501000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">4000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">375000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">177000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">11756000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">1037000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">15759000</ACTG:ContingentLegalFees>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">4000000</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">0</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">4000000</us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">7803000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">987000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">1549000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">8866000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">1160000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">1855000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">3801000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">1689000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">2639000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">2989000</ACTG:LitigationAndLicensingExpensesPatents>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">3194000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">863000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">4952000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">27120000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-01-01to2018-12-31_us-gaap_PatentsMember" unitRef="USD" decimals="-3">8307000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">857000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">818000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">656000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">11560000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">5278000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">5330000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">18288000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">2186000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">12833000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">109257000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">3794000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">5671000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">6637000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">36407000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">10195000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">49822000</us-gaap:CostOfRevenue>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-7042000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-475000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">892000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">22249000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">-3106000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-211000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-3250000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">12796000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-3710000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">12271000</ACTG:NetPortfolioIncomeLoss>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">16376000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">4630000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">5855000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">18728000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">15301000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">19045000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">4328000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">3763000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">3655000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">2754000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">6916000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">3301000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">28210000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">28210000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-23418000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-5105000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-4963000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-24689000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">-7434000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-3974000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-6905000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">10042000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-38836000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">8970000</us-gaap:OperatingIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">9899000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-59103000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="From2019-01-01to2019-12-31_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">-1308000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="From2018-01-01to2018-12-31_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">-11895000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="From2019-01-01to2019-12-31_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">11207000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="From2018-01-01to2018-12-31_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">-47208000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">2000000</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:GainLossOnSaleOfOtherInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:GainLossOnSaleOfOtherInvestments>
    <us-gaap:InterestAndOtherIncome contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">5473000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">218000</us-gaap:InterestAndOtherIncome>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">4465000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-2503000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-27595000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-78980000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">5921000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-1774000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">2821000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">-21012000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">10615000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">-40890000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-18953000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-7608000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-32558000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-103669000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">-1513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-5748000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-4084000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">-10970000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-28221000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">-31920000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-1824000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">306000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">1179000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">-2147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">9000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">314000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">397000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">285000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">191000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-17422000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-7608000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-33195000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-105029000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">327000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-5757000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-4384000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">-11369000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-28427000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">-32038000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">88000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-17129000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-104760000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-17115000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-104941000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:DepreciationAndAmortization contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">3227000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">27145000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">1075000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-317000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_StockCompensationExpenseGeneralMember" unitRef="USD" decimals="-3">1075000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31_custom_StockCompensationExpenseGeneralMember" unitRef="USD" decimals="-3">2133000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_StockCompensationExpenseProfitsInterestsMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31_custom_StockCompensationExpenseProfitsInterestsMember" unitRef="USD" decimals="-3">-2450000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">1672000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">28000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">907000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">460000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">-2450000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_PerformanceBasedMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_PerformanceBasedMember" unitRef="USD" decimals="-3">140000</us-gaap:ShareBasedCompensation>
    <us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">2241000</us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss>
    <us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">28210000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-436000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-32373000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">28189000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">220000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">208000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">109000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">963000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-20510000</ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
    <ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">19359000</ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-2308000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-65748</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">20877000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">-66026</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-58812</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-03-31_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-1958</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-04-01to2019-06-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-2268</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-07-01to2019-09-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-846</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">4420000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">6628000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">19097000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">75090000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">66640000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">183000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">34000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-68063000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">3721</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-24066000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">625</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">3288</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-03-31_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-53566</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-04-01to2019-06-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-63133</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-07-01to2019-09-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-61181</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">4634000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">229000</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">79000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">257000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">33921000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">79</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-4606000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">79</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-03-31_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-04-01to2019-06-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">79</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-07-01to2019-09-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">79</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <ACTG:TaxOnUnrealizedGainLossOnForeignCurrencyTranslation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</ACTG:TaxOnUnrealizedGainLossOnForeignCurrencyTranslation>
    <ACTG:TaxOnUnrealizedGainLossOnForeignCurrencyTranslation contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</ACTG:TaxOnUnrealizedGainLossOnForeignCurrencyTranslation>
    <us-gaap:PaymentsForProceedsFromLongtermInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-2000000</us-gaap:PaymentsForProceedsFromLongtermInvestments>
    <us-gaap:PaymentsForProceedsFromLongtermInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">7000000</us-gaap:PaymentsForProceedsFromLongtermInvestments>
    <us-gaap:GainLossOnInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">669000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-78198000</us-gaap:GainLossOnInvestments>
    <us-gaap:ProceedsFromSaleOfOtherInvestments contextRef="From2019-01-01to2019-12-31_custom_MisoRoboticsMember" unitRef="USD" decimals="-3">2000000</us-gaap:ProceedsFromSaleOfOtherInvestments>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="AsOf2018-02-28_custom_StockRepurchaseProgramMember" unitRef="USD" decimals="-3">20000000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="AsOf2019-08-05_custom_StockRepurchaseProgramMember" unitRef="USD" decimals="-3">10000000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">1756000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-475000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">2202000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2602000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">1581000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">0</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">650000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">400000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">0</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">0</us-gaap:OtherCostAndExpenseOperating>
    <dei:EntityPublicFloat contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">147673000</dei:EntityPublicFloat>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">35000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1765000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">3698000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">507000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">350000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">17974000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1264000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:PreferredStockRedemptionAmount contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">8089000</us-gaap:PreferredStockRedemptionAmount>
    <us-gaap:PreferredStockRedemptionAmount contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockRedemptionAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">174958000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">191240000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">51000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember" unitRef="USD" decimals="-3">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31_us-gaap_TreasuryStockMember" unitRef="USD" decimals="-3">-34640000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">652003000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">651156000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">648996000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_ComprehensiveIncomeMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_ComprehensiveIncomeMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31_us-gaap_ComprehensiveIncomeMember" unitRef="USD" decimals="-3">-88000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-439656000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-422541000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-320018000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="-3">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="-3">1847000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="-3">1358000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">295659000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember516066125" unitRef="USD" decimals="-3">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2017-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="USD" decimals="-3">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="USD" decimals="-3">8089000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-14000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">331000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="-3">-14000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">181000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2018-01-01to2018-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="-3">181000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-14000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">2000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-79000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">-73000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-17115000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-7608000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-33195000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-17115000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-105029000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-105029000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">634000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-5757000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-4384000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">-11369000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-28427000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">-32038000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">50370987</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">49639319</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">50639926</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2017-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">25136</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">82615</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">25000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">79000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">79000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">257000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">257000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">706532</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">166998</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">1075000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1075000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2133000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">2132000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">59800</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">229000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">229000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1190420</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">4634000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">2000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="From2018-01-01to2018-12-31_us-gaap_TreasuryStockMember" unitRef="USD" decimals="-3">4632000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">88000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2018-01-01to2018-12-31_us-gaap_ComprehensiveIncomeMember" unitRef="USD" decimals="-3">88000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-11-18_custom_StarboardValueMember" unitRef="Shares" decimals="INF">350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">307000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">307000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue contextRef="From2019-01-01to2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="USD" decimals="-3">-307000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">147178000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">102769000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">33842000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">92359000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">128809000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">136604000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Accounting Principles.&amp;#160;&amp;#160;&lt;/i&gt;The&#13;consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally&#13;accepted accounting principles in the United States of America (&amp;#34;U.S. GAAP&amp;#34;).&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Revenue Recognition.&amp;#160;&amp;#160;&lt;/i&gt;Revenue&#13;is recognized upon transfer of control of promised bundled IP rights (hereinafter &amp;#8220;IP Rights&amp;#8221;) and other contractual&#13;performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP&#13;Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which&#13;the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized&#13;at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have&#13;been met.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For the periods presented, revenue&#13;contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license&#13;fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia&#13;(&amp;#8220;Paid-up Revenue Agreements&amp;#8221;). Revenues also included license fees from sales-based revenue contracts, the&#13;majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on&#13;quarterly sales of applicable product units by licensees (&amp;#8220;Recurring Revenue Agreements&amp;#8221;). Revenues may also&#13;include court ordered settlements or awards related to our patent portfolio (&amp;#34;Other Settlements&amp;#34;) or sales of our&#13;patent portfolio (&amp;#34;Sales&amp;#34;). IP Rights granted included the following, as applicable: (i) the grant of a&#13;non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a&#13;covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending&#13;litigation.&amp;#160;The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related&#13;patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the&#13;promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and&#13;(ii) the Company's promise to transfer each individual IP right described above to the customer is not separately&#13;identifiable from other promises to transfer IP Rights in the contract.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Since the promised IP Rights are not individually&#13;distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted&#13;for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were &amp;#8220;functional&#13;IP rights&amp;#8221; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that&#13;functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&amp;#8217;s operating&#13;subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain&#13;or upgrade the technology, or provide future support or services.&amp;#160;&amp;#160;The contracts provide for the grant (i.e., transfer&#13;of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract.&amp;#160;Licensees&#13;legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is&#13;recognized upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have&#13;been met. Revenue contracts generally provide for payment of contractual amounts with 30-90 days of execution of the contract,&#13;or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees&#13;are generally non-refundable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For sales-based royalties, the Company&#13;includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is&#13;probable that a significant reversal in the amount of cumulative&amp;#160;revenue&amp;#160;recognized will not occur when the&#13;uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue&amp;#160;is recognized&#13;for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage&#13;occurs, or (ii) the&amp;#160;performance obligation&amp;#160;to which some or all of the sales-based royalty has been allocated has&#13;been satisfied. Estimates are generally based on historical levels of activity, if available.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Revenues from contracts with significant&#13;financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have&#13;paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price,&#13;the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient,&#13;the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company&#13;expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the&#13;customer pays for the IP Rights will be one year or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In general, the Company is required to make&#13;certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include&#13;identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining&#13;whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers&#13;to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining&#13;whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based&#13;royalties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Revenues were comprised of the following&#13;for the periods presented:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Paid-up&#13;    Revenue Agreements&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;6,343&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;100,496&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Recurring Revenue Agreements&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4,903&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;13,040&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other Settlements&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,470&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Sales&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;14,500&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;11,246&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;131,506&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Refer to &amp;#8220;Inventor Royalties and Contingent&#13;Legal Expenses&amp;#8221; below for information on related direct costs of revenues.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Paid-up&#13;    Revenue Agreements&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;6,343&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;100,496&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Recurring Revenue Agreements&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4,903&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;13,040&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other Settlements&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,470&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Sales&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;14,500&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;11,246&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;131,506&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <ACTG:PortfolioOperationsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Portfolio Operations.&lt;/i&gt;&amp;#160;&amp;#160;Cost&#13;of revenues include the costs and expenses incurred in connection with Acacia&amp;#8217;s patent licensing and enforcement activities,&#13;including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related&#13;legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid&#13;to third-parties and the amortization of patent-related investment costs. These costs are included under the caption &amp;#8220;Portfolio&#13;operations&amp;#8221; in the accompanying consolidated statements of operations.&amp;#160;&amp;#160;&lt;/p&gt;</ACTG:PortfolioOperationsPolicyTextBlock>
    <ACTG:InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Inventor Royalties and Contingent Legal&#13;Expenses. &lt;/i&gt;Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues&#13;are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent&#13;owners by Acacia&amp;#8217;s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from&#13;future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are&#13;earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements&#13;of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered and included in&#13;amortization expense in the consolidated statements of operations. There were no patent acquisition expenses for fiscal year 2019.&#13;Cost of revenues for fiscal year 2018 included $4.0 million of costs to acquire certain patent rights related to revenues recognized&#13;in the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Contingent legal fees are expensed in the&#13;consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries&#13;from potential infringers, no contingent legal fees are paid; however, Acacia&amp;#8217;s operating subsidiaries may be liable for&#13;certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.&lt;/p&gt;</ACTG:InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock>
    <us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Trading Securities- Debt.&amp;#160;&amp;#160;&lt;/i&gt;Investments&#13;in debt securities are reported at fair value on a recurring basis, with related realized and unrealized gains and losses recorded&#13;in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific&#13;identification method.&amp;#160;Interest is included in other income (expense).&lt;/p&gt;</us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Trading Securities - Equity. &lt;/i&gt;Investments&#13;in equity securities are reported at fair value on a recurring basis, with related realized and unrealized gains and losses in&#13;the value of such securities recorded in the statements of operations in other income (expense). Dividend income is included&#13;in other income (expense).&lt;/p&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Property and Equipment.&amp;#160;&amp;#160;&lt;/i&gt;Property&#13;and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment&#13;are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold&#13;or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated&#13;statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis&#13;over the following estimated useful lives of the assets:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; width: 57%"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; width: 43%"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3 to 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Computer hardware and software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3 to 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2 to 5 years (Lesser of lease term or useful life of improvement)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Rental payments on operating leases are&#13;charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <ACTG:ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; width: 57%"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; width: 43%"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3 to 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Computer hardware and software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3 to 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2 to 5 years (Lesser of lease term or&#13;    useful life of improvement)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</ACTG:ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Patents.&lt;/i&gt;&amp;#160;&amp;#160;Patents include&#13;the cost of patents or patent rights (hereinafter, collectively &amp;#8220;patents&amp;#8221;) acquired from third-parties or obtained&#13;in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic&#13;useful lives, ranging from one to five years.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Investments at Fair Value&lt;/i&gt;. On an&#13;individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise&#13;significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied&#13;to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial&#13;interests in the same entity that are eligible items (i.e., common stock and warrants).&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquityAndCostMethodInvestmentsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Other Investments&lt;/i&gt;. Equity investments&#13;in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has&#13;the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate&#13;share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the  consolidated&#13;statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Investments in preferred stock with substantive&#13;liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted&#13;for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments&#13;of the same issuer. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially&#13;similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock,&#13;is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference&#13;is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation&#13;to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a&#13;fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially&#13;all of the investee's losses, if any.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The initial determination of whether an&#13;investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to&#13;exercise significant influence over the operating and financial policies of the investee.&amp;#160;That determination is reconsidered&#13;if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee,&#13;including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an&#13;investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment&#13;at the date at which the Company obtains the additional interest. Refer to Note 6 for additional information.&lt;/p&gt;</us-gaap:EquityAndCostMethodInvestmentsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Impairment of Long-lived Assets.&lt;/i&gt;&#13;Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events&#13;or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted&#13;future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded&#13;equal to the excess of the asset&amp;#8217;s carrying value over its fair value. If an asset is determined to be impaired, the loss&#13;is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate&#13;of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event&#13;that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying&#13;value of the asset is recorded. Refer to Note 5 for additional information.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Fair value is generally estimated using&#13;the &amp;#8220;Income Approach,&amp;#8221; focusing on the estimated future net income-producing capability of the patent portfolios over&#13;the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through &amp;#8220;discounting,&amp;#8221;&#13;including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash&#13;inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market&#13;data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty&#13;obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with&#13;a specific patent portfolio&amp;#8217;s licensing and enforcement program. The analysis also contemplates consideration of current&#13;information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength&#13;of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ContingentLiabilityReserveEstimatePolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Contingent Liabilities. &lt;/i&gt;The Company, from time to time,&#13;is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and&#13;the Company&amp;#8217;s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable&#13;and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements.&#13;If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments,&#13;reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations&#13;where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company&#13;records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for&#13;these types of contingencies are recognized in the period in which the litigation services were provided.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Certain of Acacia&amp;#8217;s operating subsidiaries&#13;are often required to engage in litigation to enforce their patents and patent rights.&amp;#160;In connection with any of Acacia&amp;#8217;s&#13;operating subsidiaries&amp;#8217; patent enforcement actions, it is possible that a defendant may request and/or a court may rule that&#13;an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing&#13;standards relating to the substantive or procedural aspects of such enforcement actions.&amp;#160;In such event, a court may issue&#13;monetary sanctions against Acacia or its operating subsidiaries or award attorney&amp;#8217;s fees and/or expenses to a defendant(s),&#13;which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company&amp;#8217;s&#13;operating results and financial position.&lt;/p&gt;</us-gaap:ContingentLiabilityReserveEstimatePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Income Taxes.&amp;#160;&amp;#160;&lt;/i&gt;Income taxes&#13;are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for&#13;the expected future tax consequences of events that have been recognized in Acacia&amp;#8217;s consolidated financial statements or&#13;consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of&#13;such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization&#13;of such assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Under U.S. generally accepted accounting&#13;principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing&#13;that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it&#13;is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination.&#13;Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount&#13;of tax benefit that is greater than 50% likely of being realized upon settlement.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Segment Reporting.&lt;/i&gt;&amp;#160;&amp;#160;Acacia&#13;uses the management approach, which designates the internal organization that is used by management for making operating decisions&#13;and assessing performance as the basis of Acacia&amp;#8217;s reportable segments. Acacia&amp;#8217;s patent licensing and enforcement business&#13;constitutes its single reportable segment.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Treasury Stock&lt;/i&gt;. Repurchases of the&#13;Company&amp;#8217;s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the&#13;appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury&#13;stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance&#13;sheets.&lt;/p&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:GainLossOnInvestmentsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Change&#13;    in fair value of investment, warrants&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,308&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(11,895&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value&#13;    of investment, common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;11,207&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(47,208&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Loss&#13;    on sale of investment, common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(9,230&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(19,095&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    realized and unrealized gain (loss) on investment at fair value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;669&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(78,198&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;7.&amp;#160;&amp;#160;STOCKHOLDERS&amp;#8217; EQUITY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Repurchases of Common Stock. &lt;/i&gt;In February&#13;2018, Acacia&amp;#8217;s Board of Directors authorized the repurchase of up to&amp;#160;$20,000,000&amp;#160;of the Company&amp;#8217;s outstanding&#13;common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the&#13;Board of Directors at its discretion (the &amp;#8220;Stock Repurchase Program&amp;#8221;). On August 5, 2019, Acacia&amp;#8217;s Board of Directors&#13;approved a new stock repurchase program, which authorized the purchase of up to $10.0 million of the Company's common stock through&#13;open market purchases, through block trades, through 10b5-1 plans, or by means of private purchases, from time to time, through&#13;July 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In determining whether or not to repurchase&#13;any shares of Acacia&amp;#8217;s common stock, Acacia&amp;#8217;s Board of Directors consider such factors as the impact of the repurchase&#13;on Acacia&amp;#8217;s cash position, as well as Acacia&amp;#8217;s capital needs and whether there is a better alternative use of Acacia&amp;#8217;s&#13;capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases&#13;to date were made in the open market in compliance with applicable SEC rules. The authorization to repurchase shares presented&#13;an opportunity to reduce the outstanding share count and enhance stockholder value. The repurchased shares are expected to be retired.&#13;Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program,&#13;were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    Number&lt;br /&gt; of Shares&lt;br /&gt; Purchased&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;br /&gt;&#13;    Price&lt;br /&gt; paid per&lt;br /&gt; Share&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Approximate&#13;    Dollar&lt;br /&gt; Value of Shares that&lt;br /&gt; May Yet be Purchased&lt;br /&gt; under the Program&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Plan&#13;    Expiration Date&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 19%; font-size: 10pt; text-align: center; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;May&#13;    1, 2018 - May 30, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 17%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,190,420&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.89&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;15,366,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; width: 18%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;February&#13;    28, 2019&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Totals&#13;    for 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,190,420&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.89&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Tax Benefits Preservation Plan&lt;/i&gt;. On&#13;March 12, 2019, Acacia&amp;#8217;s Board of Directors announced that it had unanimously approved the adoption of a Tax Benefits Preservation&#13;Plan (the &amp;#8220;Plan&amp;#8221;). The purpose of the Plan is to protect the Company&amp;#8217;s ability to utilize potential tax assets,&#13;such as net operating loss carryforwards and tax credits to offset potential future taxable income.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Plan is designed to reduce the likelihood&#13;that the Company will experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership&#13;of 4.9% or more of the Company&amp;#8217;s outstanding common stock and (ii) any existing stockholders who, as of the time of the first&#13;public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company&amp;#8217;s then-outstanding shares&#13;of the Company&amp;#8217;s common stock from acquiring additional shares of the Company&amp;#8217;s common stock (subject to certain exceptions).&#13;There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In connection with the adoption of the Plan,&#13;Acacia&amp;#8217;s Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the&#13;Company&amp;#8217;s common stock to stockholders of record at the close of business on March 16, 2019. On or after the distribution&#13;date, each right would initially entitle the holder to purchase one one-thousandth of a share of the Company&amp;#8217;s Series B Junior&#13;Participating Preferred Stock, $0.001 par value for a purchase price of $12.00.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Company also has a provision in its&#13;Amended and Restated Certificate of Incorporation, as amended (the &amp;#8220;Charter Provision&amp;#8221;) which generally prohibits transfers&#13;of its common stock that could result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect&#13;the Company&amp;#8217;s ability to utilize potential tax assets, such as net operating loss carryforwards and tax credits to offset&#13;potential future taxable income. The Charter Provision was approved by the Company&amp;#8217;s stockholders on July 15, 2019.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:AcceleratedShareRepurchasesTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    Number&lt;br /&gt; of Shares&lt;br /&gt; Purchased&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;br /&gt;&#13;    Price&lt;br /&gt; paid per&lt;br /&gt; Share&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Approximate&#13;    Dollar&lt;br /&gt; Value of Shares that&lt;br /&gt; May Yet be Purchased&lt;br /&gt; under the Program&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Plan&#13;    Expiration Date&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 19%; font-size: 10pt; text-align: center; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;May&#13;    1, 2018 - May 30, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 17%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,190,420&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.89&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;15,366,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; width: 18%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;February&#13;    28, 2019&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Totals&#13;    for 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,190,420&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.89&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Deferred&#13;    tax assets:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    operating loss and capital loss carryforwards and credits&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;112,280&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;104,862&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Unrealized&#13;    loss on investments held at fair value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;538&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2,455&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Stock&#13;    compensation&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;358&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,365&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Fixed&#13;    assets and intangibles&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,316&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,330&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Basis&#13;    of investments in affiliates&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;300&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;286&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accrued&#13;    liabilities and other&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;631&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;208&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&#13;    taxes&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred tax assets&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;115,448&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;112,532&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Valuation&#13;    allowance&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(115,077&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(112,514&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred tax assets, net of valuation allowance&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;371&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Deferred&#13;    tax liabilities:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;ROU&#13;    Asset&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(347&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(24&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(371&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    deferred tax assets (liabilities)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;9.&amp;#160;&amp;#160;EQUITY-BASED INCENTIVE&#13;PLANS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Stock-Based Incentive Plans&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The 2013 Acacia Research Corporation Stock&#13;Incentive Plan (&amp;#8220;2013 Plan&amp;#8221;) and the 2016 Acacia Research Corporation Stock Incentive Plan (&amp;#8220;2016 Plan&amp;#8221;)&#13;(collectively, the &amp;#8220;Plans&amp;#8221;) were approved by the stockholders of Acacia in May 2013 and June 2016, respectively. All&#13;Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals,&#13;which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of&#13;the Plans are identical in all material respects.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia&amp;#8217;s compensation committee&#13;administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible&#13;individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or&#13;issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either&#13;an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect&#13;for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding.&amp;#160;The&#13;exercise price of options is generally equal to the fair market value of Acacia&amp;#8217;s common stock on the date of grant.&#13;Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after&#13;grant.&amp;#160;Stock options with time-based vesting generally vest over two to three years and restricted shares with time&#13;based vesting generally vest in full after one to three years (generally representing the requisite service period). The&#13;Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia&amp;#8217;s&#13;stockholders.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Plans provide for the following separate&#13;programs:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 60px"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8226;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Discretionary Option Grant Program&lt;/i&gt;. Under the discretionary option grant program, Acacia&amp;#8217;s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia&amp;#8217;s voting stock or the voting stock of any of its subsidiaries).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 60px"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8226;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Automatic Option Grant Program&lt;/i&gt;. Through fiscal year 2016, each non-employee director received restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia&amp;#8217;s common stock on the grant date. In addition, each new non-employee director received restricted stock units or stock options for the number of shares determined by dividing the annual Board of Directors retainer by the grant date fair value of Acacia&amp;#8217;s common stock on the commencement date. These restricted stock units and stock options vested in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the unrestricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director&amp;#8217;s service as a member of the Company&amp;#8217;s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 60px"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8226;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;i&gt;Stock Issuance Program&lt;/i&gt;. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals receiving restricted stock awards (&amp;#8220;RSA&amp;#8221;) shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares. The eligible individuals receiving restricted stock units (&amp;#8220;RSU&amp;#8221;) shall not have full stockholder rights until they vest.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The number of shares of Common Stock initially&#13;reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without&#13;security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013&#13;Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including&#13;shares repurchased by the Company on the open market. In June 2016, 625,390 shares of common stock available for issuance under&#13;the 2013 Plan were transferred into the 2016 Plan. At December&amp;#160;31, 2019, there were 1,024,419 shares available for grant under&#13;the 2013 Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The number of shares of Common Stock initially&#13;reserved for issuance under the 2016 Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under&#13;the 2013 Plan, as of the effective date of the Plan. At December&amp;#160;31, 2019, there were 4,067,891 shares available for grant&#13;under the 2016 Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Upon the exercise of stock options, the&#13;granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia&amp;#8217;s policy&#13;to issue new shares of common stock. Acacia&amp;#8217;s Board of Directors may amend or modify the Plans at any time, subject to any&#13;required stockholder approval. As of December&amp;#160;31, 2019, there are 6,875,564 shares of common stock reserved for issuance under&#13;the Plans.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Stock-based award grant activity for the&#13;periods presented was as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&#13;    fair value (in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&#13;    fair value (in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted&#13;    stock awards with time-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;777,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2,332&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;102,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;386&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted stock units&#13;    with market-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,280&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Stock&#13;    options with time-based service vesting conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;930,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,588&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 20pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    incentive awards granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,677,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,612&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,032,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The following table summarizes stock option&#13;activity for the Plans for the year ended December&amp;#160;31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="12" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-Average&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Exercise&#13;    Price&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Remaining&#13;    Contractual Term&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&#13;    Intrinsic Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 40%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at December 31,&#13;    2018&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,509,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.96&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(25,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.12&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Expired/forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(3,158,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;5.04&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at&#13;    December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;326,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.38&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.4&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;281,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.45&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.9 years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;281,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.45&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.9 years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The aggregate intrinsic&#13;value of options exercised during the years ended December 31, 2019 and 2018 was $4,000 and $51,000, respectively.&amp;#160;The aggregate&#13;intrinsic value of options vested during the year ended December 31, 2019 was $0. No options were granted during the year ended&#13;December 31, 2019. The aggregate fair value of options vested during the years ended December 31, 2019 and 2018 was $294,000 and&#13;$1,918,000, respectively.&amp;#160;&amp;#160;As of December&amp;#160;31, 2019, the total unrecognized compensation expense related to non-vested&#13;stock option awards was $1,074,000, which is expected to be recognized over a weighted-average term of approximately 2 year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table&#13;summarizes non-vested restricted share activity for the year ended December&amp;#160;31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&lt;br /&gt;&#13;    Restricted&lt;br /&gt; Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br /&gt;&#13;    Average Grant&lt;br /&gt; Date Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested restricted&#13;    stock at December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;777,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.00&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(214,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.14&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Canceled&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(87,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2.81&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&#13;    restricted stock at December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;476,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2.98&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The weighted-average grant date fair value&#13;of non-vested restricted stock granted during the years ended December 31, 2019 and 2018 was $2.98 and $3.79, respectively.&#13;The aggregate fair value of restricted stock that vested during the years ended December 31, 2019 and 2018 was $672,000 and $972,000,&#13;respectively. As of December&amp;#160;31, 2019, unrecognized compensation expense related to non-vested restricted stock awards&#13;was $1,321,000, which is expected to be recognized over a weighted-average term of approximately 2 year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The following table summarizes restricted&#13;stock units activity for the year ended December&amp;#160;31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&lt;br /&gt;&#13;    Restricted&lt;br /&gt; Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br /&gt;&#13;    Average Grant&lt;br /&gt; Date Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&#13;    &lt;font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400"&gt;restricted stock units at December&#13;    31, 2018&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Canceled&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&#13;    &lt;font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400"&gt;restricted stock units at December&#13;    31, 2019&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&#13;    &lt;font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400"&gt;restricted stock units at December&#13;    31, 2019&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;14,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;16.72&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The weighted-average grant date fair&#13;value of restricted units granted during the years ended December 31, 2019 was $1.42. There were no restricted units granted&#13;during the year ended December 31, 2018. The aggregate fair value of restricted stock units granted during the year ended&#13;December 31, 2019 was $1,280,000. The aggregate fair value of restricted stock units that vested during the years ended&#13;December 31, 2019 and 2018 was $240,000 and $40,000, respectively. As of December&amp;#160;31, 2019, unrecognized compensation&#13;expense related to non-vested restricted stock units was $1,140,000. Stock compensation expense is recognized in general and&#13;administrative expenses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Profits Interest Plan &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;On February&amp;#160;16, 2017, AIP Operation&#13;LLC, a Delaware limited liability company (&amp;#8220;AIP&amp;#8221;), and an indirect subsidiary of Acacia, adopted a Profits Interest&#13;Plan (the&amp;#160;&amp;#8220;Plan&amp;#8221;) that provides for the grant of membership interests in AIP to certain members of management&#13;and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit&#13;granted pursuant to the Plan is intended to qualify as a &amp;#8220;profits interest&amp;#8221; for U.S. federal income tax purposes and&#13;will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership&#13;interests. The membership interests are represented by units (the &amp;#8220;Units&amp;#8221;) reserved for the issuance of awards&#13;under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share&#13;in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the&amp;#160;&amp;#8220;LLC&#13;Agreement&amp;#8221;). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which&#13;Units may be granted from time to time. Units vest upon AIP&amp;#8217;s achievement of certain performance milestones (one-third upon&#13;150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia&amp;#8217;s aggregate investment in Veritone),&#13;subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest&#13;Agreement and the LLC Agreement. The Units were fully vested in September 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia owns 60% of the membership interests&#13;in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to&#13;portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients. As&#13;of December&amp;#160;31, 2019, AIP holds the Veritone  Warrant described at Note 6.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Profits interests totaling 400 Units, or&#13;40% of the membership interests in AIP, were granted in February 2017, with an aggregate grant date fair value of $722,000. The&#13;fair value of the Units totaled $591,000 as of December&amp;#160;31, 2019. Upon full vesting of the units in September 2017, all previously&#13;unrecognized compensation expense was immediately recognized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Compensation expense for the periods presented&#13;was comprised of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(in&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted&#13;    stock awards with time-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;907&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;460&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted stock units&#13;    awards with time-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted stock units&#13;    with performance-based vesting conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;140&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Stock options with&#13;    time-based service vesting conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;28&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,672&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Profits interests units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2,450&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    compensation expense&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,075&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(317&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&#13;    fair value (in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&#13;    fair value (in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted&#13;    stock awards with time-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;777,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2,332&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;102,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;386&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted stock units&#13;    with market-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,280&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Stock&#13;    options with time-based service vesting conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;930,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,588&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 20pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    incentive awards granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,677,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,612&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,032,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="12" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-Average&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Exercise&#13;    Price&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Remaining&#13;    Contractual Term&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&#13;    Intrinsic Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 40%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at December 31,&#13;    2018&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,509,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.96&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(25,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.12&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Expired/forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(3,158,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;5.04&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at&#13;    December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;326,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.38&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.4&#13;    years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;281,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.45&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.9 years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Exercisable at December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;281,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.45&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.9 years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&lt;br /&gt;&#13;    Restricted&lt;br /&gt; Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br /&gt;&#13;    Average Grant&lt;br /&gt; Date Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested restricted&#13;    stock at December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;777,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.00&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(214,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3.14&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Canceled&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(87,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2.81&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&#13;    restricted stock at December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;476,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2.98&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&lt;br /&gt;&#13;    Restricted&lt;br /&gt; Shares&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br /&gt;&#13;    Average Grant&lt;br /&gt; Date Fair Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&#13;    &lt;font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400"&gt;restricted stock units at December&#13;    31, 2018&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Canceled&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Non-vested&#13;    &lt;font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400"&gt;restricted stock units at December&#13;    31, 2019&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1.42&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Vested&#13;    &lt;font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400"&gt;restricted stock units at December&#13;    31, 2019&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;14,000&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;16.72&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(in&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted&#13;    stock awards with time-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;907&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;460&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted stock units&#13;    awards with time-based service conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Restricted stock units&#13;    with performance-based vesting conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;140&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Stock options with&#13;    time-based service vesting conditions&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;28&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,672&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Profits interests units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2,450&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    compensation expense&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,075&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(317&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;11.&amp;#160; RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE&#13;POLICY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Retirement Savings Plan.&lt;/i&gt; Acacia&#13;has an employee savings and retirement plan under section 401(k) of the Code (the &amp;#8220;Plan&amp;#8221;).&amp;#160;The Plan is a&#13;defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the&#13;Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the&#13;discretion of the Board of Directors. There were no contributions made by Acacia during the periods presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Executive Severance Policy.&lt;/i&gt;&#13;Under Acacia&amp;#8217;s Amended Executive Severance Policy, full-time employees as of July 2017 and prior with the title of&#13;Senior Vice President and higher (&amp;#8220;SVP and higher&amp;#8221;) are entitled to receive certain benefits upon termination of&#13;employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death&#13;or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a)&#13;accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any&#13;compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and&#13;reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full&#13;year that the SVP and higher employee was employed by the Company (the &amp;#8220;Severance Period&amp;#8221;), up to a maximum of&#13;twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii)&#13;provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year&#13;in which the termination occurs, for the duration of the Severance Period. Results for the year ended December 31, 2019 and&#13;2018 include $420,000 and $2,458,000 of expenses incurred under the executive severance policy.&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;12.&amp;#160;&amp;#160;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Cash paid for state income taxes totaled&#13;$85,000 and $140,000 for the years ended December 31, 2019 and 2018, respectively. Foreign taxes withheld totaled $249,000 and&#13;$1,093,000 for the years ended December 31, 2019 and 2018, respectively. Refer to Note 4 for accrued foreign taxes payable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Refer to Note 6 for information regarding&#13;noncash investing activity related to the investment in Veritone for the periods presented.&lt;/p&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" unitRef="USD" decimals="-3">93843000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" unitRef="USD" decimals="-3">33642000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" unitRef="USD" decimals="-3">17140000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" unitRef="USD" decimals="-3">3012000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">757000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">2064000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">743000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">5395000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">17883000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">8407000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">94600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">35706000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">591000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">591000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ProfitInterestUnitsMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" unitRef="USD" decimals="-3">3568000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" unitRef="USD" decimals="-3">17974000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">4159000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">591000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">17974000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements contextRef="From2019-01-01to2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" unitRef="USD" decimals="-3">21232000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" unitRef="USD" decimals="-3">17974000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="AsOf2018-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" unitRef="USD" decimals="-3">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_FurnitureAndFixturesMember">3 to 5 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_ComputerEquipmentMember">3 to five years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-01-01to2019-12-31_us-gaap_LeaseholdImprovementsMember">2 to 5 years (Lesser of lease term or useful life of improvement)</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="Percent" decimals="INF">0.0226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="Percent" decimals="INF">.0138</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember">P4Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="Percent" decimals="INF">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="Percent" decimals="INF">.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="Percent" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="Percent" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:OtherPreferredStockDividendsAndAdjustments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-307000</us-gaap:OtherPreferredStockDividendsAndAdjustments>
    <us-gaap:OtherPreferredStockDividendsAndAdjustments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:OtherPreferredStockDividendsAndAdjustments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-17129000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-7608000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-32864000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-104848000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">634000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-5757000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-4398000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">-11367000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-28506000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">-32111000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member" unitRef="Percent" decimals="INF">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member" unitRef="Percent" decimals="INF">0.17</us-gaap:ConcentrationRiskPercentage1>
    <ACTG:FiniteLivedIntangibleAssetUsefulLifeTerm contextRef="From2019-01-01to2019-12-31_us-gaap_PatentsMember">1 to 5 years</ACTG:FiniteLivedIntangibleAssetUsefulLifeTerm>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_MeasurementInputPriceVolatilityMember">30%</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">1.86%</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_MeasurementInputCommodityFuturePriceMember">25%</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">0%</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment contextRef="From2019-01-01to2019-12-31_us-gaap_DebtSecuritiesMember" unitRef="USD" decimals="-3">49751000</us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment>
    <us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment contextRef="From2018-01-01to2018-12-31_us-gaap_DebtSecuritiesMember" unitRef="USD" decimals="-3">65144000</us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment>
    <us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment contextRef="From2019-01-01to2019-12-31_us-gaap_EquitySecuritiesMember" unitRef="USD" decimals="-3">25339000</us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment>
    <us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment contextRef="From2018-01-01to2018-12-31_us-gaap_EquitySecuritiesMember" unitRef="USD" decimals="-3">1496000</us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">152000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">122000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">27000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:AccruedIncomeTaxesCurrent>
    <ACTG:ForeignTaxesPayable contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">0</ACTG:ForeignTaxesPayable>
    <ACTG:ForeignTaxesPayable contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">374000</ACTG:ForeignTaxesPayable>
    <ACTG:AccruedConsultingAndOtherProfessionalFees contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">470000</ACTG:AccruedConsultingAndOtherProfessionalFees>
    <ACTG:AccruedConsultingAndOtherProfessionalFees contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</ACTG:AccruedConsultingAndOtherProfessionalFees>
    <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">330588000</us-gaap:FiniteLivedPatentsGross>
    <us-gaap:FiniteLivedPatentsGross contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">326167000</us-gaap:FiniteLivedPatentsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">2555000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1695000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1695000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1620000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">249000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-34000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-87000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">1858000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-1092000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">1824000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-1179000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">115448000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">112532000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">115077000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">112514000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">371000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">18000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">112280000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">104862000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">538000</us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">2455000</us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1316000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">3330000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsInvestments contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">300000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">286000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">358000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">1365000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsOtherTaxCarryforwards contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">25000</us-gaap:DeferredTaxAssetsOtherTaxCarryforwards>
    <us-gaap:DeferredTaxAssetsOtherTaxCarryforwards contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">26000</us-gaap:DeferredTaxAssetsOtherTaxCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">631000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">208000</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">371000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">18000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">347000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">24000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">18000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">0.07</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">-0.01</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">-0.01</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">0.10</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">-0.01</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">-0.04</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">-0.13</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">-0.20</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="From2019-01-01to2019-12-31" unitRef="Percent" decimals="INF">-0.02</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther contextRef="From2018-01-01to2018-12-31" unitRef="Percent" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2019-12-31_us-gaap_DomesticCountryMember" unitRef="USD" decimals="-3">253824000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2019-12-31_us-gaap_StateAndLocalJurisdictionMember" unitRef="USD" decimals="-3">19683000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2019-01-01to2019-12-31_us-gaap_DomesticCountryMember">2026-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2019-01-01to2019-12-31_us-gaap_StateAndLocalJurisdictionMember">2028-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">23652000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <ACTG:CapitalLossCarryforwardsExpirationDate contextRef="From2019-01-01to2019-12-31">2025-12-31</ACTG:CapitalLossCarryforwardsExpirationDate>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">51508000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <ACTG:ForeignTaxCreditBeginningExpirationDate contextRef="From2019-01-01to2019-12-31">2020-12-31</ACTG:ForeignTaxCreditBeginningExpirationDate>
    <ACTG:DeferredTaxAssetFromLossOnInvestment contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">538000</ACTG:DeferredTaxAssetFromLossOnInvestment>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">731000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">816000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember" unitRef="Shares" decimals="INF">777000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="Shares" decimals="INF">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember" unitRef="Shares" decimals="INF">102000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">1588000</ACTG:AggregateFairValueAwardsGranted>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">0</ACTG:AggregateFairValueAwardsGranted>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">2332000</ACTG:AggregateFairValueAwardsGranted>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">1280000</ACTG:AggregateFairValueAwardsGranted>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">386000</ACTG:AggregateFairValueAwardsGranted>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="USD" decimals="-3">0</ACTG:AggregateFairValueAwardsGranted>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2019-01-01to2019-12-31_custom_AllAwardsMember" unitRef="USD" decimals="-3">3612000</ACTG:AggregateFairValueAwardsGranted>
    <ACTG:AggregateFairValueAwardsGranted contextRef="From2018-01-01to2018-12-31_custom_AllAwardsMember" unitRef="USD" decimals="-3">1974000</ACTG:AggregateFairValueAwardsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">3509000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">326000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">3158000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">281000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">214000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">281000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">4.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">4.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">3.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">5.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">4.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">4.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P4Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P3Y10M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P3Y10M25D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-12-31_us-gaap_RestrictedStockMember" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31_us-gaap_RestrictedStockMember" unitRef="USDPShares" decimals="INF">2.98</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USDPShares" decimals="INF">1.42</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="USDPShares" decimals="INF">1.42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="USDPShares" decimals="INF">3.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2018-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_TimeBasedServiceMember" unitRef="USDPShares" decimals="INF">16.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2019-12-31_custom_Plan2016Member" unitRef="Shares" decimals="INF">4067891</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2019-12-31_custom_AllPlansMember" unitRef="Shares" decimals="INF">6875564</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2018-01-01to2018-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">51000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">4000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="AsOf2018-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">1918000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">294000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_us-gaap_StockOptionMember" unitRef="USD" decimals="-3">1074000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">1140000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2019-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember" unitRef="USD" decimals="-3">1321000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2019-01-01to2019-12-31_us-gaap_StockOptionMember">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USDPShares" decimals="INF">1.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember" unitRef="USDPShares" decimals="INF">2.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember" unitRef="USDPShares" decimals="INF">3.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember" unitRef="USD" decimals="-3">672000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockMember_custom_NonVestedMember" unitRef="USD" decimals="-3">972000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">240000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">1280000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <ACTG:FairValueOfProfitsInterests contextRef="AsOf2019-12-31_custom_ProfitsInterestMember" unitRef="USD" decimals="-3">591000</ACTG:FairValueOfProfitsInterests>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">434000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <ACTG:ExcessOfLeasePaymentsOverSubleaseIncome contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">629000</ACTG:ExcessOfLeasePaymentsOverSubleaseIncome>
    <us-gaap:DefinedBenefitPlanAdministrationExpenses contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">420000</us-gaap:DefinedBenefitPlanAdministrationExpenses>
    <us-gaap:DefinedBenefitPlanAdministrationExpenses contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2458000</us-gaap:DefinedBenefitPlanAdministrationExpenses>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-12-31_us-gaap_StateAndLocalJurisdictionMember" unitRef="USD" decimals="-3">85000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2018-01-01to2018-12-31_us-gaap_StateAndLocalJurisdictionMember" unitRef="USD" decimals="-3">140000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-12-31_us-gaap_ForeignCountryMember" unitRef="USD" decimals="-3">249000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2018-01-01to2018-12-31_us-gaap_ForeignCountryMember" unitRef="USD" decimals="-3">1093000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="From2018-01-01to2018-12-31_custom_SidusInvestmentMember" unitRef="USD" decimals="-3">976000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember" unitRef="USDPShares" decimals="INF">3.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">3.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">35000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="-3">4800000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2019-01-01to2019-12-31_custom_EmbeddedDerivativeMember" unitRef="USD" decimals="-3">21200000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2019-01-01to2019-12-31_custom_SeriesARedeemableConvertibleStockMember" unitRef="USD" decimals="-3">8900000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">1300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <ACTG:WarrantsIssuedShares contextRef="From2019-01-01to2019-11-18_custom_StarboardValueMember" unitRef="Shares" decimals="INF">5000000</ACTG:WarrantsIssuedShares>
    <ACTG:WarrantsIssuedShares contextRef="From2019-01-01to2019-11-18_custom_StarboardValueMember_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">5000000</ACTG:WarrantsIssuedShares>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_WarrantMember" unitRef="USD" decimals="-3">4800000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2019-12-31_custom_StarboardValueMember_us-gaap_WarrantMember" unitRef="USD" decimals="-3">3600000</us-gaap:WarrantsAndRightsOutstanding>
    <ACTG:WarrantsExercisedShares contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">0</ACTG:WarrantsExercisedShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2018-12-31_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2019-12-31_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">476000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">777000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="Shares" decimals="INF">87000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="USDPShares" decimals="INF">3.14</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockMember" unitRef="USDPShares" decimals="INF">2.81</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2019-01-01to2019-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2019-01-01to2019-12-31">No</dei:EntityVoluntaryFilers>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">3568000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">307000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">307000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-3258000</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">-3258000</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">0</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">1260000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Embedded&#13;    Derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Opening balance as of January 1, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 83%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Issuance&#13;    of Series A redeemable convertible preferred stock with embedded derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;21,232&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement&#13;    of Series A redeemable convertible preferred stock embedded derivative to fair value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total Level 3&#13;    recurring fair value measurements as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="From2019-01-01to2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" unitRef="USD" decimals="-3">-3258000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Statutory&#13;    federal tax rate - (benefit) expense&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;21%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;21%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&#13;    income and foreign taxes, net of federal tax effect&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;7%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Foreign&#13;    tax credit&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Noncontrolling&#13;    interests in operating subsidiaries&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Nondeductible&#13;    permanent items&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Change&#13;    in tax rate&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Expired capitalized&#13;    loss&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Valuation&#13;    allowance&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(13)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(20)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(4)%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;10%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1)%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">4518000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:EarningsPerShareBasic contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">-0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2019-07-01to2019-09-30" unitRef="USDPShares" decimals="INF">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-07-01to2018-09-30" unitRef="USDPShares" decimals="INF">-0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">-2.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2019-10-01to2019-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2019-04-01to2019-06-30" unitRef="USDPShares" decimals="INF">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2019-01-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-10-01to2018-12-31" unitRef="USDPShares" decimals="INF">-0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-04-01to2018-06-30" unitRef="USDPShares" decimals="INF">-0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-01-01to2018-03-31" unitRef="USDPShares" decimals="INF">-0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">49764002</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-07-01to2019-09-30" unitRef="Shares" decimals="INF">49828361</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-07-01to2018-09-30" unitRef="Shares" decimals="INF">49557748</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">49969062</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-10-01to2019-12-31" unitRef="Shares" decimals="INF">49875750</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-04-01to2019-06-30" unitRef="Shares" decimals="INF">49696016</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-01-01to2019-03-31" unitRef="Shares" decimals="INF">49655881</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-10-01to2018-12-31" unitRef="Shares" decimals="INF">49639172</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-04-01to2018-06-30" unitRef="Shares" decimals="INF">50061812</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-01-01to2018-03-31" unitRef="Shares" decimals="INF">50632958</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-20373000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="-3">-7608000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-33195000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-105029000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2019-10-01to2019-12-31" unitRef="USD" decimals="-3">-2624000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="-3">-5757000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="-3">-4384000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2018-10-01to2018-12-31" unitRef="USD" decimals="-3">-11369000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="-3">-28427000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="-3">-32038000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">-0.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2019-07-01to2019-09-30" unitRef="USDPShares" decimals="INF">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-07-01to2018-09-30" unitRef="USDPShares" decimals="INF">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">-2.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2019-10-01to2019-12-31" unitRef="USDPShares" decimals="INF">-0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2019-04-01to2019-06-30" unitRef="USDPShares" decimals="INF">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2019-01-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-10-01to2018-12-31" unitRef="USDPShares" decimals="INF">-0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-04-01to2018-06-30" unitRef="USDPShares" decimals="INF">-0.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-01-01to2018-03-31" unitRef="USDPShares" decimals="INF">-0.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">50896773</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-07-01to2019-09-30" unitRef="Shares" decimals="INF">49828361</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-07-01to2018-09-30" unitRef="Shares" decimals="INF">49557748</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">49969062</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-10-01to2019-12-31" unitRef="Shares" decimals="INF">54406835</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-04-01to2019-06-30" unitRef="Shares" decimals="INF">49696016</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-01-01to2019-03-31" unitRef="Shares" decimals="INF">49655881</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-10-01to2018-12-31" unitRef="Shares" decimals="INF">49639172</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-04-01to2018-06-30" unitRef="Shares" decimals="INF">50061812</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-01-01to2018-03-31" unitRef="Shares" decimals="INF">50632958</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">-36450000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">-7795000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt; The fair values of stock options granted during the year ended December 31, 2018 were estimated&#13;using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;For&#13;    the Year Ended&lt;br /&gt; December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Risk-free&#13;    interest rate&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2.26%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Term&lt;/font&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4.37&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;51%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Dividend&#13;    yield&lt;/font&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">435000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Current:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Federal&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; width: 46%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(87&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Foreign&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,858&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,092&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    current&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,824&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,179&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Deferred:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Federal&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Income&#13;    tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,824&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,179&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">780000</us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue>
    <us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">65000</us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue>
    <us-gaap:OperatingLeaseCost contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">65000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">1106000</us-gaap:OperatingLeaseCost>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;13.&amp;#160;&amp;#160;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recent Accounting Pronouncements - Recently Adopted. &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In February 2016, FASB issued ASU 2016-02,&#13;&lt;i&gt;Leases&lt;/i&gt;, or ASC 842 which requires a lessee to recognize in the statement of financial position a liability to make lease&#13;payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset. In July 2018, FASB&#13;issued ASU 2018-11, Leases, which provides an additional transition option for an entity to apply the provisions of ASC 842 by&#13;recognizing a cumulative effect adjustment at the effective date of adoption without adjusting the prior comparative periods presented.&#13;Further, in January 2019, FASB issued ASU 2019-01, Leases: Codification Improvements, which provides disclosure relief for the&#13;interim periods when adopting ASC 842. The primary impact of adopting ASC 842 for the Company was the recognition in the consolidated&#13;balance sheet of certain lease-related assets and liabilities for operating leases with terms longer than 12 months as of January&#13;1, 2019. Such amounts were not previously accounted for in the Company's consolidated balance sheets. The Company adopted ASC&#13;842 as of January 1, 2019, electing the practical expedient approaches. As a result, we recognized approximately $1.6 million&#13;of right-of-use assets and an increase of $1.7 million in lease-related liabilities as of December 31, 2019. The adoption of ASC&#13;842 did not have a material impact on the Company's consolidated results of operations for the year ending December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recent Accounting Pronouncements - Not Yet Adopted. &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In December 2019, the FASB issued ASU No.&#13;2019-12 Income Taxes (Topic 740)&amp;#8212;Simplifying the Accounting for Income Taxes, to remove certain exceptions and improve consistency&#13;of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or&#13;rates in the annual effective tax rate computation in the interim period that includes the enactment date. The amendments in this&#13;update will be effective for the Company beginning with fiscal year 2021, with early adoption permitted. Most amendments within&#13;the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or&#13;modified retrospective basis. Management is currently evaluating the impact that the amendments in this update will have on the&#13;Company&amp;#8217;s consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <ACTG:WarrantDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;17.&amp;#160;&amp;#160;SERIES A WARRANTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;On November 18, 2019, in connection with&#13;the issuance of the Series A Redeemable Convertible Preferred Stock, the Company issued a detachable Series A Warrant to acquire&#13;up to purchase 5,000,000 shares of common stock at a price of $3.65 per share (subject to certain anti-dilution adjustments) at&#13;any time during a period of eight years beginning on the instrument&amp;#8217;s issuance date of the Series A Warrants. The fair value&#13;of the Series A Warrants was $4.8 million. The Series A Warrants will be recognized at fair value at each reporting period until&#13;exercised, with changes in fair value recognized in other income (expense) in the accompanying consolidated statements of operations.&#13;As of December 31, 2019, the fair value of the Series A Warrants was $3.6 million. As of December 31, 2019, the Series A Warrants&#13;have not been exercised.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Series A Warrants are classified as&#13;a liability in accordance with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement&#13;upon a change in control, which is outside the control of the Company.&lt;/p&gt;</ACTG:WarrantDisclosureTextBlock>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="-3">3258000</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Loss Per Share.&amp;#160;&amp;#160;&lt;/i&gt;For periods&#13;in which the Company generates net income, the Company computes earnings per share attributable to common stockholders using the&#13;two-class method required for capital structures that include participating securities. Under the two-class method, securities&#13;that participate in non-forfeitable dividends, such as the Company&amp;#8217;s outstanding unvested restricted stock and Series A Redeemable&#13;Convertible Preferred Stock, are considered participating securities and are allocated a portion of the Company&amp;#8217;s earnings.&#13;For periods in which the Company generates a net loss, net losses are not allocated to holders of the Company&amp;#8217;s participating&#13;securities as the security holders are not contractually obligated to share in the Company&amp;#8217;s losses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For the periods presented, due to the Company&amp;#8217;s&#13;net loss, the Company did not apply the two-class method to allocate earnings to the participating securities. Basic net loss&#13;per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number&#13;of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed by dividing net loss&#13;attributable to common stockholders by the weighted average number of common and dilutive common equivalent shares outstanding&#13;for the period using the treasury stock method or the as-converted method. Potentially dilutive common stock equivalents consist&#13;of stock options, restricted stock units, unvested restricted stock, Series A Redeemable Convertible Preferred Stock, and Series&#13;A Warrants. &lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The following table presents the calculation&#13;of basic and diluted loss per share of common stock:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In thousands, except percentage&#13;    change values)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(17,115&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accretion&#13;    of Series A Redeemable Convertible Preferred Stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(307&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(17,422&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,764,002&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Basic&#13;    net loss per share of common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(0.35&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2.10&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(17,115&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Mark-to-market&#13;    adjustment for preferred stock embedded derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to common stockholders - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(20,373&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,764,002&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Effect&#13;    of potentially dilutive securities: Series A preferred stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,132,771&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;50,896,773&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Diluted&#13;    net loss per share of common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(0.40&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2.10&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;As the Company reported a net loss for&#13;the years ended December 31, 2019 and 2018, all potentially dilutive shares of common stock other than those associated with the&#13;Series A Redeemable Convertible Preferred Stock have been excluded from the calculation of diluted net loss per share of common&#13;stock because including such instruments would be anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In thousands, except percentage&#13;    change values)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(17,115&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accretion&#13;    of Series A Redeemable Convertible Preferred Stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(307&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(17,422&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,764,002&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Basic&#13;    net loss per share of common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(0.35&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2.10&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(17,115&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Mark-to-market&#13;    adjustment for preferred stock embedded derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to common stockholders - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(20,373&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,764,002&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Effect&#13;    of potentially dilutive securities: Series A preferred stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,132,771&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;50,896,773&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Diluted&#13;    net loss per share of common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(0.40&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2.10&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">1132771</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.&amp;#160; ACCRUED EXPENSES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Accrued expenses consist of the following&#13;at December 31, 2019 and 2018:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accrued&#13;    litigation liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;6,181&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,803&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accrued consulting&#13;    and other professional fees&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;470&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Foreign taxes payable&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;374&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State income taxes&#13;    payable&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Short-term lease liability&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;435&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other&#13;    accrued liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;152&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;122&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;7,265&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4,299&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accrued&#13;    litigation liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;6,181&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,803&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accrued consulting&#13;    and other professional fees&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;470&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Foreign taxes payable&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;374&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State income taxes&#13;    payable&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Short-term lease liability&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;435&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other&#13;    accrued liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;152&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;122&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;7,265&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4,299&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:LitigationReserve contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">6181000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve contextRef="AsOf2018-12-31" unitRef="USD" decimals="-3">3803000</us-gaap:LitigationReserve>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Three months ended&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Three months ended&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Three months ended&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;March 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;June 30,&#13;    2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As reported&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As adjusted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As reported&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As adjusted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As reported&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As adjusted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 34%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Net cash provided by (used in) operating&#13;    activities&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(58,812&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,958&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(66,026&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(2,268&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(65,748&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(846&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Net cash provided by (used in) investing activities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,288&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(53,566&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;625&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(63,133&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,721&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(61,181&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Net cash provided by financing activities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Increase/(decrease) in cash and cash equivalent&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(55,524&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(55,524&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(65,322&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(65,322&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(61,948&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(61,948&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2019-07-01to2019-09-30" unitRef="USD" decimals="0">-61948</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">-65322</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-55524</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2019-01-01to2019-03-31_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-55524</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2019-04-01to2019-06-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-65322</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2019-07-01to2019-09-30_us-gaap_ScenarioAdjustmentMember" unitRef="USD" decimals="0">-61948</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" unitRef="USD" decimals="-3">7782000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ACTG:CumulativeEffectOfNewAccountingPrinciple contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="-3">2814000</ACTG:CumulativeEffectOfNewAccountingPrinciple>
    <ACTG:CumulativeEffectOfNewAccountingPrinciple contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">2506000</ACTG:CumulativeEffectOfNewAccountingPrinciple>
    <ACTG:CumulativeEffectOfNewAccountingPrinciple contextRef="From2018-01-01to2018-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="-3">308000</ACTG:CumulativeEffectOfNewAccountingPrinciple>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;2.&amp;#160;&amp;#160;SUMMARY OF SIGNIFICANT&#13;ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Accounting Principles.&amp;#160;&amp;#160;&lt;/i&gt;The&#13;consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally&#13;accepted accounting principles in the United States of America (&amp;#34;U.S. GAAP&amp;#34;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Principles of Consolidation.&amp;#160;&amp;#160;&lt;/i&gt;The&#13;accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled&#13;subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Noncontrolling interests in&#13;Acacia&amp;#8217;s majority-owned and controlled operating subsidiaries (&amp;#8220;noncontrolling interests&amp;#8221;) are separately presented&#13;as a component of stockholders&amp;#8217; equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss&#13;attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements&#13;of Series A redeemable convertible preferred stock and stockholders&amp;#8217; equity for total noncontrolling interests.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;A wholly owned subsidiary of Acacia is the&#13;general partner of the Acacia Intellectual Property Fund, L.P. (the &amp;#8220;Acacia IP Fund&amp;#8221;), which was formed in August 2010.&#13;The Acacia IP Fund is included in the Company&amp;#8217;s consolidated financial statements since 2010, as Acacia&amp;#8217;s wholly owned&#13;subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia&#13;IP Fund was terminated as of December 31, 2017 and is in the process of being liquidated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Revenue Recognition.&amp;#160;&amp;#160;&lt;/i&gt;Revenue&#13;is recognized upon transfer of control of promised bundled IP rights (hereinafter &amp;#8220;IP Rights&amp;#8221;) and other contractual&#13;performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP&#13;Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which&#13;the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized&#13;at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have&#13;been met.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For the periods presented, revenue&#13;contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license&#13;fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia&#13;(&amp;#8220;Paid-up Revenue Agreements&amp;#8221;). Revenues also included license fees from sales-based revenue contracts, the&#13;majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on&#13;quarterly sales of applicable product units by licensees (&amp;#8220;Recurring Revenue Agreements&amp;#8221;). Revenues may also&#13;include court ordered settlements or awards related to our patent portfolio (&amp;#34;Other Settlements&amp;#34;) or sales of our&#13;patent portfolio (&amp;#34;Sales&amp;#34;). IP Rights granted included the following, as applicable: (i) the grant of a&#13;non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a&#13;covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending&#13;litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related&#13;patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the&#13;promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and&#13;(ii) the Company's promise to transfer each individual IP right described above to the customer is not separately&#13;identifiable from other promises to transfer IP Rights in the contract.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Since the promised IP Rights are not&#13;individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is&#13;distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights&#13;granted were &amp;#8220;functional IP rights&amp;#8221; that have significant standalone functionality. Acacia's subsequent&#13;activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the&#13;licensee has rights. Acacia&amp;#8217;s operating subsidiaries have no further obligation with respect to the grant of IP Rights,&#13;including no express or implied obligation to maintain or upgrade the technology, or provide future support or services. The&#13;contracts provide for the grant (i.e., transfer of control) of the licenses, covenants-not-to-sue, releases, and other&#13;significant deliverables upon execution of the contract. Licensees legally obtain control of the IP Rights upon execution of&#13;the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when&#13;collectability is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for&#13;payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or&#13;usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For sales-based royalties, the Company&#13;includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is&#13;probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the&#13;uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue&amp;#160;is recognized&#13;for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage&#13;occurs, or (ii) the&amp;#160;performance obligation&amp;#160;to which some or all of the sales-based royalty has been allocated has&#13;been satisfied. Estimates are generally based on historical levels of activity, if available.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Revenues from contracts with significant&#13;financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have&#13;paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price,&#13;the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient,&#13;the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company&#13;expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the&#13;customer pays for the IP Rights will be one year or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In general, the Company is required to make&#13;certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include&#13;identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining&#13;whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers&#13;to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining&#13;whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based&#13;royalties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Revenues were comprised of the following&#13;for the periods presented:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In&#13;    thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Paid-up&#13;    Revenue Agreements&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,343&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,496&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Recurring&#13;    Revenue Agreements&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,903&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;13,040&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&#13;    Settlements&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,470&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Sales&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14,500&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;11,246&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;131,506&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Refer to&#13;&amp;#8220;Inventor Royalties and Contingent Legal Expenses&amp;#8221; below for information on related direct costs of revenues.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Portfolio&#13;Operations.&lt;/i&gt;&amp;#160;&amp;#160;Cost of revenues include the costs and expenses incurred in connection with Acacia&amp;#8217;s patent licensing&#13;and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external&#13;patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research,&#13;consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included&#13;under the caption &amp;#8220;Portfolio operations&amp;#8221; in the accompanying consolidated statements of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Inventor&#13;Royalties and Contingent Legal Expenses. &lt;/i&gt;Inventor royalties are expensed in the consolidated statements of operations in the&#13;period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements,&#13;upfront advances paid to patent owners by Acacia&amp;#8217;s operating subsidiaries are recoverable from future net revenues. Patent&#13;costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents,&#13;or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense&#13;in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the&#13;period recovered and included in amortization expense in the consolidated statements of operations. There were no patent acquisition&#13;expenses for fiscal year 2019. Cost of revenues for fiscal year 2018 included $4.0 million of costs to acquire certain patent&#13;rights related to revenues recognized in the period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Contingent&#13;legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In&#13;instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia&amp;#8217;s&#13;operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services&#13;agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Fair Value&#13;Measurements.&lt;/i&gt; U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be&#13;paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants&#13;on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable&#13;inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 96px"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(i)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level 1 - &lt;i&gt;Observable&#13;    Inputs&lt;/i&gt;:&amp;#160;&amp;#160;Quoted prices in active markets for identical investments;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 96px"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(ii)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level 2 - &lt;i&gt;Pricing&#13;    Models with Significant Observable Inputs&lt;/i&gt;:&amp;#160;&amp;#160;Other significant observable inputs, including quoted prices for&#13;    similar investments, interest rates, credit risk, etc.; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 96px"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(iii)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level 3 - &lt;i&gt;Unobservable&#13;    Inputs&lt;/i&gt;:&amp;#160;&amp;#160;Significant unobservable inputs, including the entity&amp;#8217;s own assumptions in determining the fair&#13;    value of investments.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Whenever&#13;possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value.&#13;In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant&#13;to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors&#13;specific to the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels&#13;of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level&#13;    1&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level&#13;    2&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level&#13;    3&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(In&#13;    thousands)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Assets as of December&#13;    31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;93,843&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17,140&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - warrants (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;757&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - common stock (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;743&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    recurring fair value measurements as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17,883&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;94,600&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Assets as of December&#13;    31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;33,642&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,012&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - warrants (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,064&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - common stock (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,395&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    recurring fair value measurements as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8,407&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;35,706&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities as of December&#13;    31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Profits&#13;    interest units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Series&#13;    A warrants&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,568&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Embedded&#13;    derivative liability&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    liabilities as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,159&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities as of December&#13;    31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Profits&#13;    interest units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    liabilities as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;The following table sets forth&#13;a summary of the changes in the estimated fair value of the Company&amp;#8217;s embedded derivative, which is measured at fair value&#13;as a Level 3 liability on a recurring basis:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Embedded&#13;    Derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Opening balance as of&#13;    January 1, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 83%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Issuance&#13;    of Series A redeemable convertible preferred stock with embedded derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;21,232&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Remeasurement&#13;    of Series A redeemable convertible preferred stock embedded derivative to fair value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    Level 3 recurring fair value measurements as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Cash and&#13;Cash Equivalents&lt;/i&gt;.&amp;#160;&amp;#160;Acacia considers all highly liquid, trading securities with original maturities of three months&#13;or less when purchased to be cash equivalents. For the periods presented, Acacia&amp;#8217;s cash equivalents are comprised of investments&#13;in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper,&#13;securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase&#13;agreements. Acacia&amp;#8217;s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Long Term&#13;Restricted Cash&lt;/i&gt;.&amp;#160;&amp;#160;Long-term restricted cash relates to the proceeds received from the issuance of Series A redeemable&#13;convertible preferred stock (the &amp;#8220;Series A Redeemable Convertible Preferred Stock&amp;#8221;) which are held in an escrow account.&#13;The amounts are to be released to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition&#13;by the Company or (ii) the conversion of Series A Redeemable Convertible Preferred Stock into common stock (see Note 16).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Trading&#13;Securities- Debt.&amp;#160;&amp;#160;&lt;/i&gt;Investments in debt securities are reported at fair value on a recurring basis, with related&#13;realized and unrealized gains and losses recorded in the statements of operations in other income (expense). Realized and unrealized&#13;gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Trading&#13;Securities - Equity. &lt;/i&gt;Investments in equity securities are reported at fair value on a recurring basis, with related realized&#13;and unrealized gains and losses in the value of such securities recorded in the statements of operations in other income (expense).&#13;Dividend income is included in other income (expense).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Impairment&#13;of Other Investments. &lt;/i&gt;Acacia evaluates its investments in marketable securities for potential impairment, employing a methodology&#13;on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment&#13;exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument&#13;issuers, the duration and extent to which the fair value is less than cost, and the Company&amp;#8217;s intent and ability to hold,&#13;or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined&#13;by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary.&#13;Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment&#13;as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent&#13;to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating&#13;that the investment&amp;#8217;s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary.&#13;All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence,&#13;the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale,&#13;unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Concentration&#13;of Credit Risks.&amp;#160;&amp;#160;&lt;/i&gt;Financial instruments that potentially subject Acacia to concentrations of credit risk are cash&#13;equivalents, trading securities and accounts receivable. Acacia places its cash equivalents and trading securities primarily in&#13;highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits&#13;with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant&#13;losses on its deposits of cash and cash equivalents.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Three licensees&#13;individually accounted for 43%, 22% and 15%, respectively, of revenues recognized during the year ended December&amp;#160;31, 2019.&#13;Three licensees individually accounted for 45%, 17% and 17%, respectively, of revenues recognized during the year ended December&amp;#160;31,&#13;2018. Two licensees individually represented approximately 70% and 17%, respectively, of accounts receivable at December&amp;#160;31,&#13;2019. Four licensees individually represented approximately 38%, 36%, 12% and 11%, respectively, of accounts receivable at December&amp;#160;31,&#13;2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;For 2019&#13;and 2018, 39% and 26%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the&#13;jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company&#13;does not have any material foreign operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Acacia performs&#13;credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit&#13;losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not&#13;required. An allowance for doubtful accounts may be established to reflect the Company&amp;#8217;s best estimate of probable losses&#13;inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating&#13;expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts,&#13;historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the&#13;periods presented.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Fair Value&#13;of Financial Instruments.&amp;#160;&amp;#160;&lt;/i&gt;The carrying value of cash and cash equivalents, restricted cash, accounts receivables,&#13;and current liabilities approximates their fair values due to their short-term maturities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Property&#13;and Equipment.&amp;#160;&amp;#160;&lt;/i&gt;Property and equipment are recorded at cost. Major additions and improvements that materially extend&#13;useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations&#13;as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain&#13;or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization&#13;is computed on a straight-line basis over the following estimated useful lives of the assets:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; width: 57%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture&#13;    and fixtures&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; width: 43%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 to 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Computer hardware and&#13;    software&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3 to 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2 to 5 years (Lesser&#13;    of lease term or useful life of improvement)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Rental payments&#13;on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease&#13;term.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Patents.&lt;/i&gt;&amp;#160;&amp;#160;Patents&#13;include the cost of patents or patent rights (hereinafter, collectively &amp;#8220;patents&amp;#8221;) acquired from third-parties or&#13;obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining&#13;economic useful lives, ranging from one to five years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Leases.&#13;&lt;/i&gt;The Company adopted ASC 842 as of January 1, 2019, electing the practical expedient approaches. The primary impact of adopting&#13;ASC 842 for the Company was the recognition in the consolidated balance sheet of certain lease-related assets and liabilities&#13;for operating leases with terms longer than 12 months. Such amounts were not previously accounted for in the Company's consolidated&#13;balance sheets. The Company&amp;#8217;s leases primarily consist of facility leases which are classified as operating leases. The&#13;Company assesses whether an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual&#13;payments under all leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right&#13;to use the underlying asset for the lease term. Upon adoption of ASC 842 on January 1, 2019, the carrying value of certain lease&#13;related liabilities for its excess of lease payments over anticipated sublease income existing at that date, was offset against&#13;the related right-of-use assets. Lease expense is recognized on a straight-line basis over the lease term.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Investments&#13;at Fair Value&lt;/i&gt;. On an individual investment basis, Acacia may elect to account for investments in companies where the Company&#13;has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the&#13;fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it&#13;is applied to all of the financial interests in the same entity that are eligible items (i.e., common stock and warrants).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Other&#13;Investments&lt;/i&gt;. Equity investments in common stock and in-substance common stock without readily determinable fair values in&#13;companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method&#13;of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings&#13;(losses) of investee in the consolidated statements of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Investments&#13;in preferred stock with substantive liquidation preferences are accounted for at cost, (subject to impairment considerations,&#13;as described below, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions&#13;for identical or similar investments of the same issuer. In-substance common stock is an investment in an entity that has risk&#13;and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with&#13;substantive liquidation preferences over common stock, is not substantially similar to common stock, and therefore is not considered&#13;in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that&#13;is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in&#13;an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation,&#13;the investment will not participate in substantially all of the investee's losses, if any.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;The initial&#13;determination of whether an investment is substantially similar to common stock is made on the initial date of investment if the&#13;Company has the ability to exercise significant influence over the operating and financial policies of the investee. That determination&#13;is reconsidered if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure&#13;of the investee, including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional&#13;interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics&#13;of the investment at the date at which the Company obtains the additional interest. Refer to Note 6 for additional information.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Impairment&#13;of Investments. &lt;/i&gt;Acacia reviews its investments quarterly for indicators of other-than-temporary impairment. This determination&#13;requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating&#13;potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors,&#13;general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific&#13;adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance,&#13;changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary,&#13;an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Impairment&#13;of Long-lived Assets.&lt;/i&gt; Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly&#13;for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the&#13;event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the&#13;asset, an impairment loss is recorded equal to the excess of the asset&amp;#8217;s carrying value over its fair value. If an asset&#13;is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market&#13;prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of&#13;estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment&#13;loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Fair value&#13;is generally estimated using the &amp;#8220;Income Approach,&amp;#8221; focusing on the estimated future net income-producing capability&#13;of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted&#13;to present value through &amp;#8220;discounting,&amp;#8221; including an estimated rate of return that accounts for both the time value&#13;of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for&#13;the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations,&#13;such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other&#13;estimates of out-of-pocket expenses associated with a specific patent portfolio&amp;#8217;s licensing and enforcement program. The&#13;analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation,&#13;periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information&#13;that could impact future net cash flows.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Contingent&#13;Liabilities. &lt;/i&gt;The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside&#13;counsel handling its defense in these matters and the Company&amp;#8217;s analysis of potential outcomes, if the Company determines&#13;that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is&#13;recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range&#13;that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in&#13;the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate&#13;of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense&#13;in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation&#13;services were provided.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Certain of&#13;Acacia&amp;#8217;s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In&#13;connection with any of Acacia&amp;#8217;s operating subsidiaries&amp;#8217; patent enforcement actions, it is possible that a defendant&#13;may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal&#13;rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions.&#13;In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney&amp;#8217;s fees&#13;and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries,&#13;could materially harm the Company&amp;#8217;s operating results and financial position.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Stock-Based&#13;Compensation.&lt;/i&gt; The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the&#13;award, and is recognized as an expense on a straight-line basis over the employee&amp;#8217;s requisite service period (generally&#13;the vesting period of the equity award). The fair value of restricted stock and restricted stock units awards is determined by&#13;the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair&#13;value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted&#13;for as they occur.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;No stock&#13;options were granted during the year ended December 31, 2019. The fair values of stock options granted during the year ended December&#13;31, 2018 were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;For&#13;    the Year Ended&lt;br /&gt; December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free&#13;    interest rate&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2.26%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;Term&lt;/font&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;4.37&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;Volatility&lt;/font&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;51%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Due to a&#13;lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the&#13;expected term. Expected volatility is based on the historical volatility of the Company&amp;#8217;s stock for the length of time corresponding&#13;to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for&#13;the expected term of the option.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Restricted&#13;stock units awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over&#13;a three-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options&#13;utilizing a Monte Carlo valuation technique. Compensation cost is recognized with a market-based vesting condition provided that&#13;the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. Assumptions utilized in connection&#13;with the Monte Carlo valuation technique included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected&#13;volatility of 38 percent; and expected dividend yield of 0 percent. The risk-free interest rate was determined based on the yields&#13;available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility.&#13;The expected dividend yield was based on expectations regarding dividend payments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Profits Interest&#13;Units (&amp;#8220;Units&amp;#8221;) are accounted for in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 718-10,&#13;&amp;#8220;Compensation - Stock Compensation.&amp;#8221; The Units vest as described at Note 9, and therefore, the vesting conditions&#13;do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified&#13;as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period&#13;at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated&#13;for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis&#13;over the employee&amp;#8217;s requisite service period (generally the vesting period of the equity award) which was five years. Upon&#13;full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation&#13;expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until&#13;the Units are settled. The Company has a purchase option to purchase the vested Units that are not otherwise forfeited after termination&#13;of continuous service. The exercise price of the purchase option is the fair market value of the Units on the date of termination&#13;of continuous service. At each reporting date, the value of the Units that are subject to the purchase option will be the measured&#13;at the fair value on the termination date. Non-cash stock compensation expense related to the Units is reflected in general and&#13;administrative expense in the accompanying consolidated statements of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Series&#13;A Warrants. &lt;/i&gt;The fair value of the Series A warrants (the &amp;#8220;Series A Warrants&amp;#8221;) is estimated using a Black-Scholes&#13;option-pricing model. The fair value of the Series A Warrants as of December 31, 2019 was estimated based on the following assumptions:&#13;volatility of 30 percent, risk-free rate of 1.85 percent, term of 7.79 years and a dividend yield of 0 percent.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Embedded&#13;derivatives. &lt;/i&gt;Embedded derivatives that are required to be bifurcated from their host contract are valued separately from host&#13;instrument. A binomial lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable&#13;Convertible Preferred Stock (see Note 16). The binomial model utilizes the Tsiveriotis and Fernandes (&amp;#8220;TF&amp;#8221;) implementation&#13;in which a convertible instrument is split into two separate components: a cash-only component which is subject to the selected&#13;risk-adjusted discount rate and an equity component which is subject only to the risk-free rate. The model considers the (i) implied&#13;volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield,&#13;(v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various conversion and redemption scenarios.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;The implied&#13;volatility of the Company&amp;#8217;s common stock is estimated based on a haircut applied to the historical volatility. A volatility&#13;haircut is a concept used to describe a commonly observed occurrence in which the volatility implied by market prices involving&#13;options, warrants, and convertible debt is lower than historical actual realized volatility. The assumed base case term used in&#13;the valuation model is the period remaining until November 15, 2027 (the maturity date). The risk-free interest rate is based&#13;on the yield on the U.S. Treasury with a remaining term equal to the expected term of the conversion and early redemption options.&#13;The significant assumptions utilized in the Company&amp;#8217;s valuation of the embedded derivative at December 31, 2019 are as follows:&#13;volatility of 30 percent, risk-free rate of 1.86 percent, a credit spread of 25 percent and a dividend yield of 0 percent. The&#13;fair value measurement of the embedded derivative is sensitive to these assumptions and changes in these assumptions could result&#13;in a materially different fair value measurement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Income&#13;Taxes.&amp;#160;&amp;#160;&lt;/i&gt;Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred&#13;tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia&amp;#8217;s consolidated&#13;financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if&#13;all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding&#13;future realization of such assets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;Under U.S.&#13;generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected&#13;to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions&#13;are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position&#13;will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability&#13;weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Segment&#13;Reporting.&lt;/i&gt;&amp;#160;&amp;#160;Acacia uses the management approach, which designates the internal organization that is used by management&#13;for making operating decisions and assessing performance as the basis of Acacia&amp;#8217;s reportable segments. Acacia&amp;#8217;s patent&#13;licensing and enforcement business constitutes its single reportable segment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Use of&#13;Estimates&lt;/i&gt;.&amp;#160;&amp;#160;The preparation of financial statements in conformity with generally accepted accounting principles&#13;in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets&#13;and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the&#13;reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia&#13;believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition,&#13;the valuation of the equity instruments discussed at Note 6, the valuation of Series A redeemable convertible preferred stock,&#13;Series A warrants and embedded derivatives, stock-based compensation expense, impairment of patent-related intangible assets,&#13;the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against&#13;net deferred tax assets, require its most difficult, subjective or complex judgments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Loss Per&#13;Share.&amp;#160;&amp;#160;&lt;/i&gt;For periods in which the Company generates net income, the Company computes earnings per share attributable&#13;to common stockholders using the two-class method required for capital structures that include participating securities. Under&#13;the two-class method, securities that participate in non-forfeitable dividends, such as the Company&amp;#8217;s outstanding unvested&#13;restricted stock and Series A Redeemable Convertible Preferred Stock, are considered participating securities and are allocated&#13;a portion of the Company&amp;#8217;s earnings. For periods in which the Company generates a net loss, net losses are not allocated&#13;to holders of the Company&amp;#8217;s participating securities as the security holders are not contractually obligated to share in&#13;the Company&amp;#8217;s losses.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;For the periods&#13;presented, due to the Company&amp;#8217;s net loss, the Company did not apply the two-class method to allocate earnings to the participating&#13;securities. Basic net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the&#13;weighted average number of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed&#13;by dividing net loss attributable to common stockholders by the weighted average number of common and dilutive common equivalent&#13;shares outstanding for the period using the treasury stock method or the as-converted method. Potentially dilutive common stock&#13;equivalents consist of stock options, restricted stock units, unvested restricted stock, Series A Redeemable Convertible Preferred&#13;Stock, and Series A Warrants.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;The following&#13;table presents the calculation of basic and diluted loss per share of common stock:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(In&#13;    thousands, except percentage change values)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(17,115&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accretion&#13;    of Series A Redeemable Convertible Preferred Stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(307&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(17,422&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49,764,002&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&#13;    net loss per share of common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(0.35&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.10&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(17,115&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Mark-to-market&#13;    adjustment for preferred stock embedded derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    loss attributable to common stockholders - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(20,373&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(105,029&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49,764,002&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effect&#13;    of potentially dilutive securities: Series A preferred stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,132,771&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    shares used in computing net loss per share attributable to common stockholders - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,896,773&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49,969,062&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted&#13;    net loss per share of common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(0.40&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2.10&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;As the Company&#13;reported a net loss for the years ended December 31, 2019 and 2018, all potentially dilutive shares of common stock other than&#13;those associated with the Series A Redeemable Convertible Preferred Stock have been excluded from the calculation of diluted net&#13;loss per share of common stock because including such instruments would be anti-dilutive.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;i&gt;Treasury&#13;Stock&lt;/i&gt;. Repurchases of the Company&amp;#8217;s outstanding common stock are accounted for using the cost method. The applicable&#13;par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any&#13;excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock&#13;on the consolidated balance sheets.&lt;/font&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Principles of Consolidation.&amp;#160;&amp;#160;&lt;/i&gt;The&#13;accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled&#13;subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Noncontrolling interests in&#13;Acacia&amp;#8217;s majority-owned and controlled operating subsidiaries (&amp;#8220;noncontrolling interests&amp;#8221;) are separately presented&#13;as a component of stockholders&amp;#8217; equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss&#13;attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements&#13;of Series A redeemable convertible preferred stock and stockholders&amp;#8217; equity for total noncontrolling interests.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;A wholly owned subsidiary of Acacia is the&#13;general partner of the Acacia Intellectual Property Fund, L.P. (the &amp;#8220;Acacia IP Fund&amp;#8221;), which was formed in August 2010.&#13;The Acacia IP Fund is included in the Company&amp;#8217;s consolidated financial statements since 2010, as Acacia&amp;#8217;s wholly owned&#13;subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia&#13;IP Fund was terminated as of December 31, 2017 and is in the process of being liquidated.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Fair Value Measurements.&lt;/i&gt; U.S. GAAP&#13;defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability&#13;in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and&#13;also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The&#13;three-level hierarchy of valuation techniques established to measure fair value is defined as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 96px"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(i)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level 1 - &lt;i&gt;Observable Inputs&lt;/i&gt;:&amp;#160;&amp;#160;Quoted prices in active markets for identical investments;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 96px"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(ii)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level 2 - &lt;i&gt;Pricing Models with Significant Observable Inputs&lt;/i&gt;:&amp;#160;&amp;#160;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="font-size: 10pt; width: 96px"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(iii)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level 3 - &lt;i&gt;Unobservable Inputs&lt;/i&gt;:&amp;#160;&amp;#160;Significant unobservable inputs, including the entity&amp;#8217;s own assumptions in determining the fair value of investments.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Whenever possible,&#13;the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases,&#13;the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair&#13;value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to&#13;the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair&#13;value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level&#13;    1&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level&#13;    2&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level&#13;    3&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Assets as of December 31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;93,843&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,140&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - warrants (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;757&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - common stock (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;743&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    recurring fair value measurements as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,883&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;94,600&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Assets as of December 31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;33,642&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,012&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - warrants (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2,064&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - common stock (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;5,395&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    recurring fair value measurements as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;8,407&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;35,706&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Liabilities as of December 31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Profits&#13;    interest units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Series&#13;    A warrants&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,568&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Embedded&#13;    derivative liability&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    liabilities as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4,159&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Liabilities as of December 31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Profits&#13;    interest units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    liabilities as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table sets forth a summary of the changes in the&#13;estimated fair value of the Company&amp;#8217;s embedded derivative, which is measured at fair value as a Level 3 liability on a recurring&#13;basis:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Embedded&#13;    Derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Opening balance as of January 1, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 83%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Issuance&#13;    of Series A redeemable convertible preferred stock with embedded derivative&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;21,232&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement&#13;    of Series A redeemable convertible preferred stock embedded derivative to fair value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total Level 3&#13;    recurring fair value measurements as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level&#13;    1&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level&#13;    2&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Level&#13;    3&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Assets as of December 31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;93,843&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,140&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - warrants (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;757&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - common stock (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;743&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    recurring fair value measurements as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,883&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;94,600&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Assets as of December 31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;33,642&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,012&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - warrants (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2,064&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Investment&#13;    at fair value - common stock (Note 6)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;5,395&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    recurring fair value measurements as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;8,407&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;35,706&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Liabilities as of December 31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Profits&#13;    interest units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Series&#13;    A warrants&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,568&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Embedded&#13;    derivative liability&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    liabilities as of December 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;4,159&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,974&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Liabilities as of December 31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Profits&#13;    interest units&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    liabilities as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;591&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;.&amp;#160;&amp;#160;Acacia&#13;considers all highly liquid, trading securities with original maturities of three months or less when purchased to be cash equivalents.&#13;For the periods presented, Acacia&amp;#8217;s cash equivalents are comprised of investments in AAA rated money market funds that invest&#13;in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S.&#13;government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia&amp;#8217;s cash equivalents&#13;are measured at fair value using quoted prices that represent Level 1 inputs.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Long Term Restricted Cash&lt;/i&gt;.&amp;#160;&amp;#160;Long-term&#13;restricted cash relates to the proceeds received from the issuance of Series A redeemable convertible preferred stock (the &amp;#8220;Series&#13;A Redeemable Convertible Preferred Stock&amp;#8221;) which are held in an escrow account. The amounts are to be released to the Company&#13;upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the conversion of&#13;Series A Redeemable Convertible Preferred Stock into common stock (see Note 16).&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <ACTG:ImpairmentOfInvestmentsPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Impairment of Other Investments. &lt;/i&gt;Acacia&#13;evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis&#13;that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its&#13;estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument&#13;issuers, the duration and extent to which the fair value is less than cost, and the Company&amp;#8217;s intent and ability to&#13;hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates&#13;determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be&#13;other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the&#13;classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless&#13;(a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying&#13;amount and (b) positive evidence indicating that the investment&amp;#8217;s carrying amount is recoverable within a reasonable&#13;period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to&#13;determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a&#13;reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary&#13;are recognized in the consolidated statements of operations.&lt;/p&gt;</ACTG:ImpairmentOfInvestmentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Concentration of Credit Risks.&amp;#160;&amp;#160;&lt;/i&gt;Financial&#13;instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, trading securities and accounts&#13;receivable. Acacia places its cash equivalents and trading securities primarily in highly rated money market funds and investment&#13;grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may,&#13;at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash&#13;equivalents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Three licensees individually accounted for&#13;43%, 22% and 15%, respectively, of revenues recognized during the year ended December&amp;#160;31, 2019. Three licensees individually&#13;accounted for 45%, 17% and 17%, respectively, of revenues recognized during the year ended December&amp;#160;31, 2018. Two licensees&#13;individually represented approximately 70% and 17%, respectively, of accounts receivable at December&amp;#160;31, 2019. Four licensees&#13;individually represented approximately 38%, 36%, 12% and 11%, respectively, of accounts receivable at December&amp;#160;31, 2018.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For 2019 and 2018, 39% and 26%, respectively,&#13;of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated&#13;to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia performs credit evaluations of its&#13;licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable&#13;are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful&#13;accounts may be established to reflect the Company&amp;#8217;s best estimate of probable losses inherent in the accounts receivable&#13;balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of&#13;operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and&#13;other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Stock-Based&#13;Compensation.&lt;/i&gt; The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the&#13;award, and is recognized as an expense on a straight-line basis over the employee&amp;#8217;s requisite service period (generally&#13;the vesting period of the equity award). The fair value of restricted stock and restricted stock units awards is determined by&#13;the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair&#13;value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted&#13;for as they occur.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;No stock options were granted during the&#13;year ended December 31, 2019. The fair values of stock options granted during the year ended December 31, 2018 were estimated&#13;using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;For the Year&#13;    Ended&lt;br /&gt; December 31, 2018&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"&gt;2.26%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Term&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;4.37&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;51%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&amp;#8211;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Due to a lack of sufficient historical stock&#13;option exercise experience, the Company utilized the simplified method for estimating the expected term. Expected volatility&#13;is based on the historical volatility of the Company&amp;#8217;s stock for the length of time corresponding to the expected term of&#13;the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the&#13;option.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Restricted stock units awards with market-based&#13;vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of&#13;a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation&#13;technique. Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered,&#13;regardless of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation&#13;technique included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent;&#13;and expected dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury&#13;zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield&#13;was based on expectations regarding dividend payments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Profits Interest Units (&amp;#8220;Units&amp;#8221;)&#13;are accounted for in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 718-10, &amp;#8220;Compensation - Stock&#13;Compensation.&amp;#8221; The Units vest as described at Note 9, and therefore, the vesting conditions do not meet the definition of&#13;service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability&#13;classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award&#13;is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite&#13;service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&amp;#8217;s requisite&#13;service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred&#13;during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the&#13;period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. The Company has a&#13;purchase option to purchase the vested Units that are not otherwise forfeited after termination of continuous service. The exercise&#13;price of the purchase option is the fair market value of the Units on the date of termination of continuous service. At each reporting&#13;date, the value of the Units that are subject to the purchase option will be the measured at the fair value on the termination&#13;date. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying&#13;consolidated statements of operations.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <ACTG:WarrantPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Series A Warrants. &lt;/i&gt;The fair value&#13;of the Series A warrants (the &amp;#8220;Series A Warrants&amp;#8221;) is estimated using a Black-Scholes&#13;option-pricing model. The fair value of the Series A Warrants as of December 31, 2019 was estimated based on the following assumptions:&#13;volatility of 30 percent, risk-free rate of 1.85 percent, term of 7.79 years and a dividend yield of 0 percent.&lt;/p&gt;</ACTG:WarrantPolicyTextBlock>
    <us-gaap:DerivativesEmbeddedDerivatives contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Embedded derivatives. &lt;/i&gt;Embedded derivatives&#13;that are required to be bifurcated from their host contract are valued separately from host instrument. A binomial lattice framework&#13;is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock (see Note&#13;16). The binomial model utilizes the Tsiveriotis and Fernandes (&amp;#8220;TF&amp;#8221;) implementation in which a convertible instrument&#13;is split into two separate components: a cash-only component which is subject to the selected risk-adjusted discount rate and an&#13;equity component which is subject only to the risk-free rate. The model considers the (i) implied volatility of the value of our&#13;common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield, (v) dividend accrual (and a step-up&#13;in rates), and (vi) event probabilities of the various conversion and redemption scenarios.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The implied volatility of the Company&amp;#8217;s&#13;common stock is estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe&#13;a commonly observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt&#13;is lower than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining&#13;until November 15, 2027 (the maturity date). The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining&#13;term equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&amp;#8217;s&#13;valuation of the embedded derivative at December 31, 2019 are as follows: volatility of 30 percent, risk-free rate of 1.86&#13;percent, a credit spread of 25 percent and a dividend yield of 0 percent. The fair value measurement of the embedded derivative&#13;is sensitive to these assumptions and changes in these assumptions could result in a materially different fair value measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;</us-gaap:DerivativesEmbeddedDerivatives>
    <us-gaap:UseOfEstimates contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;.&amp;#160;&amp;#160;The&#13;preparation of financial statements in conformity with generally accepted accounting principles in the United States of America&#13;requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure&#13;of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues&#13;and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant&#13;accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the equity&#13;instruments discussed at Note 6, the valuation of Series A redeemable convertible preferred stock, Series A warrants and embedded&#13;derivatives, stock-based compensation expense, impairment of patent-related intangible assets, the determination of the economic&#13;useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its&#13;most difficult, subjective or complex judgments.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;3.&amp;#160;&amp;#160;TRADING SECURITIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Trading securities for the&#13;periods presented were comprised of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Cost&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Gross&lt;br /&gt;&#13;    Unrealized&lt;br /&gt; Gain&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Gross&lt;br /&gt;&#13;    Unrealized&lt;br /&gt; Loss&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Fair&#13;    Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Security&amp;#160;Type&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;December 31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 28%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;93,712&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;143&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(12&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;93,843&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,674&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;211&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(745&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,140&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;111,386&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;354&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;110,983&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;December 31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading securities&#13;    - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;33,643&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(19&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;33,642&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,389&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(404&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,012&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;37,032&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(423&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;36,654&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Trading securities as of December 31, 2019&#13;and 2018, were comprised of investments in corporate bonds (debt securities) and investments in equity securities of publicly&#13;held companies (equity securities). For the year ended December 31, 2019, proceeds from the sale and maturity of debt securities&#13;and equity securities were $49,751,000 and $25,339,000, respectively. For the year ended December&amp;#160;31, 2018, proceeds from&#13;the sale and maturity of debt securities and equity securities were $65,144,000 and $1,496,000, respectively.&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;5.&amp;#160;&amp;#160;PATENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia&amp;#8217;s only identifiable intangible&#13;assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to five years. For all periods&#13;presented, all of Acacia&amp;#8217;s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated&#13;amortization related to investments in intangible assets as of December 31, 2019 and 2018 are as follows (in thousands):&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Gross carrying&#13;    amount - patents&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;330,588&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;326,167&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accumulated&#13;    amortization - patents&lt;sup&gt;(1)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(322,774&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(319,580&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Patents,&#13;    net&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;7,814&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;6,587&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;sup&gt;(1)&lt;/sup&gt; &lt;font style="font-size: 8pt"&gt;Includes&#13;patent impairment charges for the applicable periods.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The weighted-average remaining estimated&#13;economic useful life of Acacia&amp;#8217;s patents and patent rights is 4 years. Scheduled annual aggregate amortization expense is&#13;estimated to be $2,555,000 in 2020, $1,695,000 in 2021, $1,695,000 in 2022, $1,620,000 in 2023 and $249,000 in 2024.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia did not record charges related to&#13;the impairment of patent-related intangible assets for the year ended December 31, 2019. Acacia recorded impairment of patent-related&#13;intangible asset charges totaling $28,210,000 for the year ended December 31, 2018. The impairment charges related to impairments&#13;of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management&#13;determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios,&#13;due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future&#13;resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment&#13;charges for the periods presented consisted of the excess of the asset&amp;#8217;s carrying value over its estimated fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For the year ended December 31, 2018, pursuant&#13;to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights&#13;to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling $8,307,000.&#13;There is no accelerated amortization or sales for patent-related assets for the year ended December 31, 2019.&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 46%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Gross carrying&#13;    amount - patents&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;330,588&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;326,167&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accumulated&#13;    amortization - patents&lt;sup&gt;(1)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(322,774&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(319,580&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Patents,&#13;    net&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;7,814&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;6,587&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;sup&gt;(1)&lt;/sup&gt; &lt;font style="font-size: 8pt"&gt;Includes&#13;patent impairment charges for the applicable periods.&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;8.&amp;#160;&amp;#160;INCOME TAXES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&amp;#8217;s income tax benefit (expense) for the fiscal periods&#13;presented consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Current:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Federal&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; width: 46%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(87&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Foreign&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,858&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,092&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    current&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,824&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,179&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Deferred:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Federal&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Income&#13;    tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,824&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,179&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;The&#13;tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities&#13;consist of the following at &lt;/font&gt;December 31, 2019 and 2018&lt;font style="font-family: Times New Roman, Times, Serif"&gt;:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(in thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Deferred&#13;    tax assets:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    operating loss and capital loss carryforwards and credits&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;112,280&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;104,862&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Unrealized&#13;    loss on investments held at fair value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;538&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2,455&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Stock&#13;    compensation&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;358&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,365&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Fixed&#13;    assets and intangibles&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,316&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,330&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Basis&#13;    of investments in affiliates&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;300&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;286&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Accrued&#13;    liabilities and other&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;631&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;208&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&#13;    taxes&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;25&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;26&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred tax assets&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;115,448&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;112,532&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Valuation&#13;    allowance&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(115,077&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(112,514&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred tax assets, net of valuation allowance&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;371&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Deferred&#13;    tax liabilities:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;ROU&#13;    Asset&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(347&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(24&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;    deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(371&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(18&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    deferred tax assets (liabilities)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;A reconciliation of the federal statutory&#13;income tax rate and the effective income tax rate is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Statutory&#13;    federal tax rate - (benefit) expense&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;21%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;21%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;State&#13;    income and foreign taxes, net of federal tax effect&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;7%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Foreign&#13;    tax credit&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Noncontrolling&#13;    interests in operating subsidiaries&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Nondeductible&#13;    permanent items&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Change&#13;    in tax rate&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Expired capitalized&#13;    loss&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(2)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Valuation&#13;    allowance&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(13)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(20)%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(4)%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#8211;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;10%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1)%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;For the periods presented, the Company recorded&#13;full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance&#13;set forth in ASC 740, &amp;#8220;Income Taxes.&amp;#8221; In future periods, if the Company determines it will more likely than not be&#13;able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will&#13;generally be recognized in the statements of operations in the period the determination is made.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;At December&amp;#160;31, 2019, Acacia had U.S.&#13;federal and state income tax net operating loss carryforwards (&amp;#8220;NOLs&amp;#8221;) totaling approximately $253,824,000 and $19,683,000,&#13;respectively. For federal income tax purposes, our NOL carryovers generated for tax years beginning before January 1, 2018 will&#13;begin to expire in 2026. Pursuant to the Tax Cuts and Jobs Act enacted by the U.S. federal government in December 2017, for federal&#13;income tax purposes, NOL carryovers generated for our tax years beginning January 1, 2018 can be carried forward indefinitely&#13;but will be subject to a taxable income limitation. For state income tax purposes, our NOLs will expire between 2028 and 2039.&#13;Our capital loss carryovers totaled $23,652,000 at December&amp;#160;31, 2019, expiring between 2025 and 2029.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;As of December&amp;#160;31, 2019, Acacia had&#13;approximately $51,508,000 of foreign tax credits, expiring between 2020 and 2026. In general, foreign taxes withheld may be claimed&#13;as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject&#13;to certain limitations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Tax expense (benefit) for the periods presented&#13;primarily reflects foreign taxes withheld and refunded on revenue agreements executed with licensees in foreign jurisdictions&#13;and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were 23% for fiscal&#13;year 2019 and 19% for fiscal year 2018. Results for fiscal year 2019 included an unrealized loss on Acacia&amp;#8217;s investment&#13;in Veritone which created a deferred tax asset totaling approximately $538,000. Results for fiscal year 2018 included an unrealized&#13;loss on Acacia&amp;#8217;s investment in Veritone which created a deferred tax asset totaling approximately $2,455,000. The 2017 deferred&#13;tax liability was reversed in fiscal year 2018 as a result of the 2018 unrealized loss on Acacia&amp;#8217;s investment in Veritone&#13;and the realized loss on the sale of Veritone common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia is subject to taxation in the U.S.&#13;and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign&#13;jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities&#13;for years before 2011. The California Franchise Tax Board is auditing the 2011 through 2016 California combined income tax returns.&#13;The California Franchise Tax Board has proposed adjustments for 2011 and 2012 that, if expensed, would not be material to the consolidated&#13;statements of operations for the periods presented. We have protested these adjustments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;At December&amp;#160;31, 2019 and 2018, the&#13;Company had total unrecognized tax benefits of approximately $731,000 and $816,000, respectively. No interest and penalties have&#13;been recorded for the unrecognized tax benefits for the periods presented. At December 31, 2019, if recognized, approximately $731,000&#13;of tax benefits, net of valuation allowance, would impact the Company&amp;#8217;s effective tax rate. The Company does not expect that&#13;the liability for unrecognized tax benefits will change significantly within the next 12 months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia recognizes interest and&#13;penalties with respect to unrecognized tax benefits in income tax expense (benefit). Acacia has identified no uncertain tax position&#13;for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or&#13;decrease within 12 months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;14.&amp;#160;&amp;#160;FAIR VALUE DISCLOSURES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia holds&#13;the following types of financial instruments at December 31, 2019 and 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Trading securities - debt. &lt;/i&gt;Debt securities&#13;includes corporate bonds with fair value that is determined by third party quotations from outside pricing services and/or computerized&#13;pricing models, which may be based on transactions, bids or estimates. Acacia classifies the fair value of corporate bonds within&#13;Level 2 of the valuation hierarchy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Trading securities - equity. &lt;/i&gt;Equity&#13;securities includes investments in public companies common stock and are recorded at fair value based on the quoted market price&#13;of each share on the valuation date. The fair value of these securities are within Level 1 of the valuation hierarchy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Investments at fair value - common stock&lt;/i&gt;.&#13;Acacia&amp;#8217;s equity investment in Veritone common stock is recorded at fair value based on the quoted market price of Veritone&amp;#8217;s&#13;common stock on the applicable valuation date (Level 1).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Investments at fair value - warrants.&#13;&lt;/i&gt;Warrants are recorded at fair value, as based on the Black-Scholes option-pricing model (Level 2).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Profits&#13;interests. &lt;/i&gt;For the years ended December&amp;#160;31, 2019 and 2018, the fair value of the Units was estimated at 40% of the fair&#13;value of the 10% Warrant, based on the Black-Scholes option-pricing model (Level 2).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Series A&#13;Warrants. &lt;/i&gt;Series A Warrants are recorded at fair value, using Black-Scholes option-pricing model (Level 2).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Embedded derivative liability. &lt;/i&gt;Embedded&#13;derivatives that are required to be bifurcated from their host contract are evaluated and valued separately from the host instrument.&#13;A binomial lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible&#13;Preferred Stock issued by the Company in 2019 (Level 3).&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;15.&amp;#160;&amp;#160;RELATED PARTY TRANSACTIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;During&#13;the year ended December 31, 2019, the Company purchased shares of common stock of Drive Shack, Inc. (&amp;#8220;Drive Shack&amp;#8221;)&#13;for an aggregate purchase price of $2.4 million. Drive Shack and Clifford Press, Chief Executive Officer and director of Acacia,&#13;are related parties as Mr. Press is a board member of Drive Shack. During&#13;the year ended December 31, 2018, the Company paid $976,000 in expenses related to the reimbursement of costs incurred by Sidus&#13;Investment Management, LLC (&amp;#8220;Sidus&amp;#8221;) on behalf of the participants (together with Sidus, the &amp;#8220;Participants&amp;#8221;)&#13;named in the proxy statement filed on June 7, 2018 by the Participants, in connection with a contested proxy election. These expenses&#13;are included in general and administrative expenses on the consolidated statements of operations. Alfred V. Tobia, Jr. and Clifford&#13;Press are related parties as each of them are Participants and members of the Company&amp;#8217;s Board of Directors. In addition,&#13;Sidus is a related party as Mr. Tobia is a Co-Founder and Managing Member at Sidus.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2019-01-01to2019-12-31_custom_DriveShackMember" unitRef="USD" decimals="-3">2400000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PreferredStockTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;16.&amp;#160;&amp;#160;SERIES A REDEEMABLE CONVERTIBLE PREFERRED&#13;STOCK&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;On November 18, 2019, the Company entered&#13;into a Securities Purchase Agreement with Starboard Value LP (&amp;#8220;Starboard&amp;#8221;) pursuant to which the Company issued (i)&#13;350,000 shares of Series A Redeemable Convertible Preferred Stock with a par value of $0.001&#13;per share and a stated value of $100 per share, and (ii) Series A Warrants to purchase up to 5,000,000&#13;shares of the Company&amp;#8217;s common stock (see Note 17) to Starboard. The Securities Purchase Agreement also established the terms&#13;of certain senior secured notes and additional warrants (the &amp;#8220;Series B Warrants&amp;#8221;) which may be issued to Starboard&#13;in the future.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Series A Redeemable Convertible Preferred&#13;Stock can be converted into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends,&#13;divided by (ii) the conversion price of $3.65 (subject to certain anti-dilution adjustments). Holders may elect to convert the&#13;Series A Redeemable Convertible Preferred Stock into common stock at any time. The Company may elect to convert the Series A Redeemable&#13;Convertible Preferred Stock into shares of Common Stock any time on or after November 15, 2025, provided that the closing price&#13;of the Company&amp;#8217;s common stock equals or exceeds 190% of the conversion price for 30 consecutive trading days and assuming&#13;certain other conditions of the common stock have been met.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Holders have the option to redeem all or&#13;a portion of the Series A Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and&#13;May 15, 2022 through August 15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of senior&#13;secured notes to Starboard pursuant to the Securities Purchase Agreement. Holders also have the option to redeem all or a portion&#13;of the Series A Redeemable Convertible Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally,&#13;holders have the option to redeem all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of&#13;(i) a change of control or (ii) various other triggering events, such as the suspension from trading or delisting of the Company&amp;#8217;s&#13;common stock. If the Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price&#13;may include a make-whole amount or a stated premium, depending on the redemption scenario.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Company may redeem all, and not less&#13;than all, of the Series A Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May&#13;15, 2022 through August 15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of the senior&#13;secured notes, and assuming certain conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred&#13;Stock is redeemed at the option of the Company, the redemption price would include a make-whole amount or a 15% premium depending&#13;on the circumstances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;If any Series A Redeemable Convertible Preferred&#13;Stock remains outstanding on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in&#13;cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In all redemption scenarios, the redemption&#13;price for the Series A Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In&#13;addition, depending on the redemption scenario, the redemption price may also include a make-whole amount or stated premium as&#13;described above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;If the Company issues senior secured notes,&#13;the Holder may exchange the Series A Redeemable Convertible Preferred Stock for (i) senior secured notes and (ii) Series B Warrants&#13;to purchase common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Series A Redeemable Convertible Preferred&#13;Stock accrues cumulative dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of an approved investment&#13;(an investment to be identified and approved by each of the Company and Starboard), the dividend rate will increase to 8.0% on&#13;the stated value. Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering event occurs before&#13;an approved investment or 10.0% on the stated value if the triggering event occurs after an approved investment. The Series A Redeemable&#13;Convertible Preferred Stock also participates on an as-converted basis in any regular or special dividends paid to common stockholders.&#13;Total accrued and unpaid dividends as of December 31, 2019 was $0.1 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Holders of the Series A Redeemable Convertible&#13;Preferred Stock have the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable&#13;Convertible Preferred Stock will also be entitled to a separate class vote with respect to amendments to the Company&amp;#8217;s organizational&#13;documents that generally have an adverse effect on the Series A Redeemable Convertible Preferred Stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Upon liquidation of the Company, holders&#13;of Series A Redeemable Convertible Preferred Stock have a liquidation preference over holders of our common stock and will be entitled&#13;to receive, prior to any distribution to holders of our common stock, an amount equal to the greater of (i) the stated value plus&#13;accrued and unpaid dividends or (ii) the amount that would have been received if the Series A Redeemable Convertible Preferred&#13;Stock had been converted into common stock immediately prior to the liquidation event at the then effective conversion price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Company determined that certain features&#13;of the Series A Redeemable Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features&#13;are bundled together as a single, compound embedded derivative.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Total proceeds received and transaction&#13;costs incurred from the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $35 million and $1.3 million,&#13;respectively. Proceeds received were allocated based on the fair value of the instrument without the Series&#13;A Warrants and of the Series A Warrants themselves at the time of issuance. The proceeds&#13;allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated between the host preferred stock&#13;instrument and the embedded derivative, with the embedded derivative recorded at fair value and the Series A Redeemable Convertible&#13;Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the Series&#13;A Warrants, embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and&#13;$8.9 million, respectively. Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock&#13;and the Series A Warrants on the same basis as the proceeds. The transaction costs allocated to&#13;the Series A Redeemable Convertible Preferred Stock were treated as a discount to the Series A Redeemable Convertible Preferred&#13;Stock. The transaction costs allocated to the Series A Warrants were expensed as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Company classifies the Series A Redeemable&#13;Convertible Preferred Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various&#13;scenarios or otherwise on November 15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become&#13;redeemable, the Company accretes the instrument to its redemption value using the effective interest method and recognizes any&#13;changes against additional paid in capital in the absence of retained earnings. Accretion for the year ended December 31, 2019&#13;was $0.3 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In connection with the issuance of the Series&#13;A Redeemable Convertible Preferred Stock, the Company executed a Registration Rights Agreement and a Governance Agreement with&#13;Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain registration rights with respect to the&#13;Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon conversion. In accordance with the Governance&#13;Agreement, the Company agreed to (i) increase the size of the Board of Directors from six to seven members, (ii) appoint a director&#13;of the Company, (iii) grant Starboard the right to recommend two additional directors for appointment to the board, (iv) form a&#13;Strategic Committee of the Board tasked with sourcing and performing due diligence on potential acquisition targets, (v) appoint&#13;certain directors to the Strategic Committee, and (vi) appoint a director to the Nominating and Corporate Governance Committee.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The following features of the Series A Redeemable&#13;Convertible Preferred Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded&#13;derivative: (i) the right of the holders to redeem the shares (the &amp;#8220;put option&amp;#8221;), (ii) the right of the holders to&#13;receive common stock upon conversion of the shares (the &amp;#8220;conversion option&amp;#8221;), (iii) the right of the Company to redeem&#13;the shares (the &amp;#8220;call option&amp;#8221;), and (iv) the change in dividend rate upon consummation of an approved investment or&#13;a triggering event (the &amp;#8220;contingent dividend rate feature&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;These features are required to be accounted&#13;for separately from the Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly&#13;and closely related to the debt-like host and also did not meet any other scope exceptions for derivative accounting. Therefore,&#13;these features are bundled together and are accounted for as a single, compound embedded derivative liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Accordingly, we have recorded an embedded&#13;derivative liability representing the combined fair value of each of these features. The embedded derivative liability is adjusted&#13;to reflect fair value at each period end with changes in fair value recorded in the &amp;#8220;Change in fair value of redeemable preferred&#13;stock embedded derivative&amp;#8221; financial statement line item of the accompanying consolidated statements of operations.&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;18.&amp;#160;&amp;#160; QUARTERLY FINANCIAL DATA&#13;(unaudited)&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following table&#13;sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December&amp;#160;31, 2019.&#13;This information has been derived from Acacia&amp;#8217;s unaudited condensed consolidated financial statements that have been prepared&#13;on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments,&#13;consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the&#13;audited consolidated financial statements and related notes thereto. Acacia&amp;#8217;s quarterly results have been, and may in the&#13;future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should&#13;not be relied upon as any indication of the results to be expected in any future periods.&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="23" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Quarter&#13;    Ended&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Dec. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Sept. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Jun. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Mar. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Dec. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Sept. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Jun. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Mar. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="23" style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;(Unaudited, in thousands, except&#13;    share and per share information)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 36%; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;Revenues&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;688&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,711&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,460&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,387&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,203&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;13,725&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;6,485&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;62,093&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Portfolio operations:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Inventor royalties&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;192&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;776&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,623&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,353&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;11,002&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,181&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,241&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;21,744&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Contingent legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;35&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;375&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;177&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;11,756&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,949&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,037&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;15,759&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Patent acquisition expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Litigation and licensing expenses - patents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,160&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;987&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,855&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,801&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,689&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,549&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,639&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,989&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;Amortization of patents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;857&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;863&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;818&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;656&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;11,560&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,952&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,278&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,330&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Other&#13;    portfolio expenses (income)&lt;/font&gt; &lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,581&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(475&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;650&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;400&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,202&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Total portfolio operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,794&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,186&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,671&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;6,637&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;36,407&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;12,833&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;10,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,822&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Net portfolio income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,106&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(475&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(211&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,250&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;12,796&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;892&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,710&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;12,271&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;General and administrative expenses (including&#13;    non-cash stock compensation expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,328&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,630&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,763&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,655&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,754&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,855&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;6,916&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,301&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Impairment of patent-related&#13;    intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;28,210&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Operating income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,434&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,105&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,974&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(6,905&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;10,042&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,963&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(38,836&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;8,970&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Total other income (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,921&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(2,503&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(1,774&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,821&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(21,012&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(27,595&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;10,615&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(40,890&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Income (loss) before provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(1,513&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,748&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,084&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(10,970&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,558&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,221&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(31,920&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,147&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(9&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(314&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(397&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(306&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(285&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(191&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Net income (loss) including noncontrolling interests&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;634&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,398&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,367&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,864&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,506&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,111&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Net (income) loss attributable&#13;    to noncontrolling interests in subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(2&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(331&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Net income (loss) attributable&#13;    to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;634&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,384&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,369&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(33,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,427&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,038&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Less: Accretion of redeemable&#13;    preferred stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(307&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Net income (loss) attributable&#13;    to common shareholders &amp;#8211; basic:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;327&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,384&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,369&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(33,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,427&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,038&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Basic income (loss) per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.15&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.12&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.09&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.23&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.67&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.57&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.63&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Weighted-average number&#13;    of shares outstanding, basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,875,750&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,828,361&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,696,016&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,655,881&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,639,172&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,557,748&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,061,812&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,632,958&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 28%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Add: Accretion of redeemable preferred&#13;    stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;307&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Less: Mark-to-market adjustment&#13;    for preferred stock embedded derivative&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Net&#13;    loss attributable to common shareholders &amp;#8211; diluted:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(2,624&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,384&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,369&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(33,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,427&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,038&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Diluted income (loss) per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.05&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.15&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.12&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.09&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.23&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.67&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.57&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.63&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Weighted-average number&#13;    of shares outstanding, diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;54,406,835&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,828,361&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,696,016&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,655,881&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,639,172&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,557,748&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,061,812&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,632,958&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Restatement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Subsequent to the issuance of the interim&#13;reports for the periods ended March, June and September 2019, the Company identified balances that were presented incorrectly relating&#13;to the presentation of cash flows. The Company re-evaluated its determination of the classification of cash flows related to trading&#13;securities and determined the classification of such cash flows within investing activities to be more appropriate.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Included below is a summary of the previously&#13;reported amounts, the impact of these adjustments and the as-adjusted amounts for the interim periods ended March, June and September&#13;2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Three months ended&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Three months ended&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Three months ended&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;March 31, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;June 30, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;September 30, 2019&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As reported&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As adjusted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As reported&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As adjusted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As reported&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;As adjusted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 34%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Net cash provided by (used in) operating&#13;    activities&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(58,812&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(1,958&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(66,026&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(2,268&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(65,748&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(846&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Net cash provided by (used in) investing activities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,288&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(53,566&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;625&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(63,133&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;3,721&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(61,181&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Net cash provided by financing activities&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;Increase/(decrease) in cash and cash equivalent&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(55,524&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(55,524&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(65,322&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(65,322&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(61,948&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;(61,948&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 8pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="23" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Quarter&#13;    Ended&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Dec. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Sept. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Jun. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Mar. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Dec. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Sept. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Jun. 30,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;Mar. 31,&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="23" style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-size: 7pt"&gt;(Unaudited, in thousands, except&#13;    share and per share information)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 36%; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;Revenues&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;688&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,711&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,460&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,387&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,203&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;13,725&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;6,485&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 6%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;62,093&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Portfolio operations:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Inventor royalties&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;192&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;776&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,623&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,353&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;11,002&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,181&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,241&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;21,744&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Contingent legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;35&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;375&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;177&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;11,756&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,949&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,037&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;15,759&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Patent acquisition expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,000&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Litigation and licensing expenses - patents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,160&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;987&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,855&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,801&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,689&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,549&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,639&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,989&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;Amortization of patents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;857&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;863&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;818&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;656&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;11,560&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,952&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,278&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,330&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Other&#13;    portfolio expenses (income)&lt;/font&gt; &lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;1,581&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(475&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;650&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;400&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,202&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Total portfolio operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,794&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,186&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,671&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;6,637&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;36,407&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;12,833&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;10,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,822&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Net portfolio income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,106&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(475&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(211&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,250&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;12,796&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;892&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,710&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;12,271&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;General and administrative expenses (including&#13;    non-cash stock compensation expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,328&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;4,630&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,763&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,655&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,754&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,855&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;6,916&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;3,301&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Impairment of patent-related&#13;    intangible assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;28,210&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Operating income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,434&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,105&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,974&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(6,905&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;10,042&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,963&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(38,836&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;8,970&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Total other income (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;5,921&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(2,503&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(1,774&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,821&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(21,012&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(27,595&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;10,615&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(40,890&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Income (loss) before provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(1,513&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,748&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,084&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(10,970&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,558&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,221&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(31,920&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;2,147&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(9&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(314&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(397&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(306&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(285&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(191&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Net income (loss) including noncontrolling interests&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;634&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,398&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,367&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,864&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,506&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,111&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Net (income) loss attributable&#13;    to noncontrolling interests in subsidiaries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(2&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(331&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Net income (loss) attributable&#13;    to Acacia Research Corporation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;634&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,384&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,369&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(33,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,427&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,038&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Less: Accretion of redeemable&#13;    preferred stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(307&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Net income (loss) attributable&#13;    to common shareholders &amp;#8211; basic:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;327&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,384&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,369&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(33,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,427&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,038&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Basic income (loss) per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.15&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.12&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.09&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.23&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.67&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.57&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.63&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Weighted-average number&#13;    of shares outstanding, basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,875,750&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,828,361&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,696,016&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,655,881&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,639,172&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,557,748&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,061,812&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,632,958&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 28%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;Add: Accretion of redeemable preferred&#13;    stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;307&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 7%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-size: 7pt"&gt;Less: Mark-to-market adjustment&#13;    for preferred stock embedded derivative&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(3,258&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#8211;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Net&#13;    loss attributable to common shareholders &amp;#8211; diluted:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(2,624&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(7,608&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(5,757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(4,384&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(11,369&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(33,195&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(28,427&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(32,038&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Diluted income (loss) per share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.05&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.15&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.12&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.09&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.23&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.67&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.57&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;(0.63&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 7pt"&gt;Weighted-average number&#13;    of shares outstanding, diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;54,406,835&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,828,361&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,696,016&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,655,881&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,639,172&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;49,557,748&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,061,812&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-size: 7pt"&gt;50,632,958&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-size: 7pt"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;font style="font-size: 8pt"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;19. SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Stockholder approval&lt;/i&gt;. On February&#13;14, 2020, the Company&amp;#8217;s stockholders approved, for purposes of Nasdaq Rules 5635(b) and 5635(d), as applicable, (i) the voting&#13;of the Series A Convertible Preferred Stock on an as-converted basis and (ii) the issuance of the maximum number of shares of common&#13;stock issuable in connection with the potential future (A) conversion of the Series A Convertible Preferred Stock and (B) exercise&#13;of the Series A and Series B Warrants, in each case, without giving effect to the exchange cap set forth in the Series A Preferred&#13;Stock Certificate of Designations and in the Series A Warrants, issued pursuant to the Securities Purchase Agreement dated November&#13;18, 2019 (see Note 16). The Company&amp;#8217;s stockholders also approved an amendment to the Company&amp;#8217;s Amended and Restated&#13;Certificate of Incorporation to increase the total number of authorized shares of common stock by 200,000,000 shares, from 100,000,000&#13;shares to 300,000,000 shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Issuance of Series B Warrants to Starboard&lt;/i&gt;.&#13;On February 25, 2020, pursuant to the terms of the Securities Purchase Agreement with Starboard, the Company issued Series B Warrants&#13;to purchase up to 100 million shares of the Company&amp;#8217;s common stock at an exercise price of either (i) $5.25 per share, if&#13;exercising by cash payment, or (ii) $3.65 per share, if exercising by cancellation of a portion of senior secured notes. The Company&#13;issued the Series B Warrants for an aggregate purchase price of $4.6 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;1.&amp;#160; DESCRIPTION OF BUSINESS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Description of Business. &lt;/i&gt;As used&#13;herein, &amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221; &amp;#8220;our,&amp;#8221; &amp;#8220;Acacia&amp;#8221; and the &amp;#8220;Company&amp;#8221; refer to Acacia&#13;Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its&#13;management.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia&amp;#8217;s operating subsidiaries invest&#13;in, license and enforce patented technologies. Acacia&amp;#8217;s operating subsidiaries partner with inventors and patent owners,&#13;applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent&#13;years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed&#13;as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement and/or supplement&#13;Acacia&amp;#8217;s primary licensing and enforcement business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia&amp;#8217;s operating subsidiaries generate&#13;revenues and related cash flows from the granting of IP rights for the use of patented technologies that its operating subsidiaries&#13;control or own. Acacia&amp;#8217;s operating subsidiaries assist patent owners with the prosecution and development of their patent&#13;portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of&#13;their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies&#13;through the filing of patent infringement litigation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia&amp;#8217;s operating subsidiaries are&#13;principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the&#13;patent portfolio outright. Acacia&amp;#8217;s operating subsidiaries own or control the rights to multiple patent portfolios, which&#13;include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Neither Acacia nor its operating subsidiaries&#13;invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and&#13;companies that own IP through its relationships with inventors, universities, research institutions, technology companies and others.&#13;If Acacia&amp;#8217;s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then&#13;they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;During fiscal year 2019, Acacia obtained&#13;control of five new patent portfolios. During fiscal year 2018, Acacia did not obtain control of any new patent portfolios.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia was incorporated on January 25, 1993&#13;under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Fair Value of Financial Instruments.&amp;#160;&amp;#160;&lt;/i&gt;The&#13;carrying value of cash and cash equivalents, restricted cash, accounts receivables, and current liabilities approximates their&#13;fair values due to their short-term maturities.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Leases. &lt;/i&gt;The Company adopted ASC&#13;842 as of January 1, 2019, electing the practical expedient approaches. The primary impact of adopting ASC 842 for the Company&#13;was the recognition in the consolidated balance sheet of certain lease-related assets and liabilities for operating leases with&#13;terms longer than 12 months. Such amounts were not previously accounted for in the Company's consolidated balance sheets. The&#13;Company&amp;#8217;s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether&#13;an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all&#13;leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying&#13;asset for the lease term. Upon adoption of ASC 842 on January 1, 2019, the carrying value of certain lease related liabilities&#13;for its excess of lease payments over anticipated sublease income existing at that date, was offset against the related right-of-use&#13;assets. Lease expense is recognized on a straight-line basis over the lease term.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:InvestmentHoldingsTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;6. INVESTMENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Investment at Fair Value&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;During 2016 and 2017, Acacia made certain&#13;investments in Veritone, Inc. (&amp;#8220;Veritone&amp;#8221;). As a result of these transactions, Acacia received an aggregate total&#13;of 4,119,521 shares of Veritone common stock and warrants to purchase a total of 1,120,432 shares of Veritone common stock at&#13;an exercise price of $13.61 per share expiring between 2020 and 2027. During the year ended December 31, 2018, Acacia sold 2,700,000&#13;shares Veritone common stock and recorded a realized loss of $19.1 million. During the year ended December 31, 2019, Acacia sold&#13;1,121,071 shares Veritone common stock and recorded a realized loss of $9.2 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;At December&amp;#160;31, 2019, the fair value&#13;of the 298,449 shares of Veritone common stock owned by Acacia totaled $743,000. At December&amp;#160;31, 2019, the fair value of&#13;the 1,120,432 common stock purchase warrants held by Acacia totaled $757,000. At December 31, 2018, the fair value of the 1,419,521&#13;shares of Veritone common stock owned by Acacia totaled $5,395,000. At December 31, 2018, the fair value of the 1,120,432 common&#13;stock purchase warrants held by Acacia totaled $2,064,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Changes in the fair value of Acacia&amp;#8217;s&#13;investment in Veritone are recorded as unrealized gains or losses in the consolidated statements of operations. For the year ended&#13;December&amp;#160;31, 2019, and 2018, the accompanying consolidated statements of operations reflected the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 66%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Change&#13;    in fair value of investment, warrants&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(1,308&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(11,895&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value&#13;    of investment, common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;11,207&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(47,208&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Loss&#13;    on sale of investment, common stock&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(9,230&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(19,095&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    realized and unrealized gain (loss) on investment at fair value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;669&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(78,198&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Miso Robotics Investment &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In June 2017, Acacia made an investment&#13;in the Series A Preferred financing round for Miso Robotics, Inc. (&amp;#8220;Miso Robotics&amp;#8221;), an innovative leader in robotics&#13;and artificial intelligence solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Series A preferred stock of&#13;Miso Robotics, and one board seat. In February 2018, Acacia made an additional equity investment in the Series B Preferred financing&#13;round for Miso Robotics totaling $6,000,000, increasing its ownership interest (Series B preferred stock) in Miso Robotics to approximately&#13;30%, and acquiring an additional board seat. As of June 30, 2019, Acacia recorded an impairment of $8.2 million for its investment&#13;in Miso Robotics. In September 2019, Acacia received a cash payment of $2.0 million upon the sale of its entire investment, and&#13;therefore relinquished its ownership interest in Miso Robotics.&lt;/p&gt;</us-gaap:InvestmentHoldingsTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;10.&amp;#160;&amp;#160;COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Facility Leases&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Company primarily leases office facilities&#13;under operating lease arrangements that will end in various years through July 2024.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;On June 7, 2019, we entered into a building&#13;lease agreement (the &amp;#8220;New Lease&amp;#8221;) with Jamboree Center 4 LLC (the &amp;#8220;Landlord&amp;#8221;). Pursuant to the New Lease,&#13;we have leased approximately 8,293 square feet of office space for our corporate headquarters in Irvine, California. The New Lease&#13;commenced on August 1, 2019. The term of the New Lease is 60 months from the commencement date, provides for annual rent increases,&#13;and does not provide us the right to early terminate or extend our lease terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The Company has subleased a facility under&#13;another operating lease agreement (the &amp;#8220;Old Lease&amp;#8221;) that we ceased using in December 2018, and the sublease will go&#13;through the remaining term of the Old Lease, which ended on January 31, 2020. During the year ended December 31, 2018, the Company&#13;recorded a one-time charge of $629,000 for the excess of lease payments over the anticipated sublease income through expiration&#13;of the lease. &lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Operating lease costs, net of sublease income&#13;of $780,000, were $426,000 for the year ended December 31, 2019. Operating lease costs, net of sublease income of $65,000, were&#13;$1,106,000 for the year ended December 31, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;The table below presents aggregate future&#13;minimum payments due under the New Lease and the Old Lease, reconciled to lease liabilities included in the consolidated balance&#13;sheet as of December 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Operating&#13;    Leases&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 31%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;434&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;334&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;349&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;364&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;218&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;                                         minimum payments&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,699&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Less:&#13;                                         short-term lease liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(435&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Long-term&#13;                                         lease liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,264&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In connection with the investment in certain&#13;patents and patent rights, certain of Acacia&amp;#8217;s operating subsidiaries executed related agreements which grant to the former&#13;owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined&#13;in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia&amp;#8217;s operating subsidiaries may&#13;retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing&#13;and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a&#13;scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments&#13;are obtained.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Patent Enforcement &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&lt;/i&gt;Certain of Acacia&amp;#8217;s&#13;operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection&#13;with any of Acacia&amp;#8217;s operating subsidiaries&amp;#8217; patent enforcement actions, it is possible that a defendant may&#13;request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal&#13;rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement&#13;actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award&#13;attorney&amp;#8217;s fees and/or expenses to a defendant(s), which could be material.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Other&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;On June 17, 2015, Celltrace Communications&#13;Ltd. (&amp;#8220;Celltrace&amp;#8221;) filed a lawsuit against Acacia in U.S. District Court for the Southern District of New York, Case&#13;No. 1:15-cv-04746, alleging, among other things, significant damages for alleged breach of contract, unjust enrichment and fraud.&#13;Acacia disputes the allegations and does not believe that Celltrace is entitled to any damages.&amp;#160; Acacia successfully moved&#13;to compel arbitration of the dispute, and the District Court stayed the litigation pending arbitration before the International&#13;Court of Arbitration for the International Chamber of Commerce (the &amp;#8220;ICC&amp;#8221;). Celltrace appealed the decision to the&#13;U.S. Court of Appeals for the Second Circuit, which denied the appeal. Celltrace filed its request for arbitration of the claims&#13;with the ICC on November 28, 2016. Acacia filed an answer denying all allegations of wrongdoing and asserting affirmative defenses.&#13;A tribunal was appointed to preside over the arbitration and conducted its first case management conference on June 26, 2017. The&#13;parties conducted discovery and submitted their cases in chief to the tribunal in a series of written submissions per the tribunal&amp;#8217;s&#13;orders between January 2018 and December 2018. The tribunal held an evidentiary hearing with live witness testimony in New York&#13;City between February 4, 2019 and February 13, 2019. At the end of the hearing, the tribunal set a schedule for post-hearing briefing&#13;by the parties, which concluded in April 2019. We are now waiting for the tribunal to issue its decision. Acacia continues to vigorously contest all allegations of wrongdoing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In a separate case on December 6, 2017,&#13;the Federal Court of Canada allowed a counterclaim for invalidity of a patent asserted by Rapid Completions LLC and awarded costs&#13;payable by Rapid Completions LLC in an amount to be determined.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Acacia is subject to claims, counterclaims&#13;and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect&#13;to these claims and legal actions, if any, will not have a material effect on Acacia&amp;#8217;s consolidated financial position,&#13;results of operations or cash flows. Fiscal year 2019 operating expenses included expenses for settlement and contingency accruals&#13;totaling $1,756,000, net of prior accruals. Refer to Note 4 for information on accrued expenses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Guarantees and Indemnifications&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;Certain of Acacia&amp;#8217;s operating&#13;subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or&#13;indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In&#13;connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for&#13;certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum&#13;extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy&#13;that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be&#13;payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to&#13;statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential&#13;future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and&#13;indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and&#13;therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance&#13;sheets. Additionally, no events or transactions have occurred that would result in a material liability at December&amp;#160;31,&#13;2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Other&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;In August 2010, a wholly owned subsidiary&#13;of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund invests in, licenses&#13;and enforces IP consisting primarily of patents, patent rights, and patented technologies. The Acacia IP Fund was terminated as&#13;of December 31, 2017. The final distribution to the partners of the Acacia IP Fund will be made in 2020.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Operating&#13;    Leases&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 31%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;434&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;334&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;349&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;364&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2024&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;218&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Total&#13;                                         minimum payments&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,699&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Less:&#13;                                         short-term lease liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(435&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Long-term&#13;                                         lease liabilities&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;1,264&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2019-12-31" unitRef="USD" decimals="-3">1699000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="From2019-01-01to2019-12-31">&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Cost&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Gross&lt;br /&gt;&#13;    Unrealized&lt;br /&gt; Gain&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Gross&lt;br /&gt;&#13;    Unrealized&lt;br /&gt; Loss&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Fair&#13;    Value&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(In&#13;    thousands)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Security&amp;#160;Type&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;December 31, 2019:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="width: 28%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;93,712&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;143&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(12&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;93,843&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,674&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;211&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(745&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;17,140&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;111,386&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;354&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(757&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;110,983&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;December 31, 2018:&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading securities&#13;    - debt&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;33,643&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(19&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;33,642&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trading&#13;    securities - equity&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,389&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(404&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,012&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;&#13;    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;37,032&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;45&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(423&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;36,654&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2018-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="Shares" decimals="INF">350000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2018-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="Shares" decimals="INF">350000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2018-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="Shares" decimals="INF">350000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2018-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="USD" decimals="-3">35125000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="AsOf2018-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="USD" decimals="-3">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="USDPShares" decimals="INF">100</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="AsOf2018-12-31_us-gaap_RedeemablePreferredStockMember" unitRef="USDPShares" decimals="INF">0</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:CostMethodInvestmentsPolicy contextRef="From2019-01-01to2019-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;Impairment of Investments. &lt;/i&gt;Acacia&#13;evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that&#13;considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated&#13;fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration&#13;and extent to which the fair value is less than cost, and the Company&amp;#8217;s intent and ability to hold, or plans or ability to&#13;sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments&#13;are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments&#13;associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary.&#13;An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of&#13;time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment&amp;#8217;s carrying amount&#13;is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive&#13;and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is&#13;recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary&#13;are recognized in the consolidated statements of operations.&lt;/p&gt;</us-gaap:CostMethodInvestmentsPolicy>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>actg-20191231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: acacia_10k%2D2019.xfr; Date: 2020%2D03%2D16T20:32:32Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa+FCaPty552uYkxvmR8fWlqDyEupobgjiDVyzN2oboF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ACTG="http://acaciaresearch.com/20191231" elementFormDefault="qualified" targetNamespace="http://acaciaresearch.com/20191231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://acaciaresearch.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical" id="StatementsOfOperationsGeneralAndAdminExpensesParenthetical">
	  <link:definition>00000005 - Statement - Consolidated Statements of Operations (General and Admin Expenses) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLoss" id="StatementsOfComprehensiveLoss">
	  <link:definition>00000006 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical" id="StatementsOfComprehensiveLossParenthetical">
	  <link:definition>00000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StatementsOfStockholdersEquity" id="StatementsOfStockholdersEquity">
	  <link:definition>00000008 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000009 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
	  <link:definition>00000010 - Disclosure - 1. Description of Business and Basis of Presentation</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000011 - Disclosure - 2. Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/TradingSecurities" id="TradingSecurities">
	  <link:definition>00000012 - Disclosure - 3. Trading Securities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/AccruedExpenses" id="AccruedExpenses">
	  <link:definition>00000013 - Disclosure - 4. Accrued Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Patents" id="Patents">
	  <link:definition>00000014 - Disclosure - 5. Patents</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Investments" id="Investments">
	  <link:definition>00000015 - Disclosure - 6. Investments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000016 - Disclosure - 7. Stockholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000017 - Disclosure - 8. Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlans" id="Equity-basedIncentivePlans">
	  <link:definition>00000018 - Disclosure - 9. Equity-Based Incentive Plans</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000019 - Disclosure - 10. Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy" id="RetirementSavingsPlanAndExecutiveSeverancePolicy">
	  <link:definition>00000020 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
	  <link:definition>00000021 - Disclosure - 12. Supplemental Cash Flow Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" id="RecentAccountingPronouncements">
	  <link:definition>00000022 - Disclosure - 13. Recent Accounting Pronouncements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/FairValueDisclosures" id="FairValueDisclosures">
	  <link:definition>00000023 - Disclosure - 14. Fair Value Disclosures</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000024 - Disclosure - 15. Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" id="SeriesRedeemableConvertiblePreferredStock">
	  <link:definition>00000025 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesWarrants" id="SeriesWarrants">
	  <link:definition>00000026 - Disclosure - 17. Series A Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/QuarterlyFinancialData" id="QuarterlyFinancialData">
	  <link:definition>00000027 - Disclosure - 18. Quarterly Financial Data (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000028 - Disclosure - 19. Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000030 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/TradingSecuritiesTables" id="TradingSecuritiesTables">
	  <link:definition>00000031 - Disclosure - 3. Trading Securities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
	  <link:definition>00000032 - Disclosure - 4. Accrued Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsTables" id="PatentsTables">
	  <link:definition>00000033 - Disclosure - 5. Patents (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentsTables" id="InvestmentsTables">
	  <link:definition>00000034 - Disclosure - 6. Investments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
	  <link:definition>00000035 - Disclosure - 7. Stockholders' Equity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000036 - Disclosure - 8. Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansTables" id="Equity-basedIncentivePlansTables">
	  <link:definition>00000037 - Disclosure - 9. Equity-Based Incentive Plans (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000038 - Disclosure - 10. Commitments and Contingencies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataTables" id="QuarterlyFinancialDataTables">
	  <link:definition>00000039 - Disclosure - 18. Quarterly Financial Data (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000040 - Disclosure - 1. Description of Business and Basis of Presentation (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DisaggregationOfRevenueDetails" id="DisaggregationOfRevenueDetails">
	  <link:definition>00000041 - Disclosure - 2. Disaggregation of Revenue (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails" id="FairValueOnRecurringBasisDetails">
	  <link:definition>00000042 - Disclosure - 2. Fair Value on a Recurring Basis (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details" id="ChangesToFairValueMeasurementLevel3Details">
	  <link:definition>00000043 - Disclosure - 2. Changes to fair value measurement Level 3 (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails" id="PropertyAndEquipmentUsefulLivesDetails">
	  <link:definition>00000044 - Disclosure - 2. Property and Equipment Useful Lives (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockOptionAssumptionsDetails" id="StockOptionAssumptionsDetails">
	  <link:definition>00000045 - Disclosure - 2. Stock Option Assumptions (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails" id="BasicAndDilutedLossPerShareDetails">
	  <link:definition>00000046 - Disclosure - 2. Basic and Diluted Loss Per Share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000047 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetails" id="TradingSecuritiesDetails">
	  <link:definition>00000048 - Disclosure - 3. Trading Securities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative" id="TradingSecuritiesDetailsNarrative">
	  <link:definition>00000049 - Disclosure - 3. Trading Securities (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative" id="AccruedExpensesDetailsNarrative">
	  <link:definition>00000050 - Disclosure - 4. Accrued Expenses (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsDetails" id="PatentsDetails">
	  <link:definition>00000051 - Disclosure - 5. Patents (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" id="PatentsDetailsNarrative">
	  <link:definition>00000052 - Disclosure - 5. Patents (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentsDetails" id="InvestmentsDetails">
	  <link:definition>00000053 - Disclosure - 6. Investments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" id="InvestmentsDetailsNarrative">
	  <link:definition>00000054 - Disclosure - 6. Investments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
	  <link:definition>00000055 - Disclosure - 7. Stockholders' Equity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
	  <link:definition>00000056 - Disclosure - 7. Stockholders' Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes" id="IncomeTaxesDetails-ProvisionForIncomeTaxes">
	  <link:definition>00000057 - Disclosure - 8. Income Taxes (Details - Provision for Income Taxes)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets" id="IncomeTaxesDetails-DeferredTaxAssets">
	  <link:definition>00000058 - Disclosure - 8. Income Taxes (Details - Deferred tax assets)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates" id="IncomeTaxesDetails-ReconciliationOfTaxRates">
	  <link:definition>00000059 - Disclosure - 8. Income Taxes (Details - Reconciliation of tax rates)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000060 - Disclosure - 8. Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted" id="Equity-basedIncentivePlansDetails-OptionsGranted">
	  <link:definition>00000061 - Disclosure - 9. Equity-Based Incentive Plans (Details - Options Granted)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity" id="Equity-basedIncentivePlansDetails-OptionActivity">
	  <link:definition>00000062 - Disclosure - 9. Equity-Based Incentive Plans (Details - Option Activity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" id="Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity">
	  <link:definition>00000063 - Disclosure - 9. Equity-Based Incentive Plans (Details - Nonvested Restricted Stock Activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" id="Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity">
	  <link:definition>00000064 - Disclosure - 9. Equity-Based Incentive Plans (Details - Restricted Stock Units Activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation" id="Equity-basedIncentivePlansDetails-Share-basedCompensation">
	  <link:definition>00000065 - Disclosure - 9. Equity-Based Incentive Plans (Details - Share-based Compensation)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative" id="Equity-basedIncentivePlansDetailsNarrative">
	  <link:definition>00000066 - Disclosure - 9. Equity-Based Incentive Plans (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
	  <link:definition>00000067 - Disclosure - 10. Commitments and Contingencies (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000068 - Disclosure - 10. Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" id="RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative">
	  <link:definition>00000069 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
	  <link:definition>00000070 - Disclosure - 12. Supplemental Cash Flow Information (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative" id="RecentAccountingPronouncementsDetailsNarrative">
	  <link:definition>00000071 - Disclosure - 13. Recent Accounting Pronouncements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000072 - Disclosure - 15. Related Party Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" id="SeriesRedeemableConvertiblePreferredStockDetailsNarrative">
	  <link:definition>00000073 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" id="SeriesWarrantsDetailsNarrative">
	  <link:definition>00000074 - Disclosure - 17. Series A Warrants (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataDetails" id="QuarterlyFinancialDataDetails">
	  <link:definition>00000075 - Disclosure - 18. Quarterly Financial Data (Unaudited) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RestatementDetails" id="RestatementDetails">
	  <link:definition>00000076 - Disclosure - 18. Restatement (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
    <element id="ACTG_RoyaltiesAndContingentLegalFeesPayable" name="RoyaltiesAndContingentLegalFeesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NumberOfPatentPortfoliosAcquired" name="NumberOfPatentPortfoliosAcquired" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_InvestmentWarrants" name="InvestmentWarrants" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_InvestmentSharesSold" name="InvestmentSharesSold" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" name="ApproximateValueOfSharesThatMayYetBePurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ContingentLegalFees" name="ContingentLegalFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_LitigationAndLicensingExpensesPatents" name="LitigationAndLicensingExpensesPatents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NetPortfolioIncomeLoss" name="NetPortfolioIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" name="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation" name="TaxOnUnrealizedGainLossOnForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" name="AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PortfolioOperationsPolicyTextBlock" name="PortfolioOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" name="InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" name="ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm" name="FiniteLivedIntangibleAssetUsefulLifeTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ForeignTaxesPayable" name="ForeignTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccruedConsultingAndOtherProfessionalFees" name="AccruedConsultingAndOtherProfessionalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_CapitalLossCarryforwardsExpirationDate" name="CapitalLossCarryforwardsExpirationDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ForeignTaxCreditBeginningExpirationDate" name="ForeignTaxCreditBeginningExpirationDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DeferredTaxAssetFromLossOnInvestment" name="DeferredTaxAssetFromLossOnInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AggregateFairValueAwardsGranted" name="AggregateFairValueAwardsGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_FairValueOfProfitsInterests" name="FairValueOfProfitsInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome" name="ExcessOfLeasePaymentsOverSubleaseIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantsIssuedShares" name="WarrantsIssuedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantsExercisedShares" name="WarrantsExercisedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantDisclosureTextBlock" name="WarrantDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" name="ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_CumulativeEffectOfNewAccountingPrinciple" name="CumulativeEffectOfNewAccountingPrinciple" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ImpairmentOfInvestmentsPolicyTextBlock" name="ImpairmentOfInvestmentsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantPolicyTextBlock" name="WarrantPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PaidUpRevenueAgreementsMember" name="PaidUpRevenueAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RecurringRevenueAgreementsMember" name="RecurringRevenueAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritesDebtMember" name="TradingSecuritesDebtMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritesEquityMember" name="TradingSecuritesEquityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritiesDebtMember" name="TradingSecuritiesDebtMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritiesEquityMember" name="TradingSecuritiesEquityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantInvestmentMember" name="WarrantInvestmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_CommonStockInvestmentMember" name="CommonStockInvestmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_VeritoneMember" name="VeritoneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_MisoRoboticsMember" name="MisoRoboticsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StockCompensationExpenseGeneralMember" name="StockCompensationExpenseGeneralMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StockCompensationExpenseProfitsInterestsMember" name="StockCompensationExpenseProfitsInterestsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OtherSettlementsMember" name="OtherSettlementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StockRepurchaseProgramMember" name="StockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ProfitInterestUnitsMember" name="ProfitInterestUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAWarrantsMember" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EmbeddedDerivativeLiabilityMember" name="EmbeddedDerivativeLiabilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicensee2Member" name="OneLicensee2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicensee3Member" name="OneLicensee3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TimeBasedServiceMember" name="TimeBasedServiceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AllAwardsMember" name="AllAwardsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PerformanceBasedMember" name="PerformanceBasedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_Plan2016Member" name="Plan2016Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AllPlansMember" name="AllPlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NonVestedMember" name="NonVestedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ProfitsInterestMember" name="ProfitsInterestMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccountingStandardsUpdate201901Member" name="AccountingStandardsUpdate201901Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SidusInvestmentMember" name="SidusInvestmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StarboardValueMember" name="StarboardValueMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EmbeddedDerivativeMember" name="EmbeddedDerivativeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesARedeemableConvertiblePreferredStockMember" name="SeriesARedeemableConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DriveShackMember" name="DriveShackMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesARedeemableConvertibleStockMember" name="SeriesARedeemableConvertibleStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" name="EarningsPerShareBasicAndDilutedDeniminatorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DilutedNumeratorAbstract" name="DilutedNumeratorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DilutedDenominatorAbstract" name="DilutedDenominatorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AggregateIntrinsicValueAbstract" name="AggregateIntrinsicValueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NonvestedRestrictedSharesAbstract" name="NonvestedRestrictedSharesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract" name="WeightedAverageGrantDateFairValuePerShareAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>actg-20191231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: acacia_10k%2D2019.xfr; Date: 2020%2D03%2D16T20:32:32Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20191231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BalanceSheets" xlink:href="actg-20191231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BalanceSheetsParenthetical" xlink:href="actg-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfOperations" xlink:href="actg-20191231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:href="actg-20191231.xsd#StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLoss" xlink:href="actg-20191231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical" xlink:href="actg-20191231.xsd#StatementsOfComprehensiveLossParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfStockholdersEquity" xlink:href="actg-20191231.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfCashFlows" xlink:href="actg-20191231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20191231.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecurities" xlink:href="actg-20191231.xsd#TradingSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpenses" xlink:href="actg-20191231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Patents" xlink:href="actg-20191231.xsd#Patents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Investments" xlink:href="actg-20191231.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20191231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxes" xlink:href="actg-20191231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlans" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20191231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:href="actg-20191231.xsd#RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformation" xlink:href="actg-20191231.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:href="actg-20191231.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueDisclosures" xlink:href="actg-20191231.xsd#FairValueDisclosures" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RelatedPartyTransactions" xlink:href="actg-20191231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:href="actg-20191231.xsd#SeriesRedeemableConvertiblePreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrants" xlink:href="actg-20191231.xsd#SeriesWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialData" xlink:href="actg-20191231.xsd#QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvents" xlink:href="actg-20191231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesTables" xlink:href="actg-20191231.xsd#TradingSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpensesTables" xlink:href="actg-20191231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsTables" xlink:href="actg-20191231.xsd#PatentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsTables" xlink:href="actg-20191231.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20191231.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesTables" xlink:href="actg-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansTables" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataTables" xlink:href="actg-20191231.xsd#QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20191231.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DisaggregationOfRevenueDetails" xlink:href="actg-20191231.xsd#DisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails" xlink:href="actg-20191231.xsd#FairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details" xlink:href="actg-20191231.xsd#ChangesToFairValueMeasurementLevel3Details" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails" xlink:href="actg-20191231.xsd#PropertyAndEquipmentUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockOptionAssumptionsDetails" xlink:href="actg-20191231.xsd#StockOptionAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails" xlink:href="actg-20191231.xsd#BasicAndDilutedLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetails" xlink:href="actg-20191231.xsd#TradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative" xlink:href="actg-20191231.xsd#TradingSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative" xlink:href="actg-20191231.xsd#AccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetails" xlink:href="actg-20191231.xsd#PatentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:href="actg-20191231.xsd#PatentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetails" xlink:href="actg-20191231.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:href="actg-20191231.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20191231.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20191231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-DeferredTaxAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative" xlink:href="actg-20191231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-OptionsGranted" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:href="actg-20191231.xsd#RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="actg-20191231.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative" xlink:href="actg-20191231.xsd#RecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="actg-20191231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:href="actg-20191231.xsd#SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:href="actg-20191231.xsd#SeriesWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataDetails" xlink:href="actg-20191231.xsd#QuarterlyFinancialDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RestatementDetails" xlink:href="actg-20191231.xsd#RestatementDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapPreferredStockRedemptionAmount" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfRevenue" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ContingentLegalFees" xlink:label="loc_ACTGContingentLegalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfRevenue" xlink:to="loc_ACTGContingentLegalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfRevenue" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="loc_ACTGLitigationAndLicensingExpensesPatents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfRevenue" xlink:to="loc_ACTGLitigationAndLicensingExpensesPatents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfRevenue" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfRevenue" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="loc_ACTGNetPortfolioIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ACTGNetPortfolioIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ACTGNetPortfolioIncomeLoss" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_ACTGNetPortfolioIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfOtherInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfOtherInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (General and Admin Expenses) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfComprehensiveLoss" xlink:title="00000006 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical" xlink:title="00000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfStockholdersEquity" xlink:title="00000008 - Statement - Consolidated Statements of Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfCashFlows" xlink:title="00000009 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfOtherInvestments" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfOtherInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromLongtermInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromLongtermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfOtherEquity" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfOtherEquity" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000010 - Disclosure - 1. Description of Business and Basis of Presentation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000011 - Disclosure - 2. Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecurities" xlink:title="00000012 - Disclosure - 3. Trading Securities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - 4. Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Patents" xlink:title="00000014 - Disclosure - 5. Patents" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Investments" xlink:title="00000015 - Disclosure - 6. Investments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000016 - Disclosure - 7. Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - 8. Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlans" xlink:title="00000018 - Disclosure - 9. Equity-Based Incentive Plans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - 10. Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:title="00000020 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SupplementalCashFlowInformation" xlink:title="00000021 - Disclosure - 12. Supplemental Cash Flow Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:title="00000022 - Disclosure - 13. Recent Accounting Pronouncements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueDisclosures" xlink:title="00000023 - Disclosure - 14. Fair Value Disclosures" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RelatedPartyTransactions" xlink:title="00000024 - Disclosure - 15. Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:title="00000025 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrants" xlink:title="00000026 - Disclosure - 17. Series A Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialData" xlink:title="00000027 - Disclosure - 18. Quarterly Financial Data (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - 19. Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesTables" xlink:title="00000031 - Disclosure - 3. Trading Securities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpensesTables" xlink:title="00000032 - Disclosure - 4. Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsTables" xlink:title="00000033 - Disclosure - 5. Patents (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsTables" xlink:title="00000034 - Disclosure - 6. Investments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000035 - Disclosure - 7. Stockholders&apos; Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - 8. Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansTables" xlink:title="00000037 - Disclosure - 9. Equity-Based Incentive Plans (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000038 - Disclosure - 10. Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialDataTables" xlink:title="00000039 - Disclosure - 18. Quarterly Financial Data (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000040 - Disclosure - 1. Description of Business and Basis of Presentation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DisaggregationOfRevenueDetails" xlink:title="00000041 - Disclosure - 2. Disaggregation of Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails" xlink:title="00000042 - Disclosure - 2. Fair Value on a Recurring Basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details" xlink:title="00000043 - Disclosure - 2. Changes to fair value measurement Level 3 (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails" xlink:title="00000044 - Disclosure - 2. Property and Equipment Useful Lives (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockOptionAssumptionsDetails" xlink:title="00000045 - Disclosure - 2. Stock Option Assumptions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails" xlink:title="00000046 - Disclosure - 2. Basic and Diluted Loss Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000047 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesDetails" xlink:title="00000048 - Disclosure - 3. Trading Securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative" xlink:title="00000049 - Disclosure - 3. Trading Securities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative" xlink:title="00000050 - Disclosure - 4. Accrued Expenses (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccruedConsultingAndOtherProfessionalFees" xlink:label="loc_ACTGAccruedConsultingAndOtherProfessionalFees" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_ACTGAccruedConsultingAndOtherProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ForeignTaxesPayable" xlink:label="loc_ACTGForeignTaxesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_ACTGForeignTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaapLitigationReserve" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapLitigationReserve" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetails" xlink:title="00000051 - Disclosure - 5. Patents (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaapFiniteLivedPatentsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedPatentsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:title="00000052 - Disclosure - 5. Patents (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetails" xlink:title="00000053 - Disclosure - 6. Investments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:title="00000054 - Disclosure - 6. Investments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000055 - Disclosure - 7. Stockholders&apos; Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000056 - Disclosure - 7. Stockholders&apos; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:title="00000057 - Disclosure - 8. Income Taxes (Details - Provision for Income Taxes)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets" xlink:title="00000058 - Disclosure - 8. Income Taxes (Details - Deferred tax assets)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:label="loc_us-gaapDeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="loc_us-gaapDeferredTaxAssetsInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherTaxCarryforwards" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOtherTaxCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="loc_us-gaapDeferredTaxLiabilitiesLeasingArrangements" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:title="00000059 - Disclosure - 8. Income Taxes (Details - Reconciliation of tax rates)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000060 - Disclosure - 8. Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted" xlink:title="00000061 - Disclosure - 9. Equity-Based Incentive Plans (Details - Options Granted)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity" xlink:title="00000062 - Disclosure - 9. Equity-Based Incentive Plans (Details - Option Activity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:title="00000063 - Disclosure - 9. Equity-Based Incentive Plans (Details - Nonvested Restricted Stock Activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:title="00000064 - Disclosure - 9. Equity-Based Incentive Plans (Details - Restricted Stock Units Activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:title="00000065 - Disclosure - 9. Equity-Based Incentive Plans (Details - Share-based Compensation)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative" xlink:title="00000066 - Disclosure - 9. Equity-Based Incentive Plans (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000067 - Disclosure - 10. Commitments and Contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000068 - Disclosure - 10. Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:title="00000069 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000070 - Disclosure - 12. Supplemental Cash Flow Information (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative" xlink:title="00000071 - Disclosure - 13. Recent Accounting Pronouncements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000072 - Disclosure - 15. Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:title="00000073 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:title="00000074 - Disclosure - 17. Series A Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialDataDetails" xlink:title="00000075 - Disclosure - 18. Quarterly Financial Data (Unaudited) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RestatementDetails" xlink:title="00000076 - Disclosure - 18. Restatement (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>actg-20191231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: acacia_10k%2D2019.xfr; Date: 2020%2D03%2D16T20:32:32Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20191231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BalanceSheets" xlink:href="actg-20191231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BalanceSheetsParenthetical" xlink:href="actg-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfOperations" xlink:href="actg-20191231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:href="actg-20191231.xsd#StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLoss" xlink:href="actg-20191231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical" xlink:href="actg-20191231.xsd#StatementsOfComprehensiveLossParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfStockholdersEquity" xlink:href="actg-20191231.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfCashFlows" xlink:href="actg-20191231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20191231.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecurities" xlink:href="actg-20191231.xsd#TradingSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpenses" xlink:href="actg-20191231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Patents" xlink:href="actg-20191231.xsd#Patents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Investments" xlink:href="actg-20191231.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20191231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxes" xlink:href="actg-20191231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlans" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20191231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:href="actg-20191231.xsd#RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformation" xlink:href="actg-20191231.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:href="actg-20191231.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueDisclosures" xlink:href="actg-20191231.xsd#FairValueDisclosures" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RelatedPartyTransactions" xlink:href="actg-20191231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:href="actg-20191231.xsd#SeriesRedeemableConvertiblePreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrants" xlink:href="actg-20191231.xsd#SeriesWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialData" xlink:href="actg-20191231.xsd#QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvents" xlink:href="actg-20191231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesTables" xlink:href="actg-20191231.xsd#TradingSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpensesTables" xlink:href="actg-20191231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsTables" xlink:href="actg-20191231.xsd#PatentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsTables" xlink:href="actg-20191231.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20191231.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesTables" xlink:href="actg-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansTables" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataTables" xlink:href="actg-20191231.xsd#QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20191231.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DisaggregationOfRevenueDetails" xlink:href="actg-20191231.xsd#DisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails" xlink:href="actg-20191231.xsd#FairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details" xlink:href="actg-20191231.xsd#ChangesToFairValueMeasurementLevel3Details" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails" xlink:href="actg-20191231.xsd#PropertyAndEquipmentUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockOptionAssumptionsDetails" xlink:href="actg-20191231.xsd#StockOptionAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails" xlink:href="actg-20191231.xsd#BasicAndDilutedLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetails" xlink:href="actg-20191231.xsd#TradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative" xlink:href="actg-20191231.xsd#TradingSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative" xlink:href="actg-20191231.xsd#AccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetails" xlink:href="actg-20191231.xsd#PatentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:href="actg-20191231.xsd#PatentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetails" xlink:href="actg-20191231.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:href="actg-20191231.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20191231.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20191231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-DeferredTaxAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative" xlink:href="actg-20191231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-OptionsGranted" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:href="actg-20191231.xsd#RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="actg-20191231.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative" xlink:href="actg-20191231.xsd#RecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="actg-20191231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:href="actg-20191231.xsd#SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:href="actg-20191231.xsd#SeriesWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataDetails" xlink:href="actg-20191231.xsd#QuarterlyFinancialDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RestatementDetails" xlink:href="actg-20191231.xsd#RestatementDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="loc_us-gaapRedeemablePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapRedeemablePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (General and Admin Expenses) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockCompensationExpenseGeneralMember" xlink:label="loc_ACTGStockCompensationExpenseGeneralMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ACTGStockCompensationExpenseGeneralMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockCompensationExpenseProfitsInterestsMember" xlink:label="loc_ACTGStockCompensationExpenseProfitsInterestsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ACTGStockCompensationExpenseProfitsInterestsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfComprehensiveLoss" xlink:title="00000006 - Statement - Consolidated Statements of Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical" xlink:title="00000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfStockholdersEquity" xlink:title="00000008 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeMember" xlink:label="loc_us-gaapComprehensiveIncomeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapComprehensiveIncomeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:label="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CumulativeEffectOfNewAccountingPrinciple" xlink:label="loc_ACTGCumulativeEffectOfNewAccountingPrinciple_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGCumulativeEffectOfNewAccountingPrinciple_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_90" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfCashFlows" xlink:title="00000009 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000010 - Disclosure - 1. Description of Business and Basis of Presentation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000011 - Disclosure - 2. Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecurities" xlink:title="00000012 - Disclosure - 3. Trading Securities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - 4. Accrued Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Patents" xlink:title="00000014 - Disclosure - 5. Patents" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Investments" xlink:title="00000015 - Disclosure - 6. Investments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000016 - Disclosure - 7. Stockholders&apos; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - 8. Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlans" xlink:title="00000018 - Disclosure - 9. Equity-Based Incentive Plans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - 10. Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:title="00000020 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SupplementalCashFlowInformation" xlink:title="00000021 - Disclosure - 12. Supplemental Cash Flow Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:title="00000022 - Disclosure - 13. Recent Accounting Pronouncements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueDisclosures" xlink:title="00000023 - Disclosure - 14. Fair Value Disclosures" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RelatedPartyTransactions" xlink:title="00000024 - Disclosure - 15. Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:title="00000025 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrants" xlink:title="00000026 - Disclosure - 17. Series A Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialData" xlink:title="00000027 - Disclosure - 18. Quarterly Financial Data (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - 19. Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesTables" xlink:title="00000031 - Disclosure - 3. Trading Securities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpensesTables" xlink:title="00000032 - Disclosure - 4. Accrued Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsTables" xlink:title="00000033 - Disclosure - 5. Patents (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsTables" xlink:title="00000034 - Disclosure - 6. Investments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000035 - Disclosure - 7. Stockholders&apos; Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - 8. Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansTables" xlink:title="00000037 - Disclosure - 9. Equity-Based Incentive Plans (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000038 - Disclosure - 10. Commitments and Contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialDataTables" xlink:title="00000039 - Disclosure - 18. Quarterly Financial Data (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000040 - Disclosure - 1. Description of Business and Basis of Presentation (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DisaggregationOfRevenueDetails" xlink:title="00000041 - Disclosure - 2. Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="loc_ACTGPaidUpRevenueAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGPaidUpRevenueAgreementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="loc_ACTGRecurringRevenueAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGRecurringRevenueAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OtherSettlementsMember" xlink:label="loc_ACTGOtherSettlementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGOtherSettlementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaapSalesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapSalesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails" xlink:title="00000042 - Disclosure - 2. Fair Value on a Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-gaapAssetsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAssetsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritiesDebtMember" xlink:label="loc_ACTGTradingSecuritiesDebtMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesDebtMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritiesEquityMember" xlink:label="loc_ACTGTradingSecuritiesEquityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesEquityMember_60" xlink:type="arc" order="64" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember_120" xlink:type="arc" order="124" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGCommonStockInvestmentMember_180" xlink:type="arc" order="184" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitInterestUnitsMember" xlink:label="loc_ACTGProfitInterestUnitsMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGProfitInterestUnitsMember_300" xlink:type="arc" order="304" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_360" xlink:type="arc" order="364" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGEmbeddedDerivativeLiabilityMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmbeddedDerivativeLiabilityMember_390" xlink:type="arc" order="394" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_490" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure_490" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details" xlink:title="00000043 - Disclosure - 2. Changes to fair value measurement Level 3 (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGEmbeddedDerivativeLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmbeddedDerivativeLiabilityMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_20" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails" xlink:title="00000044 - Disclosure - 2. Property and Equipment Useful Lives (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockOptionAssumptionsDetails" xlink:title="00000045 - Disclosure - 2. Stock Option Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails" xlink:title="00000046 - Disclosure - 2. Basic and Diluted Loss Per Share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000047 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OneLicensee2Member" xlink:label="loc_ACTGOneLicensee2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OneLicensee3Member" xlink:label="loc_ACTGOneLicensee3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee3Member_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputCommodityFuturePriceMember" xlink:label="loc_us-gaapMeasurementInputCommodityFuturePriceMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputCommodityFuturePriceMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm" xlink:label="loc_ACTGFiniteLivedIntangibleAssetUsefulLifeTerm_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGFiniteLivedIntangibleAssetUsefulLifeTerm_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_100" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesDetails" xlink:title="00000048 - Disclosure - 3. Trading Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritesDebtMember" xlink:label="loc_ACTGTradingSecuritesDebtMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesDebtMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritesEquityMember" xlink:label="loc_ACTGTradingSecuritesEquityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesEquityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative" xlink:title="00000049 - Disclosure - 3. Trading Securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="loc_us-gaapDebtSecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapDebtSecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapEquitySecuritiesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapProceedsFromSaleOfTradingSecuritiesHeldforinvestment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfTradingSecuritiesHeldforinvestment_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative" xlink:title="00000050 - Disclosure - 4. Accrued Expenses (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetails" xlink:title="00000051 - Disclosure - 5. Patents (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:title="00000052 - Disclosure - 5. Patents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_60" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetails" xlink:title="00000053 - Disclosure - 6. Investments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGWarrantInvestmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGCommonStockInvestmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnInvestments_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:title="00000054 - Disclosure - 6. Investments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_VeritoneMember" xlink:label="loc_ACTGVeritoneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGVeritoneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGCommonStockInvestmentMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_MisoRoboticsMember" xlink:label="loc_ACTGMisoRoboticsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_ACTGMisoRoboticsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InvestmentWarrants" xlink:label="loc_ACTGInvestmentWarrants_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGInvestmentWarrants_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InvestmentSharesSold" xlink:label="loc_ACTGInvestmentSharesSold_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGInvestmentSharesSold_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedAtFairValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedAtFairValue_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfOtherInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfOtherInvestments_130" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000055 - Disclosure - 7. Stockholders&apos; Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="loc_us-gaapStockRepurchaseProgramExpirationDate_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramExpirationDate_20" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000056 - Disclosure - 7. Stockholders&apos; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="loc_ACTGStockRepurchaseProgramMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_ACTGStockRepurchaseProgramMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:title="00000057 - Disclosure - 8. Income Taxes (Details - Provision for Income Taxes)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets" xlink:title="00000058 - Disclosure - 8. Income Taxes (Details - Deferred tax assets)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:title="00000059 - Disclosure - 8. Income Taxes (Details - Reconciliation of tax rates)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000060 - Disclosure - 8. Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsCapitalLossCarryforwards_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsCapitalLossCarryforwards_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CapitalLossCarryforwardsExpirationDate" xlink:label="loc_ACTGCapitalLossCarryforwardsExpirationDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGCapitalLossCarryforwardsExpirationDate_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCreditsForeign_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCreditsForeign_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ForeignTaxCreditBeginningExpirationDate" xlink:label="loc_ACTGForeignTaxCreditBeginningExpirationDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGForeignTaxCreditBeginningExpirationDate_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DeferredTaxAssetFromLossOnInvestment" xlink:label="loc_ACTGDeferredTaxAssetFromLossOnInvestment_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGDeferredTaxAssetFromLossOnInvestment_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_80" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted" xlink:title="00000061 - Disclosure - 9. Equity-Based Incentive Plans (Details - Options Granted)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AllAwardsMember" xlink:label="loc_ACTGAllAwardsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGAllAwardsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TimeBasedServiceMember" xlink:label="loc_ACTGTimeBasedServiceMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGTimeBasedServiceMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AggregateFairValueAwardsGranted" xlink:label="loc_ACTGAggregateFairValueAwardsGranted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAggregateFairValueAwardsGranted_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity" xlink:title="00000062 - Disclosure - 9. Equity-Based Incentive Plans (Details - Option Activity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_40" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AggregateIntrinsicValueAbstract" xlink:label="loc_ACTGAggregateIntrinsicValueAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAggregateIntrinsicValueAbstract_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGAggregateIntrinsicValueAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGAggregateIntrinsicValueAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGAggregateIntrinsicValueAbstract_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_40" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:title="00000063 - Disclosure - 9. Equity-Based Incentive Plans (Details - Nonvested Restricted Stock Activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:title="00000064 - Disclosure - 9. Equity-Based Incentive Plans (Details - Restricted Stock Units Activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TimeBasedServiceMember" xlink:label="loc_ACTGTimeBasedServiceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGTimeBasedServiceMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NonvestedRestrictedSharesAbstract" xlink:label="loc_ACTGNonvestedRestrictedSharesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGNonvestedRestrictedSharesAbstract_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WeightedAverageGrantDateFairValuePerShareAbstract" xlink:label="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract_40" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract_40" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:title="00000065 - Disclosure - 9. Equity-Based Incentive Plans (Details - Share-based Compensation)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitInterestUnitsMember" xlink:label="loc_ACTGProfitInterestUnitsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGProfitInterestUnitsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TimeBasedServiceMember" xlink:label="loc_ACTGTimeBasedServiceMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGTimeBasedServiceMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PerformanceBasedMember" xlink:label="loc_ACTGPerformanceBasedMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGPerformanceBasedMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative" xlink:title="00000066 - Disclosure - 9. Equity-Based Incentive Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_Plan2016Member" xlink:label="loc_ACTGPlan2016Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ACTGPlan2016Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AllPlansMember" xlink:label="loc_ACTGAllPlansMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ACTGAllPlansMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitsInterestMember" xlink:label="loc_ACTGProfitsInterestMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGProfitsInterestMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NonVestedMember" xlink:label="loc_ACTGNonVestedMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGNonVestedMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_FairValueOfProfitsInterests" xlink:label="loc_ACTGFairValueOfProfitsInterests_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGFairValueOfProfitsInterests_160" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000067 - Disclosure - 10. Commitments and Contingencies (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000068 - Disclosure - 10. Commitments and Contingencies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:title="00000069 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000070 - Disclosure - 12. Supplemental Cash Flow Information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxesPaidNet_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative" xlink:title="00000071 - Disclosure - 13. Recent Accounting Pronouncements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccountingStandardsUpdate201901Member" xlink:label="loc_ACTGAccountingStandardsUpdate201901Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_ACTGAccountingStandardsUpdate201901Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_20" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000072 - Disclosure - 15. Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SidusInvestmentMember" xlink:label="loc_ACTGSidusInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ACTGSidusInvestmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DriveShackMember" xlink:label="loc_ACTGDriveShackMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_ACTGDriveShackMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:title="00000073 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeMember" xlink:label="loc_ACTGEmbeddedDerivativeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGEmbeddedDerivativeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWarrantsIssuedShares_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:title="00000074 - Disclosure - 17. Series A Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWarrantsIssuedShares_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsExercisedShares" xlink:label="loc_ACTGWarrantsExercisedShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWarrantsExercisedShares_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialDataDetails" xlink:title="00000075 - Disclosure - 18. Quarterly Financial Data (Unaudited) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RestatementDetails" xlink:title="00000076 - Disclosure - 18. Restatement (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScenarioAdjustmentMember" xlink:label="loc_us-gaapScenarioAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease_70" xlink:type="arc" order="4" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>actg-20191231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: acacia_10k%2D2019.xfr; Date: 2020%2D03%2D16T20:32:32Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeMember" xlink:label="us-gaap_ComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeMember" xlink:to="us-gaap_ComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated Comprehensive Income / Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="ACTG_PaidUpRevenueAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PaidUpRevenueAgreementsMember" xlink:to="ACTG_PaidUpRevenueAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PaidUpRevenueAgreementsMember_lbl" xml:lang="en-US">Paid-up Revenue Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="ACTG_RecurringRevenueAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RecurringRevenueAgreementsMember" xlink:to="ACTG_RecurringRevenueAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RecurringRevenueAgreementsMember_lbl" xml:lang="en-US">Recurring Revenue Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritesDebtMember" xlink:label="ACTG_TradingSecuritesDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritesDebtMember" xlink:to="ACTG_TradingSecuritesDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritesDebtMember_lbl" xml:lang="en-US">Trading securities - Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritesEquityMember" xlink:label="ACTG_TradingSecuritesEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritesEquityMember" xlink:to="ACTG_TradingSecuritesEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritesEquityMember_lbl" xml:lang="en-US">Trading securities - Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsMember" xlink:label="us-gaap_AssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsMember" xlink:to="us-gaap_AssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsMember_lbl" xml:lang="en-US">Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritiesDebtMember" xlink:label="ACTG_TradingSecuritiesDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritiesDebtMember" xlink:to="ACTG_TradingSecuritiesDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritiesDebtMember_lbl" xml:lang="en-US">Trading Securities - Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritiesEquityMember" xlink:label="ACTG_TradingSecuritiesEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritiesEquityMember" xlink:to="ACTG_TradingSecuritiesEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritiesEquityMember_lbl" xml:lang="en-US">Trading Securities - Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantInvestmentMember" xlink:label="ACTG_WarrantInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantInvestmentMember" xlink:to="ACTG_WarrantInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantInvestmentMember_lbl" xml:lang="en-US">Investments - Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CommonStockInvestmentMember" xlink:label="ACTG_CommonStockInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_CommonStockInvestmentMember" xlink:to="ACTG_CommonStockInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_CommonStockInvestmentMember_lbl" xml:lang="en-US">Investments - Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_VeritoneMember" xlink:label="ACTG_VeritoneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_VeritoneMember" xlink:to="ACTG_VeritoneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_VeritoneMember_lbl" xml:lang="en-US">Veritone [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_MisoRoboticsMember" xlink:label="ACTG_MisoRoboticsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_MisoRoboticsMember" xlink:to="ACTG_MisoRoboticsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_MisoRoboticsMember_lbl" xml:lang="en-US">Miso Robotics [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockCompensationExpenseGeneralMember" xlink:label="ACTG_StockCompensationExpenseGeneralMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StockCompensationExpenseGeneralMember" xlink:to="ACTG_StockCompensationExpenseGeneralMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StockCompensationExpenseGeneralMember_lbl" xml:lang="en-US">Stock Compensation Expense - General and Admin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockCompensationExpenseProfitsInterestsMember" xlink:label="ACTG_StockCompensationExpenseProfitsInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StockCompensationExpenseProfitsInterestsMember" xlink:to="ACTG_StockCompensationExpenseProfitsInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StockCompensationExpenseProfitsInterestsMember_lbl" xml:lang="en-US">Stock Compensation Expense - Profits Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OtherSettlementsMember" xlink:label="ACTG_OtherSettlementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OtherSettlementsMember" xlink:to="ACTG_OtherSettlementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OtherSettlementsMember_lbl" xml:lang="en-US">Other Settlements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="us-gaap_ShareRepurchaseProgramAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareRepurchaseProgramAxis" xlink:to="us-gaap_ShareRepurchaseProgramAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareRepurchaseProgramAxis_lbl" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="ACTG_StockRepurchaseProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StockRepurchaseProgramMember" xlink:to="ACTG_StockRepurchaseProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StockRepurchaseProgramMember_lbl" xml:lang="en-US">Stock Repurchase Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="us-gaap_SalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesMember_lbl" xml:lang="en-US">Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityMember" xlink:label="us-gaap_LiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityMember" xlink:to="us-gaap_LiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityMember_lbl" xml:lang="en-US">Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitInterestUnitsMember" xlink:label="ACTG_ProfitInterestUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ProfitInterestUnitsMember" xlink:to="ACTG_ProfitInterestUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ProfitInterestUnitsMember_lbl" xml:lang="en-US">Profit Interest Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesAWarrantsMember" xlink:label="ACTG_SeriesAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAWarrantsMember" xlink:to="ACTG_SeriesAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="ACTG_EmbeddedDerivativeLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EmbeddedDerivativeLiabilityMember" xlink:to="ACTG_EmbeddedDerivativeLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EmbeddedDerivativeLiabilityMember_lbl" xml:lang="en-US">Embedded Derivative Liability [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_2_lbl" xml:lang="en-US">Fair Value Inputs Level 2 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_2_lbl" xml:lang="en-US">Fair Value Inputs Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture And Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales Revenue Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk By Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OneLicensee2Member" xlink:label="ACTG_OneLicensee2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee2Member" xlink:to="ACTG_OneLicensee2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicensee2Member_lbl" xml:lang="en-US">One Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OneLicensee3Member" xlink:label="ACTG_OneLicensee3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee3Member" xlink:to="ACTG_OneLicensee3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_OneLicensee3Member_lbl" xml:lang="en-US">One Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputCommodityFuturePriceMember" xlink:label="us-gaap_MeasurementInputCommodityFuturePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputCommodityFuturePriceMember" xlink:to="us-gaap_MeasurementInputCommodityFuturePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputCommodityFuturePriceMember_lbl" xml:lang="en-US">Measurement Input Credit Spread [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="us-gaap_DebtSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesMember" xlink:to="us-gaap_DebtSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesMember_lbl" xml:lang="en-US">Debt Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xml:lang="en-US">Equity Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Federal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">Statel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TimeBasedServiceMember" xlink:label="ACTG_TimeBasedServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TimeBasedServiceMember" xlink:to="ACTG_TimeBasedServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TimeBasedServiceMember_lbl" xml:lang="en-US">Time Based Service [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units R S U [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AllAwardsMember" xlink:label="ACTG_AllAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AllAwardsMember" xlink:to="ACTG_AllAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AllAwardsMember_lbl" xml:lang="en-US">All Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PerformanceBasedMember" xlink:label="ACTG_PerformanceBasedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PerformanceBasedMember" xlink:to="ACTG_PerformanceBasedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PerformanceBasedMember_lbl" xml:lang="en-US">Performance Based [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_Plan2016Member" xlink:label="ACTG_Plan2016Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_Plan2016Member" xlink:to="ACTG_Plan2016Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_Plan2016Member_lbl" xml:lang="en-US">2016 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AllPlansMember" xlink:label="ACTG_AllPlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AllPlansMember" xlink:to="ACTG_AllPlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AllPlansMember_lbl" xml:lang="en-US">All Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NonVestedMember" xlink:label="ACTG_NonVestedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NonVestedMember" xlink:to="ACTG_NonVestedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NonVestedMember_lbl" xml:lang="en-US">Non-Vested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitsInterestMember" xlink:label="ACTG_ProfitsInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ProfitsInterestMember" xlink:to="ACTG_ProfitsInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ProfitsInterestMember_lbl" xml:lang="en-US">Profits Interests [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StateAndLocalJurisdictionMember_2_lbl" xml:lang="en-US">State And Local Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccountingStandardsUpdate201901Member" xlink:label="ACTG_AccountingStandardsUpdate201901Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccountingStandardsUpdate201901Member" xlink:to="ACTG_AccountingStandardsUpdate201901Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccountingStandardsUpdate201901Member_lbl" xml:lang="en-US">ASU 2019-01 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SidusInvestmentMember" xlink:label="ACTG_SidusInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SidusInvestmentMember" xlink:to="ACTG_SidusInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SidusInvestmentMember_lbl" xml:lang="en-US">Sidus Investment Management [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StarboardValueMember" xlink:label="ACTG_StarboardValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StarboardValueMember" xlink:to="ACTG_StarboardValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StarboardValueMember_lbl" xml:lang="en-US">Starboard [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeMember" xlink:label="ACTG_EmbeddedDerivativeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EmbeddedDerivativeMember" xlink:to="ACTG_EmbeddedDerivativeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EmbeddedDerivativeMember_lbl" xml:lang="en-US">Embedded Derivative [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="us-gaap_RedeemablePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemablePreferredStockMember" xlink:to="us-gaap_RedeemablePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemablePreferredStockMember_lbl" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScenarioAdjustmentMember" xlink:label="us-gaap_ScenarioAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioAdjustmentMember" xlink:to="us-gaap_ScenarioAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioAdjustmentMember_lbl" xml:lang="en-US">Scenario Adjustment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="ACTG_SeriesARedeemableConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:to="ACTG_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesARedeemableConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series A Redeemable Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_lbl" xml:lang="en-US">Investments in and Advances to Affiliates Categorization [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DriveShackMember" xlink:label="ACTG_DriveShackMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DriveShackMember" xlink:to="ACTG_DriveShackMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DriveShackMember_lbl" xml:lang="en-US">Drive Shack, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="ACTG_SeriesARedeemableConvertibleStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesARedeemableConvertibleStockMember" xlink:to="ACTG_SeriesARedeemableConvertibleStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesARedeemableConvertibleStockMember_lbl" xml:lang="en-US">Series A Redeemable Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">State of Incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex transition period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Well Known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xml:lang="en-US">Trading securities - debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent_lbl" xml:lang="en-US">Trading securities - equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xml:lang="en-US">Long-term restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investment at fair value (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Other investments (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Patents, net of accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Leased right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_RoyaltiesAndContingentLegalFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Series A warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US">Series A embedded derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Long-term lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="us-gaap_PreferredStockRedemptionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionAmount" xlink:to="us-gaap_PreferredStockRedemptionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionAmount_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of December 31, 2019; no shares authorized, issued or outstanding as of December 31, 2018; aggregate liquidation preference of $35,125 and $0 as of December 31, 2019 and December 31, 2018, respectively (Note 16)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized;</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,370,987 and 49,639,319 shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost, 2,919,828 shares as of September 30, 2019 and December 31, 2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Acacia Research Corporation stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, liquidation preference</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenueAbstract_lbl" xml:lang="en-US">Portfolio operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Inventor royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ContingentLegalFees" xlink:label="ACTG_ContingentLegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ContingentLegalFees" xlink:to="ACTG_ContingentLegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ContingentLegalFees_lbl" xml:lang="en-US">Contingent legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:label="us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:to="us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_lbl" xml:lang="en-US">Patent acquisition expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="ACTG_LitigationAndLicensingExpensesPatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_LitigationAndLicensingExpensesPatents" xlink:to="ACTG_LitigationAndLicensingExpensesPatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_LitigationAndLicensingExpensesPatents_lbl" xml:lang="en-US">Litigation and licensing expenses - patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="us-gaap_OtherCostAndExpenseOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostAndExpenseOperating_lbl" xml:lang="en-US">Other portfolio expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Total portfolio expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="ACTG_NetPortfolioIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetPortfolioIncomeLoss" xlink:to="ACTG_NetPortfolioIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NetPortfolioIncomeLoss_lbl" xml:lang="en-US">Net portfolio income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US">Impairment of patent-related intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Change in fair value of investment, net (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="us-gaap_LossOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LossOnSaleOfInvestments_lbl" xml:lang="en-US">Loss on sale of investment (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="us-gaap_ImpairmentOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ImpairmentOfInvestments_lbl" xml:lang="en-US">Impairment of other investment (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments" xlink:label="us-gaap_GainLossOnSaleOfOtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherInvestments" xlink:to="us-gaap_GainLossOnSaleOfOtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfOtherInvestments_lbl" xml:lang="en-US">Gain on disposal of other investment (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in fair value of the Series A warrants and embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest income and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax (expense) benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss including noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xml:lang="en-US">Less: Accretion of redeemable preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss attributable to common stockholders - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per share of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares outstanding - basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_2_lbl" xml:lang="en-US">Add: Accretion of redeemable preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:to="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_lbl" xml:lang="en-US">Less: Mark-to-market adjustment for preferred stock embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Net loss attributable to common stockholders - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per share of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of shares outstanding - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Non-cash stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net loss including noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xml:lang="en-US">Other comprehensive income (loss):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Unrealized loss on foreign currency translation, net of tax of $0</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total other comprehensive loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation" xlink:label="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation" xlink:to="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation_lbl" xml:lang="en-US">Tax on unrealized loss on foreign currency translation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of shares of Series A redeemable convertible preferred stock, net of embedded derivative, Series A warrants, and issuance costs, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of shares of Series A redeemable convertible preferred stock, net of embedded derivative, Series A warrants, and issuance costs, value</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_lbl" xml:lang="en-US">Accretion of Series A redeemable convertible preferred stock to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CumulativeEffectOfNewAccountingPrinciple" xlink:label="ACTG_CumulativeEffectOfNewAccountingPrinciple" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_CumulativeEffectOfNewAccountingPrinciple" xlink:to="ACTG_CumulativeEffectOfNewAccountingPrinciple_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_CumulativeEffectOfNewAccountingPrinciple_lbl" xml:lang="en-US">Cumulative effect of new accounting principle</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Compensation expense for share-based awards, net of forfeitures, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Compensation expense for share-based awards, net of forfeitures, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Repurchase of restricted common stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Repurchase of restricted common stock, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xml:lang="en-US">Repurchase of common stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xml:lang="en-US">Repurchase of common stock, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Net income (loss) attributable to noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Unrealized loss on foreign currency translation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Net loss including noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Change in fair value of investment, net (Note 6)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossOnSaleOfInvestments_2_lbl" xml:lang="en-US">Loss on sale of investment (Note 6)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfInvestments_2_lbl" xml:lang="en-US">Impairment of other investment (note 6)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherInvestments" xlink:to="us-gaap_GainLossOnSaleOfOtherInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfOtherInvestments_2_lbl" xml:lang="en-US">Gain on disposal of other investment (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_lbl" xml:lang="en-US">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">Change in fair value of Series A warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:to="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xml:lang="en-US">Change in value of trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment of patent-related intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Patent acquisition costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_lbl" xml:lang="en-US">Sale of investment at fair value (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:label="us-gaap_PaymentsForProceedsFromLongtermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromLongtermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromLongtermInvestments_lbl" xml:lang="en-US">(Purchase) Sale of other Investments (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchases of trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Maturities and sales of trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Repurchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:label="us-gaap_PaymentsForRepurchaseOfOtherEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfOtherEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfOtherEquity_lbl" xml:lang="en-US">Repurchase of restricted common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Issuance of redeemable convertible preferred stock and Series A warrants, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Decrease in cash and cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Trading Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xml:lang="en-US">Schedule of Investments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentHoldingsTextBlock" xlink:label="us-gaap_InvestmentHoldingsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTextBlock" xlink:to="us-gaap_InvestmentHoldingsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsTextBlock_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US">Equity-Based Incentive Plans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">Retirement Savings Plan and Executive Severance Policy</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Disclosures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">Series A Redeemable Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantDisclosureTextBlock" xlink:label="ACTG_WarrantDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantDisclosureTextBlock" xlink:to="ACTG_WarrantDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantDisclosureTextBlock_lbl" xml:lang="en-US">Series A Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">Quarterly Financial Data (Unaudited)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Accounting Principles</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PortfolioOperationsPolicyTextBlock" xlink:label="ACTG_PortfolioOperationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PortfolioOperationsPolicyTextBlock" xlink:to="ACTG_PortfolioOperationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PortfolioOperationsPolicyTextBlock_lbl" xml:lang="en-US">Portfolio Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" xlink:label="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" xlink:to="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock_lbl" xml:lang="en-US">Inventor Royalties and Contingent Legal Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Long Term Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:to="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_lbl" xml:lang="en-US">Trading Securities- Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US">Trading Securities - Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostMethodInvestmentsPolicy" xlink:label="us-gaap_CostMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostMethodInvestmentsPolicy" xlink:to="us-gaap_CostMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostMethodInvestmentsPolicy_lbl" xml:lang="en-US">Impairment of Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investments at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAndCostMethodInvestmentsPolicy" xlink:label="us-gaap_EquityAndCostMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAndCostMethodInvestmentsPolicy" xlink:to="us-gaap_EquityAndCostMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAndCostMethodInvestmentsPolicy_lbl" xml:lang="en-US">Other Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ImpairmentOfInvestmentsPolicyTextBlock" xlink:label="ACTG_ImpairmentOfInvestmentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ImpairmentOfInvestmentsPolicyTextBlock" xlink:to="ACTG_ImpairmentOfInvestmentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ImpairmentOfInvestmentsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Other Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl" xml:lang="en-US">Contingent Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantPolicyTextBlock" xlink:label="ACTG_WarrantPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantPolicyTextBlock" xlink:to="ACTG_WarrantPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_WarrantPolicyTextBlock_lbl" xml:lang="en-US">Series A Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives" xlink:label="us-gaap_DerivativesEmbeddedDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesEmbeddedDerivatives" xlink:to="us-gaap_DerivativesEmbeddedDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesEmbeddedDerivatives_lbl" xml:lang="en-US">Embedded Derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xml:lang="en-US">Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Disaggregation of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of fair value of financial assets and liabilities on a recurring basis</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Summary of changes in finacial liability Level 3</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:to="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Schedule of useful lives of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Stock-based compensation assumptions used</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Calculation of basic and diluted loss per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US">Schedule of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xml:lang="en-US">Schedule of gain (loss) on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:label="us-gaap_AcceleratedShareRepurchasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="us-gaap_AcceleratedShareRepurchasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcceleratedShareRepurchasesTextBlock_lbl" xml:lang="en-US">Schedule of repurchased shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Reconciliation of income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xml:lang="en-US">Schedule of stock-based awards granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of non-vested restricted stock activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of restricted stock activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xml:lang="en-US">Schedule of share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Schedule of quarterly financial data (Unaudited)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">Restated quarterly period report</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NumberOfPatentPortfoliosAcquired" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfPatentPortfoliosAcquired" xlink:to="ACTG_NumberOfPatentPortfoliosAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired_lbl" xml:lang="en-US">Number of new patent portfolios acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_2_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Fair value beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl" xml:lang="en-US">Issuance of Series A redeemable convertible preferred stock with embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xml:lang="en-US">Remeasurement of Series A redeemable convertible preferred stock embedded derivative to fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Fair value ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Property and equipment useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Basic Numerator:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:label="us-gaap_OtherPreferredStockDividendsAndAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:to="us-gaap_OtherPreferredStockDividendsAndAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPreferredStockDividendsAndAdjustments_lbl" xml:lang="en-US">Accretion of Series A Redeemable Convertible Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net loss attributable to common stockholders - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_lbl" xml:lang="en-US">Basic Denominator:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DilutedNumeratorAbstract" xlink:label="ACTG_DilutedNumeratorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DilutedNumeratorAbstract" xlink:to="ACTG_DilutedNumeratorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DilutedNumeratorAbstract_lbl" xml:lang="en-US">Diluted Numerator:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:to="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_2_lbl" xml:lang="en-US">Mark-to-market adjustment for preferred stock embedded derivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2_lbl" xml:lang="en-US">Net loss attributable to common stockholders - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DilutedDenominatorAbstract" xlink:label="ACTG_DilutedDenominatorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DilutedDenominatorAbstract" xlink:to="ACTG_DilutedDenominatorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DilutedDenominatorAbstract_lbl" xml:lang="en-US">Diluted Denominator:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Effect of potentially dilutive securities: Series A preferred stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_2_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payment ot acquire patent rights</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm" xlink:label="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm" xlink:to="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm_lbl" xml:lang="en-US">Patent useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:to="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_lbl" xml:lang="en-US">Assumptions used for embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xml:lang="en-US">Gross unrealized gain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xml:lang="en-US">Gross unrealized loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="us-gaap_InvestmentOwnedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:label="us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:to="us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_lbl" xml:lang="en-US">Proceeds from the sale of securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="us-gaap_LitigationReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationReserve" xlink:to="us-gaap_LitigationReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LitigationReserve_lbl" xml:lang="en-US">Accrued litigation liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccruedConsultingAndOtherProfessionalFees" xlink:label="ACTG_AccruedConsultingAndOtherProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccruedConsultingAndOtherProfessionalFees" xlink:to="ACTG_AccruedConsultingAndOtherProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccruedConsultingAndOtherProfessionalFees_lbl" xml:lang="en-US">Accrued consulting and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ForeignTaxesPayable" xlink:label="ACTG_ForeignTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ForeignTaxesPayable" xlink:to="ACTG_ForeignTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ForeignTaxesPayable_lbl" xml:lang="en-US">Foreign taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Short-term lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="us-gaap_AccountsPayableOtherCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Other accrued liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="us-gaap_FiniteLivedPatentsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedPatentsGross" xlink:to="us-gaap_FiniteLivedPatentsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedPatentsGross_lbl" xml:lang="en-US">Gross carrying amount - patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization - patents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Patents, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2024</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2_lbl" xml:lang="en-US">Impairment of intangible assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xml:lang="en-US">Accelerated amortization of patents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_LossOnSaleOfInvestments_3_lbl" xml:lang="en-US">Loss on sale of investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_3_lbl" xml:lang="en-US">Change in fair value of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestments_lbl" xml:lang="en-US">Net realized and unrealized gain (loss) on investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="us-gaap_InvestmentOwnedBalanceShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceShares" xlink:to="us-gaap_InvestmentOwnedBalanceShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalanceShares_lbl" xml:lang="en-US">Investment owned, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InvestmentWarrants" xlink:label="ACTG_InvestmentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentWarrants" xlink:to="ACTG_InvestmentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_InvestmentWarrants_lbl" xml:lang="en-US">Investment warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt converted, shares received</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InvestmentSharesSold" xlink:label="ACTG_InvestmentSharesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentSharesSold" xlink:to="ACTG_InvestmentSharesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_InvestmentSharesSold_lbl" xml:lang="en-US">Investment shares sold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="us-gaap_GainLossOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfInvestments" xlink:to="us-gaap_GainLossOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfInvestments_lbl" xml:lang="en-US">Loss from sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xml:lang="en-US">Fair value of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xml:lang="en-US">Payment to acquire investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfInvestments_3_lbl" xml:lang="en-US">Impairment of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleOfOtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:to="us-gaap_ProceedsFromSaleOfOtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfOtherInvestments_lbl" xml:lang="en-US">Proceeds from sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="us-gaap_TreasuryStockAcquiredAverageCostPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="us-gaap_TreasuryStockAcquiredAverageCostPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockAcquiredAverageCostPerShare_lbl" xml:lang="en-US">Average price paid per share</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:to="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_lbl" xml:lang="en-US">Approximate value of shares that may yet be purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramExpirationDate" xlink:to="us-gaap_StockRepurchaseProgramExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate_lbl" xml:lang="en-US">Plan expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Value of shares authorized for repurchase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Current:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Deferred:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxesAbstract" xlink:label="us-gaap_DeferredIncomeTaxesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAbstract" xlink:to="us-gaap_DeferredIncomeTaxesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss and capital loss carryforwards and credits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_lbl" xml:lang="en-US">Unrealized loss on investments held at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xml:lang="en-US">Stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Fixed assets and intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="us-gaap_DeferredTaxAssetsInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInvestments" xlink:to="us-gaap_DeferredTaxAssetsInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInvestments_lbl" xml:lang="en-US">Basis of investments in affiliates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpense_lbl" xml:lang="en-US">Accrued liabilities and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOtherTaxCarryforwards_lbl" xml:lang="en-US">State taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets, net of valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xml:lang="en-US">ROU Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory federal tax rate - (benefit) expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State income and foreign taxes, net of federal tax effect</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign tax credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Noncontrolling interests in operating subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Nondeductible permanent items</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Change in tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xml:lang="en-US">Expired capitalized loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Net effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xml:lang="en-US">NOL beginning expiration dates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl" xml:lang="en-US">Capital loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CapitalLossCarryforwardsExpirationDate" xlink:label="ACTG_CapitalLossCarryforwardsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_CapitalLossCarryforwardsExpirationDate" xlink:to="ACTG_CapitalLossCarryforwardsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_CapitalLossCarryforwardsExpirationDate_lbl" xml:lang="en-US">Capital loss carryforward beginning expiration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_lbl" xml:lang="en-US">Foreign tax credit</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ForeignTaxCreditBeginningExpirationDate" xlink:label="ACTG_ForeignTaxCreditBeginningExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ForeignTaxCreditBeginningExpirationDate" xlink:to="ACTG_ForeignTaxCreditBeginningExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ForeignTaxCreditBeginningExpirationDate_lbl" xml:lang="en-US">Foreign tax credit beginning expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DeferredTaxAssetFromLossOnInvestment" xlink:label="ACTG_DeferredTaxAssetFromLossOnInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DeferredTaxAssetFromLossOnInvestment" xlink:to="ACTG_DeferredTaxAssetFromLossOnInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DeferredTaxAssetFromLossOnInvestment_lbl" xml:lang="en-US">Deferred tax asset from loss on investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Other than options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AggregateFairValueAwardsGranted" xlink:label="ACTG_AggregateFairValueAwardsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AggregateFairValueAwardsGranted" xlink:to="ACTG_AggregateFairValueAwardsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AggregateFairValueAwardsGranted_lbl" xml:lang="en-US">Aggregate fair value awards granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Number of Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options Outstanding, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of Options Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Number of Options Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Options Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options Outstanding, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Number of Options Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Options Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl" xml:lang="en-US">Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Options Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Options Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AggregateIntrinsicValueAbstract" xlink:label="ACTG_AggregateIntrinsicValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AggregateIntrinsicValueAbstract" xlink:to="ACTG_AggregateIntrinsicValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AggregateIntrinsicValueAbstract_lbl" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_lbl" xml:lang="en-US">Number of Nonvested Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Number of Nonvested Shares Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of Nonvested Shares Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Nonvested Shares Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Number of Nonvested Shares Cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Nonvested Shares Outstanding, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_lbl" xml:lang="en-US">Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Exercise Price Cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NonvestedRestrictedSharesAbstract" xlink:label="ACTG_NonvestedRestrictedSharesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NonvestedRestrictedSharesAbstract" xlink:to="ACTG_NonvestedRestrictedSharesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NonvestedRestrictedSharesAbstract_lbl" xml:lang="en-US">Restricted Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Nonvested restricted stock outstanding, beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_lbl" xml:lang="en-US">Restricted stock granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Restricted stock vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Restricted stock cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Nonvested restricted stock outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Vested restricted stock outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WeightedAverageGrantDateFairValuePerShareAbstract" xlink:label="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Restricted stock granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Restricted stock vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Restricted stock cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Vested restricted stock outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Shares available for grant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Intrinsic value of options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Intrinsic value of options vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Options granted, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Fair value of options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Unrecognized compensation expense period for recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xml:lang="en-US">Fair value of other than options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Fair value of restricted stock units granted</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_FairValueOfProfitsInterests" xlink:label="ACTG_FairValueOfProfitsInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_FairValueOfProfitsInterests" xlink:to="ACTG_FairValueOfProfitsInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_FairValueOfProfitsInterests_lbl" xml:lang="en-US">Fair value of profits interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total minimum payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Less: short-term lease liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettlementLiabilitiesCurrent" xlink:label="us-gaap_SettlementLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SettlementLiabilitiesCurrent" xlink:to="us-gaap_SettlementLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SettlementLiabilitiesCurrent_lbl" xml:lang="en-US">Settlement and contingency related accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ExcessOfLeasePaymentsOverSubleaseIncome" xlink:label="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome" xlink:to="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome_lbl" xml:lang="en-US">Excess of lease payments over sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:label="us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:to="us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_lbl" xml:lang="en-US">Sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAdministrationExpenses" xlink:label="us-gaap_DefinedBenefitPlanAdministrationExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAdministrationExpenses" xlink:to="us-gaap_DefinedBenefitPlanAdministrationExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAdministrationExpenses_lbl" xml:lang="en-US">Plan expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">State taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="us-gaap_CostsAndExpensesRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xml:lang="en-US">Reimbursement of expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Purchase of investment shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsIssuedShares" xlink:label="ACTG_WarrantsIssuedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsIssuedShares" xlink:to="ACTG_WarrantsIssuedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantsIssuedShares_lbl" xml:lang="en-US">Warrants issued, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Proceeds from issuance of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payment of stock issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsExercisedShares" xlink:label="ACTG_WarrantsExercisedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercisedShares" xlink:to="ACTG_WarrantsExercisedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantsExercisedShares_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCostAndExpenseOperating_2_lbl" xml:lang="en-US">Other portfolio expenses (income)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Total portfolio expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating income (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (loss) before provision for income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax expense (benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Net income (loss) including noncontrolling interests in subsidiaries</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3_lbl" xml:lang="en-US">Net income (loss) attributable to common shareholders &#8211; basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic net income (loss) per common share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Increase/(decrease) in cash and cash equivalent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_RoyaltiesAndContingentLegalFeesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable_doc" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ContingentLegalFees" xlink:to="ACTG_ContingentLegalFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ContingentLegalFees_doc" xml:lang="en-US">Contingent legal fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_LitigationAndLicensingExpensesPatents" xlink:to="ACTG_LitigationAndLicensingExpensesPatents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_LitigationAndLicensingExpensesPatents_doc" xml:lang="en-US">Litigation and licensing expenses - patents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetPortfolioIncomeLoss" xlink:to="ACTG_NetPortfolioIncomeLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NetPortfolioIncomeLoss_doc" xml:lang="en-US">Net portfolio income (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_doc" xml:lang="en-US">Increase/Decrease in Royalties and contingent legal fees payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PortfolioOperationsPolicyTextBlock" xlink:to="ACTG_PortfolioOperationsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_PortfolioOperationsPolicyTextBlock_doc" xml:lang="en-US">Portfolio Operations Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfPatentPortfoliosAcquired" xlink:to="ACTG_NumberOfPatentPortfoliosAcquired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired_doc" xml:lang="en-US">Number of patent portfolios acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentWarrants" xlink:to="ACTG_InvestmentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_InvestmentWarrants_doc" xml:lang="en-US">Investment warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentSharesSold" xlink:to="ACTG_InvestmentSharesSold_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_InvestmentSharesSold_doc" xml:lang="en-US">Investment shares sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:to="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_doc" xml:lang="en-US">Approximate value of shares that may yet be purchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation" xlink:to="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation_doc" xml:lang="en-US">Tax on unrealized gain (loss) on foreign currency translation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_doc" xml:lang="en-US">Accretion of Series A Convertible Preferred Stock to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" xlink:to="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock_doc" xml:lang="en-US">Inventor Royalties and Contingent Legal Expenses [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:to="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock_doc" xml:lang="en-US">Schedule of useful lives of property and equipment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ImpairmentOfInvestmentsPolicyTextBlock" xlink:to="ACTG_ImpairmentOfInvestmentsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ImpairmentOfInvestmentsPolicyTextBlock_doc" xml:lang="en-US">Impairment of Investments [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantDisclosureTextBlock" xlink:to="ACTG_WarrantDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantDisclosureTextBlock_doc" xml:lang="en-US">Disclosure for Series A Warrants [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_doc" xml:lang="en-US">Denominator [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm" xlink:to="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm_doc" xml:lang="en-US">Useful life of intangible asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ForeignTaxesPayable" xlink:to="ACTG_ForeignTaxesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ForeignTaxesPayable_doc" xml:lang="en-US">Foreign taxes payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccruedConsultingAndOtherProfessionalFees" xlink:to="ACTG_AccruedConsultingAndOtherProfessionalFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AccruedConsultingAndOtherProfessionalFees_doc" xml:lang="en-US">Accrued consulting and other professional fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_CapitalLossCarryforwardsExpirationDate" xlink:to="ACTG_CapitalLossCarryforwardsExpirationDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_CapitalLossCarryforwardsExpirationDate_doc" xml:lang="en-US">Capital loss carryforward beginning expiration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ForeignTaxCreditBeginningExpirationDate" xlink:to="ACTG_ForeignTaxCreditBeginningExpirationDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ForeignTaxCreditBeginningExpirationDate_doc" xml:lang="en-US">Foreign tax credit beginning expiration date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DeferredTaxAssetFromLossOnInvestment" xlink:to="ACTG_DeferredTaxAssetFromLossOnInvestment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_DeferredTaxAssetFromLossOnInvestment_doc" xml:lang="en-US">Deferred tax asset from loss on investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AggregateFairValueAwardsGranted" xlink:to="ACTG_AggregateFairValueAwardsGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AggregateFairValueAwardsGranted_doc" xml:lang="en-US">Aggregate fair value awards granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AggregateIntrinsicValueAbstract" xlink:to="ACTG_AggregateIntrinsicValueAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AggregateIntrinsicValueAbstract_doc" xml:lang="en-US">Aggregate Intrinsic Value [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NonvestedRestrictedSharesAbstract" xlink:to="ACTG_NonvestedRestrictedSharesAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NonvestedRestrictedSharesAbstract_doc" xml:lang="en-US">Nonvested Restricted Shares [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WeightedAverageGrantDateFairValuePerShareAbstract_doc" xml:lang="en-US">Weighted Average Grant Date Fair Value Per Share [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_FairValueOfProfitsInterests" xlink:to="ACTG_FairValueOfProfitsInterests_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_FairValueOfProfitsInterests_doc" xml:lang="en-US">Fair value of profits interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome" xlink:to="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ExcessOfLeasePaymentsOverSubleaseIncome_doc" xml:lang="en-US">Excess of lease payments over sublease income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsIssuedShares" xlink:to="ACTG_WarrantsIssuedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantsIssuedShares_doc" xml:lang="en-US">Warrants issued, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercisedShares" xlink:to="ACTG_WarrantsExercisedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantsExercisedShares_doc" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DilutedNumeratorAbstract" xlink:to="ACTG_DilutedNumeratorAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_DilutedNumeratorAbstract_doc" xml:lang="en-US">Diluted Numerator: [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DilutedDenominatorAbstract" xlink:to="ACTG_DilutedDenominatorAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_DilutedDenominatorAbstract_doc" xml:lang="en-US">Diluted Denominator: [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_doc" xml:lang="en-US">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantPolicyTextBlock" xlink:to="ACTG_WarrantPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantPolicyTextBlock_doc" xml:lang="en-US">Series A Warrant [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_CumulativeEffectOfNewAccountingPrinciple" xlink:to="ACTG_CumulativeEffectOfNewAccountingPrinciple_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_CumulativeEffectOfNewAccountingPrinciple_doc" xml:lang="en-US">Cumulative effect of new accounting principle</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee3Member" xlink:to="ACTG_OneLicensee3Member_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicensee3Member_2_lbl" xml:lang="en-US">OneLicensee3Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_3_lbl" xml:lang="en-US">AccretionOfSeriesConvertiblePreferredStockToRedemptionValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_2_lbl" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_3_lbl" xml:lang="en-US">ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:to="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_2_lbl" xml:lang="en-US">Trading Securities, Change in Unrealized Holding Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_2_lbl" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_3_lbl" xml:lang="en-US">IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromLongtermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromLongtermInvestments_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Long-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfOtherEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfOtherEquity_2_lbl" xml:lang="en-US">Payments for Repurchase of Other Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_2_lbl" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantPolicyTextBlock" xlink:to="ACTG_WarrantPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantPolicyTextBlock_3_lbl" xml:lang="en-US">WarrantPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_2_lbl" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_2_lbl" xml:lang="en-US">Available-for-sale Securities, Gross Unrealized Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsForeign_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>actg-20191231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: acacia_10k%2D2019.xfr; Date: 2020%2D03%2D16T20:32:32Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20191231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BalanceSheets" xlink:href="actg-20191231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BalanceSheetsParenthetical" xlink:href="actg-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfOperations" xlink:href="actg-20191231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:href="actg-20191231.xsd#StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLoss" xlink:href="actg-20191231.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical" xlink:href="actg-20191231.xsd#StatementsOfComprehensiveLossParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfStockholdersEquity" xlink:href="actg-20191231.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StatementsOfCashFlows" xlink:href="actg-20191231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20191231.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecurities" xlink:href="actg-20191231.xsd#TradingSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpenses" xlink:href="actg-20191231.xsd#AccruedExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Patents" xlink:href="actg-20191231.xsd#Patents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Investments" xlink:href="actg-20191231.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20191231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxes" xlink:href="actg-20191231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlans" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20191231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:href="actg-20191231.xsd#RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformation" xlink:href="actg-20191231.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:href="actg-20191231.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueDisclosures" xlink:href="actg-20191231.xsd#FairValueDisclosures" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RelatedPartyTransactions" xlink:href="actg-20191231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:href="actg-20191231.xsd#SeriesRedeemableConvertiblePreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrants" xlink:href="actg-20191231.xsd#SeriesWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialData" xlink:href="actg-20191231.xsd#QuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvents" xlink:href="actg-20191231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesTables" xlink:href="actg-20191231.xsd#TradingSecuritiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpensesTables" xlink:href="actg-20191231.xsd#AccruedExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsTables" xlink:href="actg-20191231.xsd#PatentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsTables" xlink:href="actg-20191231.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20191231.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesTables" xlink:href="actg-20191231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansTables" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataTables" xlink:href="actg-20191231.xsd#QuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20191231.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DisaggregationOfRevenueDetails" xlink:href="actg-20191231.xsd#DisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails" xlink:href="actg-20191231.xsd#FairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details" xlink:href="actg-20191231.xsd#ChangesToFairValueMeasurementLevel3Details" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails" xlink:href="actg-20191231.xsd#PropertyAndEquipmentUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockOptionAssumptionsDetails" xlink:href="actg-20191231.xsd#StockOptionAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails" xlink:href="actg-20191231.xsd#BasicAndDilutedLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetails" xlink:href="actg-20191231.xsd#TradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative" xlink:href="actg-20191231.xsd#TradingSecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative" xlink:href="actg-20191231.xsd#AccruedExpensesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetails" xlink:href="actg-20191231.xsd#PatentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:href="actg-20191231.xsd#PatentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetails" xlink:href="actg-20191231.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:href="actg-20191231.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20191231.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20191231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-DeferredTaxAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:href="actg-20191231.xsd#IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative" xlink:href="actg-20191231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-OptionsGranted" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative" xlink:href="actg-20191231.xsd#Equity-basedIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20191231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:href="actg-20191231.xsd#RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="actg-20191231.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative" xlink:href="actg-20191231.xsd#RecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="actg-20191231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:href="actg-20191231.xsd#SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:href="actg-20191231.xsd#SeriesWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/QuarterlyFinancialDataDetails" xlink:href="actg-20191231.xsd#QuarterlyFinancialDataDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RestatementDetails" xlink:href="actg-20191231.xsd#RestatementDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockRedemptionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="loc_us-gaapRedeemablePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapRedeemablePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaapCostOfRevenueAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ContingentLegalFees" xlink:label="loc_ACTGContingentLegalFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGContingentLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="loc_ACTGLitigationAndLicensingExpensesPatents" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGLitigationAndLicensingExpensesPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="loc_ACTGNetPortfolioIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGNetPortfolioIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfOtherInvestments" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfOtherInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_2" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (General and Admin Expenses) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockCompensationExpenseGeneralMember" xlink:label="loc_ACTGStockCompensationExpenseGeneralMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ACTGStockCompensationExpenseGeneralMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockCompensationExpenseProfitsInterestsMember" xlink:label="loc_ACTGStockCompensationExpenseProfitsInterestsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ACTGStockCompensationExpenseProfitsInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfComprehensiveLoss" xlink:title="00000006 - Statement - Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical" xlink:title="00000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation" xlink:label="loc_ACTGTaxOnUnrealizedGainLossOnForeignCurrencyTranslation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_ACTGTaxOnUnrealizedGainLossOnForeignCurrencyTranslation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfStockholdersEquity" xlink:title="00000008 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeMember" xlink:label="loc_us-gaapComprehensiveIncomeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:label="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CumulativeEffectOfNewAccountingPrinciple" xlink:label="loc_ACTGCumulativeEffectOfNewAccountingPrinciple" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGCumulativeEffectOfNewAccountingPrinciple" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StatementsOfCashFlows" xlink:title="00000009 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfOtherInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfOtherInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfOtherInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherOperatingActivitiesCashFlowStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromLongtermInvestments" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromLongtermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfOtherEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfOtherEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000010 - Disclosure - 1. Description of Business and Basis of Presentation">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000011 - Disclosure - 2. Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecurities" xlink:title="00000012 - Disclosure - 3. Trading Securities">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpenses" xlink:title="00000013 - Disclosure - 4. Accrued Expenses">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Patents" xlink:title="00000014 - Disclosure - 5. Patents">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Investments" xlink:title="00000015 - Disclosure - 6. Investments">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentHoldingsTextBlock" xlink:label="loc_us-gaapInvestmentHoldingsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapInvestmentHoldingsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000016 - Disclosure - 7. Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - 8. Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlans" xlink:title="00000018 - Disclosure - 9. Equity-Based Incentive Plans">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - 10. Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy" xlink:title="00000020 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SupplementalCashFlowInformation" xlink:title="00000021 - Disclosure - 12. Supplemental Cash Flow Information">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:title="00000022 - Disclosure - 13. Recent Accounting Pronouncements">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueDisclosures" xlink:title="00000023 - Disclosure - 14. Fair Value Disclosures">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RelatedPartyTransactions" xlink:title="00000024 - Disclosure - 15. Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:title="00000025 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaapPreferredStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrants" xlink:title="00000026 - Disclosure - 17. Series A Warrants">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantDisclosureTextBlock" xlink:label="loc_ACTGWarrantDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_ACTGWarrantDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialData" xlink:title="00000027 - Disclosure - 18. Quarterly Financial Data (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaapQuarterlyFinancialInformationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapQuarterlyFinancialInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - 19. Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PortfolioOperationsPolicyTextBlock" xlink:label="loc_ACTGPortfolioOperationsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGPortfolioOperationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" xlink:label="loc_ACTGInventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGInventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:label="loc_us-gaapAvailableForSaleSecuritiesPurchasedOptionsPricePolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostMethodInvestmentsPolicy" xlink:label="loc_us-gaapCostMethodInvestmentsPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAndCostMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityAndCostMethodInvestmentsPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityAndCostMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ImpairmentOfInvestmentsPolicyTextBlock" xlink:label="loc_ACTGImpairmentOfInvestmentsPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGImpairmentOfInvestmentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:label="loc_us-gaapContingentLiabilityReserveEstimatePolicy" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapContingentLiabilityReserveEstimatePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantPolicyTextBlock" xlink:label="loc_ACTGWarrantPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGWarrantPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives" xlink:label="loc_us-gaapDerivativesEmbeddedDerivatives" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesEmbeddedDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="loc_us-gaapStockholdersEquityPolicyTextBlock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStockholdersEquityPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:label="loc_ACTGScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesTables" xlink:title="00000031 - Disclosure - 3. Trading Securities (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaapMarketableSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpensesTables" xlink:title="00000032 - Disclosure - 4. Accrued Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsTables" xlink:title="00000033 - Disclosure - 5. Patents (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsTables" xlink:title="00000034 - Disclosure - 6. Investments (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="loc_us-gaapGainLossOnInvestmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapGainLossOnInvestmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000035 - Disclosure - 7. Stockholders&apos; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:label="loc_us-gaapAcceleratedShareRepurchasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAcceleratedShareRepurchasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - 8. Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansTables" xlink:title="00000037 - Disclosure - 9. Equity-Based Incentive Plans (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaapScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000038 - Disclosure - 10. Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialDataTables" xlink:title="00000039 - Disclosure - 18. Quarterly Financial Data (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000040 - Disclosure - 1. Description of Business and Basis of Presentation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NumberOfPatentPortfoliosAcquired" xlink:label="loc_ACTGNumberOfPatentPortfoliosAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGNumberOfPatentPortfoliosAcquired" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DisaggregationOfRevenueDetails" xlink:title="00000041 - Disclosure - 2. Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="loc_ACTGPaidUpRevenueAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGPaidUpRevenueAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="loc_ACTGRecurringRevenueAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGRecurringRevenueAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OtherSettlementsMember" xlink:label="loc_ACTGOtherSettlementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGOtherSettlementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaapSalesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails" xlink:title="00000042 - Disclosure - 2. Fair Value on a Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-gaapAssetsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritiesDebtMember" xlink:label="loc_ACTGTradingSecuritiesDebtMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritiesEquityMember" xlink:label="loc_ACTGTradingSecuritiesEquityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGCommonStockInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitInterestUnitsMember" xlink:label="loc_ACTGProfitInterestUnitsMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGProfitInterestUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGEmbeddedDerivativeLiabilityMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmbeddedDerivativeLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details" xlink:title="00000043 - Disclosure - 2. Changes to fair value measurement Level 3 (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGEmbeddedDerivativeLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmbeddedDerivativeLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails" xlink:title="00000044 - Disclosure - 2. Property and Equipment Useful Lives (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockOptionAssumptionsDetails" xlink:title="00000045 - Disclosure - 2. Stock Option Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails" xlink:title="00000046 - Disclosure - 2. Basic and Diluted Loss Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPreferredStockDividendsAndAdjustments" xlink:label="loc_us-gaapOtherPreferredStockDividendsAndAdjustments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapOtherPreferredStockDividendsAndAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DilutedNumeratorAbstract" xlink:label="loc_ACTGDilutedNumeratorAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGDilutedNumeratorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDilutedNumeratorAbstract" xlink:to="loc_us-gaapNetIncomeLoss_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDilutedNumeratorAbstract" xlink:to="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDilutedNumeratorAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DilutedDenominatorAbstract" xlink:label="loc_ACTGDilutedDenominatorAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGDilutedDenominatorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDilutedDenominatorAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDilutedDenominatorAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDilutedDenominatorAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDilutedDenominatorAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000047 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OneLicensee2Member" xlink:label="loc_ACTGOneLicensee2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_OneLicensee3Member" xlink:label="loc_ACTGOneLicensee3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee3Member" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputCommodityFuturePriceMember" xlink:label="loc_us-gaapMeasurementInputCommodityFuturePriceMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputCommodityFuturePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm" xlink:label="loc_ACTGFiniteLivedIntangibleAssetUsefulLifeTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGFiniteLivedIntangibleAssetUsefulLifeTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesDetails" xlink:title="00000048 - Disclosure - 3. Trading Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritesDebtMember" xlink:label="loc_ACTGTradingSecuritesDebtMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TradingSecuritesEquityMember" xlink:label="loc_ACTGTradingSecuritesEquityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative" xlink:title="00000049 - Disclosure - 3. Trading Securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesMember" xlink:label="loc_us-gaapDebtSecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapDebtSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapProceedsFromSaleOfTradingSecuritiesHeldforinvestment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative" xlink:title="00000050 - Disclosure - 4. Accrued Expenses (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaapLitigationReserve" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapLitigationReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccruedConsultingAndOtherProfessionalFees" xlink:label="loc_ACTGAccruedConsultingAndOtherProfessionalFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_ACTGAccruedConsultingAndOtherProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ForeignTaxesPayable" xlink:label="loc_ACTGForeignTaxesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_ACTGForeignTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetails" xlink:title="00000051 - Disclosure - 5. Patents (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaapFiniteLivedPatentsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedPatentsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:title="00000052 - Disclosure - 5. Patents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetails" xlink:title="00000053 - Disclosure - 6. Investments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGCommonStockInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:title="00000054 - Disclosure - 6. Investments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_VeritoneMember" xlink:label="loc_ACTGVeritoneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGVeritoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGCommonStockInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_MisoRoboticsMember" xlink:label="loc_ACTGMisoRoboticsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_ACTGMisoRoboticsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="loc_us-gaapInvestmentOwnedBalanceShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedBalanceShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InvestmentWarrants" xlink:label="loc_ACTGInvestmentWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGInvestmentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_InvestmentSharesSold" xlink:label="loc_ACTGInvestmentSharesSold" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGInvestmentSharesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedAtFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfOtherInvestments" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfOtherInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000055 - Disclosure - 7. Stockholders&apos; Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="loc_us-gaapStockRepurchaseProgramExpirationDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramExpirationDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000056 - Disclosure - 7. Stockholders&apos; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="loc_ACTGStockRepurchaseProgramMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_ACTGStockRepurchaseProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes" xlink:title="00000057 - Disclosure - 8. Income Taxes (Details - Provision for Income Taxes)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets" xlink:title="00000058 - Disclosure - 8. Income Taxes (Details - Deferred tax assets)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxesAbstract" xlink:label="loc_us-gaapDeferredIncomeTaxesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:label="loc_us-gaapDeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments" xlink:label="loc_us-gaapDeferredTaxAssetsInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOtherTaxCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherTaxCarryforwards" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOtherTaxCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="loc_us-gaapDeferredTaxLiabilitiesLeasingArrangements" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates" xlink:title="00000059 - Disclosure - 8. Income Taxes (Details - Reconciliation of tax rates)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000060 - Disclosure - 8. Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsCapitalLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_CapitalLossCarryforwardsExpirationDate" xlink:label="loc_ACTGCapitalLossCarryforwardsExpirationDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGCapitalLossCarryforwardsExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:label="loc_us-gaapIncomeTaxReconciliationTaxCreditsForeign" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxReconciliationTaxCreditsForeign" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ForeignTaxCreditBeginningExpirationDate" xlink:label="loc_ACTGForeignTaxCreditBeginningExpirationDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGForeignTaxCreditBeginningExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DeferredTaxAssetFromLossOnInvestment" xlink:label="loc_ACTGDeferredTaxAssetFromLossOnInvestment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGDeferredTaxAssetFromLossOnInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted" xlink:title="00000061 - Disclosure - 9. Equity-Based Incentive Plans (Details - Options Granted)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AllAwardsMember" xlink:label="loc_ACTGAllAwardsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGAllAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TimeBasedServiceMember" xlink:label="loc_ACTGTimeBasedServiceMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGTimeBasedServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AggregateFairValueAwardsGranted" xlink:label="loc_ACTGAggregateFairValueAwardsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAggregateFairValueAwardsGranted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity" xlink:title="00000062 - Disclosure - 9. Equity-Based Incentive Plans (Details - Option Activity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AggregateIntrinsicValueAbstract" xlink:label="loc_ACTGAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity" xlink:title="00000063 - Disclosure - 9. Equity-Based Incentive Plans (Details - Nonvested Restricted Stock Activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity" xlink:title="00000064 - Disclosure - 9. Equity-Based Incentive Plans (Details - Restricted Stock Units Activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TimeBasedServiceMember" xlink:label="loc_ACTGTimeBasedServiceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGTimeBasedServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NonvestedRestrictedSharesAbstract" xlink:label="loc_ACTGNonvestedRestrictedSharesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGNonvestedRestrictedSharesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGNonvestedRestrictedSharesAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WeightedAverageGrantDateFairValuePerShareAbstract" xlink:label="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGWeightedAverageGrantDateFairValuePerShareAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation" xlink:title="00000065 - Disclosure - 9. Equity-Based Incentive Plans (Details - Share-based Compensation)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitInterestUnitsMember" xlink:label="loc_ACTGProfitInterestUnitsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGProfitInterestUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_TimeBasedServiceMember" xlink:label="loc_ACTGTimeBasedServiceMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGTimeBasedServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_PerformanceBasedMember" xlink:label="loc_ACTGPerformanceBasedMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGPerformanceBasedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative" xlink:title="00000066 - Disclosure - 9. Equity-Based Incentive Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_Plan2016Member" xlink:label="loc_ACTGPlan2016Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ACTGPlan2016Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AllPlansMember" xlink:label="loc_ACTGAllPlansMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ACTGAllPlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ProfitsInterestMember" xlink:label="loc_ACTGProfitsInterestMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGProfitsInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NonVestedMember" xlink:label="loc_ACTGNonVestedMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_ACTGNonVestedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_FairValueOfProfitsInterests" xlink:label="loc_ACTGFairValueOfProfitsInterests" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGFairValueOfProfitsInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000067 - Disclosure - 10. Commitments and Contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000068 - Disclosure - 10. Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettlementLiabilitiesCurrent" xlink:label="loc_us-gaapSettlementLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSettlementLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ExcessOfLeasePaymentsOverSubleaseIncome" xlink:label="loc_ACTGExcessOfLeasePaymentsOverSubleaseIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_ACTGExcessOfLeasePaymentsOverSubleaseIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:label="loc_us-gaapOperatingLeasesIncomeStatementSubleaseRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesIncomeStatementSubleaseRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative" xlink:title="00000069 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAdministrationExpenses" xlink:label="loc_us-gaapDefinedBenefitPlanAdministrationExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAdministrationExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000070 - Disclosure - 12. Supplemental Cash Flow Information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaapStateAndLocalJurisdictionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapStateAndLocalJurisdictionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative" xlink:title="00000071 - Disclosure - 13. Recent Accounting Pronouncements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_AccountingStandardsUpdate201901Member" xlink:label="loc_ACTGAccountingStandardsUpdate201901Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_ACTGAccountingStandardsUpdate201901Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000072 - Disclosure - 15. Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SidusInvestmentMember" xlink:label="loc_ACTGSidusInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ACTGSidusInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_DriveShackMember" xlink:label="loc_ACTGDriveShackMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_ACTGDriveShackMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="loc_us-gaapCostsAndExpensesRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:title="00000073 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_EmbeddedDerivativeMember" xlink:label="loc_ACTGEmbeddedDerivativeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGEmbeddedDerivativeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWarrantsIssuedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:title="00000074 - Disclosure - 17. Series A Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWarrantsIssuedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_WarrantsExercisedShares" xlink:label="loc_ACTGWarrantsExercisedShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGWarrantsExercisedShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/QuarterlyFinancialDataDetails" xlink:title="00000075 - Disclosure - 18. Quarterly Financial Data (Unaudited) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaapCostOfRevenueAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapCostOfRevenueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_ContingentLegalFees" xlink:label="loc_ACTGContingentLegalFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_ACTGContingentLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="loc_ACTGLitigationAndLicensingExpensesPatents" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_ACTGLitigationAndLicensingExpensesPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20191231.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="loc_ACTGNetPortfolioIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_ACTGNetPortfolioIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapEmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RestatementDetails" xlink:title="00000076 - Disclosure - 18. Restatement (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScenarioAdjustmentMember" xlink:label="loc_us-gaapScenarioAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_us-gaapScenarioAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6760875184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Trading Securities (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment', window );">Proceeds from the sale of securities</a></td>
<td class="nump">$ 49,751<span></span>
</td>
<td class="nump">$ 65,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment', window );">Proceeds from the sale of securities</a></td>
<td class="nump">$ 25,339<span></span>
</td>
<td class="nump">$ 1,496<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6865963168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Stock Option Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.26%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.38%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6865537792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 688<span></span>
</td>
<td class="nump">$ 1,711<span></span>
</td>
<td class="nump">$ 5,460<span></span>
</td>
<td class="nump">$ 3,387<span></span>
</td>
<td class="nump">$ 49,203<span></span>
</td>
<td class="nump">$ 13,725<span></span>
</td>
<td class="nump">$ 6,485<span></span>
</td>
<td class="nump">$ 62,093<span></span>
</td>
<td class="nump">$ 11,246<span></span>
</td>
<td class="nump">$ 131,506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember', window );">Paid-up Revenue Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,343<span></span>
</td>
<td class="nump">100,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember', window );">Recurring Revenue Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,903<span></span>
</td>
<td class="nump">13,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ACTG_OtherSettlementsMember', window );">Other Settlements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_SalesMember', window );">Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ACTG_OtherSettlementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ACTG_OtherSettlementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001683168-20-000836-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-20-000836-xbrl.zip
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MY<J!])K.=J"I/"ZS49GUT[0!EK]1W[US)VY S4)*<M0I1RT[8N+746ZFMT:
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MI:8[?W<B-OP^QW>W?3%N@XVP9.;@^B%)N+*!XUSSWX4)C<(L7I9H72)*0]^
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M1KIKFJ$7J;AHL+C["_P/8"&\$\]/84?SMA_,WN7M:V*^?$3$O:7XFM@@,=\
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M: OANTMMJ:A4Z*@S01.B:)%'6+F\28R.N?-P0$@=['L(WV*)EIF+.';<,W5
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MK1V@UYOC0(S%PG-?Z!RHL)=:A_'QLADKJ8DK.Y/ZD\]4G/XSGD,$4E3R=F;
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MV]"&5/,^GO;,O(JG8 56H1'+%DC,3"7_M$KG)Q,9,0(0E$QO6K2X7SP)'5!
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M;>8B)02<GM\XHJ4X1!G@X4=&+@'U%LSS^J8:9!(ZSCENB4G!$:0))NV?H;/
M0GQ#+D9SF !?GA>""0GLP$%@<@(>J(L__HY;:>Y@AFP<%']K"N8;:#M+B=/#
M[W>IG]*"1<#H$'@3F^:0!M!0I#I"\%B:#A+. 60 VIGM&A)PG! Q!)3U)KF9
MD.1/' ^@-=MWHB] ?*/6H.<)C,5#PP4CA9=,(V0PU,QWT*5AFA#1\98M:LC]
M1? 4B($QMAT[ .9*(+_8CD/.[/? 1!#@ -@Z!XF28K2.)H,XX0Q@%LZ(,>,]
MT;]#$%+YFO'TY-,GO+ 2"#@SWO/N@28?!=L;@XXQA%"=V4W:;$ 7+KZ-^YY
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M.+WNQ6F+S2@E-CEU2;L[.&V8C%*2,\HE.9U1?^G4Q0GR)&5S\HA.M]-NMX_
M$V@7XQC1(F;L[N)"[<53:+B***NN?Z5!=@7GUJ5?;!.+Q-).@6BJ/4R50-Q
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M3T\^?0(O+RGES=UI_AXM+'.;!KNR(,LHY?%MH65?NG>=I$W5)XY'\7XF964
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MU>E6"/;-E]5LH*I_(!$L-H.#HKQ:NM\V>U_S;1BPP' M6>EM!Y6_[IKSB^$
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MT6FX"K$\>+=6%JL!YAE>##'U0F:X%GNO,LNJA5Y%(B6]I0\J,W:[7GVS8JH
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M=SO['6@^<_&VUCLV*+(O'F,$>$,X<U9Z>XF&^PRB+5.!,CTHY3;MA#Q1EXI
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M+*FDO4]@?:,6I5YU9'Y"D7G1^K&JYY@U:M\(:G4!)S571DHK,",.9NA*3KI
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M?834RA &26 YF%P$D'8H2?$@ L!LS7@,\0R*,$JGIP)/J?"XBRF30G9L]6*
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M3J86?'S86S[(77]L+RZA+;J9)4SAA>%DV2HLY C>  B!S:8H5VF>3&T0'0A
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M@],D4=I^=9K5<)@GFQ(":%&NN$0.F]LVD_J!P3/4:>;;02AXB4W/C$4#@Z9
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M5 8C;G"T'95JM+")CQ*)Z5P%J^+#B,W:Z#JBA$<PP>T>X(49VOS6KL)8(IV
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M%_4@O1?^27_%T5#=[XARB'T!B!V=^N?],P=9!]F#@>R3;:WNX?90^U5<^/>
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M:B$L:#5Q*6"!W_#:#L^::\LNB[4C;@6*[J+(XW')$K^P4([!;;#%$Q;HL-O
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MM/+A(+7/DWH9Z(--9QI_$A,!2B4ZI%1C]Z*9^XG\;HBJCK#*8<EAZ5"2"%N
MKLO='NK6.<P$G .3 U.G!/&AI #6R/ ZC_;Y>K1K;U<7B'&P=;#MI.HYZ*1
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MA5\5=&5//Y.QJ9K$E6;3"9RN& V;0&9I,(;%A.MD3!%.  FM*>]9#FHB3A^
M2!T;0'O.0<V<GAP)];<"S1ZP,KP/+'_[KI3'UT$P?\L!95!)/X&E!R87.*17
M<*,?$S"L_O[?_X59I[_I:S\$<8YUJ:*Z5IJ+4>,@"9_%Y(=7'_)LA@+CN#^
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M"EE[_W:8 "A&-R@AF49ZJLKS&EUE:Y2:=5$\I"4K,4/J\J%U\,P:V+OMR>N
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M=$'#QVMMK3A)[!B/?>'M3]L=7>(HYKJ]F1!<B*\&AX?97%BS>TDB6+$*]>H
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MC9N (&TU;.#==PW?:B#HGJ!L:,11%K*:6R!H1*&' R]^^3#\=L_ZZP7@R[N
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M8>,=)KM?W\/H03F*!C"E<<%\]:9*A?#D34+ +CQ1RE36E;J0^R9*?"F4T"Q
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M_!F!E*WA(^S:E\1 R[,HF-C(M$7 0H%_%#]*0@0/@C/K_5*W.=,00_@W +N
M@-;W -4"/,T,/P1)F<N18?.*<UD+ JP02,/<#[&Q>W@G9#<<>7-6EEK%$F4+
MI9# TT#\-==R!Q_O9AS%"XQ: (VAV$Z?H%F]*.DX1=Z=)IFY.[.42E@QR!:_
M$R6IUB0($<'OV,J=G\RJ*PMR/1^I4-(:0&O^U/<T:U!*[TL]6@R>RRC+.;=*
ML23K/"R_YR-3@8>31]^ N4!*S0E[G8UVQA1%&?)(K)86+2$K"H2JSZP%6*8(
M.IE*&H"[,.)T"@/RLV=B[D6W/%92#^S)%1.4*-6R>'+]&LR(\)=4&CJ;2,;
MLV@@)'D% 4MRO=*H) 98H/N60"!6/DI'S)F(0OE=3KTE*8_2Y([[-S-A*7W7
M=,#XE64)$RT@05 2\>PY&S<*9_DX<@T.^8VT53:"LBR[N32@Y").=J%,V*6D
M1EIOD8+N%SU)>E88&4U7. 3]22+6XP+H.:!6%NA,2($N5C+,IX#NJ6 !D).&
MT%P@@]<@$H(KBVZALCXF?KDF(V4WH7S/#S,FRPUMJ5X"5P,4#4!<!'1*-1%G
MQ9Q:^"O/>![@I/SRT_?K./#?X+_AX_\'4$L#!!0    ( )F%<%"UD'POF!$
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M"R8!Y2":O_%PO/9JR;?;_&W1YJ?=J UW/DAF*.&&%+L#QN#<7RZI'DLAKH$
M4KJQA*7.M(W CL*I$?+TNRC#3L4Y.88'C,,M"2A7X?H4/X)!A&R88/"+-?BZ
MLJ5.R2/A<O]&A1C16-^XE!6QH1FD0I2:UH&B2E2G4>@E]:"D(AT"'?)D,0U7
M*[UICKUX)4<>">'+S,K")B([4$9P.E#1:<HR7>]!&:X'#,HMD2-^9A6 ^PQ^
M.B3CE6Z@L4-BQ*N#8]EW),?< D&.YP$#<HDI5\>B4J-%,)3FV(UO!+(#B&0E
M'WWR*I-WR":_)9Y<&;[!/'BZ@\%:8">STUV9:S>]$?$.3F2[5[R08H:RW [8
M_%/"P<>Y)2XA2SSS"+@^,&<&%'[><#(GG!-7Q5W1#%&;W Z0$4$/((36S-$(
MI?Q1I@*4U* CP8-'[6?,H1''$T4AS6Y_([P>O,G8/V9RP!;^5PBC!.'>TR5E
MX$%2[(UQ@+6E*_+L%C="[@'$W DGE+"2YX,Q>G7/<.A2&*X.>M,XG GR+02E
M+AY3C\A(M1O>B+L'I](MC7D@S>2@K5QG9VJ;W:QZNUI#(R9OM*N%7L6_#KNK
MU 'D3LZIC2",2E@!/#9"](8 ZDH.&3YC(S*+5%6F'10C'"_=JVR-;VQ:9DU?
MGF4WO!%TEVQ@MF9/=C*SYLXGV<ULA-?IKF9KW=SV9M;"9K+=RD8DG=_J;"U=
MMN>9FV:K<NUV-P+DBOW/%H#<1FB^J1>3[28W8N+"IFAK:MON:-;R&ZGL0!BA
M\H:=TA88ZY9I%IG-9'9HS&!ZT_9I"T[58E(6%RN%'1)S1]NZL-2BT>#\])@$
MF'KBLUP/E>--XP/8!@,KEC^]R(%L]"JJ%275'C3<5.#%@I,%UH#=DD?"0A+9
M*$+43F,'K>Q0=IZA1"ABF8!SR) DFZD3=BM7(CC,%JHIYT#92&6'Q0C#A[G=
M5T %HX1OU)-:<,"3>, P=XL[/['_)X*E">4$?PVMV#O.P=2 W@Z8$= #8!%S
M%/AH+K%[5-@MTPJ0J@$=M]#)%17NKP@/GN1A*_"75]) ]X+,0^\:)H%\[ZI)
M:X?,6!T R&+&^BQ6S!IIWD@Q;\&*EPTF:EX?"1$NU:\\1G82.S3& L(P6D!
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M?JVBE!TS(\S?>)XM[6%112BJJ<5R,RHC!S*2EX<:E[)C::P?-,82Q36U4%I
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M<_Q&[=2V#SN!1+LN-_7=%IG::9Q>1/H)_?HFYK!YMV/UY_YT'#"G<XJ![>9
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M^3B\$#4RDI-G%GM^HBJ]@@!U-,8P4"U6/.Y%$Q7*SY)DS9^*O8BS<T+MK$7
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M&TUN]N8S#CS*I+,@3*E'R^]Q$+E]HD,-43:'T+WM7G7;W YJJ_:\H31T\[K
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MIN(2HI.!=#A,$/FSP_N#P_N#K4IIL1#8 [=)<76=O#*W1!W&,YH,]+7"*B3
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M%]7:=)EMME7)#'JO]5A:CB 05*LNQ9U(#@]L2AUU".-,1XBQH?=P7> G%IK
M3B0N"OS7+<Z6KW;^3\T9R/F93%%X/A4;/"0:=1TCLD>.6GJ8/J^G:MF>FMDY
M/RUK$"Q:&",%HX8/'AK-RNH<9)_["'7GI, <99*1C4T2I9=9615;JJW..:JH
MO8)0K_( =W)2.%#3ZB>@JZ%&';G/(]/$[<PT 7%H*E5:<0Z60#\VE2FH.@6[
MF^W<=+[-P ?GS< '*)N!#VZ;@0] 0&:OH_UFX,,!(.VC,](^0D':1S>D?3P
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M*"-#E YQPH#]?XL?$[I4S2KZCE=IU)C,+P[D2@ZQ,*0!A >I8@I,=+3L675
M7)RR>G#I91;CEW_'KTKK!#J_R%"H.83&B @0-N2:*<!1$R-&C0AY2'CPV>P6
M;_*B#L.OMN.#>3.Y9[!HE1YA1DH+"3HZ!54(JM<@+1/B7 &!Q-ZHTM"Q9TQ6
M0E&MH=)J%;E?(.F5'@))3@L(2%H%%4#J\= %;-0@*_!"MJBO=]33U8C*_W)6
M4%%<T;8D@$ BTTNSKBV:B[:0<]3=.DK3DVV99+A43TTC*K^(D*HX1,2 !! B
M9'HI$,%(44,;$!'G:UP\DFGOIR+_6CV=YNM-E*E]A8+:+T*T*@^1(B4%A!B=
M?@KD-"R(\Z":*>3"EQ8*RMB5WMU31!KI>EN5] TJT5*]5M,R>5X$6Q@P6@IK
M. #!RT)-U;*8<?)[VB/$F5&/.^AY?W>^>$%^(YO'E)2^S_P5JHY/_4=D(""D
MUTUY\M\_S&4, *#";R/LP#*@#0,7B;IRP/0( 4)&U,X$FOK6*!QLFNW?,B\V
M><$"XE@8?9U!YC2/U>?!!B[?VW$+$\:[<@T+"'C9ZRG/*)6OT( YY$;L":>I
M:;4])/*\#9,H.-J%]2@ P4.BEFH/1BD!K)_/7]ACT81"DGM ]7Y!0NIY\Z54
M=K3S$N@ 842IG&K/]8*JE@%M&$= P-QL'])D>9'FD?I4>$#C%R(2]8;8Z!$
M H6HE0(-G! QRH H^#/Q7O^>Y5^S.QR5>8;CR[+<:F(6E/1^T6%0>X@4!3$@
MU.@U%))4T!F'D:.&'G&&@$#Z.4_)^BDJ^(FV^EA8H/,+'(6:0\",B  !1:Z9
MPL6TQ/SJ ,;+M/9!\?6JSG-!]G@YGQ05@?1NK-[K[ED:(R3A-? %1]T$9:4[
M)K8W)[NFEADUW'L.Y]]#-M6RQ%5I@.&8R&L^5*F"@X2G PHP()*J)6:0O#N_
MOX,$A?KZW0H1 JU_8"C4%?$Q(@0&$[EVJL#?B/'\" ,VIU'YM,AB^A]:=_LY
M2C%-TUN=1D7QFF2/+"F=PGA+7I^P<C*G#S,K1C"P<]%6@"%A8B^CE_0'W+'#
M .3B.4I2^HCR(B_NB&)=GK$S_%!U_Y('B$V6XM7W33-QX!7=1( ![C2]A3J7
M142O8U'9Y: [1C$1 !W"=+!6K[N#6"D'!HP-9MH!62'D *"LU]P*S)B)  )G
MGF.]O,5+3.8*8O%G7!F0JV7Q"E(+Y0=XU-##@9Y926&K4K.@HN6!@:Z; F^B
M)#Y_V>"LI'5SKJLG7 S6U8I6L.+T6MW1WI1!T4<S&QCDV>LJUJ)BG ASUI(M
M07/*C9:#C1$,6-H ,"#4C* *!Y\JKZ+TRG;/K)H4J1"0P.@*7]>;L%[.J<^D
MX[2(L64.4]3<QB!Y=7,=)QC?Y:3N&)!7>?9X7.%BC8JN\CG=0<- 9<\4A?4#
MBD"9[F0@ZOT9#%)$G=2)YE!4H564%.B9GKF@;S_G%4:__PX&+/A.Y!.NGO+8
M#!$EM4^X&%3N0T=!"@9&>OW&D&(K*93T,AC"PM)%DB45ODJ>,3&F(IK3[&9\
M+B>[#T43F)B\%H*T,F!0$E++ 09G5FH*Z_&HHB [0AEFMYW1<KE=;WFQJ6A-
M7P7_;6_AHKN#[WJ#:?1J]GB%HQ+?)H]/U?7J2\FM5#2+@<<G]*S4[R-/RP &
M>#9:"@LI2AJC@A(?YZOC;8E!K>][&UKC<EY!ZQ59.G4'B)(1PD&21COY1)GE
MV3'$_2$W0KOU#7%4H#XC@'@XH#T5@-3;5TGTD*3LU)YL*-G#P:<\C7%17P(8
M C'LV7TBQM6H/J9L><%X'D>%A>GL<G%R>75Y?WE^=X1NS\_.SS\M3J[.T>GU
MYY_/;^\OZ<\WM^<7Y[?DC^CN_OKTWX_0XG/]XY^NK\[.;^_^"9W_QY?+^[^
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MB%I.>KK<2Z<W2J$' \G#J>$Y2E(^+_0RS]1EX$ZB,EE:33 64L*M :Q-5*\
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M1<OZJZCJ/L3S:=!GF-$+_<\_OH,QW"5MUQB^QRCVO7_%<\6M.9IH5*1KGY\
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MQ71YOG[ <8SCWJ\4P\3$Y--KV1G0=U!Z#C"^R$I-H;!838EZI#" UA:@M#T
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M2DS\X3&H,<L,1PDSX*G62O$Q5F^OOR#F62%CDVV&G!J@Y@B/OX'J9L0Q\L/
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M T B2K@KOH]><'D3)?%GK')@,D*?.%,KVD>42 4&.TK5A(F.SHNHHH1DQ98
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M;J[U.-6P'UP?NXY=31>'&,<'&"T 9,TUDU7R2(%]?2:0_Y!E@NJ4DDX,!A9
M?L)64^&!=9?2ZB>6TNJJ26G5XPYVP![1K=T=7A(710\].F7_E*?T3XVM\H-W
M6VY W3A!:?&@GHE G8PCU$7Z]/J[%MCO]U!'28-D*X,L >7Y2WUV^5.>QU^3
M-)7UM9, 0-T]36]3NIDV1T)])?QM*PHUL@+6^QLE=ZXC9,A,LL3$WXRR*;CP
M0>I7%W55&:O1MV?]XAF-!-2) -.)9,8G$(R;A['UD6B3KT =8S%-$NB.=C+
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MPVB%DVI+^O4RXZ&7<T!0\AE +FQ.Z^:$8>^[['TD^_*! K$K&CPK$"6?>4-
MU%DW)Q![WWT#0&05M>C-^GQ3LO"1-P5"E6WS0K#]ZH%/R;W%Q:AV:5,;[J9(
MY%<2GC[]-M>/5A9[6U4*Y68;?1!3Z$"QW1NEOK%M^>FWZ8BM+/;FG@%C^\'<
MW ^*YFYK@//9YWJER;0YSZ>@^>49+9P3J^VWFX4$JP88-.?GOEISN&'U"E7]
MIZ&Y78\6>X%R\RO4:O/VP#V:Y'ZB#YO.H@JWX?JSXMOX];?HG>V-G@WE W_]
M-E<6/X>#M^6GWQ"V72V>TWW_K((UTP=1A5#W/.C0]H1-X:>R*EA-61YK<_\4
M9?)%X%YWA:X?AX9PKS;/@/&Z@%M/F3J/3474T:S%WQS(^1AOCNNG.WD(RD%;
MQ8-JDW"#B&O<W<P GU"N-YA>)F6/-.(5EQ=;>L/Y*<F2]7;=I,$ZVV)-15TW
M"8!0.U%QH7AW(P9Q.4>(2T*UJ 9')3JCKXH_TZ?I]U]Q^DPH\JQZ"K45M#3_
M,KO_FO\%1X7TQ,)9R.'UOT3WR1 XHAB@OH&(1$PF^,Y_*C#>0_>W8@X2 *+V
M>X  %7H8(+@@S;X[!EHIAP@!4?G=$4!E'@@ DN<].(%6RD$"0%!^#P"@@;@'
M ( =>OWPNGH_"SU)A_9_=45^(K]N?D7^A^XYR&_^-U!+ P04    " "9A7!0
MDKW^.996  "*-08 %0   &%C=&<M,C Q.3$R,S%?<')E+GAM;.U]ZW/C.)+G
M]XNX_X'7&S<Q\Z'<95>_:AZWH?*CU[LNVVN[IF_N2P<M0C*F*=(-DBYK_OH#
M0$JB2 )(\"$D94WL=KMM9!*9O\0C$XG$7__]=1%Z+X0E-([^]LWQT?MO/!)-
MXX!&\[]]\^7^W>3^]/+R&R])_2CPPS@B?_LFBK_Y]__S/_^'Q__WU__U[IUW
M04D8_-D[BZ?O+J-9_!?OVE^0/WL_DX@P/XW97[R_^V$F?A-?T) P[S1>/(<D
M)?P/^8?_['U_],'WWKT#L/T[B8*8?;F[7+-]2M/G/W_[[=>O7X^B^,7_&K/?
MDJ-I#&-W'V=L2M:\_*D_I?ZOQ^]_^]\G9R?OCS\>O<ZX &=^RO]X\O[D/?_U
M^P_\'\<_/)R\__.'$_Y__P_XI=1/LV3]I?>O[XO_Y>1_#6GTVY_%/Q[]A'@<
MEBCY\VM"__9-2;ZO'XYB-O_VY/W[XV__[^>K^^D36?CO:"3@F9)O5E2"2Q/=
M\<>/'[^5?UTUK;5\?63AZAL?OEUU9\V9_Y5JVI=ZDM _)[)[5_'43Z5U&3_C
M*5N(_WJW:O9._.K=\<F[#\='KTGPS4KY4H,L#LD=F7GBW]Q*UE_-D64D(3Z;
M/G'[6'PKFGQ[&G/KY_V5Q$^,S/[VC3]-Y^\$^,<G^1?^;:M1NGSFHR"APHB_
M\;[M]/5/?BCT=?]$2)J8>M'8>+#>W/(&4?I$4CKU0ZNN-5+VV4\QE,B"?R.Y
MF=T\BUF&VY=1?7JJX?N73XCA) HFP8)&YZ_/)$J(G9Z[<QY*3C&I,_+$/TQ?
MR%6<6,&A)-Y9;UNC .,TE!SW:3S][2D. [Z0GO^>T71ITW<U]6!Z]Y.GBS#^
M:F<=5:(^>W=&DBFCSV(<W<P^90F-2)+PD?3)3RC_]JV@B%(YSDQ];L&J5SUG
MBX7/EAQ6.H_HC)M?E$ZFTSB+4KZ;NXU#.J7$K'@K+GWV_X'Y8MMY3Z89HRF@
MJTJ"/GO%96<9"59SJJE/BN9]]NB6CXS(O%NH-.NS!Y?1"TG2!:07#4W[G5OL
MY[]=S'F7W(=:D ?_U6PQ#4W[[$DNXSNQ;P[XIS@0?)VZY;LU8\?,E'WVDZ^C
M"YH;"I\R3V,YW7!7%# / $C[[.D=7]J97)ON_1?^I43HA'_X_)5/1$)']X1[
M"V([+&=+HT6VY=?OVO',N8@^^.%JN17.*UN 5CX@>;\H"(LLK4PLCOB/4P*:
MEF#4??;WPJ=,NOYG-)F&<9(QLV'K:/K59<@7BX#O7-,E7U2CA'<%XE&9Z'JU
M4,+X>+XC 2$+_S$D?)CS49%2_B/?6,T(8R20<[O15FT9]2_%+S[CVC);:7/K
M/OOSWQG'CK!P>4$C/L-0/SSS4]_4+SU5O_/28T)^S_B@/'^!C&M5^]WOL_O=
M;P^Y[X;UX$&,E9ZDV>8UJ \!Z[:!;$!_ M8_+=$ O@6L5XV-!_(S8#U2$@SK
M<P#'AH%N(/\#JCD%P6Y\$5@GH?0[\DM@G08S&'Y=AW480NLH G=&4I^&R;78
M$0GL>XS(J5CW*BE-_/F<D;F?]^B..W81W]WGGS8* Z(>Q&>YB>[$TLBXY4K5
M 7L,I>]UO#[Y?'@E#_'ZXY^)+SPG,0*ON,K"#\#>VW/J=25F\3-W2Y8B$,"G
MO6?QT2\)F67A%;=.* )V7'I?)6_DT)LD2;:0/T&[#2+N]^0SH5.NI#,:9MRC
ME><XA-T_\:; +L,Y['[O;CMM=N,ZZ'X>B(:);A=]!*L;S&! /\2VST#R 7P3
MZ,S7V'JX_H U9R ;R'\":DU-,6R_P-H#D [KZ]FL8#K"G?02/N.#.0SDI1:?
M>\<W+"]4Y 1>Q*S=(1J0T\!RG!619/Y+OH,!)'?9\!BX[WRO'G._+Z2%H\'_
M>,<GK38BF%@-*XG%K&(DW4T<9*6W?.^;_"P"_R1H'Q?1\W,ATV3*_P XIV_+
M;[<R7<=R/2+!'?\GH].T.#OJ3TKH%W8K=Z4S7R*:)OW)#.&^6WFE'Y<W$ E_
M?,\+.A?OS'BG4H*G2WM..XK(0B,[8 Z[[3<8@!:L7&; V(K7%_\=9LC8AUA:
ML=M=!HT]9FVX[2*+Q5X2.SY.LERL[:TKX^&R8-J)8J(>_C0-N-B B/L=!\DJ
M>1[8136%KE_/I=.S*_Z++1+RFI(HV+@:HF=V=[%2F@J2XI+<L?=.W*C+1!_Y
MCWG+HCNK#H7Q=*L/H;AY%E<N=XDN)+P/\GY90J9'\_CEVX#0;X5&Q ]2->_>
M'Q>WR_Z-_^I7^;G)(]^5<N6M^(7^(PGE5W[E;2I-OMU9WU9:>>!\F[NVW:+:
MLS*,$S;U8A80QO6^XL4AV@*O?CFO:/'ML[SY\F[Z1,,U[C,6+U0Z*O01*SI:
M5A?_Q"YU.N&]"$1/+D)_WJS42A.@5H]=J+51&B=Z70%\RZ?P.#B/ G&Q5F^T
ME:9 /9^X--]&Z9SH^S1C0J8+FDS]\!]\MM6J7-T:J/4/+K1NDM&)XL_Y'CA=
MBNONU]GB<;.H;2N\W@JHZ.]<*%HEDT,%WY$Y%?V-4G''7J?D:DN@HK]WI^AF
MV1PJ^Y1+Q?SPDF_K7O^++'7:KC4%JOL'=^I62.=2W_G$=D>>8R8\ZKR A%;M
M"@J@]G]TJ'VMK Y!N(RX[R8" "]$N&U%/W4@J"B (/SD#@2]K([747;*U_1Y
MS+3S3J4A4.4?W:ZF-<D<:OI^X8?A*E%6I^E*0[#[XT[5C:(Y5/7Y@K YG^I^
M9O'7]$D<_OB1UK@5!%#5.W$] :*Z7&'CQ2*.9-A3GL,E-UDJ*UWQOFK762T=
M%! G/BI<<*<!@HTW=\%_HYB)E(VA"#CQ5PTB(E!['K\ *WZK.53U3CQ8HYA.
M-YK3F/'=K]24K'YS*D[2&!^K@=:S-1!" 7'HZ8)$=[DI>B)A"%B@M]M!%>_0
MYVT2S.6.Z%4>MU*AH7QP:K=##:VA.G?HZ:J%=*CYV^PQI-.+,/:UKNU6,ZBN
M'3JT#6(Y5/(O?+#]5Q1_C>Z)G\01"2Z3)-.'AI4D4.4[=&T-XCH$XN]QR)<7
MG^7>M];-K34%GS^Y4[Q"O :%__7;F@Q7_!<#G_(WES'=.NT_\=YYZPJ \K@_
M2N*0!B(OQROHO8)!6^-9V<[,3QXE%EGR;N[[S[D!D3!-5K^I6E+QZU_7/;R9
MK7,[;N-\:M<D"Q3D,.K68Z.[>/F= [,@U7:N$@RL]+H]=A22]#=3]85&$9.%
M@E)K[BQ-0:_A)A@4HN) 0Z1LBLQ;_B^1#/WBAT3DXJ:G/F-+&LWE=7$U.D!R
M9\D.("#B-B)A G'RXM-0)$->Q.R>][=\ ?<QW?R7^M!GI2=;1L[R*5H VU)+
MV"'.[S#T K*2E;-LCEYA-F@*"=!YXGDBTM#YY,/EN":I&5,ME;,<D3;P >3'
M@=0M(\\^754.X$O&3?K$O9JRK&K 0,3.DDU:X&:A#1SP 8%J!TG_<;G6^\X&
MK3^O+DI<Y>(JNR;[E<:I'\J63O':W*4L=FBE"@K7<30U 0FE=Y;>8H.PG3)P
M#+B&"NIUE+8:.4M[L8%"61C>M;[S[<YGDC[% 4CW2@)W23$V0!CDQ0'*!8UH
M2D3-,M['U(_FXN):+A[?YZBQ,=&Y2YZQ@0@F/0ZDBE>)HOD5\1-R1^=/Z<WL
M2Y)W5PV4@<Q=3HT-3B#9D<"TV69"=@&*YNX2;:Q@T<F* X[M^CZJ[;3+])J^
MHNO[LJ^^HOXC#65 A.\CZ_6SS"%Z. =WJ23=4;?5$X[Q6.HU^,A%1^,N,:4M
M#$H449_+K,)@M_Y25CF !@"K[=TEM\ 5WAP ;)8<)3KBO<J\C&A=6C!D>B;N
M\F1ZPA&B(QS@GB^>PWA)2%$^Q092 *F[O)NV0(+UT16^AN*\IP\__WH7+_VP
MF._7%:+2*S+WPPM"5O;5 (J@AA)#81G,?X;#8B,6IG%E,Y"ZC)S!7.?>MQ[[
MXD*<$49?9-&BDHP0;]Q(",5\,+^\(^9 S> 8H.>+1Q($)-AT>O/NQ:S^QY5$
M35<)UDM'6XY0X >+#W0$OJLN<5C$=AQPW4E0H,U,"L5XL+R$CAB#M8,$3!$]
MM)R@=310^ 8+YG2%SZ@/'+B5N@C:,,&1&2Q(TT^8;5^V1X!GG1LR:W5$4( '
MBP9T !C\R+7K<;==3E14',V?;YHL1%Q#C9R)#IPSBQ \F$YPX-?F**.'PXL/
M@_F?'7 ;RW'%MGT9+A\T-H:B-)C':+T/T<B, Y12D0W3=9!:2R@< Y[S6L*A
MDA8'%@],/MVXA*#1U!:*QV ^ES4>:HGM]X4?\WUA))X>+=JZ/4<* CE[\WG<
MI\%E=.H_4[YEU9P9J0B@N YXLFZ)JT%V',/M3E01CTAP[K-(O-\PF4ZS12;/
M0<[(C$ZI-N'83 N%;4!/S1(VN$9P(%@7T&;W!T=HL -T:X34$H_=D?Y,HYBM
MZCN21#/VZBW!5]C0X*B2%NNXNHRF81;(=W69U&J:,OJ8I>(D\B$6T37NZW-]
M\:[,S0CVQ1^*^X!>6^?QVT6S8Q_SIB O*"2JH(3:!L8D5*A>>L4?09V56ZG7
M)Y+2:6FSN%5TY0.\Z(KWQRU^?SH481E<O =%MDY5D =88D[-RK$-U*I Y<M2
M&/#@8Y1<\A\U9Q%-;9'ALF55*@1*W2^GV6% X33TD^1FEK^(^DHA8-1)QHA)
M78I2Z1Z70<]2O\[B!?=Y-6'/AK;(L%#95S7XV2#)ILR5TT#,ZL&_[7#Y9Z)X
ME68=KM#3N2Y@HS:S6MP%H@ <ON%V#_D.ZX9)0PQD^/:6,%FK&WJPHZ;'4J"M
MMH1J3WA,^L"(85Y<?9*E3S&C_]KLWTW8U>E<%VYK"9I* 7C!DE5*+8%:T;BN
MU]8)I&W!\0*D?Z-!(V";1QH&/.[N -5 KS7T<,Q*%J*..UOFP13[)0S,P'5I
M-3!^EBI!B2-\&3,2NJZIUA8WW M98V=-*YF6R'4-M6XX85S+&CL*6LS,E*[+
MJW5#:RS+V29O\Y;1J?UJIJ1W73NM+7P&A: $\8KR?P5^WFFQM2+1% ZA@MIU
MQ;6V &J5@0.^4EZA_7821.R\!A@8/0M=H ,/OH?4$CDO!-8&+-R;QUI'31M'
M)8'S<F#MP<&X8[1\GE(E6JO'*=T[SBW?J'23:[&6*KF9%?=;XTCQN,UWNCR+
M#2,OGGDE5BX+T'(QR;ICYJ0*)8'3@[ 7$F6ZFX.;%H[/1PSZKAUP;0N&9>I*
MTIM9T3>SQ2B:NXZGVR&AE1D'+'G]FV51;5XS%BKM7$?+]:J-M7WO1_^*(DL-
M180:M"J:-K9T'<4&Z579>TR6K2F1+(2\S&L4! _Q'8G(UQMV+E=Y]0AHR\]U
M?-MFI'33V4 CZHJF=)ZK*PJNZ)0/8FYXQ6A.;OE4W%R,71 #:5W'ML&CSDH7
M.,;A9"%R[?\E.WTSJYJ5>KR9Z%Q'N&W&%4P'./"2U5R$<-S""L-:U^=1HZ6G
M<AW.ML$*(C\.I+:D FZEW4>F;;!HE-#=11S% G5-4G&?:,9=]CAW$*[B1+4B
MJ1H[?QH$O ;IQ<4Q-'[F^Q/FAZ)6;K#@FQHAC2@/9_1SC(3.SP9LQ@]0#3@P
MNUP\^Y3E=T.J2V2^,0W%QE0398(R<'YD8(.AI5IP8+E>,;7SX6K%;6KL_.3
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M$_9O-C:*W$=#6@V;6W\IQHP('$ZG+..=I?XC#>5*V&:VT?-SGF(XW/P#4>1
M<=AZI^[BI1_*/9!XN4$6-A!IE=P<PPM"5GU51%S;LP/G6Z"#MYO<^^)LP).K
M^DA'A-O++MYC[#\1L;-=I''JAVBM(C^)["=95<L+:B7#WX#M;"4 G>%P1OC4
M5CCAD^GO&66D&G)10PP@A2(Z6-RJ SRQK;#[LH?DRIH2$LAT69&0P-?$SWXJ
M0KQ+FQ0/2S904QDL(M6?J;31'Z[9X")F92FNXFB>$K: X6[! PKZ8%&GWN<'
MN.;V8**HSHGW3S%+'VP-Q4 .M9'!0EG#K2$Z?>V!>>CFP<F+3T/A5/$!(_ZX
M.41LN:+H&$)-:+"PUF[6%K-.<:TRZW' I>)>5;J\#?THY2*)JY[/^K,N&QY0
M^ <+1@TW@Q@U-_YI!*Z\/KQ1B\LEH_1"]SQ6<4$C/YKV$ZO0\H):":8K9^UU
MAFO=X,O;IL20?(9[]<H9R"M1TD(Q'2S^U $@I3=BT-3XUP>%K-+1WG[!&6P5
M6[10J]AU#*LWJVC0U!Y816FC+ J-<E61&Y;?KS%:!8 6:A6[#E>UL JPII"L
M F47R*Y0-H 4BNNN(U+=<!U!I6RXW'ULY.! #U\%;8@-W+YL\X6XXO_%1/3"
MIR29_\5U1*=\E1%_D 4FR[\HM<R+359/^]<YQ/P'>77JCN.0/Q&AMJQ=]P-J
MG<.7Z();IQNLWK2%#V2P\!H*F!(V>M'D?KQSA]&H+"H/?H<IPZ.ST+T8%I;2
M@V<DF3+ZG#^>]2E+:$02D37WR4]H<C.[+7UP+7FY(.'Q>^^==T:3:1@G&2/\
M/XZ/O!)348APQ=;SH\"3C,5OMU@[O*?#YGY47+O?%%/,K^27NW@S*[9E?K@I
MLVB.1?;$WN'<LT*O!&JS?3QP _P4:J-V;7@Y+GG8JWU4IJ+VJFWP\1R5+LT6
M"Y\M;V;W=![1&9V*<ZO-HVQ<6].R^[(U=1Q7IXZ3(Z_@)R:($D=OP]);\W18
M8J\F(*!0GH;&Y3UY'6R $0VE=SR*S8A5[\);Z07-<*Q=X6X>>2?5D??AR"M(
MO1*MRWLOZP2:,_*X.@E/EYO.06Y+PGDXO>*S[N9E5'3TL\]^([)>::W+47!*
M6.K3J, KSU;=@ D8L\-]T?$HM[>:VBVA8;% ,T\45YV*VW.*6>)#=9;X[L@K
M"+TUI=.#0H%*LKJYY8> 24%+Y+)J+^ VFM4@;\W0\1@&H%JMO-M-=6C&Y"WW
M&LJ1JZVQ^%UU+'Y_Y*T('!:,+,IV<)U7[T]L.FL>E)9LG"[6JNZ!UET L>/A
MUPK1VBH*5A*:P=>4L;TU +^O#L ?CKPRD4,7;OI$@JQ2,ACPQH:>#,6.N"@[
M!7%$M42NG\V (*3<BBJ5@&;PU)_U:1Y#/U3'T(]'7IGV#_YSG/S%*UBX,\"\
M ^8A5&V'ZK6JZS@E5LN3!0O'XZD9'^-;4P:-H!E.><FL!_]5Y9C]6!U'/XFU
M2!!Y.97KYW)X+VSV?UHBYV__;/4+M!+IJ)R'2(SX-+ZWHU<"FJ&3#_1WC[Y,
MI)IRYO2%B,LTBI'T4W4D?3PJEI]WLA"JMV;BY5P<Y@"4:K*NG^$5^P.;D6;%
MQ&7"PW8_SQ?/8;PDY!.)R(RF$@K 2+3CXGADML"WFMG00FEH1JZXRT"+G7&I
M:(_Z]/!C+?'@_9%7XB*S#;;Y.+5GE726P]>&C=L!;.XI; A;\7$_B.UQK@_C
M%JI#,Y W$]>]_R+\5C'QB.GHE4PSL9+>DQ?"Q*T$>9S:["J>U-.*CH^\#6NO
MX"U793G2U^R]-7^O^ ":96R_U^Q;\:2W[**\@70;\SZM^UHL0G:#OSU']]-
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M6!T#/?QY&[-TQK\8%Z\/<CLRXR$H(83@!P^<HP&5:% LQ$6[B#?6O!FZ*G8
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M]3";D:DH.+'NH !O6_.3<IIUQCNRW&JL%KH7YJ-+).A1I3CV^1"!FO,>=7N
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M(DYO0>X8(*7N:Q!9R#10S"CUV6/LL[S,M3YDU-C4F3]CI[V&())&<AP[X_4
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M*.$FN;K[?\OWO<V7Z04QD-9U"F0/(]5*2SC&[F01<\\\K\-Q,ZL:G'J,FNB
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M !$              ( !     &%C=&<M,C Q.3$R,S$N>&UL4$L! A0#%
M  @ F85P4+60?"^8$0  -\   !$              ( !J(P! &%C=&<M,C Q
M.3$R,S$N>'-D4$L! A0#%     @ F85P4-B4-'D.&@  5V,! !4
M     ( !;YX! &%C=&<M,C Q.3$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( )F%
M<%"I.,A&(C,  "?2 P 5              "  ;"X 0!A8W1G+3(P,3DQ,C,Q
M7V1E9BYX;6Q02P$"% ,4    " "9A7!0 SNEC;9O   &MP8 %0
M    @ $%[ $ 86-T9RTR,#$Y,3(S,5]L86(N>&UL4$L! A0#%     @ F85P
M4)*]_CF65@  BC4& !4              ( ![EL" &%C=&<M,C Q.3$R,S%?
=<')E+GAM;%!+!08     !@ & (H!  "WL@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6866757184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans (Details - Option Activity - Stock Options [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Beginning</a></td>
<td class="nump">3,509,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options Exercised</a></td>
<td class="num">(25,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options Forfeited</a></td>
<td class="num">(3,158,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Ending</a></td>
<td class="nump">326,000<span></span>
</td>
<td class="nump">3,509,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Vested</a></td>
<td class="nump">281,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options Exercisable</a></td>
<td class="nump">281,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Beginning</a></td>
<td class="nump">$ 4.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Exercised</a></td>
<td class="nump">3.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Forfeited</a></td>
<td class="nump">5.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Ending</a></td>
<td class="nump">4.38<span></span>
</td>
<td class="nump">$ 4.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Vested</a></td>
<td class="nump">4.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Exercisable</a></td>
<td class="nump">$ 4.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Remaining Contractual Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Options Outstanding</a></td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options Vested</a></td>
<td class="text">3 years 10 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options Exercisable</a></td>
<td class="text">3 years 10 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value options outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value options vested</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value options exercisable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6786321104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Fair value of options vested</a></td>
<td class="nump">$ 294<span></span>
</td>
<td class="nump">$ 1,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 1,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense period for recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Non-Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 1,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense period for recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share</a></td>
<td class="nump">$ 2.98<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of other than options vested</a></td>
<td class="nump">$ 672<span></span>
</td>
<td class="nump">$ 972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units R S U [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per share</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of other than options vested</a></td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Fair value of restricted stock units granted</a></td>
<td class="nump">1,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ACTG_ProfitsInterestMember', window );">Profits Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_FairValueOfProfitsInterests', window );">Fair value of profits interests</a></td>
<td class="nump">$ 591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ACTG_Plan2016Member', window );">2016 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant</a></td>
<td class="nump">4,067,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ACTG_AllPlansMember', window );">All Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant</a></td>
<td class="nump">6,875,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_FairValueOfProfitsInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of profits interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_FairValueOfProfitsInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ACTG_NonVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ACTG_NonVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_ProfitsInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_ProfitsInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ACTG_Plan2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ACTG_Plan2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ACTG_AllPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ACTG_AllPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6781347168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Retirement Savings Plan and Executive Severance Policy<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Savings Plan and Executive Severance Policy</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11.&#160; RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE
POLICY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Retirement Savings Plan.</i> Acacia
has an employee savings and retirement plan under section 401(k) of the Code (the &#8220;Plan&#8221;).&#160;The Plan is a
defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the
Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the
discretion of the Board of Directors. There were no contributions made by Acacia during the periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Executive Severance Policy.</i>
Under Acacia&#8217;s Amended Executive Severance Policy, full-time employees as of July 2017 and prior with the title of
Senior Vice President and higher (&#8220;SVP and higher&#8221;) are entitled to receive certain benefits upon termination of
employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death
or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a)
accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any
compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and
reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full
year that the SVP and higher employee was employed by the Company (the &#8220;Severance Period&#8221;), up to a maximum of
twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii)
provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year
in which the termination occurs, for the duration of the Severance Period. Results for the year ended December 31, 2019 and
2018 include $420,000 and $2,458,000 of expenses incurred under the executive severance policy.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6782678368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>15.&#160;&#160;RELATED PARTY TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During
the year ended December 31, 2019, the Company purchased shares of common stock of Drive Shack, Inc. (&#8220;Drive Shack&#8221;)
for an aggregate purchase price of $2.4 million. Drive Shack and Clifford Press, Chief Executive Officer and director of Acacia,
are related parties as Mr. Press is a board member of Drive Shack. During
the year ended December 31, 2018, the Company paid $976,000 in expenses related to the reimbursement of costs incurred by Sidus
Investment Management, LLC (&#8220;Sidus&#8221;) on behalf of the participants (together with Sidus, the &#8220;Participants&#8221;)
named in the proxy statement filed on June 7, 2018 by the Participants, in connection with a contested proxy election. These expenses
are included in general and administrative expenses on the consolidated statements of operations. Alfred V. Tobia, Jr. and Clifford
Press are related parties as each of them are Participants and members of the Company&#8217;s Board of Directors. In addition,
Sidus is a related party as Mr. Tobia is a Co-Founder and Managing Member at Sidus.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6638506960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>19. Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 8pt"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 8pt"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>19. SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Stockholder approval</i>. On February
14, 2020, the Company&#8217;s stockholders approved, for purposes of Nasdaq Rules 5635(b) and 5635(d), as applicable, (i) the voting
of the Series A Convertible Preferred Stock on an as-converted basis and (ii) the issuance of the maximum number of shares of common
stock issuable in connection with the potential future (A) conversion of the Series A Convertible Preferred Stock and (B) exercise
of the Series A and Series B Warrants, in each case, without giving effect to the exchange cap set forth in the Series A Preferred
Stock Certificate of Designations and in the Series A Warrants, issued pursuant to the Securities Purchase Agreement dated November
18, 2019 (see Note 16). The Company&#8217;s stockholders also approved an amendment to the Company&#8217;s Amended and Restated
Certificate of Incorporation to increase the total number of authorized shares of common stock by 200,000,000 shares, from 100,000,000
shares to 300,000,000 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Issuance of Series B Warrants to Starboard</i>.
On February 25, 2020, pursuant to the terms of the Securities Purchase Agreement with Starboard, the Company issued Series B Warrants
to purchase up to 100 million shares of the Company&#8217;s common stock at an exercise price of either (i) $5.25 per share, if
exercising by cash payment, or (ii) $3.65 per share, if exercising by cancellation of a portion of senior secured notes. The Company
issued the Series B Warrants for an aggregate purchase price of $4.6 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868709936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Trading Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Trading Securities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>3.&#160;&#160;TRADING SECURITIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Trading securities for the
periods presented were comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Cost</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Gross<br />
    Unrealized<br /> Gain</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Gross<br />
    Unrealized<br /> Loss</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Fair
    Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Security&#160;Type</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">December 31, 2019:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">93,712</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">143</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(12</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">93,843</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,674</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">211</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(745</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,140</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">111,386</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">354</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">110,983</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">December 31, 2018:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading securities
    - debt</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">33,643</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">18</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(19</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">33,642</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,389</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">27</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(404</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,012</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">37,032</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">45</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(423</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">36,654</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Trading securities as of December 31, 2019
and 2018, were comprised of investments in corporate bonds (debt securities) and investments in equity securities of publicly
held companies (equity securities). For the year ended December 31, 2019, proceeds from the sale and maturity of debt securities
and equity securities were $49,751,000 and $25,339,000, respectively. For the year ended December&#160;31, 2018, proceeds from
the sale and maturity of debt securities and equity securities were $65,144,000 and $1,496,000, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6606100368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>7.&#160;&#160;STOCKHOLDERS&#8217; EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;&#160;&#160;&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Repurchases of Common Stock. </i>In February
2018, Acacia&#8217;s Board of Directors authorized the repurchase of up to&#160;$20,000,000&#160;of the Company&#8217;s outstanding
common stock in open market purchases or private purchases, from time to time, in amounts and at prices to be determined by the
Board of Directors at its discretion (the &#8220;Stock Repurchase Program&#8221;). On August 5, 2019, Acacia&#8217;s Board of Directors
approved a new stock repurchase program, which authorized the purchase of up to $10.0 million of the Company's common stock through
open market purchases, through block trades, through 10b5-1 plans, or by means of private purchases, from time to time, through
July 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In determining whether or not to repurchase
any shares of Acacia&#8217;s common stock, Acacia&#8217;s Board of Directors consider such factors as the impact of the repurchase
on Acacia&#8217;s cash position, as well as Acacia&#8217;s capital needs and whether there is a better alternative use of Acacia&#8217;s
capital. Acacia has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases
to date were made in the open market in compliance with applicable SEC rules. The authorization to repurchase shares presented
an opportunity to reduce the outstanding share count and enhance stockholder value. The repurchased shares are expected to be retired.
Monthly stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program,
were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Total
    Number<br /> of Shares<br /> Purchased</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Average<br />
    Price<br /> paid per<br /> Share</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Approximate
    Dollar<br /> Value of Shares that<br /> May Yet be Purchased<br /> under the Program</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Plan
    Expiration Date</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 19%; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">May
    1, 2018 - May 30, 2018</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; width: 17%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,190,420</font></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.89</font></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">15,366,000</font></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center; width: 18%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">February
    28, 2019</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Totals
    for 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,190,420</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.89</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Tax Benefits Preservation Plan</i>. On
March 12, 2019, Acacia&#8217;s Board of Directors announced that it had unanimously approved the adoption of a Tax Benefits Preservation
Plan (the &#8220;Plan&#8221;). The purpose of the Plan is to protect the Company&#8217;s ability to utilize potential tax assets,
such as net operating loss carryforwards and tax credits to offset potential future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Plan is designed to reduce the likelihood
that the Company will experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership
of 4.9% or more of the Company&#8217;s outstanding common stock and (ii) any existing stockholders who, as of the time of the first
public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company&#8217;s then-outstanding shares
of the Company&#8217;s common stock from acquiring additional shares of the Company&#8217;s common stock (subject to certain exceptions).
There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the adoption of the Plan,
Acacia&#8217;s Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the
Company&#8217;s common stock to stockholders of record at the close of business on March 16, 2019. On or after the distribution
date, each right would initially entitle the holder to purchase one one-thousandth of a share of the Company&#8217;s Series B Junior
Participating Preferred Stock, $0.001 par value for a purchase price of $12.00.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company also has a provision in its
Amended and Restated Certificate of Incorporation, as amended (the &#8220;Charter Provision&#8221;) which generally prohibits transfers
of its common stock that could result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect
the Company&#8217;s ability to utilize potential tax assets, such as net operating loss carryforwards and tax credits to offset
potential future taxable income. The Charter Provision was approved by the Company&#8217;s stockholders on July 15, 2019.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878230736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. Quarterly Financial Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of quarterly financial data (Unaudited)</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="23" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Quarter
    Ended</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Dec. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Sept. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Jun. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Mar. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Dec. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Sept. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Jun. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Mar. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="23" style="font-size: 10pt; text-align: center"><font style="font-size: 7pt">(Unaudited, in thousands, except
    share and per share information)</font></td><td style="font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 36%; font-size: 10pt"><font style="font-size: 7pt">Revenues</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">688</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,711</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,460</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,387</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,203</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">13,725</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">6,485</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">62,093</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Portfolio operations:</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Inventor royalties</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">192</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">776</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,623</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,353</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">11,002</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,181</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,241</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">21,744</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Contingent legal fees</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">35</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">375</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">177</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">11,756</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,949</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,037</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">15,759</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Patent acquisition expenses</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Litigation and licensing expenses - patents</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,160</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">987</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,855</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,801</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,689</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,549</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,639</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,989</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"><font style="font-size: 7pt">Amortization of patents</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">857</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">863</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">818</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">656</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">11,560</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,952</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,278</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,330</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Other
    portfolio expenses (income)</font> </td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,581</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(475</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">650</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">400</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,202</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Total portfolio operations</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,794</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,186</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,671</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">6,637</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">36,407</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">12,833</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">10,195</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,822</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Net portfolio income (loss)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,106</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(475</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(211</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,250</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">12,796</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">892</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,710</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">12,271</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">General and administrative expenses (including
    non-cash stock compensation expense)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,328</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,630</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,763</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,655</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,754</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,855</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">6,916</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,301</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Impairment of patent-related
    intangible assets</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">28,210</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Operating income (loss)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,434</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,105</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,974</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(6,905</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">10,042</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,963</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(38,836</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">8,970</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Total other income (expense)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,921</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(2,503</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(1,774</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,821</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(21,012</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(27,595</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">10,615</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(40,890</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Income (loss) before provision for income taxes</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(1,513</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,748</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,084</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(10,970</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,558</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,221</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(31,920</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Provision for income taxes</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,147</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(9</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(314</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(397</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(306</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(285</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(191</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Net income (loss) including noncontrolling interests</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">634</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,398</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,367</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,864</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,506</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,111</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Net (income) loss attributable
    to noncontrolling interests in subsidiaries</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">14</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(2</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(331</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">79</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">73</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Net income (loss) attributable
    to Acacia Research Corporation</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">634</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,384</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,369</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(33,195</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,427</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,038</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Less: Accretion of redeemable
    preferred stock</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(307</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Net income (loss) attributable
    to common shareholders &#8211; basic:</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">327</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,384</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,369</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(33,195</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,427</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,038</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-size: 7pt">Basic income (loss) per share</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">0.01</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.15</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.12</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.09</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.23</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.67</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.57</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.63</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Weighted-average number
    of shares outstanding, basic</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,875,750</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,828,361</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,696,016</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,655,881</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,639,172</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,557,748</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,061,812</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,632,958</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 28%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Add: Accretion of redeemable preferred
    stock</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">307</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Less: Mark-to-market adjustment
    for preferred stock embedded derivative</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Net
    loss attributable to common shareholders &#8211; diluted:</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(2,624</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,384</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,369</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(33,195</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,427</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,038</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-size: 7pt">Diluted income (loss) per share</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.05</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.15</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.12</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.09</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.23</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.67</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.57</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.63</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Weighted-average number
    of shares outstanding, diluted</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">54,406,835</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,828,361</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,696,016</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,655,881</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,639,172</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,557,748</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,061,812</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,632,958</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Restated quarterly period report</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">Three months ended</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">Three months ended</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">Three months ended</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">March 31, 2019</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">June 30,
    2019</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">September 30, 2019</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As reported</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As adjusted</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As reported</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As adjusted</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As reported</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As adjusted</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 34%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">Net cash provided by (used in) operating
    activities</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(58,812</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(1,958</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(66,026</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(2,268</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(65,748</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(846</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">Net cash provided by (used in) investing activities</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">3,288</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(53,566</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">625</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(63,133</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">3,721</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(61,181</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">Net cash provided by financing activities</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">Increase/(decrease) in cash and cash equivalent</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(55,524</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(55,524</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(65,322</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(65,322</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(61,948</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(61,948</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118952077&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868553152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation', window );">Tax on unrealized loss on foreign currency translation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax on unrealized gain (loss) on foreign currency translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_TaxOnUnrealizedGainLossOnForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878502048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">50,370,987<span></span>
</td>
<td class="nump">49,639,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">50,370,987<span></span>
</td>
<td class="nump">49,639,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series A redeemable convertible preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Series A redeemable convertible preferred stock, shares authorized</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Series A redeemable convertible preferred stock, shares issued</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series A redeemable convertible preferred stock, shares outstanding</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Series A redeemable convertible preferred stock, value per share</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Series A redeemable convertible preferred stock, liquidation preference</a></td>
<td class="nump">$ 35,125<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>35
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    " "9A7!0[[N0B^X    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+!3L,P#(9?!>7>NFFAAZCK98@32$A, G&+$F^+:)HH,6KW]J1A
MZX3@ 3C&_O/YL^1.>:%<P.?@/ 8R&&]F.XQ1*+]A1R(O *(ZHI6Q3(DQ-?<N
M6$GI&0[@I?J0!X2ZJEJP2%)+DK  "[\26=]I)51 22Z<\5JM>/\9A@S3"G!
MBR-%X"4'UB\3_6D>.K@"%AAAL/&[@'HEYNJ?V-P!=D[.T:RI:9K*J<FYM .'
MMZ?'E[QN8<9(<E28?D4CZ.1QPRZ37YOM_>Z!]7555T75%+S=\5;<-N*.OR^N
M/_RNPM9ILS?_V/@BV'?PZR[Z+U!+ P04    " "9A7!0F5R<(Q &  "<)P
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MQT$ECJ;[G-EOU3>D_<#(=FBVD['C7_\%4$L#!!0    ( )F%<% -$+H>>00
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M.DPJME=F6.BQZ%JR;J)XV[>;T=#SKOX#4$L#!!0    ( )F%<%"KE<,'N 0
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MO9-NCI>J:(;/Q<M[TU;E-$IGI<R_C=_'T_!]&?])XRD,!_ 4P-< 2CX-T%.
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M7O\PGAG@F26>&7$W]1B509V*%0<636- :P!HV1X[#<BKY>-6!E2!BTQC-FO
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MUSM[5V'D@V'D,&TSF?]2RG]02P,$%     @ F85P4&C4P#V2!   (!8  !@
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MX0=;#06-#\?W>+;SF,V&-\/R@]CZC<N_4$L#!!0    ( )F%<%"\;MI#M@$
M -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;&U386_<( S]*X@?
M4.Y(KJM.2:1>IZJ3-NG4:=MG+G$25 @9D$OW[V=(FJ5=O@ V?L_/QF2CL2^N
M!?#D5:O.Y;3UOC\RYLH6M' WIH<.;VICM?!HVH:YWH*H(D@KQG>[6Z:%[&B1
M1=_9%ID9O)(=G"UQ@];"_CF!,F-.]_3-\2R;U@<'*[)>-/ =_(_^;-%B"TLE
M-71.FHY8J'-ZOS^>TA ? WY*&-WJ3$(E%V->@O&ERNDN" (%I0\, K<K/(!2
M@0AE_)XYZ9(R -?G-_;'6#O6<A$.'HSZ)2O?YO2.D@IJ,2C_;,8GF.LY4#(7
M_Q6NH# \*,$<I5$NKJ0<G#=Z9D$I6KQ.N^SB/DXWAV2&;0/X#. +X"[F85.B
MJ/RS\*+(K!F)G7K?B_#$^R/'WI3!&5L1[U"\0^^UX#S)V#40S3&G*8:O8O9+
M!$/V)07?2G'B_\'Y-CS95)A$>/).8;I-D&X2I)$@?4=P^%#B5LSMAR1LU5,-
MMHG3Y$AIABY.\LJ[#.P]CV_R+WR:]F_"-K)SY&(\OFSL?VV,!Y2RN\$1:O&#
M+8:"VH?C)SS;:<PFPYM^_D%L^<;%7U!+ P04    " "9A7!0-*XU[K@!  #2
M P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6QM4V%OW" ,_2N('U!R
MY+K>3DFD7J=IDS;IU&G=9RYQ$E0(&9!+]^]G2)JE7;X -G[/S\9DH['/K@7P
MY$6KSN6T];X_,N;*%K1P-Z:'#F]J8[7P:-J&N=Z"J")(*\:3Y /30G:TR*+O
M;(O,#%[)#LZ6N$%K8?^<0)DQISOZZGB43>N#@Q59+QKX ?YG?[9HL86EDAHZ
M)TU'+-0YO=\=3_L0'P.>)(QN=2:ADHLQS\'X6N4T"8) 0>D#@\#M"@^@5"!"
M&;]G3KJD#,#U^97]<ZP=:[D(!P]&_9*5;W-ZH*2"6@S*/YKQ"\SUW%(R%_\-
MKJ P/"C!'*51+JZD')PW>F9!*5J\3+OLXCY.-^GM#-L&\!G %\ AYF%3HJC\
MD_"BR*P9B9UZWXOPQ+LCQ]Z4P1E;$>]0O$/OM>#\+F/70#3'G*88OHK9+1$,
MV9<4?"O%B?\'Y]OP=%-A&N'I&X6';8+])L$^$NS?$'Q\5^)&3)J\2\)6/=5@
MFSA-CI1FZ.(DK[S+P-[S^";_PJ=I_RYL(SM'+L;CR\;^U\9X0"G)#8Y0BQ]L
M,134/ASO\&RG,9L,;_KY!['E&Q=_ 5!+ P04    " "9A7!0! +@>[4!  #2
M P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6QU4V%OW" ,_2N('U#N
M2-95IR12K]/42IMTZK3M,Y<X"2K$*9!+]^\')$W3+OL"V/@]/QN3C6B>; O@
MR(M6G<UIZUQ_8,R6+6AAK["'SM_4:+1PWC0-L[T!44605HSO=M=,"]G1(HN^
MDRDR')R2'9P,L8/6POPY@L(QIWOZZGB43>N"@Q59+QKX >YG?S+>8@M+)35T
M5F)'#-0YO=T?CFF(CP&_)(QV=2:ADC/B4S >JISN@B!04+K (/QV@3M0*A!Y
M&<\S)UU2!N#Z_,K^-=;N:SD+"W>H?LO*M3F]H:2"6@S*/>)X#W,]GRB9B_\&
M%U ^/"CQ.4I4-JZD'*Q#/;-X*5J\3+OLXCY.-SR=8=L /@/X KB)>=B4*"K_
M(IPH,H,C,5/O>Q&>>'_@OC=E<,96Q#LOWGKOI>#)/F.70#3''*<8OHIYBV">
M?4G!MU(<^3]PO@U/-A4F$9Z\4_@?@G23((T$Z3N"Y$.)6S'IAR1LU5,-IHG3
M9$F)0Q<G>>5=!O:6QS=Y"Y^F_;LPC>PL.:/S+QO[7R,Z\%)V5WZ$6O_!%D-!
M[<+QLS^;:<PFPV$__R"V?./B+U!+ P04    " "9A7!0?+JP([<!  #2 P
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M_FSF,9L-IX?E!Y'U&U=_ 5!+ P04    " "9A7!0WKI3A;<!  #2 P  &0
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M9S..V6@X[*8?Q.9OG+\#4$L#!!0    ( )F%<%"-"%9ZMP$  -(#   9
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M.)ZR$!\#?DB8W.9,0B478YZ"\;DN:!($@8+*!P:!VQ4>0*E A#)^+9QT31F
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MJ>XTT>=-W[?U%TK60T\:C8WQZB]02P,$%     @ F85P4+W5!PSS 0  RP4
M !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL=53ICILP$'X5Q .LN7(*
MD#9;K5JIE:*MVOYV8#BT-F9M)VS?OK8AE-+9/[%G^(X9.YYT$/)5-0#:>^>L
M4YG?:-T?"5%% YRJ!]%#9[Y40G*J32AKHGH)M'0DSD@4!%O":=OY>>IR9YFG
MXJI9V\%9>NK*.96_3\#$D/FA?T^\M'6C;8+D:4]K^ [Z1W^6)B*S2MERZ%0K
M.D]"E?F/X?%TL'@'^-G"H!9[SW9R$>+5!E_*S ]L0<"@T%:!FN4&3\"8%3)E
MO$V:_FQIB<O]7?W9]6YZN5 %3X+]:DO=9/[>]TJHZ)7I%S%\AJF?C>]-S7^%
M&S #MY48CT(PY7Z]XJJTX).**873]W%M.[<.D_Z=AA.BB1"M"&0T<I5_HIKF
MJ12#)\>S[ZF]XO 8F;,I;-(=A?MFBE<F>\OC.$C)S0I-F-.(B1:8<$80HSY;
M1)C%*?J/'N'T&*TP=O1X20\_$$A0@<0))/^T&*Y:Q# ?F&Q0DPTB$*],,$R"
MFVQ1DRTBL%F98)@M;K)#37:(P&YE@F'VN,D>-=DC H>5"8)) MSD@)H<$('U
MQ6.8]<63Q6/B(&LW1I17B&OG1M@B.T^JQ\@]QK_P<<Q]H[)N.^5=A#9/VCV\
M2@@-II3@P?P_&C-9YX!!I>UV9_9RG"]CH$4_C4XRS^_\#U!+ P04    " "9
MA7!0;;S)G+<!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6QM
M4]MNG# 0_17+'Q OADVC%2!E4T6)U$BK5&V?O3" %5^(;9;D[VL;0FC*B^T9
MGW/FXG$^:O-B.P"'WJ10ML"=<_V!$%MU()F]TCTH?]-H(YGSIFF)[0VP.I*D
M('2WNR:2<87+//I.ILSUX 17<#+(#E(R\WX$H<<")_C#\<S;S@4'*?.>M? 3
MW*_^9+Q%%I6:2U"6:X4,- 6^30['+. CX#>'T:[.*%1RUOHE&(]U@7<A(1!0
MN:# _':!.Q B"/DT7F=-O(0,Q/7Y0_T^UNYK.3,+=UK\X;7K"GR#40T-&X1[
MUN,#S/7L,9J+_P$7$!X>,O$Q*BUL7%$U6*?EK.)3D>QMVKF*^SC=[).9MDV@
M,X$NA)L8ATR!8N;?F6-E;O2(S-3[GH4G3@[4]Z8*SMB*>.>3M]Y[*=,LS<DE
M",V8XX2A*TRR((A77T+0K1!'^A^=;M/3S0S32$_7].1Z6R#;%,BB0/9/B=F7
M$K<P^R]!R*JG$DP;I\FB2@\J3O+*NPSL+8UO\@F?IOV)F98KB\[:^9>-_6^T
M=N!3V5WY$>K\!UL, 8T+QV_^;*8QFPRG^_D'D>4;EW\!4$L#!!0    ( )F%
M<%#^"HOQM@$  -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;&U3
MVVZ<,!#]%<L?$+.&)*L5(&531:G42JM$;9^],( 57XAMEO3O8QM":,J+[1F?
M<^;B<3YJ\V([ (?>I%"VP)US_8$06W4@F;W2/2A_TV@CF?.F:8GM#; ZDJ0@
M-$ENB&1<X3*/OI,I<STXP16<#+*#E,S\/8+08X%W^,/QQ-O.!0<I\YZU\ SN
M5W\RWB*+2LTE*,NU0@:: M_M#L<LX"/@-X?1KLXH5'+6^B48W^L")R$A$%"Y
MH,#\=H%[$"((^31>9TV\A S$]?E#_2'6[FLY,POW6OSAM>L*O,>HAH8-PCWI
M\1'F>JXQFHO_ 1<0'AXR\3$J+6Q<4358I^6LXE.1[&W:N8K[.-VDZ4S;)M"9
M0!?"/L8A4Z"8^3?F6)D;/2(S];YGX8EW!^I[4P5G;$6\\\E;[[V4:7:3DTL0
MFC''"4-7F-V"(%Y]"4&W0ASI?W2Z34\W,TPC/5W3:;(MD&T*9%$@^Z?$VR\E
M;F'V7X*054\EF#9.DT65'E2<Y)5W&=@[&M_D$SY-^T]F6JXL.FOG7S;VO]':
M@4\EN?(CU/D/MA@"&A>.M_YLIC&;#*?[^0>1Y1N7[U!+ P04    " "9A7!0
M/.Y9M;8!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6QM4^V.
MG" 4?17" RP..NUVHB8[VS1MTB:3;=K^9O2J9,%K <?MVQ?0M6;K'^!>SCGW
M@TL^H7FV'8 C+UKUMJ"=<\.),5MUH(6]PP%Z?].@T<)YT[3,#@9$'4E:,9XD
M[Y@6LJ=E'GT74^8X.B5[N!AB1ZV%^7,&A5-!#_35\23;S@4'*_-!M/ =W(_A
M8KS%5I5::NBMQ)X8: KZ<#B=LX"/@)\2)KLYDU#)%?$Y&%_J@B8A(5!0N: @
M_':#1U J"/DT?B^:= T9B-OSJ_JG6+NOY2HL/*+Z)6O7%?2>DAH:,2KWA--G
M6.HY4K(4_Q5NH#P\9.)C5*AL7$DU6H=Z4?&I:/$R[[*/^S3?'-.%MD_@"X&O
MA/L8A\V!8N8?A1-E;G B9N[](,(3'T[<]Z8*SMB*>.>3M]Y[*]/L0\YN06C!
MG&<,WV .*X)Y]34$WPMQYO_1^3X]W<TPC?1T2^?9OD"V*Y!%@6Q;XC%Y4^(>
MYFV1;--3#::-TV1)A6,?)WGC70?V@<<W^0>?I_V;,*WL+;FB\R\;^]\@.O"I
M)'=^A#K_P59#0>/"\;T_FWG,9L/AL/P@MG[C\B]02P,$%     @ F85P4"05
M?\:W 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL;5/;;MP@
M$/T5Q >$7>RTVY5M*9LH:J566J5J^LS:8QL%/"[@=?KW!>RX;NH78(9SSEP8
MLA'-BVT!''G5JK,Y;9WKCXS9L@4M[ WVT/F;&HT6SINF8;8W(*I(THKQW>X#
MTT)VM,BB[VR*# >G9 =G0^R@M3"_3Z!PS.F>OCF>9-.ZX&!%UHL&OH/[T9^-
MM]BB4DD-G978$0-U3N_VQU,:\!'P+&&TJS,)E5P07X+QI<KI+B0$"DH7%(3?
MKG /2@4AG\:O69,N(0-Q?7Y3?XRU^UHNPL(]JI^R<FU.#Y144(M!N2<</\-<
MSRTE<_%?X0K*PT,F/D:)RL:5E(-UJ&<5GXH6K],NN[B/TTWR::9M$_A,X OA
M$..P*5#,_$$X460&1V*FWO<B//'^R'UORN",K8AW/GGKO=<BN>49NP:A&7.:
M,'R%V2\(YM67$'PKQ(G_1^?;]&0SPR32DS6='[8%TDV!- JD_Y28O"MQ"Y.^
M"\)6/=5@FCA-EI0X='&25]YE8.]X?)._\&G:OPG3R,Z2"SK_LK'_-:(#G\KN
MQH]0ZS_88BBH73A^]&<SC=ED..SG'\26;US\ 5!+ P04    " "9A7!0^@#B
MQ+<!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6QU4]MNW" 0
M_17$!X1=>S>)5K:E;*HJE5IIE:K-,VN/;11@',#K].\+V'&<U'T!9CCGS(4A
M&] \VQ; D5<EM<UIZUQW8,R6+2ANK[ #[6]J-(H[;YJ&V<X KR))299L-M=,
M<:%ID47?R109]DX*#2=#;*\4-W^.(''(Z9:^.1Y%T[K@8$76\09^@OO5G8RW
MV*Q2"07:"M3$0)W3N^WAN OX"/@M8+"+,PF5G!&?@_&MRNDF) 022A<4N-\N
M< ]2!B&?QLND2>>0@;@\OZE_C;7[6L[<PCW*)U&Y-J>WE%10\UZZ1QP>8*IG
M3\E4_'>X@/3PD(F/4:*T<25E;QVJ2<6GHOCKN L=]V&\2=.)MDY()D(R$VYC
M'#8&BIE_X8X7F<&!F+'W'0]/O#TDOC=E<,96Q#N?O/7>2Y'N]QF[!*$)<QPQ
MR0*SG1',J\\ADK40Q^0?>K).3U<S3",]7=+3_PCL5@5V46#WH<3K3R6N86X^
M!6&+GBHP39PF2TKL=9SDA7<>V+LDOLD[?)SV']PT0EMR1N=?-O:_1G3@4]E<
M^1%J_0>;#0FU"\<;?S;CF(V&PV[Z06S^QL5?4$L#!!0    ( )F%<% >E#_6
MTP$  )P$   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;'54VV[<(!#]
M%<0'!-_6W:YL2]E$42NUTBI5TV?6'E\4, [@=?KW!>RXSH:\&&8XEQD,9).0
MSZH%T.B5LU[EN-5Z.!"BRA8X53=B@-ZLU$)RJDTH&Z(&";1R),Y(% 0IX;3K
M<9&YW$D6F1@UZWHX2:1&SJG\>P0FIAR'^"WQV#6MM@E29 -MX!?HW\-)FHBL
M*E7'H5>=Z)&$.L>WX>&86KP#/'4PJ<T<V4[.0CS;X'N5X\ 6! Q*;16H&2YP
M!XQ9(5/&RZ*)5TM+W,[?U!]<[Z:7,U5P)]B?KM)MCO<855#3D>E',7V#I9\=
M1DOS/^ "S,!M)<:C%$RY+RI'I05?5$PIG+[.8]>[<9I7XF2A^0G10HA6PM[Y
MD-G(57Y/-2TR*28DY[T?J/W%X2$R>U/:I-L*MV:*5R9[*>+=/B,7*[1@CC,F
MVF#"%4&,^FH1^2R.T0=ZY*?'W@IC1X^W]#CU"R1>@<0)).]:_'K5H@>3!GZ3
MG==DYQ$(KTQ\F$^V(O6:I!Z!^,K$ATFN3,CF='"0C;L7"I5B[-V=W&37JW<;
MN=/U'S[?VY]4-EVOT%EH<T;=2:J%T&!*"6Y,PZUY*M: 0:WM](N9R_G"S($6
MP_(6D/5!*OX!4$L#!!0    ( )F%<%"T/<)W[@$  &8%   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,W+GAM;'5486^;,!#]*\@_H"8$"(T J6DU;=(F19VV
M?7;@$E!MS&PG=/]^MJ&,T>L7[#N_>^_.YBX?I'K1#8 )7@7O=$$:8_H]I;IJ
M0#!])WOH[,E9*L&,-=6%ZEX!JWV0X#0*PY0*UG:DS+WOJ,I<7@UO.SBJ0%^%
M8.K/ ;@<"K(A;X[G]M(8YZ!EWK,+? ?SHS\J:]&9I6X%=+J57:#@7)"'S?Z0
M.;P'_&QAT(M]X"HY2?GBC"]U04*7$'"HC&-@=KG!(W#NB&P:OR=.,DNZP.7^
MC?V3K]W6<F(:'B7_U=:F*4A&@AK.[,K-LQP^PU1/0H*I^*]P V[A+A.K44FN
M_3>HKMI(,;'85 1['=>V\^LPGL3W4Q@>$$T!T1R0>1TZ"OG,GYAA9:[D$*CQ
M[GOFGGBSC^S=5,[IK\*?V>2U]=[*;9KD].:()LQAQ$0+S&9&4,L^2T28Q"%Z
M%Q[AX5LTPZT/WR[#XQ GB%&"V!/$_Y68KDK$,#M<)$%%$H0@6XE@F'M<)$5%
MTO<$NW E@F$^>*X=*K)#"**5"(;9XB(9*I(A!/%*!,,D*Q&Z^,\%J(OO<!U4
M\MKYZ;+PSD/D(?)]\@\^3J!O3%W:3@<G:6RW^9XX2VG IA+>V:=K[-";#0YG
MX[8[NU=CZX^&D?TTU>@\6LN_4$L#!!0    ( )F%<%#Q^Y<DMP$  -(#   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;&U3VVZ<,!#]%<L?$.^R)+M:
M 5(V595*K;1*U/;9"P-8\8789DG_/F-#*$UYL3WC<\Y</,X&8U]<"^#)FY+:
MY;3UOCLRYLH6%'<WI@.--[6QBGLT;<-<9X%7D:0D2S:;.Z:XT+3(HN]LB\ST
M7@H-9TM<KQ2W?TX@S9#3+?UP/(FF]<'!BJSC#3R#_]F=+5IL5JF$ NV$T<1"
MG=/[[?&4!GP$_!(PN,69A$HNQKP$XUN5TTU(""24/BAPW*[P %(&(4SC==*D
M<\A 7)X_U+_&VK&6"W?P8.1O4?DVIP=**JAY+_V3&1YAJN>6DJGX[W %B?"0
M"<8HC71Q)67OO%&3"J:B^-NX"QWW8;RY32;:.B&9",E,.,0X; P4,__"/2\R
M:P9BQ]YW/#SQ]IA@;\K@C*V(=YB\0^^UV.WO,G8-0A/F-&*2!68[(QBJSR&2
MM1"GY#]ZLD[?K6:XB_3=DIZFZP+IJD :!=)_2MQ_*G$-<_@4A"UZJL V<9H<
M*4VOXR0OO// WL='9'_AX[3_X+81VI&+\?BRL?^U,1XPE<T-CE"+'VPV)-0^
M'/=XMN.8C88WW?2#V/R-BW=02P,$%     @ F85P4*SU?P/% 0  -P0  !D
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M9.]J&OG),+*?MYDL?RGY7U!+ P04    " "9A7!0])LRE?$"  !N"P  &0
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M"6PB 4UP7""%!5)_&UB,Z8@]C!A$:G1>,#EU \A$S(B!&$$K _T(H@1&C?$
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M<CQQ$^/]M(,E\Z)Q,Q@\#<#C1)+2Q&W0@&"I,54:;5&.)6YJ%$H3ERJ-V=.
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MSR:'DRK?M9^$O.-WJ?'_4$L#!!0    ( )F%<%!OM@^W>@(  $<)   9
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M5%)/]VK.[3NV"\GZL46AJ4]F?P%02P,$%     @ F85P4$ EZQTV @   0<
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MF;F</L.IT&*87QBT/'/E/U!+ P04    " "9A7!0-W-B;UT#  "2#@  &0
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M;:SVO)\!_4&R;IAOWCAD\_]02P,$%     @ F85P4,D5S-,4 P  6 P  !D
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M59L/Y_K0D:P?[RS!='&J_@-02P,$%     @ F85P4'?A8UIG @  , @  !D
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MNA?]?-TO)&_MMT,T?,"L_@)02P,$%     @ F85P4+3OZ2Y7 @  O0<  !D
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M-BYX;6R-5V%OFS 0_2N('Q"P 0-5$JG)-&W2)E6=UGUV$R=!!9S93M+]^]E
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MCGO?6@@-)L?PSLQT:S9^-BC4VEX?S%WZN?>&%OVTTGC^7\G_ E!+ P04
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M3=2>3[_Z%$@VV%L,SU=I_A=02P,$%     @ F85P4*2AT!_M 0  Y00  !D
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M9\Y@26F Z_T;^Y/5KK6<B80CI[^Z2K7[X%. *JC)2-4SGS[#K&<3H%G\5[@
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M#3$L*)R5F:[T7'1MLELHWO17 !KNH?P/4$L#!!0    ( )F%<%"IX%I0[P@
M #\V   9    >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;(V;6W/;.!*%_XI*
M[XZ("P'09;LJU(T29ZI2,S6[SXI-7VIT\4IR//OOAY(81SQ]:.@EEI0/#1 '
M#70WR9OWS?;OW7-5[7O_K);KW6W_>;]_O1X,=O?/U6JQ^[)YK=;U_SQNMJO%
MOOZZ?1KL7K?5XN'8:+4<Z"1Q@]7B9=V_NSG^]FU[=[-YVR]?UM6W;6_WMEHM
MMO_/J^7F_;:O^C]_^./EZ7E_^&%P=_.Z>*K^K/9_O7[;UM\&'U8>7E;5>O>R
M6?>VU>-M_ZNZ+LVQP9'XSTOUOCO[W#M<RO?-YN_#E]G#;3\YC*A:5O?[@XE%
M_>='-:R6RX.E>AS_:XSV/_H\-#S__-/ZY'CQ]<5\7^RJX6;YWY>'_?-M/_1[
M#]7CXFVY_V/S7E3-!:7]7G/UOU4_JF6-'T92]W&_6>Z.__;NWW;[S:JQ4@]E
MM?CG]/=E??S[WMC_V8PWT$T#_=&@[ONS!J9I8'XUL)\VL$T#>VF#M&F07MK
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MXL@DCDSC2!%'9G%D?MG<E)]::BO547W1Y#$8O N4-U#[D'<8G0X9Q@(:@K&
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M\"[DZ'+J'$R= ZE;!YMRX#QPXG0!A#%*K.N]!##&& GAJ",PZ@B(FL &8M!
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M*2X=H1@^.Y7@?_=[SH;3"/5HE<';1Z+S8ON:V"2[0PL.1(&T6^CJL0A\ +4
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M"X3%_("*Z7XKWYC:Z8)BOL&X6>>L]#"$AKA[(=(]D#EUEYI2O+<.(G*E?4Z
M('A .HKC8 CR-4=;5J10XZ][II*MR H/ '/&$VE?C!$9EL+(ON;';@$P+ZMV
M(1XSHN."@!(C?[540HY795<?'8UUKO)YX;L[C'?B^]R)N0R;?>YB&Q ,/(3
M5X9PYR;@EE<K7')Q;VI3!,"#Q<?15Q!14 -8PA$#(L1NGSX2) ])EE/Z2KBD
MLFK9AS\)+* L]@^/<GG7<LP"VBR_+]$#O^%X4'6?'WU.96K$L@2W66]4-RJG
M]_!Y%T?%W0ZV@T]8_&!?J:">#"2+M&<8(QJ%;YCZ,^APH5&.W0.&O7O#>JL
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M3K[CH)Q;]_9WQ 7LGN"UIN)R\AV:K>'1GH<^A%D$:SE44N, 68JOL$DB# Y
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M,-MEBHXFYX)X6839RK!?IE">&%5GU+S4DZR7]F)WGU1B*M:G-5(M=BPD\55
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M.5!QP@D2P.&,*Y=MN+3\$V'MZ7$JE_$%PD#_LI*@"/EN$;1Z(/OHZ3J@^3$
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MX!B9'X&]S=E!,!C$\\4DTC'"H%!3&R/ (JR6W4>[Y S^Q7)Y&*F H5K<L^+
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M^QY#<+Y7@F<<@W-UJO2#^0#@X(;G:-"S1;"XM':["[EUD!4'46!X&+RU2;B
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M(822VK4>=<*+V@8"6(?89RU8O<@I-.#N<^I>0%.#[+F4ECX^\+WVB9K?XX>
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MF0W[*;["[-/^]TTJX.ZZW@G:T(YB!\1/K@U.RV+-5%5&;> '(1 ]B7>*^ZW
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M!\Y8^^^NN\<1%]34]VU%1IMD]:78I1(@V%Q\-U0*VPQC1[7AO76]]"P(V>A
M[M(PN\,+=EX#,_?6ZO45\;Q.(OW75<&B?$ARZ02+#9&+Y=Z+'W.E^#DP%Q5Q
MZLSF!>9^ RV4:[?._H'M9EOYOP#9?(,52V*(_=&W] B+Z!A&Z/6!X>QL7_/W
M0GH4XL9EW,42NJL9-K5XH0,CQUY8=]!EXH$ZZI%=IM7N@GS6'+PC*H6RIY$#
MQUUTF9/=9 \K)2HOY1[8,(P&JIF6 @#ZU3,LK"C8U#L1IF':T@E3SYR;N6YS
MJ+71LK'PO$<;NPM 1%_DMVJBU:-&2=YE]\!P.6(,^1%'&'!\2R2M/]5!)U6_
M"NU+;%>!IM*[?;[B^RJ^#7H9[3,8FHH>?#2$1VG3[X<6<Z2,0-+9)F-/CC*Q
MG"/.U/PS-I;8+X3U+>!@-&)B\VHT<=H&Q2_U1OI%O4;G=6/%W([)%M'RXCCK
M8:$<Q*#.76T"X2W?>&;DQ.6ZM-B8']--E:XQ7T%Q+./L<(4+(Y7"U[CU63/)
M"VWG:2F(#,C#A^VV+-D\K#!7.Z%'MLB\\3:MF78M2!&[M.:67[V0U\ /K0.^
ME!WZP[%,7E&/),$,@5]H0['HV@%.[_SB]AV2</=2T%,-Z][<HF3T:CCH#=V?
M%  W[RW<-[7RUNX^B;]3<!;X;OLIOG")IG$(%E-5Y,. 7!8?Q/:CL-04L_H2
M?1";;\=8[>;*@?W54K..OH$]'+/2#BC06K2-)BY&"5I(^TG4X?2';S&Y8VA[
M^L]_@L"3IQ+JH= .R XQ?XHC*]W&#YB_O+HWQJKA87N9-N, E23E7AAPV'=)
MT.;PY;X[NVKC5AW:'U"&2#4BW]LQ9N;M*E_K9M+!M5*(WECF;.M:;H"E%=H9
MVC:7Q'(E2XV-E$1MSUE&<@M:FZ25N(:YW55B/W6I\FE28F@9)11(0;6C*H88
M40Q&3C'HJ@W1RB+-L2"O>8&U# 3V.GP0CS_,=D.!ZU%8:R^)?J:N\S1[Z!PV
MGAOSL\W3.3AD[9#Q:TG=Y1P2E9!*?Q .J&]H#-_B/:,$W8YV/&RYW(N)0,0Z
M-E\MD;\0!.R).*B89W>'HK)3PY&$8LD'.<J6,J\D&6%_-72[4;LT"7J(67:6
MK&<OO\G4E1)X#A[D<A[.P1*HC'@5-M1W!ANG>9CODJ9(BN3)]/;A$#08SO'E
ME&ML)H *J. ]9$NI0X9M#(,-[I+JMU0ZKE>@;RPUXUMJLI%7;H\6C'7VH.G7
M-F<HH@94G# )0Y4@I"(POEA86/^=6[Q2\.;*Q.?_I164MK)6P3VB99D7MBR6
M=Q_LB/7RZ"I;'Q!I#Y/_9BBI)^I;R;E-0FM1!%3_7G.EWMS*,\;),Z^M0L<(
M$CI-/*<4X2]?(3^,8 O2+S,<5X39*GH=0QHM#1,H9;4;:!T$S3G]AYI3M\VM
M=]-NQW0-3;ZWVJ!L^OPB,0(V)#HTNNV/MS&R2[AA+JMM40NPA-,(AKDJ$I\"
MI:XU&%F1PM20PN+32\DI9F?MA:;9F4E \E5?FAR=0\LU!5B3B(G>?RY:&03U
M8<#KV3K[37";<!EEVU7&?K(-E9'"=G*DN( 0N$W]2/E[\C=:12.Q(?=2L)YR
M[\RN":NF BP%;%MTZF/48C\<]ISX![[T1#4$R<KAI?VUW4<OIZ[16](VC@]U
MTK15O6?2='"%%.U&82MJ/^)T@+!V-@TO'L,T%U*N A1E)-NG[=Y$:-*".?;*
MU&OM6VRSQ$S*B;:LVQ84;\:7PY9RS,--;<&[[LS(SA#&1BC>K-=4 ^H/!;J^
M2#T4\754+<UGAZ<U:#C@K^<W-^>83-,>\->,$#5_@I4EE&W4S8OW'-""7JYO
M@NR.W#?2</"<=0[9*+K.=H4[RI<(0J]<7-_+@K"PAY:-4A+G=^*YOJE]AJ28
MN3210A-55/6P=NC6^O&-$Q2)(.B0TZ%0UFP"-5>(>TXLO5Y9X*3UC@*]*+B&
MCFP2*>#:=A5>Q<]=7=?D@:FL9 F>B-9[^GS:<>?E,@?;3C5M;!W@ H1PX#HX
M9&, 8Q.OR3QLH=(%=D0XJ\Q38F[B4\ZF=G!^>Q&-Y_V8*E !9$!NQ?PK6RH?
MQR>.>TEJ?:QZO:L2&I0YQ2H<E&GHZGB8,,:#+SS&>'CM?]#=CQH5\PN)  F$
MH":AF_>B_[1^U;>6O+Y)=DET\CE/]BNL^7]:?Z_M'2]=]3@2^ T3=^3NX"X^
MG]]\NKQY][?H[=6'\P\75^?OHC?GG\[-R=X.UMXH# NQP\KA&.V3QV$V4H/$
MU34EFN(7SR4[F66>;=8 ;&1%CDH'.8RJ(2PE[J>2?ZU 2K#0%9NEGDW$8NN-
M<[< _$ <!+;;:>1KA4;KT%J*@FU062XR\,;+O;"Q$>@S=+0Z-EZ2?8$MQ0 2
M&#J"%C:BV]ZS<#.P0AR&V)%DQM3#R0+62N_@284#00U?R9WY^SX/#2WF1;NT
MPJO$,J* N2L:=2)=K()6^K%PCVT-$8:7UL:X"YN]^L4E[M=[;&FIZ1:NX&7L
M:B;X]8_:JPMQ8K.?A%F)6\DP:<2]96H/(:T1U[BR)3!L-5 :7-O#2\LQ<;9K
MH0\>OV?DCIM+[9/4(^3'0OCP"2CF7_<Y?WB/'<?PMV,>LM7I:_^9U_YC'"D1
M_)3ZLK%H$,:E#3AAP\,?+'<OQ4E?1=/YG$K S@8#;-P9CZ?<)G4TIZ+VBWC8
M'^$#HW@VQ-+MTW@\IW^'F-YNKFU3!W<JKXVM)>MJI X6PV@VFT;#>#H<P7RC
M"?P7FP]@-];!?(!5:,>#: @K&8^-5W66"UAAB<QH'(TFT6@VB0:S&;X\F^!X
MB_&"&KK.T,P[FRR,5,CT;2TV"ZC>2/;8?ZE?F7GG2BY2;2U;X]2.?V9KK\*N
M )0+ .,@GD]@W?&\C[N<SG&Y$U@T@&*$_UW,%^9\@[+./RU6ZBCSR2R:3T?1
M' Y_"MN%74]@V'&\F SAM(:S.?QW-.H;JDWB]=BP*SIAL>>4>N4.HI,QP._4
M[FLZZ5//BB&<\[#1KU=<HBUG#-N9+<;PVF ^A15,9P/ C"F<P0@0I ]['L;S
M$9QP/QXL)HA&H.R8#ZE7B-:*8]C+YY0ZR/:GL#)9X DL(**OA]A7  ><+:;1
M'- (OIL-Y+OA;&!^/B+[Z\3U>,=^8BR)=+8).P4 CX9S^.]TU,>MP@F,XBF<
M(JQB,H8-XXE.X\5@BE>E/S!7((MDI1)L/KTSH:N8IP02#JDCTB3EI>@WG,?#
M@>OGX"ITUX XB\>C,8)M M"<,/RPO3%\@-72-W D_3$ $5 (=H5/S.&H$/)S
M>+0O9]XA,4_BQ7" S1XF?7H7[B"-#J=-W\,]' SI]&;Q9"'330<3F*X?SQ?8
M(.(J6+%4*251L5*'0U#. ^:8#&BR63SMSWESLS%]@%LYI\W!++!VV@VL;4(_
M(LR&C$,#6#;.?=T]#6#R>.;:62SX/1I\M)C1/XR>PSG!=;" H0FCPR-PY=*P
MM 9+K&L^*>V<,84C"C8SF?%F1@OZ!N[X:#J3S<RG8]G,A.>'[P8#G=M>;IP<
M-">.C"$9D#OGM:\@R\,::EUH!_L_H>,<C1"0LT4T&[7LN3ZO,/ ;D&434)6M
MT1D!_XJV_\H!X)4#P2L" IWH*P'#@C^/1D1'Z#. 8CR4Q[&+]VB.%<ZQ%KKG
MMPK,,:9N6X:SG'E$\(7_'@$!M0(@ZU5#L8Z"XNCR-3+9X>S/!\1/.'IM=4X*
M>!7U>WUD]"?]WD"&@4]#_=1?Z*?A2#]-9_II8C\AY7"MS+5C)V>[&2_;S05K
MQ[QO8@4SW&>?N<(<]C; C]/%%(C'E#Y.@,#.^=O1(A[,AOAQ,IG1O<>DRRGP
M5%@U?)S"SA>3N3E?K3K/OV&.P^/_UL-G3 .A[;>S77&V@7_1E&L%>C)*U_&M
MS6Q)G&W^Q[#0-*Y]] SRD6DI7;TF_ %13%#LS\7!-SS) 2Q$5'/H]]^,B *#
M:#(&464*S&_RIZ(BTCVKO=T"F<6JU,[K6#=@BOIBV-Q5-0HJL9K]'@EIS(GU
M'+'C==VJI4=[T=U2-T^[!J7$:K7;(QX/55!2_P55.9 *;/R4E4?]&JY^?$B9
MGDD=EG0E98:U_)NG7ZGA:=DR7N ZX6PKXU4(H;H.?@!BVVB4V>$-R65MFD6M
MLE1UO U*'>3+VI89E>:YTGH"W(2$,N>Y,?23"[:R;<WXM-"0QK4P^02D!HUU
M7GAZOHT*2ZHS=5+80IJVEV9-E7WF[(W:6[#[DO0=XE>.^LK0P"Z^FR9 C93^
M<ABF7Z'1T^[[W/E:HA=^3_R33LLF8F'6\KXBG#SU2N5ZQW8RF=,](Z%SP1+>
M%*[ID(6R>#CEKZQL.!]/14@Z,%4KA@!A!J7X9#("50M'GX+B>S(%HC="4H2*
M,(BZ4]9:.V804TLX;IV0HS@E_T.IF.(J?CA9I?SIE*-VJD>NA8L?T \*EXV<
MJT"7)D,6]>TGV/QH.*Q] F@Q0.RGAL%TT?/IU.67MK)HC0<.UOX[/%B'Q1.7
M\?FGV\O__(S%URY_H4IKMRX!0'S/:);U:&@C?R=,QJVOC<H@VEM]ZUFD_"IK
M6$.1L$X_-:S%04TV2@)<'UF5J?7-9K$A]QO'^*@AKZ5RXH%'>]&';B7 U"Q\
M6C#WC"N9:IEM?!4#B-OK+VL=C2YEP]9AH#:JSEOONC:2,YJ<T+GHSW[6AZS.
M%HJZ\$V:N9/$,2)?5#"/!.U< AL2V-S7F> -?,&H_)1JN_%.I4F\$,<4D+$E
M&(_U, 6)%Y[LNO2<F6TQ,MVP8K9"ZGS7IGHP5T?U6E=$"0&*1MUG*M?"F&OT
MMV/$,BC:  M8 A>S?=>[[@7Q(&%!5Q>:\ES56_/IL5GUMMF[Z\4%W3 6 LB)
M%/2MZJ9O'T2N?KOS>=4@$Y/'@\,LV;_&E2O(>\7N!&M'XS GRR-:"][ZE79-
M9Z7=-N_AC&LN.M<-ACASI[J[E#J\289(2[U.,1)C$4ITI;81GI9'J$AJ(,#:
MBQYK!7FC/7J\7EY2):K9*].R52L8<XULFQ.>$,JM_3R5V.L.C &P9_NM%D0V
M9$EFOPEZ%FO];SC4T"M( ^"6.(A[VTTK#0LAR]4I2I]:PG[DP)1 7LM"%&@V
MWM*2R%YD#?-^ZJT:FKE1E(15@AA02?]6K<MOH4K"J/'+G\N]0OD?OGO(J':#
M WZ62]Z0G)E>1(UG;0&]\P8%B]-<$^-^IZ5&KL8G$[("N\Y($]D[.XC'3VZL
MM^PH@&F^LE%RO^1>(]A;!NE:V%Q+.O)ZJ@?FCM5[I44GWW')[UOW]G?$-^R>
MX#73\MHM_OX=MGJWZ./:.\NA[GS'+9$2!R 7QF@1,B'#=?H[O%U1X@85RTRD
MC1PVMF(WE1X'U9O/]_=X/=@;] .%RU%[9H(^TL4OJ=28:\5L#=0U^"!0S=U9
M7NS0[%'MTR X,>6^@D*]]# 95<,>#+7PPU5688,@+J! %U^*![CN5DS]FH!D
M;38MMRFQ')@AIU"Q6'J@(NI0R BOB=Q(KL5F$/:BAGKQNO",Z";\P@DX;G+N
MN;-KAM/9Y%"O.;-?89\.6 ^5%RJS&S@.@($D&SDI8P?;\(H"25.SK!)%.:_N
MJ<*/Q-!AM%@55BR3<5>UY6?Y=L_ZJ+&1K4)V_U+I2\$D%(X3@H/#46NI_BKN
M+(%?@X15XF(16$[J,VJ;("I Z,&>!IDVW)Q;MP<5! /(\,2O#^R2JGC8)</,
M*_+'+VO1[19^G7NL31W9CLD8:(GGHT^*D26K(C=5$,1LI&&='JI;L-U#?3(O
M3K,#L0[>#B&E]Q(?D*R-7:R&'[H "M\[S\6 UU3@V[XL0:#(U/Y"O9!4R?/D
M%VFF@3_N,)8-T[TB6\,AV9E@..FRQZ^XZ3' F[.=$1C['<M0#FH!EEMB@S(7
M[ZV[Q65+\YV\L/F##JIM61J.%%MH^]UQ<O*Y4E%(]"UMI."Q&Y((,KH"0?&"
M)_9;&$_4$DMS0:0D\[&P7:;HU7Z+O(7XCG3AY%-W8E2=4?-23[)>VHOM?3*N
MBLYIC513(RLF\55 XX6R"]F6:&6_%V.*#=9*O,X5!UFP4.$;_^RE?:=,WA U
M1HGZ3DOA^)%=#IN?&_&\(ML?WVG-7[)2;D:%U[#55RIQ+BQ(9)7QX@-M6:G.
M>6*.N%D6I-]XT<8VB8P#O-5MJO.43BR.@$Y2EQ%".N/J^MS4A3>O!(!_JNU2
MK[4@$KZ.^F>+/A>%PX#0SNT8#>]R";TBKB$!<E<+I1S$NGU%C4^Y_ 4NYI!L
M1AJZ79]M:$.].GQ!C_*UW5Y1N 'M%J@JMS!XJU*6"KD:21(VZK:U<H1R^KF0
M''A;B7% "*^K"( @DHXY*THF5'7;4PODYDL_)Z;O2.)-F#Z8!'<"C[^LO%P[
M.Y]7 Z:&(_],5ZXG&T':MH<U6.Z?1"A*GJR*);>=M3E<'6O/?!K-45O%^@M&
MB'XH=OBR\XBXB^&MA]E5RR$\!?S*ENCAQU7\],FDZW2[;I1=<%PDP#;#V!8'
MA1;:.:!C![6C5A2NK]Z&([HT6?B*[R3&@53H.NE%E[:=4HBIKH\O=43*L +_
M&@"X9B5'VF=P(ZPO2;;6EARBJ+!,;&\[9Y(Y[#'.=&Q-8B XIAE1%N P:(_<
M618#GT\E2<8/I_;:&7+P'&5":)ISMK1X:[FG*UQA.&7TOLY=5YQ+RFX6;1?;
M..(G)[[9(A0\!.4@JHZN.2"-^\HEH&SR(=GQ;'HV(YUWGUIU>$Z=M;84"IBW
MT=@;@.B3!!QN\0CH_## 995A3&<PO6T S.OXYF6$]*'EA!7<2M8X!!&Y[LZ7
M/"4_*(YLTK+$XFJFO+UHTA%#SZ)J$Y-)CK6RNM^1VMAOM\A,6DY;@OA10*34
M8+2E2J\_O2KU5(M&NT*;[.CURL8L)'OOVEN#>]E0M+*&^4/R F0+6/F?"CRB
M5R7RZB.J+O(D*09M6EM=((]U=19_LXT$^3+E$%3&&+ N/="[ @8 3O<Z\?4N
M%MX<*?4TBA:5:14]% 57I%'I,/9[8[@IK&5 D<+4,("R52B/%+>=,3'E-L1D
M2A-ZV7EW.='W.3VX;?_N[/!3PMV$#U^9V$<6KSUE52>%M2W=AX*%L8*%1Z-)
M><*92@*P$!)KK#&=38]>VR#>N3FYPO)G$IM[:L3\9YH2$T75CL849MOOQ^/%
MU!P2L##XLS_"B-S^6.(^?0.5=2^.XO&L;\@2Y05TQ9-^W[S".-+A>$J!O0.*
M++/^"FWMK2&\-S:$E_.'-3#7O".+RJ5$6*H^R=[SEF:J:FOC!&4I5$%A.@ST
MAOW9A19_M.;R8YYI#/3L5J)P*]_XOKFT;6+;PY<3O^*&!,H?EY01)EY8XJ\@
MM9@?"@)$C#'SBT- OCY*P9Q26T=KDT^LP4"$Q26JP^$A^E&R?EZX;KN-#:%,
M\&/T&+8M;2K>H<]0BK&OQ0SD-6K%ZD-(/(LEAE7Q7+6"2_7RRM398$U4G)]7
M,NA2D1HHX375>0]L85^V]@)K]]]VO-NC0L3O4!",!M%9]/$.GZ<-7I'%C:UM
M_, 0'K@&DDEM&(H5RH[2A</1O-8![ @C&.%S7M2?B7X%%HY'@8V9*W0:AA)-
MC0UCUK,WAD2SB87PQ&WF'_L"$4U^)V)?G;*XL"$8$#.V:6^$>1J4HV4]249&
MBNP43"]1;N- "5^OUZ2]>X$_01$K[!I>[61$6JVUO?E<0Q $9S&-6:095P7K
MJ_Q$&S< QQ<D4IF1ZBWR7 +!R@HNZBHG*;#"KL)4NH%*,\)06B^(@K])5+*)
M=^R%DV7QC;7V<K:[R&%0R H*3ORH#SH$%YLE5]D]5=W;>0I)#0*/&=S(<OF(
MW0RM(U2BTCFGP:7WZ;)J"9H%-_%2#L7I55R_J1(F6;TVA#QFP.AJAO+OJ,X6
MSV7J]N3'U^93,R2,^TD![U*N]BI:C.(Y,5";N=#VFKC%![-X,.XWXBE=?QW3
MU5<J.N&&BBYH$V,ECQ@@[*.A@\Q@R:TI%\9!M_V*=!?I?(7;F\\1%HMQ/.WW
M/: <A/7\6%B/1O%T/#P2UB-*"/A30#V,^]/QMP-[$H\6DS\9W)@Z-:=\%P#+
M))[UIQY8_$393O2N]RD3CZ@/[\EBX(UJ2R990#EY;S*=V^<N#]9B: 3ZSS!-
M1*"Q?G[AP0+'\6 BB(>#/+_O^3?L^]BES;O':$N5C;Q4V4:\IY=:CK*:LQ8V
M$[SK$2?MQ00UJ[F#L)*W1]F[.ZR0WAJBMZ_= ;^Q,]1I*\C$_W][U];;-I*E
MGX>_@@\)1@8HM4A*))4!!G [G4$&G<O&G086@WV0;=G1MB-Y)"MI#^;'[[G5
MA76A*,7)]BX"S'1DB:PZ576JZER_L^(3FJ* 9<;^/E]Q00=W*1,55G=,*!(7
MG@S$N1>@:90%:#36?CJF@U#;<.59TZ<BZB6%22;R2\]23)]RQ<<S%99)'W[2
M89F>ZO S5B_]!608"@H'L0FY!U]R'U2U$4VMD"$0=''?2R*-O>P'%?I/PGG)
M"?Q']J3?]SMKY\19=1M[=15]V^\(U"VLD[O1\>!GP#;+^_3=<NM5).MZEMQJ
M&"5MHE%L%W+;Z9],RJ? )\538H1\^K2-<9G9NJUMDK#J5G2!ZG63DK3C#R;8
M>UX+*?7CDH)%/3^O+<=-:TXTJL]"<.1_IS,2?JG'7?3( !1JK0)\#,S#"PS-
M.;CWLH%>RPKG12U1_@5T-.R1<@IUES-NNJC<IA-[REDV=K)TS,)>K3^")GC+
M1@%5T?N_86VV5\M+,9JUU!_[-W4!B<%7+&T,@,0FR0?C.[0,FZX6;05G*8,J
M"1@WEK+DF<4%HQSKP9!S\U:3WZJER,&,8A#<II>\XY2-4@J@H#1@YL1UB]C+
MHY):V,6",(&X!JIT"UI8X&:!!ZZ(-+L1Z1FC?A<,<^FN?:),*#80KXZ3,W$9
M;/O'?HUC2 (9+A;SC8ZP15O0+7F]T*C"%"H%' A@']1GNIT)\VN]N[B_WMTF
MFBW%5-(JG&>@K4*BQP6*4TI6(6.*\E7RN(&V#ZPD6O@W[C3('&<J?E0Z7 AN
M+4_$D!5:>5]QIY(V@-:% M\$26IS0VQO+$(Z-WMIU6!0UJ_$ 7EP6)0M8:+"
MZQF,6 Q^6ZT_8ZD)F%O<9&JXF>W ,US#X,52/TT7F]:>/&!;]!L(G#4PRV?B
MN\@ZFKFU%S!J/NZR4\%"VK@TNB#SH3:K6#NA# 0)XL8UQ$O^#A_L]]0H>;';
M@$@OH8?I]?)W!JDKJ?PDXU11X>T=>H2!/:X^*]"*[?KZGOYH/?LSQJ%@G+LJ
M(<^L4EC/H,4*.)(<S!R0B,S /N4%KL;M\IHAR4T+)R"9K>[M2(7URF)2CGY!
M2V?"/$S;3UCWH)0 %N,Q8P9=:$.">)/J%9\$<];0[!O#)3+1$S")OEX\P(\&
MQ+1V06W#*NZ#[&J(RW'^ ZW/RU58:;!BQ9)P"8EM",&070A9"T5M:63&ED^6
MHR]-M"(Y*=3U<<*QMRHY3>?BZ5P^I08R2@PI$N2%,W93]GY9ZB*%'=\^V"XR
M :LAGR.>..B&6GY<LE51SY+"5R/@(H*GVZ!1<"B3=.F C"X)!]6"XB3(&NW]
MY=@^#(O;_B814!CX3,<Q4 7'#UP3EQ*X2/DY:BU(R%3TD8B L&S4[)_;Y2SI
M%FM3L&^9(Y5"9">T*G@D*H34)BRU"'/K?5RQAX-0)>1=Q0HD8$5F$A-APE0E
M$D>C:%^JM%T]X@\<I<D%1")%4 +FZ8S9:&ZKI7!:*"&2L'TX+1?K*$E:KE<]
MO4U+?!C"&?SH8F%X8[O#"NI+BL#971# )PU$Y1 1C4F8QM29&P%2U;!94C?I
MVJ8I<Z=/ASU9%9 40H7A12NF1XT!&)$E&K635=SVDEQ87B:R]H2O$IM?M_V8
MB^PV&,2F(16E&Y&R[";;*+U^,I &,6Q)I\O5-<RO+IES;Q*%!+S99"[=J01%
M9TIP!N;WSM EJDMM@F3)X5=V&"'58?;9B5$#Z5B[,CC(O+/:#GJ#X4<7HH#-
MHW!Q:86Z:SJSQ 3..DM*0N@=ISP8,.\6:^IH !4>UHYBEZC2+5=/TDUH4R/M
M!(L%,NMDEP$(U+[1#U6P"8W.1/'I-MF/T]+2W$/6F]U$U OBH)9?S!T(<8\_
M$BO+D*W<?#/:#VH7O.\5;]E7]MWM?6PT7AO[3$)H'1O>$B(@NR8.?'S$PHI4
M;;,C9XVIEBHJD/=-!S90NN@I6@OFEQ\RC<.[ON3J"RH:V%A[.0S;Y)H..8&&
MPE'F=]I,*R !3C80WVI)NTFN9DE:$&Q#U/]M$=6./816I7^J.S>\G_]N(QW0
M!M6EH:@$ >D2NH XET"5L:MR([AU9-S61D3!P5 HQ]IF 9VO1$)0R@RRV<5:
MPK$"\76L-9ICA.0/\8J:P7$L88+'GAK*_<,="D=VE.7"G@J,X0+.)BN%1'-N
MZ+> CF@'U=/7(KOKWMF;G2#BI4L4QB$8J@PMOPNHHWUVMH*;5"WA4,"$GA4+
M&N\A:><(A>BT$NRT38FN6+732:_F^%![LF ,P_7U4&(IM+KMA! G<^.G=GE7
MVQ0,TAT%7>&Q<JE!7F\V\X^BBL.A\T!@FYB^2#E,'^]NB9YVC"3%0I-NG=AA
M0O,+57W*RZG3;)J1I+7;2O+SG*L#FW2Q3-1J&(Z%&<F!J!J]3S($L"T@X@9F
M(;)[,XN-.%T..S2Y$*CZ+CF"TQH'ETGCVKFL1EAGB 6E$C!.ZY BX^GJ]]0H
M/5,Q--?]PG#(U@6Z-H&)FI@0F(\Y7^76A-'WM.HX3<N-!B@DE$F>-)5\$RC^
M0I>92U82)DLEL4NK-K/-E3E4:OA(B(L*9KZ"VW!UA>((UZ?^YV[!X/L_4&@Z
M9X323SMY">N#!JA@F>W3<GVK5?H=[%DXUW8@%VPHO)M+<+K?7B^NR-2'/0"=
M&"]Y*QW+5T#*#97>()<YY5GI5%02A]8Z,%Z)U9P2=+FXVA',(4G?6XU[$Y@@
M$W]#$GC6&CQIE0F>T_<XTNU\)?JIJAXD]EK45N^C(5PJB1;MVNL-G/F:V3@T
MC"=='SH4::K79[ ]R1(6=RY5#4!E0A:3X[5;]H&"SW56=3=UF32KVJ1RFIN/
M(7.IQ83JN'!%;<80]38K(9,,?Z2[X<P"D>QX+K&?PSP,42W64O:!' 4J@\]X
M9Y)]CB(['&BK 31TLWZ+G?X>J0VF[I_$%*7Z\78.0SF_Q!K06VE^>"=Q;!\Q
MCLWQ5!AO^V<7HXOJH=\)8*S"#/A/($MP==$A-[Q&%Y@6LDDF*49%]30AG^ID
M5-;)K[A)60*;YD^3YZJ\R,-R 1P@KNVGZ?/=@ID0A\![1^N]EAV8JP-*R3&M
MI=G685L^I]3$?TDN]Y82,@AV2]0'%$J<>'&-+4Q6/@HYI3\_Z5&@O:$UAQ9U
MYJE8W,%65[YF@R+>;?0L"FD$][6]6W-NM,YMLBA"RSOKG2:W=!-9")?.]Z/S
M$56WV^[@6.'IATO^D]:8.:Z=M!V=(^%T3MRN.K=<YE)2AV)$)'>?[A46X222
M6T$Y(7[XDCG_$^EF1*5.\S.UV3XL%Y_HZ&#Y1_<CP>Q<GXF5\3F*THO%D/:-
M[7U097FOD[D*C]3]MQTGR[9>H5:09F7(L^*%E:@=S(S&)1]>H5B5GLTWM^M4
MN] 2$E.6_\382_N0(2-I.Z]+;N36W*7>W!G<#2O<F &5%RK"EMM=D54!JY+>
MP,+<"KP(QH:278;C@DFI#DR/E6]U:@X$L[$B*2![YD"#+#RS-9H('P.Q^:AL
M<%4Q,N OFA?+T7C,CH6_&$9M;T'K-2H'I!^[:A]#\.A8/=F]JS[/XV&OU-;6
M\D7!][3K?I%=E_QKL5D/X>Z[H]G=[G3='$67S>#64)Q>^<0/'CQ.>^UQ4B5
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M+C9H"DB*1@K'$QU;\D:'WW?'WB CFTBAZ!R]Q225K:JZ8I]@'=R[;',OQ^V
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M-3.\8%^V*+Y@@/"[J/D8^YCFU%F=5>2N@,'5$_H N[)A*]88::?1 &T48S#
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M(O"=BUJ'WTT\%;L5!KD7$ +&O;A=;/S%,!&P[BLNLL+!_/*SY";[\ 3>@1Z
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M%*1E^LXNT043/-H?K?!H,<Q:#A0)'NU/D-.67[J"XYLS_0902P,$%     @
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M[35OZKEF[H]?)I7FA5LJM>J;YAJV?>X^*NZV^VOL_Z/CXE]02P,$%     @
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M>BO06_EZ*]!;^7H'H'?@ZQV WH&O=P!Z![[> >@=%MCK1IO=?+T#T#OP]0Y
M[\#7.P"] U_O /0.?+T#T#OP]8Y [\C7.P*](U_O"/2.?+TCT#OR]8Y [[C
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MBJP5BJP5BJP5BJS5"66=C^5@N_&C)/?.[=[FL_FOQE?/4$L! A0#%     @
MF85P4!\CSP/     $P(   L              ( !     %]R96QS+RYR96QS
M4$L! A0#%     @ F85P4"?HAPZ"    L0   !               ( !Z0
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "9A7!0[[N0B^X    K @
M$0              @ &9 0  9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "9A7!0F5R<(Q &  "<)P  $P              @ &V @  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( )F%<%"\UC)BWP(  /T+   8
M      "  ?<(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "9A7!0#1"Z'GD$  !N%@  &               @ $,#   >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ F85P4%C%;;ZJ @  _PH  !@
M             ( !NQ   'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( )F%<%"KE<,'N 0  .(6   8              "  9L3  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "9A7!0FD_-U$4"   9
M!P  &               @ &)&   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ F85P4#;C>\Y" @  V08  !@              ( !!!L
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( )F%<% M8"D
MU@$  %X$   8              "  7P=  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " "9A7!0:-3 /9($   @%@  &
M@ &('P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ F85P
M4#9FA+V^!   7Q<  !@              ( !4"0  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( )F%<%# V/<BM $  -(#   9
M      "  40I  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ F85P4(FORE*V 0  T@,  !D              ( !+RL  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "9A7!0\1>:"K<!  #2 P
M&0              @ $<+0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( )F%<%!XXUJ]M0$  -(#   9              "  0HO  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ F85P4+QNVD.V
M 0  T@,  !D              ( !]C   'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " "9A7!0-*XU[K@!  #2 P  &0
M@ 'C,@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( )F%
M<% $ N![M0$  -(#   9              "  =(T  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ F85P4'RZL".W 0  T@,  !D
M         ( !OC8  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " "9A7!07E>!-+8!  #2 P  &0              @ &L.   >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( )F%<%#>NE.%MP$  -(#
M   9              "  9DZ  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ F85P4(T(5GJW 0  T@,  !D              ( !ASP
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "9A7!071NZ
M#+8!  #2 P  &0              @ %U/@  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( )F%<%!A+HZFMP$  -(#   9
M  "  6)   !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
MF85P4.V:<+"W 0  T@,  !D              ( !4$(  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " "9A7!05'=Y9K8!  #2 P  &0
M            @ $^1   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( )F%<% [ T:@N@$  -(#   9              "  2M&  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ F85P4 #]LU*W 0
MT@,  !D              ( !'$@  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " "9A7!0VZ1,KK<!  #2 P  &0              @ $*
M2@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( )F%<% E
M$1/\MP$  -(#   9              "  ?A+  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ F85P4%KSYY8M P  ) \  !D
M     ( !YDT  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )F%<% D%7_&MP$  -(#   9              "
M 3Q9  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ F85P
M4/H XL2W 0  T@,  !D              ( !*EL  'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " "9A7!0'I0_UM,!  "<!   &0
M        @ $870  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( )F%<%"T/<)W[@$  &8%   9              "  2)?  !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ F85P4/'[ER2W 0  T@,
M !D              ( !1V$  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " "9A7!0K/5_ \4!   W!   &0              @ $U8P
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( )F%<%!/3M 7
MUP$  %X$   9              "  3%E  !X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ F85P4/2;,I7Q @  ;@L  !D
M ( !/V<  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " "9
MA7!0N'R^'N $  #R'@  &0              @ %G:@  >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( )F%<%#3V_GB] $   <%   9
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M970T-RYX;6Q02P$"% ,4    " "9A7!02R022],"  "Y"@  &0
M    @ 'Y?0  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M )F%<%"0;S@K_ $  #,%   9              "  0.!  !X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ F85P4$ EZQTV @   0<  !D
M             ( !-H,  'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    " "9A7!01]PP8.H!  #R!   &0              @ &CA0  >&PO
M=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( )F%<% W<V)O70,
M )(.   9              "  <2'  !X;"]W;W)K<VAE971S+W-H965T-3(N
M>&UL4$L! A0#%     @ F85P4!@1CBE= @  < <  !D              ( !
M6(L  'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "9A7!0
MR17,TQ0#  !8#   &0              @ 'LC0  >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;%!+ 0(4 Q0    ( )F%<%!K&L-0Z@$  ,X$   9
M      "  3>1  !X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%
M  @ F85P4'="&@FQ 0  W0,  !D              ( !6),  'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "9A7!0/JU%R T#  ""#
M&0              @ % E0  >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+
M 0(4 Q0    ( )F%<%!!4-FNUP(  #8+   9              "  828  !X
M;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ F85P4-\W2&Q\
M @  1 D  !D              ( !DIL  'AL+W=O<FMS:&5E=',O<VAE970U
M.2YX;6Q02P$"% ,4    " "9A7!0=^%C6F<"   P"   &0
M@ %%G@  >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( )F%
M<%"AM:'!=@(  &X(   9              "  >.@  !X;"]W;W)K<VAE971S
M+W-H965T-C$N>&UL4$L! A0#%     @ F85P4 J"J',; P  S P  !D
M         ( !D*,  'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
M    " "9A7!0M._I+E<"  "]!P  &0              @ 'BI@  >&PO=V]R
M:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( )F%<%#&'DB==@(  ,D(
M   9              "  7"I  !X;"]W;W)K<VAE971S+W-H965T-C0N>&UL
M4$L! A0#%     @ F85P4!)/S\%A @  ' @  !D              ( !':P
M 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " "9A7!0"C0H
M&!8#  "?#   &0              @ &UK@  >&PO=V]R:W-H965T<R]S:&5E
M=#8V+GAM;%!+ 0(4 Q0    ( )F%<%"/>M>!* (  +H&   9
M  "  0*R  !X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @
MF85P4,2_O4HZ @  HP8  !D              ( !8;0  'AL+W=O<FMS:&5E
M=',O<VAE970V."YX;6Q02P$"% ,4    " "9A7!0$"TPQ-L!  !C!   &0
M            @ '2M@  >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4
M Q0    ( )F%<%"N.A>@^0$  "P%   9              "  >2X  !X;"]W
M;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ F85P4+U06G_J 0
M5@4  !D              ( !%+L  'AL+W=O<FMS:&5E=',O<VAE970W,2YX
M;6Q02P$"% ,4    " "9A7!0I*'0'^T!  #E!   &0              @ $U
MO0  >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( )F%<%"1
M_QFF@0(  $H)   9              "  5F_  !X;"]W;W)K<VAE971S+W-H
M965T-S,N>&UL4$L! A0#%     @ F85P4 9D0'(I @  DP8  !D
M     ( !$<(  'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4
M" "9A7!0J>!:4.\(   _-@  &0              @ %QQ   >&PO=V]R:W-H
M965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( )F%<% WYY]P! ,  * +   9
M              "  9?-  !X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L!
M A0#%     @ F85P4*Z ;DX\F   6E," !0              ( !TM   'AL
M+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ F85P4*Q.*80\ @  @ H
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;72YX;6Q02P4&     %4 50!%%P  N'8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6635779168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of repurchased shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Total
    Number<br /> of Shares<br /> Purchased</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Average<br />
    Price<br /> paid per<br /> Share</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Approximate
    Dollar<br /> Value of Shares that<br /> May Yet be Purchased<br /> under the Program</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Plan
    Expiration Date</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 19%; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">May
    1, 2018 - May 30, 2018</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; width: 17%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,190,420</font></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.89</font></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; width: 16%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">15,366,000</font></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: center; width: 18%; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">February
    28, 2019</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Totals
    for 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,190,420</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.89</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6781424864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Trading Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of short-term investments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Cost</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Gross<br />
    Unrealized<br /> Gain</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Gross<br />
    Unrealized<br /> Loss</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Fair
    Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Security&#160;Type</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">December 31, 2019:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">93,712</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">143</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(12</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">93,843</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,674</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">211</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(745</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,140</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">111,386</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">354</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">110,983</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">December 31, 2018:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading securities
    - debt</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">33,643</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">18</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(19</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">33,642</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,389</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">27</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(404</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,012</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">37,032</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">45</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(423</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">36,654</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6880891312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>4. Accrued Expenses (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Accrued litigation liabilities</a></td>
<td class="nump">$ 6,181<span></span>
</td>
<td class="nump">$ 3,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccruedConsultingAndOtherProfessionalFees', window );">Accrued consulting and other professional fees</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ForeignTaxesPayable', window );">Foreign taxes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">State income taxes payable</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term lease liability</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 7,265<span></span>
</td>
<td class="nump">$ 4,299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccruedConsultingAndOtherProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued consulting and other professional fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccruedConsultingAndOtherProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ForeignTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign taxes payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ForeignTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6875967392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investments (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,195<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ACTG_MisoRoboticsMember', window );">Miso Robotics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">22.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherInvestments', window );">Proceeds from sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ACTG_MisoRoboticsMember', window );">Miso Robotics [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payment to acquire investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ACTG_MisoRoboticsMember', window );">Miso Robotics [Member] | Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payment to acquire investment</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_VeritoneMember', window );">Veritone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_InvestmentSharesSold', window );">Investment shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,121,071<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Loss from sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,200)<span></span>
</td>
<td class="num">$ (19,100)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_VeritoneMember', window );">Veritone [Member] | Investments - Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment owned, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,449<span></span>
</td>
<td class="nump">1,419,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 743<span></span>
</td>
<td class="nump">$ 5,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_VeritoneMember', window );">Veritone [Member] | Investments - Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_InvestmentWarrants', window );">Investment warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,120,432<span></span>
</td>
<td class="nump">1,120,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
<td class="nump">$ 2,064<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_InvestmentSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment shares sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_InvestmentSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_InvestmentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_InvestmentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42546-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611322-123010<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-12C.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611225-123010<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.Column B)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611133-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ACTG_MisoRoboticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ACTG_MisoRoboticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_VeritoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_VeritoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_CommonStockInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_CommonStockInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6866387424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>8. Income Taxes (Details - Deferred tax assets) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforwards and credits</a></td>
<td class="nump">$ 112,280<span></span>
</td>
<td class="nump">$ 104,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross', window );">Unrealized loss on investments held at fair value</a></td>
<td class="nump">538<span></span>
</td>
<td class="nump">2,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Stock compensation</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Fixed assets and intangibles</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">3,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Basis of investments in affiliates</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Accrued liabilities and other</a></td>
<td class="nump">631<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards', window );">State taxes</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">115,448<span></span>
</td>
<td class="nump">112,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(115,077)<span></span>
</td>
<td class="num">(112,514)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets, net of valuation allowance</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">ROU Asset</a></td>
<td class="num">(347)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(371)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherTaxCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherTaxCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6867028896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Series A Redeemable Convertible Preferred Stock (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 18, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_EmbeddedDerivativeMember', window );">Embedded Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember', window );">Series A Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsIssuedShares', window );">Warrants issued, shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsIssuedShares', window );">Warrants issued, shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_EmbeddedDerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_EmbeddedDerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_StarboardValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6641979232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.&#160; ACCRUED EXPENSES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Accrued expenses consist of the following
at December 31, 2019 and 2018:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Accrued
    litigation liabilities</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">6,181</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,803</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Accrued consulting
    and other professional fees</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">470</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Foreign taxes payable</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">374</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">State income taxes
    payable</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">27</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Short-term lease liability</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">435</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Other
    accrued liabilities</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">152</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">122</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">7,265</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4,299</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6764342400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>8.&#160;&#160;INCOME TAXES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s income tax benefit (expense) for the fiscal periods
presented consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(in thousands)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Current:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Federal</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 46%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">State</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(34</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(87</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Foreign</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,858</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,092</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Total
    current</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,824</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,179</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Deferred:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Federal</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">State</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Income
    tax benefit (expense)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,824</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,179</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">The
tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities
consist of the following at </font>December 31, 2019 and 2018<font style="font-family: Times New Roman, Times, Serif">:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">(in thousands)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Net
    operating loss and capital loss carryforwards and credits</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">112,280</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">104,862</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Unrealized
    loss on investments held at fair value</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">538</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2,455</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Stock
    compensation</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">358</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,365</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Fixed
    assets and intangibles</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,316</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,330</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Basis
    of investments in affiliates</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">300</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">286</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Accrued
    liabilities and other</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">631</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">208</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">State
    taxes</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">25</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">26</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">115,448</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">112,532</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Valuation
    allowance</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(115,077</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(112,514</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets, net of valuation allowance</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">371</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">18</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Deferred
    tax liabilities:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">ROU
    Asset</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(347</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Other</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(24</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(18</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred tax liabilities</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(371</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(18</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets (liabilities)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A reconciliation of the federal statutory
income tax rate and the effective income tax rate is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Statutory
    federal tax rate - (benefit) expense</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">21%</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">21%</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">State
    income and foreign taxes, net of federal tax effect</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">7%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Foreign
    tax credit</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Noncontrolling
    interests in operating subsidiaries</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Nondeductible
    permanent items</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Change
    in tax rate</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Expired capitalized
    loss</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Valuation
    allowance</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(13)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(20)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Other</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(4)%</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">10%</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1)%</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, the Company recorded
full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance
set forth in ASC 740, &#8220;Income Taxes.&#8221; In future periods, if the Company determines it will more likely than not be
able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will
generally be recognized in the statements of operations in the period the determination is made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December&#160;31, 2019, Acacia had U.S.
federal and state income tax net operating loss carryforwards (&#8220;NOLs&#8221;) totaling approximately $253,824,000 and $19,683,000,
respectively. For federal income tax purposes, our NOL carryovers generated for tax years beginning before January 1, 2018 will
begin to expire in 2026. Pursuant to the Tax Cuts and Jobs Act enacted by the U.S. federal government in December 2017, for federal
income tax purposes, NOL carryovers generated for our tax years beginning January 1, 2018 can be carried forward indefinitely
but will be subject to a taxable income limitation. For state income tax purposes, our NOLs will expire between 2028 and 2039.
Our capital loss carryovers totaled $23,652,000 at December&#160;31, 2019, expiring between 2025 and 2029.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of December&#160;31, 2019, Acacia had
approximately $51,508,000 of foreign tax credits, expiring between 2020 and 2026. In general, foreign taxes withheld may be claimed
as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject
to certain limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Tax expense (benefit) for the periods presented
primarily reflects foreign taxes withheld and refunded on revenue agreements executed with licensees in foreign jurisdictions
and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were 23% for fiscal
year 2019 and 19% for fiscal year 2018. Results for fiscal year 2019 included an unrealized loss on Acacia&#8217;s investment
in Veritone which created a deferred tax asset totaling approximately $538,000. Results for fiscal year 2018 included an unrealized
loss on Acacia&#8217;s investment in Veritone which created a deferred tax asset totaling approximately $2,455,000. The 2017 deferred
tax liability was reversed in fiscal year 2018 as a result of the 2018 unrealized loss on Acacia&#8217;s investment in Veritone
and the realized loss on the sale of Veritone common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia is subject to taxation in the U.S.
and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign
jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities
for years before 2011. The California Franchise Tax Board is auditing the 2011 through 2016 California combined income tax returns.
The California Franchise Tax Board has proposed adjustments for 2011 and 2012 that, if expensed, would not be material to the consolidated
statements of operations for the periods presented. We have protested these adjustments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December&#160;31, 2019 and 2018, the
Company had total unrecognized tax benefits of approximately $731,000 and $816,000, respectively. No interest and penalties have
been recorded for the unrecognized tax benefits for the periods presented. At December 31, 2019, if recognized, approximately $731,000
of tax benefits, net of valuation allowance, would impact the Company&#8217;s effective tax rate. The Company does not expect that
the liability for unrecognized tax benefits will change significantly within the next 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia recognizes interest and
penalties with respect to unrecognized tax benefits in income tax expense (benefit). Acacia has identified no uncertain tax position
for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or
decrease within 12 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868553696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of gain (loss) on investments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In thousands)</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Change
    in fair value of investment, warrants</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,308</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(11,895</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Change in fair value
    of investment, common stock</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">11,207</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(47,208</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Loss
    on sale of investment, common stock</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(9,230</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(19,095</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Net
    realized and unrealized gain (loss) on investment at fair value</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">669</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(78,198</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868627344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Paid-up
    Revenue Agreements</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">6,343</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">100,496</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Recurring Revenue Agreements</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4,903</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">13,040</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Other Settlements</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,470</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Sales</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">14,500</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">11,246</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">131,506</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of fair value of financial assets and liabilities on a recurring basis</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Level
    1</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Level
    2</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Level
    3</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Assets as of December 31, 2019:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">93,843</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,140</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - warrants (Note 6)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">757</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - common stock (Note 6)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">743</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    recurring fair value measurements as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,883</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">94,600</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Assets as of December 31, 2018:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">33,642</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,012</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - warrants (Note 6)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2,064</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - common stock (Note 6)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">5,395</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    recurring fair value measurements as of December 31, 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">8,407</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">35,706</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Liabilities as of December 31, 2019:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Profits
    interest units</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">591</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Series
    A warrants</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,568</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Embedded
    derivative liability</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    liabilities as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4,159</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Liabilities as of December 31, 2018:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Profits
    interest units</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">591</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    liabilities as of December 31, 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">591</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of changes in finacial liability Level 3</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Embedded
    Derivative</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Opening balance as of January 1, 2019</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 83%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Issuance
    of Series A redeemable convertible preferred stock with embedded derivative</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">21,232</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Remeasurement
    of Series A redeemable convertible preferred stock embedded derivative to fair value</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total Level 3
    recurring fair value measurements as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock', window );">Schedule of useful lives of property and equipment</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; width: 57%"><font style="font-family: Times New Roman, Times, Serif">Furniture and fixtures</font></td>
    <td style="font-size: 10pt; width: 43%"><font style="font-family: Times New Roman, Times, Serif">3 to 5 years</font></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Computer hardware and software</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">3 to 5 years</font></td></tr>
<tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Leasehold improvements</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">2 to 5 years (Lesser of lease term or
    useful life of improvement)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock-based compensation assumptions used</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> The fair values of stock options granted during the year ended December 31, 2018 were estimated
using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-family: Times New Roman, Times, Serif">For
    the Year Ended<br /> December 31, 2018</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Risk-free
    interest rate</font></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2.26%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Term</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-family: Times New Roman, Times, Serif">4.37</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Volatility</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-family: Times New Roman, Times, Serif">51%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Dividend
    yield</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Calculation of basic and diluted loss per common share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">(In thousands, except percentage
    change values)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Basic</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Numerator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to Acacia Research Corporation</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(17,115</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Accretion
    of Series A Redeemable Convertible Preferred Stock</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(307</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to common stockholders - basic</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(17,422</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Denominator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - basic</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,764,002</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,969,062</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Basic
    net loss per share of common stock</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(0.35</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2.10</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Diluted</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Numerator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to Acacia Research Corporation</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(17,115</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Mark-to-market
    adjustment for preferred stock embedded derivative</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to common stockholders - diluted</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(20,373</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Denominator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - basic</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,764,002</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,969,062</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Effect
    of potentially dilutive securities: Series A preferred stock</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,132,771</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - diluted</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">50,896,773</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,969,062</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Diluted
    net loss per share of common stock</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(0.40</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2.10</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of useful lives of property and equipment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ScheduleOfUsefulLivesOfPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868555984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum operating lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom">
    <td colspan="2"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Operating
    Leases</font></td><td style="font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 31%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">2020</font></td><td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right"><font style="font-family: Times New Roman, Times, Serif">434</font></td><td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">2021</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">334</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">2022</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">349</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">2023</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">364</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">2024</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif">218</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">Total
                                         minimum payments</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-weight: bold; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,699</font></td><td style="font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Less:
                                         short-term lease liabilities</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(435</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Long-term
                                         lease liabilities</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,264</font></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6871789696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss including noncontrolling interests</a></td>
<td class="num">$ (17,129)<span></span>
</td>
<td class="num">$ (104,848)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized loss on foreign currency translation, net of tax of $0</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total other comprehensive loss</a></td>
<td class="num">(17,129)<span></span>
</td>
<td class="num">(104,760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Acacia Research Corporation</a></td>
<td class="num">$ (17,115)<span></span>
</td>
<td class="num">$ (104,941)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32157-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878513392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 57,359<span></span>
</td>
<td class="nump">$ 128,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Trading securities - debt</a></td>
<td class="nump">93,843<span></span>
</td>
<td class="nump">33,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent', window );">Trading securities - equity</a></td>
<td class="nump">17,140<span></span>
</td>
<td class="nump">3,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">32,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,912<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">171,765<span></span>
</td>
<td class="nump">201,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Long-term restricted cash</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investment at fair value (Note 6)</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">7,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Other investments (Note 6)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patents, net of accumulated amortization</a></td>
<td class="nump">7,814<span></span>
</td>
<td class="nump">6,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Leased right-of-use assets</a></td>
<td class="nump">1,264<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">818<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">218,161<span></span>
</td>
<td class="nump">223,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">3,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">7,265<span></span>
</td>
<td class="nump">4,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_RoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="nump">2,178<span></span>
</td>
<td class="nump">22,688<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,715<span></span>
</td>
<td class="nump">31,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Series A warrant liabilities</a></td>
<td class="nump">3,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Series A embedded derivative liabilities</a></td>
<td class="nump">17,974<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">1,264<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">593<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">35,114<span></span>
</td>
<td class="nump">32,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionAmount', window );">Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of December 31, 2019; no shares authorized, issued or outstanding as of December 31, 2018; aggregate liquidation preference of $35,125 and $0 as of December 31, 2019 and December 31, 2018, respectively (Note 16)</a></td>
<td class="nump">8,089<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized;</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,370,987 and 49,639,319 shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 2,919,828 shares as of September 30, 2019 and December 31, 2018</a></td>
<td class="num">(39,272)<span></span>
</td>
<td class="num">(39,272)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">652,003<span></span>
</td>
<td class="nump">651,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(439,656)<span></span>
</td>
<td class="num">(422,541)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Acacia Research Corporation stockholders' equity</a></td>
<td class="nump">173,125<span></span>
</td>
<td class="nump">189,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">174,958<span></span>
</td>
<td class="nump">191,240<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</a></td>
<td class="nump">$ 218,161<span></span>
</td>
<td class="nump">$ 223,949<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_RoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties and contingent legal fees payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_RoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in equity securities and other forms of securities that provide ownership interests classified as available-for-sale, expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878505536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Income Taxes (Details - Reconciliation of tax rates)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal tax rate - (benefit) expense</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income and foreign taxes, net of federal tax effect</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax credit</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interests in operating subsidiaries</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible permanent items</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Change in tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Expired capitalized loss</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(13.00%)<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Net effective income tax rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6876115104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>5. Patents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedPatentsGross', window );">Gross carrying amount - patents</a></td>
<td class="nump">$ 330,588<span></span>
</td>
<td class="nump">$ 326,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization - patents</a></td>
<td class="num">(322,774)<span></span>
</td>
<td class="num">(319,580)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patents, net</a></td>
<td class="nump">$ 7,814<span></span>
</td>
<td class="nump">$ 6,587<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedPatentsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedPatentsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6608460208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. Stockholders' Equity (Details) - Common Stock<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>May 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased | shares</a></td>
<td class="nump">1,190,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share | $ / shares</a></td>
<td class="nump">$ 3.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ApproximateValueOfSharesThatMayYetBePurchased', window );">Approximate value of shares that may yet be purchased | $</a></td>
<td class="nump">$ 15,366,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramExpirationDate', window );">Plan expiration date</a></td>
<td class="text">Feb. 28,  2019<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ApproximateValueOfSharesThatMayYetBePurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Approximate value of shares that may yet be purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ApproximateValueOfSharesThatMayYetBePurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6866083296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. Restatement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">$ (65,748)<span></span>
</td>
<td class="num">$ (66,026)<span></span>
</td>
<td class="num">$ (58,812)<span></span>
</td>
<td class="num">$ (2,308,000)<span></span>
</td>
<td class="nump">$ 20,877,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">3,721<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="nump">3,288<span></span>
</td>
<td class="num">(68,063,000)<span></span>
</td>
<td class="num">(24,066,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 33,921,000<span></span>
</td>
<td class="num">$ (4,606,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase/(decrease) in cash and cash equivalent</a></td>
<td class="num">(61,948)<span></span>
</td>
<td class="num">(65,322)<span></span>
</td>
<td class="num">(55,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember', window );">Scenario Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(846)<span></span>
</td>
<td class="num">(2,268)<span></span>
</td>
<td class="num">(1,958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(61,181)<span></span>
</td>
<td class="num">(63,133)<span></span>
</td>
<td class="num">(53,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase/(decrease) in cash and cash equivalent</a></td>
<td class="num">$ (61,948)<span></span>
</td>
<td class="num">$ (65,322)<span></span>
</td>
<td class="num">$ (55,524)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=us-gaap_ScenarioAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6623423872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. Related Party Transactions (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=ACTG_DriveShackMember', window );">Drive Shack, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investment shares</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ACTG_SidusInvestmentMember', window );">Sidus Investment Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Reimbursement of expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 976<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=ACTG_DriveShackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=ACTG_DriveShackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ACTG_SidusInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ACTG_SidusInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6776205744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Property and Equipment Useful Lives (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture And Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment useful life</a></td>
<td class="text">3 to 5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment useful life</a></td>
<td class="text">3 to five years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment useful life</a></td>
<td class="text">2 to 5 years (Lesser of lease term or useful life of improvement)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878230736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Description of Business and Basis of Presentation (Details Narrative) - Integer<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NumberOfPatentPortfoliosAcquired', window );">Number of new patent portfolios acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NumberOfPatentPortfoliosAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patent portfolios acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NumberOfPatentPortfoliosAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878258064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. Trading Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Cost</a></td>
<td class="nump">$ 111,386<span></span>
</td>
<td class="nump">$ 37,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Gross unrealized gain</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Gross unrealized loss</a></td>
<td class="num">(757)<span></span>
</td>
<td class="num">(423)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair value</a></td>
<td class="nump">11,093<span></span>
</td>
<td class="nump">36,654<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesDebtMember', window );">Trading securities - Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Cost</a></td>
<td class="nump">93,712<span></span>
</td>
<td class="nump">33,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Gross unrealized gain</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Gross unrealized loss</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair value</a></td>
<td class="nump">93,843<span></span>
</td>
<td class="nump">33,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesEquityMember', window );">Trading securities - Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Cost</a></td>
<td class="nump">17,674<span></span>
</td>
<td class="nump">3,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Gross unrealized gain</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Gross unrealized loss</a></td>
<td class="num">(745)<span></span>
</td>
<td class="num">(404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair value</a></td>
<td class="nump">$ 17,140<span></span>
</td>
<td class="nump">$ 3,012<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-12C.Column C.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611225-123010<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14.Column E.2,3)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611322-123010<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.Column C.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611133-123010<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13.Column C.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611282-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6776610672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans (Details - Nonvested Restricted Stock Activity) - Restricted Stock [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward', window );"><strong>Number of Nonvested Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Nonvested Shares Outstanding, Beginning | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of Nonvested Shares Granted | shares</a></td>
<td class="nump">777,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Nonvested Shares Vested | shares</a></td>
<td class="num">(214,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Nonvested Shares Cancelled | shares</a></td>
<td class="num">(87,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Nonvested Shares Outstanding, Ending | shares</a></td>
<td class="nump">476,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Outstanding, Beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Granted | $ / shares</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Vested | $ / shares</a></td>
<td class="nump">3.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Cancelled | $ / shares</a></td>
<td class="nump">2.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Outstanding, Ending | $ / shares</a></td>
<td class="nump">$ 2.98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6653148080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>10. Commitments and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2020</a></td>
<td class="nump">$ 434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2021</a></td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2022</a></td>
<td class="nump">349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2023</a></td>
<td class="nump">364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2024</a></td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total minimum payments</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: short-term lease liabilities</a></td>
<td class="num">(435)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">$ 1,264<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6776612320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Accounting Principles</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Accounting Principles.&#160;&#160;</i>The
consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally
accepted accounting principles in the United States of America (&#34;U.S. GAAP&#34;).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Principles of Consolidation.&#160;&#160;</i>The
accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled
subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Noncontrolling interests in
Acacia&#8217;s majority-owned and controlled operating subsidiaries (&#8220;noncontrolling interests&#8221;) are separately presented
as a component of stockholders&#8217; equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss
attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements
of Series A redeemable convertible preferred stock and stockholders&#8217; equity for total noncontrolling interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A wholly owned subsidiary of Acacia is the
general partner of the Acacia Intellectual Property Fund, L.P. (the &#8220;Acacia IP Fund&#8221;), which was formed in August 2010.
The Acacia IP Fund is included in the Company&#8217;s consolidated financial statements since 2010, as Acacia&#8217;s wholly owned
subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia
IP Fund was terminated as of December 31, 2017 and is in the process of being liquidated.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Revenue Recognition.&#160;&#160;</i>Revenue
is recognized upon transfer of control of promised bundled IP rights (hereinafter &#8220;IP Rights&#8221;) and other contractual
performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP
Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which
the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized
at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have
been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, revenue
contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license
fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia
(&#8220;Paid-up Revenue Agreements&#8221;). Revenues also included license fees from sales-based revenue contracts, the
majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on
quarterly sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may also
include court ordered settlements or awards related to our patent portfolio (&#34;Other Settlements&#34;) or sales of our
patent portfolio (&#34;Sales&#34;). IP Rights granted included the following, as applicable: (i) the grant of a
non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a
covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending
litigation.&#160;The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related
patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the
promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and
(ii) the Company's promise to transfer each individual IP right described above to the customer is not separately
identifiable from other promises to transfer IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the promised IP Rights are not individually
distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is distinct, and accounted
for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were &#8220;functional
IP rights&#8221; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that
functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating
subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain
or upgrade the technology, or provide future support or services.&#160;&#160;The contracts provide for the grant (i.e., transfer
of control) of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract.&#160;Licensees
legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is
recognized upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have
been met. Revenue contracts generally provide for payment of contractual amounts with 30-90 days of execution of the contract,
or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees
are generally non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For sales-based royalties, the Company
includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is
probable that a significant reversal in the amount of cumulative&#160;revenue&#160;recognized will not occur when the
uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue&#160;is recognized
for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage
occurs, or (ii) the&#160;performance obligation&#160;to which some or all of the sales-based royalty has been allocated has
been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues from contracts with significant
financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have
paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price,
the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient,
the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company
expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the
customer pays for the IP Rights will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In general, the Company is required to make
certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include
identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining
whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers
to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining
whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based
royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues were comprised of the following
for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Paid-up
    Revenue Agreements</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">6,343</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">100,496</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Recurring Revenue Agreements</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4,903</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">13,040</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Other Settlements</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,470</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Sales</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">14,500</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">11,246</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">131,506</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to &#8220;Inventor Royalties and Contingent
Legal Expenses&#8221; below for information on related direct costs of revenues.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PortfolioOperationsPolicyTextBlock', window );">Portfolio Operations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Portfolio Operations.</i>&#160;&#160;Cost
of revenues include the costs and expenses incurred in connection with Acacia&#8217;s patent licensing and enforcement activities,
including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related
legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid
to third-parties and the amortization of patent-related investment costs. These costs are included under the caption &#8220;Portfolio
operations&#8221; in the accompanying consolidated statements of operations.&#160;&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock', window );">Inventor Royalties and Contingent Legal Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Inventor Royalties and Contingent Legal
Expenses. </i>Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues
are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent
owners by Acacia&#8217;s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from
future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are
earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements
of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered and included in
amortization expense in the consolidated statements of operations. There were no patent acquisition expenses for fiscal year 2019.
Cost of revenues for fiscal year 2018 included $4.0 million of costs to acquire certain patent rights related to revenues recognized
in the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Contingent legal fees are expensed in the
consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries
from potential infringers, no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for
certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Fair Value Measurements.</i> U.S. GAAP
defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability
in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and
also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The
three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 96px"><font style="font-family: Times New Roman, Times, Serif">(i)</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Level 1 - <i>Observable Inputs</i>:&#160;&#160;Quoted prices in active markets for identical investments;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 96px"><font style="font-family: Times New Roman, Times, Serif">(ii)</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Level 2 - <i>Pricing Models with Significant Observable Inputs</i>:&#160;&#160;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 96px"><font style="font-family: Times New Roman, Times, Serif">(iii)</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Level 3 - <i>Unobservable Inputs</i>:&#160;&#160;Significant unobservable inputs, including the entity&#8217;s own assumptions in determining the fair value of investments.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whenever possible,
the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. In such cases,
the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair
value measurement. The assessment of the significance of a particular input requires judgment and considers factors specific to
the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair
value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Level
    1</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Level
    2</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Level
    3</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Assets as of December 31, 2019:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">93,843</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,140</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - warrants (Note 6)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">757</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - common stock (Note 6)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">743</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    recurring fair value measurements as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,883</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">94,600</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Assets as of December 31, 2018:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">33,642</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,012</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - warrants (Note 6)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2,064</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Investment
    at fair value - common stock (Note 6)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">5,395</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    recurring fair value measurements as of December 31, 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">8,407</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">35,706</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Liabilities as of December 31, 2019:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Profits
    interest units</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">591</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Series
    A warrants</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,568</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Embedded
    derivative liability</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    liabilities as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4,159</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Liabilities as of December 31, 2018:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Profits
    interest units</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">591</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    liabilities as of December 31, 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">591</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth a summary of the changes in the
estimated fair value of the Company&#8217;s embedded derivative, which is measured at fair value as a Level 3 liability on a recurring
basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Embedded
    Derivative</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Opening balance as of January 1, 2019</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 83%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Issuance
    of Series A redeemable convertible preferred stock with embedded derivative</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">21,232</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Remeasurement
    of Series A redeemable convertible preferred stock embedded derivative to fair value</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total Level 3
    recurring fair value measurements as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Cash and Cash Equivalents</i>.&#160;&#160;Acacia
considers all highly liquid, trading securities with original maturities of three months or less when purchased to be cash equivalents.
For the periods presented, Acacia&#8217;s cash equivalents are comprised of investments in AAA rated money market funds that invest
in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S.
government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia&#8217;s cash equivalents
are measured at fair value using quoted prices that represent Level 1 inputs.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Long Term Restricted Cash</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Long Term Restricted Cash</i>.&#160;&#160;Long-term
restricted cash relates to the proceeds received from the issuance of Series A redeemable convertible preferred stock (the &#8220;Series
A Redeemable Convertible Preferred Stock&#8221;) which are held in an escrow account. The amounts are to be released to the Company
upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the conversion of
Series A Redeemable Convertible Preferred Stock into common stock (see Note 16).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy', window );">Trading Securities- Debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Trading Securities- Debt.&#160;&#160;</i>Investments
in debt securities are reported at fair value on a recurring basis, with related realized and unrealized gains and losses recorded
in the statements of operations in other income (expense). Realized and unrealized gains and losses are recorded based on the specific
identification method.&#160;Interest is included in other income (expense).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Trading Securities - Equity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Trading Securities - Equity. </i>Investments
in equity securities are reported at fair value on a recurring basis, with related realized and unrealized gains and losses in
the value of such securities recorded in the statements of operations in other income (expense). Dividend income is included
in other income (expense).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostMethodInvestmentsPolicy', window );">Impairment of Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Impairment of Investments. </i>Acacia
evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis that
considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated
fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration
and extent to which the fair value is less than cost, and the Company&#8217;s intent and ability to hold, or plans or ability to
sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments
are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments
associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary.
An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of
time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment&#8217;s carrying amount
is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive
and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is
recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary
are recognized in the consolidated statements of operations.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Concentration of Credit Risks.&#160;&#160;</i>Financial
instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, trading securities and accounts
receivable. Acacia places its cash equivalents and trading securities primarily in highly rated money market funds and investment
grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may,
at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash
equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Three licensees individually accounted for
43%, 22% and 15%, respectively, of revenues recognized during the year ended December&#160;31, 2019. Three licensees individually
accounted for 45%, 17% and 17%, respectively, of revenues recognized during the year ended December&#160;31, 2018. Two licensees
individually represented approximately 70% and 17%, respectively, of accounts receivable at December&#160;31, 2019. Four licensees
individually represented approximately 38%, 36%, 12% and 11%, respectively, of accounts receivable at December&#160;31, 2018.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For 2019 and 2018, 39% and 26%, respectively,
of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated
to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia performs credit evaluations of its
licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable
are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful
accounts may be established to reflect the Company&#8217;s best estimate of probable losses inherent in the accounts receivable
balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statements of
operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and
other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Fair Value of Financial Instruments.&#160;&#160;</i>The
carrying value of cash and cash equivalents, restricted cash, accounts receivables, and current liabilities approximates their
fair values due to their short-term maturities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Property and Equipment.&#160;&#160;</i>Property
and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment
are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold
or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated
statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis
over the following estimated useful lives of the assets:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; width: 57%"><font style="font-family: Times New Roman, Times, Serif">Furniture and fixtures</font></td>
    <td style="font-size: 10pt; width: 43%"><font style="font-family: Times New Roman, Times, Serif">3 to 5 years</font></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Computer hardware and software</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">3 to 5 years</font></td></tr>
<tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Leasehold improvements</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">2 to 5 years (Lesser of lease term or useful life of improvement)</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Rental payments on operating leases are
charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Patents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Patents.</i>&#160;&#160;Patents include
the cost of patents or patent rights (hereinafter, collectively &#8220;patents&#8221;) acquired from third-parties or obtained
in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic
useful lives, ranging from one to five years.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Leases. </i>The Company adopted ASC
842 as of January 1, 2019, electing the practical expedient approaches. The primary impact of adopting ASC 842 for the Company
was the recognition in the consolidated balance sheet of certain lease-related assets and liabilities for operating leases with
terms longer than 12 months. Such amounts were not previously accounted for in the Company's consolidated balance sheets. The
Company&#8217;s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether
an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all
leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying
asset for the lease term. Upon adoption of ASC 842 on January 1, 2019, the carrying value of certain lease related liabilities
for its excess of lease payments over anticipated sublease income existing at that date, was offset against the related right-of-use
assets. Lease expense is recognized on a straight-line basis over the lease term.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments at Fair Value</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Investments at Fair Value</i>. On an
individual investment basis, Acacia may elect to account for investments in companies where the Company has the ability to exercise
significant influence over operating and financial policies of the investee, at fair value. If the fair value option is applied
to an investment that would otherwise be accounted for under the equity method of accounting, it is applied to all of the financial
interests in the same entity that are eligible items (i.e., common stock and warrants).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAndCostMethodInvestmentsPolicy', window );">Other Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Other Investments</i>. Equity investments
in common stock and in-substance common stock without readily determinable fair values in companies over which the Company has
the ability to exercise significant influence, are accounted for using the equity method of accounting. Acacia includes its proportionate
share of earnings and/or losses of its equity method investees in equity in earnings (losses) of investee in the  consolidated
statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Investments in preferred stock with substantive
liquidation preferences are accounted for at cost, (subject to impairment considerations, as described below, if any), as adjusted
for the impact of changes resulting from observable price changes in orderly transactions for identical or similar investments
of the same issuer. In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially
similar to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock,
is not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference
is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation
to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a
fair value perspective is substantive because, in the event of liquidation, the investment will not participate in substantially
all of the investee's losses, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The initial determination of whether an
investment is substantially similar to common stock is made on the initial date of investment if the Company has the ability to
exercise significant influence over the operating and financial policies of the investee.&#160;That determination is reconsidered
if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure of the investee,
including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional interest in an
investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment
at the date at which the Company obtains the additional interest. Refer to Note 6 for additional information.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ImpairmentOfInvestmentsPolicyTextBlock', window );">Impairment of Other Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Impairment of Other Investments. </i>Acacia
evaluates its investments in marketable securities for potential impairment, employing a methodology on a quarterly basis
that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its
estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument
issuers, the duration and extent to which the fair value is less than cost, and the Company&#8217;s intent and ability to
hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates
determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be
other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the
classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless
(a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying
amount and (b) positive evidence indicating that the investment&#8217;s carrying amount is recoverable within a reasonable
period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to
determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a
reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary
are recognized in the consolidated statements of operations.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-lived Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Impairment of Long-lived Assets.</i>
Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events
or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted
future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded
equal to the excess of the asset&#8217;s carrying value over its fair value. If an asset is determined to be impaired, the loss
is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate
of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. In the event
that management decides to no longer allocate resources to a patent portfolio, an impairment loss equal to the remaining carrying
value of the asset is recorded. Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fair value is generally estimated using
the &#8220;Income Approach,&#8221; focusing on the estimated future net income-producing capability of the patent portfolios over
the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221;
including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash
inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market
data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty
obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with
a specific patent portfolio&#8217;s licensing and enforcement program. The analysis also contemplates consideration of current
information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength
of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentLiabilityReserveEstimatePolicy', window );">Contingent Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Contingent Liabilities. </i>The Company, from time to time,
is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and
the Company&#8217;s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable
and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements.
If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments,
reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations
where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company
records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for
these types of contingencies are recognized in the period in which the litigation services were provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain of Acacia&#8217;s operating subsidiaries
are often required to engage in litigation to enforce their patents and patent rights.&#160;In connection with any of Acacia&#8217;s
operating subsidiaries&#8217; patent enforcement actions, it is possible that a defendant may request and/or a court may rule that
an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing
standards relating to the substantive or procedural aspects of such enforcement actions.&#160;In such event, a court may issue
monetary sanctions against Acacia or its operating subsidiaries or award attorney&#8217;s fees and/or expenses to a defendant(s),
which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company&#8217;s
operating results and financial position.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Stock-Based
Compensation.</i> The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the
award, and is recognized as an expense on a straight-line basis over the employee&#8217;s requisite service period (generally
the vesting period of the equity award). The fair value of restricted stock and restricted stock units awards is determined by
the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair
value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted
for as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No stock options were granted during the
year ended December 31, 2019. The fair values of stock options granted during the year ended December 31, 2018 were estimated
using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Year
    Ended<br /> December 31, 2018</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Risk-free interest rate</td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">2.26%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Term</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">4.37</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif">Volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">51%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#8211;%</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Due to a lack of sufficient historical stock
option exercise experience, the Company utilized the simplified method for estimating the expected term. Expected volatility
is based on the historical volatility of the Company&#8217;s stock for the length of time corresponding to the expected term of
the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the
option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Restricted stock units awards with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation
technique. Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered,
regardless of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation
technique included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent;
and expected dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury
zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield
was based on expectations regarding dividend payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Profits Interest Units (&#8220;Units&#8221;)
are accounted for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock
Compensation.&#8221; The Units vest as described at Note 9, and therefore, the vesting conditions do not meet the definition of
service, market or performance conditions, as defined in ASC 718. As such, the Units are classified as liability awards. Liability
classified awards are measured at fair value on the grant date and re-measured each reporting period at fair value until the award
is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated for the portion of the requisite
service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s requisite
service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred
during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized in the
period, and will continue to be fully recognized for any changes in fair value, until the Units are settled. The Company has a
purchase option to purchase the vested Units that are not otherwise forfeited after termination of continuous service. The exercise
price of the purchase option is the fair market value of the Units on the date of termination of continuous service. At each reporting
date, the value of the Units that are subject to the purchase option will be the measured at the fair value on the termination
date. Non-cash stock compensation expense related to the Units is reflected in general and administrative expense in the accompanying
consolidated statements of operations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantPolicyTextBlock', window );">Series A Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Series A Warrants. </i>The fair value
of the Series A warrants (the &#8220;Series A Warrants&#8221;) is estimated using a Black-Scholes
option-pricing model. The fair value of the Series A Warrants as of December 31, 2019 was estimated based on the following assumptions:
volatility of 30 percent, risk-free rate of 1.85 percent, term of 7.79 years and a dividend yield of 0 percent.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesEmbeddedDerivatives', window );">Embedded Derivatives</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Embedded derivatives. </i>Embedded derivatives
that are required to be bifurcated from their host contract are valued separately from host instrument. A binomial lattice framework
is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock (see Note
16). The binomial model utilizes the Tsiveriotis and Fernandes (&#8220;TF&#8221;) implementation in which a convertible instrument
is split into two separate components: a cash-only component which is subject to the selected risk-adjusted discount rate and an
equity component which is subject only to the risk-free rate. The model considers the (i) implied volatility of the value of our
common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield, (v) dividend accrual (and a step-up
in rates), and (vi) event probabilities of the various conversion and redemption scenarios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The implied volatility of the Company&#8217;s
common stock is estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe
a commonly observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt
is lower than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining
until November 15, 2027 (the maturity date). The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining
term equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&#8217;s
valuation of the embedded derivative at December 31, 2019 are as follows: volatility of 30 percent, risk-free rate of 1.86
percent, a credit spread of 25 percent and a dividend yield of 0 percent. The fair value measurement of the embedded derivative
is sensitive to these assumptions and changes in these assumptions could result in a materially different fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Income Taxes.&#160;&#160;</i>Income taxes
are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for
the expected future tax consequences of events that have been recognized in Acacia&#8217;s consolidated financial statements or
consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of
such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization
of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under U.S. generally accepted accounting
principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing
that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it
is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination.
Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount
of tax benefit that is greater than 50% likely of being realized upon settlement.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Segment Reporting.</i>&#160;&#160;Acacia
uses the management approach, which designates the internal organization that is used by management for making operating decisions
and assessing performance as the basis of Acacia&#8217;s reportable segments. Acacia&#8217;s patent licensing and enforcement business
constitutes its single reportable segment.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Use of Estimates</i>.&#160;&#160;The
preparation of financial statements in conformity with generally accepted accounting principles in the United States of America
requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant
accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the equity
instruments discussed at Note 6, the valuation of Series A redeemable convertible preferred stock, Series A warrants and embedded
derivatives, stock-based compensation expense, impairment of patent-related intangible assets, the determination of the economic
useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its
most difficult, subjective or complex judgments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Loss Per Share.&#160;&#160;</i>For periods
in which the Company generates net income, the Company computes earnings per share attributable to common stockholders using the
two-class method required for capital structures that include participating securities. Under the two-class method, securities
that participate in non-forfeitable dividends, such as the Company&#8217;s outstanding unvested restricted stock and Series A Redeemable
Convertible Preferred Stock, are considered participating securities and are allocated a portion of the Company&#8217;s earnings.
For periods in which the Company generates a net loss, net losses are not allocated to holders of the Company&#8217;s participating
securities as the security holders are not contractually obligated to share in the Company&#8217;s losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, due to the Company&#8217;s
net loss, the Company did not apply the two-class method to allocate earnings to the participating securities. Basic net loss
per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number
of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed by dividing net loss
attributable to common stockholders by the weighted average number of common and dilutive common equivalent shares outstanding
for the period using the treasury stock method or the as-converted method. Potentially dilutive common stock equivalents consist
of stock options, restricted stock units, unvested restricted stock, Series A Redeemable Convertible Preferred Stock, and Series
A Warrants. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table presents the calculation
of basic and diluted loss per share of common stock:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">(In thousands, except percentage
    change values)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Basic</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Numerator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to Acacia Research Corporation</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(17,115</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Accretion
    of Series A Redeemable Convertible Preferred Stock</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(307</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to common stockholders - basic</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(17,422</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Denominator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - basic</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,764,002</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,969,062</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Basic
    net loss per share of common stock</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(0.35</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2.10</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Diluted</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Numerator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to Acacia Research Corporation</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(17,115</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Mark-to-market
    adjustment for preferred stock embedded derivative</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Net
    loss attributable to common stockholders - diluted</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(20,373</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(105,029</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Denominator:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - basic</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,764,002</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,969,062</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Effect
    of potentially dilutive securities: Series A preferred stock</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,132,771</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - diluted</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">50,896,773</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">49,969,062</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Diluted
    net loss per share of common stock</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(0.40</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2.10</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As the Company reported a net loss for
the years ended December 31, 2019 and 2018, all potentially dilutive shares of common stock other than those associated with the
Series A Redeemable Convertible Preferred Stock have been excluded from the calculation of diluted net loss per share of common
stock because including such instruments would be anti-dilutive.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Treasury Stock</i>. Repurchases of the
Company&#8217;s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the
appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury
stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance
sheets.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ImpairmentOfInvestmentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment of Investments [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ImpairmentOfInvestmentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventor Royalties and Contingent Legal Expenses [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PortfolioOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portfolio Operations Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PortfolioOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Series A Warrant [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for premium paid to acquire option for investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6435544&amp;loc=d3e41834-113960<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentLiabilityReserveEstimatePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the claims loss reserve for insurance contracts with a life contingency (permanent life, some term life, accident and health, some annuities), describing the loss exposures and bases and methodologies for making the relevant accounting estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentLiabilityReserveEstimatePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the cost method of accounting for investments in common stock or other interests including unconsolidated subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. An entity also may describe how such investments are assessed for impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75025870&amp;loc=d3e40691-111596<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesEmbeddedDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=107671284&amp;loc=SL5844817-113951<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77984636&amp;loc=d3e40733-113955<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56949186&amp;loc=d3e50579-113967<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118946261&amp;loc=d3e48542-113965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesEmbeddedDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAndCostMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the equity method of accounting for investments in common stock or other interests including unconsolidated domestic subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. Additionally, this element describes the entity's application of the cost method to equity investments or other interests that are not consolidated or accounted for under the equity method of accounting. The disclosure provided may include how equity method or cost investments are assessed for impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAndCostMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32247-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32280-109318<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21459-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868545504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Supplemental Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>12.&#160;&#160;SUPPLEMENTAL CASH FLOW INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Cash paid for state income taxes totaled
$85,000 and $140,000 for the years ended December 31, 2019 and 2018, respectively. Foreign taxes withheld totaled $249,000 and
$1,093,000 for the years ended December 31, 2019 and 2018, respectively. Refer to Note 4 for accrued foreign taxes payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Refer to Note 6 for information regarding
noncash investing activity related to the investment in Veritone for the periods presented.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6781374240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>16. Series A Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>16.&#160;&#160;SERIES A REDEEMABLE CONVERTIBLE PREFERRED
STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 18, 2019, the Company entered
into a Securities Purchase Agreement with Starboard Value LP (&#8220;Starboard&#8221;) pursuant to which the Company issued (i)
350,000 shares of Series A Redeemable Convertible Preferred Stock with a par value of $0.001
per share and a stated value of $100 per share, and (ii) Series A Warrants to purchase up to 5,000,000
shares of the Company&#8217;s common stock (see Note 17) to Starboard. The Securities Purchase Agreement also established the terms
of certain senior secured notes and additional warrants (the &#8220;Series B Warrants&#8221;) which may be issued to Starboard
in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series A Redeemable Convertible Preferred
Stock can be converted into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends,
divided by (ii) the conversion price of $3.65 (subject to certain anti-dilution adjustments). Holders may elect to convert the
Series A Redeemable Convertible Preferred Stock into common stock at any time. The Company may elect to convert the Series A Redeemable
Convertible Preferred Stock into shares of Common Stock any time on or after November 15, 2025, provided that the closing price
of the Company&#8217;s common stock equals or exceeds 190% of the conversion price for 30 consecutive trading days and assuming
certain other conditions of the common stock have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders have the option to redeem all or
a portion of the Series A Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and
May 15, 2022 through August 15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of senior
secured notes to Starboard pursuant to the Securities Purchase Agreement. Holders also have the option to redeem all or a portion
of the Series A Redeemable Convertible Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally,
holders have the option to redeem all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of
(i) a change of control or (ii) various other triggering events, such as the suspension from trading or delisting of the Company&#8217;s
common stock. If the Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price
may include a make-whole amount or a stated premium, depending on the redemption scenario.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company may redeem all, and not less
than all, of the Series A Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May
15, 2022 through August 15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of the senior
secured notes, and assuming certain conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred
Stock is redeemed at the option of the Company, the redemption price would include a make-whole amount or a 15% premium depending
on the circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If any Series A Redeemable Convertible Preferred
Stock remains outstanding on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in
cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In all redemption scenarios, the redemption
price for the Series A Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In
addition, depending on the redemption scenario, the redemption price may also include a make-whole amount or stated premium as
described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Company issues senior secured notes,
the Holder may exchange the Series A Redeemable Convertible Preferred Stock for (i) senior secured notes and (ii) Series B Warrants
to purchase common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series A Redeemable Convertible Preferred
Stock accrues cumulative dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of an approved investment
(an investment to be identified and approved by each of the Company and Starboard), the dividend rate will increase to 8.0% on
the stated value. Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering event occurs before
an approved investment or 10.0% on the stated value if the triggering event occurs after an approved investment. The Series A Redeemable
Convertible Preferred Stock also participates on an as-converted basis in any regular or special dividends paid to common stockholders.
Total accrued and unpaid dividends as of December 31, 2019 was $0.1 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of the Series A Redeemable Convertible
Preferred Stock have the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable
Convertible Preferred Stock will also be entitled to a separate class vote with respect to amendments to the Company&#8217;s organizational
documents that generally have an adverse effect on the Series A Redeemable Convertible Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon liquidation of the Company, holders
of Series A Redeemable Convertible Preferred Stock have a liquidation preference over holders of our common stock and will be entitled
to receive, prior to any distribution to holders of our common stock, an amount equal to the greater of (i) the stated value plus
accrued and unpaid dividends or (ii) the amount that would have been received if the Series A Redeemable Convertible Preferred
Stock had been converted into common stock immediately prior to the liquidation event at the then effective conversion price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company determined that certain features
of the Series A Redeemable Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features
are bundled together as a single, compound embedded derivative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Total proceeds received and transaction
costs incurred from the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $35 million and $1.3 million,
respectively. Proceeds received were allocated based on the fair value of the instrument without the Series
A Warrants and of the Series A Warrants themselves at the time of issuance. The proceeds
allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated between the host preferred stock
instrument and the embedded derivative, with the embedded derivative recorded at fair value and the Series A Redeemable Convertible
Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the Series
A Warrants, embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and
$8.9 million, respectively. Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock
and the Series A Warrants on the same basis as the proceeds. The transaction costs allocated to
the Series A Redeemable Convertible Preferred Stock were treated as a discount to the Series A Redeemable Convertible Preferred
Stock. The transaction costs allocated to the Series A Warrants were expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company classifies the Series A Redeemable
Convertible Preferred Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various
scenarios or otherwise on November 15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become
redeemable, the Company accretes the instrument to its redemption value using the effective interest method and recognizes any
changes against additional paid in capital in the absence of retained earnings. Accretion for the year ended December 31, 2019
was $0.3 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the issuance of the Series
A Redeemable Convertible Preferred Stock, the Company executed a Registration Rights Agreement and a Governance Agreement with
Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain registration rights with respect to the
Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon conversion. In accordance with the Governance
Agreement, the Company agreed to (i) increase the size of the Board of Directors from six to seven members, (ii) appoint a director
of the Company, (iii) grant Starboard the right to recommend two additional directors for appointment to the board, (iv) form a
Strategic Committee of the Board tasked with sourcing and performing due diligence on potential acquisition targets, (v) appoint
certain directors to the Strategic Committee, and (vi) appoint a director to the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following features of the Series A Redeemable
Convertible Preferred Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded
derivative: (i) the right of the holders to redeem the shares (the &#8220;put option&#8221;), (ii) the right of the holders to
receive common stock upon conversion of the shares (the &#8220;conversion option&#8221;), (iii) the right of the Company to redeem
the shares (the &#8220;call option&#8221;), and (iv) the change in dividend rate upon consummation of an approved investment or
a triggering event (the &#8220;contingent dividend rate feature&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These features are required to be accounted
for separately from the Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly
and closely related to the debt-like host and also did not meet any other scope exceptions for derivative accounting. Therefore,
these features are bundled together and are accounted for as a single, compound embedded derivative liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Accordingly, we have recorded an embedded
derivative liability representing the combined fair value of each of these features. The embedded derivative liability is adjusted
to reflect fair value at each period end with changes in fair value recorded in the &#8220;Change in fair value of redeemable preferred
stock embedded derivative&#8221; financial statement line item of the accompanying consolidated statements of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878307360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Series A Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Comprehensive Income / Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2017</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,639,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2017</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="num">$ (34,640)<span></span>
</td>
<td class="nump">$ 648,996<span></span>
</td>
<td class="num">$ (88)<span></span>
</td>
<td class="num">$ (320,018)<span></span>
</td>
<td class="nump">$ 1,358<span></span>
</td>
<td class="nump">$ 295,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Acacia Research Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(105,029)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(105,029)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_CumulativeEffectOfNewAccountingPrinciple', window );">Cumulative effect of new accounting principle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,506<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="nump">2,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of restricted common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of restricted common stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(229)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,190,420)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">(4,632)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,634)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Unrealized loss on foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2018</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49,639,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">(39,272)<span></span>
</td>
<td class="nump">651,156<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(422,541)<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="nump">191,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Acacia Research Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,115)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of shares of Series A redeemable convertible preferred stock, net of embedded derivative, Series A warrants, and issuance costs, shares</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares of Series A redeemable convertible preferred stock, net of embedded derivative, Series A warrants, and issuance costs, value</a></td>
<td class="nump">$ 7,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue', window );">Accretion of Series A redeemable convertible preferred stock to redemption value</a></td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">706,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2019</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">50,370,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 8,089<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">$ (39,272)<span></span>
</td>
<td class="nump">$ 652,003<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (439,656)<span></span>
</td>
<td class="nump">$ 1,833<span></span>
</td>
<td class="nump">$ 174,958<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of Series A Convertible Preferred Stock to redemption value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_CumulativeEffectOfNewAccountingPrinciple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative effect of new accounting principle</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_CumulativeEffectOfNewAccountingPrinciple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6781357392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(in thousands)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Current:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Federal</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 46%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">State</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(34</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(87</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Foreign</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,858</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,092</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Total
    current</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,824</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,179</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">Deferred:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Federal</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">State</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Income
    tax benefit (expense)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,824</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,179</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">(in thousands)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Net
    operating loss and capital loss carryforwards and credits</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">112,280</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">104,862</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Unrealized
    loss on investments held at fair value</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">538</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2,455</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Stock
    compensation</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">358</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,365</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Fixed
    assets and intangibles</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,316</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,330</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Basis
    of investments in affiliates</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">300</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">286</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Accrued
    liabilities and other</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">631</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">208</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">State
    taxes</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">25</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">26</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">115,448</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">112,532</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Valuation
    allowance</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(115,077</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(112,514</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets, net of valuation allowance</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">371</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">18</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Deferred
    tax liabilities:</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">ROU
    Asset</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(347</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt"><font style="font-family: Times New Roman, Times, Serif">Other</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(24</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(18</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><font style="font-family: Times New Roman, Times, Serif">Total
    deferred tax liabilities</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(371</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(18</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets (liabilities)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of income tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Statutory
    federal tax rate - (benefit) expense</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">21%</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">21%</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">State
    income and foreign taxes, net of federal tax effect</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">7%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Foreign
    tax credit</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Noncontrolling
    interests in operating subsidiaries</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Nondeductible
    permanent items</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Change
    in tax rate</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Expired capitalized
    loss</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Valuation
    allowance</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(13)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(20)%</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Other</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(4)%</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font: normal 400 10pt Times New Roman, Times, Serif; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;%</font></td><td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">10%</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1)%</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868649888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Accrued
    litigation liabilities</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">6,181</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,803</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Accrued consulting
    and other professional fees</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">470</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Foreign taxes payable</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">374</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">State income taxes
    payable</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">27</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Short-term lease liability</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">435</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Other
    accrued liabilities</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">152</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">122</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">7,265</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4,299</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6880115504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 11,246<span></span>
</td>
<td class="nump">$ 131,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Portfolio operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Inventor royalties</a></td>
<td class="nump">4,944<span></span>
</td>
<td class="nump">35,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ContingentLegalFees', window );">Contingent legal fees</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">31,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend', window );">Patent acquisition expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_LitigationAndLicensingExpensesPatents', window );">Litigation and licensing expenses - patents</a></td>
<td class="nump">7,803<span></span>
</td>
<td class="nump">8,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">3,194<span></span>
</td>
<td class="nump">27,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other portfolio expenses</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total portfolio expenses</a></td>
<td class="nump">18,288<span></span>
</td>
<td class="nump">109,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetPortfolioIncomeLoss', window );">Net portfolio income (loss)</a></td>
<td class="num">(7,042)<span></span>
</td>
<td class="nump">22,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">16,376<span></span>
</td>
<td class="nump">18,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of patent-related intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,210<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(23,418)<span></span>
</td>
<td class="num">(24,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment, net (Note 6)</a></td>
<td class="nump">9,899<span></span>
</td>
<td class="num">(59,103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment (Note 6)</a></td>
<td class="num">(9,230)<span></span>
</td>
<td class="num">(19,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of other investment (Note 6)</a></td>
<td class="num">(8,195)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherInvestments', window );">Gain on disposal of other investment (Note 6)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of the Series A warrants and embedded derivative</a></td>
<td class="nump">4,518<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income and other</a></td>
<td class="nump">5,473<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">4,465<span></span>
</td>
<td class="num">(78,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(18,953)<span></span>
</td>
<td class="num">(103,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="nump">1,824<span></span>
</td>
<td class="num">(1,179)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss including noncontrolling interests in subsidiaries</a></td>
<td class="num">(17,129)<span></span>
</td>
<td class="num">(104,848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests in subsidiaries</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Acacia Research Corporation</a></td>
<td class="num">(17,115)<span></span>
</td>
<td class="num">(105,029)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Less: Accretion of redeemable preferred stock</a></td>
<td class="num">(307)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders - basic</a></td>
<td class="num">$ (17,422)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share of common stock</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (2.10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - basic</a></td>
<td class="nump">49,764,002<span></span>
</td>
<td class="nump">49,969,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Add: Accretion of redeemable preferred stock</a></td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet', window );">Less: Mark-to-market adjustment for preferred stock embedded derivative</a></td>
<td class="num">(3,258)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common stockholders - diluted</a></td>
<td class="num">$ (20,373)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share of common stock</a></td>
<td class="num">$ (0.40)<span></span>
</td>
<td class="num">$ (2.10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted</a></td>
<td class="nump">50,896,773<span></span>
</td>
<td class="nump">49,969,062<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ContingentLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent legal fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ContingentLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_LitigationAndLicensingExpensesPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation and licensing expenses - patents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_LitigationAndLicensingExpensesPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NetPortfolioIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net portfolio income (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NetPortfolioIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) included in earnings for investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion of the preferred stock redemption discount during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockAccretionOfRedemptionDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6638506960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2.&#160;&#160;SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Accounting Principles.&#160;&#160;</i>The
consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally
accepted accounting principles in the United States of America (&#34;U.S. GAAP&#34;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Principles of Consolidation.&#160;&#160;</i>The
accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled
subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Noncontrolling interests in
Acacia&#8217;s majority-owned and controlled operating subsidiaries (&#8220;noncontrolling interests&#8221;) are separately presented
as a component of stockholders&#8217; equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss
attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements
of Series A redeemable convertible preferred stock and stockholders&#8217; equity for total noncontrolling interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A wholly owned subsidiary of Acacia is the
general partner of the Acacia Intellectual Property Fund, L.P. (the &#8220;Acacia IP Fund&#8221;), which was formed in August 2010.
The Acacia IP Fund is included in the Company&#8217;s consolidated financial statements since 2010, as Acacia&#8217;s wholly owned
subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia
IP Fund was terminated as of December 31, 2017 and is in the process of being liquidated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Revenue Recognition.&#160;&#160;</i>Revenue
is recognized upon transfer of control of promised bundled IP rights (hereinafter &#8220;IP Rights&#8221;) and other contractual
performance obligations to licensees in an amount that reflects the consideration we expect to receive in exchange for those IP
Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist at the point in time at which
the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time and revenue is recognized
at the point in time that the applicable performance obligations are satisfied and all other revenue recognition criteria have
been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the periods presented, revenue
contracts executed by the Company primarily provided for the payment of contractually determined, one-time, paid-up license
fees in consideration for the grant of certain IP Rights for patented technologies owned or controlled by Acacia
(&#8220;Paid-up Revenue Agreements&#8221;). Revenues also included license fees from sales-based revenue contracts, the
majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on
quarterly sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may also
include court ordered settlements or awards related to our patent portfolio (&#34;Other Settlements&#34;) or sales of our
patent portfolio (&#34;Sales&#34;). IP Rights granted included the following, as applicable: (i) the grant of a
non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a
covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending
litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related
patents. The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the
promise, within the context of the contract, is to transfer combined items to which the promised IP Rights are inputs and
(ii) the Company's promise to transfer each individual IP right described above to the customer is not separately
identifiable from other promises to transfer IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the promised IP Rights are not
individually distinct, the Company combined each individual IP right in the contract into a bundle of IP rights that is
distinct, and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights
granted were &#8220;functional IP rights&#8221; that have significant standalone functionality. Acacia's subsequent
activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the
licensee has rights. Acacia&#8217;s operating subsidiaries have no further obligation with respect to the grant of IP Rights,
including no express or implied obligation to maintain or upgrade the technology, or provide future support or services. The
contracts provide for the grant (i.e., transfer of control) of the licenses, covenants-not-to-sue, releases, and other
significant deliverables upon execution of the contract. Licensees legally obtain control of the IP Rights upon execution of
the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when
collectability is probable and all other revenue recognition criteria have been met. Revenue contracts generally provide for
payment of contractual amounts with 30-90 days of execution of the contract, or the end of the quarter in which the sale or
usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For sales-based royalties, the Company
includes in the transaction price some or all of an amount of estimated variable consideration to the extent that it is
probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the
uncertainty associated with the variable consideration is subsequently resolved. Notwithstanding, revenue&#160;is recognized
for a sales-based royalty promised in exchange for a license of IP Rights when the later of (i) the subsequent sale or usage
occurs, or (ii) the&#160;performance obligation&#160;to which some or all of the sales-based royalty has been allocated has
been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues from contracts with significant
financing components (either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have
paid if the licensee had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price,
the Company adjusts the promised amount of consideration for the effects of the time value of money. As a practical expedient,
the Company does not adjust the promised amount of consideration for the effects of a significant financing component if the Company
expects, at contract inception, that the period between when the entity transfers promised IP Rights to a customer and when the
customer pays for the IP Rights will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In general, the Company is required to make
certain judgments and estimates in connection with the accounting for revenue contracts with customers. Such areas may include
identifying performance obligations in the contract, estimating the timing of satisfaction of performance obligations, determining
whether a promise to grant a license is distinct from other promised goods or services, evaluating whether a license transfers
to a customer at a point in time or over time, allocating the transaction price to separate performance obligations, determining
whether contracts contain a significant financing component, and estimating revenues recognized at a point in time for sales-based
royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Revenues were comprised of the following
for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>(In
    thousands)</b></font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Paid-up
    Revenue Agreements</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,343</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">100,496</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Recurring
    Revenue Agreements</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,903</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,040</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other
    Settlements</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,470</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Sales</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,500</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">11,246</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,506</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Refer to
&#8220;Inventor Royalties and Contingent Legal Expenses&#8221; below for information on related direct costs of revenues.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Portfolio
Operations.</i>&#160;&#160;Cost of revenues include the costs and expenses incurred in connection with Acacia&#8217;s patent licensing
and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external
patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research,
consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included
under the caption &#8220;Portfolio operations&#8221; in the accompanying consolidated statements of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Inventor
Royalties and Contingent Legal Expenses. </i>Inventor royalties are expensed in the consolidated statements of operations in the
period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements,
upfront advances paid to patent owners by Acacia&#8217;s operating subsidiaries are recoverable from future net revenues. Patent
costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents,
or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense
in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the
period recovered and included in amortization expense in the consolidated statements of operations. There were no patent acquisition
expenses for fiscal year 2019. Cost of revenues for fiscal year 2018 included $4.0 million of costs to acquire certain patent
rights related to revenues recognized in the period.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Contingent
legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In
instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia&#8217;s
operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services
agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Fair Value
Measurements.</i> U.S. GAAP defines fair value as the price that would be received for an asset or the exit price that would be
paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants
on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable
inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 96px"><font style="font: 10pt Times New Roman, Times, Serif">(i)</font></td>
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 - <i>Observable
    Inputs</i>:&#160;&#160;Quoted prices in active markets for identical investments;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 96px"><font style="font: 10pt Times New Roman, Times, Serif">(ii)</font></td>
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 - <i>Pricing
    Models with Significant Observable Inputs</i>:&#160;&#160;Other significant observable inputs, including quoted prices for
    similar investments, interest rates, credit risk, etc.; and</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 96px"><font style="font: 10pt Times New Roman, Times, Serif">(iii)</font></td>
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 - <i>Unobservable
    Inputs</i>:&#160;&#160;Significant unobservable inputs, including the entity&#8217;s own assumptions in determining the fair
    value of investments.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">Whenever
possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value.
In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant
to the fair value measurement. The assessment of the significance of a particular input requires judgment and considers factors
specific to the asset or liability being measured. In certain cases, inputs used to measure fair value fall into different levels
of the fair value hierarchy. Financial assets and liabilities measured at fair value on a recurring basis were as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level
    1</b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level
    2</b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level
    3</b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>(In
    thousands)</b></font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Assets as of December
    31, 2019:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 55%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">93,843</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,140</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Investment
    at fair value - warrants (Note 6)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">757</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Investment
    at fair value - common stock (Note 6)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">743</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Total
    recurring fair value measurements as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,883</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">94,600</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Assets as of December
    31, 2018:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trading
    securities - debt</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">33,642</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trading
    securities - equity</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,012</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Investment
    at fair value - warrants (Note 6)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,064</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Investment
    at fair value - common stock (Note 6)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,395</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Total
    recurring fair value measurements as of December 31, 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,407</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">35,706</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Liabilities as of December
    31, 2019:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Profits
    interest units</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">591</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Series
    A warrants</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,568</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Embedded
    derivative liability</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Total
    liabilities as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,159</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Liabilities as of December
    31, 2018:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Profits
    interest units</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">591</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Total
    liabilities as of December 31, 2018</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">591</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">The following table sets forth
a summary of the changes in the estimated fair value of the Company&#8217;s embedded derivative, which is measured at fair value
as a Level 3 liability on a recurring basis:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Embedded
    Derivative</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Opening balance as of
    January 1, 2019</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 83%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Issuance
    of Series A redeemable convertible preferred stock with embedded derivative</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21,232</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Remeasurement
    of Series A redeemable convertible preferred stock embedded derivative to fair value</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Total
    Level 3 recurring fair value measurements as of December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">17,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Cash and
Cash Equivalents</i>.&#160;&#160;Acacia considers all highly liquid, trading securities with original maturities of three months
or less when purchased to be cash equivalents. For the periods presented, Acacia&#8217;s cash equivalents are comprised of investments
in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper,
securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase
agreements. Acacia&#8217;s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Long Term
Restricted Cash</i>.&#160;&#160;Long-term restricted cash relates to the proceeds received from the issuance of Series A redeemable
convertible preferred stock (the &#8220;Series A Redeemable Convertible Preferred Stock&#8221;) which are held in an escrow account.
The amounts are to be released to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition
by the Company or (ii) the conversion of Series A Redeemable Convertible Preferred Stock into common stock (see Note 16).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Trading
Securities- Debt.&#160;&#160;</i>Investments in debt securities are reported at fair value on a recurring basis, with related
realized and unrealized gains and losses recorded in the statements of operations in other income (expense). Realized and unrealized
gains and losses are recorded based on the specific identification method. Interest is included in other income (expense).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Trading
Securities - Equity. </i>Investments in equity securities are reported at fair value on a recurring basis, with related realized
and unrealized gains and losses in the value of such securities recorded in the statements of operations in other income (expense).
Dividend income is included in other income (expense).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Impairment
of Other Investments. </i>Acacia evaluates its investments in marketable securities for potential impairment, employing a methodology
on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment
exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument
issuers, the duration and extent to which the fair value is less than cost, and the Company&#8217;s intent and ability to hold,
or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined
by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary.
Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment
as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent
to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating
that the investment&#8217;s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary.
All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence,
the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale,
unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Concentration
of Credit Risks.&#160;&#160;</i>Financial instruments that potentially subject Acacia to concentrations of credit risk are cash
equivalents, trading securities and accounts receivable. Acacia places its cash equivalents and trading securities primarily in
highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits
with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant
losses on its deposits of cash and cash equivalents.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Three licensees
individually accounted for 43%, 22% and 15%, respectively, of revenues recognized during the year ended December&#160;31, 2019.
Three licensees individually accounted for 45%, 17% and 17%, respectively, of revenues recognized during the year ended December&#160;31,
2018. Two licensees individually represented approximately 70% and 17%, respectively, of accounts receivable at December&#160;31,
2019. Four licensees individually represented approximately 38%, 36%, 12% and 11%, respectively, of accounts receivable at December&#160;31,
2018.</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">For 2019
and 2018, 39% and 26%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the
jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company
does not have any material foreign operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Acacia performs
credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit
losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not
required. An allowance for doubtful accounts may be established to reflect the Company&#8217;s best estimate of probable losses
inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating
expenses in the statements of operations for the applicable period. The allowance is determined based on known troubled accounts,
historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the
periods presented.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Fair Value
of Financial Instruments.&#160;&#160;</i>The carrying value of cash and cash equivalents, restricted cash, accounts receivables,
and current liabilities approximates their fair values due to their short-term maturities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Property
and Equipment.&#160;&#160;</i>Property and equipment are recorded at cost. Major additions and improvements that materially extend
useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations
as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain
or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization
is computed on a straight-line basis over the following estimated useful lives of the assets:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; width: 57%"><font style="font: 10pt Times New Roman, Times, Serif">Furniture
    and fixtures</font></td>
    <td style="font-size: 10pt; width: 43%"><font style="font: 10pt Times New Roman, Times, Serif">3 to 5 years</font></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Computer hardware and
    software</font></td>
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">3 to 5 years</font></td></tr>
<tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</font></td>
    <td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">2 to 5 years (Lesser
    of lease term or useful life of improvement)</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Rental payments
on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease
term.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Patents.</i>&#160;&#160;Patents
include the cost of patents or patent rights (hereinafter, collectively &#8220;patents&#8221;) acquired from third-parties or
obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining
economic useful lives, ranging from one to five years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Leases.
</i>The Company adopted ASC 842 as of January 1, 2019, electing the practical expedient approaches. The primary impact of adopting
ASC 842 for the Company was the recognition in the consolidated balance sheet of certain lease-related assets and liabilities
for operating leases with terms longer than 12 months. Such amounts were not previously accounted for in the Company's consolidated
balance sheets. The Company&#8217;s leases primarily consist of facility leases which are classified as operating leases. The
Company assesses whether an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual
payments under all leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right
to use the underlying asset for the lease term. Upon adoption of ASC 842 on January 1, 2019, the carrying value of certain lease
related liabilities for its excess of lease payments over anticipated sublease income existing at that date, was offset against
the related right-of-use assets. Lease expense is recognized on a straight-line basis over the lease term.</font></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Investments
at Fair Value</i>. On an individual investment basis, Acacia may elect to account for investments in companies where the Company
has the ability to exercise significant influence over operating and financial policies of the investee, at fair value. If the
fair value option is applied to an investment that would otherwise be accounted for under the equity method of accounting, it
is applied to all of the financial interests in the same entity that are eligible items (i.e., common stock and warrants).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Other
Investments</i>. Equity investments in common stock and in-substance common stock without readily determinable fair values in
companies over which the Company has the ability to exercise significant influence, are accounted for using the equity method
of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees in equity in earnings
(losses) of investee in the consolidated statements of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Investments
in preferred stock with substantive liquidation preferences are accounted for at cost, (subject to impairment considerations,
as described below, if any), as adjusted for the impact of changes resulting from observable price changes in orderly transactions
for identical or similar investments of the same issuer. In-substance common stock is an investment in an entity that has risk
and reward characteristics that are substantially similar to that entity's common stock. An investment in preferred stock with
substantive liquidation preferences over common stock, is not substantially similar to common stock, and therefore is not considered
in-substance common stock. A liquidation preference is substantive if the investment has a stated liquidation preference that
is significant, from a fair value perspective, in relation to the purchase price of the investment. A liquidation preference in
an investee that has sufficient subordinated equity from a fair value perspective is substantive because, in the event of liquidation,
the investment will not participate in substantially all of the investee's losses, if any.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">The initial
determination of whether an investment is substantially similar to common stock is made on the initial date of investment if the
Company has the ability to exercise significant influence over the operating and financial policies of the investee. That determination
is reconsidered if (i) contractual terms of the investment are changed, (ii) there is a significant change in the capital structure
of the investee, including the investee's receipt of additional subordinated financing, or (iii) the Company obtains an additional
interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics
of the investment at the date at which the Company obtains the additional interest. Refer to Note 6 for additional information.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Impairment
of Investments. </i>Acacia reviews its investments quarterly for indicators of other-than-temporary impairment. This determination
requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative evidence in evaluating
potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates, among other factors,
general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers specific
adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance,
changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary,
an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Impairment
of Long-lived Assets.</i> Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly
for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the
event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the
asset, an impairment loss is recorded equal to the excess of the asset&#8217;s carrying value over its fair value. If an asset
is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market
prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of
estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment
loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Fair value
is generally estimated using the &#8220;Income Approach,&#8221; focusing on the estimated future net income-producing capability
of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted
to present value through &#8220;discounting,&#8221; including an estimated rate of return that accounts for both the time value
of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for
the applicable technology, applied to estimated market data. Estimated cash outflows are based on existing contractual obligations,
such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other
estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s licensing and enforcement program. The
analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation,
periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information
that could impact future net cash flows.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Contingent
Liabilities. </i>The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside
counsel handling its defense in these matters and the Company&#8217;s analysis of potential outcomes, if the Company determines
that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is
recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range
that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in
the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate
of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense
in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation
services were provided.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Certain of
Acacia&#8217;s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In
connection with any of Acacia&#8217;s operating subsidiaries&#8217; patent enforcement actions, it is possible that a defendant
may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal
rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions.
In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney&#8217;s fees
and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries,
could materially harm the Company&#8217;s operating results and financial position.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Stock-Based
Compensation.</i> The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the
award, and is recognized as an expense on a straight-line basis over the employee&#8217;s requisite service period (generally
the vesting period of the equity award). The fair value of restricted stock and restricted stock units awards is determined by
the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair
value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted
for as they occur.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">No stock
options were granted during the year ended December 31, 2019. The fair values of stock options granted during the year ended December
31, 2018 were estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-size: 10pt">&#160;</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">For
    the Year Ended<br /> December 31, 2018</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-size: 10pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-size: 10pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"><font style="font-size: 10pt">Risk-free
    interest rate</font></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><font style="font-size: 10pt">2.26%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Term</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">4.37</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-size: 10pt">Volatility</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">51%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-size: 10pt">Dividend yield</font></td><td style="font: 10pt Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">&#8211;%</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Due to a
lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the
expected term. Expected volatility is based on the historical volatility of the Company&#8217;s stock for the length of time corresponding
to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for
the expected term of the option.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Restricted
stock units awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over
a three-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options
utilizing a Monte Carlo valuation technique. Compensation cost is recognized with a market-based vesting condition provided that
the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. Assumptions utilized in connection
with the Monte Carlo valuation technique included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected
volatility of 38 percent; and expected dividend yield of 0 percent. The risk-free interest rate was determined based on the yields
available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility.
The expected dividend yield was based on expectations regarding dividend payments.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Profits Interest
Units (&#8220;Units&#8221;) are accounted for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10,
&#8220;Compensation - Stock Compensation.&#8221; The Units vest as described at Note 9, and therefore, the vesting conditions
do not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the Units are classified
as liability awards. Liability classified awards are measured at fair value on the grant date and re-measured each reporting period
at fair value until the award is settled. Compensation expense is adjusted each reporting period for changes in fair value prorated
for the portion of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis
over the employee&#8217;s requisite service period (generally the vesting period of the equity award) which was five years. Upon
full vesting of the award, which occurred during the three months ended September 30, 2017, previously unrecognized compensation
expense was immediately recognized in the period, and will continue to be fully recognized for any changes in fair value, until
the Units are settled. The Company has a purchase option to purchase the vested Units that are not otherwise forfeited after termination
of continuous service. The exercise price of the purchase option is the fair market value of the Units on the date of termination
of continuous service. At each reporting date, the value of the Units that are subject to the purchase option will be the measured
at the fair value on the termination date. Non-cash stock compensation expense related to the Units is reflected in general and
administrative expense in the accompanying consolidated statements of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>&#160;</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Series
A Warrants. </i>The fair value of the Series A warrants (the &#8220;Series A Warrants&#8221;) is estimated using a Black-Scholes
option-pricing model. The fair value of the Series A Warrants as of December 31, 2019 was estimated based on the following assumptions:
volatility of 30 percent, risk-free rate of 1.85 percent, term of 7.79 years and a dividend yield of 0 percent.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>&#160;</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Embedded
derivatives. </i>Embedded derivatives that are required to be bifurcated from their host contract are valued separately from host
instrument. A binomial lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable
Convertible Preferred Stock (see Note 16). The binomial model utilizes the Tsiveriotis and Fernandes (&#8220;TF&#8221;) implementation
in which a convertible instrument is split into two separate components: a cash-only component which is subject to the selected
risk-adjusted discount rate and an equity component which is subject only to the risk-free rate. The model considers the (i) implied
volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield,
(v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various conversion and redemption scenarios.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">The implied
volatility of the Company&#8217;s common stock is estimated based on a haircut applied to the historical volatility. A volatility
haircut is a concept used to describe a commonly observed occurrence in which the volatility implied by market prices involving
options, warrants, and convertible debt is lower than historical actual realized volatility. The assumed base case term used in
the valuation model is the period remaining until November 15, 2027 (the maturity date). The risk-free interest rate is based
on the yield on the U.S. Treasury with a remaining term equal to the expected term of the conversion and early redemption options.
The significant assumptions utilized in the Company&#8217;s valuation of the embedded derivative at December 31, 2019 are as follows:
volatility of 30 percent, risk-free rate of 1.86 percent, a credit spread of 25 percent and a dividend yield of 0 percent. The
fair value measurement of the embedded derivative is sensitive to these assumptions and changes in these assumptions could result
in a materially different fair value measurement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>&#160;</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Income
Taxes.&#160;&#160;</i>Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred
tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia&#8217;s consolidated
financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if
all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding
future realization of such assets.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">Under U.S.
generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected
to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions
are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position
will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability
weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Segment
Reporting.</i>&#160;&#160;Acacia uses the management approach, which designates the internal organization that is used by management
for making operating decisions and assessing performance as the basis of Acacia&#8217;s reportable segments. Acacia&#8217;s patent
licensing and enforcement business constitutes its single reportable segment.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Use of
Estimates</i>.&#160;&#160;The preparation of financial statements in conformity with generally accepted accounting principles
in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia
believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition,
the valuation of the equity instruments discussed at Note 6, the valuation of Series A redeemable convertible preferred stock,
Series A warrants and embedded derivatives, stock-based compensation expense, impairment of patent-related intangible assets,
the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against
net deferred tax assets, require its most difficult, subjective or complex judgments.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Loss Per
Share.&#160;&#160;</i>For periods in which the Company generates net income, the Company computes earnings per share attributable
to common stockholders using the two-class method required for capital structures that include participating securities. Under
the two-class method, securities that participate in non-forfeitable dividends, such as the Company&#8217;s outstanding unvested
restricted stock and Series A Redeemable Convertible Preferred Stock, are considered participating securities and are allocated
a portion of the Company&#8217;s earnings. For periods in which the Company generates a net loss, net losses are not allocated
to holders of the Company&#8217;s participating securities as the security holders are not contractually obligated to share in
the Company&#8217;s losses.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 10pt">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">For the periods
presented, due to the Company&#8217;s net loss, the Company did not apply the two-class method to allocate earnings to the participating
securities. Basic net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the
weighted average number of shares of common stock outstanding for the period. Diluted net loss per share of common stock is computed
by dividing net loss attributable to common stockholders by the weighted average number of common and dilutive common equivalent
shares outstanding for the period using the treasury stock method or the as-converted method. Potentially dilutive common stock
equivalents consist of stock options, restricted stock units, unvested restricted stock, Series A Redeemable Convertible Preferred
Stock, and Series A Warrants.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">The following
table presents the calculation of basic and diluted loss per share of common stock:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">(In
    thousands, except percentage change values)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">Numerator:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net
    loss attributable to Acacia Research Corporation</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(17,115</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(105,029</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Accretion
    of Series A Redeemable Convertible Preferred Stock</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(307</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Net
    loss attributable to common stockholders - basic</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(17,422</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(105,029</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">Denominator:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - basic</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,764,002</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,969,062</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Basic
    net loss per share of common stock</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.35</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.10</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">Numerator:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net
    loss attributable to Acacia Research Corporation</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(17,115</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(105,029</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Mark-to-market
    adjustment for preferred stock embedded derivative</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Net
    loss attributable to common stockholders - diluted</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(20,373</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(105,029</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">Denominator:</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - basic</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,764,002</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,969,062</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Effect
    of potentially dilutive securities: Series A preferred stock</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,132,771</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net loss per share attributable to common stockholders - diluted</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">50,896,773</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,969,062</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Diluted
    net loss per share of common stock</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(0.40</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2.10</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">As the Company
reported a net loss for the years ended December 31, 2019 and 2018, all potentially dilutive shares of common stock other than
those associated with the Series A Redeemable Convertible Preferred Stock have been excluded from the calculation of diluted net
loss per share of common stock because including such instruments would be anti-dilutive.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-size: 10pt"><i>Treasury
Stock</i>. Repurchases of the Company&#8217;s outstanding common stock are accounted for using the cost method. The applicable
par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any
excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock
on the consolidated balance sheets.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6781380064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsTextBlock', window );">Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6. INVESTMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investment at Fair Value</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During 2016 and 2017, Acacia made certain
investments in Veritone, Inc. (&#8220;Veritone&#8221;). As a result of these transactions, Acacia received an aggregate total
of 4,119,521 shares of Veritone common stock and warrants to purchase a total of 1,120,432 shares of Veritone common stock at
an exercise price of $13.61 per share expiring between 2020 and 2027. During the year ended December 31, 2018, Acacia sold 2,700,000
shares Veritone common stock and recorded a realized loss of $19.1 million. During the year ended December 31, 2019, Acacia sold
1,121,071 shares Veritone common stock and recorded a realized loss of $9.2 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At December&#160;31, 2019, the fair value
of the 298,449 shares of Veritone common stock owned by Acacia totaled $743,000. At December&#160;31, 2019, the fair value of
the 1,120,432 common stock purchase warrants held by Acacia totaled $757,000. At December 31, 2018, the fair value of the 1,419,521
shares of Veritone common stock owned by Acacia totaled $5,395,000. At December 31, 2018, the fair value of the 1,120,432 common
stock purchase warrants held by Acacia totaled $2,064,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Changes in the fair value of Acacia&#8217;s
investment in Veritone are recorded as unrealized gains or losses in the consolidated statements of operations. For the year ended
December&#160;31, 2019, and 2018, the accompanying consolidated statements of operations reflected the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In thousands)</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Change
    in fair value of investment, warrants</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(1,308</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(11,895</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Change in fair value
    of investment, common stock</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">11,207</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(47,208</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Loss
    on sale of investment, common stock</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(9,230</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(19,095</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Net
    realized and unrealized gain (loss) on investment at fair value</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">669</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(78,198</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Miso Robotics Investment </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In June 2017, Acacia made an investment
in the Series A Preferred financing round for Miso Robotics, Inc. (&#8220;Miso Robotics&#8221;), an innovative leader in robotics
and artificial intelligence solutions, totaling $2,250,000, acquiring a 22.6% ownership interest in Series A preferred stock of
Miso Robotics, and one board seat. In February 2018, Acacia made an additional equity investment in the Series B Preferred financing
round for Miso Robotics totaling $6,000,000, increasing its ownership interest (Series B preferred stock) in Miso Robotics to approximately
30%, and acquiring an additional board seat. As of June 30, 2019, Acacia recorded an impairment of $8.2 million for its investment
in Miso Robotics. In September 2019, Acacia received a cash payment of $2.0 million upon the sale of its entire investment, and
therefore relinquished its ownership interest in Miso Robotics.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611322-123010<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611133-123010<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611282-123010<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-12C)<br> -URI http://asc.fasb.org/extlink&amp;oid=50485924&amp;loc=d3e611225-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868709936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>10.&#160;&#160;COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Facility Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company primarily leases office facilities
under operating lease arrangements that will end in various years through July 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 7, 2019, we entered into a building
lease agreement (the &#8220;New Lease&#8221;) with Jamboree Center 4 LLC (the &#8220;Landlord&#8221;). Pursuant to the New Lease,
we have leased approximately 8,293 square feet of office space for our corporate headquarters in Irvine, California. The New Lease
commenced on August 1, 2019. The term of the New Lease is 60 months from the commencement date, provides for annual rent increases,
and does not provide us the right to early terminate or extend our lease terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has subleased a facility under
another operating lease agreement (the &#8220;Old Lease&#8221;) that we ceased using in December 2018, and the sublease will go
through the remaining term of the Old Lease, which ended on January 31, 2020. During the year ended December 31, 2018, the Company
recorded a one-time charge of $629,000 for the excess of lease payments over the anticipated sublease income through expiration
of the lease. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Operating lease costs, net of sublease income
of $780,000, were $426,000 for the year ended December 31, 2019. Operating lease costs, net of sublease income of $65,000, were
$1,106,000 for the year ended December 31, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The table below presents aggregate future
minimum payments due under the New Lease and the Old Lease, reconciled to lease liabilities included in the consolidated balance
sheet as of December 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom">
    <td colspan="2"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Operating
    Leases</font></td><td style="font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(In
    thousands)</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 31%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">2020</font></td><td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right"><font style="font-family: Times New Roman, Times, Serif">434</font></td><td style="width: 1%; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">2021</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">334</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">2022</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">349</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">2023</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">364</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">2024</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif">218</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">Total
                                         minimum payments</font></td><td style="text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-weight: bold; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,699</font></td><td style="font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Less:
                                         short-term lease liabilities</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(435</font></td><td style="padding-bottom: 1pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Long-term
                                         lease liabilities</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,264</font></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties and Contingent Legal Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the investment in certain
patents and patent rights, certain of Acacia&#8217;s operating subsidiaries executed related agreements which grant to the former
owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined
in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&#8217;s operating subsidiaries may
retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing
and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a
scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments
are obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Patent Enforcement </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i>Certain of Acacia&#8217;s
operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection
with any of Acacia&#8217;s operating subsidiaries&#8217; patent enforcement actions, it is possible that a defendant may
request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal
rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement
actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award
attorney&#8217;s fees and/or expenses to a defendant(s), which could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Other</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 17, 2015, Celltrace Communications
Ltd. (&#8220;Celltrace&#8221;) filed a lawsuit against Acacia in U.S. District Court for the Southern District of New York, Case
No. 1:15-cv-04746, alleging, among other things, significant damages for alleged breach of contract, unjust enrichment and fraud.
Acacia disputes the allegations and does not believe that Celltrace is entitled to any damages.&#160; Acacia successfully moved
to compel arbitration of the dispute, and the District Court stayed the litigation pending arbitration before the International
Court of Arbitration for the International Chamber of Commerce (the &#8220;ICC&#8221;). Celltrace appealed the decision to the
U.S. Court of Appeals for the Second Circuit, which denied the appeal. Celltrace filed its request for arbitration of the claims
with the ICC on November 28, 2016. Acacia filed an answer denying all allegations of wrongdoing and asserting affirmative defenses.
A tribunal was appointed to preside over the arbitration and conducted its first case management conference on June 26, 2017. The
parties conducted discovery and submitted their cases in chief to the tribunal in a series of written submissions per the tribunal&#8217;s
orders between January 2018 and December 2018. The tribunal held an evidentiary hearing with live witness testimony in New York
City between February 4, 2019 and February 13, 2019. At the end of the hearing, the tribunal set a schedule for post-hearing briefing
by the parties, which concluded in April 2019. We are now waiting for the tribunal to issue its decision. Acacia continues to vigorously contest all allegations of wrongdoing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In a separate case on December 6, 2017,
the Federal Court of Canada allowed a counterclaim for invalidity of a patent asserted by Rapid Completions LLC and awarded costs
payable by Rapid Completions LLC in an amount to be determined.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia is subject to claims, counterclaims
and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect
to these claims and legal actions, if any, will not have a material effect on Acacia&#8217;s consolidated financial position,
results of operations or cash flows. Fiscal year 2019 operating expenses included expenses for settlement and contingency accruals
totaling $1,756,000, net of prior accruals. Refer to Note 4 for information on accrued expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Guarantees and Indemnifications</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain of Acacia&#8217;s operating
subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or
indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In
connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for
certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum
extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy
that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be
payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to
statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential
future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and
indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and
therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance
sheets. Additionally, no events or transactions have occurred that would result in a material liability at December&#160;31,
2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Other</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In August 2010, a wholly owned subsidiary
of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund invests in, licenses
and enforces IP consisting primarily of patents, patent rights, and patented technologies. The Acacia IP Fund was terminated as
of December 31, 2017. The final distribution to the partners of the Acacia IP Fund will be made in 2020.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6782870224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. Series A Warrants (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 18, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsExercisedShares', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsIssuedShares', window );">Warrants issued, shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsIssuedShares', window );">Warrants issued, shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsExercisedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsExercisedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_StarboardValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>204</ContextCount>
  <ElementCount>442</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Operations (General and Admin Expenses) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StatementsOfOperationsGeneralAndAdminExpensesParenthetical</Role>
      <ShortName>Consolidated Statements of Operations (General and Admin Expenses) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StatementsOfComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - 1. Description of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>1. Description of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - 2. Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>2. Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - 3. Trading Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/TradingSecurities</Role>
      <ShortName>3. Trading Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - 4. Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/AccruedExpenses</Role>
      <ShortName>4. Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - 5. Patents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Patents</Role>
      <ShortName>5. Patents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - 6. Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Investments</Role>
      <ShortName>6. Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - 7. Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquity</Role>
      <ShortName>7. Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - 8. Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeTaxes</Role>
      <ShortName>8. Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - 9. Equity-Based Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlans</Role>
      <ShortName>9. Equity-Based Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - 10. Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingencies</Role>
      <ShortName>10. Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy</Role>
      <ShortName>11. Retirement Savings Plan and Executive Severance Policy</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - 12. Supplemental Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>12. Supplemental Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - 13. Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RecentAccountingPronouncements</Role>
      <ShortName>13. Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - 14. Fair Value Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/FairValueDisclosures</Role>
      <ShortName>14. Fair Value Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - 15. Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RelatedPartyTransactions</Role>
      <ShortName>15. Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock</Role>
      <ShortName>16. Series A Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - 17. Series A Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesWarrants</Role>
      <ShortName>17. Series A Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - 18. Quarterly Financial Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/QuarterlyFinancialData</Role>
      <ShortName>18. Quarterly Financial Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - 19. Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SubsequentEvents</Role>
      <ShortName>19. Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - 2. Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>2. Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - 2. Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>2. Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - 3. Trading Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/TradingSecuritiesTables</Role>
      <ShortName>3. Trading Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/TradingSecurities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - 4. Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/AccruedExpensesTables</Role>
      <ShortName>4. Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/AccruedExpenses</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - 5. Patents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsTables</Role>
      <ShortName>5. Patents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Patents</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - 6. Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentsTables</Role>
      <ShortName>6. Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Investments</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - 7. Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityTables</Role>
      <ShortName>7. Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StockholdersEquity</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - 8. Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeTaxesTables</Role>
      <ShortName>8. Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - 9. Equity-Based Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlansTables</Role>
      <ShortName>9. Equity-Based Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Equity-basedIncentivePlans</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - 10. Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>10. Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - 18. Quarterly Financial Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/QuarterlyFinancialDataTables</Role>
      <ShortName>18. Quarterly Financial Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/QuarterlyFinancialData</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - 1. Description of Business and Basis of Presentation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>1. Description of Business and Basis of Presentation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - 2. Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DisaggregationOfRevenueDetails</Role>
      <ShortName>2. Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - 2. Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/FairValueOnRecurringBasisDetails</Role>
      <ShortName>2. Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - 2. Changes to fair value measurement Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/ChangesToFairValueMeasurementLevel3Details</Role>
      <ShortName>2. Changes to fair value measurement Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - 2. Property and Equipment Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PropertyAndEquipmentUsefulLivesDetails</Role>
      <ShortName>2. Property and Equipment Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - 2. Stock Option Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockOptionAssumptionsDetails</Role>
      <ShortName>2. Stock Option Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - 2. Basic and Diluted Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/BasicAndDilutedLossPerShareDetails</Role>
      <ShortName>2. Basic and Diluted Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - 2. Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>2. Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - 3. Trading Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/TradingSecuritiesDetails</Role>
      <ShortName>3. Trading Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/TradingSecuritiesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - 3. Trading Securities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/TradingSecuritiesDetailsNarrative</Role>
      <ShortName>3. Trading Securities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/TradingSecuritiesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - 4. Accrued Expenses (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/AccruedExpensesDetailsNarrative</Role>
      <ShortName>4. Accrued Expenses (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/AccruedExpensesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - 5. Patents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsDetails</Role>
      <ShortName>5. Patents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/PatentsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - 5. Patents (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsDetailsNarrative</Role>
      <ShortName>5. Patents (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/PatentsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - 6. Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentsDetails</Role>
      <ShortName>6. Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/InvestmentsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - 6. Investments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentsDetailsNarrative</Role>
      <ShortName>6. Investments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/InvestmentsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - 7. Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityDetails</Role>
      <ShortName>7. Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StockholdersEquityTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - 7. Stockholders' Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>7. Stockholders' Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StockholdersEquityTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - 8. Income Taxes (Details - Provision for Income Taxes)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeTaxesDetails-ProvisionForIncomeTaxes</Role>
      <ShortName>8. Income Taxes (Details - Provision for Income Taxes)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomeTaxesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - 8. Income Taxes (Details - Deferred tax assets)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeTaxesDetails-DeferredTaxAssets</Role>
      <ShortName>8. Income Taxes (Details - Deferred tax assets)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomeTaxesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - 8. Income Taxes (Details - Reconciliation of tax rates)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeTaxesDetails-ReconciliationOfTaxRates</Role>
      <ShortName>8. Income Taxes (Details - Reconciliation of tax rates)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomeTaxesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - 8. Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>8. Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomeTaxesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - 9. Equity-Based Incentive Plans (Details - Options Granted)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionsGranted</Role>
      <ShortName>9. Equity-Based Incentive Plans (Details - Options Granted)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Equity-basedIncentivePlansTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - 9. Equity-Based Incentive Plans (Details - Option Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-OptionActivity</Role>
      <ShortName>9. Equity-Based Incentive Plans (Details - Option Activity</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - 9. Equity-Based Incentive Plans (Details - Nonvested Restricted Stock Activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-NonvestedRestrictedStockActivity</Role>
      <ShortName>9. Equity-Based Incentive Plans (Details - Nonvested Restricted Stock Activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Equity-basedIncentivePlansTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - 9. Equity-Based Incentive Plans (Details - Restricted Stock Units Activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-RestrictedStockUnitsActivity</Role>
      <ShortName>9. Equity-Based Incentive Plans (Details - Restricted Stock Units Activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Equity-basedIncentivePlansTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - 9. Equity-Based Incentive Plans (Details - Share-based Compensation)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlansDetails-Share-basedCompensation</Role>
      <ShortName>9. Equity-Based Incentive Plans (Details - Share-based Compensation)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Equity-basedIncentivePlansTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - 9. Equity-Based Incentive Plans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Equity-basedIncentivePlansDetailsNarrative</Role>
      <ShortName>9. Equity-Based Incentive Plans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Equity-basedIncentivePlansTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - 10. Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>10. Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - 10. Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>10. Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - 11. Retirement Savings Plan and Executive Severance Policy (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicyDetailsNarrative</Role>
      <ShortName>11. Retirement Savings Plan and Executive Severance Policy (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - 12. Supplemental Cash Flow Information (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>12. Supplemental Cash Flow Information (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - 13. Recent Accounting Pronouncements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RecentAccountingPronouncementsDetailsNarrative</Role>
      <ShortName>13. Recent Accounting Pronouncements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/RecentAccountingPronouncements</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - 15. Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>15. Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/RelatedPartyTransactions</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - 16. Series A Redeemable Convertible Preferred Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative</Role>
      <ShortName>16. Series A Redeemable Convertible Preferred Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - 17. Series A Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative</Role>
      <ShortName>17. Series A Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SeriesWarrants</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - 18. Quarterly Financial Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/QuarterlyFinancialDataDetails</Role>
      <ShortName>18. Quarterly Financial Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/QuarterlyFinancialDataTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="actg-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - 18. Restatement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RestatementDetails</Role>
      <ShortName>18. Restatement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>actg-20191231.xml</File>
    <File>actg-20191231.xsd</File>
    <File>actg-20191231_cal.xml</File>
    <File>actg-20191231_def.xml</File>
    <File>actg-20191231_lab.xml</File>
    <File>actg-20191231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868691376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. Supplemental Cash Flow Information (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">Statel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">State taxes paid</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">State taxes paid</a></td>
<td class="nump">$ 249<span></span>
</td>
<td class="nump">$ 1,093<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6880070016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="num">$ (9,230)<span></span>
</td>
<td class="num">$ (19,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">9,899<span></span>
</td>
<td class="num">(59,103)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="nump">669<span></span>
</td>
<td class="num">(78,198)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember', window );">Investments - Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="num">(1,308)<span></span>
</td>
<td class="num">(11,895)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember', window );">Investments - Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="num">(9,230)<span></span>
</td>
<td class="num">(19,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">$ 11,207<span></span>
</td>
<td class="num">$ (47,208)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6866516368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Income Taxes (Details - Provision for Income Taxes) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,858<span></span>
</td>
<td class="num">(1,092)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,824<span></span>
</td>
<td class="num">(1,179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="nump">$ 2,147<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="num">$ (314)<span></span>
</td>
<td class="num">$ (397)<span></span>
</td>
<td class="num">$ (306)<span></span>
</td>
<td class="num">$ (285)<span></span>
</td>
<td class="num">$ (191)<span></span>
</td>
<td class="nump">$ 1,824<span></span>
</td>
<td class="num">$ (1,179)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6866789872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans (Details - Options Granted) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AggregateFairValueAwardsGranted', window );">Aggregate fair value awards granted</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Time Based Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Other than options granted</a></td>
<td class="nump">777,000<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AggregateFairValueAwardsGranted', window );">Aggregate fair value awards granted</a></td>
<td class="nump">$ 2,332<span></span>
</td>
<td class="nump">$ 386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units R S U [Member] | Time Based Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Other than options granted</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AggregateFairValueAwardsGranted', window );">Aggregate fair value awards granted</a></td>
<td class="nump">$ 1,280<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ACTG_AllAwardsMember', window );">All Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AggregateFairValueAwardsGranted', window );">Aggregate fair value awards granted</a></td>
<td class="nump">$ 3,612<span></span>
</td>
<td class="nump">$ 1,974<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AggregateFairValueAwardsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value awards granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AggregateFairValueAwardsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ACTG_TimeBasedServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ACTG_TimeBasedServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_AllAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_AllAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6867130256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans (Details - Share-based Compensation) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="num">$ (317)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member] | Time Based Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units R S U [Member] | Time Based Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units R S U [Member] | Performance Based [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">1,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ACTG_ProfitInterestUnitsMember', window );">Profit Interest Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,450)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ACTG_TimeBasedServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ACTG_TimeBasedServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ACTG_PerformanceBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ACTG_PerformanceBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_ProfitInterestUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_ProfitInterestUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6781290448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. Retirement Savings Plan and Executive Severance Policy (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAdministrationExpenses', window );">Plan expenses</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,458<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAdministrationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of administration expense of defined benefit plan which decreases plan assets. Excludes plan administration expense paid by employer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAdministrationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6880178160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Basic and Diluted Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Acacia Research Corporation</a></td>
<td class="nump">$ 634<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="num">$ (5,757)<span></span>
</td>
<td class="num">$ (4,384)<span></span>
</td>
<td class="num">$ (11,369)<span></span>
</td>
<td class="num">$ (33,195)<span></span>
</td>
<td class="num">$ (28,427)<span></span>
</td>
<td class="num">$ (32,038)<span></span>
</td>
<td class="num">$ (17,115)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPreferredStockDividendsAndAdjustments', window );">Accretion of Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders - basic</a></td>
<td class="nump">$ 327<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="num">$ (5,757)<span></span>
</td>
<td class="num">$ (4,384)<span></span>
</td>
<td class="num">$ (11,369)<span></span>
</td>
<td class="num">$ (33,195)<span></span>
</td>
<td class="num">$ (28,427)<span></span>
</td>
<td class="num">$ (32,038)<span></span>
</td>
<td class="num">$ (17,422)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Basic Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders - basic</a></td>
<td class="nump">49,875,750<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">49,696,016<span></span>
</td>
<td class="nump">49,655,881<span></span>
</td>
<td class="nump">49,639,172<span></span>
</td>
<td class="nump">49,557,748<span></span>
</td>
<td class="nump">50,061,812<span></span>
</td>
<td class="nump">50,632,958<span></span>
</td>
<td class="nump">49,764,002<span></span>
</td>
<td class="nump">49,969,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share of common stock</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (2.10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DilutedNumeratorAbstract', window );"><strong>Diluted Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Acacia Research Corporation</a></td>
<td class="nump">$ 634<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="num">$ (5,757)<span></span>
</td>
<td class="num">$ (4,384)<span></span>
</td>
<td class="num">$ (11,369)<span></span>
</td>
<td class="num">$ (33,195)<span></span>
</td>
<td class="num">$ (28,427)<span></span>
</td>
<td class="num">$ (32,038)<span></span>
</td>
<td class="num">$ (17,115)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet', window );">Mark-to-market adjustment for preferred stock embedded derivative</a></td>
<td class="num">(3,258)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,258)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common stockholders - diluted</a></td>
<td class="num">$ (2,624)<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="num">$ (5,757)<span></span>
</td>
<td class="num">$ (4,384)<span></span>
</td>
<td class="num">$ (11,369)<span></span>
</td>
<td class="num">$ (33,195)<span></span>
</td>
<td class="num">$ (28,427)<span></span>
</td>
<td class="num">$ (32,038)<span></span>
</td>
<td class="num">$ (20,373)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DilutedDenominatorAbstract', window );"><strong>Diluted Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders - basic</a></td>
<td class="nump">49,875,750<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">49,696,016<span></span>
</td>
<td class="nump">49,655,881<span></span>
</td>
<td class="nump">49,639,172<span></span>
</td>
<td class="nump">49,557,748<span></span>
</td>
<td class="nump">50,061,812<span></span>
</td>
<td class="nump">50,632,958<span></span>
</td>
<td class="nump">49,764,002<span></span>
</td>
<td class="nump">49,969,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Effect of potentially dilutive securities: Series A preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,132,771<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted</a></td>
<td class="nump">54,406,835<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">49,696,016<span></span>
</td>
<td class="nump">49,655,881<span></span>
</td>
<td class="nump">49,639,172<span></span>
</td>
<td class="nump">49,557,748<span></span>
</td>
<td class="nump">50,061,812<span></span>
</td>
<td class="nump">50,632,958<span></span>
</td>
<td class="nump">50,896,773<span></span>
</td>
<td class="nump">49,969,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share of common stock</a></td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
<td class="num">$ (2.10)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DilutedDenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted Denominator: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DilutedDenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DilutedNumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted Numerator: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DilutedNumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPreferredStockDividendsAndAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of preferred stock dividends and adjustments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 7<br> -Subparagraph (SAB Topic 5.Q)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187283-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPreferredStockDividendsAndAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6880187680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>2. Fair Value on a Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">$ 17,883<span></span>
</td>
<td class="nump">$ 8,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Trading Securities - Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Trading Securities - Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">17,140<span></span>
</td>
<td class="nump">3,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Investments - Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Investments - Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">5,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">94,600<span></span>
</td>
<td class="nump">35,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Trading Securities - Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">93,843<span></span>
</td>
<td class="nump">33,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Trading Securities - Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Investments - Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">757<span></span>
</td>
<td class="nump">2,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Investments - Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Trading Securities - Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Trading Securities - Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Investments - Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Investments - Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Profit Interest Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">4,159<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Profit Interest Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">3,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">17,974<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Profit Interest Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">$ 17,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_CommonStockInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_CommonStockInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_ProfitInterestUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_ProfitInterestUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6781374240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. Fair Value Disclosures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>14.&#160;&#160;FAIR VALUE DISCLOSURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia holds
the following types of financial instruments at December 31, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Trading securities - debt. </i>Debt securities
includes corporate bonds with fair value that is determined by third party quotations from outside pricing services and/or computerized
pricing models, which may be based on transactions, bids or estimates. Acacia classifies the fair value of corporate bonds within
Level 2 of the valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;&#160;&#160;&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Trading securities - equity. </i>Equity
securities includes investments in public companies common stock and are recorded at fair value based on the quoted market price
of each share on the valuation date. The fair value of these securities are within Level 1 of the valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Investments at fair value - common stock</i>.
Acacia&#8217;s equity investment in Veritone common stock is recorded at fair value based on the quoted market price of Veritone&#8217;s
common stock on the applicable valuation date (Level 1).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Investments at fair value - warrants.
</i>Warrants are recorded at fair value, as based on the Black-Scholes option-pricing model (Level 2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Profits
interests. </i>For the years ended December&#160;31, 2019 and 2018, the fair value of the Units was estimated at 40% of the fair
value of the 10% Warrant, based on the Black-Scholes option-pricing model (Level 2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Series A
Warrants. </i>Series A Warrants are recorded at fair value, using Black-Scholes option-pricing model (Level 2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Embedded derivative liability. </i>Embedded
derivatives that are required to be bifurcated from their host contract are evaluated and valued separately from the host instrument.
A binomial lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible
Preferred Stock issued by the Company in 2019 (Level 3).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6645933840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. Quarterly Financial Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Data (Unaudited)</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>18.&#160;&#160; QUARTERLY FINANCIAL DATA
(unaudited)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December&#160;31, 2019.
This information has been derived from Acacia&#8217;s unaudited condensed consolidated financial statements that have been prepared
on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments,
consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the
audited consolidated financial statements and related notes thereto. Acacia&#8217;s quarterly results have been, and may in the
future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should
not be relied upon as any indication of the results to be expected in any future periods.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="23" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Quarter
    Ended</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Dec. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Sept. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Jun. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Mar. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Dec. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Sept. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Jun. 30,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">Mar. 31,</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 7pt">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td>
    <td colspan="23" style="font-size: 10pt; text-align: center"><font style="font-size: 7pt">(Unaudited, in thousands, except
    share and per share information)</font></td><td style="font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 36%; font-size: 10pt"><font style="font-size: 7pt">Revenues</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">688</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,711</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,460</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,387</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,203</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">13,725</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">6,485</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="width: 6%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">62,093</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Portfolio operations:</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Inventor royalties</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">192</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">776</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,623</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,353</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">11,002</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,181</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,241</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">21,744</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Contingent legal fees</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">35</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">375</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">177</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">11,756</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,949</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,037</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">15,759</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Patent acquisition expenses</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Litigation and licensing expenses - patents</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,160</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">987</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,855</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,801</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,689</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,549</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,639</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,989</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt"><font style="font-size: 7pt">Amortization of patents</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">857</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">863</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">818</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">656</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">11,560</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,952</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,278</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,330</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Other
    portfolio expenses (income)</font> </td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">1,581</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(475</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">650</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">400</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,202</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Total portfolio operations</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,794</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,186</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,671</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">6,637</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">36,407</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">12,833</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">10,195</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,822</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Net portfolio income (loss)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,106</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(475</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(211</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,250</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">12,796</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">892</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,710</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">12,271</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">General and administrative expenses (including
    non-cash stock compensation expense)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,328</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">4,630</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,763</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,655</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,754</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,855</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">6,916</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">3,301</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Impairment of patent-related
    intangible assets</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">28,210</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Operating income (loss)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,434</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,105</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,974</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(6,905</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">10,042</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,963</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(38,836</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">8,970</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Total other income (expense)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">5,921</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(2,503</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(1,774</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,821</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(21,012</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(27,595</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">10,615</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(40,890</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Income (loss) before provision for income taxes</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(1,513</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,748</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,084</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(10,970</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,558</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,221</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(31,920</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Provision for income taxes</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">2,147</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(9</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(314</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(397</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(306</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(285</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(191</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Net income (loss) including noncontrolling interests</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">634</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,398</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,367</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,864</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,506</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,111</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Net (income) loss attributable
    to noncontrolling interests in subsidiaries</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">14</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(2</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(331</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">79</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">73</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Net income (loss) attributable
    to Acacia Research Corporation</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">634</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,384</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,369</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(33,195</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,427</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,038</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Less: Accretion of redeemable
    preferred stock</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(307</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Net income (loss) attributable
    to common shareholders &#8211; basic:</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">327</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,384</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,369</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(33,195</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,427</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,038</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-size: 7pt">Basic income (loss) per share</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">0.01</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.15</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.12</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.09</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.23</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.67</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.57</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.63</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Weighted-average number
    of shares outstanding, basic</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,875,750</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,828,361</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,696,016</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,655,881</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,639,172</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,557,748</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,061,812</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,632,958</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>

<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 28%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">Add: Accretion of redeemable preferred
    stock</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">307</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-size: 7pt">Less: Mark-to-market adjustment
    for preferred stock embedded derivative</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(3,258</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-size: 7pt">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Net
    loss attributable to common shareholders &#8211; diluted:</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(2,624</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(7,608</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(5,757</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(4,384</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(11,369</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(33,195</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(28,427</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(32,038</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><font style="font-size: 7pt">Diluted income (loss) per share</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.05</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.15</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.12</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.09</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.23</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.67</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.57</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">(0.63</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-size: 7pt">Weighted-average number
    of shares outstanding, diluted</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">54,406,835</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,828,361</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,696,016</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,655,881</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,639,172</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">49,557,748</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,061,812</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-size: 7pt">50,632,958</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-size: 7pt">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Restatement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subsequent to the issuance of the interim
reports for the periods ended March, June and September 2019, the Company identified balances that were presented incorrectly relating
to the presentation of cash flows. The Company re-evaluated its determination of the classification of cash flows related to trading
securities and determined the classification of such cash flows within investing activities to be more appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Included below is a summary of the previously
reported amounts, the impact of these adjustments and the as-adjusted amounts for the interim periods ended March, June and September
2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 8pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">Three months ended</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">Three months ended</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">Three months ended</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">March 31, 2019</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">June 30, 2019</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">September 30, 2019</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As reported</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As adjusted</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As reported</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As adjusted</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As reported</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-size: 8pt">As adjusted</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 34%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">Net cash provided by (used in) operating
    activities</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(58,812</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(1,958</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(66,026</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(2,268</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(65,748</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="width: 2%; font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="width: 7%; font-size: 10pt; text-align: right"><font style="font-size: 8pt">(846</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">Net cash provided by (used in) investing activities</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">3,288</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(53,566</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">625</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(63,133</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">3,721</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(61,181</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">Net cash provided by financing activities</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">79</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">Increase/(decrease) in cash and cash equivalent</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(55,524</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(55,524</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(65,322</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(65,322</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(61,948</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td><td style="font-size: 10pt"><font style="font-size: 8pt">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-size: 8pt">(61,948</font></td><td style="font-size: 10pt; text-align: left"><font style="font-size: 8pt">)</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 8pt">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6642319168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. Commitments and Contingencies (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset</a></td>
<td class="nump">$ 1,264<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SettlementLiabilitiesCurrent', window );">Settlement and contingency related accrual</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ExcessOfLeasePaymentsOverSubleaseIncome', window );">Excess of lease payments over sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue', window );">Sublease income</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 1,106<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ExcessOfLeasePaymentsOverSubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of lease payments over sublease income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ExcessOfLeasePaymentsOverSubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue recognized for the period under subleasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 55<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=77891322&amp;loc=d3e41620-112719<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SettlementLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SettlementLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6776645424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. Income Taxes (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital loss carryforward</a></td>
<td class="nump">$ 23,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_CapitalLossCarryforwardsExpirationDate', window );">Capital loss carryforward beginning expiration</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign', window );">Foreign tax credit</a></td>
<td class="nump">$ 51,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ForeignTaxCreditBeginningExpirationDate', window );">Foreign tax credit beginning expiration date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DeferredTaxAssetFromLossOnInvestment', window );">Deferred tax asset from loss on investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit</a></td>
<td class="nump">$ 731<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 253,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">NOL beginning expiration dates</a></td>
<td class="text">Dec. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">Statel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 19,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">NOL beginning expiration dates</a></td>
<td class="text">Dec. 31,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_CapitalLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital loss carryforward beginning expiration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_CapitalLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DeferredTaxAssetFromLossOnInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax asset from loss on investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DeferredTaxAssetFromLossOnInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ForeignTaxCreditBeginningExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign tax credit beginning expiration date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ForeignTaxCreditBeginningExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878383216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans (Details - Restricted Stock Units Activity) - Restricted Stock Units R S U [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NonvestedRestrictedSharesAbstract', window );"><strong>Restricted Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested restricted stock outstanding, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested restricted stock outstanding, ending balance</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Vested restricted stock outstanding</a></td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WeightedAverageGrantDateFairValuePerShareAbstract', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price Outstanding, Ending</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Time Based Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NonvestedRestrictedSharesAbstract', window );"><strong>Restricted Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock granted</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock vested</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Restricted stock cancelled</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WeightedAverageGrantDateFairValuePerShareAbstract', window );"><strong>Weighted Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Restricted stock granted</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested restricted stock outstanding</a></td>
<td class="nump">$ 16.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NonvestedRestrictedSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonvested Restricted Shares [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NonvestedRestrictedSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WeightedAverageGrantDateFairValuePerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Grant Date Fair Value Per Share [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WeightedAverageGrantDateFairValuePerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=ACTG_TimeBasedServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=ACTG_TimeBasedServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6865995536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payment ot acquire patent rights</a></td>
<td class="nump">$ 4,420<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for embedded derivative</a></td>
<td class="text">30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for embedded derivative</a></td>
<td class="text">1.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCommodityFuturePriceMember', window );">Measurement Input Credit Spread [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for embedded derivative</a></td>
<td class="text">25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for embedded derivative</a></td>
<td class="text">0%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm', window );">Patent useful life</a></td>
<td class="text">1 to 5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue Net [Member] | One Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue Net [Member] | One Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of intangible asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_FiniteLivedIntangibleAssetUsefulLifeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCommodityFuturePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCommodityFuturePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868704640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. Changes to fair value measurement Level 3 (Details) - Liability [Member] - Fair Value, Inputs, Level 3 [Member] - Fair Value, Measurements, Recurring [Member] - Embedded Derivative Liability [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Issuance of Series A redeemable convertible preferred stock with embedded derivative</a></td>
<td class="nump">21,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Remeasurement of Series A redeemable convertible preferred stock embedded derivative to fair value</a></td>
<td class="num">(3,258)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">$ 17,974<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6653519216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>13.&#160;&#160;RECENT ACCOUNTING PRONOUNCEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Accounting Pronouncements - Recently Adopted. </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February 2016, FASB issued ASU 2016-02,
<i>Leases</i>, or ASC 842 which requires a lessee to recognize in the statement of financial position a liability to make lease
payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset. In July 2018, FASB
issued ASU 2018-11, Leases, which provides an additional transition option for an entity to apply the provisions of ASC 842 by
recognizing a cumulative effect adjustment at the effective date of adoption without adjusting the prior comparative periods presented.
Further, in January 2019, FASB issued ASU 2019-01, Leases: Codification Improvements, which provides disclosure relief for the
interim periods when adopting ASC 842. The primary impact of adopting ASC 842 for the Company was the recognition in the consolidated
balance sheet of certain lease-related assets and liabilities for operating leases with terms longer than 12 months as of January
1, 2019. Such amounts were not previously accounted for in the Company's consolidated balance sheets. The Company adopted ASC
842 as of January 1, 2019, electing the practical expedient approaches. As a result, we recognized approximately $1.6 million
of right-of-use assets and an increase of $1.7 million in lease-related liabilities as of December 31, 2019. The adoption of ASC
842 did not have a material impact on the Company's consolidated results of operations for the year ending December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Accounting Pronouncements - Not Yet Adopted. </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In December 2019, the FASB issued ASU No.
2019-12 Income Taxes (Topic 740)&#8212;Simplifying the Accounting for Income Taxes, to remove certain exceptions and improve consistency
of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or
rates in the annual effective tax rate computation in the interim period that includes the enactment date. The amendments in this
update will be effective for the Company beginning with fiscal year 2021, with early adoption permitted. Most amendments within
the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or
modified retrospective basis. Management is currently evaluating the impact that the amendments in this update will have on the
Company&#8217;s consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6638506960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>17. Series A Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantDisclosureTextBlock', window );">Series A Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>17.&#160;&#160;SERIES A WARRANTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 18, 2019, in connection with
the issuance of the Series A Redeemable Convertible Preferred Stock, the Company issued a detachable Series A Warrant to acquire
up to purchase 5,000,000 shares of common stock at a price of $3.65 per share (subject to certain anti-dilution adjustments) at
any time during a period of eight years beginning on the instrument&#8217;s issuance date of the Series A Warrants. The fair value
of the Series A Warrants was $4.8 million. The Series A Warrants will be recognized at fair value at each reporting period until
exercised, with changes in fair value recognized in other income (expense) in the accompanying consolidated statements of operations.
As of December 31, 2019, the fair value of the Series A Warrants was $3.6 million. As of December 31, 2019, the Series A Warrants
have not been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series A Warrants are classified as
a liability in accordance with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement
upon a change in control, which is outside the control of the Company.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure for Series A Warrants [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6878413392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (General and Admin Expenses) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 16,376<span></span>
</td>
<td class="nump">$ 18,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="nump">1,075<span></span>
</td>
<td class="num">(317)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">15,301<span></span>
</td>
<td class="nump">19,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ACTG_StockCompensationExpenseGeneralMember', window );">Stock Compensation Expense - General and Admin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="nump">1,075<span></span>
</td>
<td class="nump">2,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ACTG_StockCompensationExpenseProfitsInterestsMember', window );">Stock Compensation Expense - Profits Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,450)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ACTG_StockCompensationExpenseGeneralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ACTG_StockCompensationExpenseGeneralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ACTG_StockCompensationExpenseProfitsInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ACTG_StockCompensationExpenseProfitsInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6876095680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 11, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-37721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ACACIA RESEARCH CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000934549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,385,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">State of Incorporation</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,673,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Well Known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6880119056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss including noncontrolling interests in subsidiaries</a></td>
<td class="num">$ (17,129,000)<span></span>
</td>
<td class="num">$ (104,848,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment, net (Note 6)</a></td>
<td class="num">(9,899,000)<span></span>
</td>
<td class="nump">59,103,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment (Note 6)</a></td>
<td class="nump">9,230,000<span></span>
</td>
<td class="nump">19,095,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of other investment (note 6)</a></td>
<td class="nump">8,195,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherInvestments', window );">Gain on disposal of other investment (Note 6)</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,227,000<span></span>
</td>
<td class="nump">27,145,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative', window );">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</a></td>
<td class="num">(3,258,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of Series A warrant</a></td>
<td class="num">(1,260,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="nump">1,075,000<span></span>
</td>
<td class="num">(317,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss', window );">Change in value of trading securities</a></td>
<td class="num">(2,241,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of patent-related intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,210,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(436,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">32,373,000<span></span>
</td>
<td class="num">(28,189,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(220,000)<span></span>
</td>
<td class="num">(208,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">109,000<span></span>
</td>
<td class="nump">963,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="num">(20,510,000)<span></span>
</td>
<td class="nump">19,359,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(2,308,000)<span></span>
</td>
<td class="nump">20,877,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Patent acquisition costs</a></td>
<td class="num">(4,420,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Sale of investment at fair value (Note 6)</a></td>
<td class="nump">6,628,000<span></span>
</td>
<td class="nump">19,097,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromLongtermInvestments', window );">(Purchase) Sale of other Investments (Note 6)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of trading securities</a></td>
<td class="num">(147,178,000)<span></span>
</td>
<td class="num">(102,769,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Maturities and sales of trading securities</a></td>
<td class="nump">75,090,000<span></span>
</td>
<td class="nump">66,640,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(183,000)<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(68,063,000)<span></span>
</td>
<td class="num">(24,066,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,634,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfOtherEquity', window );">Repurchase of restricted common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(229,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Issuance of redeemable convertible preferred stock and Series A warrants, net of issuance costs</a></td>
<td class="nump">33,842,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">79,000<span></span>
</td>
<td class="nump">257,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">33,921,000<span></span>
</td>
<td class="num">(4,606,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Decrease in cash and cash equivalents and restricted cash</a></td>
<td class="num">(36,450,000)<span></span>
</td>
<td class="num">(7,795,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning</a></td>
<td class="nump">128,809,000<span></span>
</td>
<td class="nump">136,604,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, ending</a></td>
<td class="nump">$ 92,359,000<span></span>
</td>
<td class="nump">$ 128,809,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of Series A redeemable convertible preferred stock embedded derivative</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase/Decrease in Royalties and contingent legal fees payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) included in earnings for investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of long-term investments which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to reacquire equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized holding gain (loss) recognized in the income statement for investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6646506432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Schedule of stock-based awards granted</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Aggregate
    fair value (in thousands)</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Aggregate
    fair value (in thousands)</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 48%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted
    stock awards with time-based service conditions</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">777,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2,332</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">102,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">386</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted stock units
    with market-based service conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">900,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,280</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Stock
    options with time-based service vesting conditions</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">930,000</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,588</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    incentive awards granted</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,677,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,612</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,032,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="12" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Weighted-Average</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Options</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Exercise
    Price</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Remaining
    Contractual Term</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Outstanding at December 31,
    2018</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,509,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.96</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 13%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Granted</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Exercised</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(25,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.12</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Expired/forfeited</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(3,158,000</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">5.04</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Outstanding at
    December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">326,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.38</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">4.4
    years</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Vested</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">281,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.45</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">3.9 years</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Exercisable at December 31, 2019</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">281,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.45</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">3.9 years</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of non-vested restricted stock activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Non-vested<br />
    Restricted<br /> Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Weighted<br />
    Average Grant<br /> Date Fair Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Non-vested restricted
    stock at December 31, 2018</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Granted</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">777,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.00</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Vested</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(214,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.14</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Canceled</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(87,000</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2.81</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Non-vested
    restricted stock at December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">476,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2.98</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of restricted stock activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Non-vested<br />
    Restricted<br /> Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Weighted<br />
    Average Grant<br /> Date Fair Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Non-vested
    <font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400">restricted stock units at December
    31, 2018</font></font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Granted</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">900,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1.42</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Vested</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Canceled</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Non-vested
    <font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400">restricted stock units at December
    31, 2019</font></font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">900,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1.42</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Vested
    <font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400">restricted stock units at December
    31, 2019</font></font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">14,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">16.72</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of share-based compensation expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(in
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted
    stock awards with time-based service conditions</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">907</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">460</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted stock units
    awards with time-based service conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted stock units
    with performance-based vesting conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">140</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Stock options with
    time-based service vesting conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">28</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,672</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Profits interests units</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2,450</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    compensation expense</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,075</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(317</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6635779168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Patents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Gross carrying
    amount - patents</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">330,588</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">326,167</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Accumulated
    amortization - patents<sup>(1)</sup></font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(322,774</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(319,580</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Patents,
    net</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">7,814</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">6,587</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><sup>(1)</sup> <font style="font-size: 8pt">Includes
patent impairment charges for the applicable periods.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6770372624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. Equity-Based Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Equity-Based Incentive Plans</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>9.&#160;&#160;EQUITY-BASED INCENTIVE
PLANS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Stock-Based Incentive Plans</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The 2013 Acacia Research Corporation Stock
Incentive Plan (&#8220;2013 Plan&#8221;) and the 2016 Acacia Research Corporation Stock Incentive Plan (&#8220;2016 Plan&#8221;)
(collectively, the &#8220;Plans&#8221;) were approved by the stockholders of Acacia in May 2013 and June 2016, respectively. All
Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals,
which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of
the Plans are identical in all material respects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&#8217;s compensation committee
administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible
individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or
issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either
an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect
for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding.&#160;The
exercise price of options is generally equal to the fair market value of Acacia&#8217;s common stock on the date of grant.
Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after
grant.&#160;Stock options with time-based vesting generally vest over two to three years and restricted shares with time
based vesting generally vest in full after one to three years (generally representing the requisite service period). The
Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia&#8217;s
stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Plans provide for the following separate
programs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 60px"><font style="font-family: Times New Roman, Times, Serif">&#8226;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif"><i>Discretionary Option Grant Program</i>. Under the discretionary option grant program, Acacia&#8217;s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia&#8217;s voting stock or the voting stock of any of its subsidiaries).</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 60px"><font style="font-family: Times New Roman, Times, Serif">&#8226;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif"><i>Automatic Option Grant Program</i>. Through fiscal year 2016, each non-employee director received restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia&#8217;s common stock on the grant date. In addition, each new non-employee director received restricted stock units or stock options for the number of shares determined by dividing the annual Board of Directors retainer by the grant date fair value of Acacia&#8217;s common stock on the commencement date. These restricted stock units and stock options vested in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the unrestricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director&#8217;s service as a member of the Company&#8217;s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 60px"><font style="font-family: Times New Roman, Times, Serif">&#8226;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif"><i>Stock Issuance Program</i>. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals receiving restricted stock awards (&#8220;RSA&#8221;) shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares. The eligible individuals receiving restricted stock units (&#8220;RSU&#8221;) shall not have full stockholder rights until they vest.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The number of shares of Common Stock initially
reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without
security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013
Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market. In June 2016, 625,390 shares of common stock available for issuance under
the 2013 Plan were transferred into the 2016 Plan. At December&#160;31, 2019, there were 1,024,419 shares available for grant under
the 2013 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The number of shares of Common Stock initially
reserved for issuance under the 2016 Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under
the 2013 Plan, as of the effective date of the Plan. At December&#160;31, 2019, there were 4,067,891 shares available for grant
under the 2016 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon the exercise of stock options, the
granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia&#8217;s policy
to issue new shares of common stock. Acacia&#8217;s Board of Directors may amend or modify the Plans at any time, subject to any
required stockholder approval. As of December&#160;31, 2019, there are 6,875,564 shares of common stock reserved for issuance under
the Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock-based award grant activity for the
periods presented was as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Aggregate
    fair value (in thousands)</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Aggregate
    fair value (in thousands)</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 48%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted
    stock awards with time-based service conditions</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">777,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2,332</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">102,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 9%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">386</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted stock units
    with market-based service conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">900,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,280</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Stock
    options with time-based service vesting conditions</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">930,000</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,588</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    incentive awards granted</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,677,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,612</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,032,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,974</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes stock option
activity for the Plans for the year ended December&#160;31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="12" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Weighted-Average</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Options</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Exercise
    Price</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Remaining
    Contractual Term</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Outstanding at December 31,
    2018</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3,509,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.96</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 13%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 11%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Granted</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Exercised</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(25,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.12</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Expired/forfeited</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(3,158,000</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">5.04</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Outstanding at
    December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">326,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.38</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">4.4
    years</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Vested</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">281,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.45</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">3.9 years</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Exercisable at December 31, 2019</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">281,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">4.45</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">3.9 years</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The aggregate intrinsic
value of options exercised during the years ended December 31, 2019 and 2018 was $4,000 and $51,000, respectively.&#160;The aggregate
intrinsic value of options vested during the year ended December 31, 2019 was $0. No options were granted during the year ended
December 31, 2019. The aggregate fair value of options vested during the years ended December 31, 2019 and 2018 was $294,000 and
$1,918,000, respectively.&#160;&#160;As of December&#160;31, 2019, the total unrecognized compensation expense related to non-vested
stock option awards was $1,074,000, which is expected to be recognized over a weighted-average term of approximately 2 year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
summarizes non-vested restricted share activity for the year ended December&#160;31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Non-vested<br />
    Restricted<br /> Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Weighted<br />
    Average Grant<br /> Date Fair Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Non-vested restricted
    stock at December 31, 2018</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Granted</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">777,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.00</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Vested</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(214,000</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">3.14</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Canceled</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(87,000</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2.81</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Non-vested
    restricted stock at December 31, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">476,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">2.98</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The weighted-average grant date fair value
of non-vested restricted stock granted during the years ended December 31, 2019 and 2018 was $2.98 and $3.79, respectively.
The aggregate fair value of restricted stock that vested during the years ended December 31, 2019 and 2018 was $672,000 and $972,000,
respectively. As of December&#160;31, 2019, unrecognized compensation expense related to non-vested restricted stock awards
was $1,321,000, which is expected to be recognized over a weighted-average term of approximately 2 year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes restricted
stock units activity for the year ended December&#160;31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Non-vested<br />
    Restricted<br /> Shares</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Weighted<br />
    Average Grant<br /> Date Fair Value</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Non-vested
    <font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400">restricted stock units at December
    31, 2018</font></font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Granted</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">900,000</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1.42</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Vested</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Canceled</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Non-vested
    <font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400">restricted stock units at December
    31, 2019</font></font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">900,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1.42</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Vested
    <font style="font-size: 10pt; font-style: normal; font-variant: normal; font-weight: 400">restricted stock units at December
    31, 2019</font></font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">14,000</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">16.72</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The weighted-average grant date fair
value of restricted units granted during the years ended December 31, 2019 was $1.42. There were no restricted units granted
during the year ended December 31, 2018. The aggregate fair value of restricted stock units granted during the year ended
December 31, 2019 was $1,280,000. The aggregate fair value of restricted stock units that vested during the years ended
December 31, 2019 and 2018 was $240,000 and $40,000, respectively. As of December&#160;31, 2019, unrecognized compensation
expense related to non-vested restricted stock units was $1,140,000. Stock compensation expense is recognized in general and
administrative expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Profits Interest Plan </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February&#160;16, 2017, AIP Operation
LLC, a Delaware limited liability company (&#8220;AIP&#8221;), and an indirect subsidiary of Acacia, adopted a Profits Interest
Plan (the&#160;&#8220;Plan&#8221;) that provides for the grant of membership interests in AIP to certain members of management
and the Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit
granted pursuant to the Plan is intended to qualify as a &#8220;profits interest&#8221; for U.S. federal income tax purposes and
will only have value to the extent the fair value of AIP increases beyond the fair value at the issuance date of the membership
interests. The membership interests are represented by units (the &#8220;Units&#8221;) reserved for the issuance of awards
under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share
in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the&#160;&#8220;LLC
Agreement&#8221;). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which
Units may be granted from time to time. Units vest upon AIP&#8217;s achievement of certain performance milestones (one-third upon
150% appreciation, and the remaining two-thirds upon 300% appreciation in value of Acacia&#8217;s aggregate investment in Veritone),
subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest
Agreement and the LLC Agreement. The Units were fully vested in September 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia owns 60% of the membership interests
in AIP and at all times will control AIP. Acacia from time to time may contribute to AIP certain assets or securities related to
portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients. As
of December&#160;31, 2019, AIP holds the Veritone  Warrant described at Note 6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Profits interests totaling 400 Units, or
40% of the membership interests in AIP, were granted in February 2017, with an aggregate grant date fair value of $722,000. The
fair value of the Units totaled $591,000 as of December&#160;31, 2019. Upon full vesting of the units in September 2017, all previously
unrecognized compensation expense was immediately recognized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Compensation expense for the periods presented
was comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">(in
    thousands)</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted
    stock awards with time-based service conditions</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">907</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">460</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted stock units
    awards with time-based service conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Restricted stock units
    with performance-based vesting conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">140</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Stock options with
    time-based service vesting conditions</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">28</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,672</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Profits interests units</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#8211;</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(2,450</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Total
    compensation expense</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">1,075</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(317</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868715440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. Description of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1.&#160; DESCRIPTION OF BUSINESS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Description of Business. </i>As used
herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia
Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its
management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&#8217;s operating subsidiaries invest
in, license and enforce patented technologies. Acacia&#8217;s operating subsidiaries partner with inventors and patent owners,
applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent
years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed
as a leader in the IP industry to pursue these opportunities. In some cases, these opportunities will complement and/or supplement
Acacia&#8217;s primary licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&#8217;s operating subsidiaries generate
revenues and related cash flows from the granting of IP rights for the use of patented technologies that its operating subsidiaries
control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and development of their patent
portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of
their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies
through the filing of patent infringement litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&#8217;s operating subsidiaries are
principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the
patent portfolio outright. Acacia&#8217;s operating subsidiaries own or control the rights to multiple patent portfolios, which
include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Neither Acacia nor its operating subsidiaries
invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and
companies that own IP through its relationships with inventors, universities, research institutions, technology companies and others.
If Acacia&#8217;s operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then
they may not be able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During fiscal year 2019, Acacia obtained
control of five new patent portfolios. During fiscal year 2018, Acacia did not obtain control of any new patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia was incorporated on January 25, 1993
under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868714752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Patents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Patents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5.&#160;&#160;PATENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia&#8217;s only identifiable intangible
assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to five years. For all periods
presented, all of Acacia&#8217;s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated
amortization related to investments in intangible assets as of December 31, 2019 and 2018 are as follows (in thousands):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2019</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><font style="font-family: Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 46%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">Gross carrying
    amount - patents</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">330,588</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">326,167</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">Accumulated
    amortization - patents<sup>(1)</sup></font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(322,774</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">(319,580</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">Patents,
    net</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">7,814</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font-family: Times New Roman, Times, Serif">6,587</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><sup>(1)</sup> <font style="font-size: 8pt">Includes
patent impairment charges for the applicable periods.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The weighted-average remaining estimated
economic useful life of Acacia&#8217;s patents and patent rights is 4 years. Scheduled annual aggregate amortization expense is
estimated to be $2,555,000 in 2020, $1,695,000 in 2021, $1,695,000 in 2022, $1,620,000 in 2023 and $249,000 in 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Acacia did not record charges related to
the impairment of patent-related intangible assets for the year ended December 31, 2019. Acacia recorded impairment of patent-related
intangible asset charges totaling $28,210,000 for the year ended December 31, 2018. The impairment charges related to impairments
of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management
determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios,
due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future
resources would be allocated to other licensing and enforcement programs with higher potential return profiles. The impairment
charges for the periods presented consisted of the excess of the asset&#8217;s carrying value over its estimated fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the year ended December 31, 2018, pursuant
to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights
to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling $8,307,000.
There is no accelerated amortization or sales for patent-related assets for the year ended December 31, 2019.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6879874192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>18. Quarterly Financial Data (Unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 688<span></span>
</td>
<td class="nump">$ 1,711<span></span>
</td>
<td class="nump">$ 5,460<span></span>
</td>
<td class="nump">$ 3,387<span></span>
</td>
<td class="nump">$ 49,203<span></span>
</td>
<td class="nump">$ 13,725<span></span>
</td>
<td class="nump">$ 6,485<span></span>
</td>
<td class="nump">$ 62,093<span></span>
</td>
<td class="nump">$ 11,246<span></span>
</td>
<td class="nump">$ 131,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Portfolio operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Inventor royalties</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">776<span></span>
</td>
<td class="nump">2,623<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
<td class="nump">11,002<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">1,241<span></span>
</td>
<td class="nump">21,744<span></span>
</td>
<td class="nump">4,944<span></span>
</td>
<td class="nump">35,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ContingentLegalFees', window );">Contingent legal fees</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">11,756<span></span>
</td>
<td class="nump">2,949<span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">15,759<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">31,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend', window );">Patent acquisition expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_LitigationAndLicensingExpensesPatents', window );">Litigation and licensing expenses - patents</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
<td class="nump">3,801<span></span>
</td>
<td class="nump">1,689<span></span>
</td>
<td class="nump">1,549<span></span>
</td>
<td class="nump">2,639<span></span>
</td>
<td class="nump">2,989<span></span>
</td>
<td class="nump">7,803<span></span>
</td>
<td class="nump">8,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">857<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="nump">11,560<span></span>
</td>
<td class="nump">4,952<span></span>
</td>
<td class="nump">5,278<span></span>
</td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">3,194<span></span>
</td>
<td class="nump">27,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other portfolio expenses (income)</a></td>
<td class="nump">1,581<span></span>
</td>
<td class="num">(475)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">2,202<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total portfolio expenses</a></td>
<td class="nump">3,794<span></span>
</td>
<td class="nump">2,186<span></span>
</td>
<td class="nump">5,671<span></span>
</td>
<td class="nump">6,637<span></span>
</td>
<td class="nump">36,407<span></span>
</td>
<td class="nump">12,833<span></span>
</td>
<td class="nump">10,195<span></span>
</td>
<td class="nump">49,822<span></span>
</td>
<td class="nump">18,288<span></span>
</td>
<td class="nump">109,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetPortfolioIncomeLoss', window );">Net portfolio income (loss)</a></td>
<td class="num">(3,106)<span></span>
</td>
<td class="num">(475)<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="num">(3,250)<span></span>
</td>
<td class="nump">12,796<span></span>
</td>
<td class="nump">892<span></span>
</td>
<td class="num">(3,710)<span></span>
</td>
<td class="nump">12,271<span></span>
</td>
<td class="num">(7,042)<span></span>
</td>
<td class="nump">22,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">4,328<span></span>
</td>
<td class="nump">4,630<span></span>
</td>
<td class="nump">3,763<span></span>
</td>
<td class="nump">3,655<span></span>
</td>
<td class="nump">2,754<span></span>
</td>
<td class="nump">5,855<span></span>
</td>
<td class="nump">6,916<span></span>
</td>
<td class="nump">3,301<span></span>
</td>
<td class="nump">16,376<span></span>
</td>
<td class="nump">18,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of patent-related intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,210<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(7,434)<span></span>
</td>
<td class="num">(5,105)<span></span>
</td>
<td class="num">(3,974)<span></span>
</td>
<td class="num">(6,905)<span></span>
</td>
<td class="nump">10,042<span></span>
</td>
<td class="num">(4,963)<span></span>
</td>
<td class="num">(38,836)<span></span>
</td>
<td class="nump">8,970<span></span>
</td>
<td class="num">(23,418)<span></span>
</td>
<td class="num">(24,689)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">5,921<span></span>
</td>
<td class="num">(2,503)<span></span>
</td>
<td class="num">(1,774)<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
<td class="num">(21,012)<span></span>
</td>
<td class="num">(27,595)<span></span>
</td>
<td class="nump">10,615<span></span>
</td>
<td class="num">(40,890)<span></span>
</td>
<td class="nump">4,465<span></span>
</td>
<td class="num">(78,980)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before provision for income taxes</a></td>
<td class="num">(1,513)<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="num">(5,748)<span></span>
</td>
<td class="num">(4,084)<span></span>
</td>
<td class="num">(10,970)<span></span>
</td>
<td class="num">(32,558)<span></span>
</td>
<td class="num">(28,221)<span></span>
</td>
<td class="num">(31,920)<span></span>
</td>
<td class="num">(18,953)<span></span>
</td>
<td class="num">(103,669)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">2,147<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="num">(397)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">1,824<span></span>
</td>
<td class="num">(1,179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income (loss) including noncontrolling interests in subsidiaries</a></td>
<td class="nump">634<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="num">(5,757)<span></span>
</td>
<td class="num">(4,398)<span></span>
</td>
<td class="num">(11,367)<span></span>
</td>
<td class="num">(32,864)<span></span>
</td>
<td class="num">(28,506)<span></span>
</td>
<td class="num">(32,111)<span></span>
</td>
<td class="num">(17,129)<span></span>
</td>
<td class="num">(104,848)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests in subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(331)<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Acacia Research Corporation</a></td>
<td class="nump">634<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="num">(5,757)<span></span>
</td>
<td class="num">(4,384)<span></span>
</td>
<td class="num">(11,369)<span></span>
</td>
<td class="num">(33,195)<span></span>
</td>
<td class="num">(28,427)<span></span>
</td>
<td class="num">(32,038)<span></span>
</td>
<td class="num">(17,115)<span></span>
</td>
<td class="num">(105,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Less: Accretion of redeemable preferred stock</a></td>
<td class="num">(307)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(307)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common shareholders &#8211; basic</a></td>
<td class="nump">$ 327<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="num">$ (5,757)<span></span>
</td>
<td class="num">$ (4,384)<span></span>
</td>
<td class="num">$ (11,369)<span></span>
</td>
<td class="num">$ (33,195)<span></span>
</td>
<td class="num">$ (28,427)<span></span>
</td>
<td class="num">$ (32,038)<span></span>
</td>
<td class="num">$ (17,422)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (2.10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - basic</a></td>
<td class="nump">49,875,750<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">49,696,016<span></span>
</td>
<td class="nump">49,655,881<span></span>
</td>
<td class="nump">49,639,172<span></span>
</td>
<td class="nump">49,557,748<span></span>
</td>
<td class="nump">50,061,812<span></span>
</td>
<td class="nump">50,632,958<span></span>
</td>
<td class="nump">49,764,002<span></span>
</td>
<td class="nump">49,969,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Add: Accretion of redeemable preferred stock</a></td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet', window );">Less: Mark-to-market adjustment for preferred stock embedded derivative</a></td>
<td class="num">(3,258)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,258)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common stockholders - diluted</a></td>
<td class="num">$ (2,624)<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="num">$ (5,757)<span></span>
</td>
<td class="num">$ (4,384)<span></span>
</td>
<td class="num">$ (11,369)<span></span>
</td>
<td class="num">$ (33,195)<span></span>
</td>
<td class="num">$ (28,427)<span></span>
</td>
<td class="num">$ (32,038)<span></span>
</td>
<td class="num">$ (20,373)<span></span>
</td>
<td class="num">$ (105,029)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share of common stock</a></td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
<td class="num">$ (2.10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted</a></td>
<td class="nump">54,406,835<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">49,696,016<span></span>
</td>
<td class="nump">49,655,881<span></span>
</td>
<td class="nump">49,639,172<span></span>
</td>
<td class="nump">49,557,748<span></span>
</td>
<td class="nump">50,061,812<span></span>
</td>
<td class="nump">50,632,958<span></span>
</td>
<td class="nump">50,896,773<span></span>
</td>
<td class="nump">49,969,062<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ContingentLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent legal fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ContingentLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_LitigationAndLicensingExpensesPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation and licensing expenses - patents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_LitigationAndLicensingExpensesPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NetPortfolioIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net portfolio income (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NetPortfolioIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion of the preferred stock redemption discount during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockAccretionOfRedemptionDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6643169744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>13. Recent Accounting Pronouncements (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 02, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset</a></td>
<td class="nump">$ 1,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ACTG_AccountingStandardsUpdate201901Member', window );">ASU 2019-01 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ACTG_AccountingStandardsUpdate201901Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=ACTG_AccountingStandardsUpdate201901Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6866246640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. Patents (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 322,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 319,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 322,774<span></span>
</td>
<td class="nump">$ 319,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2020</a></td>
<td class="nump">2,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2021</a></td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2022</a></td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">1,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2024</a></td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 28,210<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accelerated amortization of patents</a></td>
<td class="nump">$ 857<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="nump">$ 818<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
<td class="nump">$ 11,560<span></span>
</td>
<td class="nump">$ 4,952<span></span>
</td>
<td class="nump">$ 5,278<span></span>
</td>
<td class="nump">$ 5,330<span></span>
</td>
<td class="nump">$ 3,194<span></span>
</td>
<td class="nump">27,120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accelerated amortization of patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6868576784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>7. Stockholders' Equity (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 05, 2019</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember', window );">Stock Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Value of shares authorized for repurchase</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
